PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chiu, L; Sampson, HA; Sicherer, SH				Chiu, L; Sampson, HA; Sicherer, SH			Estimation of the sensitization rate to peanut by prick skin test in the general population: Results from the national health and nutrition examination survey 1988-94 (NHANES III)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Mt Sinai Sch Med, Jaffe Food Allergy Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	6	6	1	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		638	S192	S192						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300634
J	Fitch, N; Morton, M; Bowden, A; Shanafelt, MC; Shanafelt, A; Wetzel, G; Moy, J				Fitch, N; Morton, M; Bowden, A; Shanafelt, MC; Shanafelt, A; Wetzel, G; Moy, J			Preclinical evaluation of BAY 16-9966 a dual IL-4/IL-13 receptor antagonist	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Bayer Corp, Biotechnol Res, Berkeley, CA USA	Bayer AG									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		209	S61	S61						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300209
J	Frieri, M; Cardenas, P; Moll, B; Kumar, S; Dominquez, P				Frieri, M; Cardenas, P; Moll, B; Kumar, S; Dominquez, P			Effects of enoxaparin sodium (Lovenox) on the proliferation and secretion of bronchial epithelial cells (BEC) and small airway epithelial cells (SAEC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Nassau Univ, Med Ctr, E Meadow, NY USA										0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		329	S98	S98						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300329
J	Merlos, M; Ferrando, R; Giral, M; Ramis, I; Forn, J				Merlos, M; Ferrando, R; Giral, M; Ramis, I; Forn, J			Effect of topical rupatadine in experimental conjunctivitis in guinea pigs: Macroscopic evaluation of ocular lesions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									J Uriach & Cia, Barcelona, Spain										0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		1016	S310	S310						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172301012
J	O'Connor, B; McSorley, LC; Turbitt, ML				O'Connor, B; McSorley, LC; Turbitt, ML			Use of formoterol (Oxis (R)) Turbuhaler (R) as needed in moderate to severe asthma reduces the number of inhalers used whilst maintaining effectiveness	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract							ONSET		Kings Coll London, Sch Med, London, England; AstraZeneca UK Ltd, Kings Langley, England	University of London; King's College London; AstraZeneca								Palmqvist M, 1997, EUR RESPIR J, V10, P2484, DOI 10.1183/09031936.97.10112489; Seberova E, 2000, RESP MED, V94, P607, DOI 10.1053/rmed.2000.0788	2	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		360	S108	S108						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300359
J	Palosuo, T; Ovod, V; Karkkainen, T; Kalkkinen, N; Kulomaa, M; Reunala, T; Turjanmaa, K; Reinikka-Railo, H				Palosuo, T; Ovod, V; Karkkainen, T; Kalkkinen, N; Kulomaa, M; Reunala, T; Turjanmaa, K; Reinikka-Railo, H			The major latex allergens Hev b 6.02 (hevein) and Hev b 5 are regularly detected in medical gloves with moderate or high allergen content	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Publ Hlth Inst, Helsinki, Finland; Finnish Immunotechnol Ltd, Tampere, Finland; Univ Helsinki, Helsinki, Finland; Univ Jyvaskyla, Jyvaskyla, Finland; Univ Tampere, FIN-33101 Tampere, Finland; Natl Agcy Med, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Jyvaskyla			Kalkkinen, Nisse EJ/B-3923-2010						0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		1047	S321	S321						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172301043
J	Rosenwasser, LJ; Klemm, JD; Klemm, DJ; Drazen, JM; Burchard, EG; Leung, DYM				Rosenwasser, LJ; Klemm, JD; Klemm, DJ; Drazen, JM; Burchard, EG; Leung, DYM			Association of asthmatic steroid insensitivity with an IL-4 gene promoter polymorphism	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Jewish Med & Res Ctr, Denver, CO USA; Brigham & Womens Hosp, Boston, MA 02115 USA	National Jewish Health; Harvard University; Brigham & Women's Hospital									0	6	9	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		771	S235	S235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300767
J	Shin, SH; Kita, H				Shin, SH; Kita, H			Abnormal immunologic responses to fungal antigens in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic									0	6	6	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		536	S163	S163						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300534
J	Sienra-Monge, JJL; Del Rio, BE; Alvarez, ME; Magana, AJ				Sienra-Monge, JJL; Del Rio, BE; Alvarez, ME; Magana, AJ			Comparison of quality of life and pulmonary function on moderate asthmatic children treated with beclomethasone and beclomethasone plus salmeterol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Hosp Infantil Mexico, Mexico City, DF, Mexico										0	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		860	S263	S263						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300856
J	Mio, M; Kirino, Y; Kamei, C				Mio, M; Kirino, Y; Kamei, C			Desensitization of beta(2)-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta(2)-agonists in guinea pig eosinophils	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophil; beta(2)-adrenoceptor; cyclic adenosine monophosphate; protein kinase A; desensitization; eosinophil peroxidase; phosphodiesterase	PROTEIN-COUPLED RECEPTORS; BETA-ADRENOCEPTOR; AGONISTS; KINASES; CELLS; INTERNALIZATION; POLYMORPHISMS; ASSOCIATION; RELEASE; BINDING	Background: Although the existence of functional beta (2)-adrenoceptor on eosinophils has been reported, the effects of desensitization of beta (2)-adrenoceptors on eosinophils have not been well documented. Objective: The effects of desensitization of beta (2)-adrenoceptors on the degranulation of guinea pig eosinophils were investigated. Methods: Guinea pig eosinophils mere stimulated with the calcium ionophore A23187, and eosinophil peroxidase (EPO) release was determined. Changes in intracellular cyclic adenosine monophosphate (cAMP) levels were also measured. Results: A23187-induced EPO release from guinea pig eosinophils was inhibited in a concentration-dependent manner by pretreatment for 5 minutes with fenoterol, clenbuterol, and salbutamol, Such effects of beta (2)-agonists were abolished by pretreatment with KT5720, an inhibitor of protein kinase A. Desensitization of the inhibitory effects of beta (2)-agonists was observed when the incubation time was prolonged. Fenoterol (10(-6) mol/L) induced almost complete desensitization after 120 minutes of incubation, whereas clenbuterol did not bring about significant desensitization. The inhibitory effects of fenoterol and clenbuterol on A23187-induced EPO release mere correlated with increases in the intracellular cAMP levels evoked by either compound. After incubation of eosinophils with 10(-6) mol/L fenoterol for 120 minutes to induce complete desensitization of beta (2)-adrenoceptors, the inhibitory effects of theophylline and rolipram were increased by about 100-fold in the desensitized cells, although the effects of forskolin and dibutyryl cAMP mere not affected by beta (2)-adrenoceptor desensitization. Conclusions: Prolonged incubation with beta (2)-agonists induced desensitization of beta (2)-adrenoceptors. Also, we postulated that hypersensitization of phosphodiesterase to its inhibitors occurs in beta (2)-adrenoceptor-desensitized guinea pig eosinophils.	Okayama Univ, Fac Pharmaceut Sci, Dept Pharmacol, Okayama 7008530, Japan	Okayama University	Kamei, C (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Pharmacol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.							Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Beasley R, 1999, J ALLERGY CLIN IMMUN, V104, pS18, DOI 10.1016/S0091-6749(99)70270-8; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Buscher R, 1999, TRENDS PHARMACOL SCI, V20, P94, DOI 10.1016/S0165-6147(99)01322-X; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; Ezeamuzie CI, 1998, INT ARCH ALLERGY IMM, V115, P162, DOI 10.1159/000023897; Giembycz MA, 1996, TRENDS PHARMACOL SCI, V17, P331, DOI 10.1016/0165-6147(96)10039-0; Giembycz MA, 1999, PHARMACOL REV, V51, P213; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KIRINO Y, IN PRESS JPN J PHARM; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; MUNOZ NM, 1995, J PHARMACOL EXP THER, V273, P850; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; PINCUS SH, 1978, BLOOD, V52, P127; POPPER H, 1989, INFLAMMATION, V13, P147, DOI 10.1007/BF00924786; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; TORPHY TJ, 1995, J BIOL CHEM, V270, P23598, DOI 10.1074/jbc.270.40.23598; YUKAWA T, 1990, AM REV RESPIR DIS, V141, P1446, DOI 10.1164/ajrccm/141.6.1446	24	6	6	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2000	106	5					896	903		10.1067/mai.2000.110099	http://dx.doi.org/10.1067/mai.2000.110099			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	417ZK	11080712	Bronze			2022-12-18	WOS:000167865200014
J	Tsicopoulos, A; Janin, A; Akoum, H; Lamblin, C; Vorng, H; Hamid, Q; Tonnel, AB; Wallaert, B				Tsicopoulos, A; Janin, A; Akoum, H; Lamblin, C; Vorng, H; Hamid, Q; Tonnel, AB; Wallaert, B			Cytokine profile in minor salivary glands from patients with bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						major salivary gland; asthma; cytokines; common mucosal system	COLONY-STIMULATING FACTOR; MESSENGER-RNA EXPRESSION; CELL-ADHESION MOLECULE-1; PHASE CUTANEOUS REACTIONS; HUMAN EOSINOPHILS; MAST-CELLS; T-CELLS; ACTIVATED EOSINOPHILS; ENDOTHELIAL-CELLS; INTRINSIC ASTHMA	Background: T lymphocytes are important components of the bronchial inflammatory cell infiltrate in asthma, Because lymphocytes activated in the respiratory tract recirculate to remote glandular and mucosal sites, we previously studied the histologic features of minor salivary glands (MSGs) in bronchial asthma and found an airway-like inflammation with T-lymphocyte infiltration, the presence of mast cells that were often degranulated, and basement membrane thickening but no eosinophil infiltration. Objective: We sought to investigate the cellular infiltration and cytokine profile in MSGs from untreated asthmatic subjects, steroid-treated asthmatic subjects, and control subjects and to compare these values with those found in bronchial biopsy specimens. Methods: The cellular infiltration was studied by using immunohistochemistry. Cytokine messenger (m)RNA expression for IL-4, IL-5, and IFN-gamma was determined by using in situ hybridization and cytokine immunoreactivity with immunohistochemistry. Results: A significant increase in CD4 and IL-4 mRNA(+) cells was observed in MSGs from asthmatic patients (both untreated and steroid-treated subjects) when compared with control subjects, which correlated with the clinical severity of asthma (FEV1 and Aas score). In contrast to the bronchi, no IL-5 mRNA expression was observed in MSGs, and no difference was observed for MSG IFN-gamma mRNA between the groups. At the level of MSG protein expression, the 3 cytokines were seen, with a significant increase in IL-4 protein expression in steroid-treated asthmatic subjects compared with untreated asthmatic subjects and control subjects, but there were no differences between the groups in IL-5 and IFN-gamma protein expression. Conclusion: The cytokine mRNA expression pattern observed in the MSGs of asthmatic subjects was different from that found in the bronchi, suggesting a different local immune regulation.	Inst Pasteur, U416 INSERM, F-59019 Lille, France; CHRU, Hop Calmette, Serv Anat Pathol C, Lille, France; McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille; McGill University	Tsicopoulos, A (corresponding author), Inst Pasteur, U416 INSERM, BP245, F-59019 Lille, France.		Tsicopoulos, Anne/C-2260-2019	Tsicopoulos, Anne/0000-0002-1579-2763				AAS K, 1981, ALLERGY, V36, P3, DOI 10.1111/j.1398-9995.1981.tb01818.x; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; AZZAWI M, 1992, AM REV RESPIR DIS, V145, P1477, DOI 10.1164/ajrccm/145.6.1477; Barata LT, 1998, J ALLERGY CLIN IMMUN, V101, P222, DOI 10.1016/S0091-6749(98)70387-2; BENTLEY AM, 1992, AM REV RESPIR DIS, V146, P500, DOI 10.1164/ajrccm/146.2.500; BOHJANEN PR, 1990, P NATL ACAD SCI USA, V87, P5283, DOI 10.1073/pnas.87.14.5283; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; BRISCOE DM, 1992, J IMMUNOL, V149, P2954; CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; CRONIN DC, 1995, J IMMUNOL, V154, P3118; DELNESTE Y, 1995, CLIN EXP IMMUNOL, V101, P164; Druilhe A, 1998, AM J RESP CELL MOL, V19, P747, DOI 10.1165/ajrcmb.19.5.3166; DURHAM SR, 1992, J IMMUNOL, V148, P2390; GEHA RS, 1992, J ALLERGY CLIN IMMUN, V90, P143, DOI 10.1016/0091-6749(92)90064-9; GOSSET P, 1995, INT ARCH ALLERGY IMM, V106, P69, DOI 10.1159/000236892; HAMID Q, 1987, P NATL ACAD SCI USA, V84, P6760, DOI 10.1073/pnas.84.19.6760; Hisada T, 1999, AM J RESP CELL MOL, V20, P992, DOI 10.1165/ajrcmb.20.5.3473; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; JEFFERY PK, 1992, RESPIRATION, V59, P13; JUNG T, 1995, EUR J IMMUNOL, V25, P2413, DOI 10.1002/eji.1830250843; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; Kon OM, 1998, LANCET, V352, P1109, DOI 10.1016/S0140-6736(97)12261-9; KRAAL G, 1983, J IMMUNOL, V130, P1097; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; MOQBEL R, 1995, J IMMUNOL, V155, P4939; NAIR PNR, 1986, IMMUNOLOGY, V57, P171; NAKAJIMA H, 1994, J EXP MED, V179, P1145, DOI 10.1084/jem.179.4.1145; NONAKA M, 1995, J IMMUNOL, V155, P3234; OKAYAMA Y, 1995, J IMMUNOL, V155, P1796; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; ROBINSON DS, 1993, THORAX, V48, P26, DOI 10.1136/thx.48.1.26; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; SCHROEDER JT, 1994, J IMMUNOL, V153, P1808; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Sun Y, 1997, J IMMUNOL, V158, P512; SUN Y, 1995, AM J RESP CELL MOL B, V12, P477; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; TSICOPOULOS A, 1994, J ALLERGY CLIN IMMUN, V94, P764, DOI 10.1016/0091-6749(94)90185-6; TSICOPOULOS A, 1992, J IMMUNOL, V148, P2058; VERCELLI D, 1990, J IMMUNOL, V144, P570; VITALI C, 1994, ANN RHEUM DIS, V53, P637, DOI 10.1136/ard.53.10.637; WALLAERT B, 1994, AM J RESP CRIT CARE, V150, P802, DOI 10.1164/ajrccm.150.3.8087355; WALLAERT B, 1995, J EXP MED, V182, P1897, DOI 10.1084/jem.182.6.1897; WALSH GM, 1991, J IMMUNOL, V146, P3419; WALSH GM, 1990, IMMUNOLOGY, V71, P258; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845	53	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					687	696		10.1067/mai.2000.109826	http://dx.doi.org/10.1067/mai.2000.109826			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031339				2022-12-18	WOS:000089980600012
J	Richards, DH				Richards, DH			Preservation of nasal sprays	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PERENNIAL ALLERGIC RHINITIS; MUCOSA IN-VIVO; BENZALKONIUM CHLORIDE; PLACEBO		Glaxo Wellcome Res & Dev Ltd, Intranasals, Clin Dev, Uxbridge UB11 1BT, Middx, England	GlaxoSmithKline	Richards, DH (corresponding author), Glaxo Wellcome Res & Dev Ltd, Intranasals, Clin Dev, Stocklet Pk W, Uxbridge UB11 1BT, Middx, England.							Berg OH, 1997, ALLERGY, V52, P627, DOI 10.1111/j.1398-9995.1997.tb01041.x; Bernstein IL, 2000, J ALLERGY CLIN IMMUN, V105, P39, DOI 10.1016/S0091-6749(00)90175-1; BRAAT JPM, 1995, CLIN EXP ALLERGY, V25, P957, DOI 10.1111/j.1365-2222.1995.tb00398.x; Hallen H, 1997, CLIN EXP ALLERGY, V27, P552, DOI 10.1046/j.1365-2222.1997.d01-529.x; Holm AF, 1998, CLIN OTOLARYNGOL, V23, P69; Klossek JM, 2000, J ALLERGY CLIN IMMUN, V105, pS201, DOI 10.1016/S0091-6749(00)91032-7; Laliberte F, 2000, J ALLERGY CLIN IMMUN, V105, pS382, DOI 10.1016/S0091-6749(00)91543-4; McMahon C, 1997, CLIN OTOLARYNGOL, V22, P318, DOI 10.1046/j.1365-2273.1997.00042.x	8	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2000	106	3					595	595		10.1067/mai.2000.109175	http://dx.doi.org/10.1067/mai.2000.109175			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	356YN	10984385	Bronze			2022-12-18	WOS:000089471900028
J	Tamaoki, J; Nakata, J; Nishimura, K; Kondo, M; Aoshiba, K; Kawatani, K; Nagai, A				Tamaoki, J; Nakata, J; Nishimura, K; Kondo, M; Aoshiba, K; Kawatani, K; Nagai, A			Effect of inhaled indomethacin in asthmatic patients taking high doses of inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						indomethacin; corticosteroid; airway inflammation; nitric oxide; asthma	ACETYLSALICYLATE L-ASA; LYSINE ACETYLSALICYLATE; NITRIC-OXIDE; EXHALED AIR	Background: Cyclooxygenase products of arachidonic acid may play a part in bronchoconstriction and airway inflammation in asthma. Objective: We sought to determine the effect of inhaled indomethacin on asthma control and asthma exacerbations during reduction of inhaled corticosteroids in patients with moderate-to-severe steroid-dependent asthma. Methods: We conducted a double-blind, randomized, parallel-group, multicenter study in 38 patients with asthma taking high doses (greater than or equal to 1500 mu g/d) of beclomethasone dipropionate (BDP). After a run- in period, patients were assigned inhaled indomethacin (50 mg/d) or placebo for 6 weeks, during which the daily doses of BDP were reduced to half at week 2 and then to one third of the baseline dose at week 4. Results: Data were available from 34 patients. After the reduction of BDP doses, FEV1, peak expiratory flow, asthma symptoms, and exhaled nitric oxide concentrations deteriorated in both treatment groups, but these effects were less pronounced in the indomethacin group compared with the placebo group. During the 6-week treatment period, 89% of the patients receiving placebo had relapse of asthma, whereas only 38% of those receiving inhaled indomethacin did so (P = .003). Conclusion: Inhalation of indomethacin can reduce asthma exacerbations induced by reduction of high-dose inhaled corticosteroid in steroid-dependent asthma.	Tokyo Womens Med Univ, Sch Med, Dept Med 1, Shinjuku Ku, Tokyo 1628666, Japan; Airi Hosp, Dept Med, Tokyo, Japan; Kurihashi Saiseikai Hosp, Dept Respirol, Tokyo, Japan; Ayase Minshu Hosp, Dept Resp Med, Tokyo, Japan; Hamacho Ctr Clin, Tokyo, Japan	Tokyo Women's Medical University	Tamaoki, J (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Med 1, Shinjuku Ku, 8-1 Kawada-cho, Tokyo 1628666, Japan.							CRIMI N, 1995, EUR RESPIR J, V8, P905; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; Kharitonov SA, 1997, THORAX, V52, P540, DOI 10.1136/thx.52.6.540; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P454, DOI 10.1164/ajrccm.153.1.8542158; KORDANSKY D, 1978, ANN INTERN MED, V88, P508, DOI 10.7326/0003-4819-88-4-508; LEE TH, 1992, AM REV RESPIR DIS, V145, P34; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Polosa R, 1997, EUR RESPIR J, V10, P866; Sestini P, 1997, J ALLERGY CLIN IMMUN, V100, P71, DOI 10.1016/S0091-6749(97)70197-0; SHIMIZU T, 1995, AM J RESP CRIT CARE, V152, P625, DOI 10.1164/ajrccm.152.2.7633717; Tamaoki J, 1997, AM J RESP CRIT CARE, V155, P1235, DOI 10.1164/ajrccm.155.4.9105060; WEBER C, 1995, CIRCULATION, V91, P1914, DOI 10.1161/01.CIR.91.7.1914; Wenzel SE, 1997, PHARMACOTHERAPY, V17, pS3	14	6	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2000	105	6	1				1134	1139		10.1067/mai.2000.106212	http://dx.doi.org/10.1067/mai.2000.106212			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	327EX	10856147				2022-12-18	WOS:000087781800014
J	Akdis, M; Trautmann, A; Blaser, K; Akdis, CA				Akdis, M; Trautmann, A; Blaser, K; Akdis, CA			Life span of skin homing T cells in atopic dermatitis: Survival in skin, activation induced apoptosis in peripheral blood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland	Swiss Institute of Allergy & Asthma Research			Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X					0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		508	S167	S167		10.1016/S0091-6749(00)90937-0	http://dx.doi.org/10.1016/S0091-6749(00)90937-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100505
J	Anthes, JC; Richard, C; West, RE; Williams, S; Greenfeder, S; Gilchrest, H; Egan, RW; Billah, M				Anthes, JC; Richard, C; West, RE; Williams, S; Greenfeder, S; Gilchrest, H; Egan, RW; Billah, M			Functional characterization of desloratadine and other antihistamines in a Chinese hamster ovary (CHO) cell line that expresses the cloned human histamine H-1 receptor and in human bronchial smooth muscle cells (HBSMC)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Res Inst, Kenilworth, NJ USA	Merck & Company; Schering-Plough Research Institute									0	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1125	S385	S385		10.1016/S0091-6749(00)91551-3	http://dx.doi.org/10.1016/S0091-6749(00)91551-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530101119
J	Baroody, FM; deTineo, M; Haney, L; Clark, K; Blair, C; Naclerio, RM				Baroody, FM; deTineo, M; Haney, L; Clark, K; Blair, C; Naclerio, RM			Influx of eosinophils into the maxillary sinus after nasal challenge with allergen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Chicago, Chicago, IL 60637 USA	University of Chicago									0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		217	S70	S71		10.1016/S0091-6749(00)90647-X	http://dx.doi.org/10.1016/S0091-6749(00)90647-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100215
J	Michele, TM; Lu, S; Malice, MP; Malmstrom, K; LaForce, C; Wolfe, J; Meltzer, EO; Reiss, TF				Michele, TM; Lu, S; Malice, MP; Malmstrom, K; LaForce, C; Wolfe, J; Meltzer, EO; Reiss, TF			Combination of montelukast and loratadine in seasonal allergic rhinitis: An analysis of three spring studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Merck Res Labs, Rahway, NJ USA	Merck & Company									0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1131	S387	S387		10.1016/S0091-6749(00)91557-4	http://dx.doi.org/10.1016/S0091-6749(00)91557-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530101125
J	Petersen, H; Kullberg, A; Edsbacker, S; Greiff, L				Petersen, H; Kullberg, A; Edsbacker, S; Greiff, L			Fatty acid ester formation appears to increase and prolong the retention of budesonide in human nasal mucosa in vivo as compared with fluticasone propionate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Lund Hosp, Dept Clin Pharmacol, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Otorhinolaryngol Head & Neck Surg, S-22185 Lund, Sweden; AstraZeneca R&D, Expt Med, Lund, Sweden; Reykjavik Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland	Lund University; Skane University Hospital; Lund University; Skane University Hospital; AstraZeneca; Landspitali National University Hospital									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		605	S202	S202		10.1016/S0091-6749(00)91033-9	http://dx.doi.org/10.1016/S0091-6749(00)91033-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100601
J	Sehmi, R; Howie, K; Rerecich, T; Watson, RM; Foley, R; O'Byrne, PM; Denburg, JA				Sehmi, R; Howie, K; Rerecich, T; Watson, RM; Foley, R; O'Byrne, PM; Denburg, JA			Increased numbers of eosinophil progenitor cells (CD34(+)IL5R alpha(+)) in the bone marrow of atopic asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McMaster Univ, Dept Med, Asthma Res Grp, Hamilton, ON, Canada	McMaster University									0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		521	S172	S172		10.1016/S0091-6749(00)90949-7	http://dx.doi.org/10.1016/S0091-6749(00)90949-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100517
J	Wagenmann, M; Gartner-Akerboom, M; Helmig, P				Wagenmann, M; Gartner-Akerboom, M; Helmig, P			Increased production of type-2 and type-1 cytokines in nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Dusseldorf, D-4000 Dusseldorf, Germany	Heinrich Heine University Dusseldorf			Wagenman, Martin/B-2524-2012	Wagenman, Martin/0000-0002-9734-0241					0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		622	S210	S210		10.1016/S0091-6749(00)91050-9	http://dx.doi.org/10.1016/S0091-6749(00)91050-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR		Bronze			2022-12-18	WOS:000085530100618
J	Brehler, R; Luger, TA				Brehler, R; Luger, TA			Atopy: Immunodeviation and environment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							HOUSE-DUST MITE; IGE RESPONSES; CPG OLIGODEOXYNUCLEOTIDES; CUTTING EDGE; DERMATITIS; ASTHMA; SENSITIZATION; TH1; TOLERANCE; INDUCTION		Univ Munster, Dept Dermatol, D-48149 Munster, Germany; Univ Munster, Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, D-48149 Munster, Germany	University of Munster; University of Munster	Luger, TA (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.							Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; BJORKSTEN B, 1994, ALLERGY, V49, P400, DOI 10.1111/j.1398-9995.1994.tb00831.x; BJORKSTEN F, 1980, CLIN ALLERGY, V10, P585, DOI 10.1111/j.1365-2222.1980.tb02140.x; Bottomly K, 1999, SCIENCE, V283, P1124, DOI 10.1126/science.283.5405.1124; Cookson WOCM, 1997, SCIENCE, V275, P41, DOI 10.1126/science.275.5296.41; Erb KJ, 1999, IMMUNOL TODAY, V20, P317, DOI 10.1016/S0167-5699(99)01475-9; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; HATTEVIG G, 1984, CLIN ALLERGY, V14, P551, DOI 10.1111/j.1365-2222.1984.tb02243.x; Heinrich J, 1998, ALLERGY, V53, P89, DOI 10.1111/j.1398-9995.1998.tb03779.x; HOLT PG, 1990, PEDIATR ALLERGY IMMU, V1, P3; Johnston SL, 1998, ALLERGY, V53, P922, DOI 10.1111/j.1398-9995.1998.tb03792.x; Kline JN, 1998, J IMMUNOL, V160, P2555; Marone G, 1998, IMMUNOL TODAY, V19, P5, DOI 10.1016/S0167-5699(97)01187-0; MCMENAMIN C, 1991, INT ARCH ALLER A IMM, V94, P78, DOI 10.1159/000235331; McRae BL, 1998, J IMMUNOL, V160, P4298; NINAN TK, 1992, BRIT MED J, V304, P873, DOI 10.1136/bmj.304.6831.873; Nishioka K, 1998, J ALLERGY CLIN IMMUN, V101, P28, DOI 10.1016/S0091-6749(98)70189-7; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Rook GAW, 1998, IMMUNOL TODAY, V19, P113, DOI 10.1016/S0167-5699(97)01204-8; SAGER N, 1992, J ALLERGY CLIN IMMUN, V89, P801, DOI 10.1016/0091-6749(92)90434-4; SEDGWICK JD, 1984, EUR J IMMUNOL, V14, P893, DOI 10.1002/eji.1830141006; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Tan BB, 1996, LANCET, V347, P15, DOI 10.1016/S0140-6736(96)91556-1; TANAKA Y, 1990, Journal of Dermatological Science, V1, P361, DOI 10.1016/0923-1811(90)90593-3; THOMPSON SJ, 1988, IMMUNOLOGY, V64, P311; Tupker RA, 1996, J ALLERGY CLIN IMMUN, V97, P1064, DOI 10.1016/S0091-6749(96)70259-2; Zimmermann S, 1998, J IMMUNOL, V160, P3627	28	6	7	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					1128	1130		10.1016/S0091-6749(99)70003-5	http://dx.doi.org/10.1016/S0091-6749(99)70003-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10588991				2022-12-18	WOS:000084289200002
J	Lipworth, BJ; Jackson, CM				Lipworth, BJ; Jackson, CM			Effects of oral and inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							TRIAMCINOLONE ACETONIDE; SYSTEMIC BIOACTIVITY; BUDESONIDE; FLUTICASONE		Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.		jackson, cathy/H-4869-2013; Goharimoghadam, Keivan/AAO-5358-2021					ALTMAN LC, 1992, CHEST, V101, P1250, DOI 10.1378/chest.101.5.1250; Andersson O, 1999, J ALLERGY CLIN IMMUN, V103, P595, DOI 10.1016/S0091-6749(99)70230-7; Boorsma M, 1996, EUR RESPIR J, V9, P1427, DOI 10.1183/09031936.96.09071427; BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243; Clark DJ, 1997, THORAX, V52, P55, DOI 10.1136/thx.52.1.55; DERENDORF H, 1995, J CLIN PHARMACOL, V35, P302, DOI 10.1002/j.1552-4604.1995.tb04064.x; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Lipworth BJ, 1997, THORAX, V52, P476, DOI 10.1136/thx.52.5.476; Lipworth BJ, 1998, SEMIN RESP CRIT CARE, V19, P625, DOI 10.1055/s-2007-1009437; Wilson AM, 1998, J CLIN ENDOCR METAB, V83, P922, DOI 10.1210/jc.83.3.922; Wilson AM, 1998, J ALLERGY CLIN IMMUN, V102, P751, DOI 10.1016/S0091-6749(98)70014-4	11	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1999	104	3	1				713	713		10.1016/S0091-6749(99)70352-0	http://dx.doi.org/10.1016/S0091-6749(99)70352-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241EP	10482856				2022-12-18	WOS:000082870000045
J	Engelhart, ST; Wilmes-Link, M; Gilges, S; Exner, M; Kramer, MH				Engelhart, ST; Wilmes-Link, M; Gilges, S; Exner, M; Kramer, MH			Exposure of submarine personnel to house dust mite allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INTERNATIONAL WORKSHOP; ASTHMA		Univ Bonn, Inst Hyg, D-53105 Bonn, Germany	University of Bonn	Engelhart, ST (corresponding author), Univ Bonn, Inst Hyg, Sigmund Freud Str 25, D-53105 Bonn, Germany.							BURR RG, 1987, UNDERSEA BIOMED RES, V14, P535; LAU S, 1989, J ALLERGY CLIN IMMUN, V84, P718, DOI 10.1016/0091-6749(89)90300-X; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Tovey ER, 1995, J ALLERGY CLIN IMMUN, V96, P999, DOI 10.1016/S0091-6749(95)70239-3	5	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1999	104	1					242	243		10.1016/S0091-6749(99)70144-2	http://dx.doi.org/10.1016/S0091-6749(99)70144-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	221QZ	10400870				2022-12-18	WOS:000081738900040
J	Sakamoto, A; Oishi, Y; Kurasawa, K; Kita, Y; Saito, Y; Iwamoto, I				Sakamoto, A; Oishi, Y; Kurasawa, K; Kita, Y; Saito, Y; Iwamoto, I			Characteristics of T-cell receptor V alpha 24J alpha QT cells, a human counterpart of murine NK1(+) T cells, from normal subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology 1997	JUL   12, 1997	TOKYO, JAPAN	Novartis Pharma K K Tokyo		V alpha 24J alpha Q T cells; double-negative TCR alpha beta T cells; CD4(+) T cells; NKR-P1A; IL-4	ANTIGEN RECEPTOR; SELECTIVE REDUCTION; SYSTEMIC-SCLEROSIS; ALPHA-CHAIN; BONE-MARROW; TCR-ALPHA; LPR MICE; THYMOCYTES; EXPRESSION; POPULATION	Background: In mice, natural killer (NK)T cells are specialized subsets of T cells that express an invariate T cell receptor (TCR) a chain and NK markers. In particular, murine NK1(+/-) T cells rapidly produce IL-4 and function as regulatory T cells. Objective: We investigated the distribution of invariate TCR V alpha 24J alpha Q T cells in CD4(-)CD8(-) double-negative (DN) and CD4(+) T cell populations of healthy individuals, We also studied the NK phenotypes and IL-4 production of Va24JaQ T cells. Methods: The frequency of V alpha 24(+/-) DN or CD4+ T cells was determined by three-color FAGS analysis, and subsequently the frequency of Va24JaQ rearrangement among V alpha 24(+/-) DN or CD4(+) T cells was determined by sequencing. Results: While the majority of DN V alpha 24(+) T cells (68% to 88%) possessed TCR V alpha 24J alpha Q, few of CD4(+) V alpha 24(+) T cells (0.4% to 4%) did, indicating that V alpha 24J alpha Q T cells are a major population of DN T cells, but not of CD4(+) T cells, in healthy subjects. The DN Va24JaQ T cells expressed a natural killer surface receptor NKR-P1A and CD56, but not CD16, on the cell surface. Moreover, DN V alpha 24J alpha Q T cells promptly expressed IL-4 mRNA by stimulation with anti-V alpha 24 monoclonal antibody in vitro. Conclusion: From these phenotypic and functional similarities of human DN V alpha 24J alpha Q T cells with murine NK1(+) V alpha 14J alpha 281 T cells, we conclude that DN Va24JaQ T cells are a counterpart of murine NK1+ T cells, suggesting that they may play a regulatory role in autoimmune responses in vivo.	Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 260, Japan	Chiba University	Iwamoto, I (corresponding author), Chiba Univ, Sch Med, Dept Internal Med 2, 1-8-1 Inohana, Chiba 260, Japan.							BALLAS ZK, 1990, J IMMUNOL, V145, P1039; BUDD RC, 1987, J EXP MED, V166, P577, DOI 10.1084/jem.166.2.577; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; KUBOTA H, 1992, J IMMUNOL, V149, P1143; LANIER LL, 1994, J IMMUNOL, V153, P2417; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; Makino Y, 1994, Int Rev Immunol, V11, P31, DOI 10.3109/08830189409061715; Mieza MA, 1996, J IMMUNOL, V156, P4035; MOZES E, 1993, SCIENCE, V261, P91, DOI 10.1126/science.8316860; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Porcelli S, 1996, HUM IMMUNOL, V48, P63, DOI 10.1016/0198-8859(96)00090-0; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; ROBEY EA, 1992, INT IMMUNOL, V4, P969, DOI 10.1093/intimm/4.9.969; SAKAMOTO A, 1992, ARTHRITIS RHEUM, V35, P944, DOI 10.1002/art.1780350815; SEKI S, 1991, J IMMUNOL, V147, P1214; SEMAN M, 1990, EUR J IMMUNOL, V20, P1265, DOI 10.1002/eji.1830200611; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; VONBOEHMER H, 1991, J EXP MED, V174, P1001, DOI 10.1084/jem.174.5.1001; WILSON A, 1988, J IMMUNOL, V140, P1470; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845	29	6	6	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	2	S			S445	S451		10.1016/S0091-6749(99)70160-0	http://dx.doi.org/10.1016/S0091-6749(99)70160-0			7	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199TV	10329847				2022-12-18	WOS:000080500200006
J	Yoshida, S; Onuma, K; Akahori, K; Sakamoto, H; Yamawaki, Y; Shoji, T; Nakagawa, H; Hasegawa, H; Amayasu, H				Yoshida, S; Onuma, K; Akahori, K; Sakamoto, H; Yamawaki, Y; Shoji, T; Nakagawa, H; Hasegawa, H; Amayasu, H			Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									AOKI Int Med Ctr, Dept Med, Yokohama, Kanagawa 224, Japan; Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 47011, Japan; Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; Kanto Rosai Hosp, Dept Pharm, Yokohama, Kanagawa, Japan	Fujita Health University; Tohoku University	Yoshida, S (corresponding author), AOKI Int Med Ctr, Dept Med, 6-56 Kuzugaya Tsuzuki, Yokohama, Kanagawa 224, Japan.							BOOKBINDER SA, 1984, CLIN EXP RHEUMATOL, V2, P185; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321; SEARLES G, 1987, J RHEUMATOL, V14, P1164; STRIETER RM, 1992, AM J PATHOL, V141, P397; WHITE DA, 1989, AM REV RESPIR DIS, V139, P18, DOI 10.1164/ajrccm/139.1.18	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				952	954		10.1016/S0091-6749(99)70445-8	http://dx.doi.org/10.1016/S0091-6749(99)70445-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329835				2022-12-18	WOS:000080470200036
J	Larsen, GL				Larsen, GL			Focusing on childhood asthma: The Childhood Asthma Management Program (CAMP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							AIRWAY INFLAMMATION; EPIDEMIOLOGY; BUDESONIDE; GROWTH; LIFE; AGE								NHLBI NIH HHS [P01 HL-36577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P809; BUSSE W, 1995, AM J RESP CRIT CARE, V151, P1635, DOI 10.1164/ajrccm.151.5.7735626; Busse WW, 1997, AM J RESP CRIT CARE, V156, P314, DOI 10.1164/ajrccm.156.1.9612121; CRONER S, 1992, ALLERGY, V47, P150, DOI 10.1111/j.1398-9995.1992.tb00956.x; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Haahtela T, 1997, CLIN EXP ALLERGY, V27, P351; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; Landau LI, 1996, PEDIATR PULM, V22, P314, DOI 10.1002/(SICI)1099-0496(199611)22:5<314::AID-PPUL4>3.3.CO;2-Y; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lanz MJ, 1997, PEDIATR PULM, V24, P305; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; *NAT ASTHM ED PREV, 1997, NIH PUBL; Persson CGA, 1997, LANCET, V350, P1021, DOI 10.1016/S0140-6736(96)02335-5; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; Szefler SJ, 1998, J ALLERGY CLIN IMMUN, V102, P719, DOI 10.1016/S0091-6749(98)70009-0; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Woolcock AJ, 1998, THORAX, V53, P442, DOI 10.1136/thx.53.6.442; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	24	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1999	103	3	1				371	373		10.1016/S0091-6749(99)70458-6	http://dx.doi.org/10.1016/S0091-6749(99)70458-6			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	176WU	10069867				2022-12-18	WOS:000079175700002
J	Bensch, GW; Borish, L				Bensch, GW; Borish, L			Leukotriene receptor antagonists in the treatment of chronic idiopathic urticaria.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Natl Jewish Med & Res Ctr, Denver, CO USA	National Jewish Health									0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		590	S154	S155						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000594
J	Brezin, AL; Brezin, JH; Raible, DG; Schwartz, LB; Schulman, ES				Brezin, AL; Brezin, JH; Raible, DG; Schwartz, LB; Schulman, ES			Elevated stem cell factor and alpha-protryptase levels in uremia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; MCP, Hahnemann Sch Med, Philadelphia, PA USA	Virginia Commonwealth University; Drexel University									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		899	S233	S233						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000901
J	Chapman, MD; Ichikawa, K; Vailes, LD				Chapman, MD; Ichikawa, K; Vailes, LD			Molecular cloning of a new cat allergen, cystatin, a cysteine protease inhibitor.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Virginia, Charlottesville, VA USA	University of Virginia									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		466	S122	S122						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000471
J	Edelman, JM; Milewski, KA; Turpin, JA; Santanello, NC; Bird, SR; Rader, CA				Edelman, JM; Milewski, KA; Turpin, JA; Santanello, NC; Bird, SR; Rader, CA			Effectiveness and safety of montelukast, a leukotriene receptor antagonist, compared to inhaled cromolyn in moderate asthmatic children ages 6 to 11.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Merck & Co Inc, Horsham, PA USA	Merck & Company									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		510	S134	S134						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000515
J	Kay, AB; Meng, Q; Barkans, J; MacFarlane, A; Gilmour, J; Lee, TH; Robinson, DS; Ying, S				Kay, AB; Meng, Q; Barkans, J; MacFarlane, A; Gilmour, J; Lee, TH; Robinson, DS; Ying, S			Leukotrienes (LT) C-4, D-4, E-4 and histamine induce eotaxin expression by human endothelial cell line and human umbilical vein endothelial cells (HUVEC).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Guys Hosp, London SE1 9RT, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust				Lee, Tak/0000-0002-7554-4059					0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		778	S203	S203						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000780
J	Kay, GG				Kay, GG			Self-reported sedation doesn't predict impaired CNS functioning after dose of sedating antihistamine.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Schering Plough Corp, Kenilworth, NJ 07033 USA; Univ Miami, Miami, FL 33152 USA	Merck & Company; Schering Plough Corporation; University of Miami									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		975	S254	S254						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000977
J	Lumry, W; Windom, H; Mendelson, L; Pedinoff, A; Prillaman, B; Baitinger, L; Woodring, A; House, K; Shah, T				Lumry, W; Windom, H; Mendelson, L; Pedinoff, A; Prillaman, B; Baitinger, L; Woodring, A; House, K; Shah, T			The salmeterol/fluticasone propionate (50/250mcg) dry powder combination Diskus (R) has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Allergy & Asthma Res Assoc, Dallas, TX USA; Asthma & Allergy Res Ctr, Sarasota, FL USA; CT Asthma & Allergy Ctr, W Hartford, CT USA; Princeton Allergy & Asthma Res, Princeton, NJ USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		501	S132	S132						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000506
J	Shearer, WT				Shearer, WT			Monitoring cellular immune function in HIV infection by the delayed hypersensitivity skin test: Alternative to the CD4(+) T-cell count?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY; VIRUS		Baylor Coll Med, Dept Pediat, Sect Allergy Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Shearer, WT (corresponding author), Baylor Coll Med, Dept Pediat, Sect Allergy Immunol, 1 Baylor Plaza, Houston, TX 77030 USA.			Shearer, William/0000-0002-2483-2130				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BUCKLEY RH, 1992, JAMA-J AM MED ASSOC, V268, P2797, DOI 10.1001/jama.268.20.2797; *CDC, 1991, MMWR-MORBID MORTAL W, V40, P27; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; HELMS S, 1956, ACTA TUBERC SCAND, V35, P166; HOPEWELL PC, 1997, MED MANAGEMENT AIDS, P311; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; Klein RS, 1999, J ALLERGY CLIN IMMUN, V103, P93, DOI 10.1016/S0091-6749(99)70531-2; KLIMAS N, 1997, MANUAL CLIN LAB IMMU, P276; Lafeuillade A, 1997, J INFECT DIS, V176, P1378, DOI 10.1086/517326; LANE HC, 1997, IMPROVING MANAGEMENT, V5, P4; Maas JJ, 1998, J INFECT DIS, V178, P1024, DOI 10.1086/515655; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MOFENSON LM, 1995, ARCH INTERN MED, V155, P1066, DOI 10.1001/archinte.155.10.1066; Noroski LM, 1998, CLIN IMMUNOL IMMUNOP, V86, P237, DOI 10.1006/clin.1997.4469; PACHECO SE, 1994, PEDIATR CLIN N AM, V41, P623; PAUL ME, 1996, CLIN IMMUNOLOGY PRIN, P609; PETER G, 1997, 1997 RED BOOK REPORT, P541; Sell S, 1996, CLIN IMMUNOLOGY PRIN, P449; Shearer WT, 1996, ANN ALLERG ASTHMA IM, V76, P282, DOI 10.1016/S1081-1206(10)63442-4; SMITH DL, 1992, MANUAL CLIN LABORATO, P202	23	6	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	1				26	28		10.1016/S0091-6749(99)70520-8	http://dx.doi.org/10.1016/S0091-6749(99)70520-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	158JM	9893180				2022-12-18	WOS:000078112300004
J	Tsay, BS; Williams, L; Chandler, J; Chapman, MD				Tsay, BS; Williams, L; Chandler, J; Chapman, MD			Rapid test for mite allergen detection in the home.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	2	S		905	S235	S235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	165FC					2022-12-18	WOS:000078509000907
J	Jenne, JW				Jenne, JW			The debate on S-enantiomers of beta-agonists: Tempest in a teapot or gathering storm?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							PULMONARY PARASYMPATHETIC NERVES; AIRWAY SMOOTH-MUSCLE; GUINEA-PIGS; REDUCED PROTECTION; ASTHMA; RESPONSIVENESS; SALBUTAMOL; SALMETEROL; METHACHOLINE; ALBUTEROL				Jenne, JW (corresponding author), 54 PAA-KO Dr, Sandia Pk, NM 87047 USA.							AHRENS RC, 1991, ANN ALLERGY, V67, P296; AHRENS RC, 1987, J ALLERGY CLIN IMMUN, V79, P876, DOI 10.1016/0091-6749(87)90235-1; AYALA LE, 1989, CHEST, V96, P1285, DOI 10.1378/chest.96.6.1285; BAI TR, 1990, AM REV RESPIR DIS, V141, P552, DOI 10.1164/ajrccm/141.3.552; Belvisi MG, 1996, BRIT J PHARMACOL, V117, P1413, DOI 10.1111/j.1476-5381.1996.tb15300.x; Bhagat R, 1996, J ALLERGY CLIN IMMUN, V97, P47, DOI 10.1016/S0091-6749(96)70282-8; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; COCKCROFT DW, 1995, AM J RESP CRIT CARE, V152, P1485, DOI 10.1164/ajrccm.152.5.7582281; Cockcroft DW, 1997, THORAX, V52, P845, DOI 10.1136/thx.52.10.845; CONOLLY ME, 1971, BRIT J PHARMACOL, V43, P389; Eaton EA, 1996, BRIT J CLIN PHARMACO, V41, P201, DOI 10.1111/j.1365-2125.1996.tb00183.x; ELLULMICALLEF R, 1975, LANCET, V2, P1269; *FOOD DRUG ADM, 1996, P FDA JOINT ADV COMM; FRYER AD, 1991, BRIT J PHARMACOL, V102, P267, DOI 10.1111/j.1476-5381.1991.tb12164.x; FRYER AD, 1991, J APPL PHYSIOL, V71, P2255, DOI 10.1152/jappl.1991.71.6.2255; Handley DA, 1998, CHIRALITY, V10, P262, DOI 10.1002/(SICI)1520-636X(1998)10:3<262::AID-CHIR9>3.0.CO;2-B; Hoiting BH, 1996, BRIT J PHARMACOL, V117, P419, DOI 10.1111/j.1476-5381.1996.tb15207.x; Ind PW, 1997, THORAX, V52, P839, DOI 10.1136/thx.52.10.839; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; MAZZONI L, 1994, PULM PHARMACOL, V7, P367, DOI 10.1006/pulp.1994.1043; MINETTE PA, 1988, J APPL PHYSIOL, V64, P2532, DOI 10.1152/jappl.1988.64.6.2532; MINETTE PAH, 1989, J APPL PHYSIOL, V67, P2461, DOI 10.1152/jappl.1989.67.6.2461; Mitra S, 1998, MOL PHARMACOL, V53, P347, DOI 10.1124/mol.53.3.347; Morley J, 1996, CLIN REV ALLERG IMMU, V14, P65, DOI 10.1007/BF02772204; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; Penn RB, 1996, CLIN REV ALLERG IMMU, V14, P37, DOI 10.1007/BF02772201; RAMAGE L, 1994, RESP MED, V88, P363, DOI 10.1016/0954-6111(94)90042-6; RHODEN KJ, 1988, J APPL PHYSIOL, V65, P700, DOI 10.1152/jappl.1988.65.2.700; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SIMONS FER, 1992, J ALLERGY CLIN IMMUN, V90, P840, DOI 10.1016/0091-6749(92)90110-N; STEPHAN WC, 1980, J ALLERGY CLIN IMMUN, V65, P105, DOI 10.1016/0091-6749(80)90193-1; Stoschitzky K, 1997, TRENDS PHARMACOL SCI, V18, P306, DOI 10.1016/S0165-6147(97)90649-0; TAKUWA Y, 1988, J BIOL CHEM, V263, P762; Tan KS, 1997, AM J RESP CRIT CARE, V156, P28, DOI 10.1164/ajrccm.156.1.9610113; UDEM BJ, 1988, J PHARMACOL EXP THER, V246, P47; Verberne AAPH, 1996, J ALLERGY CLIN IMMUN, V97, P938, DOI 10.1016/S0091-6749(96)80068-6; WANG ZL, 1994, AM J RESP CRIT CARE, V149, P960, DOI 10.1164/ajrccm.149.4.8143062; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3; WHICKER S D, 1990, Pulmonary Pharmacology, V3, P129, DOI 10.1016/0952-0600(90)90043-I; WILLSKARP M, 1993, J APPL PHYSIOL, V74, P2729, DOI 10.1152/jappl.1993.74.6.2729; Yates DH, 1996, AM J RESP CRIT CARE, V154, P1603, DOI 10.1164/ajrccm.154.6.8970342; Zhang XY, 1998, AM J PHYSIOL-LUNG C, V274, pL32, DOI 10.1152/ajplung.1998.274.1.L32	42	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1998	102	6	1				893	895		10.1016/S0091-6749(98)70324-0	http://dx.doi.org/10.1016/S0091-6749(98)70324-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	150XE	9847427				2022-12-18	WOS:000077690700003
J	Szefler, SJ				Szefler, SJ			Early intervention for childhood asthma: Inhaled glucocorticoids as the "preferred" medication	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							MILD ASTHMA; BECLOMETHASONE DIPROPIONATE; AIRWAY INFLAMMATION; FLUTICASONE PROPIONATE; BASEMENT-MEMBRANE; TERM TREATMENT; CHILDREN; CORTICOSTEROIDS; BUDESONIDE; PLACEBO											AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; Allen DB, 1998, J PEDIATR-US, V132, P472, DOI 10.1016/S0022-3476(98)70023-X; [Anonymous], PUBL NIH; Blais L, 1998, AM J RESP CRIT CARE, V158, P126, DOI 10.1164/ajrccm.158.1.9707107; BOOTH H, 1995, AM J RESP CRIT CARE, V152, P45, DOI 10.1164/ajrccm.152.1.7599861; BOSCHETTO P, 1991, AM REV RESPIR DIS, V143, P605, DOI 10.1164/ajrccm/143.3.605; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; DOULL IJM, 1995, AM J RESP CRIT CARE, V151, P1715, DOI 10.1164/ajrccm.151.6.7767512; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee T, 1996, AM J RESP CRIT CARE, V154, pS1, DOI 10.1164/ajrccm/154.2_Pt_2.S1; LUNDGREN JD, 1990, AM REV RESPIR DIS, V141, pS52; *NIH NAT HEART LUN, 1995, PUBL NIH; Olivieri D, 1997, AM J RESP CRIT CARE, V155, P1864, DOI 10.1164/ajrccm.155.6.9196087; Overbeek SE, 1996, CHEST, V110, P35, DOI 10.1378/chest.110.1.35; PEDERSEN S, 1995, J ALLERGY CLIN IMMUN, V95, P29, DOI 10.1016/S0091-6749(95)70149-4; SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228; Shapiro G, 1998, J ALLERGY CLIN IMMUN, V102, P789, DOI 10.1016/S0091-6749(98)70019-3; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; TINKELMAN DG, 1993, PEDIATRICS, V92, P64; Toogood JH, 1998, J ALLERGY CLIN IMMUN, V102, P705, DOI 10.1016/S0091-6749(98)70007-7; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745; VANDESTOLPE A, 1993, AM J RESP CELL MOL, V8, P340, DOI 10.1165/ajrcmb/8.3.340; Verberne AAPH, 1997, AM J RESP CRIT CARE, V156, P688, DOI 10.1164/ajrccm.156.3.9611067; WANG JH, 1994, J ALLERGY CLIN IMMUN, V94, P1025, DOI 10.1016/0091-6749(94)90121-X	29	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					719	721		10.1016/S0091-6749(98)70009-0	http://dx.doi.org/10.1016/S0091-6749(98)70009-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819286				2022-12-18	WOS:000077033400003
J	Vieira, FDM; Ferreira, EN; Cruz, AA				Vieira, FDM; Ferreira, EN; Cruz, AA			Grass allergy increases the risk of tree pollen sensitization: A warning to urban planners	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Univ Caxias Do Sul, Dept Ciencias Biomed, Sch Med, BR-95070560 Caxias Do Sul, RS, Brazil; Univ Fed Bahia, Fac Med, Div Pulm Med, BR-41170290 Salvador, BA, Brazil; Hosp Univ Prof Edgar Santos, Serv Imunol, Salvador, BA, Brazil	Universidade de Caxias do Sul; Universidade Federal da Bahia	Vieira, FDM (corresponding author), Univ Caxias Do Sul, Dept Ciencias Biomed, Sch Med, Rua Francisco Getulio Vargas 1130, BR-95070560 Caxias Do Sul, RS, Brazil.		Cruz, Alvaro A/I-1676-2012	Cruz, Alvaro A/0000-0002-7403-3871				CONNELL JT, 1968, J ALLERGY, V41, P123, DOI 10.1016/0021-8707(68)90053-1; LEWIS WH, 1979, ANN ALLERGY, V42, P309; Vieira FAM, 1989, REV SOC BRAS ALERG I, V12, P114; VILLAVECES JW, 1973, J ASTHMA RES, V11, P47, DOI 10.3109/02770907309100278	4	6	7	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1998	102	4	1				700	701		10.1016/S0091-6749(98)70293-3	http://dx.doi.org/10.1016/S0091-6749(98)70293-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	131XK	9802385				2022-12-18	WOS:000076600400027
J	Szefler, SJ				Szefler, SJ			Leukotriene modifiers: What is their position in asthma therapy?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							5-LIPOXYGENASE INHIBITOR; RECEPTOR ANTAGONIST; PULMONARY-FUNCTION; TERM TREATMENT; TRIAL; ZILEUTON											AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; BARNARD C., 1957, AUSTRALIAN JOUR BOT, V5, P1, DOI 10.1071/BT9570001; DuBuske LM, 1997, AM J MANAG C, V3, P633; FUJIMURA M, 1993, RESP MED, V87, P133, DOI 10.1016/0954-6111(93)90141-L; Hamilton A, 1998, J ALLERGY CLIN IMMUN, V102, P177, DOI 10.1016/S0091-6749(98)70083-1; Holgate ST, 1996, J ALLERGY CLIN IMMUN, V98, P1, DOI 10.1016/S0091-6749(96)70220-8; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Israel E, 1996, JAMA-J AM MED ASSOC, V275, P931, DOI 10.1001/jama.275.12.931; Knorr B, 1998, JAMA-J AM MED ASSOC, V279, P1181, DOI 10.1001/jama.279.15.1181; Liu MC, 1996, J ALLERGY CLIN IMMUN, V98, P859, DOI 10.1016/S0091-6749(96)80002-9; *NAT ASTHM ED PREV, 1997, PUB NATL HEART LUNG; Olivieri D, 1997, AM J RESP CRIT CARE, V155, P1864, DOI 10.1164/ajrccm.155.6.9196087; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; TAKI F, 1994, ARZNEIMITTEL-FORSCH, V44-1, P330; Tamaoki J, 1997, AM J RESP CRIT CARE, V155, P1235, DOI 10.1164/ajrccm.155.4.9105060; TAYLOR IK, 1991, LANCET, V337, P690, DOI 10.1016/0140-6736(91)90277-V	16	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1998	102	2					170	172		10.1016/S0091-6749(98)70081-8	http://dx.doi.org/10.1016/S0091-6749(98)70081-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	113EH	9723656				2022-12-18	WOS:000075537100003
J	Volcheck, GW; Butterfield, JH; Yunginger, JW; Klee, GG				Volcheck, GW; Butterfield, JH; Yunginger, JW; Klee, GG			Elevated serum levels of calcitonin gene-related peptide in Hymenoptera sting-induced anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Mayo Clin & Mayo Fdn, Div Allergy & Outpatient Infect Dis & Internal Me, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Allerg Dis Res Lab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Volcheck, GW (corresponding author), Mayo Clin & Mayo Fdn, Div Allergy & Outpatient Infect Dis & Internal Me, 200 1st St SW, Rochester, MN 55905 USA.							Brain SD, 1996, GEN PHARMACOL, V27, P607, DOI 10.1016/0306-3623(95)00125-5; BUTTERFIELD JH, 1995, MAYO CLIN PROC, V70, P481, DOI 10.4065/70.5.481; PREIBISZ JJ, 1993, AM J HYPERTENS, V6, P434, DOI 10.1093/ajh/6.5.434; Schuligoi R, 1997, N-S ARCH PHARMACOL, V355, P224, DOI 10.1007/PL00004936; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; STRUTHERS AD, 1986, CLIN SCI, V70, P389, DOI 10.1042/cs0700389	6	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1998	102	1					149	151		10.1016/S0091-6749(98)70068-5	http://dx.doi.org/10.1016/S0091-6749(98)70068-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	102DX	9679861				2022-12-18	WOS:000074909500023
J	Aaronson, DW				Aaronson, DW			Side effects of rhinitis medications	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS				ALLERGIC RHINITIS; FLUTICASONE PROPIONATE; SHORT-TERM; ANTIHISTAMINE; PERFORMANCE		Univ Chicago, Sch Med, Dept Med, Chicago, IL 60657 USA	University of Chicago	Aaronson, DW (corresponding author), Univ Chicago, Sch Med, Dept Med, 3500 N Lake Shore Dr, Chicago, IL 60657 USA.							ADELSBERG BR, 1991, J ALLERGY CLIN IMMUN, V97, P279; BETTS T, 1984, BRIT MED J, V288, P281, DOI 10.1136/bmj.288.6413.281; BRANNAN MD, 1995, CLIN THER, V17, P637, DOI 10.1016/0149-2918(95)80040-9; DOCKHORN R, 1995, J ALLERGY CLIN IMMUN, V95, P194; HOLOPAINEN E, 1982, ACTA OTOLARYNGOLOG S, V386, P270; JUNIPER EF, 1991, CLIN EXP ALLERGY, V21, P77, DOI 10.1111/j.1365-2222.1991.tb00807.x; LORING DW, 1989, ANN ALLERGY, V63, P604; MARSHALL PS, 1993, ANN ALLERGY, V71, P251; MCDOWALL JE, 1995, J ALLERGY CLIN IMMUN, V95, P1294; MELTZER EO, 1990, J OCCUP ENVIRON MED, V32, P327, DOI 10.1097/00043764-199004000-00013; Mostafa BE, 1996, ARCH OTOLARYNGOL, V122, P729; MYGIND N, 1997, BR J CLIN PHARM, V4; NICHOLSON AN, 1982, BRIT J CLIN PHARMACO, V14, P683, DOI 10.1111/j.1365-2125.1982.tb04957.x; OHANLON JF, 1988, CUTIS, V42, P10; OPATOWSKY I, 1995, OPHTHALMOLOGY, V102, P177; ROEHRS TA, 1984, SLEEP, V7, P137, DOI 10.1093/sleep/7.2.137; SEIDEL WF, 1987, ANN ALLERGY 2, V59, P48; VUURMAN EFPM, 1993, ANN ALLERGY, V71, P121; WALSH JK, 1992, ANN ALLERGY, V69, P195; WARREN R, 1981, ALCHOL DRUGS TRAFFIC, V1, P203; WOLTHERS OD, 1993, ACTA PAEDIATR, V82, P635, DOI 10.1111/j.1651-2227.1993.tb12780.x	21	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S379	S382		10.1016/S0091-6749(98)70225-8	http://dx.doi.org/10.1016/S0091-6749(98)70225-8			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500733				2022-12-18	WOS:000072343900009
J	Bleecker, E				Bleecker, E			Inhaled corticosteroids: Current products and their role in patient care	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS				METERED-DOSE INHALER; ASTHMA; BUDESONIDE		Univ Maryland, Sch Med, Div Pulm Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Bleecker, E (corresponding author), Univ Maryland, Sch Med, Div Pulm Med, MSTF 800,10 S Pine St, Baltimore, MD 21201 USA.							DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; DOCKHORN R, 1995, J ALLERGY CLIN IMMUN, V96, P50, DOI 10.1016/S0091-6749(95)70032-3; FAHY JV, 1995, CLIN CHEST MED, V16, P715; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; Kleerup EC, 1996, CHEST, V109, P702, DOI 10.1378/chest.109.3.702; *WHO STUD GROUP GL, 1995, NHLBI PUBL NIH	8	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S400	S402		10.1016/S0091-6749(98)70230-1	http://dx.doi.org/10.1016/S0091-6749(98)70230-1			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500738				2022-12-18	WOS:000072343900014
J	de Longueville, M; Deruyter, B				de Longueville, M; Deruyter, B		ETAC Study Grp	RR, QT and QTc in 799 infants aged 1-2 years.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			816	S198	S198						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800815
J	Furlong, TJ; Sicherer, SH; Munoz-Furlong, A; Burks, AW; Sampson, HA				Furlong, TJ; Sicherer, SH; Munoz-Furlong, A; Burks, AW; Sampson, HA			Establishment of a registry for allergic reactions to peanut (PN).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Mt Sinai Med Ctr, New York, NY 10029 USA; Univ Arkansas, Sch Med, Little Rock, AR 72204 USA; Arkansas & Food Allergy Network, Fairfax, VA USA	Icahn School of Medicine at Mount Sinai; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			433	S104	S104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800433
J	Golden, DBK; Kagey-Sobotka, A; Norman, PS; Lichtenstein, LM				Golden, DBK; Kagey-Sobotka, A; Norman, PS; Lichtenstein, LM			Sting challenge trial I: Spectrum of a population with sting allergy.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			657	S159	S159						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800657
J	Kasti, GL; Codina, R; Ledford, DK; Lockey, RF				Kasti, GL; Codina, R; Ledford, DK; Lockey, RF			Mite contamination of food stuffs.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ S Florida, Tampa, FL 33620 USA; James A Haley Vet Hosp, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital									0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			106	S24	S25						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800107
J	Seymour, ML; Aberg, D; Riise, G; Rak, S; Holgate, ST; Sampson, AP				Seymour, ML; Aberg, D; Riise, G; Rak, S; Holgate, ST; Sampson, AP			Seasonal allergen exposure increases expression of leukotriene pathway enzymes and induces eosinophil influx in bronchial mucosa of atopic asthmatics.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Southampton Gen Hosp, Immunopharmacol Grp, Southampton SO9 4XY, Hants, England; Sahlgrens Univ Hosp, Allergy Ctr, S-41345 Gothenburg, Sweden	University of Southampton; Sahlgrenska University Hospital			Sampson, Anthony/C-1112-2011						0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			711	S172	S173						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800711
J	Upham, JW; Hayes, LM; Sehmi, R; Denburg, JA				Upham, JW; Hayes, LM; Sehmi, R; Denburg, JA			Retinoic acid selectively inhibits IL-5 receptor expression during differentiation of hemopoietic progenitor cells.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									McMaster Univ, Hamilton, ON, Canada	McMaster University			Upham, John/F-4420-2010	Upham, John/0000-0002-0017-3433					0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	2			888	S214	S214						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YW339					2022-12-18	WOS:000071924800886
J	Yoshii, H; Fukata-Yamazaki, Y; Yamamoto, K; Yago, H; Yanagihara, Y; Okudaira, H				Yoshii, H; Fukata-Yamazaki, Y; Yamamoto, K; Yago, H; Yanagihara, Y; Okudaira, H			A complex of histamine/mouse gamma-globulin preferentially inhibits allergen-induced peritoneal accumulation of eosinophils, but not neutrophils, in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						histamine; gamma-globulin; eosinophil accumulation; ragweed pollen; complex of histamine/human gamma-globulin; complex of histamine/mouse gamma-globulin	PLATELET-ACTIVATING FACTOR; COLONY-STIMULATING FACTOR; MESSENGER-RNA EXPRESSION; CD4+ T-CELLS; BRONCHOALVEOLAR LAVAGE; MILD ASTHMA; MAST-CELLS; INTERLEUKIN-5; INFLAMMATION; PROVOCATION	A complex of histamine/human gamma-globulin (HhG) has been widely used in Japan for more than 25 years as a nonspecific hyposensitization drug in the treatment of allergic diseases. It has been reported that HhG decreases the number of eosinophils in the nasal secretions and peripheral blood of patients with allergy. In this study me used a mouse system to explore the possibility that HhG may actively inhibit the accumulation of eosinophils at inflammation sites. A complex of 0.15 mu g of histamine dihydrochloride/12 mg of mouse gamma-globulin (HmG) was incubated for 2 hours in saline solution in the normal fashion for HhG. HmG at 50 to 150 mg/kg/day inhibited the peritoneal accumulation of eosinophils induced by ragweed pollen in BALB/c mice in a dose-dependent fashion when the HmG was administered subcutaneously six times during a 20-day sensitization period. The inhibitory effect of HmG on this eosinophil accumulation was significant at 24 and 48 hours after challenge, but HmG had no effect on neutrophil accumulation. Complexes of serotonin/mouse gamma-globulin (m gamma G), glutamine/m gamma G, and histamine dihydrochloride (His)/mouse albumin had no inhibitory effect when administered in the same way. The optimum combination ratio was between 0.15 mu g of His/12 mg of m gamma G and 0.015 mu g of His/12 mg of m gamma G for this eosinophil inhibition. Moreover, a 1- to 2-hour incubation period of His and m gamma G was needed to induce a plateau inhibition of the eosinophil accumulation. These results in mice suggest that HhG may actively inhibit allergen-induced eosinophil accumulation, which may be therapeutically useful in the treatment of allergic disease.	Nippom Zoki Pharmaceut Co, Inst Bioact Sci, Dept Allergol, Yashir, Hyogo 67314, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Clin Immunol, Oita, Japan; Natl Sagamihara Hosp, Clin Res Ctr Allergy, Kanagawa, Japan; Univ Tokyo, Fac Med, Dept Med & Phys Therapy, Tokyo 113, Japan	Kyushu University; University of Tokyo	Yoshii, H (corresponding author), Nippom Zoki Pharmaceut Co, Inst Bioact Sci, Dept Allergol, Yashir, Hyogo 67314, Japan.		Yamamoto, Kazuhiko/N-5096-2015					ASANO T, 1969, SHONIKASHINRYO, V32, P781; ATKINS PC, 1983, CLIN REV ALLERG, V1, P385; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; BASCOM R, 1988, AM REV RESPIR DIS, V138, P406, DOI 10.1164/ajrccm/138.2.406; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; CAPRON M, 1989, CLIN EXP ALLERGY, V19, P3; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; DURHAM SR, 1992, J IMMUNOL, V148, P2390; FRICK WE, 1988, J ALLERGY CLIN IMMUN, V82, P119, DOI 10.1016/0091-6749(88)90061-9; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GRAZIANO RF, 1989, J IMMUNOL, V142, P230; HEKITANI T, 1969, SINYAKUTORINSHO, V18, P883; HIGUCHI Y, 1968, SHONIKARINSHO, V21, P1661; HISAMATU K, 1979, JIBIINKOKATENBO, V22, P38; ISHIKAWA T, 1979, INT ARCH ALLER A IMM, V59, P403, DOI 10.1159/000232287; ITO A, 1979, JIBIINKOKARINSHO, V72, P1539; ITO K, 1979, RINSHOUTEKENKYUU, V56, P3085; KANEKO M, 1991, INT ARCH ALLER A IMM, V96, P41, DOI 10.1159/000235532; KAY AB, 1992, AM REV RESPIR DIS, V145, pS22, DOI 10.1164/ajrccm/145.2_Pt_2.S22; KITA H, 1992, J IMMUNOL, V149, P629; KUKITA J, 1980, NISHINIPPONHIFUKA, V42, P470; LABORDE C, 1953, PRESSE MED, V61, P1151; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; MENCIAHUERTA JM, 1983, J IMMUNOL, V131, P2958; MORI A, 1994, ENV DERMATOL, V1, P42; NAGY L, 1982, CLIN EXP IMMUNOL, V47, P541; OHNISHI A, 1985, CLIN IMMUNOL, V17, P1145; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; PARROT JL, 1951, J PHYSL, V40, P885; PINCKARD RN, 1988, INFLAMMATION BASIC P, P139; RAIBLE DG, 1994, AM J RESP CRIT CARE, V149, P1506, DOI 10.1164/ajrccm.149.6.8004306; ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; SILBERSTEIN DS, 1987, IMMUNOL TODAY, V8, P380, DOI 10.1016/0167-5699(87)90214-3; TAMURA N, 1987, BIOCHEM BIOPH RES CO, V142, P638, DOI 10.1016/0006-291X(87)91462-8; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WARDLAW AJ, 1986, J CLIN INVEST, V78, P1701, DOI 10.1172/JCI112765; WATANABE K, 1979, ARERUGI, V28, P666	43	6	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	1				809	816		10.1016/S0091-6749(97)70278-1	http://dx.doi.org/10.1016/S0091-6749(97)70278-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YQ151	9438491				2022-12-18	WOS:000071353600015
J	Cremer, R				Cremer, R			The role of shunted hydrocephalus in the development of allergy to latex in patients with spina bifida	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Cremer, R (corresponding author), CHILDRENS HOSP,PEDIAT CLIN,AMSTERDAMER STR 59,D-50735 COLOGNE,GERMANY.							Nieto A, 1996, J ALLERGY CLIN IMMUN, V98, P501, DOI 10.1016/S0091-6749(96)70082-9; Rihs HP, 1997, TISSUE ANTIGENS, V49, P92, DOI 10.1111/j.1399-0039.1997.tb02719.x	2	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1997	100	5					719	719						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YG202	9389308				2022-12-18	WOS:A1997YG20200025
J	Jaakkola, MS; Tammivaara, R; Tuppurainen, M; Lahdenne, L; Tupasela, O; Keskinen, H				Jaakkola, MS; Tammivaara, R; Tuppurainen, M; Lahdenne, L; Tupasela, O; Keskinen, H			Asthma caused by occupational exposure to pectin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ALAND CENT HOSP,MARIEHAMN,FINLAND; MALMINTORI MED CTR,HELSINKI,FINLAND		Jaakkola, MS (corresponding author), FINNISH INST OCCUPAT HLTH,TOPELIUKSENKATU 41 AA,FIN-00250 HELSINKI,FINLAND.			Jaakkola, Maritta S./0000-0003-1373-7784				CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; COHEN AJ, 1993, CHEST, V103, P309, DOI 10.1378/chest.103.1.309; KRAUT A, 1992, CHEST, V102, P1605, DOI 10.1378/chest.102.5.1605; TIIKKAINEN U, 1989, ALLERGY, V44, P419, DOI 10.1111/j.1398-9995.1989.tb04173.x; Westphal W, 1990, Pneumologie, V44 Suppl 1, P337	5	6	7	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1997	100	4					575	576		10.1016/S0091-6749(97)70153-2	http://dx.doi.org/10.1016/S0091-6749(97)70153-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YA529	9338555				2022-12-18	WOS:A1997YA52900024
J	SanchezBorges, M; CaprilesHulett, A				SanchezBorges, M; CaprilesHulett, A			Atopy and NSAID sensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											SanchezBorges, M (corresponding author), CTR MED DOCENTE LA TRINIDAD,ALLERGY CLIN IMMUNOL SERV,CARACAS,VENEZUELA.							Blanco C, 1997, J ALLERGY CLIN IMMUN, V99, P308, DOI 10.1016/S0091-6749(97)70047-2; HOIGNE RV, 1992, NSAIDS PROFILE ADVER, P157; Quiralte J, 1996, J ALLERGY CLIN IMMUN, V98, P678, DOI 10.1016/S0091-6749(96)70102-1; SANCHEZBORGES M, 1992, PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, VOL 2, KYOTO, P333; SANCHEZBORGES M, 1996, IN PRESS CUTIS; SANCHEZBORGES M, 1997, IN PRESS J ALLERGY C	6	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1997	100	1					143	144						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XP428	9257803				2022-12-18	WOS:A1997XP42800026
J	Angelini, B; VanDeusen, MA; Doyle, WJ; Seroky, J; Cohen, S; Skoner, DP				Angelini, B; VanDeusen, MA; Doyle, WJ; Seroky, J; Cohen, S; Skoner, DP			Lower airway responses to rhinovirus-Hanks in healthy subjects with and without allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INFECTION		CHILDRENS HOSP PITTSBURGH,PITTSBURGH,PA 15213; UNIV PITTSBURGH,DEPT PEDIAT,PITTSBURGH,PA; UNIV PITTSBURGH,DEPT OTOLARYNGOL,PITTSBURGH,PA; CARNEGIE MELLON UNIV,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University				Cohen, Sheldon/0000-0003-2248-4600	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050429] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH50429] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; HALPERIN SA, 1983, AM REV RESPIR DIS, V126, P806; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Skoner DP, 1996, AM J RESP CRIT CARE, V154, P661, DOI 10.1164/ajrccm.154.3.8810602; SKONER DP, 1997, IN PRESS EUR RESPIR; SUMMERS QA, 1992, EUR RESPIR J, V5, P313	7	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1997	99	5					618	619		10.1016/S0091-6749(97)70022-8	http://dx.doi.org/10.1016/S0091-6749(97)70022-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WY600	9155827	Bronze			2022-12-18	WOS:A1997WY60000008
J	Xia, HZ; Zweiman, B; Schwartz, LB				Xia, HZ; Zweiman, B; Schwartz, LB			Levels of tryptase, chymase, and Fc epsilon RI alpha messenger RNA in human skin are unchanged after IgE-dependent stimulation of cutaneous mast cells in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,DIV RHEUMATOL ALLERGY & IMMUNOL,RICHMOND,VA 23298; UNIV PENN,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,PHILADELPHIA,PA 19104	Virginia Commonwealth University; University of Pennsylvania					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332, R37AI020487, R01AI020487, R21AI020487] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-14332, AI-20487] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DVORAK AM, 1988, BLOOD, V71, P76; VOWELS BR, 1995, J ALLERGY CLIN IMMUN, V96, P92, DOI 10.1016/S0091-6749(95)70037-4; XIA HZ, 1995, J IMMUNOL, V154, P5472	5	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1997	99	2					224	226		10.1016/S0091-6749(97)70100-3	http://dx.doi.org/10.1016/S0091-6749(97)70100-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH831	9042049	hybrid			2022-12-18	WOS:A1997WH83100012
J	Filipovich, AH; Pelz, C; Sobocinski, K; Ireland, M; Kollman, C; Horowitz, MM				Filipovich, AH; Pelz, C; Sobocinski, K; Ireland, M; Kollman, C; Horowitz, MM			Allogeneic bone marrow transplantation (BMT) for Wiskott Aldrich Syndrome (WAS): Comparison of outcomes by donor type.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									MED COLL WISCONSIN,INT BONE MARROW TRANSPLANT REGISTRY,MILWAUKEE,WI 53226; NATL MARROW DONOR PROGRAM NMDP,MINNEAPOLIS,MN; CHMC,DIV HEMATOL ONCOL,CINCINNATI,OH	Medical College of Wisconsin; National Marrow Donor Program			horowitz, Mary/ABH-2173-2021						0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			415	415						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14200413
J	Lauter, CB; Haver, T; Davidson, A				Lauter, CB; Haver, T; Davidson, A			Pruritus and urticaria due to lamivudine (3TC, Epivir(R)): Allergic evaluation of a patient on combination therapy and successful oral ''rush'' desensitization.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									WILLIAM BEAUMONT HOSP,ROYAL OAK,MI 48072	Beaumont Health									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1757	1757						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201751
J	Lin, FL				Lin, FL			Rifampin-induced deterioration in steroid-dependent asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USN HOSP,NAVAL MED CTR,DEPT INTERNAL MED,DIV ALLERGY,SAN DIEGO,CA 92134	United States Department of Defense; United States Navy; Naval Medical Center San Diego	Lin, FL (corresponding author), USN HOSP,DEPT CLIN INVEST,NAVAL MED CTR,34800 BOB WILSON DR,SAN DIEGO,CA 92134, USA.							HENDRICKSE W, 1979, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.6159.306; POWELLJACKSON PR, 1983, AM REV RESPIR DIS, V128, P307; UDWADIA ZF, 1993, RESP MED, V87, P629, DOI 10.1016/S0954-6111(05)80267-7	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1125	1125		10.1016/S0091-6749(96)80203-X	http://dx.doi.org/10.1016/S0091-6749(96)80203-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977517				2022-12-18	WOS:A1996WB37800021
J	Altraja, A; Laitinen, A; Meriste, S; Marran, S; Martson, T; Sillastu, H; Laitinen, LA				Altraja, A; Laitinen, A; Meriste, S; Marran, S; Martson, T; Sillastu, H; Laitinen, LA			Effect of regular nedocromil sodium or albuterol on bronchial inflammation in chronic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nedocromil sodium; albuterol; antiinflammatory therapy; bronchial biopsy; asthma	NEWLY DIAGNOSED ASTHMA; NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELLS; DOUBLE-BLIND; ACTIVATION; MANAGEMENT; HISTAMINE; MAST	Nedocromil sodium is recommended for daily treatment of mild persistent asthma brit its effect on cellular changes in asthmatic airways is poorly understood. We compared the antiinflammatory effects of nedocromil sodium and albuterol in 32 patients with asthma who received either nedocromil sodium 4 mg of albuterol 0.2 mg four times daily for 12 weeks; according to a double-blind protocol. Patients underwent fiberoptic bronchoscopy, and lung function and bronchial responsiveness to histamine were measured. Numbers of inflammatory cells were studied by immunohistochemistry and image analysis. We were unable to identify any statistical differences between treatment groups for any of the variables measured We conclude that our immunohistochemical study does not support the concept of nedocromil sodium as a potent/antiinflammatory drug.	UNIV HELSINKI,CENT HOSP,DEPT MED,FIN-00290 HELSINKI,FINLAND; TARTU STATE UNIV,DEPT PULM MED,TARTU,ESTONIA; UNIV HELSINKI,INST BIOMED,DEPT ANAT,FIN-00014 HELSINKI,FINLAND	University of Helsinki; Helsinki University Central Hospital; University of Tartu; University of Helsinki								AAS K, 1981, ALLERGY, V36, P4; BISSONNETTE EY, 1995, INT ARCH ALLERGY IMM, V107, P156, DOI 10.1159/000236962; BLEECKER ER, 1991, J ALLERGY CLIN IMMUN, V88, P808; CALHOUN WJ, 1996, J ALLERGY CLIN IMMUN, V98, P46; CHEMIACK RM, 1990, CHEST, V97, P1299; DEJONG JW, 1994, AM J RESP CRIT CARE, V149, P91, DOI 10.1164/ajrccm.149.1.8111606; DEVALIA JL, 1995, INT ARCH ALLERGY IMM, V107, P417, DOI 10.1159/000237061; DEVALIA JL, 1994, AM J RESP CRIT CARE, V149, pA317; FINK JN, 1994, J ALLERGY CLIN IMMUN, V94, P473, DOI 10.1016/0091-6749(94)90203-8; HACKETT RJ, 1988, J IMMUNOL, V140, P2639; HOSNI R, 1994, AM J RESP CRIT CARE, V149, pA941; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LEONARD EJ, 1990, J IMMUNOL, V144, P1323; MANOLITSAS ND, 1995, AM J RESP CRIT CARE, V151, P1925, DOI 10.1164/ajrccm.151.6.7767541; *NIH, 1995, 953659 NIH; OHEHIR RE, 1989, DRUGS, V37, P23, DOI 10.2165/00003495-198900371-00006; RAINEY DK, 1992, CLIN EXP ALLERGY, V22, P976, DOI 10.1111/j.1365-2222.1992.tb03023.x; SILVA JRLE, 1995, EUR RESPIR J, V8, P1321, DOI 10.1183/09031936.95.08081321; SOVIJARVI ARA, 1993, CHEST, V104, P164, DOI 10.1378/chest.104.1.164; VITTORI E, 1992, J ALLERGY CLIN IMMUN, V90, P76, DOI 10.1016/S0091-6749(06)80013-8; WASSERMAN SI, 1995, J ALLERGY CLIN IMMUN, V95, P541, DOI 10.1016/S0091-6749(95)70316-0	22	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S58	S64		10.1016/S0091-6749(96)80130-8	http://dx.doi.org/10.1016/S0091-6749(96)80130-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939178				2022-12-18	WOS:A1996VW14000011
J	Anderson, DF; McGill, JI; Roche, WR				Anderson, DF; McGill, JI; Roche, WR			Improving the safety of conjunctival provocation tests	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHALLENGE; ALLERGY				Anderson, DF (corresponding author), SOUTHAMPTON GEN HOSP,MRC,LEVEL E PATHOL,S BLOCK,TREMONA RD,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND.							ABELSON MB, 1990, ARCH OPHTHALMOL-CHIC, V108, P84, DOI 10.1001/archopht.1990.01070030090035; AICHANE A, 1993, J ALLERGY CLIN IMMUN, V92, P49, DOI 10.1016/0091-6749(93)90036-F; BONINI S, 1990, J ALLERGY CLIN IMMUN, V86, P869, DOI 10.1016/S0091-6749(05)80148-4; CIPRANDI G, 1995, J ALLERGY CLIN IMMUN, V95, P612, DOI 10.1016/S0091-6749(95)70324-1; GARCIAORTEGA P, 1989, CLIN EXP ALLERGY, V19, P529, DOI 10.1111/j.1365-2222.1989.tb02428.x; SALMINEN L, 1990, J OCUL PHARMACOL, V6, P243, DOI 10.1089/jop.1990.6.243	6	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	1				1000	1000		10.1016/S0091-6749(96)80022-4	http://dx.doi.org/10.1016/S0091-6749(96)80022-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VU764	8939168	Bronze			2022-12-18	WOS:A1996VU76400022
J	Bleecker, ER; Mason, PL; Moore, WC				Bleecker, ER; Mason, PL; Moore, WC			Clinical effects of nedocromil sodium on allergen-related mechanisms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergen challenge; nedocromil sodium; ragweed antigen	BRONCHIAL ANTIGEN CHALLENGE; LATE ASTHMATIC RESPONSE; BECLOMETHASONE DIPROPIONATE; INDUCED BRONCHOCONSTRICTION; BUDESONIDE BUD; CROMOLYN DSCG; PLACEBO; RESPONSIVENESS; METHACHOLINE; INHALATION	Many studies have demonstrated the ability of nedocromil sodium to block the acute response to allergen in persons who are sensitive to allergen. One study with subjects sensitive to ragweed showed a significant protective effect after a single 4 mg close of nedocromil sodium, with no further protection achieved at higher doses. Numerous studies have also shown the ability of the drug to reduce or abolish the late asthmatic response in sensitive subjects when it was given before allergen challenge. Nedocromil sodium has also been shown to prevent the subsequent development of bronchial hyperresponsiveness. In addition nedocromil sodium prevented the late asthmatic response when given after allergen challenge and an intact early response. These findings suggest that nedocromil sodium may be preventing the inflammatory events initiated by mast cell mediator and cytokine release.			Bleecker, ER (corresponding author), UNIV MARYLAND,SCH MED,DIV PULM MED,10 S PINE ST,BALTIMORE,MD 21210, USA.							AALBERS R, 1991, J ALLERGY CLIN IMMUN, V87, P993, DOI 10.1016/0091-6749(91)90422-K; AALBERS R, 1992, ANN ALLERGY, V69, P339; BEL EH, 1990, AM REV RESPIR DIS, V141, P21, DOI 10.1164/ajrccm/141.1.21; BLEECKER E R, 1990, American Review of Respiratory Disease, V141, pA656; BLEECKER E R, 1981, American Review of Respiratory Disease, V123, P53; BLEECKER ER, 1982, CHEST, V82, P227; BLEECKER ER, 1991, J ALLERGY CLIN IMMUN, V88, P808; BONIFAZI F, 1987, ALLERGOL IMMUNOPATH, V15, P151; Calhoun WJ, 1996, J ALLERGY CLIN IMMUN, V98, pS46, DOI 10.1016/S0091-6749(96)80128-X; COCCO G, 1986, EUR J RESPIR DIS, V146, pA37; CRIMI E, 1989, J ALLERGY CLIN IMMUN, V83, P985, DOI 10.1016/0091-6749(89)90116-4; CRIMI E, 1993, J ALLERGY CLIN IMMUN, V92, P777, DOI 10.1016/0091-6749(93)90053-I; DAHL R, 1986, EUR J RESPIR DIS, V69, P263; DAHL R, 1987, REV ESP ALLERGOL IMM, V2, P269; HAMM T, 1987, PRAX KLIN PNEUMOL, V41, P651; JOHANSSON SA, 1995, J ALLERGY CLIN IMMUN, V95, P310; JOUBERT JR, 1986, B EUR PHYSIOPATHO S8, V22, P720; KNOTTNERUS I, 1994, J ALLERGY CLIN IMMUN, V93, P198; KOPFERSCHMITTKUBLER MC, 1993, RESPIRATION, V60, P21; LOWHAGEN O, 1989, CLIN EXP ALLERGY, V19, P555, DOI 10.1111/j.1365-2222.1989.tb02433.x; MIRONE C, 1994, CLIN EXP ALLERGY, V24, P281, DOI 10.1111/j.1365-2222.1994.tb00232.x; NAIR N, 1989, ANN ALLERGY, V62, P329; *NIH, 1992, 923091 NIH NATL HEAR; OREFICE U, 1994, AM J RESP CRIT CARE, V149, pA528; OSHAUGHNESSY KM, 1993, AM REV RESPIR DIS, V147, P1431, DOI 10.1164/ajrccm/147.6_Pt_1.1431; PELIKAN Z, 1993, J ALLERGY CLIN IMMUN, V92, P19, DOI 10.1016/0091-6749(93)90032-B; PELIKAN Z, 1991, Journal of Allergy and Clinical Immunology, V87, P249, DOI 10.1016/0091-6749(91)91720-E; PELIKAN Z, 1994, ALLERGY CLIN IMMUN S, V2, P68; ROBUSCHI M, 1986, EUR J RESPIR DIS, V69, P289; SHEFFER AL, 1991, J ALLERGY CLIN IMMUN, V88, P425; SVENDSEN UG, 1986, ALLERGY, V41, P468, DOI 10.1111/j.1398-9995.1986.tb00328.x; TWENTYMAN OP, 1993, AM REV RESPIR DIS, V147, P1425, DOI 10.1164/ajrccm/147.6_Pt_1.1425; VERDIANI P, 1989, EUR RESPIR J S5, V2, pS399; YOUNGCHAIYUD P, 1986, CLIN ALLERGY, V16, P129, DOI 10.1111/j.1365-2222.1986.tb00756.x	34	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1996	98	5	2	S			S118	S123		10.1016/S0091-6749(96)80139-4	http://dx.doi.org/10.1016/S0091-6749(96)80139-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VW140	8939187				2022-12-18	WOS:A1996VW14000027
J	Sampson, HA; Rosen, JP; Selcow, JE; Mendelson, L; Grodofsky, MP; Factor, JM; Bock, SA; Burks, AW; James, JM; Zeiger, R; Yunginger, JW				Sampson, HA; Rosen, JP; Selcow, JE; Mendelson, L; Grodofsky, MP; Factor, JM; Bock, SA; Burks, AW; James, JM; Zeiger, R; Yunginger, JW			Intradermal skin tests in the diagnostic evaluation of food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXTRACTS; RAST		UNIV CONNECTICUT,FARMINGTON,CT; UNIV COLORADO,HLTH SCI CTR,BOULDER,CO 80309; UNIV ARKANSAS,SCH MED,FAYETTEVILLE,AR 72701; UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103; MAYO CLIN,SCH MED,ROCHESTER,MN	University of Connecticut; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California San Diego; Mayo Clinic	Sampson, HA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21218, USA.			Zeiger, Robert/0000-0001-5788-5063				BOCK SA, 1978, CLIN ALLERGY, V8, P559, DOI 10.1111/j.1365-2222.1978.tb01509.x; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; SAMPSON HA, 1984, J ALLERGY CLIN IMMUN, V74, P26, DOI 10.1016/0091-6749(84)90083-6; 1994, J ALLERGY CLIN IMMUN, V93, P1068	4	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					714	714		10.1016/S0091-6749(96)70111-2	http://dx.doi.org/10.1016/S0091-6749(96)70111-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428	8828554	hybrid			2022-12-18	WOS:A1996VJ42800034
J	Wells, JH				Wells, JH			Systemic reactions to immunotherapy: Comparisons between two large allergy practices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											Wells, JH (corresponding author), UNIV OKLAHOMA,OKLAHOMA ALLERGY & ASTHMA CLIN,CTR HLTH SCI,POB 26827,OKLAHOMA CITY,OK 73126, USA.							CRETICOS PS, 1992, IMMUNOL ALLERGY CLIN, V12, P13; TINKELMAN DG, 1995, J ALLERGY CLIN IMMUN, V95, P8, DOI 10.1016/S0091-6749(95)70146-X	2	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					1030	1032		10.1016/S0091-6749(96)80081-9	http://dx.doi.org/10.1016/S0091-6749(96)80081-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655881				2022-12-18	WOS:A1996UG08600021
J	Hawrylowicz, CM; Jarman, ER; Guida, L; OHehir, RE; Lamb, JR				Hawrylowicz, CM; Jarman, ER; Guida, L; OHehir, RE; Lamb, JR			T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-beta(1) production	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BETA		UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT BIOL,INFECT & IMMUN SECT,LONDON,ENGLAND	Imperial College London	Hawrylowicz, CM (corresponding author), ST MARYS HOSP,SCH MED,UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT IMMUNOL,NORFOLK PL,LONDON W2 1PG,ENGLAND.		O'Hehir, Robyn E/H-3627-2011; Hawrylowicz, Catherine/Q-8483-2017	O'Hehir, Robyn E/0000-0002-3489-7595; Hawrylowicz, Catherine/0000-0002-2337-7463	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AYANLARBATUMAN O, 1991, J CLIN INVEST, V88, P1574, DOI 10.1172/JCI115469; JARMAN ER, 1994, J ALLERGY CLIN IMMUN, V94, P844, DOI 10.1016/0091-6749(94)90152-X; KHANNA A, 1994, TRANSPLANTATION, V57, P577; LIKE B, 1986, J BIOL CHEM, V261, P3426; MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401, DOI 10.1002/jlb.55.3.401; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; WEDDERBURN LR, 1993, P NATL ACAD SCI USA, V90, P8214, DOI 10.1073/pnas.90.17.8214	7	6	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1996	97	2					707	709		10.1016/S0091-6749(96)70318-4	http://dx.doi.org/10.1016/S0091-6749(96)70318-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW087	8621858				2022-12-18	WOS:A1996TW08700018
J	Parry, DE; Blumenthal, J; Tomar, RH; Horowitz, SD; Elder, ME; Gern, JE				Parry, DE; Blumenthal, J; Tomar, RH; Horowitz, SD; Elder, ME; Gern, JE			A 3-year-old boy with ZAP-70 deficiency, thrombocytopenia and ulcerative colitis.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				830	830						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600830
J	Pollard, C; Bevin, S; Little, SA; Hourihane, JOB; Warner, JO; Dean, TP				Pollard, C; Bevin, S; Little, SA; Hourihane, JOB; Warner, JO; Dean, TP			Influence of maternal diet during lactation upon allergic manifestation in infants - Tolerisation or sensitisation?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Warner, John/AAF-9587-2020						0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				231	231						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600231
J	Vailes, LD; Rizzo, MC; Naspitz, CK; Montealegre, F; FernandezCaldas, E; PlattsMills, TAE; Chapman, MD; Arruda, LK				Vailes, LD; Rizzo, MC; Naspitz, CK; Montealegre, F; FernandezCaldas, E; PlattsMills, TAE; Chapman, MD; Arruda, LK			Analysis of IgE antibody responses to D-pteronyssinus and Blomia tropicalis using recombinant group 5 allergens.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Rizzo, Maria/HGD-6576-2022; Arruda, L. Karla/D-5845-2013	Arruda, L. Karla/0000-0002-7505-210X					0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				121	121						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600121
J	Cockcroft, DW; Bhagat, R; Kalra, S; Swystun, VA				Cockcroft, DW; Bhagat, R; Kalra, S; Swystun, VA			Inhaled beta(2)-agonists and allergen-induced airway responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											Cockcroft, DW (corresponding author), UNIV SASKATCHEWAN,ROYAL UNIV HOSP,DIV RESP MED,SASKATOON,SK S7N 0W8,CANADA.							BHAGAT R, 1995, J ALLERGY CLIN IMMUN, V95, P387; COCKCROFT DW, 1995, J ALLERGY CLIN IMMUN, V96, P44, DOI 10.1016/S0091-6749(95)70031-5; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; COCKCROFT DW, 1995, IN PRESS AM J RESPIR; Gauvreau GM, 1995, AM J RESP CRIT CARE, V151, pA39; INMAN MD, 1995, IN PRESS CLIN INVEST; MCFADDEN, 1995, J ALLERGY CLIN IMMUN, V95, P641; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704	8	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				1013	1014		10.1016/S0091-6749(95)70245-8	http://dx.doi.org/10.1016/S0091-6749(95)70245-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543737	Bronze			2022-12-18	WOS:A1995TN12400025
J	Watanabe, M; Sakaguchi, M; Inouye, S; Miyazawa, H; Mitsuseki, M; Nitta, H; Ohtsuka, R; Yasueda, H				Watanabe, M; Sakaguchi, M; Inouye, S; Miyazawa, H; Mitsuseki, M; Nitta, H; Ohtsuka, R; Yasueda, H			Removal of mite allergens from blankets: Comparison of dry cleaning and hot water washing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DER-II; HOUSE		NATL INST HLTH,DEPT EPIDEMIOL,SHINJUKU KU,TOKYO 162,JAPAN; UNIV TOKYO,DEPT HUMAN ECOL,TOKYO 113,JAPAN; KYORIN UNIV,DEPT MED TECHNOL,HACHIOJI,TOKYO,JAPAN; HITACHI LIFESTYLE RES CTR,TOKYO,JAPAN; NATL INST ENVIRONM STUDIES,DIV REG ENVIRONM,TSUKUBA,IBARAKI,JAPAN; NATL SAGAMIHARA HOSP,CLIN RES CTR ALLERGY & RHEUMATOL,SAGAMIHARA,KANAGAWA,JAPAN	University of Tokyo; Kyorin University; Hitachi Limited; National Institute for Environmental Studies - Japan			Inouye, Sharon/R-7216-2019					MCDONALD LG, 1992, J ALLERGY CLIN IMMUN, V90, P599, DOI 10.1016/0091-6749(92)90132-L; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; SAKAGUCHI M, 1993, J ALLERGY CLIN IMMUN, V92, P797, DOI 10.1016/0091-6749(93)90056-L; SAKAGUCHI M, 1989, INT ARCH ALLER A IMM, V90, P190, DOI 10.1159/000235022; VANDENHOVE T, 1993, ALLERGY, V48, P264, DOI 10.1111/j.1398-9995.1993.tb00726.x	5	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				1010	1012		10.1016/S0091-6749(95)70244-X	http://dx.doi.org/10.1016/S0091-6749(95)70244-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543736				2022-12-18	WOS:A1995TN12400024
J	SHAIKH, WA				SHAIKH, WA			EPHEDRINE-SALINE NASAL WASH IN ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						EPHEDRINE-SALINE NASAL WASH; PERENNIAL ALLERGIC RHINITIS; PLACEBO		Background: Ephedrine nasal wash (0.25% to 1%) was once used int he treatment of sinusitis and other nasal and paranasal symptoms, but there are no reported controlled trials in allergic rhinitis Methods: In a blinded study, 118 patients with perennial allergic rhinitis were randomly divided into two groups of 65 and 53 patients, respectively, and administered either a placebo or a 1% ephedrine-saline nasal wash once every 48 hours for a period of 4 weeks. These groups were then crossed over after a 4-week interval, and their weekly symptoms scores peak nasal inspiratory flow rates were monitored. Results: Use of ephedrine-saline nasal wash resulted in significant improvement in symptom scores and peak nasal inspiratory flow rates as compare with placebo (p less than or equal to 0.001). A statistically significant difference between the two groups began in the second week. The effects of treatment lasted for more than 2 weeks after the study, without notable side effects, in most patients. Conclusion: A 1% ephedrine-saline nasal wash is an inexpensive and effective treatment for allergic rhinitis.	BOMBAY HOSP INST MED SCI, ALLERGY CLIN, BOMBAY, MAHARASHTRA, INDIA	Bombay Hospital & Medical Research Centre								HOLMSTROM M, 1990, Rhinology (Utrecht), V28, P191; KATZUNG BG, 1992, BASIC CLIN PHARM, P118; PROETZ AW, 1939, DISPLACEMENT METHOD; SHAH KU, 1965, INDIAN J OTOLARYNGOL, V17, P80; SHAIKH WA, 1994, INDIAN J CLIN PRACT, V4, P19; VENGE P, 1994, ALLERGY, V49, P1, DOI 10.1111/j.1398-9995.1994.tb00765.x; YOULTEN LJF, 1983, NASAL AIRWAY PATENCY, P111; 1993, AMA DRUG EVALUATION, P462	8	6	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				597	600		10.1016/S0091-6749(95)70257-1	http://dx.doi.org/10.1016/S0091-6749(95)70257-1			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499675				2022-12-18	WOS:A1995TG52800004
J	SUBIZA, J; SUBIZA, JL; HINOJOSA, M; VARELA, S; CABRERA, M; MARCO, F				SUBIZA, J; SUBIZA, JL; HINOJOSA, M; VARELA, S; CABRERA, M; MARCO, F			OCCUPATIONAL ASTHMA CAUSED BY GRASS JUICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV MADRID,HOSP SAN CARLOS,SERV IMMUNOL,MADRID,SPAIN	Hospital Clinico San Carlos	SUBIZA, J (corresponding author), GEN PARDINAS,CTR ALERGIA & INMUNOL CLIN,GEN PARDINAS 116,E-28006 MADRID,SPAIN.		MARCO, FRANCISCO M/L-8723-2014	MARCO, FRANCISCO M/0000-0001-5113-3637				FERNANDEZCALDAS E, 1992, GRANA, V31, P157, DOI 10.1080/00173139209430735; MORROW BH, 1989, 14TH P C EUR AC AL B, V1366, P23; ROWE MS, 1986, J ALLERGY CLIN IMMUN, V77, P714, DOI 10.1016/0091-6749(86)90416-1; SOLOMON WR, 1988, ALLERGY PRINCIPLES P, V312, P72; SUBIZA J, 1991, J ALLERGY CLIN IMMUN, V88, P731, DOI 10.1016/0091-6749(91)90179-R; SUBIZA JL, 1992, J AUTOIMMUN, V5, P363, DOI 10.1016/0896-8411(92)90149-K	6	6	6	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1995	96	5	1				693	695		10.1016/S0091-6749(95)70270-9	http://dx.doi.org/10.1016/S0091-6749(95)70270-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TG528	7499688	Bronze			2022-12-18	WOS:A1995TG52800017
J	KEMP, SF; LOCKEY, RF				KEMP, SF; LOCKEY, RF			AMPHOTERICIN-B - EMERGENCY CHALLENGE IN A NEUTROPENIC, ASTHMATIC PATIENT WITH FUNGAL SEPSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV S FLORIDA,DEPT INTERNAL MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612	State University System of Florida; University of South Florida	KEMP, SF (corresponding author), UNIV S FLORIDA,JAMES A HALEY VET HOSP,DIV ALLERGY & IMMUNOL,13000 BRUCE B DOWNS BLVD VAR 111D,TAMPA,FL 33612, USA.							BENNETT JE, 1974, NEW ENGL J MED, V290, P30, DOI 10.1056/NEJM197401032900107; CLEMENTS JS, 1990, AM J MED, V88, pN22; GIGLIOTTI F, 1987, J INFECT DIS, V156, P784, DOI 10.1093/infdis/156.5.784; LORBER B, 1976, ANN INTERN MED, V84, P54, DOI 10.7326/0003-4819-84-1-54; MURRAY HW, 1974, NEW ENGL J MED, V290, P693	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1995	96	3					425	427		10.1016/S0091-6749(95)70064-1	http://dx.doi.org/10.1016/S0091-6749(95)70064-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RU660	7560647				2022-12-18	WOS:A1995RU66000017
J	PROEBSTLE, TM; JUGERT, FK; MERK, HF; GALL, H				PROEBSTLE, TM; JUGERT, FK; MERK, HF; GALL, H			SEVERE ANAPHYLACTIC REACTION TO TOPICAL ADMINISTRATION OF FRAMYCETIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV COLOGNE,DEPT DERMATOL,W-5000 COLOGNE,GERMANY	University of Cologne	PROEBSTLE, TM (corresponding author), UNIV ULM,DEPT DERMATOL,D-89081 ULM,GERMANY.							EARL HS, 1987, J ALLERGY CLIN IMMUN, V79, P477, DOI 10.1016/0091-6749(87)90365-4; FRAEKI JE, 1985, ACTA OTOLARYNGOL, V100, P414; HOLMES RC, 1982, J ROY SOC MED, V75, P27; OSULLIVAN TL, 1993, J INFECT DIS, V168, P733; WALLACE MR, 1991, J INFECT DIS, V164, P1180, DOI 10.1093/infdis/164.6.1180	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1995	96	3					429	430		10.1016/S0091-6749(95)70066-8	http://dx.doi.org/10.1016/S0091-6749(95)70066-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RU660	7560649				2022-12-18	WOS:A1995RU66000019
J	FEGER, TA; DOLEN, WK; FORD, JL; PONDER, RD; HOFFMAN, DR; STAFFORD, CT				FEGER, TA; DOLEN, WK; FORD, JL; PONDER, RD; HOFFMAN, DR; STAFFORD, CT			LABORATORY EVALUATION OF A COMMERCIAL IMMUNOASSAY FOR FIRE ANT ALLERGEN-SPECIFIC IGE ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGY DIAGNOSIS; IMPORTED FIRE ANT; SKIN TESTING; IN VITRO TESTING; ROC CURVE	PHARMACIA CAP SYSTEM; WHOLE-BODY EXTRACT; ANAPHYLACTIC REACTIONS; HYMENOPTERA VENOMS; SOLENOPSIS-INVICTA; STING ALLERGY; PHADEBAS RAST; DIAGNOSIS; IMMUNOTHERAPY; ASSAYS	Background: In vitro testing for fire ant sensitization would be useful for research purposes and in special clinical situations. Methods: Laboratory performance of a commercial assay (Pharmacia CAP System, [PCS]), for specific IgE to Solenopsis invicta whole body extract was studied in 46 persons. Assay results were compared with those of venom skin testing, RAST, and ELISA. The manufacturer's global cutoffs were compared with cutoffs set by using methods derived from analytical detection limit theory. Results: Thirty-two study subjects had positive skin test results, and 14 had negative results. Raw PCS data demonstrated a high level of correlation with RAST (rho = 0.941) and ELISA (rho = 0.931), and showed good correlation with skin testing (rho = -0.769). Analysis of binormal receiver operating characteristic curves, using skin test results as the reference standard, demonstrated no difference in performance among the three assays. The fixed global quantitative cutoff of 0.35 kUa/L was relatively insensitive. Use of the manufacturer's qualitative alternate scoring method cutoff substantially increased sensitivity without loss of specificity as did lower limit of detection set by use of diluent. Conclusions: In situations in which skin testing for fire ant sensitization is not feasible, PCS appears to be an acceptable in vitro alternative method for determination of fire ant allergen-specific	MED COLL GEORGIA,DEPT PEDIAT,ALLERGY IMMUNOL SECT,AUGUSTA,GA 30912; MED COLL GEORGIA,DEPT MED,AUGUSTA,GA 30912; E CAROLINA UNIV,SCH MED,GREENVILLE,NC	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of North Carolina; East Carolina University								AXEN RE, 1988, NEW ENG REG ALLERGY, V9, P503; BAHNA SL, 1988, J ALLERGY CLIN IMMUN, V82, P419, DOI 10.1016/0091-6749(88)90014-0; BEGG CB, 1990, MED DECIS MAKING, V10, P29, DOI 10.1177/0272989X9001000106; BERNTON HS, 1966, J ALLERGY, V36, P315; BOUSQUET J, 1990, J ALLERGY CLIN IMMUN, V85, P1039, DOI 10.1016/0091-6749(90)90048-9; BUTCHER BT, 1988, INT ARCH ALLER A IMM, V85, P458, DOI 10.1159/000234551; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P33, DOI 10.1016/0091-6749(88)90217-5; BUTCHER BT, 1988, J ALLERGY CLIN IMMUN, V81, P1096, DOI 10.1016/0091-6749(88)90875-5; DESHAZO RD, 1990, NEW ENGL J MED, V323, P462, DOI 10.1056/NEJM199008163230707; DESHAZO RD, 1991, ANN ALLERGY, V66, P1; DOLEN WK, 1992, ANN ALLERGY, V69, P151; DOLEN WK, IN PRESS ALLERGY P; FREEMAN TM, 1992, J ALLERGY CLIN IMMUN, V90, P210, DOI 10.1016/0091-6749(92)90073-B; FREEMAN TM, 1994, ALLERGY PROC, V15, P11, DOI 10.2500/108854194778816580; GALEN RS, 1975, NORMALITY PREDICTIVE, P129; HANNAN CJ, 1986, J ALLERGY CLIN IMMUN, V78, P331, DOI 10.1016/S0091-6749(86)80085-9; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P828, DOI 10.1016/0091-6749(88)90085-1; HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P818, DOI 10.1016/0091-6749(88)90084-X; HOFFMAN DR, 1991, ANN ALLERGY, V66, P29; JEEP S, 1992, ALLERGY, V47, P212, DOI 10.1111/j.1398-9995.1992.tb00653.x; KELSO JM, 1991, ANN ALLERGY, V67, P511; LEIMGRUBER A, 1993, ALLERGY, V48, P415, DOI 10.1111/j.1398-9995.1993.tb00739.x; MILLER JC, 1988, STATISTICS ANAL CHEM; MULLER U, 1993, ALLERGY, V48, P37; NORDVALL SL, 1988, J ALLERGY CLIN IMMUN, V82, P567, DOI 10.1016/0091-6749(88)90966-9; PAULL BR, 1983, J ALLERGY CLIN IMMUN, V71, P448, DOI 10.1016/0091-6749(83)90460-8; PONDER RD, 1994, ANN ALLERGY, V72, P329; REISMAN RE, 1992, MED CLIN N AM, V76, P883, DOI 10.1016/S0025-7125(16)30330-3; RHOADES RB, 1989, J ALLERGY CLIN IMMUN, V84, P159, DOI 10.1016/0091-6749(89)90319-9; STAFFORD CT, 1989, J ALLERGY CLIN IMMUN, V83, P1107, DOI 10.1016/0091-6749(89)90453-3; STAFFORD CT, 1989, SOUTHERN MED J, V82, P1520, DOI 10.1097/00007611-198912000-00015; STAFFORD CT, 1992, ALLERGY PROC, V13, P11, DOI 10.2500/108854192778878971; STAFFORD CT, 1992, J ALLERGY CLIN IMMUN, V90, P653, DOI 10.1016/0091-6749(92)90139-S; STAFFORD CT, 1990, ANN ALLERGY, V64, P368; STROM GB, 1983, J ALLERGY CLIN IMMUN, V72, P46, DOI 10.1016/0091-6749(83)90051-9; WILLIAMS PB, 1992, ANN ALLERGY, V68, P35; 1992, J ALLERGY CLIN IMMUN, V90, P263; [No title captured]	38	6	7	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1995	96	2					182	187		10.1016/S0091-6749(95)70006-4	http://dx.doi.org/10.1016/S0091-6749(95)70006-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RQ001	7636055				2022-12-18	WOS:A1995RQ00100006
J	KELSO, JM				KELSO, JM			ORAL ALLERGY SYNDROME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											KELSO, JM (corresponding author), USN,MED CTR,DIV ALLERGY,SAN DIEGO,CA 92134, USA.							DAMATO, 1994, J ALLERGY CLIN IMMUN, V94, P931	1	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1995	96	2					275	275		10.1016/S0091-6749(95)70022-6	http://dx.doi.org/10.1016/S0091-6749(95)70022-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RQ001	7636069				2022-12-18	WOS:A1995RQ00100022
J	FALLIERS, CJ				FALLIERS, CJ			AT-HOME ADMINISTRATION OF ALLERGENIC EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											FALLIERS, CJ (corresponding author), ALLERGY & ASTHMA CLIN PC,360 S GARFIELD,DENVER,CO 80209, USA.							[Anonymous], 1994, J Allergy Clin Immunol, V93, P811	1	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1061	1061		10.1016/S0091-6749(95)70112-5	http://dx.doi.org/10.1016/S0091-6749(95)70112-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751507				2022-12-18	WOS:A1995QY91700023
J	MOSIMANN, B; STOLL, B; FRANCILLON, C; PECOUD, A				MOSIMANN, B; STOLL, B; FRANCILLON, C; PECOUD, A			YELLOW-FEVER VACCINE AND EGG ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											MOSIMANN, B (corresponding author), POLICLIN MED UNIV,19 RUE CESAR ROUX,CH-1005 LAUSANNE,SWITZERLAND.							MILLER JR, 1983, J ALLERGY CLIN IMMUN, V71, P568; PATTERSON R, 1986, NEW ENGL REG ALLERGY, V7, P325; ROSEN JP, 1994, J ALLERGY CLIN IMMUN, V93, P1068, DOI 10.1016/S0091-6749(94)70056-7	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1064	1064		10.1016/S0091-6749(95)70118-4	http://dx.doi.org/10.1016/S0091-6749(95)70118-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7751510				2022-12-18	WOS:A1995QY91700029
J	WELLS, JH				WELLS, JH			HOME ALLERGENIC EXTRACT ADMINISTRATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNOTHERAPY; FATALITIES				WELLS, JH (corresponding author), OKLAHOMA ALLERGY & ASTHMA CLIN,POB 26827,OKLAHOMA CITY,OK 73126, USA.							[Anonymous], 1994, J Allergy Clin Immunol, V93, P811; LOCKEY RF, 1987, J ALLERGY CLIN IMMUN, V79, P660, DOI 10.1016/S0091-6749(87)80164-1; REID MJ, 1993, J ALLERGY CLIN IMMUN, V92, P6, DOI 10.1016/0091-6749(93)90030-J	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1995	95	5	1				1061	1062		10.1016/S0091-6749(95)70113-3	http://dx.doi.org/10.1016/S0091-6749(95)70113-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QY917	7619145				2022-12-18	WOS:A1995QY91700024
J	SPERBER, K; CHANEZ, P; BOUSQUET, J; GOSWAMI, S; MAROM, Z				SPERBER, K; CHANEZ, P; BOUSQUET, J; GOSWAMI, S; MAROM, Z			DETECTION OF A NOVEL MACROPHAGE-DERIVED MUCUS SECRETAGOGUE (MMS-68) IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						MUCUS SECRETAGOGUE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID INTERLEUKIN-6; TUMOR NECROSIS FACTOR	NECROSIS-FACTOR-ALPHA; RESISTANT BRONCHIAL-ASTHMA; ALVEOLAR MACROPHAGES; GLYCOCONJUGATE SECRETION; MONONUCLEAR PHAGOCYTES; ALLERGIC ASTHMATICS; SYMPTOMATIC ASTHMA; RESPIRATORY MUCUS; HEALTHY-SUBJECTS; HUMAN-MONOCYTES	Background: We have previously described a novel high-molecular-weight macrophage-derived mucus secretagogue (MMS-68) that causes mucuslike glycoconjugate release front cultured airways, nasal explants, and the Ishikawa adenocarcinoma cell line. We have generated monoclonal antibodies against MMS-68 and have developed an antigen-capture ELISA to measure MMS-68 levels in biologic fluids. Using this ELISA, we have demonstrated elevated levels of MMS-68 in the bronchoalveolar lavage fluid (BALF) of smokers and persons chronic bronchitis, in a patient with asthma and bronchorrhea, and in nasal lavage from patients with allergic rhinitis challenged with histamine and methacholine. We have also demonstrated that both spontaneous and lipopolysaccharide induced MMS-68 production is increased in the culture supernatants of monocytes from patients with steroid-dependent asthmas compared with those from normal control subjects. Methods: To delineate further a role for MMS-68 in the regulation of mucus secretion in asthma, we measured MMS-68 levels in the BALF of 37 patients with non-steroid-dependent asthma and of 16 control subjects. Results: There were 22 men and 16 women in the asthma group (age range, 17 to 62 years; mean, 33.8 years) and 11 men and five women in the control group (age range, 18 to 42 years; mean, 27.8 years). There were no statistical differences in either total cell count (145.5 x 103 +/- 75.7 cells/mm(3) x 10(3) cells/mm(3) vs 134 x 10(3) +/- 65.9 x 10(3) cells/mm(3), p < 0.234) or numbers of alveolar macrophages (103.7 x 10(3) +/- 71.7 x 10(3)/mm(3) vs 98. 7 x 10(3) +/- 65 x 10 cells/mm(3), p < 0.244) when the asthmatic group was compared with the control group. The MMS-68 level in the asthmatic group was 2.1 +/- 0.25 mu g MMS-68 per milligram protein compared with 2.09 +/- 0.26 mu g MMS-68 per milligram protein (p < 0.256) in the control group. Conclusions: There was no correlation between MMS-68 levels and total protein content, numbers of alveolar macrophages, or the production of other macrophage-derived cytokines including interleukin-1, interleukin-5 or tumor necrosis factor in the asthmatic BALF. Mild asthma, which is clinically not associated with mucus hypersecretion, was not associated with elevated levels of MMS-68. We believe that direct correlation exists between mucus hypersecretion and MMS-68 levels.	MT SINAI MED CTR,DIV PULM & CRIT CARE MED,NEW YORK,NY 10029; HOSP ARNAUND VILLENEUVE,MALAD RESP CLIN,MONTPELLIER,FRANCE	Icahn School of Medicine at Mount Sinai	SPERBER, K (corresponding author), MT SINAI MED CTR,DIV CLIN IMMUNOL,BOX 1089,1 GUSTAVE LEVY PL,NEW YORK,NY 10029, USA.		Bousquet, Jean/O-4221-2019	chanez, pascal/0000-0003-4059-0917	NHLBI NIH HHS [NHL-37254] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037254] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; AAS K, 1981, ALLERGY, V36, P3, DOI 10.1111/j.1398-9995.1981.tb01818.x; [Anonymous], 1985, USERS GUIDE; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BORISH L, 1992, J IMMUNOL, V149, P3078; BORISH L, 1991, J IMMUNOL, V146, P63; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; DAMON M, 1987, PROSTAG OTH LIPID M, V34, P291, DOI 10.1016/0090-6980(87)90251-6; GIBSON PG, 1989, THORAX, V44, P696; GODARD P, 1982, J ALLERGY CLIN IMMUN, V70, P88, DOI 10.1016/0091-6749(82)90234-2; GOLLUB E, 1992, J ALLERGY CLIN IMMUN, V89, P656; GOSSET P, 1992, AM REV RESPIR DIS, V146, P768, DOI 10.1164/ajrccm/146.3.768; GOSSET P, 1984, J ALLERGY CLIN IMMUN, V74, P827, DOI 10.1016/0091-6749(84)90186-6; GOSSET P, 1991, J ALLERGY CLIN IMMUN, V88, P561, DOI 10.1016/0091-6749(91)90149-I; HERNANDEZ A, 1991, PHARMACOL RES, V24, P385, DOI 10.1016/1043-6618(91)90043-W; KALINER M, 1984, J ALLERGY CLIN IMMUN, V73, P318, DOI 10.1016/0091-6749(84)90403-2; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; LANE SJ, 1993, AM REV RESPIR DIS, V147, P690, DOI 10.1164/ajrccm/147.3.690; LEE TH, 1992, AM REV RESPIR DIS, V145, pS27, DOI 10.1164/ajrccm/145.2_Pt_2.S27; LUNDGREN JD, 1990, J ALLERGY CLIN IMMUN, V85, P399, DOI 10.1016/0091-6749(90)90147-V; MARINI M, 1992, CHEST, V102, P661, DOI 10.1378/chest.102.3.661; MAROM ZM, 1991, J ALLERGY CLIN IMMUN, V87, P1050, DOI 10.1016/0091-6749(91)92149-U; MATTOLI S, 1991, J ALLERGY CLIN IMMUN, V87, P794, DOI 10.1016/0091-6749(91)90125-8; MICHEL O, 1992, AM REV RESPIR DIS, V146, P352, DOI 10.1164/ajrccm/146.2.352; PUJOL JL, 1990, INT ARCH ALLER A IMM, V91, P207, DOI 10.1159/000235117; SIRACUSA A, 1992, AM REV RESPIR DIS, V146, P408, DOI 10.1164/ajrccm/146.2.408; SPERBER K, 1993, J ALLERGY CLIN IMMUN, V92, P581, DOI 10.1016/0091-6749(93)90082-Q; SPERBER K, 1990, J IMMUNOL METHODS, V129, P31, DOI 10.1016/0022-1759(90)90417-T; SPERBER K, 1992, AM REV RESPIR DIS, V146, P1589, DOI 10.1164/ajrccm/146.6.1589; SPERBER K, 1993, J RHEUMATOL, V20, P803; WANG JY, 1992, J ASTHMA, V29, P193, DOI 10.3109/02770909209099027; WILKINSON JRW, 1989, J CLIN INVEST, V84, P1930, DOI 10.1172/JCI114381; YING S, 1991, Clinical and Experimental Allergy, V21, P745, DOI 10.1111/j.1365-2222.1991.tb03205.x; Zar J. H, 1984, BIOSTAT ANAL, P176; 1962, AM REV RESPIR DIS, V85, P762	38	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1995	95	4					868	876		10.1016/S0091-6749(95)70131-1	http://dx.doi.org/10.1016/S0091-6749(95)70131-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QT468	7722168	Bronze			2022-12-18	WOS:A1995QT46800013
J	NEWILL, CA; EGGLESTON, PA; PRENGER, VL; FISH, JE; DIAMOND, EL; WEI, QY; EVANS, R				NEWILL, CA; EGGLESTON, PA; PRENGER, VL; FISH, JE; DIAMOND, EL; WEI, QY; EVANS, R			PROSPECTIVE-STUDY OF OCCUPATIONAL ASTHMA TO LABORATORY-ANIMAL ALLERGENS - STABILITY OF AIRWAY RESPONSIVENESS TO METHACHOLINE CHALLENGE FOR ONE-YEAR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						METHACHOLINE CHALLENGE; LABORATORY ANIMAL ALLERGENS; OCCUPATIONAL DISEASES; AIRWAY HYPERREACTIVITY	FOLLOW-UP; BRONCHIAL HYPERREACTIVITY; WORKERS; DIISOCYANATE; REACTIVITY; POPULATION; CHILDREN; ADULTS; SAMPLE	The stability of airway hyperresponsiveness was studied in a group of 178 young adults working with laboratory animals. At the time of their entry into the study, 132 of 178 subjects (74%) had less than 20% response to the inhalation of 25 mg/ml methacholine, whereas 26 (15%) had a methacholine dose causing a 20% fall in forced expiratory volume in 1 second after fewer than 80 breath units. The distribution of methachacholine responsiveness did not differ at 6 months and 1 year; 155 of 178 volunteers (90.4%) responded during the repeated challenges to doses within one dilution of their results at entry. One hundred forty-one subjects were consistently unreactive during the year, and 17 were consistently reactive. Approximately equal numbers gained and lost reactivity. Those with consistently positive responses to methacholine were more likely to have skin test reactivity and chest symptoms. The presence of consistent chest symptoms was loosely associated with consistent methacholine responsiveness; 55% of those with consistent hyperresponsive airways had symptoms and 24% of those who consistently had symptoms had hyperresponsive airways. We concluded that the methacholine response is relatively stable during the course of a year in laboratory animal workers who remain at their jobs and that the presence of a positive skin test response to laboratory animals ol of chest symptoms does not change the pattern of stable responsiveness.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT IMMUNOL & INFECT DIS,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD; JEFFERSON MED COLL,DEPT MED,PHILADELPHIA,PA; NORTHWESTERN UNIV,SCH MED,DEPT PEDIAT,CHICAGO,IL 60611	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Jefferson University; Northwestern University					NHLBI NIH HHS [HL30532] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030532] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEESON MF, 1983, CLIN ALLERGY, V13, P433, DOI 10.1111/j.1365-2222.1983.tb02619.x; BOTHAM PA, 1987, BRIT J IND MED, V44, P627; BUTCHER BT, 1977, AM REV RESPIR DIS, V116, P411, DOI 10.1164/arrd.1977.116.3.411; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHANYEUNG M, 1987, J ALLERGY CLIN IMMUN, V79, P792, DOI 10.1016/0091-6749(87)90212-0; COCKCROFT A, 1981, LANCET, V1, P827; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; ENARSON DA, 1988, CLIN INVEST MED, V11, P193; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P55; FISH JE, 1979, J ALLERGY CLIN IMMUN, V64, P592, DOI 10.1016/0091-6749(79)90019-8; Fleiss JL, 1981, STATISTICAL METHODS, P217; FREIDHOFF LR, 1984, J ALLERGY CLIN IMMUN, V73, P490, DOI 10.1016/0091-6749(84)90360-9; HUDSON P, 1985, J ALLERGY CLIN IMMUN, V76, P682, DOI 10.1016/0091-6749(85)90671-2; JOSEPHS LK, 1989, AM REV RESPIR DIS, V140, P350, DOI 10.1164/ajrccm/140.2.350; JUNIPER EF, 1982, THORAX, V37, P288, DOI 10.1136/thx.37.4.288; MAPP CE, 1988, AM REV RESPIR DIS, V137, P1326, DOI 10.1164/ajrccm/137.6.1326; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; NEWILL CA, 1992, AM REV RESPIR DIS, V146, P1494, DOI 10.1164/ajrccm/146.6.1494; PLATTSMILLS TAE, 1982, LANCET, V2, P675; REDLINE S, 1989, AM REV RESPIR DIS, V140, P172, DOI 10.1164/ajrccm/140.1.172; SANTILLI J, 1980, J ALLERGY CLIN IMMUN, V65, P406, DOI 10.1016/0091-6749(80)90232-8; WEISS ME, 1989, AM REV RESPIR DIS, V139, P67, DOI 10.1164/ajrccm/139.1.67; WOOLCOCK AJ, 1985, AIRWAY RESPONSIVENES, P80; 1985, SAS USERS GUIDE STAT	24	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1995	95	3					707	715		10.1016/S0091-6749(95)70176-1	http://dx.doi.org/10.1016/S0091-6749(95)70176-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QM017	7897154				2022-12-18	WOS:A1995QM01700011
J	BRESSER, H; SANDNER, C; RAKOSKI, J				BRESSER, H; SANDNER, C; RAKOSKI, J			ANAPHYLACTIC EMERGENCIES IN MUNICH IN 1992	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				368	368						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400909
J	PEREZ, C; TEJEDOR, MA; DELAHOZ, B; PURAS, A				PEREZ, C; TEJEDOR, MA; DELAHOZ, B; PURAS, A			ANAPHYLAXIS - A DESCRIPTIVE STUDY OF 182 PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													de la Hoz, Belen/AAA-8067-2019; Alonso, Miguel Angel Tejedor/AAM-8217-2021	de la Hoz, Belen/0000-0002-5127-8702; 					0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				368	368						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400908
J	POULSEN, LK; JOHNSEN, CR; LOVBORG, U; WIDE, L; LINDQVIST, A; SORENSEN, TB; BERTHELSENSECHER, A; KOBER, A				POULSEN, LK; JOHNSEN, CR; LOVBORG, U; WIDE, L; LINDQVIST, A; SORENSEN, TB; BERTHELSENSECHER, A; KOBER, A			A SYSTEM FOR IN-VITRO MONITORING OF OCCUPATIONAL SENSITIZATION OF WORKERS IN BIOINDUSTRIAL PLANTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X					0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				207	207						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400266
J	PRIETO, A; HERRERO, T; ARANZABAL, A; CAO, A; BAEZA, ML; TORNERO, P; OLALDE, S; BARRIO, M				PRIETO, A; HERRERO, T; ARANZABAL, A; CAO, A; BAEZA, ML; TORNERO, P; OLALDE, S; BARRIO, M			SYSTEMIC CELL-MEDIATED HYPERSENSITIVITY TO BETA-LACTAM ANTIBIOTICS - CROSS ACTIVITY STUDY BY SKIN-TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				286	286						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400580
J	WARREN, MS; SLOAN, SI; WESTCOTT, J; HAMILOS, D; WENZEL, SE				WARREN, MS; SLOAN, SI; WESTCOTT, J; HAMILOS, D; WENZEL, SE			LTE4 INCREASES IN BRONCHOALVEOLAR LAVAGE FLUID (BALF) OF ASPIRIN-INTOLERANT ASTHMATICS (AIA) AFTER INSTILLATION OF INDOMETHACIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				170	170						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400119
J	DICKLER, HB; COLLIER, E				DICKLER, HB; COLLIER, E			GENE-THERAPY IN THE TREATMENT OF DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CYSTIC-FIBROSIS; ADENOVIRUSES; EPITHELIA; CORRECTS; DEFECT; CELLS; CFTR				DICKLER, HB (corresponding author), NIAID,DIV ALLERGY IMMUNOL & TRANSPLANTAT,SOLAR BLDG,ROOM 4A19,BETHESDA,MD 20892, USA.							AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; ARAN JM, 1994, P NATL ACAD SCI USA, V91, P3176, DOI 10.1073/pnas.91.8.3176; BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; Blaese R M, 1992, Immunodefic Rev, V3, P329; BLAESE RM, 1990, HUM GENE THER, V1, P327; BLAESE RM, 1993, PEDIATR RES, V33, pS49, DOI 10.1203/00006450-199304001-00010; BRENNER MK, 1993, LANCET, V341, P85, DOI 10.1016/0140-6736(93)92560-G; BRENNER MK, 1992, HUM GENE THER, V3, P665, DOI 10.1089/hum.1992.3.6-665; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; KARPATI G, 1993, MUSCLE NERVE, V16, P1141, DOI 10.1002/mus.880161102; MORGAN RA, 1993, ANNU REV BIOCHEM, V62, P191; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; RICH DP, 1993, HUM GENE THER, V4, P461, DOI 10.1089/hum.1993.4.4-461; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSENFELD MA, 1994, HUM GENE THER, V5, P331, DOI 10.1089/hum.1994.5.3-331; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; VANDENDRIESSCHE T, 1994, AIDS UPDATES, V7, P1; VINCENT N, 1993, NAT GENET, V5, P130, DOI 10.1038/ng1093-130; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WIVEL NA, 1993, SCIENCE, V262, P533, DOI 10.1126/science.8211180; YU M, 1994, GENE THER, V1, P13; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	25	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1994	94	6	1				942	951		10.1016/0091-6749(94)90111-2	http://dx.doi.org/10.1016/0091-6749(94)90111-2			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PY230	7798542				2022-12-18	WOS:A1994PY23000002
J	BAXEVANIS, CN; PAPADOPOULOS, NG; KATSAROUKATSARI, A; PAPAMICHAIL, M				BAXEVANIS, CN; PAPADOPOULOS, NG; KATSAROUKATSARI, A; PAPAMICHAIL, M			REGULATION OF ALLERGEN-SPECIFIC IMMUNE-RESPONSES BY CD4+ CD45R+ CELLS IN PATIENTS WITH ALLERGIC CONTACT-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CONTACT DERMATITIS; PATCH TEST; CD4+ T LYMPHOCYTES; IMMUNOREGULATION	MEMORY T-CELLS; ANTIGEN EXPRESSION; NATURAL-KILLER; HLA-DR; SUPPRESSOR; HELPER; LYMPHOCYTES; URTICARIA; MONOCYTES; MOLECULE	Circulating T lymphocytes from 20 patients with an immediate patch test reaction were tested for proliferative responses in vitro to contact allergens during both immediate and delayed skin reactions. T lymphocytes collected during the immediate patch test reaction responded specifically to the challenge allergens in the presence of autologous monocytes. Subset analysis revealed that the proliferation pattern was dominated by the CD4+ CD29+ T-cell subpopulation, whereas CD8+ or CD4+ CD45R+ cells did not respond. A similar pattern in T-cell subset proliferation was observed when cells were collected during a positive delayed skin reaction. In contrast, in the case of a negative delayed skin reaction, proliferative responses of lymphocytes to the specific allergens were dominated by CD45R+ cells. The latter T-lymphocyte subset could greatly suppress in an allergen-specific manner the proliferation of CD29+ autologous cells. The in vitro allergen-specific proliferation of CD29+ or CD45R+ cells was restricted by the major histocompatibility complex class II (HLA-DR) gene products. If is suggested that allergen-specific immune responses take place in the induction and evolution of an immediate patch test reaction into a delayed one.	UNIV ATHENS,A SYGROS HOSP,DEPT DERMATOL,ATHENS,GREECE	National & Kapodistrian University of Athens	BAXEVANIS, CN (corresponding author), AGIOS SAVAS HOSP,DEPT IMMUNOL,171 ALEXANDRAS AVE,GR-11522 ATHENS,GREECE.		N.G., Papadopoulos/L-8670-2013; Papadopoulos, Nikolaos/ABE-1774-2021	N.G., Papadopoulos/0000-0002-4448-3468; Papadopoulos, Nikolaos/0000-0002-4448-3468; Papadopoulos, Nikolaos/0000-0002-2508-3872				AKBAR AN, 1991, IMMUNOL TODAY, V12, P184, DOI 10.1016/0167-5699(91)90050-4; BAER RL, 1986, CONTACT DERMATITIS, P732; BAXEVANIS CN, 1983, J IMMUNOL, V131, P628; BAXEVANIS CN, 1982, SCAND J IMMUNOL, V16, P25, DOI 10.1111/j.1365-3083.1982.tb00695.x; BAXEVANIS CN, 1986, EUR J IMMUNOL, V16, P1013, DOI 10.1002/eji.1830160824; BAXEVANIS CN, 1993, INT J CANCER, V53, P264, DOI 10.1002/ijc.2910530216; BAXEVANIS CN, 1992, J IMMUNOL, V148, P1979; BAXEVANIS CN, 1990, J IMMUNOL, V144, P4166; BAXEVANIS CN, 1981, P NATL ACAD SCI-BIOL, V78, P3809, DOI 10.1073/pnas.78.6.3809; BAXEVANIS CN, 1993, CANCER-AM CANCER SOC, V72, P491, DOI 10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO;2-1; BAXEVANIS CN, 1982, J EXP MED, V156, P822, DOI 10.1084/jem.156.3.822; Bell E B, 1992, Semin Immunol, V4, P43; BEVERLEY P, 1991, CURR OPIN IMMUNOL, V3, P355, DOI 10.1016/0952-7915(91)90038-3; Beverley P C, 1992, Semin Immunol, V4, P35; DIKEAKOU T, 1988, CONTACT DERMATITIS, V19, P151, DOI 10.1111/j.1600-0536.1988.tb05522.x; Fisher AA, 1986, CONTACT DERMATITIS, P686; FREW AJ, 1988, J IMMUNOL, V141, P4158; FREW AJ, 1991, CLIN EXP IMMUNOL, V84, P270; FRIEDLAENDER MH, 1972, J IMMUNOL, V109, P1122; HIRAYAMA K, 1987, NATURE, V327, P426, DOI 10.1038/327426a0; LAHTI A, 1987, CONTACT DERMATITIS, V16, P133, DOI 10.1111/j.1600-0536.1987.tb01405.x; LAHTI A, 1980, Acta Dermato-Venereologica Supplementum, V60, P1; LAHTI A, 1983, ACTA DERM-VENEREOL, V63, P425; Mackay C R, 1992, Semin Immunol, V4, P51; MORIMOTO C, 1985, J IMMUNOL, V134, P3762; NAUME B, 1992, J IMMUNOL, V148, P2429; OLIVEIRA DBG, 1985, IMMUNOGENETICS, V22, P169, DOI 10.1007/BF00563514; RUDD CE, 1987, J EXP MED, V166, P1758, DOI 10.1084/jem.166.6.1758; SARRI C, 1992, MUTAT RES, V270, P125, DOI 10.1016/0027-5107(92)90123-J; von Krogh G, 1982, SEMIN DERMATOL, V1, P59; WARIN RP, 1982, CONTACT DERMATITIS, V8, P117, DOI 10.1111/j.1600-0536.1982.tb04156.x	31	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1994	94	5					917	927		10.1016/0091-6749(94)90160-0	http://dx.doi.org/10.1016/0091-6749(94)90160-0			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PR240	7525680				2022-12-18	WOS:A1994PR24000017
J	NORDMAN, SAS; NYBERG, PW				NORDMAN, SAS; NYBERG, PW			WHOLE-BLOOD CHEMILUMINESCENCE AS A SYSTEMIC INFLAMMATORY PARAMETER IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; CHEMILUMINESCENCE; HYDROGEN PEROXIDE; PHAGOCYTES; REACTIVE OXYGEN METABOLITES; SUPEROXIDE	AIR-FLOW OBSTRUCTION; CHEMI-LUMINESCENCE; POLYMORPHONUCLEAR LEUKOCYTES; ALVEOLAR MACROPHAGES; BRONCHIAL HYPERRESPONSIVENESS; BECLOMETHASONE DIPROPIONATE; SUPEROXIDE PRODUCTION; NEUTROPHILS; LUMINOL; CELLS	Blood phagocytes from patients with asthma not treated with antiinflammatory drugs have an increased capacity to produce reactive oxygen metabolites. We studied the phenomenon in a group of patients with asthma receiving inhaled steroids with whole blood chemiluminescence (CL), a simple reactive oxygen metabolite assay suitable for routine use. There was no difference in CL values between patients with stable asthma and no current obstruction (n = 19; mean CL +/- SD = 26.01 +/- 6.51 mV x min) and healthy control subjects (n = 20; mean CL +/- SD = 27.37 +/- 615 mV x min), whereas the patients with asthma and current obstruction (n = 27) had significantly higher CL responses (mean CL +/- SD = 41.10 +/- 14.79 mV x min) than both the patients with nonobstructive asthma and the healthy control subjects (p < 0.0005). There was a negative correlation between whole blood CL and the forced expiratory volume in 1 second of the patients with asthma (Spearman's r = -0.47). When the CL values were corrected for the number of phagocytes present in the reactions, the patients with nonobstructive asthma had significantly lower values than the healthy control subjects (p < 0.05). We suggest that the CL values of the patients with nonobstructive asthma reflect the result of effective antiinflammatory treatment and that whole blood CL may be useful as a systemic parameter in the follow-up of the inflammatory process in asthma.	MJOLBOLSTA HOSP,SF-10350 MJOLBOLSTA,FINLAND									BERGSTRAND H, 1990, THORAX, V45, P362, DOI 10.1136/thx.45.5.362; CALHOUN WJ, 1992, AM REV RESPIR DIS, V145, P317, DOI 10.1164/ajrccm/145.2_Pt_1.317; CALHOUN WJ, 1991, J LAB CLIN MED, V117, P514; CHANEZ P, 1990, EUR RESPIR J, V3, P987; CLUZEL M, 1987, J ALLERGY CLIN IMMUN, V80, P195, DOI 10.1016/0091-6749(87)90129-1; DAMON M, 1989, J BIOLUM CHEMILUM, V4, P279, DOI 10.1002/bio.1170040140; DESOLE P, 1983, J CLIN LAB AUTOMAT, V3, P391; DESOLE P, 1989, J BIOLUM CHEMILUM, V4, P251, DOI 10.1002/bio.1170040136; DUDDRIDGE M, 1993, EUR RESPIR J, V6, P489; FISHER H, 1981, BIOLUMINESCENCE CHEM, P617; JARJOUR NN, 1992, AM REV RESPIR DIS, V146, P905, DOI 10.1164/ajrccm/146.4.905; JOHANSSON SA, 1982, EUR J CLIN PHARMACOL, V22, P523, DOI 10.1007/BF00609625; KALLENBACH J, 1992, J ALLERGY CLIN IMMUN, V90, P272, DOI 10.1016/0091-6749(92)90084-F; KATO M, 1991, INT ARCH ALLER A IMM, V96, P128, DOI 10.1159/000235483; KATO M, 1991, INT ARCH ALLER A IMM, V95, P17, DOI 10.1159/000235448; KELLY C, 1988, THORAX, V43, P684, DOI 10.1136/thx.43.9.684; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LAITINEN LA, 1992, ASTHMA, P232; MELTZER S, 1989, J ALLERGY CLIN IMMUN, V83, P960, DOI 10.1016/0091-6749(89)90112-7; MONTEFORT S, 1992, CLIN EXP ALLERGY, V22, P511, DOI 10.1111/j.1365-2222.1992.tb00159.x; MULLER A, 1984, ANAL APPLICATIONS BI, P343; NEIJENS HJ, 1984, AM REV RESPIR DIS, V130, P744; NIELSON CP, 1992, J ALLERGY CLIN IMMUN, V90, P825, DOI 10.1016/0091-6749(92)90108-E; ONEILL SJ, 1986, AM REV RESPIR DIS, V134, P1225; POSTMA DS, 1988, AM REV RESPIR DIS, V137, P57, DOI 10.1164/ajrccm/137.1.57; RENKEMA TEJ, 1993, EUR RESPIR J, V6, P90; RISTOLA M, 1989, APMIS, V97, P503, DOI 10.1111/j.1699-0463.1989.tb00823.x; SAGONE AL, 1976, J CLIN INVEST, V57, P1352, DOI 10.1172/JCI108403; SUSTIEL AM, 1989, AM REV RESPIR DIS, V140, P1556, DOI 10.1164/ajrccm/140.6.1556; TONOOKA T, 1983, CLIN IMMUNOL IMMUNOP, V26, P66, DOI 10.1016/0090-1229(83)90174-5; TOOGOOD JH, 1984, AM REV RESPIR DIS, V129, P723, DOI 10.1164/arrd.1984.129.5.723; TOSI MF, 1992, AM J CLIN PATHOL, V97, P566, DOI 10.1093/ajcp/97.4.566; VACHIER I, 1992, AM REV RESPIR DIS, V146, P1161, DOI 10.1164/ajrccm/146.5_Pt_1.1161; VILJANEN AA, 1982, SCAND J CLIN LAB INV, V42, P35; VILJANEN AA, 1982, SCAND J CLIN LAB INV, V42, P5; VIRCHOW JC, 1992, AM REV RESPIR DIS, V146, P604, DOI 10.1164/ajrccm/146.3.604; WARD C, 1990, EUR RESPIR J, V3, P1008; Woodhead Mark, 1993, Thorax, V48, pS1; YUKAWA T, 1989, AM REV RESPIR DIS, V140, P327, DOI 10.1164/ajrccm/140.2.327; 1987, AM REV RESPIR DIS, V136, P225	40	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1994	94	5					853	860		10.1016/0091-6749(94)90153-8	http://dx.doi.org/10.1016/0091-6749(94)90153-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PR240	7963154				2022-12-18	WOS:A1994PR24000010
J	CHEN, JX; WATANABE, S; MUTO, A; MIYAJIMA, A; YOKOTA, T; ARAI, K				CHEN, JX; WATANABE, S; MUTO, A; MIYAJIMA, A; YOKOTA, T; ARAI, K			ACTIVATION OF EARLY RESPONSE GENES AND CELL-PROLIFERATION BY HUMAN INTERLEUKIN-3, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND INTERLEUKIN-5 RECEPTORS - COMPARISON WITH HUMAN INTERLEUKIN-4 RECEPTOR SIGNALING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	New Trends in Immunopharmacology 1993 Conference	JUL   17, 1993	TOKYO, JAPAN			TRANSFECTED HUMAN IL-4 RECEPTOR; RECEPTOR SIGNALING; SIGNAL TRANSDUCTION	GM-CSF RECEPTOR; HIGH-AFFINITY; BETA-SUBUNIT; GAMMA-CHAIN; C-FOS; TRANSDUCTION; BINDING; PROTEIN; EXPRESSION; IL-4	Interleukin (IL)-3, granulocyte-macrophage colony-stimulating factor, and IL-5 receptors (IL-3R, GMR, and IL-5R) are composed of the alpha chain specific to each and the common beta chain, and both the alpha and beta subunits are members of the cytokine receptor superfamily. We previously showed that the high-affinity human GMR reconstituted by cotransfecting the alpha and beta chain cDNA clones transduces signals in response to hGM-CSF to activate transcription of c-fos, c-jun, and c-myc proto-oncogenes in mouse proB cell line BA/F3 or in mouse fibroblast NIH3T3 cells. These results indicated that molecules, such as tyrosine kinase, unique to hematopoietic cells are not essential to transduce signals. In this study, the function of the alpha subunit of GMR was compared with those of IL-3R and IL-5R by cotransfecting human cDNAs encoding the alpha subunit of IL-3R or IL-5R and the common beta subunit into BA/F3 or NIH3T3 cells. We found that the reconstituted human IL-3R, in response to hIL-3, transduced signals to activate transcription of c-fos promoter and induced DNA synthesis in both types of cells in a manner similar to hGMR. Likewise, hIL-5 activates c-fos promoter in transfected NIH3T3 cells expressing hIL-5R. These results indicated that the alpha subunits of IL-3R and IL-5R have properties similar to those of the GMR alpha subunit. In contrast, transfected human IL-4 receptor (hIL-4R) cDNA, which weakly activated c-fos promoter and induced DNA synthesis in BA/F3 cells, failed to elicit these activities in NIH3T3 cells in response to hIL-4. It is likely that NIH3T3 cells lack some component or components required fdr signal transduction by hIL-4R.	UNIV TOKYO,INST MED SCI,DEPT MOLEC & DEV BIOL,MINATO KU,TOKYO,JAPAN; DNAX RES INST MOLEC & CELLULAR BIOL INC,DEPT MOLEC BIOL,PALO ALTO,CA 94304	University of Tokyo; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.			Muto, Akihiko/O-1199-2016; Yokota, Takashi/F-6021-2011; Yokota, Takashi/J-8483-2015					ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; EDER M, 1993, EMBO J, V12, P1647, DOI 10.1002/j.1460-2075.1993.tb05810.x; FOXWELL BMJ, 1989, EUR J IMMUNOL, V19, P1637, DOI 10.1002/eji.1830190918; GALIZZI JP, 1990, J BIOL CHEM, V265, P439; HARADA N, 1992, J BIOL CHEM, V267, P22752; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; LOPEZ AF, 1990, J CELL PHYSIOL, V145, P69, DOI 10.1002/jcp.1041450111; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; MCGARVIE GM, 1989, IMMUNOL LETT, V22, P221, DOI 10.1016/0165-2478(89)90195-8; MIRESLUIS AR, 1991, J BIOL CHEM, V266, P18113; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MUTO A, UNPUB HIGH AFFINITY; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WATANABE S, 1993, MOL CELL BIOL, V13, P1440, DOI 10.1128/MCB.13.3.1440; WATANABE S, 1993, MOL BIOL CELL, V4, P983, DOI 10.1091/mbc.4.10.983; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	24	6	6	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1994	94	3	2	S			605	611		10.1016/0091-6749(94)90136-8	http://dx.doi.org/10.1016/0091-6749(94)90136-8			7	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PH235	8083468	Bronze			2022-12-18	WOS:A1994PH23500005
J	COHN, JR				COHN, JR			MULTIPLE CHEMICAL-SENSITIVITY OR MULTIORGAN DYSESTHESIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,PHILADELPHIA,PA 19107	Jefferson University								Cohn J R, 1991, Pa Med, V94, P32; CULLEN MR, 1987, WORKERS MULTIPLE CHE, V204, P655; TERR AI, 1993, ANN INTERN MED, V119, P163, DOI 10.7326/0003-4819-119-2-199307150-00012; 1990, STEDMANS MED DIRECTO, P476; 1986, J ALLERGY CLIN IMMUN, V78, P269; 1989, ANN INTERN MED, V111, P168; 1992, JAMA-J AM MED ASSOC, V268, P3465; 1986, W J MED, V144, P239	8	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1994	93	6					953	954		10.1016/S0091-6749(94)70041-9	http://dx.doi.org/10.1016/S0091-6749(94)70041-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT172	8006316				2022-12-18	WOS:A1994NT17200001
J	SEGGEV, JS; FINK, JN				SEGGEV, JS; FINK, JN			URINARY RETENTION AS A RESULT OF ADMINISTRATION OF TERFENADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									UNIV NEVADA,SCH MED,DEPT INTERNAL MED,ALLERGY SECT,LAS VEGAS,NV 89154; UNIV NEVADA,SCH MED,DEPT INTERNAL MED,CLIN IMMUNOL SECT,LAS VEGAS,NV 89154; MED COLL WISCONSIN,MILWAUKEE,WI 53226	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Medical College of Wisconsin								Jonides L, 1993, J Pediatr Health Care, V7, P52; JONIDES L, 1993, J PEDIATR HLTH CARE, V7, P52; SELDANE, 1993, PHYSICIANS DESK REFE, P1398; SIMONS FER, 1991, ANN ALLERGY, V66, P5; SKLAREW PR, 1991, J ALLERGY CLIN IMMUN, V87, P562; 1986, AMA DRUG EVALUATION, P1041	6	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1994	93	6					1071	1072		10.1016/S0091-6749(94)70057-5	http://dx.doi.org/10.1016/S0091-6749(94)70057-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT172	8006312				2022-12-18	WOS:A1994NT17200017
J	MARIASSY, AT; ABRAHAM, WM; WANNER, A				MARIASSY, AT; ABRAHAM, WM; WANNER, A			EFFECT OF ANTIGEN ON THE GLYCOCONJUGATE PROFILE OF TRACHEAL SECRETIONS AND THE EPITHELIAL GLYCOCALYX IN ALLERGIC SHEEP	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ANTIGEN; LECTIN; GLYCOSYL; GLYCOCONJUGATE; TRACHEAL SECRETIONS; LAVAGE; HISTOCHEMISTRY; EPITHELIAL GLYCOCALYX; ALLERGIC SHEEP	HUMAN RESPIRATORY MUCINS; PSEUDOMONAS-AERUGINOSA; DENSITY GRADIENT; LIPIDS; MUCOSA; CELLS	To characterize the glycoconjugate composition of tracheal secretions and the apical glycocalyx of the tracheal epithelium under baseline conditions and after antigen challenge, sheep allergic to Ascaris suum were intubated with a double-balloon nasotracheal tube to create a tracheal chamber. After an initial tracheal lavage, the animals were either exposed to intratracheally nebulized phosphate-buffered saline (PBS) (3 ml, n = 6) or A. suum antigen (251,000 protein nitrogen units in 3 ml of PBS, n = 6). Tracheal lavage was repeated 2 hours later, and the animals were killed. An enzyme-linked lectin assay and lectin histochemical analysis were used to characterize carbohydrate residues in lyophilized, resuspended tracheal secretions and the apical glycocalyx of the tracheal epithelium, respectively. Eight lectins were used to detect GalNAc, alpha-Gal, beta-Gal, alpha-Fuc, (1-3)Man, alpha-Man/Glu, alpha-Man, and alpha-(2-3)sialyl residues. The amounts of total nondialyzable solids, proteins, and lipids in tracheal secretions were approximately twice as high after exposure to A. suum than after exposure to PBS. All carbohydrate residues were present in tracheal secretions after exposure to PBS and A. suum, but the reactivity was higher after exposure to A. suum for beta-Gal (+125%), alpha-Man/Glu (+150%), alpha-(1-3)Man (+287%), alpha-(2-3)sialyl (+353%), and alpha-Man (+448%) (p < 0.05). Likewise, the apical glycocalyx contained all carbohydrate residues after exposure to PBS and A. suum; afer exposure to A. suum, the reactivity was greater for alpha-GalNAc (+18%), alpha-(2-3)sialyl (+90%), beta-Gal(1-3)GalNAc (+433%), and alpha-(1-3)Man (+482%) (p < 0.05). There were no differences in other carbohydrate residues in either tracheal secretions or the apical glycocalyx. These antigen-induced changes in the respective glycoconjugate profiles of tracheal secretions and the apical glycocalyx of the tracheal epithelium could have an effect on airway defenses, including bacterial adhesion to the epithelium.			MARIASSY, AT (corresponding author), UNIV MIAMI,MT SINAI MED CTR,DIV PULM DIS,4300 ALTON RD,MIAMI BEACH,FL 33140, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003041] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20989] Funding Source: Medline; NIEHS NIH HHS [ESO3041] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; BHASKAR KR, 1986, EXP LUNG RES, V10, P401, DOI 10.3109/01902148609058290; BHASKAR KR, 1985, EXP LUNG RES, V9, P289, DOI 10.3109/01902148509057529; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CSETE ME, 1991, AM REV RESPIR DIS, V144, P59, DOI 10.1164/ajrccm/144.1.59; JOZWIAK Z, 1984, BIOCHIM BIOPHYS ACTA, V802, P282, DOI 10.1016/0304-4165(84)90172-7; KIM KC, 1990, EXP LUNG RES, V16, P279, DOI 10.3109/01902149009108845; LAMBLIN G, 1991, AM REV RESPIR DIS, V144, pS19, DOI 10.1164/ajrccm/144.3_pt_2.S19; LONG WM, 1990, J APPL PHYSIOL, V69, P584, DOI 10.1152/jappl.1990.69.2.584; MARIASSY AT, 1988, ANAT REC, V222, P49, DOI 10.1002/ar.1092220109; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; Mirelman D, 1986, MICROBIAL LECTINS AG, P1; RAMPHAL R, 1991, INFECT IMMUN, V59, P1307, DOI 10.1128/IAI.59.4.1307-1311.1991; RAMPHAL R, 1991, INFECT IMMUN, V59, P700, DOI 10.1128/IAI.59.2.700-704.1991; ROBERTS DD, 1990, AM J RESP CELL MOL, V3, P181, DOI 10.1165/ajrcmb/3.3.181; SCHARFMAN A, 1991, INFECT IMMUN, V59, P4283, DOI 10.1128/IAI.59.11.4283-4285.1991; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; WANNER A, 1979, AM J MED, V67, P477, DOI 10.1016/0002-9343(79)90797-6	18	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1994	93	3					585	593		10.1016/S0091-6749(94)70070-2	http://dx.doi.org/10.1016/S0091-6749(94)70070-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ND140	8151061				2022-12-18	WOS:A1994ND14000005
J	NASPITZ, CK; SOLE, D; SALTO, J				NASPITZ, CK; SOLE, D; SALTO, J			BETA-2-AGONISTS AND DEATH FROM ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											NASPITZ, CK (corresponding author), ESCOLA PAULISTA MED,DEPT PEDIAT,DIV ALLERGY CLIN IMMUNOL & RHEUMATOL,BR-04023 SAO PAULO,BRAZIL.		Solé, Dirceu/D-7789-2013					CRANE J, 1989, LANCET, V1, P917	1	6	8	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1994	93	3					677	677		10.1016/S0091-6749(94)70080-X	http://dx.doi.org/10.1016/S0091-6749(94)70080-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ND140	7908678				2022-12-18	WOS:A1994ND14000015
J	ALTMAN, DR; FITZGERALD, T; CHIARAMONTE, LT				ALTMAN, DR; FITZGERALD, T; CHIARAMONTE, LT			DOUBLE-BLIND PLACEBO-CONTROLLED CHALLENGE (DBPCC) OF PERSONS REPORTING ADVERSE REACTIONS TO MONOSODIUM GLUTAMATE (MSG)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				303	303						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700843
J	BERKA, C; CHIN, W				BERKA, C; CHIN, W			FLUTICASONE PROPIONATE INTRANASAL STEROID - COST-EFFECTIVENESS VS ANTIHISTAMINES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				165	165						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700013
J	GIEMBYCZ, MA; CORRIGAN, CJ; KAY, AB; BARNES, PJ				GIEMBYCZ, MA; CORRIGAN, CJ; KAY, AB; BARNES, PJ			INHIBITION OF CD4 AND CD8 T-LYMPHOCYTE (T-LC) PROLIFERATION AND CYTOKINE SECRETION BY ISOENZYME-SELECTIVE PHOSPHODIESTERASE (PDE) INHIBITORS - CORRELATION WITH INTRACELLULAR CYCLIC-AMP (CAMP) CONCENTRATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NATL HEART & LUNG INST,LONDON,ENGLAND	Imperial College London									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700028
J	HEY, JA; DELPRADO, M; CHAPMAN, RW; EGAN, RW; SIEGEL, MI; SHERWOOD, J; KREUTNER, W				HEY, JA; DELPRADO, M; CHAPMAN, RW; EGAN, RW; SIEGEL, MI; SHERWOOD, J; KREUTNER, W			LORATADINE PRODUCES ANTIHISTAMINE ACTIVITY WITHOUT ADVERSE CNS OR CARDIOVASCULAR EFFECTS IN GUINEA-PIGS - COMPARATIVE-STUDIES WITH SEDATING AND NONSEDATING H1 ANTIHISTAMINES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									SCHERING PLOUGH RES INC,KENILWORTH,NJ										0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				163	163						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700005
J	HOWARTH, PH; HARRISON, K; LAU, L; DUBE, L; COHN, J				HOWARTH, PH; HARRISON, K; LAU, L; DUBE, L; COHN, J			THE INFLUENCE OF THE 5-LIPOXYGENASE INHIBITOR A-78773 ON THE NASAL RESPONSE TO ALLERGEN IN RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				297	297						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700809
J	KANE, G; POLLICE, M; COHN, J; MURRAY, J; FISH, J; PETERS, S				KANE, G; POLLICE, M; COHN, J; MURRAY, J; FISH, J; PETERS, S			CONTROLLED TRIAL OF THE EFFECT OF A 5-LO INHIBITOR ON LUNG INFLAMMATION PRODUCED BY SEGMENTAL ANTIGEN CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				184	184						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700128
J	METZGER, WJ; RIDGER, V; TOLLEFSON, V; ARRHENIUS, T; GAETA, FCA; ELICES, M				METZGER, WJ; RIDGER, V; TOLLEFSON, V; ARRHENIUS, T; GAETA, FCA; ELICES, M			ANTI-VLA-4 ANTIBODY AND CS-1 PEPTIDE INHIBITOR MODIFIES AIRWAY INFLAMMATION AND BRONCHIAL AIRWAY HYPERRESPONSIVENESS (BHR) IN THE ALLERGIC RABBIT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Ridger, Victoria/GLN-8158-2022						0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				183	183						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700124
J	NELSON, HS; CONKLING, C; ARESON, J; SAMPSON, HA; BOCK, A; LEUNG, DYM				NELSON, HS; CONKLING, C; ARESON, J; SAMPSON, HA; BOCK, A; LEUNG, DYM			TREATMENT OF PATIENTS ANAPHYLACTICALLY SENSITIVE TO PEANUTS WITH INJECTIONS OF PEANUT EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				211	211						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700292
J	NOUREDDINE, G; THOMPSON, M; BRENNAN, F; PROUD, D; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM; TOGIAS, A				NOUREDDINE, G; THOMPSON, M; BRENNAN, F; PROUD, D; KAGEYSOBOTKA, A; LICHTENSTEIN, LM; NACLERIO, RM; TOGIAS, A			NASAL ANTIGEN CHALLENGE IN ASTHMATICS - EFFECTS OF CETIRIZINE (CET) ON NASAL AND PULMONARY RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				177	177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700086
J	OPPENHEIMER, J; BUCHMEIER, A; NELSON, HS				OPPENHEIMER, J; BUCHMEIER, A; NELSON, HS			DOUBLE-BLIND TRIAL OF A HEATED NASAL AEROSOL IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ALLERGIC RHINITIS; HEATED AEROSOL TREATMENT		Background: The effect of heated, moisturized air, delivered at 40 L/min and 43-degrees-C, on allergic rhinitis was evaluated in two studies. Methods: In the first study patients with chronic nasal symptoms and long-term exposure to a perennial allergen to which they were sensitive underwent 1 week of baseline observation and 1 week of treatment with either heated or room temperature moisturized air for 30 minutes twice daily. The effect of treatment was assessed by changes in nasal symptoms and nasal blockage index and by a global evaluation by the subjects at the end of the treatment period. In the second study subjects with a documented history of grass or weed pollen allergic rhinitis underwent titrated nasal pollen challenges immediately after treatment with either heated or room temperature moisturized air. The outcome was assessed by the end point of the nasal challenge and change in blockage index at the end point. Results: In both models there was no significant difference in the response between those treated with heated and those treated with room temperature moisturized air. Conclusion: This study did not demonstrate any evidence of a therapeutic effect of heated, moisturized air in the treatment of allergic rhinitis.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DIV ALLERGY IMMUNOL,1400 JACKSON ST,DENVER,CO 80206	National Jewish Health								BOUSQUET J, 1988, J ALLERGY CLIN IMMUN, V82, P439, DOI 10.1016/0091-6749(88)90017-6; GROSSMAN J, 1988, J ALLERGY CLIN IMMUN, V81, P175, DOI 10.1016/0091-6749(88)90263-1; MONGAR JL, 1957, J PHYSIOL-LONDON, V135, P320, DOI 10.1113/jphysiol.1957.sp005713; OPHIR D, 1988, ANN OTO RHINOL LARYN, V97, P259, DOI 10.1177/000348948809700309; TAYLOR G, 1973, J ALLERGY CLIN IMMUN, V52, P193, DOI 10.1016/0091-6749(73)90057-2; YERUSHALMI A, 1982, P NATL ACAD SCI-BIOL, V79, P4766, DOI 10.1073/pnas.79.15.4766	6	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				56	60		10.1016/0091-6749(93)90037-G	http://dx.doi.org/10.1016/0091-6749(93)90037-G			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353	8335855	Bronze			2022-12-18	WOS:A1993LQ35300009
J	RAJAKULASINGAM, K; CHURCH, MK; HOWARTH, PH; HOLGATE, ST				RAJAKULASINGAM, K; CHURCH, MK; HOWARTH, PH; HOLGATE, ST			FACTORS DETERMINING BRADYKININ BRONCHIAL RESPONSIVENESS AND REFRACTORINESS IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							INHALED BRADYKININ; BRONCHOCONSTRICTION				RAJAKULASINGAM, K (corresponding author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,IMMUNOPHARMACOL GRP,CTR BLOCK,LEVEL D,TREMONA RD,SOUTHAMPTON S09 4XY,ENGLAND.			Howarth, Peter/0000-0003-0619-7927				FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; POLOSA R, 1990, EUR RESPIR J, V3, P914; POLOSA R, 1990, ALLERGY, V45, P174, DOI 10.1111/j.1398-9995.1990.tb00480.x; POLOSA R, 1990, AM REV RESPIR DIS, V142, P1367, DOI 10.1164/ajrccm/142.6_Pt_1.1367; SIMONSSON BG, 1973, RESPIRATION, V30, P378, DOI 10.1159/000193051	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				140	142		10.1016/0091-6749(93)90049-L	http://dx.doi.org/10.1016/0091-6749(93)90049-L			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353	8335849				2022-12-18	WOS:A1993LQ35300021
J	CALL, RS; SMITH, TF; MORRIS, E; CHAPMAN, MD; PLATTSMILLS, TAE				CALL, RS; SMITH, TF; MORRIS, E; CHAPMAN, MD; PLATTSMILLS, TAE			INDOOR ALLERGEN LEVELS IN URBAN AND SUBURBAN HOMES OF ASTHMATICS IN ATLANTA, GEORGIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				172	172						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100125
J	EGMAR, L; EMENIUS, G; AXELSSON, G; PERSHAGEN, G; WICKMAN, M				EGMAR, L; EMENIUS, G; AXELSSON, G; PERSHAGEN, G; WICKMAN, M			DIRECT AND INDIRECT EXPOSURE TO CAT (FEL-D-I) AND DOG (CAN-F-I) ALLERGENS IN HOMES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				324	324						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100732
J	GAROFALO, R; PATEL, JA; SIM, TC; SCHMALSTIEG, FC; GOLDMAN, AS; OGRA, PL				GAROFALO, R; PATEL, JA; SIM, TC; SCHMALSTIEG, FC; GOLDMAN, AS; OGRA, PL			PRODUCTION OF CYTOKINES BY VIRUS-INFECTED HUMAN RESPIRATORY EPITHELIAL-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022						0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				177	177						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100146
J	MCCULLOUGH, J; OWNBY, D				MCCULLOUGH, J; OWNBY, D			A COMPARISON OF 3 INVITRO TESTS FOR LATEX SPECIFIC IGE ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1993	91	1	2				242	242						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK431					2022-12-18	WOS:A1993KK43100404
J	ZEISS, CR; HATOUM, NS; FERGUSON, J; TROUT, J; LEVITZ, D; SIDDIQUI, F; HENDERSON, J; YERMAKOFF, J; PATTERSON, R				ZEISS, CR; HATOUM, NS; FERGUSON, J; TROUT, J; LEVITZ, D; SIDDIQUI, F; HENDERSON, J; YERMAKOFF, J; PATTERSON, R			LOCALIZATION OF INHALED TRIMELLITIC ANHYDRIDE TO LUNG WITH A RESPIRATORY LYMPH-NODE ANTIBODY SECRETING CELL RESPONSE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						AEROSOL; ANHYDRIDE; IMMUNE RESPONSE; LUNG INJURY; OCCUPATION; HAPTEN; ELISPOT	INJURY	Male Sprague-Dawley rats were exposed to trimellitic anhydride (TMA) by inhalation (500 mug/m3), 4 hours a day, for 1 to 10 days. TMA was localized to lung cells by immunoelectron microscopy. Enzyme-linked immunosorbent assay (ELISA) and Western blot analysis were used in an attempt to localize TMA to lung lavage proteins. The lung-associated lymph node (LALN) B-lymphocyte response was measured by quantitation of immunoglobulin (Ig)G, IgA, and IgM antibody secreting cells specific for TMA rat serum albumin (TM-RSA) by use of the enzyme-linked immunospot assay (ELISPOT) method. The IgG, IgM, and IgA antibody response to TM-RSA in serum and lavage fluid was quantitated by ELISA. Lung injury was assessed by the number of external lung hemorrhagic foci and lung weight. Immunoelectron microscopy localized TMA to alveolar and bronchial cells on all exposure days. ELISA detected trace amounts of TMA haptenized lavage proteins that could not be detected by Western blot analysis. A marked increase occurred in lung injury from day 7 to 10. The LALN IgG, IgA, and IgM antibody secreting cell response to TM-RSA paralleled measures of lung injury. IgG, IgM, and IgA serum and lavage antibody to TM-RSA were correlated with lung injury measures. Lavage and serum IgG antibody levels had the highest correlation with lung injury.	NORTHWESTERN UNIV,SCH MED,DIV ALLERGY IMMUNOL,CHICAGO,IL 60611; IIT,RES INST,LIFE SCI RES,CHICAGO,IL 60616; AMOCO CHEM CO,DEPT ENVIRONM AFFAIRS & SAFETY,NAPERVILLE,IL 60540	Northwestern University; Illinois Institute of Technology	ZEISS, CR (corresponding author), LAKESIDE MED CTR,DEPT VET AFFAIRS,ACOS RES & DEV,400 E ONTARIO ST,CHICAGO,IL 60611, USA.				NIAID NIH HHS [AI-11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHANDLER MJ, 1987, J ALLERGY CLIN IMMUN, V80, P223, DOI 10.1016/0091-6749(87)90133-3; CZERKINSKY C, 1988, J IMMUNOL METHODS, V115, P31, DOI 10.1016/0022-1759(88)90306-7; LEACH CL, 1988, AM REV RESPIR DIS, V137, P186, DOI 10.1164/ajrccm/137.1.186; LEACH CL, 1987, TOXICOL APPL PHARM, V87, P67, DOI 10.1016/0041-008X(87)90085-8; LEDBETTER AD, 1987, AM IND HYG ASSOC J, V48, P35; McGrath K G, 1983, Clin Immunol Rev, V2, P1; SALVAGGIO JE, 1986, J ALLERGY CLIN IMMUN, V78, P1053, DOI 10.1016/0091-6749(86)90304-0; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1983, ANN INTERN MED, V98, P8, DOI 10.7326/0003-4819-98-1-8; ZEISS CR, 1989, IMMUNOL ALLERGY CLIN, V9, P235; ZEISS CR, 1988, AM REV RESPIR DIS, V137, P191, DOI 10.1164/ajrccm/137.1.191; ZEISS CR, 1990, ALLERGY PROC, V11, P71, DOI 10.2500/108854190778993245; ZZEISS CR, 1990, J ALLERGY CLIN IMMUN, V85, P190	13	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1992	90	6	1				944	952		10.1016/0091-6749(92)90467-G	http://dx.doi.org/10.1016/0091-6749(92)90467-G			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD190	1281179				2022-12-18	WOS:A1992KD19000011
J	EPSTEIN, MM; WATSKY, KL; LANZI, RA				EPSTEIN, MM; WATSKY, KL; LANZI, RA			THE ROLE OF DIET IN THE TREATMENT OF A PATIENT WITH URTICARIA AND URTICARIAL VASCULITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510	Yale University	EPSTEIN, MM (corresponding author), YALE UNIV,SCH MED,CLIN ALLERGY & IMMUNOL SECT,333 CEDAR ST,LCI 904,NEW HAVEN,CT 06510, USA.			Epstein, Michelle/0000-0002-4755-0224				JONES RR, 1983, BRIT J DERMATOL, V108, P695, DOI 10.1111/j.1365-2133.1983.tb01082.x; LEE CW, 1991, INT J DERMATOL, V30, P303; MONROE EW, 1981, J AM ACAD DERMATOL, V5, P88, DOI 10.1016/S0190-9622(81)70080-X; PAHUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P436; SOTER NA, 1974, J INVEST DERMATOL, V63, P485, DOI 10.1111/1523-1747.ep12680443; WINKELMANN RK, 1988, HUM PATHOL, V19, P389, DOI 10.1016/S0046-8177(88)80486-6	6	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	1				414	415		10.1016/S0091-6749(05)80026-0	http://dx.doi.org/10.1016/S0091-6749(05)80026-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP520	1527328				2022-12-18	WOS:A1992JP52000024
J	BEAUVAIS, F; HIEBLOT, C; BURTIN, C; BENVENISTE, J				BEAUVAIS, F; HIEBLOT, C; BURTIN, C; BENVENISTE, J			REGULATION OF HUMAN BASOPHIL ACTIVATION .3. IMPAIRMENT OF THE INHIBITORY EFFECT OF NA+ ON IGE-MEDIATED HISTAMINE-RELEASE IN PATIENTS WITH ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IMMEDIATE HYPERSENSITIVITY; ALLERGIC RHINITIS; BASOPHILS; HISTAMINE RELEASE; NA+	ATOPIC-DERMATITIS; ANTI-IGE; RELEASABILITY; HETEROGENEITY; INDIVIDUALS; ASTHMA	We recently observed that external Na+ inhibited the IgE-dependent human basophil histamine release (HR) in normal subjects. In this article we report differences in the Na+ effect on basophil HR between normal subjects (n = 16) and age matched patients with allergic rhinitis (AR) (n = 18). As expected, in vitro anti-IgE-stimulated basophils from the group with AR released greater amounts of histamine than basophils from the normal group. However, removal of external Na+ (and replacement by N-methyl-D-glucamine) abolished this difference between the two groups. HR in the normal group increased to the same high level as that of the group with AR. By contrast, the release of histamine in the group with AR was not further increased by Na+ removal. Although high releasers were more frequent in the group with AR, the absence of effect after Na+ removal was not due to the high basal release level (in the presence of Na+) because no effect after Na+ removal was also observed with medium releasers. These results strongly suggest that increased basophil HR in populations with AR, and possibly in other allergic populations, is linked to a defect in the inhibitory effect of Na+.			BEAUVAIS, F (corresponding author), UNIV PARIS SUD, INSERM, U200, 32 RUE CARNETS, F-92140 CLAMART, FRANCE.		BEAUVAIS, Francis/C-7556-2012	BEAUVAIS, Francis/0000-0002-5567-5924				ASSEM ESK, 1981, CLIN ALLERGY, V11, P367, DOI 10.1111/j.1365-2222.1981.tb01607.x; BEAUVAIS F, 1992, J IMMUNOL, V148, P149; BEAUVAIS F, 1991, J ALLERGY CLIN IMMUN, V87, P1020, DOI 10.1016/0091-6749(91)90426-O; BUSSE WW, 1986, J ALLERGY CLIN IMMUN, V78, P90, DOI 10.1016/0091-6749(86)90119-3; CASOLARO V, 1989, AM REV RESPIR DIS, V139, P1375, DOI 10.1164/ajrccm/139.6.1375; CASOLARO V, 1990, AM REV RESPIR DIS, V142, P1106; CONROY MC, 1979, INT ARCH ALLER A IMM, V60, P106, DOI 10.1159/000232329; CONROY MC, 1977, J IMMUNOL, V118, P1317; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; GADDY NK, 1984, AM REV RESPIR DIS, V134, P969; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOOK WA, 1981, IMMUNOLOGY, V43, P723; IZHIZAKA T, 1972, J IMMUNOL, V108, P1000; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACGLASHAN DW, 1986, J IMMUNOL, V136, P2231; MARONE G, 1986, J INVEST DERMATOL, V87, P19, DOI 10.1111/1523-1747.ep12523520; MARONE G, 1990, CLIN IMMUNOLOGY RESP, V7, P67; MATHE AA, 1973, BRIT MED J, V1, P193, DOI 10.1136/bmj.1.5847.193; PARISH WE, 1981, BRIT J DERMATOL, V105, P223, DOI 10.1111/j.1365-2133.1981.tb01210.x; PETERS SP, 1985, INT ARCH ALLER A IMM, V76, P344, DOI 10.1159/000233719; PLAUT M, 1986, J ALLERGY CLIN IMMUN, V78, P968, DOI 10.1016/0091-6749(86)90287-3; RUFF F, 1967, NATURE, V214, P279, DOI 10.1038/214279b0; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; TUNG R, 1982, J IMMUNOL, V128, P2067	26	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1992	90	1					52	58		10.1016/S0091-6749(06)80010-2	http://dx.doi.org/10.1016/S0091-6749(06)80010-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JE255	1378460				2022-12-18	WOS:A1992JE25500006
J	MANNING, PJ; WATSON, R; OBYRNE, PM				MANNING, PJ; WATSON, R; OBYRNE, PM			THE EFFECTS OF H2-RECEPTOR ANTAGONISTS ON EXERCISE REFRACTORINESS IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							HISTAMINE		MCMASTER UNIV,HLTH SCI CTR,DEPT MED,RM 3U2,1200 MAIN ST W,HAMILTON L8N 3Z5,ONTARIO,CANADA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba				O'Byrne, Paul/0000-0003-0979-281X				EDMUNDS AT, 1978, AM REV RESPIR DIS, V117, P247; HARTLEY JPR, 1980, THORAX, V35, P675, DOI 10.1136/thx.35.9.675; JACKSON PJ, 1988, AM REV RESPIR DIS, V138, P784, DOI 10.1164/ajrccm/138.4.784; MANNING PJ, 1987, J APPL PHYSIOL, V63, P1572, DOI 10.1152/jappl.1987.63.4.1572; OBRYNE PM, 1986, AM REV RESPIR DIS, V134, P69	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1992	90	1					125	126		10.1016/S0091-6749(06)80019-9	http://dx.doi.org/10.1016/S0091-6749(06)80019-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JE255	1352789				2022-12-18	WOS:A1992JE25500015
J	MARTIN, RJ; CICUTTO, LC; ACKERSON, LM				MARTIN, RJ; CICUTTO, LC; ACKERSON, LM			STABILITY OF THE CIRCADIAN ALTERATION IN LUNG-FUNCTION IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						NOCTURNAL ASTHMA; LUNG FUNCTION; BRONCHIAL RESPONSIVENESS	BRONCHIAL REACTIVITY; INHALED HISTAMINE; METHACHOLINE; RESPONSIVENESS	Although studies on pharmacologic interventions for nocturnal asthma are increasing, information about the long-term stability of circadian spirometric changes or bronchial responsiveness is not known. This study was undertaken to evaluate these variables in 10 patients with asthma measured quarterly during a 1-year period. We have found that the overnight decrease in peak expiratory flow rate measurements is stable (mean range, 13.8% to 16.4%) during the year, as are the quarterly 4 PM (1600-hour) and 4 AM (0400-hour) FEV1 values. The 4 PM provocative concentration of methacholine that produced a 20% fall in FEV1 (PC20) (range of geometric mean, 0.213 to 0.359 mg/ml) and the 4 AM PC20 (range, 0.057 to 0.152 mg/ml) for the group were also relatively stable. Individual variation was higher for the PC20 values than for the FEV1. We concluded that during a 1-year period, without acute respiratory events, (1) the overnight decrement in peak expiratory flow rate and the 4 AM and 4 PM FEV1 values were constant and (2) bronchial responsiveness demonstrated some individual variability, but for the group, it remained stable.			MARTIN, RJ (corresponding author), UNIV COLORADO,HLTH SCI CTR,NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DIV PULM SCI,DENVER,CO 80206, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36577] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALZANO G, 1989, CHEST, V95, P1239, DOI 10.1378/chest.95.6.1239; BENSON MK, 1975, BRIT J DIS CHEST, V69, P227, DOI 10.1016/0007-0971(75)90090-X; BHAGAT RG, 1984, AM REV RESPIR DIS, V129, P221; Cochran W.G, 1957, STAT METHODS, V6th ed; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; GREENSPON LW, 1986, AM REV RESPIR DIS, V133, P735; JOSEPHS LK, 1989, AM REV RESPIR DIS, V140, P350, DOI 10.1164/ajrccm/140.2.350; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; JUNIPER EF, 1982, THORAX, V37, P288, DOI 10.1136/thx.37.4.288; MARTIN RJ, 1990, AM REV RESPIR DIS, V141, P33, DOI 10.1164/ajrccm/141.1.33; ROSENTHAL RR, 1979, CHEST, V75, P228, DOI 10.1378/chest.75.2.228; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; YAN K, 1985, AM REV RESPIR DIS, V132, P25	13	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1992	89	3					703	708		10.1016/0091-6749(92)90377-E	http://dx.doi.org/10.1016/0091-6749(92)90377-E			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HJ340	1545091				2022-12-18	WOS:A1992HJ34000009
J	BOGUNIEWICZ, M; SCHNEIDER, LC; MILGROM, H; NEWELL, D; JAFFE, HS; IZU, AE; BUCALO, LR; LEUNG, DYM				BOGUNIEWICZ, M; SCHNEIDER, LC; MILGROM, H; NEWELL, D; JAFFE, HS; IZU, AE; BUCALO, LR; LEUNG, DYM			TREATMENT OF STEROID-DEPENDENT ASTHMA (SDA) WITH RECOMBINANT INTERFERON-GAMMA (RIFN-GAMMA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				288	288						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000524
J	CURRAN, IHA; YOUNG, NM; BURTON, M; VIJAY, HM				CURRAN, IHA; YOUNG, NM; BURTON, M; VIJAY, HM			PURIFICATION AND CHARACTERIZATION OF A LOW-MOLECULAR-WEIGHT ANTIGEN FROM ALTERNARIA-ALTERNATA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				283	283						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000504
J	FERNANDEZRIVAS, M; CESAR, JM; LOSADA, E				FERNANDEZRIVAS, M; CESAR, JM; LOSADA, E			ASTHMA RELIEVED BY ASPIRIN - CLINICAL-STUDIES, PLATELET-FUNCTION, AND ARACHIDONATE METABOLISM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							ACID METABOLISM		RAMON & CAJAL HOSP,DEPT ALLERGY,MADRID,SPAIN; RAMON & CAJAL HOSP,DEPT HEMATOL,MADRID,SPAIN	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal								BONNE C, 1985, ANN ALLERGY, V54, P158; CAPRON A, 1985, INT ARCH ALLER A IMM, V77, P107, DOI 10.1159/000233762; CESAR JM, 1990, BRIT J HAEMATOL, V74, P295, DOI 10.1111/j.1365-2141.1990.tb02586.x; SZCZEKLIK A, 1986, DRUGS, V32, P148, DOI 10.2165/00003495-198600324-00011; VANE J, 1987, DRUGS, V33, P18, DOI 10.2165/00003495-198700331-00005	5	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	1				141	143		10.1016/S0091-6749(05)80052-1	http://dx.doi.org/10.1016/S0091-6749(05)80052-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ908	1730834				2022-12-18	WOS:A1992GZ90800017
J	MATTOLI, S; VITTORI, E; MARINI, M				MATTOLI, S; VITTORI, E; MARINI, M			CORTICOSTEROIDS DOWN-REGULATE THE INCREASED EXPRESSION OF GM-CSF, IL6 AND IL8 IN BRONCHIAL EPITHELIUM OF ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									DIAGNOST CTR RESP DIS,MILAN,ITALY									CHEST, 1992, ASPEN C S; 1991, AJP, V260, pL530; 1991, JACI, V87, P794	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				164	164						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000079
J	RESLER, B; SEDGWICK, JB; BUSSE, WW				RESLER, B; SEDGWICK, JB; BUSSE, WW			INHIBITION OF INTERLEUKIN-5 (IL-5) EFFECTS ON HUMAN EOSINOPHILS (EOS) BY NEDOCROMIL SODIUM (NED)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				235	235						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000314
J	SHER, ER; SURS, W; KAM, JC; KAMADA, AK; HARBECK, R; LEUNG, DYM; SZEFLER, SJ				SHER, ER; SURS, W; KAM, JC; KAMADA, AK; HARBECK, R; LEUNG, DYM; SZEFLER, SJ			CHARACTERIZATION OF LYMPHOCYTES-T AND GLUCOCORTICOID (GC) RECEPTORS (R) IN STEROID RESISTANT (SR) ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				285	285						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000515
J	WALD, JA; FARR, RS				WALD, JA; FARR, RS			ABNORMAL LIVER-FUNCTION TESTS ASSOCIATED WITH LONG-TERM SYSTEMIC CORTICOSTEROID USE IN SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DENVER,CO	National Jewish Health								CARRYER HM, 1950, J ALLERGY, V21, P282, DOI 10.1016/0021-8707(50)90059-1; DIJOUNE CA, 1973, MED CLIN N AM, V57, P1331; WALD JA, 1986, J ALLERGY CLIN IMMUN, V78, P36, DOI 10.1016/0091-6749(86)90112-0	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1991	88	2					277	278		10.1016/0091-6749(91)90340-T	http://dx.doi.org/10.1016/0091-6749(91)90340-T			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB225	1880328				2022-12-18	WOS:A1991GB22500019
J	YANAI, M; OHRUI, T; SEKIZAWA, K; SHIMIZU, Y; SASAKI, H; TAKISHIMA, T				YANAI, M; OHRUI, T; SEKIZAWA, K; SHIMIZU, Y; SASAKI, H; TAKISHIMA, T			EFFECTIVE SITE OF BRONCHODILATION BY ANTIASTHMA DRUGS IN SUBJECTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AIRWAY SMOOTH-MUSCLE; FLOW LIMITATION; SERIAL DISTRIBUTION; VAGAL-STIMULATION; LUNG-MECHANICS; ISOPROTERENOL; METHACHOLINE; HISTAMINE; BRONCHOCONSTRICTION; AMINOPHYLLINE	We studied the effective sites of airway response to atropine and fenoterol aerosols and to the intravenous injection of aminophylline in patients with stable and spontaneous asthma, by the simultaneous assessment of respiratory resistance (Rrs) and anatomic dead space (V(D)). Central airway response was determined by V(D), and overall response was determined by Rrs. Peripheral airway response was inferred from Rrs when the change in V(D) was slight. Atropine (4 mg/ml) or fenoterol (0.4 mg/ml) was continuously inhaled during tidal breathing for 5 minutes. Inhalation of both atropine and fenoterol increased Grs (reciprocal of Rrs) (p < 0.01) with a simultaneous increase in V(D) (p < 0.01) in the patients with stable and spontaneous asthma. Fenoterol increased Grs more than did atropine at an equivalent increase in V(D) in patients with spontaneous asthma (p < 0.05). Intravenous injection of aminophylline (250 mg) had no effect on either Grs or V(D) in patients with stable asthma, but it significantly increased Grs (p < 0.01) without change in V(D) in patients with spontaneous asthma. These results suggest that the predominant sites of bronchodilation induced by inhaled atropine are the central airways, that those sites induced by intravenous injection of aminophylline are the peripheral airways, and that inhaled fenoterol dilates both the central and peripheral airways in subjects with asthma. Differences among clinically used bronchodilators on the effective sites may be considered in the treatment of bronchial asthma.	TOHOKU UNIV,SCH MED,DEPT INTERNAL MED 1,SENDAI,MIYAGI 980,JAPAN	Tohoku University								BARNES PJ, 1983, AM REV RESPIR DIS, V127, P758; BOUHUYS A, 1971, J APPL PHYSIOL, V30, P670, DOI 10.1152/jappl.1971.30.5.670; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; BRUNING JL, 1977, COMPUTATIONAL HDB ST, P55; COLLETT PW, 1983, AM REV RESPIR DIS, V128, P719; COTES JE, 1979, LUNG FUNCTION ASSESS, P369; DETROYER A, 1979, J APPL PHYSIOL, V46, P217, DOI 10.1152/jappl.1979.46.2.217; DRAZEN JM, 1979, J APPL PHYSIOL, V47, P657, DOI 10.1152/jappl.1979.47.4.657; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; ESTENNE M, 1980, AM REV RESPIR DIS, V121, P967; FAIRSHTER RD, 1980, AM REV RESPIR DIS, V122, P27; GRIMBY G, 1968, J CLIN INVEST, V47, P1455, DOI 10.1172/JCI105837; HART MC, 1963, J APPL PHYSIOL, V18, P519, DOI 10.1152/jappl.1963.18.3.519; HENSLEY MJ, 1978, J APPL PHYSIOL, V45, P778, DOI 10.1152/jappl.1978.45.5.778; HORSFIELD K, 1968, J APPL PHYSIOL, V24, P384, DOI 10.1152/jappl.1968.24.3.384; HYATT RE, 1970, J APPL PHYSIOL, V28, P675, DOI 10.1152/jappl.1970.28.5.675; INGRAM RH, 1977, J CLIN INVEST, V59, P696, DOI 10.1172/JCI108688; JACKSON AC, 1981, J APPL PHYSIOL, V50, P1286, DOI 10.1152/jappl.1981.50.6.1286; Langley FE, 1975, C I NAT SANTE RECH M, V51, P209; MCFADDEN ER, 1970, J CLIN INVEST, V49, P779, DOI 10.1172/JCI106291; MCFADDEN ER, 1977, J APPL PHYSIOL, V42, P746, DOI 10.1152/jappl.1977.42.5.746; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; NIEWOEHNER DE, 1979, J APPL PHYSIOL, V47, P330, DOI 10.1152/jappl.1979.47.2.330; NUNN JF, 1959, J APPL PHYSIOL, V14, P174, DOI 10.1152/jappl.1959.14.2.174; RODARTE JR, 1985, HDB PHYSL RESPIRAT 3, V1, P131; SEKIZAWA K, 1984, J APPL PHYSIOL, V57, P7, DOI 10.1152/jappl.1984.57.1.7; SEKIZAWA K, 1988, AM REV RESPIR DIS, V137, P1312, DOI 10.1164/ajrccm/137.6.1312; SEKIZAWA K, 1983, J APPL PHYSIOL, V55, P591, DOI 10.1152/jappl.1983.55.2.591; SEKIZAWA K, 1986, AM REV RESPIR DIS, V133, P593; SEVERINGHAUS JW, 1955, J APPL PHYSIOL, V8, P81, DOI 10.1152/jappl.1955.8.1.81; SHINDOH C, 1985, AM REV RESPIR DIS, V132, P671; TAKISHIMA T, 1981, CHEST, V80, P600, DOI 10.1378/chest.80.5.600; VANDENBRINK FG, 1972, B PHYSIO-PATHOL RESP, V8, P475; WIDDICOMBE JG, 1963, J APPL PHYSIOL, V18, P863, DOI 10.1152/jappl.1963.18.5.863; WIDDICOMBE JG, 1962, J APPL PHYSIOL, V17, P613, DOI 10.1152/jappl.1962.17.4.613; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703	37	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1991	87	6					1080	1087		10.1016/0091-6749(91)92153-R	http://dx.doi.org/10.1016/0091-6749(91)92153-R			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR066	2045613				2022-12-18	WOS:A1991FR06600007
J	MUILENBERG, ML; SKELLENGER, WS; BURGE, HA; SOLOMON, WR				MUILENBERG, ML; SKELLENGER, WS; BURGE, HA; SOLOMON, WR			PARTICLE PENETRATION INTO THE AUTOMOTIVE INTERIOR .1. INFLUENCE OF VEHICLE SPEED AND VENTILATORY MODE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ROTOROD	Penetration of particulate aeroallergens into the interiors of two, new, similar Chrysler Corporation passenger vehicles (having no evidence of intrinsic microbial contamination) was studied on a large circular test track during periods of high pollen and spore prevalence. Impactor collections were obtained at front and rear seat points and at the track center during periods with (1) windows and vents closed and air conditioning on, (2) windows closed, vents open, and no air conditioning, and (3) air conditioner off, front windows open, and vents closed. These conditions were examined sequentially during travel at 40, 50, 60, and 80 kph. Particle recoveries within the two, new, similar Chrysler Corporation passenger vehicles did not vary with the speed of travel, either overall or with regard to each of the three ventilatory modalities. In addition, collections at front and rear seat sampling points were comparable. Highest interior aeroallergen levels were recorded with WO, and yet, these levels averaged only half the concurrent outside concentrations at track center. Recoveries within the cars were well below recoveries obtained outside when windows were closed (both VO and AC modes). These findings suggest window ventilation as an overriding factor determining particle ingress into moving vehicles. Efforts to delineate additional determinants of exposure by direct sampling are feasible and would appear essential in formulating realistic strategies of avoidance.			MUILENBERG, ML (corresponding author), UNIV MICHIGAN,MED CTR,ALLERGY RES LAB,6621 KRESGE I,0529,ANN ARBOR,MI 48109, USA.				NIAID NIH HHS [AI-10181] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		EDMONDS RL, 1972, PLANT DIS REP, V56, P704; Gay LN, 1941, B JOHNS HOPKINS HOSP, V68, P179; KUMAR P, 1981, NEW ENGL J MED, V305, P1531, DOI 10.1056/NEJM198112173052515; OGDEN EC, 1967, 7 NY STAT MUS SCI SE, P2; OGDEN EC, 1969, 9 NEW YORK STAT MUS, P2; SOLOMON WR, 1980, INT J BIOMETEOROL, V24, P107, DOI 10.1007/BF02253798; 1990, HIGHWAY STATISTICS 1, P172; 1979, SERVICE MANUAL	8	6	6	2	5	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1991	87	2					581	585		10.1016/0091-6749(91)90018-J	http://dx.doi.org/10.1016/0091-6749(91)90018-J			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EX987	1993816	Bronze			2022-12-18	WOS:A1991EX98700017
J	RAVID, A; TAMIR, R; LIBERMAN, UA; ROTEM, C; PICK, AI; NOVOGRODSKY, A; KOREN, R				RAVID, A; TAMIR, R; LIBERMAN, UA; ROTEM, C; PICK, AI; NOVOGRODSKY, A; KOREN, R			1,25-DIHYDROXYVITAMIN-D3 POTENTIATES THE DECREASED RESPONSE OF LYMPHOCYTES FROM ATOPIC SUBJECTS TO AGENTS THAT INCREASE INTRACELLULAR CYCLIC ADENOSINE-MONOPHOSPHATE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PROSTAGLANDIN-E2 PGE2; AMP-PHOSPHODIESTERASE; POSSIBLE MECHANISM; MONONUCLEAR-CELLS; BRONCHIAL-ASTHMA; DERMATITIS; LEUKOCYTE; ECZEMA; SUPPRESSION; RECEPTORS	The inhibitory effect of prostaglandin E2, histamine, isobutylmethylxanthine, and 1,25-dihydroxyvitamin D3 (1,25-[OH]2D3) on the mitogenic stimulation of peripheral blood lymphocytes from normal and atopic subjects was studied. We found that lymphocytes from atopic patients were less susceptible to inhibition by the three agents that elevate intracellular cyclic adenosine monophosphate (cAMP) concentrations and by the active metabolite of vitamin D (inhibition of 27%, 14%, 12%, and 36% for the atopic patients as compared with 40%, 20%, 22%, and 46% for the normal donors, by the four agents, respectively; p < 0.02). The inhibitory effect of the cAMP-elevating agents was potentiated by the addition of 1,25-(OH)2D3 to the lymphocyte cultures. The potentiation was more pronounced on lymphocytes from the atopic donors, increasing their responsiveness to levels comparable to levels of lymphocytes from normal donors. The synthetic corticosteroid, dexamethasone, had a similar potentiating effect on the inhibitory action of prostaglandin E2. In view of the beneficial action of beta-agonists, phosphodiesterase inhibitors, and corticosteroids in the treatment of allergy, the potentiating effect of 1,25-(OH)2D3 on the action of cAMP-elevating agents may be of therapeutic interest.	BEILINSON MED CTR, DIV CLIN IMMUNOL & ALLERGY, IL-49100 PETAH TIQWA, ISRAEL; BEILINSON MED CTR, METAB DIS UNIT, IL-49100 PETAH TIQWA, ISRAEL	Rabin Medical Center; Rabin Medical Center	RAVID, A (corresponding author), BEILINSON MED CTR, ROGOFF MED RES INST, IL-49100 PETAH TIQWA, ISRAEL.							ARCHER CB, 1983, BRIT J DERMATOL, V109, P559, DOI 10.1111/j.1365-2133.1983.tb07679.x; BEER DJ, 1982, NEW ENGL J MED, V306, P454, DOI 10.1056/NEJM198202253060804; BUSSE WW, 1979, J INVEST DERMATOL, V73, P184, DOI 10.1111/1523-1747.ep12581674; BUTLER JM, 1983, J ALLERGY CLIN IMMUN, V71, P490, DOI 10.1016/0091-6749(83)90467-0; FRAJMAN M, 1987, ALLERGY, V42, P81, DOI 10.1111/j.1398-9995.1987.tb02363.x; GONZALEZ H, 1986, CHEST, V89, P491, DOI 10.1378/chest.89.4.491; GREWE SR, 1982, J ALLERGY CLIN IMMUN, V70, P452, DOI 10.1016/0091-6749(82)90008-2; KALINER M, 1985, J ALLERGY CLIN IMMUN, V76, P321, DOI 10.1016/0091-6749(85)90648-7; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; KOREN R, 1985, J CLIN INVEST, V76, P2012, DOI 10.1172/JCI112201; KOREN R, 1986, FEBS LETT, V205, P113, DOI 10.1016/0014-5793(86)80876-6; MCMILLAN JC, 1985, ACTA DERM-VENEREOL, P24; PARKER CW, 1977, J INVEST DERMATOL, V68, P302, DOI 10.1111/1523-1747.ep12494569; RAVID A, 1990, J CLIN ENDOCR METAB, V70, P1687, DOI 10.1210/jcem-70-6-1687; REED CE, 1976, J INVEST DERMATOL, V67, P333, DOI 10.1111/1523-1747.ep12514494; RIGBY WFC, 1988, IMMUNOL TODAY, V9, P54; ROCKLIN RE, 1985, J IMMUNOL, V135, P2033; ROCKLIN RE, 1986, CELL IMMUNOL, V99, P294, DOI 10.1016/0008-8749(86)90237-6; RUBIN JE, 1987, MOL CELL ENDOCRINOL, V52, P213, DOI 10.1016/0303-7207(87)90046-3; SAFKO MJ, 1981, J ALLERGY CLIN IMMUN, V68, P218, DOI 10.1016/0091-6749(81)90187-1; Smith J. M., 1978, ALLERGY PRINCIPLES P, P633; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; Szentivanyi A, 1980, ACTA DERM-VENEREOL, VS92, P19; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; WANG SR, 1978, CELL IMMUNOL, V36, P28, DOI 10.1016/0008-8749(78)90247-2	25	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1990	86	6	1				881	885		10.1016/S0091-6749(05)80150-2	http://dx.doi.org/10.1016/S0091-6749(05)80150-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EQ045	1702127				2022-12-18	WOS:A1990EQ04500008
J	FIREMAN, P				FIREMAN, P			THE ROLE OF ANTIHISTAMINES IN OTITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	MEETING ON HISTAMINE AND DISEASE : A FORUM ON CURRENT AND FUTURE MANAGEMENT	AUG 25-26, 1989	CARLSBAD, CA	MERRELL DOW PHARM							FIREMAN, P (corresponding author), CHILDRENS HOSP PITTSBURGH,ALLERGY IMMUNOL & RHEUMATOL,3705 5TH AVE,PITTSBURGH,PA 15213, USA.							ACKERMAN M, 1985, J ALLERGY CLIN IMMUN, V73, P604; Bluestone CD, 1985, ANN OTOL RHINOL S120, V94, P48, DOI 10.1177/00034894850945S235; CANTEKIN EI, 1983, NEW ENGL J MED, V308, P297, DOI 10.1056/NEJM198302103080601; CASSELBRANT ML, 1985, LARYNGOSCOPE, V95, P428; DOYLE WJ, 1988, PEDIATR INFECT DIS J, V7, P229, DOI 10.1097/00006454-198803000-00033; DOYLE WJ, 1990, IN PRESS J ALLERGY C; FIREMAN P, 1988, J ALLERGY CLIN IMMUN, V81, P953, DOI 10.1016/0091-6749(88)90159-5; FRIEDMAN RA, 1983, J ALLERGY CLIN IMMUN, V71, P442, DOI 10.1016/0091-6749(83)90459-1; Pukander J, 1984, RECENT ADV OTITIS ME, P9; RIDING KH, 1978, J PEDIATR-US, V93, P739, DOI 10.1016/S0022-3476(78)81069-5; SARKKINEN H, 1985, J INFECT DIS, V151, P444, DOI 10.1093/infdis/151.3.444; SKONER DP, 1986, ARCH OTOLARYNGOL, V112, P840; SKONER DP, 1987, J ALLERGY CLIN IMMUN, V79, P27, DOI 10.1016/S0091-6749(87)80012-X; SKONER DP, 1988, ARCH OTOLARYNGOL, V114, P1131; SKONER DP, 1988, AM J RHINOL, V2, P155; STILLWAGON PK, 1987, ANN ALLERGY, V58, P442; TEELE DW, 1980, ANN OTO RHINOL LARYN, V89, P5, DOI 10.1177/00034894800890S304	17	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	2	S			638	641		10.1016/S0091-6749(05)80229-5	http://dx.doi.org/10.1016/S0091-6749(05)80229-5			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EH093	2229826				2022-12-18	WOS:A1990EH09300010
J	DRUCE, HM				DRUCE, HM			THE EFFECTS OF AN H1-RECEPTOR ANTAGONIST, TERFENADINE, ON HISTAMINE-INDUCED MICROCIRCULATORY CHANGES AND VASOPERMEABILITY IN NASAL-MUCOSA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											DRUCE, HM (corresponding author), ST LOUIS UNIV, SCH MED, DEPT INTERNAL MED, DIV ALLERGY & IMMUNOL, 1402 S GRAND BLVD, ST LOUIS, MO 63104 USA.							ANDERSSON M, 1987, ALLERGY, V42, P631, DOI 10.1111/j.1398-9995.1987.tb00395.x; BENDE M, 1984, ACTA OTO-LARYNGOL, V97, P99, DOI 10.3109/00016488409130969; BENDE M, 1983, ACTA OTO-LARYNGOL, V96, P277, DOI 10.3109/00016488309132900; Bonner RF, 1981, NATO ASI SER B-PHYS, V73, P685; COHEN RA, 1988, CLIN ALLERGY, V18, P435, DOI 10.1111/j.1365-2222.1988.tb02893.x; DRUCE H, 1985, J ALLERGY CLIN IMMUN, V75, P111, DOI 10.1016/0091-6749(85)90162-9; DRUCE HM, 1985, ANN ALLERGY, V55, P237; DRUCE HM, 1985, J ALLERGY CLIN IMMUN, V76, P445, DOI 10.1016/0091-6749(85)90725-0; DRUCE HM, 1989, MICROVASC RES, V38, P175, DOI 10.1016/0026-2862(89)90026-5; DRUCE HM, 1984, INT J MICROCIRC, V3, P479; DRUCE HM, 1984, J APPL PHYSIOL, V57, P1276, DOI 10.1152/jappl.1984.57.4.1276; DRUCE HM, 1990, LASER DOPPLER FLOMET, P251; HAVAS TE, 1986, J ALLERGY CLIN IMMUN, V78, P856, DOI 10.1016/0091-6749(86)90230-7; HOLMBERG K, 1988, J ALLERGY CLIN IMMUN, V81, P531, DOI 10.1016/0091-6749(88)90192-3; JULIUSSON S, 1987, CLIN ALLERGY, V17, P301, DOI 10.1111/j.1365-2222.1987.tb02018.x; KALINER MA, 1988, ALLERGY PROC, V9, P649, DOI 10.2500/108854188778965528; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; NACLERIO RM, 1984, ARCH OTOLARYNGOL, V110, P25; OLANOFF LS, 1987, J CLIN INVEST, V80, P890, DOI 10.1172/JCI113148; OLSSON P, 1986, ACTA OTO-LARYNGOL, V102, P106, DOI 10.3109/00016488609108653; OLSSON P, 1988, J ALLERGY CLIN IMMUN, V82, P291, DOI 10.1016/0091-6749(88)91014-7; RAPHAEL GD, 1986, J ALLERGY CLIN IMMUN, V77, P239; RAPHAEL GD, 1988, AM REV RESPIR DIS, V138, P413, DOI 10.1164/ajrccm/138.2.413; RAPHAEL GD, 1989, AM REV RESPIR DIS, V139, P791, DOI 10.1164/ajrccm/139.3.791; ROKENES HK, 1988, CLIN ALLERGY, V18, P63, DOI 10.1111/j.1365-2222.1988.tb02844.x; SECHER C, 1982, J ALLERGY CLIN IMMUN, V70, P211, DOI 10.1016/0091-6749(82)90044-6; SERUP J, 1985, ALLERGY, V40, P233, DOI 10.1111/j.1398-9995.1985.tb00226.x; TANIMOTO H, 1983, Rhinology (Utrecht), V21, P59	29	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1990	86	3	1				344	352		10.1016/S0091-6749(05)80097-1	http://dx.doi.org/10.1016/S0091-6749(05)80097-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EA859	1976665				2022-12-18	WOS:A1990EA85900008
J	MAZER, B; FIGUEROAROSARIO, W; BENDER, B				MAZER, B; FIGUEROAROSARIO, W; BENDER, B			THE EFFECT OF ALBUTEROL AEROSOL ON FINE-MOTOR PERFORMANCE IN CHILDREN WITH CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT PSYCHIAT SERV,1400 JACKSON ST,DENVER,CO 80206; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT REHABIL SERV,DENVER,CO 80206	National Jewish Health; National Jewish Health								AHRENS RC, 1987, J ALLERGY CLIN IMMUN, V79, P876, DOI 10.1016/0091-6749(87)90235-1; Ayres AJ, 1987, SENSORY INTEGRATION; Bruininks R., 2005, BRUININKS OSERETSKY, V(2nd); CANNY GJ, 1988, ANN ALLERGY, V60, P11; GEORGE RB, 1981, ANN ALLERGY, V47, P384; HUHTI E, 1978, CHEST, V73, P348, DOI 10.1378/chest.73.3.348; JENNE JW, 1986, AM REV RESPIR DIS, V134, P708; JENNE JW, 1982, AM REV RESPIR DIS, V126, P607; JOAD JP, 1986, J ALLERGY CLIN IMMUN, V78, P1147, DOI 10.1016/0091-6749(86)90264-2; JOAD JP, 1987, J ALLERGY CLIN IMMUN, V79, P78, DOI 10.1016/S0091-6749(87)80020-9; LITTNER MR, 1983, ANN ALLERGY, V50, P309; LONNERHOLM G, 1984, J ALLERGY CLIN IMMUN, V73, P508, DOI 10.1016/0091-6749(84)90362-2; NELSON HS, 1985, ANN ALLERGY, V54, P289; SNIDER GL, 1972, J AMER MED ASSOC, V221, P682, DOI 10.1001/jama.221.7.682; SPANGLER DL, 1989, ANN ALLERGY, V62, P59; SPECTOR SL, 1977, J ALLERGY CLIN IMMUN, V59, P280, DOI 10.1016/0091-6749(77)90048-3; 1985, J ALLERGY CLIN IMMUN, V75, P443	17	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1990	86	2					243	248		10.1016/S0091-6749(05)80071-5	http://dx.doi.org/10.1016/S0091-6749(05)80071-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DV316	2384652				2022-12-18	WOS:A1990DV31600015
J	GARIBALDI, E; SLAVIN, RG				GARIBALDI, E; SLAVIN, RG			MULTITEST FALSE-POSITIVE READINGS CAN BE OBSERVED AFTER DEVIATION FROM PRODUCT USE INSTRUCTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											GARIBALDI, E (corresponding author), ST LOUIS UNIV,MED CTR,DIV ALLERGY & IMMUNOL,1402 S GRAND BLVD,ST LOUIS,MO 63104, USA.							ADINOFF AD, 1989, J ALLERGY CLIN IMMUN, V84, P168, DOI 10.1016/0091-6749(89)90321-7; GARIBALDI E, 1989, 45TH ANN M AM AC ALL; ZEIGER RS, 1989, J ALLERGY CLIN IMMUN, V84, P72, DOI 10.1016/0091-6749(89)90181-4	3	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1990	86	1					137	137						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DQ688	2370383				2022-12-18	WOS:A1990DQ68800020
J	CAVAILLON, JM; POIGNET, JL; FITTING, C; DELONS, S; PUSINERI, C; COLLIER, C; DAVID, B				CAVAILLON, JM; POIGNET, JL; FITTING, C; DELONS, S; PUSINERI, C; COLLIER, C; DAVID, B			HIGH INVITRO SPONTANEOUS HISTAMINE-RELEASE IN LONG-TERM HEMODIALYZED PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CTR MED E RIST, PARIS, FRANCE; HOSPAL RES CTR, MEYZIEU, FRANCE		CAVAILLON, JM (corresponding author), INST PASTEUR, UNITE IMMUNOALLERGIE, 28 RUE DR ROUX, F-75724 PARIS 15, FRANCE.							AKAGI K, 1989, J ALLERGY CLIN IMMUN, V83, P742, DOI 10.1016/0091-6749(89)90009-2; BOMMER J, 1985, LANCET, V2, P1382; BOUSQUET J, 1988, J ALLERGY CLIN IMMUN, V81, P590, DOI 10.1016/0091-6749(88)90201-1; BOUSQUET J, 1987, CLIN ALLERGY, V17, P499, DOI 10.1111/j.1365-2222.1987.tb02045.x; BRUNET C, 1988, J ALLERGY CLIN IMMUN, V82, P398, DOI 10.1016/0091-6749(88)90011-5; CARUANA RJ, 1985, AM J NEPHROL, V5, P271, DOI 10.1159/000166946; CHESTER EH, 1977, CLIN ALLERGY, V7, P15, DOI 10.1111/j.1365-2222.1977.tb01419.x; DOLOVICH J, 1978, J ALLERGY CLIN IMMUN, V62, P30, DOI 10.1016/0091-6749(78)90069-6; DOLOVICH J, 1984, ARTIF ORGANS, V8, P334, DOI 10.1111/j.1525-1594.1984.tb04301.x; FLINT KC, 1986, RESPIRATION, V50, P31, DOI 10.1159/000195099; GRAMMER LC, 1984, J ALLERGY CLIN IMMUN, V74, P544, DOI 10.1016/0091-6749(84)90392-0; LEBEL B, 1983, ANAL BIOCHEM, V133, P16, DOI 10.1016/0003-2697(83)90217-8; LEITMAN SF, 1986, NEW ENGL J MED, V315, P1192, DOI 10.1056/NEJM198611063151904; LEMAO J, 1985, INT ARCH ALLER A IMM, V76, P289, DOI 10.1159/000233709; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; MARSHALL C, 1984, CLIN NEPHROL, V21, P346; MARSHALL CP, 1985, J ALLERGY CLIN IMMUN, V75, P563, DOI 10.1016/0091-6749(85)90030-2; MAURICE F, 1986, J ALLERGY CLIN IMMUN, V77, P594, DOI 10.1016/0091-6749(86)90351-9; MAY CD, 1982, CLIN ALLERGY, V12, P229, DOI 10.1111/j.1365-2222.1982.tb02523.x; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; NICHOLLS A, 1986, BRIT MED J, V292, P1221, DOI 10.1136/bmj.292.6530.1221; PATTERSON R, 1986, INT ARCH ALLER A IMM, V79, P53, DOI 10.1159/000233942; POIGNET JL, 1988, NEPHROLOGIE, V9, P288; POOTHULLIL J, 1975, ANN INTERN MED, V82, P58, DOI 10.7326/0003-4819-82-1-58; RIMMER J, 1986, CLIN ALLERGY, V16, P221, DOI 10.1111/j.1365-2222.1986.tb00769.x; ROCKEL A, 1986, LANCET, V1, P382; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; STAHLEBACKDAHL M, 1988, ACTA DERM-VENEREOL, V68, P230; STOCKENHUBER F, 1987, NEW ENGL J MED, V317, P386; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WASS U, 1989, J ALLERGY CLIN IMMUN, V83, P126, DOI 10.1016/0091-6749(89)90487-9; WEYER A, 1978, CLIN ALLERGY, V8, P187, DOI 10.1111/j.1365-2222.1978.tb00463.x; WEYER A, 1982, ANN INST PASTEUR IMM, VD133, P87	33	6	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1990	85	5					859	864		10.1016/0091-6749(90)90069-G	http://dx.doi.org/10.1016/0091-6749(90)90069-G			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DD959	1692047	Bronze			2022-12-18	WOS:A1990DD95900007
J	ZEISS, CR; LEACH, CL; LEVITZ, D; HATOUM, NS; GARVIN, PJ; PATTERSON, R				ZEISS, CR; LEACH, CL; LEVITZ, D; HATOUM, NS; GARVIN, PJ; PATTERSON, R			LUNG INJURY INDUCED BY SHORT-TERM INTERMITTENT TRIMELLITIC ANHYDRIDE (TMA) INHALATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									AMOCO CORP,DEPT ENVIRONM AFFAIRS & SAFETY,CHICAGO,IL; NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; IIT,LIFE SCI RES INST,CHICAGO,IL 60616	Northwestern University; Illinois Institute of Technology	ZEISS, CR (corresponding author), VET ADM LAKESIDE MED CTR,ACOS RES & DEV,400 E ONTARIO,CHICAGO,IL 60611, USA.				NIAID NIH HHS [AI-11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHANDLER MJ, 1987, J ALLERGY CLIN IMMUN, V80, P223, DOI 10.1016/0091-6749(87)90133-3; JOHNSON KJ, 1984, J CLIN INVEST, V74, P358, DOI 10.1172/JCI111431; LEACH CL, 1988, AM REV RESPIR DIS, V137, P186, DOI 10.1164/ajrccm/137.1.186; LEACH CL, 1987, TOXICOL APPL PHARM, V87, P67, DOI 10.1016/0041-008X(87)90085-8; LEDBETTER AD, 1987, AM IND HYG ASSOC J, V48, P35; ZEISS CR, 1988, AM REV RESPIR DIS, V137, P191, DOI 10.1164/ajrccm/137.1.191; ZEISS CR, 1987, J ALLERGY CLIN IMMUN, V79, P59, DOI 10.1016/S0091-6749(87)80017-9	7	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1989	84	2					219	223		10.1016/0091-6749(89)90328-X	http://dx.doi.org/10.1016/0091-6749(89)90328-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AL836	2760362				2022-12-18	WOS:A1989AL83600013
J	LANG, DM; SUGIMOTO, SL; CURD, JG; CHRISTIANSEN, SC; ZURAW, BL				LANG, DM; SUGIMOTO, SL; CURD, JG; CHRISTIANSEN, SC; ZURAW, BL			HIGH-MOLECULAR-WEIGHT KININOGEN IS CLEAVED IN ACTIVE ERYTHEMA MULTIFORME	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCRIPPS CLIN & RES FDN, DIV ALLERGY & IMMUNOL, LA JOLLA, CA 92037 USA; SCRIPPS CLIN & RES FDN, DIV BASIC & CLIN RES, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute				Zuraw, Bruce/0000-0003-0640-6768				BEDI TR, 1976, BRIT J DERMATOL, V95, P243, DOI 10.1111/j.1365-2133.1976.tb07010.x; BERRETTINI M, 1986, BLOOD, V68, P455; BOUMA BN, 1983, BLOOD, V62, P1123; BUHNER D, 1985, URTICARIA, P107; COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8; CONN DL, 1985, TXB RHEUMATOLOGY, P1149; CUNLIFFE WJ, 1971, BRIT J DERMATOL, V84, P99, DOI 10.1111/j.1365-2133.1971.tb06850.x; DOR PJ, 1983, J ALLERGY CLIN IMMUN, V71, P363, DOI 10.1016/0091-6749(83)90063-5; DUVIC M, 1983, J AM ACAD DERMATOL, V8, P493, DOI 10.1016/S0190-9622(83)70054-X; ELIAS J, 1986, J ALLERGY CLIN IMMUN, V78, P914, DOI 10.1016/0091-6749(86)90240-X; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; GRANELLIPIPERNO A, 1977, J EXP MED, V146, P1693, DOI 10.1084/jem.146.6.1693; HOWLAND WW, 1984, J AM ACAD DERMATOL, V10, P438, DOI 10.1016/S0190-9622(84)80090-0; HUFF JC, 1983, J AM ACAD DERMATOL, V8, P763; IMAMURA S, 1980, BRIT J DERMATOL, V102, P161, DOI 10.1111/j.1365-2133.1980.tb05687.x; ISHIZAKA T, 1985, J IMMUNOL, V134, P1880; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KAPLAN AP, 1987, BLOOD, V70, P1; KAPLAN AP, 1983, FED PROC, V42, P3123; KAPLAN AP, 1983, ALLERGY PRINCIPLES P, P1341; KAZMIEROWSKI JA, 1978, J INVEST DERMATOL, V71, P366, DOI 10.1111/1523-1747.ep12556746; KERBIRIOU DM, 1979, J BIOL CHEM, V254, P2020; KLENIEWSKI J, 1987, J LAB CLIN MED, V109, P469; LAMMLE B, 1988, THROMB HAEMOSTASIS, V59, P151; LEIGH IM, 1985, CLIN EXP DERMATOL, V10, P58, DOI 10.1111/j.1365-2230.1985.tb02553.x; LEWIN MF, 1983, J BIOL CHEM, V258, P6415; MAIER M, 1983, J IMMUNOL, V130, P2352; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; MCGIFF JC, 1976, FED PROC, V35, P175; MITCHELL JC, 1964, J INVEST DERMATOL, V43, P177, DOI 10.1038/jid.1964.139; MONROE EW, 1981, J AM ACAD DERMATOL, V5, P88, DOI 10.1016/S0190-9622(81)70080-X; NEWBALL HH, 1979, J CLIN INVEST, V64, P466, DOI 10.1172/JCI109484; NEWBALL HH, 1979, J CLIN INVEST, V64, P457, DOI 10.1172/JCI109483; OISHI M, 1976, INT ARCH ALLER A IMM, V50, P463, DOI 10.1159/000231536; PROUD D, 1985, AM REV RESPIR DIS, V132, P405; PROVOST TT, 1973, J CLIN INVEST, V52, P1779, DOI 10.1172/JCI107359; ROWELL NR, 1963, ARCH DERMATOL, V88, P176, DOI 10.1001/archderm.1963.01590200064012; TONNESEN MG, 1983, J INVEST DERMATOL, V80, P282, DOI 10.1111/1523-1747.ep12534652; VANDERGRAAF F, 1982, J BIOL CHEM, V257, P4300; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; VENGE P, 1979, THROMB RES, V14, P641, DOI 10.1016/0049-3848(79)90119-1; von Hebra F, 1866, DISEASES SKIN INCLUD, P285; WASSERMAN SI, 1987, AM REV RESPIR DIS, V135, pS46; WEINSTOCK G, 1986, J ALLERGY CLIN IMMUN, V77, P188; WINTROUB BU, 1982, ADV INFLAMMAT RES, V4, P131; ZURAW B, 1987, J ALLERGY CLIN IMMUN, V79, P177; ZURAW BL, 1986, J ALLERGY CLIN IMMUN, V78, P1115, DOI 10.1016/0091-6749(86)90259-9; ZURAW BL, 1986, J CLIN INVEST, V78, P567, DOI 10.1172/JCI112610	49	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1989	83	4					802	810		10.1016/0091-6749(89)90018-3	http://dx.doi.org/10.1016/0091-6749(89)90018-3			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U3420	2708741				2022-12-18	WOS:A1989U342000015
J	GAWIN, AZ; BARANIUK, JN; KALINER, MA				GAWIN, AZ; BARANIUK, JN; KALINER, MA			GUINEA-PIG (GP) NASAL MUCOSAL SECRETORY RESPONSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									NIAID,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					304	304						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900551
J	KUO, M; LUSSIER, A; BRAUER, A; BOND, JF; GREENSTEIN, JL				KUO, M; LUSSIER, A; BRAUER, A; BOND, JF; GREENSTEIN, JL			EPITOPE MAPPING OF T-CELL RECOGNITION OF PHOSPHOLIPASE-A2	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									IMMUL PHARMACEUT CORP,CAMBRIDGE,MA										0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					251	251						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900340
J	MCCLEAN, SP; FORSYTHE, PA; GRANT, JA; BOYARS, MC; ALAM, R				MCCLEAN, SP; FORSYTHE, PA; GRANT, JA; BOYARS, MC; ALAM, R			SYNTHESIS OF HISTAMINE RELEASING-FACTOR (HRF) AND HISTAMINE-RELEASE INHIBITORY FACTOR (HRIF) BY BRONCHO-ALVEOLAR (BAL) CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					236	236						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900279
J	NUMAO, T; FUKUDA, T; AKUTSU, I; MAKINO, S; ENOKIHARA, H; HONJO, T				NUMAO, T; FUKUDA, T; AKUTSU, I; MAKINO, S; ENOKIHARA, H; HONJO, T			SELECTIVE ENHANCEMENT OF EOSINOPHIL CHEMOTAXIS BY RECOMBINANT HUMAN INTERLEUKIN-5	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					298	298						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900529
J	TRUDEAU, W; FERNANDEZCALDAS, E; FOX, R; LOCKEY, R				TRUDEAU, W; FERNANDEZCALDAS, E; FOX, R; LOCKEY, R			MITE AEROALLERGEN CONCENTRATIONS BEFORE, DURING AND AFTER VACUUM CLEANING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					264	264						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900391
J	WASS, U; BELIN, L; DELIN, K				WASS, U; BELIN, L; DELIN, K			LONGITUDINAL-STUDY OF SPECIFIC IGE AND IGG ANTIBODIES IN A PATIENT SENSITIZED TO ETHYLENE-OXIDE THROUGH DIALYSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SAHLGRENS HOSP,DEPT SHINAGAWA KU,NEPHROL SECT,S-41345 GOTHENBURG,SWEDEN	Sahlgrenska University Hospital	WASS, U (corresponding author), SAHLGRENS HOSP,DEPT SHINAGAWA KU,ASTHMA & ALLERGY RES CTR,S-41345 GOTHENBURG,SWEDEN.							BARNETT RN, 1979, CLIN LABORATORY STAT, P105; BAUR X, 1983, J ALLERGY CLIN IMMUN, V71, P197, DOI 10.1016/0091-6749(83)90100-8; BERNSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P794, DOI 10.1016/0091-6749(84)90181-7; BHAT K, 1984, ANN ALLERGY, V52, P282; BOMMER J, 1985, LANCET, V2, P1382; CARUANA RJ, 1985, AM J NEPHROL, V5, P271, DOI 10.1159/000166946; DOLOVICH J, 1978, J ALLERGY CLIN IMMUN, V62, P30, DOI 10.1016/0091-6749(78)90069-6; DOLOVICH J, 1984, ARTIF ORGANS, V8, P334, DOI 10.1111/j.1525-1594.1984.tb04301.x; GRAMMER LC, 1985, J ALLERGY CLIN IMMUN, V76, P670, DOI 10.1016/0091-6749(85)90669-4; GRAMMER LC, 1984, J ALLERGY CLIN IMMUN, V74, P544, DOI 10.1016/0091-6749(84)90392-0; GRAMMER LC, 1985, J ALLERGY CLIN IMMUN, V76, P511, DOI 10.1016/0091-6749(85)90736-5; HURLEY RM, 1984, INT J PED NEPHROL, V5, P53; LEITMAN SF, 1986, NEW ENGL J MED, V315, P1192, DOI 10.1056/NEJM198611063151904; MARSHALL C, 1984, CLIN NEPHROL, V21, P346; MARSHALL CP, 1985, J ALLERGY CLIN IMMUN, V75, P563, DOI 10.1016/0091-6749(85)90030-2; MEYNADIER JM, 1985, PRESSE MED, V14, P1245; MUYLLE L, 1986, LANCET, V2, P1225; NICHOLLS A, 1986, BRIT MED J, V292, P1221, DOI 10.1136/bmj.292.6530.1221; NICHOLLS AJ, 1982, BRIT MED J, V285, P1607, DOI 10.1136/bmj.285.6355.1607; NICHOLLS AJ, 1985, P EUR DIAL TRANS, V21, P173; NORDVALL SL, 1986, ALLERGY, V41, P575, DOI 10.1111/j.1398-9995.1986.tb00349.x; PATTERSON R, 1986, AM J KIDNEY DIS, V8, P64, DOI 10.1016/S0272-6386(86)80157-3; PIAZOLO P, 1986, LANCET, V1, P918; POOTHULLIL J, 1975, ANN INTERN MED, V82, P58, DOI 10.7326/0003-4819-82-1-58; ROCKEL A, 1986, LANCET, V1, P382; ROCKEL A, 1985, INT J ARTIF ORGANS, V8, P179; RUMPF KW, 1985, DEUT MED WOCHENSCHR, V110, P1641, DOI 10.1055/s-2008-1069061; RUMPF KW, 1985, LANCET, V2, P1385; RUMPF KW, 1986, ARCH ORTHOP TRAUM SU, V105, P250, DOI 10.1007/BF00435492; SOLOMONS TWG, 1980, ORGANIC CHEM; WASS U, IN PRESS J ALLERGY C; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380	32	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1988	82	4					679	685		10.1016/0091-6749(88)90983-9	http://dx.doi.org/10.1016/0091-6749(88)90983-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q6399	3171008				2022-12-18	WOS:A1988Q639900023
J	BIAGNINI, RE; BERNSTEIN, DI; GALLAGHER, JS; MOORMAN, WJ; KNECHT, EA; SMALLWOOD, AW; BERNSTEIN, IL				BIAGNINI, RE; BERNSTEIN, DI; GALLAGHER, JS; MOORMAN, WJ; KNECHT, EA; SMALLWOOD, AW; BERNSTEIN, IL			IMMUNE-RESPONSES OF CYNOMOLGUS MONKEYS TO PHTHALIC-ANHYDRIDE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CINCINNATI,MED CTR,DEPT INTERNAL MED,DIV IMMUNOL,CINCINNATI,OH 45267	University of Cincinnati	BIAGNINI, RE (corresponding author), NIOSH,DIV BIOMED & BEHAV SCI,EXPTL TOXICOL BRANCH,4676 COLUMBIA PKWY,CINCINNATI,OH 45226, USA.							BANKNIEDER AR, 1978, LAB ANIM SCI, V28, P742; BARDANA EJ, 1980, OCCUPATIONAL ASTHMA; BERNSTEIN DI, 1982, J ALLERGY CLIN IMMUN, V69, P311, DOI 10.1016/S0091-6749(82)80009-2; BERNSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P794, DOI 10.1016/0091-6749(84)90181-7; BERNSTEIN IL, 1976, J ALLERGY CLIN IMMUN, V57, P141, DOI 10.1016/0091-6749(76)90033-6; BIAGINI RE, 1985, TOXICOL APPL PHARM, V78, P139, DOI 10.1016/0041-008X(85)90313-8; BIAGINI RE, 1986, AM REV RESPIR DIS, V134, P719; BIAGINI RE, 1983, TOXICOL APPL PHARM, V69, P377, DOI 10.1016/0041-008X(83)90261-2; BIAGINI RE, 1985, J ALLERGY CLIN IMMUN, V76, P794, DOI 10.1016/0091-6749(85)90750-X; BUCK MG, 1981, CHEST, V79, pS43, DOI 10.1378/chest.79.4.43S; CHESTER EH, 1977, CLIN ALLERGY, V7, P15, DOI 10.1111/j.1365-2222.1977.tb01419.x; FAWCETT IW, 1977, CLIN ALLERGY, V7, P1, DOI 10.1111/j.1365-2222.1977.tb01418.x; KERN RICHARD A., 1939, JOUR ALLERGY, V10, P164, DOI 10.1016/S0021-8707(39)90050-X; KNECHT EA, 1985, AM REV RESPIR DIS, V132, P1181; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; MUNSON JW, 1974, J PHARM SCI, V63, P252, DOI 10.1002/jps.2600630216; NIELSON JE, 1984, HYGIEA, V93, P124; NORDMAN H, 1986, 4TH P FINN EST S OCC, P62; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WERNFORS M, 1986, INT ARCH ALLER A IMM, V79, P77, DOI 10.1159/000233946; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; 1986, PUBLIC HLTH SERVICE, P28	23	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					23	29		10.1016/0091-6749(88)90046-2	http://dx.doi.org/10.1016/0091-6749(88)90046-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	3392367				2022-12-18	WOS:A1988P400400005
J	LEE, HB; ADKINSON, NF				LEE, HB; ADKINSON, NF			MEASUREMENT OF IGG BLOCKING ANTIBODY IN HUMAN-SERUM - COMPARISON OF ELISA WITH MONOCLONAL-ANTIBODY AND FLUOROGENIC SUBSTRATE AND STAPHYLOCOCCUS PROTEIN-A SOLID-PHASE RIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,DEPT MED,DIV ALLERGY & CLIN IMMUNOL,BALTIMORE,MD 21239	Johns Hopkins University								ALI M, 1983, AM J CLIN PATHOL, V80, P290, DOI 10.1093/ajcp/80.3.290; Clark BR, 1980, ENZYME IMMUNOASSAY, P167; CRETICOS PS, 1984, J ALLERGY CLIN IMMUN, V73, P94, DOI 10.1016/0091-6749(84)90490-1; Ekins R., 1981, MONOCLONAL ANTIBODIE, P3; Ekins R. P., 1981, LIGAND Q, V4, P33; FORSTER J, 1979, KLIN WOCHENSCHR, V57, P421, DOI 10.1007/BF01480482; GRANT JA, 1981, J ALLERGY CLIN IMMUN, V68, P112, DOI 10.1016/0091-6749(81)90168-8; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HAMILTON RG, 1980, J IMMUNOL, V124, P2966; HAMILTON RG, 1985, J IMMUNOL METHODS, V77, P95, DOI 10.1016/0022-1759(85)90187-5; HAMILTON RG, 1981, J ALLERGY CLIN IMMUN, V67, P14, DOI 10.1016/0091-6749(81)90039-7; HAMILTON RG, 1979, J IMMUNOL, V122, P1073; HAMILTON RG, 1986, CLIN IMMUNOL NEWSLET, V7, P1; HOSOI S, 1985, J ALLERGY CLIN IMMUN, V75, P320, DOI 10.1016/0091-6749(85)90064-8; JEFFERIS R, 1985, IMMUNOL LETT, V10, P223, DOI 10.1016/0165-2478(85)90082-3; KEMENY DM, 1983, J ALLERGY CLIN IMMUN, V71, P505, DOI 10.1016/0091-6749(83)90469-4; KEMENY DM, 1986, J IMMUNOL METHODS, V87, P45, DOI 10.1016/0022-1759(86)90342-X; KEMENY DM, 1986, J IMMUNOL METHODS, V20, P581; LEE HB, 1988, INT ARCH ALLER A IMM, V85, P261, DOI 10.1159/000234515; LEVY DA, 1971, J CLIN INVEST, V50, P360, DOI 10.1172/JCI106503; LICHTENSTEIN LM, 1971, ANN INTERN MED, V75, P663, DOI 10.7326/0003-4819-75-5-663; LICHTENSTEIN LM, 1966, J CLIN INVEST, V45, P1126, DOI 10.1172/JCI105419; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; Lovgren T, 1985, ALTERNATIVE IMMUNOAS, P203; LOWE J, 1982, IMMUNOLOGY, V47, P329; NEURATH AR, 1981, J VIROL METHODS, V3, P155, DOI 10.1016/0166-0934(81)90050-1; NORMAN PS, 1980, J ALLERGY CLIN IMMUN, V65, P87, DOI 10.1016/0091-6749(80)90191-8; REID MJ, 1982, J ALLERGY CLIN IMMUN, V70, P191, DOI 10.1016/0091-6749(82)90041-0; RICHARDSON MD, 1984, J IMMUNOL METHODS, V66, P119, DOI 10.1016/0022-1759(84)90255-2; SHALEV A, 1980, J IMMUNOL METHODS, V38, P125, DOI 10.1016/0022-1759(80)90337-3; SIDDLE K, 1985, ALTERNATIVE IMMUNOAS, P13; SOBOTKA AK, 1976, J IMMUNOL, V117, P84; TYSON CJ, 1981, ANN ALLERGY, V47, P43; UNDERDOWN BJ, 1982, RECENT DEV RAST OTHE, P67; URBANEK R, 1985, J IMMUNOL METHODS, V79, P123, DOI 10.1016/0022-1759(85)90398-9; VANMETRE TE, 1980, J ALLERGY CLIN IMMUN, V65, P228; Voller A, 1986, MANUAL CLIN LABORATO, P99	37	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1988	82	1					11	19		10.1016/0091-6749(88)90044-9	http://dx.doi.org/10.1016/0091-6749(88)90044-9			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P4004	3392361				2022-12-18	WOS:A1988P400400003
J	LEVINSON, AI; TAR, L				LEVINSON, AI; TAR, L			INVITRO IGM RHEUMATOID-FACTOR PRODUCTION INDUCED BY TETANUS TOXOID	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,CTR RHEUMATOL IMMUNOL,PHILADELPHIA,PA 19104	US Department of Veterans Affairs; Veterans Health Administration (VHA)	LEVINSON, AI (corresponding author), UNIV PENN,SCH MED,DEPT ALLERGY & IMMUNOL,ALLERGY & IMMUNOL SECT,515 JOHNSON PAVIL G2,PHILADELPHIA,PA 19104, USA.							AUGUSTIN AA, 1980, J EXP MED, V151, P587, DOI 10.1084/jem.151.3.587; CESARIO T, 1983, ANN RHEUM DIS, V42, P571, DOI 10.1136/ard.42.5.571; COULIE PG, 1985, J EXP MED, V161, P88, DOI 10.1084/jem.161.1.88; COUTINHO A, 1984, IMMUNOL REV, V78, P211, DOI 10.1111/j.1600-065X.1984.tb00483.x; DEFRANCO AL, 1984, J EXP MED, V159, P861, DOI 10.1084/jem.159.3.861; EGELAND T, 1983, CLIN RHEUM DIS, V9, P135; FRIEDMAN SM, 1983, J IMMUNOL, V3, P1164; GEHA RS, 1977, J EXP MED, V145, P1436, DOI 10.1084/jem.145.6.1436; IZUI S, 1979, J IMMUNOL, V122, P2096; JOHNSON PM, 1976, CLIN IMMUNOL IMMUNOP, V6, P414, DOI 10.1016/0090-1229(76)90094-5; KOOPMAN WJ, 1980, J IMMUNOL, V125, P934; LANE HC, 1981, J EXP MED, V154, P1043, DOI 10.1084/jem.154.4.1043; LEVINE PR, 1985, CLIN EXP RHEUMATOL, V3, P147; LEVINSON AI, 1986, J CLIN INVEST, V78, P612, DOI 10.1172/JCI112617; MCCABE WR, 1973, D M, V9, P1; MOTICKA EJ, 1978, CELL IMMUNOL, V41, P406, DOI 10.1016/0008-8749(78)90237-X; NEMAZEE DA, 1985, J EXP MED, V161, P242, DOI 10.1084/jem.161.1.242; NEMAZEE DA, 1983, J EXP MED, V158, P529, DOI 10.1084/jem.158.2.529; ORCUTTTHORDARSON N, 1983, CELL IMMUNOL, V82, P184, DOI 10.1016/0008-8749(83)90152-1; PARDO I, 1984, CLIN EXP IMMUNOL, V56, P253; ROSE HM, 1948, P SOC EXP BIOL MED, V68, P1; SLAUGHTER L, 1978, J EXP MED, V148, P1429, DOI 10.1084/jem.148.5.1429; VOLKMAN DJ, 1982, J IMMUNOL, V129, P107; VOLKMAN DJ, 1981, P NATL ACAD SCI US, V78, pB252; WELCH MJ, 1983, CLIN EXP IMMUNOL, V51, P299	25	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1988	81	4					730	736		10.1016/0091-6749(88)91046-9	http://dx.doi.org/10.1016/0091-6749(88)91046-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N0650	3258604				2022-12-18	WOS:A1988N065000015
J	ADOLPHSON, RL; CHESTNUT, JC; KUIPERS, PJ; THUESON, DO; WRIGHT, CD; CONROY, MC				ADOLPHSON, RL; CHESTNUT, JC; KUIPERS, PJ; THUESON, DO; WRIGHT, CD; CONROY, MC			INHIBITION OF HISTAMINE (HI), LEUKOTRIENE C-4 D4 (LT), AND THROMBOXANE (TX) RELEASE FROM HUMAN (HU) AND GUINEA-PIG (GP) LUNG BY CI-949	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					232	232		10.1016/0091-6749(88)90492-7	http://dx.doi.org/10.1016/0091-6749(88)90492-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400279
J	BASARAN, M; HEIN, EW				BASARAN, M; HEIN, EW			EVALUATION OF A MULTITEST DEVICE FOR ALLERGY TESTING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					171	171		10.1016/0091-6749(88)90247-3	http://dx.doi.org/10.1016/0091-6749(88)90247-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400034
J	CHARLESWORTH, EN; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM				CHARLESWORTH, EN; KAGEYSOBOTKA, A; NORMAN, PS; LICHTENSTEIN, LM			EFFECTS OF CETIRIZINE ON MAST-CELL MEDIATOR RELEASE AND CELLULAR TRAFFIC DURING THE CUTANEOUS LATE PHASE RESPONSE(LPR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					212	212		10.1016/0091-6749(88)90412-5	http://dx.doi.org/10.1016/0091-6749(88)90412-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400199
J	DOCKHORN, RJ; SHELLENBERGER, MK; HASSANIEN, R; TRACHELMAN, L				DOCKHORN, RJ; SHELLENBERGER, MK; HASSANIEN, R; TRACHELMAN, L			EFFICACY OF SCH434(LORATADINE PLUS PSEUDOPHEDRINE) VERSUS COMPONENTS AND PLACEBO IN SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					178	178		10.1016/0091-6749(88)90275-8	http://dx.doi.org/10.1016/0091-6749(88)90275-8			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400062
J	FOX, RW; LOCKEY, RF				FOX, RW; LOCKEY, RF			TREATMENT OF SEVERE, CHRONIC URTICARIA (SCU) WITH DAPSONE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					260	260		10.1016/0091-6749(88)90603-3	http://dx.doi.org/10.1016/0091-6749(88)90603-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400390
J	KRELL, RD; BUCKNER, CK; KEITH, RA; SNYDER, DW; BROWN, FJ; BERNSTEIN, PR; MATASSA, V; YEE, YK; HESP, B; GILES, RE				KRELL, RD; BUCKNER, CK; KEITH, RA; SNYDER, DW; BROWN, FJ; BERNSTEIN, PR; MATASSA, V; YEE, YK; HESP, B; GILES, RE			ICI-204,219 - A POTENT, SELECTIVE PEPTIDE LEUKOTRIENE RECEPTOR ANTAGONIST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					276	276		10.1016/0091-6749(88)90665-3	http://dx.doi.org/10.1016/0091-6749(88)90665-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400452
J	MATTHIESEN, F; SCHUMACHER, M; LOWENSTEIN, H				MATTHIESEN, F; SCHUMACHER, M; LOWENSTEIN, H			CHARACTERIZATION OF THE MAJOR ALLERGEN OF CYNODON-DACTYLON (BERMUDA GRASS) POLLEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	10	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					266	266						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400414
J	MEADOR, KJ; LORING, DW				MEADOR, KJ; LORING, DW			DIFFERENTIAL COGNITIVE EFFECTS OF TERFENADINE AND CHLORPHENIRAMINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					177	177		10.1016/0091-6749(88)90272-2	http://dx.doi.org/10.1016/0091-6749(88)90272-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400059
J	OHANLON, JF				OHANLON, JF			ANTIHISTAMINES THAT ARE SAFE FOR USE BY PATIENTS WHO DRIVE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					213	213		10.1016/0091-6749(88)90414-9	http://dx.doi.org/10.1016/0091-6749(88)90414-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400201
J	PASCUAL, CY; LARRAMENDI, CH; ESTEBAN, MM; FIANDOR, A; OJEDA, JA				PASCUAL, CY; LARRAMENDI, CH; ESTEBAN, MM; FIANDOR, A; OJEDA, JA			FISH ALLERGY AND FISH ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Larramendi, Carlos H/ABI-6315-2020; Larramendi, Carlos H/D-1539-2011	Larramendi, Carlos H/0000-0001-9017-1900; Larramendi, Carlos H/0000-0001-9017-1900					0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					264	264		10.1016/0091-6749(88)90617-3	http://dx.doi.org/10.1016/0091-6749(88)90617-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400404
J	ROBERTS, J; SIMONS, FER; SIMONS, KJ; GILLESPIE, CA				ROBERTS, J; SIMONS, FER; SIMONS, KJ; GILLESPIE, CA			THE ANTIPRURITIC EFFECT OF PLACEBO (P) VERSUS HYDROXYZINE (H) VERSUS ASTEMIZOLE (A) IN CHILDREN WITH SEVERE ATOPIC-DERMATITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					210	210		10.1016/0091-6749(88)90404-6	http://dx.doi.org/10.1016/0091-6749(88)90404-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274		Bronze			2022-12-18	WOS:A1988M027400191
J	ROTHENBERG, ME; OWEN, WF; SILBERSTEIN, DS; SOBERMAN, RJ; SHEFFER, AL; AUSTEN, KF; STEVENS, RL				ROTHENBERG, ME; OWEN, WF; SILBERSTEIN, DS; SOBERMAN, RJ; SHEFFER, AL; AUSTEN, KF; STEVENS, RL			CYTOKINE REGULATION OF HUMAN EOSINOPHIL VIABILITY, DENSITY, AND FUNCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					209	209		10.1016/0091-6749(88)90401-0	http://dx.doi.org/10.1016/0091-6749(88)90401-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400188
J	SKASSABROCIEK, W; OQUIGLEY, J; BLIZARD, R; COUGNARD, J; MICHEL, FB; BOUSQUET, J				SKASSABROCIEK, W; OQUIGLEY, J; BLIZARD, R; COUGNARD, J; MICHEL, FB; BOUSQUET, J			DIFFERENTIATION BETWEEN THE ANTI-ALLERGIC AND ANTI-HISTAMINIC EFFECTS OF LORATADINE (L) AND ASTEMIZOLE (A) BY SKIN-TESTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													O'Quigley, John/E-2073-2017; Bousquet, Jean/O-4221-2019						0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					175	175		10.1016/0091-6749(88)90262-X	http://dx.doi.org/10.1016/0091-6749(88)90262-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400049
J	SPANNER, D; SUSSMAN, G; TARLO, S; BUTTOO, K; EVANS, S; DOLOVICH, J				SPANNER, D; SUSSMAN, G; TARLO, S; BUTTOO, K; EVANS, S; DOLOVICH, J			LATEX ALLERGY - 2 CASE-REPORTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					179	179		10.1016/0091-6749(88)90280-1	http://dx.doi.org/10.1016/0091-6749(88)90280-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400067
J	STEVENSON, DD; SCHRANK, PJ; HOUGHAM, AJ; GOLDLUST, MB; WILSON, RR				STEVENSON, DD; SCHRANK, PJ; HOUGHAM, AJ; GOLDLUST, MB; WILSON, RR			SALSALATE CROSS SENSITIVITY IN ASPIRIN-SENSITIVE ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					181	181		10.1016/0091-6749(88)90286-2	http://dx.doi.org/10.1016/0091-6749(88)90286-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400073
J	WEBER, RW; VAUGHAN, TR; DOLEN, WK				WEBER, RW; VAUGHAN, TR; DOLEN, WK			A 10 YEAR REVIEW OF ADVERSE REACTIONS TO IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					295	295		10.1016/0091-6749(88)90744-0	http://dx.doi.org/10.1016/0091-6749(88)90744-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400531
J	BATES, DV; BAKERANDERSON, M				BATES, DV; BAKERANDERSON, M			ASTHMA MORTALITY AND MORBIDITY IN CANADA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia									0	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			395	397		10.1016/0091-6749(87)90057-1	http://dx.doi.org/10.1016/0091-6749(87)90057-1			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624690				2022-12-18	WOS:A1987K103700009
J	DRESKIN, SC; KALINER, MA; GALLIN, JI				DRESKIN, SC; KALINER, MA; GALLIN, JI			ELEVATED URINARY HISTAMINE IN THE HYPERIMMUNOGLOBULIN-E AND RECURRENT INFECTION (JOBS) SYNDROME - ASSOCIATION WITH ECZEMATOID DERMATITIS AND NOT WITH INFECTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BLDG 10,ROOM 11C103,BETHESDA,MD 20892; NIAID,CLIN INVEST LAB,ALLERG DIS SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ANDERSON R, 1977, J IMMUNOL, V118, P1690; BERGER M, 1980, J IMMUNOL, V125, P2437; BROSTOFF J, 1980, CLIN EXP IMMUNOL, V39, P739; BUCKLEY RH, 1982, JAMA-J AM MED ASSOC, V248, P2611, DOI 10.1001/jama.248.20.2611; BUCKLEY RH, 1981, CLIN IMMUNOLOGY UPDA, P148; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; DRESKIN SC, 1985, J CLIN INVEST, V75, P26, DOI 10.1172/JCI111683; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; FRIEDMAN SJ, 1984, J IMMUNOL METHODS, V66, P369, DOI 10.1016/0022-1759(84)90350-8; FRIERI M, 1985, AM J MED, V78, P9, DOI 10.1016/0002-9343(85)90454-1; GALLIN JI, 1982, BLOOD, V59, P1317; GALLIN JI, 1983, ANN INTERN MED, V99, P657, DOI 10.7326/0003-4819-99-5-657; HILL HR, 1974, LANCET, V1, P183; HILL HR, 1976, J LAB CLIN MED, V88, P796; HILL HR, 1982, AM J DIS CHILD, V136, P767, DOI 10.1001/archpedi.1982.03970450009001; JACOBS DH, 1984, GASTROENTEROLOGY, V87, P201; KALINER M, 1982, J ALLERGY CLIN IMMUN, V69, P283, DOI 10.1016/S0091-6749(82)80005-5; KALINER M, 1984, INVEST RADIOL, V19, P116, DOI 10.1097/00004424-198403000-00007; KEYZER JJ, 1983, NEW ENGL J MED, V309, P1603, DOI 10.1056/NEJM198312293092603; KIRKPATRICK CH, 1984, ANN INTERN MED, V92, P531; MAWHINNEY H, 1980, CLIN IMMUNOL IMMUNOP, V17, P483, DOI 10.1016/0090-1229(80)90144-0; MYERS G, 1981, J ALLERGY CLIN IMMUN, V67, P305, DOI 10.1016/0091-6749(81)90026-9; OGDEN BE, 1980, IMMUNOLOGY, V41, P107; PETERSEN HO, 1979, ARCH DERMATOL RES, V264, P193, DOI 10.1007/BF00431131; RING J, 1983, CLIN ALLERGY, V13, P545, DOI 10.1111/j.1365-2222.1983.tb02636.x; SCHOPFER K, 1979, NEW ENGL J MED, V300, P835, DOI 10.1056/NEJM197904123001506; SELIGMANN BE, 1983, J IMMUNOL, V130, P1902; SODERBERGWARNER M, 1983, PEDIATR RES, V17, P820, DOI 10.1203/00006450-198310000-00011; TRUNG PH, 1982, ARCH FR PEDIATR, V39, P353; WARREN K, 1983, J ALLERGY CLIN IMMUN, V71, P206, DOI 10.1016/0091-6749(83)90101-X	30	6	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1987	79	3					515	522		10.1016/0091-6749(87)90370-8	http://dx.doi.org/10.1016/0091-6749(87)90370-8			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G4795	3819231				2022-12-18	WOS:A1987G479500015
J	KATNER, HP; DESHAZO, RD; PANKEY, GA; ANDES, WA; DAUL, CB; CORTEZ, L; DALOVISIO, J; BOZELKA, B				KATNER, HP; DESHAZO, RD; PANKEY, GA; ANDES, WA; DAUL, CB; CORTEZ, L; DALOVISIO, J; BOZELKA, B			SPONTANEOUS SUPPRESSOR-CELL ACTIVITY IN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME AND ASSOCIATED CONDITIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TULANE UNIV,SCH MED,HERBERT HARVEY LAB,CLIN IMMUNOL SECT,1700 PERDIDO ST,NEW ORLEANS,LA 70112; TULANE UNIV,SCH MED,DEPT MED,HEMATOL ONCOL SECT,NEW ORLEANS,LA 70112; ALTON OCHSNER MED FDN & OCHSNER CLIN,DEPT INTERNAL MED,INFECT DIS SECT,NEW ORLEANS,LA 70121	Tulane University; Tulane University; Ochsner Health System			Dalovisio, Joseph/A-5808-2011	Katner, Harold/0000-0002-2529-9817	NATIONAL CANCER INSTITUTE [U01CA034977] Funding Source: NIH RePORTER; NCI NIH HHS [CA34977] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOX GEP, 1978, STATISTICS EXPERIMEN, P204; DESHAZO RD, 1983, ANN INTERN MED, V99, P159, DOI 10.7326/0003-4819-99-2-159; DESHAZO RD, 1984, ARCH INTERN MED, V144, P1153, DOI 10.1001/archinte.144.6.1153; DESHAZO RD, 1985, BLOOD, V66, P993; DIXON WJ, 1977, BMDPP 77 BIOMEDICAL, P540; DWYER JM, 1982, CLIN EXP IMMUNOL, V50, P406; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; FAUCI AS, 1985, ANN INTERN MED, V102, P800, DOI 10.7326/0003-4819-102-6-800; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; HERSH EM, 1983, CANCER RES, V43, P1905; LANE HC, 1985, ANNU REV IMMUNOL, V3, P477, DOI 10.1146/annurev.iy.03.040185.002401; LAURENCE J, 1983, J CLIN INVEST, V72, P2072, DOI 10.1172/JCI111172; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MORRISON D, 1976, MULTIVARIATE STATIST, P134; REINHERZ EL, 1979, P NATL ACAD SCI USA, V76, P4061, DOI 10.1073/pnas.76.8.4061; REMINGTON RD, 1970, STATISTICS APPLICATI, P253; REUBEN JM, 1983, CANCER RES, V43, P897; SAXINGER C, 1983, LAB INVEST, V49, P371; SEIGAL FP, 1981, NEW ENGL J MED, V305, P1439; 1981, MMWR, V39, P250; 1982, MMWR, V31, P249	21	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					364	370		10.1016/0091-6749(87)90157-6	http://dx.doi.org/10.1016/0091-6749(87)90157-6			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	2950158				2022-12-18	WOS:A1987G179100012
J	MORRISON, RCA; RABSON, AR				MORRISON, RCA; RABSON, AR			THE LATE ONSET FORM OF C1 ESTERASE-INHIBITOR DEFICIENCY PRESENTING AS FOOD ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									S AFRICAN INST MED RES,SCH PATHOL,S AFRICAN MRC,HUMAN CELLULAR IMMUNOL UNIT,POB 1038,JOHANNESBURG 2000,SOUTH AFRICA; UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA	South African Medical Research Council; University of Witwatersrand								Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; FORBES CD, 1970, J LAB CLIN MED, V76, P809; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GEHA RS, 1985, NEW ENGL J MED, V312, P534, DOI 10.1056/NEJM198502283120902; GIGLI I, 1970, J IMMUNOL, V104, P574; HUDSON L, 1980, PRACTICAL IMMUNOLOGY, P146; JOHNSON TH, 1971, RADIOLOGY, V99, P61, DOI 10.1148/99.1.61; REBOUL A, 1977, FEBS LETT, V79, P45, DOI 10.1016/0014-5793(77)80347-5; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; SHEFFER AL, 1983, J ALLERGY CLIN IMMUN, V71, P107, DOI 10.1016/0091-6749(83)90197-5; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P640, DOI 10.1016/0091-6749(85)90087-9; THORVALDSSON SE, 1969, ANN INTERN MED, V71, P353, DOI 10.7326/0003-4819-71-2-353	13	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1987	79	2					336	339		10.1016/0091-6749(87)90151-5	http://dx.doi.org/10.1016/0091-6749(87)90151-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	G1791	3819217				2022-12-18	WOS:A1987G179100006
J	CUMELLA, JC; FADEN, H; MIDDLETON, E				CUMELLA, JC; FADEN, H; MIDDLETON, E			SELECTIVE ACTIVITY OF PLANT FLAVONOIDS ON NEUTROPHIL CHEMILUMINESCENCE (CL)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					157	157						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000153
J	LAWRENCE, ID; WARNER, JA; BASCOM, R; KAGEYSOBOTKA, A; LICHTENSTEIN, LM				LAWRENCE, ID; WARNER, JA; BASCOM, R; KAGEYSOBOTKA, A; LICHTENSTEIN, LM			HETEROGENEITY OF HUMAN MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					179	179						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000242
J	QUARANTA, J; ROHR, AS; RACHELEFSKY, GS; SIEGEL, SC; KATZ, RM; SPECTOR, SL				QUARANTA, J; ROHR, AS; RACHELEFSKY, GS; SIEGEL, SC; KATZ, RM; SPECTOR, SL			THE ETIOLOGY AND NATURAL-HISTORY OF CHRONIC URTICARIA ANGIOEDEMA (U/A)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					182	182						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000251
J	SCHWARTZ, HJ; SHER, TH; ELLIS, LD				SCHWARTZ, HJ; SHER, TH; ELLIS, LD			EFFICACY OF NEDOCROMIL SODIUM (NS) 1-PERCENT NASAL SOLUTION IN THE TREATMENT OF RAGWEED SEASONAL ALLERGIC RHINITIS (SAR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					186	186						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000269
J	SELNER, J; BUSH, R; NORDLEE, J; WIENER, M; BUCKLEY, J; KOEPKE, J; TAYLOR, S				SELNER, J; BUSH, R; NORDLEE, J; WIENER, M; BUCKLEY, J; KOEPKE, J; TAYLOR, S			SKIN REACTIVITY TO SULFITE AND SENSITIVITY TO SULFITED FOODS IN A SULFITE SENSITIVE ASTHMATIC	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					241	241						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000487
J	SYKES, RS; REESE, ME; MEYER, MC				SYKES, RS; REESE, ME; MEYER, MC			PHARMACOKINETIC PROPERTIES OF A NEW SUSTAINED-RELEASE ALBUTEROL PREPARATION, VOLMAX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1987	79	1					152	152						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F8810					2022-12-18	WOS:A1987F881000132
J	MEKORI, YA; CLAMAN, HN				MEKORI, YA; CLAMAN, HN			DESENSITIZATION OF EXPERIMENTAL CONTACT SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MEKORI, YA (corresponding author), UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT MED,DIV CLIN IMMUNOL B164,4200 E 9TH AVE,DENVER,CO 80262, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012685] Funding Source: NIH RePORTER; NIAID NIH HHS [5 RO1 AI-12685] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; ASHERSON GL, 1976, EUR J IMMUNOL, V6, P699, DOI 10.1002/eji.1830061008; BATTISTO JR, 1966, NATURE, V212, P156, DOI 10.1038/212156a0; Claman H N, 1976, Contemp Top Immunobiol, V5, P211; Claman H N, 1980, Adv Immunol, V30, P121, DOI 10.1016/S0065-2776(08)60195-9; CLAMAN HN, 1983, J IMMUNOL, V131, P2682; CLAMAN HN, 1976, J IMMUNOL, V116, P704; CLAMAN HN, 1980, IMMUNOL REV, V50, P105, DOI 10.1111/j.1600-065X.1980.tb00309.x; CONLON PJ, 1979, NATURE, V278, P257, DOI 10.1038/278257a0; DEWECK AL, 1966, IMMUNOTOLERANCE SIMP, P72; DWYER JM, 1973, J EXP MED, V137, P32, DOI 10.1084/jem.137.1.32; DWYER JM, 1975, J EXP MED, V142, P588, DOI 10.1084/jem.142.3.588; EISEN HN, 1952, J EXP MED, V95, P473, DOI 10.1084/jem.95.5.473; FREY JR, 1971, CLIN EXP IMMUNOL, V8, P131; GELL PGH, 1967, BRIT MED BULL, V23, P21, DOI 10.1093/oxfordjournals.bmb.a070509; JADASSOHN J, 1895, 5 VERH DTSCH DERM GE, V79, P103; KANTOR FS, 1980, BASIC CLIN ASPECTS G, P237; LIEW FY, 1975, CELL IMMUNOL, V19, P129, DOI 10.1016/0008-8749(75)90297-X; LOWY A, 1984, NATURE, V308, P373, DOI 10.1038/308373a0; MEKORI YA, 1986, CELL IMMUNOL, V98, P279, DOI 10.1016/0008-8749(86)90288-1; MEKORI YA, 1984, CELL IMMUNOL, V89, P84, DOI 10.1016/0008-8749(84)90200-4; MILLER SD, 1978, J EXP MED, V147, P788, DOI 10.1084/jem.147.3.788; MILLER SD, 1982, J IMMUNOL, V129, P461; MILLER SD, 1982, ANN NY ACAD SCI, V392, P122, DOI 10.1111/j.1749-6632.1982.tb36102.x; MILLER SD, 1977, EUR J IMMUNOL, V7, P165, DOI 10.1002/eji.1830070310; MILLER SD, 1976, J IMMUNOL, V117, P1519; MOORHEAD JW, 1981, J EXP MED, V154, P1811, DOI 10.1084/jem.154.6.1811; MOORHEAD JW, 1982, J EXP MED, V155, P820, DOI 10.1084/jem.155.3.820; MOORHEAD JW, 1977, J IMMUNOL, V119, P315; MOORHEAD JW, 1978, J IMMUNOL, V120, P137; PAPERMASTER V, 1978, CELL IMMUNOL, V35, P378, DOI 10.1016/0008-8749(78)90157-0; PERERA MACC, 1981, IMMUNOLOGY, V43, P613; POLAK L, 1975, EUR J IMMUNOL, V5, P94, DOI 10.1002/eji.1830050205; POLAK L, 1978, J INVEST DERMATOL, V70, P98, DOI 10.1111/1523-1747.ep12541235; POLAK L, 1975, CLIN EXP IMMUNOL, V19, P543; POULTER LW, 1976, CELL IMMUNOL, V23, P171, DOI 10.1016/0008-8749(76)90180-5; RAY MC, 1983, J IMMUNOL, V131, P1096; SCHLOSSMAN SF, 1971, J EXP MED, V134, P741, DOI 10.1084/jem.134.3.741; SILBERBERGSINAKIN I, 1980, J INVEST DERMATOL, V75, P61, DOI 10.1111/1523-1747.ep12521144; STINGL G, 1978, J IMMUNOL, V121, P2005; SWAMY PK, 1981, CELL IMMUNOL, V60, P308, DOI 10.1016/0008-8749(81)90272-0; SY MS, 1979, J EXP MED, V149, P1197, DOI 10.1084/jem.149.5.1197; SY MS, 1979, J IMMUNOL, V123, P2593; SY MS, 1977, J IMMUNOL, V119, P240; TAKAHASHI C, 1977, IMMUNOLOGY, V33, P589; THESTRUPPEDERSEN K, 1977, J IMMUNOL, V118, P1665; THOMAS WR, 1981, J EXP MED, V153, P1124, DOI 10.1084/jem.153.5.1124; UHR JW, 1958, ANN NY ACAD SCI, V73, P753, DOI 10.1111/j.1749-6632.1959.tb40852.x; YOSHIDA T, 1980, FED PROC, V39, P665; ZEMBALA M, 1976, CELL IMMUNOL, V25, P266, DOI 10.1016/0008-8749(76)90117-9; ZEMBALA M, 1982, IMMUNOLOGY, V47, P605; ZIMBER C, 1982, IMMUNOLOGY, V45, P449	52	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			1073	1081		10.1016/0091-6749(86)90309-X	http://dx.doi.org/10.1016/0091-6749(86)90309-X			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	2946752				2022-12-18	WOS:A1986E971900030
J	PEPYS, J				PEPYS, J			NATURAL-HISTORY OF ATOPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV LONDON IMPERIAL COLL SCI & TECHNOL, DEPT CLIN IMMUNOL, LONDON SW7 2AZ, ENGLAND	Imperial College London								BARBEE RA, 1976, ANN INTERN MED, V84, P129, DOI 10.7326/0003-4819-84-2-129; BARRICK RH, 1965, J ALLERGY, V36, P374, DOI 10.1016/0021-8707(65)90044-4; BJORKSTEN F, 1983, 11TH P INT C ALL CLI, P145; BUCKLEY RH, 1969, NEW ENGL J MED, V281, P465, DOI 10.1056/NEJM196908282810903; BURGE PS, 1980, CLIN ALLERGY, V10, P355, DOI 10.1111/j.1365-2222.1980.tb02119.x; BURGE PS, 1984, CLIN IMMUNOL ALLERGY, P74; CLAMAN HN, 1983, 11TH P INT C ALL CLI, P489; Coca AF, 1923, J IMMUNOL, V8, P163; Cooke RA, 1916, J IMMUNOL, V1, P201; DAVIS JB, 1976, CLIN ALLERGY, V6, P329, DOI 10.1111/j.1365-2222.1976.tb01913.x; FINDLAY SR, 1978, J ALLERGY CLIN IMMUN, V61, P157, DOI 10.1016/0091-6749(78)90337-8; KAUFMAN HS, 1970, LANCET, V2, P1061; KAUFMAN HS, 1971, CLIN ALLERGY, V1, P63; KJELLMAN NIM, 1976, ACTA PAEDIATR SCAND, V65, P465, DOI 10.1111/j.1651-2227.1976.tb04915.x; KUROUME T, 1976, ANN ALLERGY, V37, P41; LESKOWITZ S, 1972, Clinical Allergy, V2, P237, DOI 10.1111/j.1365-2222.1972.tb01288.x; LEVIN S, 1971, PEDIATR RES, V5, P87, DOI 10.1203/00006450-197102000-00028; LONGBOTTOM JL, 1984, CLIN IMMUNOL ALLERGY, P23; MANTLE J, 1974, CLIN ALLERGY, V4, P161, DOI 10.1111/j.1365-2222.1974.tb01373.x; MARONE G, 1986, J ALLERGY CLIN IMMUN, V78, P974, DOI 10.1016/0091-6749(86)90288-5; MATERNOWSKI CJ, 1962, J ALLERGY, V33, P130; MATTHEW DJ, 1977, LANCET, V1, P321; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; MICHEL FB, 1980, J ALLERGY CLIN IMMUN, V65, P422, DOI 10.1016/0091-6749(80)90234-1; NEIJENS HJ, 1980, MAST CELL, P322; PEARSON DJ, 1977, CLIN ALLERGY, V7, P29, DOI 10.1111/j.1365-2222.1977.tb01421.x; PEPYS J, 1973, Clinical Allergy, V3, P143, DOI 10.1111/j.1365-2222.1973.tb01318.x; PEPYS J, 1985, CLIN ASPECTS IMMUNOL, P877; PEPYS J, 1984, CLIN IMMUNOL ALLERGY, P153; PIESSENS MF, 1984, CLIN ALLERGY, V14, P287, DOI 10.1111/j.1365-2222.1984.tb02208.x; RHYNE MB, 1971, DETERMINATION PREVAL; SALVAGGIO J E, 1973, Clinical Allergy, V3, P43, DOI 10.1111/j.1365-2222.1973.tb01308.x; SCHWARTZ M, 1952, ACTA ALLERG KBH S2, V5, P3; SETTIPANE RJ, 1979, R I MED J, V62, P477; Smith J M, 1975, Allergol Immunopathol (Madr), V3, P127; SMITH JM, 1979, CLIN ALLERGY, V9, P153, DOI 10.1111/j.1365-2222.1979.tb01536.x; SMITH JM, 1983, ALLERGY PRINCIPLES P, P771; SOOTHILL JF, 1976, CLIN ALLERGY, V6, P305, DOI 10.1111/j.1365-2222.1976.tb01911.x; TAYLOR B, 1973, LANCET, V2, P111; TOMASI TB, 1971, CLIN EXP IMMUNOL, V9, P3; TUNG R, 1982, J IMMUNOL, V128, P2067; TURNER MW, 1978, CLIN EXP IMMUNOL, V34, P253; VANNIEKERK CH, 1979, CLIN ALLERGY, V9, P319; WAITE DA, 1980, CLIN ALLERGY, V10, P71, DOI 10.1111/j.1365-2222.1980.tb02082.x; WARRELL DA, 1975, Q J MED, V44, P325; WOLSTENHOLME RJ, 1979, CLIN ALLERGY, V9, P325, DOI 10.1111/j.1365-2222.1979.tb02490.x	46	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	2	S			959	961		10.1016/0091-6749(86)90285-X	http://dx.doi.org/10.1016/0091-6749(86)90285-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9719	3782673				2022-12-18	WOS:A1986E971900006
J	PEDERSEN, S				PEDERSEN, S			ABSORPTION OF THEO-DUR SPRINKLE WITH FOOD - IMPORTANCE OF TYPES OF MEALS AND MEDICATION TIMES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PEDERSEN, S (corresponding author), AALBORG HOSP N,DEPT PEDIATR,HOBROVEJ 13,DK-9000 AALBORG,DENMARK.							HOWICK J, 1983, J ALLERGY CLIN IMMUN, V71, P130, DOI 10.1016/0091-6749(83)90291-9; KARIM A, 1985, CLIN PHARMACOL THER, V38, P77, DOI 10.1038/clpt.1985.138; PEDERSEN S, 1984, PEDIATRICS, V74, P534; UPTON RA, 1982, J PHARMACOKINET BIOP, V10, P123, DOI 10.1007/BF01062330	4	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	1				653	660		10.1016/0091-6749(86)90085-0	http://dx.doi.org/10.1016/0091-6749(86)90085-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5682	3771955				2022-12-18	WOS:A1986E568200015
J	WELLER, FR; WELLER, HH; KALLENBERG, CGM; THE, TH; ORIE, NGM				WELLER, FR; WELLER, HH; KALLENBERG, CGM; THE, TH; ORIE, NGM			SENSITIVITY TO HYDROCORTISONE IS A RELEVANT FACTOR IN THE IMMUNOENDOCRINE RELATIONSHIP .1. THE CELL-MEDIATED IMMUNE-RESPONSE IN RELATION TO BLOOD-LEVELS AND INVITRO IMMUNOSUPPRESSIVE EFFECTS OF HYDROCORTISONE IN PATIENTS WITH ASTHMA AND HEALTHY CONTROL SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									STATE UNIV GRONINGEN HOSP,DEPT PULM,9713 EZ GRONINGEN,NETHERLANDS; ST ELISABETH GASTHUIS,HAARLEM,NETHERLANDS	University of Groningen	WELLER, FR (corresponding author), STATE UNIV GRONINGEN HOSP,DEPT CLIN IMMUNOL,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS.							BESEDOVSKY H, 1977, CLIN EXP IMMUNOL, V27, P1; BESEDOVSKY HO, 1981, J IMMUNOL, V126, P385; BESEDOVSKY HO, 1979, CLIN EXP IMMUNOL, V37, P106; BOOIJ-NOORD H, 1972, Clinical Allergy, V2, P43, DOI 10.1111/j.1365-2222.1972.tb01267.x; BOUCHER RC, 1977, J ALLERGY CLIN IMMUN, V60, P134, DOI 10.1016/0091-6749(77)90039-2; BROSTOFF J, 1969, LANCET, V2, P1269; CRABTREE GR, 1979, ARTHRITIS RHEUM, V22, P1246, DOI 10.1002/art.1780221112; DAHL R, 1982, EUR J RESPIR DIS, V63, P167; DELREY A, 1984, J IMMUNOL, V133, P572; DEVRIES K, 1962, INT ARCH ALLER A IMM, V20, P93, DOI 10.1159/000229248; DUNNILL MS, 1978, ALLERGY PRINCIPLES P, V2, P678; FLINT KC, 1985, BRIT MED J, V291, P923, DOI 10.1136/bmj.291.6500.923; GILLIS S, 1979, J IMMUNOL, V123, P1624; GIRARD JP, 1967, J ALLERGY, V39, P65, DOI 10.1016/0021-8707(67)90113-X; GODARD P, 1981, NOUV PRESSE MED, V10, P3141; GROSSMAN CJ, 1984, ENDOCR REV, V5, P435, DOI 10.1210/edrv-5-3-435; HEILMAN DH, 1973, CLIN EXP IMMUNOL, V15, P203; HIRATANI M, 1981, J ALLERGY CLIN IMMUN, V68, P205, DOI 10.1016/0091-6749(81)90185-8; HSIEH KH, 1985, J ALLERGY CLIN IMMUN, V76, P188, DOI 10.1016/0091-6749(85)90700-6; HSIEH KH, 1984, J ALLERGY CLIN IMMUN, V74, P34, DOI 10.1016/0091-6749(84)90084-8; IHLE JN, 1982, IMMUNOL REV, V63, P5, DOI 10.1111/j.1600-065X.1982.tb00409.x; KALLENBERG CGM, 1984, RECENT DEV CLIN IMMU, P1; KIEFFER JD, 1971, TRANSPLANTATION, V11, P45, DOI 10.1097/00007890-197101000-00006; MITCHELL E B, 1984, Journal of Allergy and Clinical Immunology, V73, P149; OTSUKA H, 1985, J ALLERGY CLIN IMMUN, V75, P153, DOI 10.1016/0091-6749(85)90330-6; PLATT JL, 1983, J EXP MED, V158, P1227, DOI 10.1084/jem.158.4.1227; POZNANSKY MC, 1985, CLIN EXP IMMUNOL, V61, P135; RAZIN E, 1984, J IMMUNOL, V132, P1479; SCHLEIMER RP, 1984, J ALLERGY CLIN IMMUN, V74, P473, DOI 10.1016/0091-6749(84)90381-6; SEALE JP, 1983, NEW ENGL J MED, V308, P846; SEDGWICK JD, 1981, CLIN EXP IMMUNOL, V45, P409; SNYDER DS, 1982, J IMMUNOL, V129, P1803; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; TINKELMAN DG, 1976, CLIN ALLERGY, V6, P507, DOI 10.1111/j.1365-2222.1976.tb01935.x; TOMIOKA M, 1984, AM REV RESPIR DIS, V129, P1000; WELLER FR, UNPUB TH EPIDERMAL E; WELLER FR, CLIN ALLERGY; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321; WILLIAMS JD, 1984, J IMMUNOL, V132, P3034; WYLE FA, 1977, CLIN EXP IMMUNOL, V27, P407	40	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				423	430		10.1016/0091-6749(86)90028-X	http://dx.doi.org/10.1016/0091-6749(86)90028-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3760402				2022-12-18	WOS:A1986E114800009
J	DYER, EL; LEFFERTS, PL; SNAPPER, JR				DYER, EL; LEFFERTS, PL; SNAPPER, JR			PHORBOL-MYRISTATE ACETATE LUNG INJURY AND AIRWAY RESPONSIVENESS TO AEROSOL HISTAMINE IN AWAKE SHEEP	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VANDERBILT UNIV,MED CTR,SCH MED,CTR PULM CIRCULAT,DEPT MED,B-1308,MED CTR N,NASHVILLE,TN 37232	Vanderbilt University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL019153, R01HL027274] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 27274, HL 19153] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATKINS PC, 1979, J ALLERGY CLIN IMMUN, V64, P251, DOI 10.1016/0091-6749(79)90140-4; BRIGHAM KL, 1979, CIRC RES, V45, P292, DOI 10.1161/01.RES.45.2.292; DANIELE RP, 1980, PULMONARY DISEASES D, P467; DIXON M, 1979, AM REV RESPIR DIS, V120, P843; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; DYER E L, 1984, American Review of Respiratory Disease, V129, pA350; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; ESBENSHADE AM, 1982, J APPL PHYSIOL, V53, P967, DOI 10.1152/jappl.1982.53.4.967; FLOYER J, 1698, TREATISE ASTHMA, P1; GORDON T, 1980, J TOXICOL ENV HEALTH, V6, P185, DOI 10.1080/15287398009529841; HEFLIN AC, 1981, J CLIN INVEST, V68, P1253, DOI 10.1172/JCI110371; HINSON JM, 1984, J APPL PHYSIOL, V56, P411, DOI 10.1152/jappl.1984.56.2.411; HINSON JM, 1983, J APPL PHYSIOL, V55, P92, DOI 10.1152/jappl.1983.55.1.92; HOIDAL JR, 1978, AM J PATHOL, V91, P469; HOLTZMAN MJ, 1983, AM REV RESPIR DIS, V127, P686; HULBERT WC, 1981, AM REV RESPIR DIS, V123, P320; HUTCHISON AA, 1983, J APPL PHYSIOL, V54, P1463, DOI 10.1152/jappl.1983.54.6.1463; IRWIN CG, 1982, FED PROC, V41, P1358; LAKSHMINARAYAN S, 1978, CHEST, V74, P489, DOI 10.1378/chest.74.5.489; LARSEN GL, 1981, AM REV RESPIR DIS, V123, P434; LEE LY, 1977, J APPL PHYSIOL, V43, P626, DOI 10.1152/jappl.1977.43.4.626; LEE TH, 1982, J CLIN INVEST, V69, P889, DOI 10.1172/JCI110528; LOYD JE, 1983, J APPL PHYSIOL, V54, P267, DOI 10.1152/jappl.1983.54.1.267; MEYRICK B, 1983, LAB INVEST, V48, P458; NEWMAN JH, 1984, J APPL PHYSIOL, V56, P999, DOI 10.1152/jappl.1984.56.4.999; OFLAHERTY JT, 1980, AM J PATHOL, V101, P79; PATARROYO M, 1982, INT J CANCER, V30, P707, DOI 10.1002/ijc.2910300606; SELTZER J, 1984, American Review of Respiratory Disease, V129, pA262; SIEGEL S, 1956, NONPARAMETRIC STAT, P75; SIMPSON DL, 1978, AM REV RESPIR DIS, V117, P449; SNAPPER JR, 1983, J CLIN INVEST, V72, P63, DOI 10.1172/JCI110985; SUGAWARA I, 1983, CLIN IMMUNOL IMMUNOP, V26, P299, DOI 10.1016/0090-1229(83)90114-9; VONNEERGAARD K, 1927, Z KLIN MED, V105, P51; WALSH JJ, 1961, ARCH INTERN MED, V108, P98; WHITE JG, 1974, AM J PATHOL, V75, P301; WHITE JG, 1974, AM J PATHOL, V75, P45	36	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	1				44	50		10.1016/0091-6749(86)90113-2	http://dx.doi.org/10.1016/0091-6749(86)90113-2			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2996	3722634				2022-12-18	WOS:A1986D299600008
J	MAY, CD				MAY, CD			DEFINED VERSUS ILL-DEFINED SYNDROMES ASSOCIATED WITH FOOD SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80202	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BARNATHAN L, 1911, THESIS FM PARIS PARI; DICKEY LD, 1976, CLIN ECOLOGY; DUKE WW, 1923, JAMA-J AM MED ASSOC, V81, P886; GOLBERT TM, 1975, J ALLERGY CLIN IMMUN, V56, P170, DOI 10.1016/0091-6749(75)90089-5; GRIECO MH, 1982, JAMA-J AM MED ASSOC, V247, P3106, DOI 10.1001/jama.247.22.3106; Hutinel VH, 1908, CLINIQUE PARIS, V3, P227; Laroche G, 1911, CR SOC BIOL, V70, P169; LAROCHE G, 1919, ANAPHYLAXIE ALIMENTA; MAY CD, 1978, ALLERGY, V33, P166, DOI 10.1111/j.1398-9995.1978.tb01532.x; MAY CD, 1982, J ALLERGY CLIN IMMUN, V69, P255, DOI 10.1016/S0091-6749(82)80001-8; METCALFE DD, 1984, J ALLERGY CLIN IMMUN, V73, P749, DOI 10.1016/0091-6749(84)90442-1; NOBECOURT P, 1909, J PHYSL PATH GEN, V11, P836; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; RANDOLPH T G, 1948, J Am Diet Assoc, V24, P841; RANDOLPH TG, 1950, J ALLERGY, V21, P471, DOI 10.1016/0021-8707(50)90094-3; RANDOLPH TG, 1974, OTOLARYNG CLIN N AM, V7, P617; RANDOLPH TG, 1976, CLIN ECOLOGY, P321; Randolph TG, 1976, CLIN ECOLOGY; RANDOLPH TG, 1946, ANN ALLERGY, V3, P418; RANDOLPH TG, 1976, CLIN ECOLOGY, P107; Rinkel HJ, 1944, ANN ALLERGY, V2, P115; Rowe A H, 1930, Cal West Med, V33, P785; ROWE AH, 1930, J MED FRANC, V19, P170; ROWE AH, 1932, FOOD ALLERGY; SAVILAHTI E, 1984, CLIN REV ALLERG, V2, P7; Schloss OM, 1920, AM J DIS CHILD, V19, P433; Schloss OM, 1912, AM J DIS CHILD, V3, P341; Shannon WR, 1922, AM J DIS CHILD, V24, P89; 1981, J ALLERGY CLIN IMMUN, V67, P332	29	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			144	148		10.1016/0091-6749(86)90005-9	http://dx.doi.org/10.1016/0091-6749(86)90005-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	D2997	3722642				2022-12-18	WOS:A1986D299700005
J	ALBERICI, GF; FELLOUS, R; BIDART, JM; TROALEN, F; MONDESIR, JM; GOODMAN, A; HO, DH; BOHUON, C				ALBERICI, GF; FELLOUS, R; BIDART, JM; TROALEN, F; MONDESIR, JM; GOODMAN, A; HO, DH; BOHUON, C			HUMAN-ANTIBODIES TO THE ANTINEOPLASTIC DRUG ELLIPTINIUM - CHARACTERIZATION AND STRUCTURE-ACTIVITY-RELATIONSHIPS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									IVES LABS INC,685 3RD AVE,NEW YORK,NY 10017; INST GUSTAVE ROUSSY,UNITE BIOL CLIN & EXPTL,F-94805 VILLEJUIF,FRANCE; SANOFI RECH,PARIS,FRANCE; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030	UNICANCER; Gustave Roussy; Sanofi-Aventis; Sanofi France; University of Texas System; UTMD Anderson Cancer Center								ADKINSON NF, 1984, J ALLERGY CLIN IMMUN, V74, P567, DOI 10.1016/0091-6749(84)90108-8; ALBERICI GF, 1985, BIOCHEM PHARMACOL, V34, P1701, DOI 10.1016/0006-2952(85)90637-9; AUCLAIR C, 1981, J MED CHEM, V24, P289, DOI 10.1021/jm00135a010; BALDO BA, 1983, NATURE, V306, P262, DOI 10.1038/306262a0; CAILLE P, 1985, CANCER TREAT REP, V69, P901; CLARYSSE A, 1984, EUR J CANCER CLIN ON, V20, P243, DOI 10.1016/0277-5379(84)90190-1; CRIEL AM, 1980, BRIT J HAEMATOL, V46, P549, DOI 10.1111/j.1365-2141.1980.tb06011.x; Gell PGH., 1975, CLIN ASPECTS IMMUNOL, V3; HABIBI B, 1983, CR ACAD SCI III-VIE, V296, P693; HANSCH C, 1977, J MED CHEM, V20, P304, DOI 10.1021/jm00212a024; JURET P, 1982, CANCER TREAT REP, V66, P1909; LEMPEREUR L, 1984, BIOCHEM PHARMACOL, V33, P2499, DOI 10.1016/0006-2952(84)90724-X; MONDESIR JM, 1985, J CLIN ONCOL, V3, P735, DOI 10.1200/JCO.1985.3.5.735; PARKER CW, 1980, MED CHEM 1, P419; PATTERSON R, 1982, JAMA-J AM MED ASSOC, V248, P2637, DOI 10.1001/jama.248.20.2637; WEISS RB, 1982, SEMIN ONCOL, V9, P5	16	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1986	77	4					624	630		10.1016/0091-6749(86)90356-8	http://dx.doi.org/10.1016/0091-6749(86)90356-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A9381	2420854	Bronze			2022-12-18	WOS:A1986A938100016
J	BURKS, A; SAMPSON, H				BURKS, A; SAMPSON, H			DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ORAL CROMOLYN SODIUM IN CHILDREN WITH EGG HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			184	184						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800249
J	DREBORG, S; AGRELL, B; BELIN, L; EINARSSON, R; GHERSON, G; HOLGERSSON, M; HALVORSEN, R; LUND, B; LOFKVIST, T; OHLSSON, H; ORTOLANI, C; STALENHEIM, G; WIHL, JA; VALA, IJ				DREBORG, S; AGRELL, B; BELIN, L; EINARSSON, R; GHERSON, G; HOLGERSSON, M; HALVORSEN, R; LUND, B; LOFKVIST, T; OHLSSON, H; ORTOLANI, C; STALENHEIM, G; WIHL, JA; VALA, IJ			PHAZET - A NEW TYPE OF SKIN PRICK TEST DEVICE - INVIVO AND INVITRO CALIBRATION AND STABILITY STUDIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			223	223						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800405
J	FINDLAY, SR; JOHNSTON, MC				FINDLAY, SR; JOHNSTON, MC			THE JUNIPERUS-ASHEI	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											FINDLAY, SR (corresponding author), ALLERGY CTR AUSTIN,ALLERGY & CLIN IMMUNOL,8701 N MOPAC,AUSTIN,TX 78759, USA.							JOHNSTON MC, 1985, TAXON, V34, P505, DOI 10.2307/1221224; Zanoni TA, 1979, BOT SCI, V38, P83, DOI [10.17129/botsci.1171, DOI 10.17129/BOTSCI.1171]	2	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				116	116		10.1016/0091-6749(86)90333-7	http://dx.doi.org/10.1016/0091-6749(86)90333-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	3944369				2022-12-18	WOS:A1986AZD3600021
J	GOLDEN, DBK; ADDISON, BI; FREIDHOFF, L; KAGEYSOBOTKA, A; VALENTINE, MD; MARSH, DG; LICHTENSTEIN, LM				GOLDEN, DBK; ADDISON, BI; FREIDHOFF, L; KAGEYSOBOTKA, A; VALENTINE, MD; MARSH, DG; LICHTENSTEIN, LM			EPIDEMIOLOGY OF HYMENOPTERA VENOM ALLERGY (HVA) - PROSPECTIVE OBSERVATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			142	142						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800086
J	HAAKFRENDSCHO, M; SATNICK, S; BAEZA, ML; DINARELLO, C; KAPLAN, AP				HAAKFRENDSCHO, M; SATNICK, S; BAEZA, ML; DINARELLO, C; KAPLAN, AP			RECOMBINANT INTERLEUKIN-I CAUSES HISTAMINE-RELEASE FROM HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									TUFTS UNIV,NEW ENGLAND MED CTR,BOSTON,MA 02111; SUNY STONY BROOK,STONY BROOK,NY 11794	Tufts Medical Center; Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook								1985, J IMMUNOL, V135, P2027	1	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			230	230						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800436
J	HONSINGER, R; THOMSEN, R				HONSINGER, R; THOMSEN, R			PROLONGED REMISSION OF CHRONIC IDIOPATHIC URTICARIA FOLLOWING ASTEMIZOLE TREATMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			187	187						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800261
J	KAGEN, SL; YUNGINGER, JW; WYNN, SR; SWANSON, MC				KAGEN, SL; YUNGINGER, JW; WYNN, SR; SWANSON, MC			MIDGE-SPECIFIC IGE AND IGG RESPONSES DURING LAKE FLY DESENSITIZATION - AN OPEN TRIAL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	5	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			140	140						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800079
J	KIRBY, J; BARDY, JD; MALO, JL; HARGREAVE, FE; SEGUIN, P; DOLOVICH, J; EVANS, S; GHEZZO, H; CARTIER, A				KIRBY, J; BARDY, JD; MALO, JL; HARGREAVE, FE; SEGUIN, P; DOLOVICH, J; EVANS, S; GHEZZO, H; CARTIER, A			PREVALENCE OF IGE SENSITIZATION TO PSYLLIUM IN 2 PHARMACEUTICAL COMPANIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			134	134						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800056
J	KOEPKE, JW; SELNER, JC				KOEPKE, JW; SELNER, JC			COMBINED MONOSODIUM GLUTAMATE (MSG)/METABISULFITE (MBS) INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			158	158						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800148
J	MCCULLOUGH, JA; OWNBY, DR				MCCULLOUGH, JA; OWNBY, DR			DO COMMERCIAL HOUSE DUST EXTRACTS (CHDE) CONTAIN UNIQUE ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	2	S			130	130						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD38					2022-12-18	WOS:A1986AZD3800038
J	CHAND, N; PILLAR, J; DIAMANTIS, W; SOFIA, RD				CHAND, N; PILLAR, J; DIAMANTIS, W; SOFIA, RD			INHIBITION OF ALLERGIC AND NONALLERGIC HISTAMINE-RELEASE (HR) BY AZELASTINE (AZ) AND LIPOXYGENASE INHIBITORS (LI)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					194	194		10.1016/0091-6749(85)90495-6	http://dx.doi.org/10.1016/0091-6749(85)90495-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200360
J	DRUCE, H; WRIGHT, R; RAMOS, D; RAPHAEL, G; KALINER, M				DRUCE, H; WRIGHT, R; RAMOS, D; RAPHAEL, G; KALINER, M			HISTAMINE HYPERREACTIVITY IN ALLERGIC AND IDIOPATHIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					111	111		10.1016/0091-6749(85)90162-9	http://dx.doi.org/10.1016/0091-6749(85)90162-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200027
J	ENGLER, RJM; CHESTNUT, RY; BORST, GC; EIL, C				ENGLER, RJM; CHESTNUT, RY; BORST, GC; EIL, C			THE EFFECTS OF TRIACETYLOLEANDOMYCIN AND OLEANDOMYCIN PHOSPHATE ON THE GLUCOCORTICOID RECEPTOR IN CULTURED SKIN FIBROBLASTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USN HOSP,DEPT MED,BETHESDA,MD 20814; UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814	United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA								AITKEN SC, 1977, J STEROID BIOCHEM, V8, P77, DOI 10.1016/0022-4731(77)90221-7; BAXTER JD, 1979, NEW ENGL J MED, V301, P1149, DOI 10.1056/NEJM197911223012104; BERNSTEIN L, 1978, ALLERGY PRINCIPLES P, P758; BROOKS SM, 1978, STATUS ASTHMATICUS, P256; BRUNING PF, 1979, J STEROID BIOCHEM, V10, P587, DOI 10.1016/0022-4731(79)90510-7; CHROUSOS GP, 1982, J CLIN INVEST, V69, P1262; DASGUPTA A, 1978, ANN ALLERGY, V41, P297; EIL C, 1980, STEROIDS, V35, P389, DOI 10.1016/0039-128X(80)90140-3; ENGEL MF, 1963, SO MED J, V56, P2279; FOX JL, 1961, PENN MED J, V64, P634; GONCHAROVA V. I., 1963, ANTIBIOTIKI, V8, P58; ITKIN IH, 1970, J ALLERGY, V45, P146, DOI 10.1016/0021-8707(70)90124-3; KAPLAN MA, 1959, ANTIBIOTICS ANN 1958, P273; KONTULA K, 1980, J CLIN ENDOCR METAB, V51, P654, DOI 10.1210/jcem-51-3-654; MURAKAMI T, 1980, ACTA ENDOCRINOL-COP, V94, P376, DOI 10.1530/acta.0.0940376; ONG KS, 1978, J ALLERGY CLIN IMMUN, V62, P115, DOI 10.1016/0091-6749(78)90088-X; PESSAYRE D, 1983, J PHARMACOL EXP THER, V224, P685; RINGLER I, 1964, METHOD HORMONE RES, V3, P227; ROSS S, 1968, PEDIATR CLIN N AM, V15, P119; SCHATZ M, 1979, AM REV RESPIR DIS, V119, P167; SCHWARTZ HJ, 1968, ANN INTERN MED, V69, P493, DOI 10.7326/0003-4819-69-3-493; SELENKE WM, 1980, J ALLERGY CLIN IMMUN, V65, P454, DOI 10.1016/0091-6749(80)90239-0; SPECTOR SL, 1974, J ALLERGY CLIN IMMUN, V54, P367, DOI 10.1016/0091-6749(74)90027-X; SZEFLER SJ, 1980, J ALLERGY CLIN IMMUN, V66, P447, DOI 10.1016/0091-6749(80)90004-4; TICKTIN HE, 1962, NEW ENGL J MED, V267, P964, DOI 10.1056/NEJM196211082671905; WEINBERGER M, 1977, J ALLERGY CLIN IMMUN, V59, P228, DOI 10.1016/0091-6749(77)90154-3; WEINSTEIN L, 1975, PHARMACOL BASIS THER, P1224; WEINSTEIN L, 1965, PHARM BASIS THERAPEU, P1272; ZEIGER RS, 1980, J ALLERGY CLIN IMMUN, V66, P438, DOI 10.1016/0091-6749(80)90003-2	29	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	3					395	400		10.1016/0091-6749(85)90078-8	http://dx.doi.org/10.1016/0091-6749(85)90078-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AEB46	3871804				2022-12-18	WOS:A1985AEB4600012
J	ERRINGTON, GW; MEKORI, YA; SILVERS, WS; SCHOCKET, AL				ERRINGTON, GW; MEKORI, YA; SILVERS, WS; SCHOCKET, AL			ALTERED MAST-CELL THRESHOLD IN EXERCISE-INDUCED ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					193	193		10.1016/0091-6749(85)90490-7	http://dx.doi.org/10.1016/0091-6749(85)90490-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22		Bronze			2022-12-18	WOS:A1985ACF2200355
J	HANSON, B; KRONENBERG, R; JOHNSON, B; BLUMENTHAL, M				HANSON, B; KRONENBERG, R; JOHNSON, B; BLUMENTHAL, M			PULMONARY-FUNCTION, SERUM IGE LEVELS, AND SPECIFIC IGE IMMUNE-RESPONSES IN MONOZYGOTIC TWINS REARED APART	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					155	155		10.1016/0091-6749(85)90337-9	http://dx.doi.org/10.1016/0091-6749(85)90337-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200202
J	MAY, CD				MAY, CD			THE ANCESTRY OF ALLERGY - BEING AN ACCOUNT OF THE ORIGINAL EXPERIMENTAL INDUCTION OF HYPERSENSITIVITY RECOGNIZING THE CONTRIBUTION OF PAUL PORTIER	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		Arthus M, 1903, CR SOC BIOL, V55, P817; BEHRING, 1893, DTSCH MED WSCHR, V19, P389; BEHRING KS, 1890, DTSCH MED WOCHENSCHR, V16, P1113; BERNARD H, 1970, B ACAD NATL MED PARI, V154, P842; BINET L, 1952, PRESSE MED, V60, P683; BINET L., 1962, B ACAD NATL MED PARI, V146, P246; Blackley CH., 1873, EXPT RES CAUSES NATU; BLITTERSDORF F, 1952, SUDHOFFS ARCH GESCH, V36, P149; COURRIER R, 1966, NOTICE VIE OEUVRE P; DOERR R, 1913, HDB PATHOGENEN MIKRO, V2, P966; DUBOS R, 1976, L PASTEUR, P317; FLEXNER S, 1894, MED NEWS, V65, P116; FONTAINE M, 1972, ALBERT 1ER CHEF PROP; FONTAINE M, 1962, B SOC SCI HYG ALIMEN, V50, P75; FONTAINE M, 1951, B I OCEANOGR, V48, P3; HERICOURT J, 1898, C R SOC BIOL, V50, P137; HOLMES FL, 1975, DICT SCI BIOGRAPHY, P425; Jenner E, 1798, INQUIRY CAUSES EFFEC; JURI M, 1965, ZURCHER MEDIZINGESCH; Koch R., 1891, DEUT MED WOCHENSCHR, V17, P101, DOI [10.1055/s-0029-1206198, DOI 10.1055/S-0029-1206198]; MASSE B, 1969, THESIS PARIS U; MONNIER AM, 1975, DICT SCI BIOGRAPHY, P101; OSTY E, 1936, REV METAPSYCHIQUE, V17, P1; Pirquet Clemens von, 1906, MUNCHEN MED WOCHEN, V30, P1457; PORTIER P, 1952, PRESSE MED, V60, P679; Portier P, 1902, CR HEBD ACAD SCI, V134, P247; PORTIER P, 1962, SEMAINE HOPITAUX S; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; PORTIER P, 1936, NOTICE TITRES TRAVAU; Portilr P, 1902, CR SOC BIOL, V54, P548; RICHARD J, 1910, B I OCEANOGR, V7; RICHET C, 1936, RESULTATS CAMPAGNES; RICHET C, 1913, ANAPHYLAXIE; RICHET C, 1928, MED GEGENWART SELBST, P184; RICHET C, 1914, PRIX NOBEL 1913; Richet Charles, 1923, TRAITE METAPSYCHIQUE; Roussy Gustave, 1945, B ACAD NATL MED PARI, V129, P725; SCHADEWALDT H, 1960, DEUT MED WOCHENSCHR, V85, P1987, DOI 10.1055/s-0028-1112688; SCHLEE S, 1973, EDGE UNFAMILIAR WORL, P132; SOURKES TL, 1966, NOBEL PRIZE WINNERS; VONPIRQUET C, 1905, SERUMKRANKHEIT; WAGNER R, 1968, C VONPIRQUET HIS LIF, P56; WOLF S, 1981, GASTROENTEROLOGY, V80, P605; 1966, REV CULTURELLE MENSU, V14; I OCEANOGRAPHIQUE BR	45	6	8	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					485	495		10.1016/S0091-6749(85)80022-1	http://dx.doi.org/10.1016/S0091-6749(85)80022-1			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3884689	Bronze			2022-12-18	WOS:A1985AFY4400009
J	MEGGS, WJ; ATKINS, FM; WRIGHT, RH; FISHMAN, M; KALINER, MA; METCALFE, DD				MEGGS, WJ; ATKINS, FM; WRIGHT, RH; FISHMAN, M; KALINER, MA; METCALFE, DD			SULFITE CHALLENGES IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS (SM) OR UNEXPLAINED ANAPHYLAXIS (UEA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					144	144		10.1016/0091-6749(85)90295-7	http://dx.doi.org/10.1016/0091-6749(85)90295-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200160
J	MESSINA, MS; PERRY, R; SILVERBERG, M; KAPLAN, AP; SMALDONE, GC				MESSINA, MS; PERRY, R; SILVERBERG, M; KAPLAN, AP; SMALDONE, GC			QUANTITATIVE ASSAYS OF PHARMACOLOGIC AEROSOLS USED IN STUDYING ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY STONY BROOK, DEPT MED, DIV PULM MED, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, DEPT MED, DIV ALLERGY & IMMUNOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NIAID NIH HHS [AI16337] Funding Source: Medline; NIEHS NIH HHS [ES07088] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI016337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007088] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BEAVEN MA, 1972, CLIN CHIM ACTA, V37, P91, DOI 10.1016/0009-8981(72)90419-6; DYER J, 1982, J ALLERGY CLIN IMMUN, V70, P82, DOI 10.1016/0091-6749(82)90233-0; ITOH H, J AEROSOL SCI; KAPLAN J, 1981, J APPL PHYSIOL, V51, P1314, DOI 10.1152/jappl.1981.51.5.1314; MACDONALD NC, 1981, AM J HOSP PHARM, V38, P868, DOI 10.1093/ajhp/38.6.868; MESSINA MS, 1985, J ALLERGY CLIN IMMUN, V75, P252, DOI 10.1016/0091-6749(85)90054-5; NOTARI RE, 1969, J PHARM SCI, V58, P1060, DOI 10.1002/jps.2600580904; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; SMALDONE GC, 1983, J APPL PHYSIOL, V54, P393, DOI 10.1152/jappl.1983.54.2.393; TILLERY MI, 1976, ENVIRON HEALTH PERSP, V16, P25, DOI 10.2307/3428581	10	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	4					605	609		10.1016/0091-6749(85)90782-1	http://dx.doi.org/10.1016/0091-6749(85)90782-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ATH66	3902937				2022-12-18	WOS:A1985ATH6600013
J	PIERSON, WE; SHAPIRO, GG; FURUKAWA, CT; BIERMAN, CW				PIERSON, WE; SHAPIRO, GG; FURUKAWA, CT; BIERMAN, CW			ALBUTEROL SYRUP IN THE TREATMENT OF ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	PIERSON, WE (corresponding author), CHILDRENS ORTHOPED HOSP & MED CTR, DIV ALLERGY, POB C5371, 4800 SAND POINT WAY NE, SEATTLE, WA 98105 USA.							ATKINS PC, 1978, J ALLERGY CLIN IMMUN, V62, P149, DOI 10.1016/0091-6749(78)90099-4; BARCLAY J, 1981, BRIT J CLIN PHARMACO, V11, P203, DOI 10.1111/j.1365-2125.1981.tb01125.x; BERG IM, 1982, EUR J RESPIR DIS, V63, P305; BIERMAN CW, 1977, CHEST, V72, P689, DOI 10.1378/chest.72.6.689; BIERMAN CW, 1974, PEDIATRICS, V54, P668; BLUMENTHAL I, 1980, J INT MED RES, V8, P400, DOI 10.1177/030006058000800606; Cochrane G M, 1973, Curr Med Res Opin, V1, P517, DOI 10.1185/03007997309111715; CONOLLY ME, 1982, J ALLERGY CLIN IMMUN, V70, P423, DOI 10.1016/0091-6749(82)90004-5; CROMPTON GK, 1979, BRIT MED J, V2, P1199, DOI 10.1136/bmj.2.6199.1199; FALLIERS CJ, 1981, ANN ALLERGY, V47, P387; FRANCIS PWJ, 1980, PEDIATRICS, V66, P103; GODFREY S, 1981, ANN ALLERGY, V47, P423; GROGGINS RC, 1980, ARCH DIS CHILD, V55, P204, DOI 10.1136/adc.55.3.204; HENDELES L, 1983, PHARMACOTHERAPY, V3, P2; JACK D, 1971, POSTGRAD MED J, V47, P8; KALINER M, 1977, J CLIN INVEST, V60, P951, DOI 10.1172/JCI108850; LARSSON S, 1979, SCAND J RESPIR DIS, P84; LEE HS, 1981, J PEDIATR-US, V99, P805, DOI 10.1016/S0022-3476(81)80418-0; LEE HS, 1982, J PEDIATR-US, V101, P632, DOI 10.1016/S0022-3476(82)80728-2; LEE TH, 1983, NEW ENGL J MED, V308, P1502, DOI 10.1056/NEJM198306233082504; NAKAYAMA Y, 1971, POSTGRAD MED J, V47, P118; NICKLAS RA, 1982, NEW ENGL J MED, V307, P557; ODONNELL TV, 1971, POSTGRAD MED J, V47, P115; ORR TSC, 1980, CLIN ALLERGY S, V10, P1; PALMER KNV, 1970, BRIT MED J, V2, P23, DOI 10.1136/bmj.2.5700.23; PARKER SS, 1971, BRIT MED J, V4, P139, DOI 10.1136/bmj.4.5780.139; PATERSON NAM, 1976, J IMMUNOL, V117, P1356; RACHELEFSKY GS, 1978, ANN ALLERGY, V40, P252; RACHELEFSKY GS, 1981, ANN ALLERGY, V47, P143; RACHELEFSKY GS, 1979, PEDIATRIC UPDATE, P304; SHAPIRO GG, 1981, PEDIATRICS, V67, P508; STAMM SJ, 1981, PEDIATRIC CARDIOLOGY; SVEDMYR N, 1979, CURR MED RES OPIN, V6, P77, DOI 10.1185/03007997909115913; TAYLOR GJ, 1970, J AMER MED ASSOC, V214, P81, DOI 10.1001/jama.214.1.81; WALKER SR, 1972, CLIN PHARMACOL THER, V13, P861; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3; WHITEHURST VE, 1983, J ALLERGY CLIN IMMUN, V71, P123, DOI 10.1016/0091-6749(83)90264-6; WILSON JD, 1981, LANCET, V1, P1235; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703; 1981, FDA DRUG B, V11, P19	40	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					228	233		10.1016/0091-6749(85)90707-9	http://dx.doi.org/10.1016/0091-6749(85)90707-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	3894481				2022-12-18	WOS:A1985APE8800019
J	SHULAN, DJ; WEILER, JM; KOONTZ, F; RICHERSON, HB				SHULAN, DJ; WEILER, JM; KOONTZ, F; RICHERSON, HB			CONTAMINATION OF INTRADERMAL SKIN-TEST SYRINGES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,DEPT PATHOL,IOWA CITY,IA 52242	University of Iowa; University of Iowa								BARKER LF, 1975, J INFECT DIS, V132, P451, DOI 10.1093/infdis/132.4.451; HARPER SD, 1980, FOOTNOTES ALLERGY, P90; LUTZ CT, 1984, NEW ENGL J MED, V310, P1335, DOI 10.1056/NEJM198405173102024; SHIKATA T, 1977, J INFECT DIS, V136, P571, DOI 10.1093/infdis/136.4.571	4	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	2					226	227		10.1016/0091-6749(85)90706-7	http://dx.doi.org/10.1016/0091-6749(85)90706-7			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	APE88	3894480	Bronze			2022-12-18	WOS:A1985APE8800018
J	SWEENEY, M; KROUTIL, L; RECHT, M; BUSH, R				SWEENEY, M; KROUTIL, L; RECHT, M; BUSH, R			KINETICS OF ALLERGEN RELEASE FROM ALTERNARIA (ALT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					118	118		10.1016/0091-6749(85)90188-5	http://dx.doi.org/10.1016/0091-6749(85)90188-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200053
J	WIENER, D; MCGRATH, K; PATTERSON, R				WIENER, D; MCGRATH, K; PATTERSON, R			FACTITIOUS SNEEZING	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY & IMMUNOL SECT,CHICAGO,IL 60611	Northwestern University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Booth BH, 1980, ALLERGIC DISEASES, P76; CO S, 1979, ARCH NEUROL-CHICAGO, V36, P111, DOI 10.1001/archneur.1979.00500380081012; HERMAN JJ, 1983, J ALLERGY CLIN IMMUN, V71, P339, DOI 10.1016/0091-6749(83)90089-1; KAPLAN MJ, 1970, ANN ALLERGY, V28, P24; SHENKER IR, 1979, INT J PEDIATR OTORHI, V1, P171, DOI 10.1016/0165-5876(79)90010-7; TENNEBAUM JZ, 1980, ALLERGIC DISEASES DI, P182	6	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					741	742		10.1016/0091-6749(85)90104-6	http://dx.doi.org/10.1016/0091-6749(85)90104-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	4008804				2022-12-18	WOS:A1985ALA8400019
J	GRAMMER, LC; SHAUGHNESSY, MA; SHAUGHNESSY, JJ; PATTERSON, R				GRAMMER, LC; SHAUGHNESSY, MA; SHAUGHNESSY, JJ; PATTERSON, R			ASTHMA AS A VARIABLE IN A STUDY OF IMMUNOTHERAPY FOR ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; HOPE COLL,HOLLAND,MI 49423	Northwestern University; Hope College				Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUCE CA, 1977, J ALLERGY CLIN IMMUN, V59, P449, DOI 10.1016/0091-6749(77)90009-4; CONNELL JT, 1969, J ALLERGY, V43, P33, DOI 10.1016/0021-8707(69)90018-5; FISH JE, 1980, J ALLERGY CLIN IMMUN, V65, P154, DOI 10.1016/0091-6749(80)90201-8; FRANKLAND AW, 1954, LANCET, V1, P1055; FRANKLAND AW, 1955, INT ARCH ALLER A IMM, V6, P45, DOI 10.1159/000228145; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; HENDRIX SG, 1980, J ALLERGY CLIN IMMUN, V66, P486, DOI 10.1016/0091-6749(80)90010-X; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; LOWELL FC, 1965, NEW ENGL J MED, V273, P675, DOI 10.1056/NEJM196509232731302; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; RICHERSON HB, 1968, J ALLERGY, V41, P269, DOI 10.1016/0021-8707(68)90032-4; RUNDCRANTZ H, 1964, Acta Otolaryngol, V58, P283, DOI 10.3109/00016486409121389; TENNENBAUM JI, 1980, ALLERGIC DIS DIAGNOS, P179; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250; ZEISS CR, 1978, J ALLERGY CLIN IMMUN, V61, P216	16	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					557	560		10.1016/0091-6749(84)90510-4	http://dx.doi.org/10.1016/0091-6749(84)90510-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS045	6715723	Bronze			2022-12-18	WOS:A1984SS04500003
J	SCOTT, RM; SHELTON, AL; ECKELS, KH; BANCROFT, WH; SUMMERS, RJ; RUSSELL, PK				SCOTT, RM; SHELTON, AL; ECKELS, KH; BANCROFT, WH; SUMMERS, RJ; RUSSELL, PK			HUMAN HYPERSENSITIVITY TO A SHAM VACCINE PREPARED FROM MOSQUITO-CELL CULTURE FLUIDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									WALTER REED ARMY RES INST,DIV COMMUNICABLE DIS & IMMUNOL,WASHINGTON,DC 20307; WALTER REED ARMY RES INST,DEPT MED,ALLERGY & IMMUNIZAT SECT,WASHINGTON,DC 20307	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)								ALLEN JR, 1966, EXP PARASITOL, V19, P132, DOI 10.1016/0014-4894(66)90061-0; FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P138; FOX I., 1966, Dermatologia International, V5, P125; FRAZIER CA, 1973, ARCH DERMATOL, V107, P400, DOI 10.1001/archderm.107.3.400; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P160, DOI 10.1016/0091-6749(82)90037-9; HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164, DOI 10.4269/ajtmh.1983.32.164; HUDSON ANNE, 1958, MOSQUITO NEWS, V18, P249; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; MCKEIL JA, 1961, CAN J ZOOL, V39, P597; MCKEIL JA, 1959, CAN J ZOOL, V37, P341; Nathanson M E, 1969, J Asthma Res, V7, P55, DOI 10.3109/02770906909104146; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; STOLLAR V, 1980, TOGAVIRUSES BIOL STR, P583; WELLS JV, 1980, BASIC CLIN IMMUNOL, P191; WIKEL SK, 1982, ANNU REV ENTOMOL, V27, P21, DOI 10.1146/annurev.en.27.010182.000321	15	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	6					808	811		10.1016/0091-6749(84)90183-0	http://dx.doi.org/10.1016/0091-6749(84)90183-0			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW418	6150050				2022-12-18	WOS:A1984TW41800008
J	SOLOMON, WR				SOLOMON, WR			UNCOVERING THE FINE DETAILS OF POLLEN ALLERGEN TRANSPORT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											SOLOMON, WR (corresponding author), UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,DIV ALLERGY,ANN ARBOR,MI 48109, USA.				PHS HHS [A110181] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; BLANCHARD DC, 1970, SCIENCE, V170, P626, DOI 10.1126/science.170.3958.626; BUSSE WW, 1972, J ALLERGY CLIN IMMUN, V50, P289, DOI 10.1016/0091-6749(72)90027-9; D'AMATO G, 1981, Zeitschrift fuer Erkrankungen der Atmungsorgane, V157, P281; DAVIS GL, 1967, AUSTR J SCI, V30, P235; FINDLAY S, 1980, J ALLERGY CLIN IMMUN, V71, P160; Gregory P.H., 1973, MICROBIOLOGY ATMOSPH, V2nd; HABENICHT HA, 1984, J ALLERGY CLIN IMMUN, V74, P64, DOI 10.1016/0091-6749(84)90088-5; Hatch TF, 1964, PULMONARY DEPOSITION, P27; HOFFMAN DR, 1980, ANN ALLERGY, V45, P205; HUSSAIN R, 1981, J ALLERGY CLIN IMMUN, V67, P217, DOI 10.1016/0091-6749(81)90064-6; KISSLER WB, 1984, J ALLERGY CLIN IMMUN, V73, P160; LEE R, 1972, EPA PUBLICATION, V108; LEE YS, 1979, J ALLERGY CLIN IMMUN, V63, P336, DOI 10.1016/0091-6749(79)90128-3; MAY KR, 1945, J SCI INSTRUM, V22, P187, DOI 10.1088/0950-7671/22/10/303; PLATTSMILLS TAE, 1983, J ALLERGY CLIN IMMUN, V71, P157, DOI 10.1016/0091-6749(83)90398-6; REBHUN J, 1954, J ALLERGY, V25, P407, DOI 10.1016/0021-8707(54)90005-2; SCHLICHTING HE, 1974, J ALLERGY CLIN IMMUN, V53, P185, DOI 10.1016/0091-6749(74)90006-2; SHAFIEE A, 1973, J PHARM SCI, V62, P1654, DOI 10.1002/jps.2600621015; SHAFIEE A, 1973, IN VITRO, V9, P23; SOLOMON WR, 1983, J ALLERGY CLIN IMMUN, V72, P443, DOI 10.1016/0091-6749(83)90579-1; SWANSON MC, 1983, J ALLERGY CLIN IMMUN, V71, P95, DOI 10.1016/0091-6749(83)90150-1; TAYLOR AN, 1977, LANCET, V2, P847; TUCHIN DA, 1976, ANN ALLERGY, V37, P26; WOOD O, 1973, CHEMOSPHERE, V2, P77	25	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	5					674	677		10.1016/0091-6749(84)90228-8	http://dx.doi.org/10.1016/0091-6749(84)90228-8			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TT169	6501739				2022-12-18	WOS:A1984TT16900003
J	BALDOCCHI, G; VERVLOET, D; CHARPIN, J				BALDOCCHI, G; VERVLOET, D; CHARPIN, J			ACETYL-SALICYLIC ACID THERAPY IN ASPIRIN-SENSITIVE ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		STEVENSON, 1980, JACI, V66, P1	1	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					148	148		10.1016/0091-6749(83)90362-7	http://dx.doi.org/10.1016/0091-6749(83)90362-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200239
J	FIREMAN, P; ACKERMAN, M; FRIEDMAN, R; DOYLE, W; BLUESTONE, C				FIREMAN, P; ACKERMAN, M; FRIEDMAN, R; DOYLE, W; BLUESTONE, C			EFFECT OF DRUGS ON PROVOCATIVE ANTIGEN-INDUCED EUSTACHIAN-TUBE OBSTRUCTION (ETO)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					155	155		10.1016/0091-6749(83)90390-1	http://dx.doi.org/10.1016/0091-6749(83)90390-1			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200267
J	GREEN, LW; GOLDSTEIN, RA; PARKER, SR				GREEN, LW; GOLDSTEIN, RA; PARKER, SR			SELF-MANAGEMENT OF CHILDHOOD ASTHMA - CONCLUSIONS AND RECOMMENDATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									NIH,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA	GREEN, LW (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR HLTH PROMOT RES & DEV,HOUSTON,TX 77025, USA.							BECK S, 1983, R28981HHS RAND HLTH	1	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	5					625	626		10.1016/0091-6749(83)90491-8	http://dx.doi.org/10.1016/0091-6749(83)90491-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RS163	6643870				2022-12-18	WOS:A1983RS16300017
J	LEVY, DA; SCOTT, AL; HAMILTON, RG; DANTONIO, R; SWINDLE, MM				LEVY, DA; SCOTT, AL; HAMILTON, RG; DANTONIO, R; SWINDLE, MM			DOG HEARTWORM INFECTION POTENTIATES IGE IN HUMANS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					115	115		10.1016/0091-6749(83)90230-0	http://dx.doi.org/10.1016/0091-6749(83)90230-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200107
J	LOCKEY, R; PEPPE, B; BAIRD, I; TURKELTAUB, P				LOCKEY, R; PEPPE, B; BAIRD, I; TURKELTAUB, P			HYMENOPTERA VENOM STUDY (HVS), SAFETY, 9/30/82	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									AAAI COMM INSECTS,TAMPA,FL				turkeltaub, paul/AAG-6160-2019; turkeltaub, paul/U-7729-2019						0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					141	141		10.1016/0091-6749(83)90334-2	http://dx.doi.org/10.1016/0091-6749(83)90334-2			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200211
J	MELTZER, EO; ORGEL, HA; KEMP, JP; CHUBB, JM; WARD, JF				MELTZER, EO; ORGEL, HA; KEMP, JP; CHUBB, JM; WARD, JF			EFFECT OF DOSING SCHEDULE ON EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE AEROSOL (BDP) IN CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					149	149		10.1016/0091-6749(83)90366-4	http://dx.doi.org/10.1016/0091-6749(83)90366-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200243
J	MENDOZA, GR; EITCHES, RW; ORNER, FB				MENDOZA, GR; EITCHES, RW; ORNER, FB			DIRECT EFFECTS OF OLEANDOMYCIN ON HISTAMINE-RELEASE IN HUMAN BASOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									UNIV CALIF LOS ANGELES,CTR HLTH SCI,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					135	135		10.1016/0091-6749(83)90310-X	http://dx.doi.org/10.1016/0091-6749(83)90310-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200187
J	PATTERSON, R; HARRIS, KE; ZEISS, CR				PATTERSON, R; HARRIS, KE; ZEISS, CR			ANTIBODIES AGAINST TOLUENE DIISOCYANATE PROTEIN CONJUGATES - 3 METHODS OF MEASUREMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATTERSON, R (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 11403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERNSTEIN IL, 1982, J ALLERGY CLIN IMMUN, V70, P24, DOI 10.1016/0091-6749(82)90197-X; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; LIDD D, 1962, J ALLERGY, V33, P45, DOI 10.1016/0021-8707(62)90062-X; PATTERSON R, 1981, INT ARCH ALLER A IMM, V66, P332, DOI 10.1159/000232838; PATTERSON R, 1983, J ALLERGY CLIN IMMUN, V71, P604, DOI 10.1016/0091-6749(83)90443-8; PATTERSON R, 1982, J ALLERGY CLIN IMMUN, V70, P19, DOI 10.1016/0091-6749(82)90196-8; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250; ZEISS CR, 1978, IMMUNOLOGY, V35, P237; ZEISS CR, 1973, J IMMUNOL, V110, P414	13	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	6					676	680		10.1016/0091-6749(83)90628-0	http://dx.doi.org/10.1016/0091-6749(83)90628-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RW048	6315802	Bronze			2022-12-18	WOS:A1983RW04800007
J	SHEFFER, AL; MELAMED, J; FEARON, DT; AUSTEN, KF				SHEFFER, AL; MELAMED, J; FEARON, DT; AUSTEN, KF			CLINICAL BIOCHEMICAL ASSESSMENT OF ACQUIRED C1BARINH DEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School									0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					107	107		10.1016/0091-6749(83)90197-5	http://dx.doi.org/10.1016/0091-6749(83)90197-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462		Bronze			2022-12-18	WOS:A1983PZ46200074
J	DECAROLIS, C; PERRICONE, R; DESANCTIS, G; FONTANA, L				DECAROLIS, C; PERRICONE, R; DESANCTIS, G; FONTANA, L			COMPLEMENT ACTIVATION BY HYMENOPTERA VENOM ALLERGENIC EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											DECAROLIS, C (corresponding author), UNIV ROME,SCH MED,INST CLIN MED 6,I-00100 ROME,ITALY.			De Carolis, Caterina/0000-0002-6597-6253; Perricone, Roberto/0000-0002-2368-9766				ARROYAVE CM, 1976, J IMMUNOL METHODS, V13, P101, DOI 10.1016/0022-1759(76)90148-4; DESPRES RM, 1975, INFECT IMMUNOL, V11, P235; GOLDEN D, 1980, ADV ALLERGY APPLIED, P425; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Mayer M.M., 1961, EXPT IMMUNOCHEMISTRY, P133; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215	7	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	3					219	220		10.1016/0091-6749(82)90045-8	http://dx.doi.org/10.1016/0091-6749(82)90045-8			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PG384	7108072	Bronze			2022-12-18	WOS:A1982PG38400010
J	FINK, JN				FINK, JN			EVALUATION OF THE PATIENT FOR OCCUPATIONAL IMMUNOLOGICAL LUNG-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											FINK, JN (corresponding author), MED COLL WISCONSIN,DEPT MED,ALLERGY SECT,MILWAUKEE,WI 53226, USA.				NHLBI NIH HHS [HL15389] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUTCHER BT, 1976, J ALLERGY CLIN IMMUN, V58, P89, DOI 10.1016/0091-6749(76)90110-X; FINK JN, 1968, ANN INTERN MED, V68, P1205, DOI 10.7326/0003-4819-68-6-1205; FINK JN, 1978, ALLERGY PRINCIPLES P, P855; MOORE VL, 1980, J ALLERGY CLIN IMMUN, V65, P365, DOI 10.1016/0091-6749(80)90214-6; PEPYS J, 1978, ALLERGY PRINCIPLES P, P812; RAMAZZINI B, 1940, MORBUS ARTIFICUM DIA; REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615; SCHLUETER DP, 1974, AM J MED, V57, P476, DOI 10.1016/0002-9343(74)90141-7; WEINBERGER SE, 1978, ANN INTERN MED, V89, P459, DOI 10.7326/0003-4819-89-4-459; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1973, J IMMUNOL, V110, P414	11	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	1					11	14		10.1016/0091-6749(82)90194-4	http://dx.doi.org/10.1016/0091-6749(82)90194-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NY715	7085998				2022-12-18	WOS:A1982NY71500005
J	MOROZ, LA				MOROZ, LA			RAST FOR DIAGNOSIS OF IGE-MEDIATED DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter											MOROZ, LA (corresponding author), ROYAL VICTORIA HOSP,DIV CLIN IMMUNOL,MONTREAL H3A 1A1,QUEBEC,CANADA.							ADKINSON NF, 1981, J ALLERGY CLIN IMMUN, V67, P87, DOI 10.1016/0091-6749(81)90001-4; MOROZ LA, 1980, NEW ENGL J MED, V302, P1126, DOI 10.1056/NEJM198005153022005	2	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	4					315	316		10.1016/0091-6749(82)90073-2	http://dx.doi.org/10.1016/0091-6749(82)90073-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PL151	7119304	Bronze			2022-12-18	WOS:A1982PL15100016
J	TREUHAFT, MW; ROBERTS, RC; HACKBARTH, C; MARX, JJ				TREUHAFT, MW; ROBERTS, RC; HACKBARTH, C; MARX, JJ			CHARACTERIZATION OF SYNTHETIC MEDIUM ANTIGENS OF MICROPOLYSPORA-FAENI AND THERMOACTINOMYCES-CANDIDUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											TREUHAFT, MW (corresponding author), MARSHFIELD MED FDN INC,510 N ST JOSEPH AVE,MARSHFIELD,WI 54449, USA.				NHLBI NIH HHS [HL-15389] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGREN CH, 1975, SCAND J IMMUNOL   S2, V4, P59; CAMPBELL RC, 1974, STATISTICS BIOL, P268; EDWARDS JH, 1972, J LAB CLIN MED, V79, P683; FLAHERTY DK, 1974, J LAB CLIN MED, V84, P298; FLETCHER SM, 1973, J HYG-CAMBRIDGE, V71, P185, DOI 10.1017/S0022172400046350; HARBOE N, 1973, Scandinavian Journal of Immunology, V2, P161; HOLLINGDALE MR, 1974, J HYG-CAMBRIDGE, V72, P79, DOI 10.1017/S002217240002324X; KROLL J, 1973, SCAND J IMMUNOL, V2, P79, DOI 10.1111/j.1365-3083.1973.tb03783.x; KURUP VP, 1977, INFECT IMMUN, V15, P608, DOI 10.1128/IAI.15.2.608-613.1977; MADSEN D, 1976, AM REV RESPIR DIS, V113, P171; MARX JJ, 1978, J ALLERGY CLIN IMMUN, V62, P185, DOI 10.1016/0091-6749(78)90105-7; MARX JJ, 1975, J CLIN MICROBIOL, V1, P480, DOI 10.1128/JCM.1.5.480-482.1975; PEPYS J, 1965, THORAX, V20, P21, DOI 10.1136/thx.20.1.21; ROBERTS RC, 1977, J LAB CLIN MED, V90, P1076; ROBERTS RC, 1976, AM REV RESPIR DIS, V114, P23; ROBERTS RC, 1976, J ALLERGY CLIN IMMUN, V57, P518, DOI 10.1016/0091-6749(76)90002-6; STARKEY PM, 1977, PROTEINASES MAMMALIA, P57; TREUHAFT MW, 1979, AM REV RESPIR DIS, V119, P571; VOLLER A, 1977, ENZYME LINKED IMMUNO, P1; WEEKE B, 1973, SCAND J IMMUNOL, V2, P37, DOI 10.1111/j.1365-3083.1973.tb03777.x; WENZEL FJ, 1974, AM REV RESPIR DIS, V109, P464	22	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1981	67	5					375	387		10.1016/0091-6749(81)90083-X	http://dx.doi.org/10.1016/0091-6749(81)90083-X			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ563	7014692	Bronze			2022-12-18	WOS:A1981LQ56300008
J	BARDANA, EJ; GABOUREL, JD; ANDERSON, CJ; DAVIES, GH				BARDANA, EJ; GABOUREL, JD; ANDERSON, CJ; DAVIES, GH			PHENYTOIN-INDUCED SUPPRESSION OF IGA AND IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					167	167						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000013
J	CAIN, WA; WELLS, JH; FROMTLING, AM; PENNOCK, BE				CAIN, WA; WELLS, JH; FROMTLING, AM; PENNOCK, BE			RESPIRATORY ALLERGIC HYPERSENSITIVITY IN GUINEA-PIGS, A MODEL OF ALLERGIC-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					229	229						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000213
J	GLEICH, GJ; CAMPBELL, AR; GLEICH, MC; SWEDLUND, HA				GLEICH, GJ; CAMPBELL, AR; GLEICH, MC; SWEDLUND, HA			DIFFERENCES IN THE REACTIVITY OF SHORT AND GIANT RAGWEED WITH IMMUNOGLOBULIN-E ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,ALLERGIC DIS RES LAB,DEPT IMMUNOL,ROCHESTER,MN 55901	Mayo Clinic	GLEICH, GJ (corresponding author), MAYO CLIN & MAYO FDN,ALLERGIC DIS RES LAB,DEPT MED,ROCHESTER,MN 55901, USA.							ARMSTRONG C, 1924, US PUBLIC HLTH REP, V39, P2422; BERNSTEIN IL, 1976, J ALLERGY CLIN IMMUN, V57, P141, DOI 10.1016/0091-6749(76)90033-6; BERNTON HS, 1924, JAMA, V82, P1435; Brown A, 1927, J IMMUNOL, V13, P73; Coca AF, 1925, J IMMUNOL, V10, P445; Cooke RA, 1916, J IMMUNOL, V1, P201; COOKE ROBERT A., 1935, JOUR ALLERGY, V6, P311, DOI 10.1016/S0021-8707(35)90086-7; CROMWELL H. W., 1933, JOUR ALLERGY, V4, P347, DOI 10.1016/S0021-8707(33)90023-4; GLEICH GJ, 1980, J ALLERGY CLIN IMMUN, V65, P20, DOI 10.1016/0091-6749(80)90172-4; GLEICH GJ, 1977, J ALLERGY CLIN IMMUN, V60, P188, DOI 10.1016/0091-6749(77)90123-3; GLEICH GJ, 1976, MANUAL CLIN IMMUNOLO, P575; GRUBB GLENN D., 1938, JOUR ALLERGY, V9, P211, DOI 10.1016/S0021-8707(38)90213-8; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P140, DOI 10.1016/0091-6749(76)90149-4; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P129, DOI 10.1016/0091-6749(76)90148-2; MOORE MARJORIE B., 1931, JOUR ALLERGY, V2, P85, DOI 10.1016/S0021-8707(31)90023-3; Rappaport BZ, 1929, P SOC EXP BIOL MED, V26, P771; SPAIN WC, 1930, J ALLERGY, V1, P209; STULL ARTHUR, 1932, JOUR ALLERGY, V3, P120, DOI 10.1016/S0021-8707(32)90371-2; WELSH PW, 1979, J ALLERGY CLIN IMMUN, V64, P209, DOI 10.1016/0091-6749(79)90097-6	19	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	2					110	117		10.1016/0091-6749(80)90194-3	http://dx.doi.org/10.1016/0091-6749(80)90194-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JF199	6985923				2022-12-18	WOS:A1980JF19900005
J	GOLDSTEIN, S; MUELLER, U; WYPYCH, J; REISMAN, R; ARBESMAN, C				GOLDSTEIN, S; MUELLER, U; WYPYCH, J; REISMAN, R; ARBESMAN, C			TREATMENT OF RAGWEED-SENSITIVE PATIENTS WITH RAGWEED FRACTION-A CONJUGATED TO D-GLUTAMIC ACID - D-LYSINE (FA-DGL)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					164	165						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000006
J	MARTIN, BG; MANSFIELD, LE; NELSON, HS				MARTIN, BG; MANSFIELD, LE; NELSON, HS			PATTERNS OF CROSS-ALLERGENICITY AMONG GRASSES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					229	230						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000216
J	MESSENGER, LJ; LI, TM; BENOVIC, JL; BURD, JF				MESSENGER, LJ; LI, TM; BENOVIC, JL; BURD, JF			STAT ASSAY FOR THEOPHYLLINE CONCENTRATIONS IN HUMAN-SERUM USING A MODIFIED SUBSTRATE-LABELED FLUORESCENT IMMUNOASSAY (SLFIA)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					175	175						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000041
J	NICKELSEN, J; GOLDSTEIN, S; MUELLER, U; WYPYCH, J; REISMAN, B; ARBESMAN, C				NICKELSEN, J; GOLDSTEIN, S; MUELLER, U; WYPYCH, J; REISMAN, B; ARBESMAN, C			LOCAL NASAL IMMUNOTHERAPY WITH AQUEOUS AND POLYMERIZED RAGWEED EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					192	192						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000093
J	SOHNLE, PG; VARKEY, B; ROSE, HD				SOHNLE, PG; VARKEY, B; ROSE, HD			LYMPHOCYTE FUNCTION IN RELAPSED PULMONARY BLASTOMYCOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233; VET ADM HOSP,MED CTR,RES SERV,PULM SECT,WOOD,WI 53193	Medical College of Wisconsin	SOHNLE, PG (corresponding author), VET ADM HOSP,MED CTR,MED SERV,INFECT DIS SECT,WOOD,WI 53193, USA.							ABERNATHY RS, 1967, ANTIMICROB AGENTS CH, V6, P208; BAUM GL, 1974, MED CLIN N AM, V58, P661, DOI 10.1016/S0025-7125(16)32151-4; CATANZARO A, 1975, CELL IMMUNOL, V15, P360, DOI 10.1016/0008-8749(75)90014-3; CLAUSEN JE, 1972, J IMMUNOL, V108, P453; FITZSIMONS RB, 1978, CAN MED ASSOC J, V119, P343; FURCOLOW ML, 1973, T NEW YORK ACAD SCI, V35, P421, DOI 10.1111/j.2164-0947.1973.tb01981.x; HANIFIN JM, 1974, BRIT J DERMATOL, V90, P1, DOI 10.1111/j.1365-2133.1974.tb06355.x; KIRKPATRICK CH, 1971, ANN INTERN MED, V74, P955, DOI 10.7326/0003-4819-74-6-955; KIRKPATRICK CH, 1974, ANN INTERN MED, V80, P310, DOI 10.7326/0003-4819-80-3-310; LANDIS FB, 1976, AM REV RESPIR DIS, V113, P77; NEWBERRY WM, 1968, J IMMUNOL, V100, P436; POUFFE J, 1979, J INFECT DIS, V139, P152; REPINE JE, 1978, AM REV RESPIR DIS, V118, P325; ROSE HD, 1978, AM REV RESPIR DIS, V118, P403; RYCROFT RJG, 1976, CLIN EXP DERMATOL, V1, P59, DOI 10.1111/j.1365-2230.1976.tb01399.x; SAROSI G, 1977, AM REV RESPIR DIS, V116, P785, DOI 10.1164/arrd.1977.116.4.785; SOHNLE PG, 1978, J CLIN INVEST, V62, P45, DOI 10.1172/JCI109112; STEVENS DA, 1974, CELL IMMUNOL, V12, P37, DOI 10.1016/0008-8749(74)90054-9; STOBO JD, 1976, J CLIN INVEST, V57, P319, DOI 10.1172/JCI108283; TWOMEY JJ, 1975, J LAB CLIN MED, V85, P968; WALTERS BAJ, 1974, INT ARCH ALLER A IMM, V46, P849, DOI 10.1159/000231187; WITORSCH P, 1968, MEDICINE, V47, P169, DOI 10.1097/00005792-196805000-00001	22	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	5					376	380		10.1016/0091-6749(80)90216-X	http://dx.doi.org/10.1016/0091-6749(80)90216-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV955	6989877				2022-12-18	WOS:A1980JV95500010
J	WILSON, MR; SALVAGGIO, JE				WILSON, MR; SALVAGGIO, JE			ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - A MECHANISM IN SEARCH OF DISEASES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									TULANE UNIV,SCH MED,DEPT MED,CLIN IMMUNOL SECT,NEW ORLEANS,LA 70112	Tulane University								ARROYAVE CM, 1976, J IMMUNOL, V117, P1866; BUTCHER BT, 1979, J ALLERGY CLIN IMMUN, V64, P146, DOI 10.1016/0091-6749(79)90049-6; COGEN FC, 1979, J ALLERGY CLIN IMMUN, V64, P299, DOI 10.1016/0091-6749(79)90148-9; EDWARDS J H, 1974, Clinical Allergy, V4, P379, DOI 10.1111/j.1365-2222.1974.tb01399.x; GINSBERG MH, 1978, ARTHRITIS RHEUM, V21, P558; HASSELBACHER P, 1979, J ALLERGY CLIN IMMUN, V64, P294, DOI 10.1016/0091-6749(79)90147-7; HO PC, 1979, CELLULAR MOL CLIN AS, V6, P179; KOLB WP, 1978, J IMMUNOL, V121, P1232; OLENCHOCK SA, 1978, J ALLERGY CLIN IMMUN, V62, P295, DOI 10.1016/0091-6749(78)90161-6; WILSON MR, 1977, J ALLERGY CLIN IMMUN, V60, P218, DOI 10.1016/0091-6749(77)90133-6; WILSON MR, CLIN ALLERGY	11	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	5					319	321		10.1016/0091-6749(80)90207-9	http://dx.doi.org/10.1016/0091-6749(80)90207-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JV955	6246151				2022-12-18	WOS:A1980JV95500001
J	BLUMENTHAL, M; NAMBOODIRI, M; GLEICH, G; ELSTON, R				BLUMENTHAL, M; NAMBOODIRI, M; GLEICH, G; ELSTON, R			STUDY OF GENETIC TRANSMISSION OF SERUM IGE LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					169	169						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400115
J	CHASE, MW				CHASE, MW			IRREVERENT RECOLLECTIONS FROM COOKE AND COCA, 1928-1978	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROCKEFELLER UNIV,IMMUNOL & HYPERSENSIT LAB,NEW YORK,NY 10021	Rockefeller University								ALLANSMITH M, 1964, J ALLERGY, V35, P339, DOI 10.1016/0021-8707(64)90097-8; AUGUSTIN R, 1960, IMMUNOLOGY, V3, P45; AUGUSTIN R, 1963, PROTIDES BIOL FLUIDS, V11, P56; BECKER CG, 1977, J EXP MED, V146, P457, DOI 10.1084/jem.146.2.457; BECKER CG, 1976, P NATL ACAD SCI USA, V73, P1712, DOI 10.1073/pnas.73.5.1712; BENNICH H, 1967, 3 NOB S, P199; BRATTSTEN I., 1955, ACTA ALLERGOL, V8, P339, DOI 10.1111/j.1398-9995.1955.tb03579.x; CAMPBELL DH, 1950, J ALLERGY, V21, P519, DOI 10.1016/0021-8707(50)90102-X; CANN JR, 1954, J IMMUNOL, V72, P270; Chase Merrill W., 1948, BACTERIAL MYCOTIC IN, P110; CHASE MW, 1958, BACTERIAL MYCOTIC IN, P149; CHASE MW, 1952, BACTERIAL MYCOTIC IN, P168; Coca AF, 1923, J IMMUNOL, V8, P163; Coca AF, 1941, J LAB CLIN MED, V26, P1878; Coca AF, 1926, ARCH PATHOL LAB MED, V1, P96; COCA AF, 1943, FAMILIAL NONREAGINIC; COCA AF, 1933, ERG HYG, V14, P538; Cooke RA, 1947, ALLERGY THEORY PRACT; Cooke RA, 1915, LARYNGOSCOPE, V25, P108; COOKE RA, 1959, NY STATE J MED, V59, P289; DUBOS RJ, 1965, BACTERIAL MYCOTIC ED, P238; FIREMAN P, 1963, J EXP MED, V117, P603, DOI 10.1084/jem.117.4.603; GOODFRIEND L, 1965, NATURE, V205, P718, DOI 10.1038/205718a0; GOODFRIEND L, 1966, INT ARCH ALLER A IMM, V30, P542, DOI 10.1159/000229841; Grove EF, 1925, J IMMUNOL, V10, P471; HARKAVY J, 1968, ANN ALLERGY, V26, P447; HARKAVY J, 1964, NEW YORK STATE J MED, V64, P1287; HARKAVY J, 1963, VASCULAR ALLERGY ITS; Heremans J., 1960, GLOBULINES SERIQUES; HEREMANS JF, 1959, CLIN CHIM ACTA, V4, P96, DOI 10.1016/0009-8981(59)90088-9; HEREMANS JF, 1962, NATURE, V193, P1091, DOI 10.1038/1931091b0; HUMPHREY JH, 1957, LANCET, V1, P196; Huntoon FM, 1921, J IMMUNOL, V6, P185; ISHIZAKA K, 1963, J ALLERGY, V34, P395, DOI 10.1016/0021-8707(63)90002-9; ISHIZAKA K, 1966, J ALLERGY, V38, P108, DOI 10.1016/0021-8707(66)90050-5; ISHIZAKA K, 1966, J IMMUNOL, V97, P75; ISHIZAKA K, 1966, J ALLERGY, V37, P336, DOI 10.1016/0021-8707(66)90133-X; ISHIZAKA K, 1966, J ALLERGY, V37, P169, DOI 10.1016/0021-8707(66)90091-8; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; JOHANSSO.SG, 1967, LANCET, V2, P951; JOHANSSON SG, 1968, LANCET, V1, P1118; JOHANSSON SG, 1968, IMMUNOLOGY, V14, P265; JOHANSSON SG, 1967, IMMUNOLOGY, V13, P381; JOHANSSON SGO, 1967, 3 NOB S GAMM GLOB ST, P193; Katz G, 1941, J AMER MED ASSOC, V117, P1782, DOI 10.1001/jama.1941.02820470030008; KING TP, 1962, BIOCHEMISTRY-US, V1, P709, DOI 10.1021/bi00910a027; KING TP, 1967, BIOCHEMISTRY-US, V6, P1992, DOI 10.1021/bi00859a017; KREMZNER LT, 1966, BIOCHEM PHARMACOL, V15, P197, DOI 10.1016/0006-2952(66)90061-X; KUHNS WJ, 1954, J EXP MED, V99, P577, DOI 10.1084/jem.99.6.577; KUNKEL HG, 1963, P SOC EXP BIOL MED, V113, P278; Landsteiner K, 1936, J EXP MED, V64, P625, DOI 10.1084/jem.64.4.625; Landsteiner K, 1936, J EXP MED, V64, P717, DOI 10.1084/jem.64.5.717; Landsteiner K, 1936, NEW ENGL J MED, V215, P1199, DOI 10.1056/NEJM193612242152601; LANDSTEINER K, 1937, J IMMUNOL, V33, P224; LANDSTEINER K, 1937, J IMMUNOL, V33, P225; LEDDY JP, 1962, P SOC EXP BIOL MED, V111, P7; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; Longsworth LG, 1939, J EXP MED, V70, P399, DOI 10.1084/jem.70.4.399; LOVELESS MH, 1964, FED PROC, V23, P403; LOVELESS MH, 1953, SCIENCE, V117, P105, DOI 10.1126/science.117.3031.105; MENZEL AEO, 1952, J ALLERGY, V23, P483, DOI 10.1016/0021-8707(52)90035-X; MURPHY JB, 1926, 21 ROCK I MED RES MO; NEWELL JOHN M., 1939, JOUR ALLERGY, V10, P513, DOI 10.1016/S0021-8707(39)90246-7; NOAH JW, 1961, J ALLERGY, V32, P236, DOI 10.1016/0021-8707(61)90053-3; NOAH JW, 1955, J ALLERGY, V26, P385, DOI 10.1016/0021-8707(55)90029-0; NOAH JW, 1954, J ALLERGY, V25, P210, DOI 10.1016/0021-8707(54)90180-X; OSGOOD H, 1960, J ALLERGY, V11, P482; Osler A G, 1968, Adv Immunol, V8, P183, DOI 10.1016/S0065-2776(08)60467-8; PERELMUT.L, 1965, FED PROC, V24, P632; PERELMUTTER L, 1966, INT ARCH ALLER A IMM, V29, P364, DOI 10.1159/000229717; PERELMUTTER L, 1966, J ALLERGY, V37, P245; PRAUSNITZ C, 1921, ZBL BAKT           1, V86, P160; REISMAN RE, 1965, J ALLERGY, V36, P362, DOI 10.1016/0021-8707(65)90043-2; ROCKEY JH, 1964, J LAB CLIN MED, V63, P205; ROCKEY JH, 1962, P SOC EXP BIOL MED, V110, P101; SCHULTZE HE, 1959, CLIN CHIM ACTA, V4, P610, DOI 10.1016/0009-8981(59)90002-6; SEHON AH, 1955, J ALLERGY, V26, P329, DOI 10.1016/0021-8707(55)90062-9; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SHORE PA, 1976, METHODS IMMUNOLOGY I, V5, P129; SPIES JB, 1977, IMMUNOLOGICAL ASPECT, P317; Spies JR, 1944, J AM CHEM SOC, V66, P748, DOI 10.1021/ja01233a028; Spies JR, 1941, J AM CHEM SOC, V63, P2163, DOI 10.1021/ja01853a039; STANWORTH DR, 1963, ADV IMMUNOL, V3, P181, DOI 10.1016/S0065-2776(08)60813-5; STANWORTH DR, 1968, LANCET, V2, P17; STANWORTH DR, 1967, LANCET, V2, P330; STANWORTH DR, 1959, IMMUNOLOGY, V2, P384; STANWORTH DR, 1968, LANCET, V2, P18; Straus HW, 1937, J IMMUNOL, V33, P215; VAERMAN JP, 1964, FED PROC, V23, P558; VAERMAN JP, 1964, NATURE, V203, P1046, DOI 10.1038/2031046a0; VANARSDEL PP, 1958, J ALLERGY, V29, P429, DOI 10.1016/0021-8707(58)90084-4; VAUGHAN JH, 1952, J ALLERGY, V23, P489, DOI 10.1016/0021-8707(52)90036-1; WICHER K, 1970, J ALLERGY, V45, P107; WIDE L, 1967, LANCET, V2, P1105; WRIGHT HE, 1960, ARCH BIOCHEM BIOPHYS, V86, P94, DOI 10.1016/0003-9861(60)90375-1; YAGI Y, 1963, J IMMUNOL, V91, P83; Zinsser H, 1921, J IMMUNOL, V6, P289; 1968, B WHO, V38, P151; 1968, B WHO, V38, P152	100	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	5					306	320		10.1016/0091-6749(79)90002-2	http://dx.doi.org/10.1016/0091-6749(79)90002-2			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HT520	385671				2022-12-18	WOS:A1979HT52000002
J	EPSTEIN, WL; BYERS, VS				EPSTEIN, WL; BYERS, VS			TRANSFER OF CONTACT SENSITIVITY TO BERYLLIUM USING DIALYZABLE LEUKOCYTE EXTRACTS (TRANSFER-FACTOR)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											EPSTEIN, WL (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143, USA.							ARALACHAVES MP, 1972, INT ARCH ALLER A IMM, V43, P410, DOI 10.1159/000230857; BASTEN A, 1976, TRANSFER FACTOR BASI, P75; BLOOM BR, 1967, PROG ALLERGY, V10, P151; BRANDRIS.MW, 1968, J CLIN INVEST, V47, P2152, DOI 10.1172/JCI105901; COHEN L, 1976, J EXP MED, V143, P791, DOI 10.1084/jem.143.4.791; EICHBERG JW, 1976, CELL IMMUNOL, V26, P114, DOI 10.1016/0008-8749(76)90353-1; Epstein W L, 1971, Adv Biol Skin, V11, P313; EPSTEIN WL, 1957, J INVEST DERMATOL, V28, P291, DOI 10.1038/jid.1957.36; FREEDMAN SO, 1962, J INVEST DERMATOL, V38, P363, DOI 10.1038/jid.1962.65; GOOD RA, 1957, ANN NY ACAD SCI, V64, P882, DOI 10.1111/j.1749-6632.1957.tb52482.x; KIRKPATRICK CH, 1975, J ALLERGY CLIN IMMUN, V55, P411, DOI 10.1016/0091-6749(75)90080-9; Landsteiner K, 1942, P SOC EXP BIOL MED, V49, P688, DOI 10.3181/00379727-49-13670; Lawrence H S, 1969, Adv Immunol, V11, P195, DOI 10.1016/S0065-2776(08)60480-0; LAWRENCE HS, 1974, HARVEY LECT, P239; RAPPAPORT FT, 1968, J IMMUNOL, V84, P358; STEELE RW, 1976, TRANSFER FACTOR, P371; TURK JL, 1975, RES MONOGRAPHS FRONT, V4, P64; WELCH TM, 1976, CLIN IMMUNOL IMMUNOP, V5, P407, DOI 10.1016/0090-1229(76)90050-7; ZUCKERMAN KS, 1974, J CLIN INVEST, V54, P997, DOI 10.1172/JCI107841	19	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	2					111	115		10.1016/0091-6749(79)90200-8	http://dx.doi.org/10.1016/0091-6749(79)90200-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GJ748	83331				2022-12-18	WOS:A1979GJ74800008
J	MICHAELS, AA; STEVENS, MB; ADKINSON, NF				MICHAELS, AA; STEVENS, MB; ADKINSON, NF			DETECTION OF INFLUENZA VACCINE-SPECIFIC IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					169	169						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400117
J	POPA, VT; GARFIELD, M				POPA, VT; GARFIELD, M			IMMUNOLOGICAL AND PHARMACOLOGIC DETERMINANTS OF BRONCHIAL RESPONSES TO INHALED RAGWEED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		1974, J LAB CLIN MED, V84, P225	1	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					141	142						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400023
J	PRUZANSKY, JJ; PATTERSON, R				PRUZANSKY, JJ; PATTERSON, R			CYTOTOXICITY OF IONOPHORE A23187 FOR BASOPHILS AND OTHER HUMAN-BLOOD CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MICROBIOL IMMUNOL,CHICAGO,IL 60611	Northwestern University	PRUZANSKY, JJ (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611, USA.							ANTON AH, 1969, J PHARMACOL EXP THER, V166, P285; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; FOREMAN JC, 1973, NATURE, V245, P249, DOI 10.1038/245249a0; LEWIS RA, 1975, J IMMUNOL, V114, P87; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LICHTENSTEIN LM, 1975, J IMMUNOL, V114, P1692; PRUZANSKY JJ, 1970, INT ARCH ALLER A IMM, V38, P522, DOI 10.1159/000230305; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SIRAGANIAN RP, 1975, J IMMUNOL, V115, P1599	9	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	1					50	55		10.1016/0091-6749(79)90083-6	http://dx.doi.org/10.1016/0091-6749(79)90083-6			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HC424	87409				2022-12-18	WOS:A1979HC42400011
J	SODERBERGWARNER, M; SIEGEL, S; KATZ, R; RACHELEFSKY, G				SODERBERGWARNER, M; SIEGEL, S; KATZ, R; RACHELEFSKY, G			TREATMENT OF CHRONIC CHILDHOOD ASTHMA WITH BECLOMETHASONE DIPROPIONATE AEROSOLS (BDA) .4. LONG-TERM EFFECTS ON GROWTH	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					164	164						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400098
J	TINKELMAN, D; KING, S				TINKELMAN, D; KING, S			SEVERE ASTHMA AND VOLATILE DIABETES-MELLITUS IN THE SAME PATIENT - TREATMENT DILEMMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Discussion									ATLANTA ALLERGY CLIN,ATLANTA,GA									Abrahamson EM, 1941, J CLIN ENDOCRINOL, V1, P402, DOI 10.1210/jcem-1-5-402; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BRODER I, 1978, J ALLERGY CLIN IMMUN, V61, P164, DOI 10.1016/0091-6749(78)90358-5; CAPLIN I, 1976, ANN ALLERGY, V36, P193; Charpin J, 1966, Mars Med, V103, P895; GODFREY S, 1973, ARCH DIS CHILD, V48, P665, DOI 10.1136/adc.48.9.665; HELANDER E, 1958, ACTA MED SCAND, V162, P165; KING RA, 1979, MINN MED, V62, P14; Laborie F, 1967, J Med Bord, V144, P1143; MENSER MA, 1975, NEW ENGL J MED, V292, P981; NERUP J, 1974, LANCET, V2, P864; NERUP J, 1978, IMMUNOLOGICAL DISEAS, P1336; SWERN N, 1932, J ALLERGY, V2, P875; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; THORSBY E, 1971, Tissue Antigens, V1, P147	15	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	3					223	226		10.1016/0091-6749(79)90099-X	http://dx.doi.org/10.1016/0091-6749(79)90099-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HL221	469120				2022-12-18	WOS:A1979HL22100011
J	BARDANA, EJ				BARDANA, EJ			CULTURE AND ANTIGEN VARIANTS OF ASPERGILLUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											BARDANA, EJ (corresponding author), UNIV OREGON, SCH MED, PORTLAND, OR 97201 USA.								0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					225	227		10.1016/0091-6749(78)90188-4	http://dx.doi.org/10.1016/0091-6749(78)90188-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	416063				2022-12-18	WOS:A1978EV08000013
J	COGEN, FC; HIRSHFELD, J; DUNSKY, E; NORMAN, M; ZWEIMAN, B				COGEN, FC; HIRSHFELD, J; DUNSKY, E; NORMAN, M; ZWEIMAN, B			RADIOCONTRAST MEDIA-INDUCED HISTAMINE-RELEASE AND COMPLEMENT CONSUMPTION IN HUMANS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					145	145		10.1016/0091-6749(78)90294-4	http://dx.doi.org/10.1016/0091-6749(78)90294-4			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300055
J	KUROSAWA, M; NEMOTO, T; AOKI, H; IKE, A; ABE, O; SUNAGA, Y; KOBAYASHI, S				KUROSAWA, M; NEMOTO, T; AOKI, H; IKE, A; ABE, O; SUNAGA, Y; KOBAYASHI, S			PROSTAGLANDIN-INDUCED EOSINOPENIA IN SPLENECTOMIZED RATS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											KUROSAWA, M (corresponding author), GUNMA UNIV,SCH MED,DEPT INTERNAL MED 1,MAEBASHI 371,JAPAN.							BOURNE HR, 1972, J IMMUNOL, V108, P695; de Groot J, 1959, RAT FOREBRAIN STEREO; EASTON JG, 1973, ANN ALLERGY, V31, P134; ESSELLIER AF, 1954, BLOOD, V9, P531, DOI 10.1182/blood.V9.5.531.531; HEDGE GA, 1972, ENDOCRINOLOGY, V91, P925, DOI 10.1210/endo-91-4-925; NEMOTO T, 1976, J ALLERGY CLIN IMMUN, V57, P89, DOI 10.1016/0091-6749(76)90028-2; OHMAN JL, 1972, J ALLERGY CLIN IMMUN, V50, P151, DOI 10.1016/0091-6749(72)90046-2; PENG T-C, 1970, Endocrinology, V86, P202; RECANT L, 1950, J CLIN ENDOCRINOL, V10, P187, DOI 10.1210/jcem-10-2-187; REED CE, 1970, J ALLERGY, V56, P90; ROSENTHALE ME, 1971, J PHARMACOL EXP THER, V178, P541; SCHWARTZ HJ, 1968, ANN INTERN MED, V69, P493, DOI 10.7326/0003-4819-69-3-493; THEVATHASAN OLIVER I., 1958, ACTA HAEMATOL, V19, P162; VALE W, 1971, Federation Proceedings, V30, P363; ZOR U, 1969, P NATL ACAD SCI USA, V63, P918, DOI 10.1073/pnas.63.3.918	15	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	62	1					33	36		10.1016/0091-6749(78)90070-2	http://dx.doi.org/10.1016/0091-6749(78)90070-2			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FG870	659738	Bronze			2022-12-18	WOS:A1978FG87000008
J	MATHEWS, KP				MATHEWS, KP			CHRONIC URTICARIA REVISITED	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											MATHEWS, KP (corresponding author), UNIV MICHIGAN, MED CTR, ANN ARBOR, MI 48109 USA.							DOEGLAS HMG, 1975, ARCH DERMATOL, V111, P979, DOI 10.1001/archderm.111.8.979; GREAVES MW, 1974, CLIN ALLERGY, V4, P265, DOI 10.1111/j.1365-2222.1974.tb01384.x; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; MATHISON DA, 1977, ANN INTERN MED, V86, P534, DOI 10.7326/0003-4819-86-5-534; SOTER NA, 1976, J INVEST DERMATOL, V66, P344, DOI 10.1111/1523-1747.ep12482901; WASSERMAN SI, 1977, J CLIN INVEST, V60, P189, DOI 10.1172/JCI108756	7	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					347	349		10.1016/0091-6749(78)90112-4	http://dx.doi.org/10.1016/0091-6749(78)90112-4			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	659725				2022-12-18	WOS:A1978FC59300001
J	PERELMUTTER, L; PHIPPS, P; POTVIN, L				PERELMUTTER, L; PHIPPS, P; POTVIN, L			ROLE OF VIRAL AND BACTERIAL-INFECTIONS IN MODULATING HUMAN IGE LEVELS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					177	177		10.1016/0091-6749(78)90402-5	http://dx.doi.org/10.1016/0091-6749(78)90402-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300163
J	ROSENTHAL, RR; BLEEKER, ER; LAUBE, B; NORMAN, PS; PERMUTT, S				ROSENTHAL, RR; BLEEKER, ER; LAUBE, B; NORMAN, PS; PERMUTT, S			CHOLINERGIC RESPONSE TO HISTAMINE CHALLENGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					139	139		10.1016/0091-6749(78)90275-0	http://dx.doi.org/10.1016/0091-6749(78)90275-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300036
J	ALTMAN, R; LEVINE, BB				ALTMAN, R; LEVINE, BB			EFFECT OF MULTIPLE INJECTIONS OF ANTIGEN ON PROLONGED IGE ANTIBODY-PRODUCTION IN HYPERSENSITIVE MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NYU,SCH MED,DEPT MED,NEW YORK,NY 10016	New York University								BACH MK, 1975, J IMMUNOL, V114, P1799; CONELL JT, 1963, J IMMUNOL, V91, P197; ISHIZAKA K, 1972, J IMMUNOL, V109, P84; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; LEVINE BB, 1971, INT ARCH ALLERGY APP, V41, P86; LEVINE BF, UNPUBLISHED; LEVY DA, 1967, J IMMUNOL, V99, P1068; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; LICHTENSTEIN LM, 1966, J IMMUNOL, V96, P169; MELAM H, 1971, J ALLERGY, V47, P262, DOI 10.1016/S0091-6749(71)80004-0; OKUMARA K, 1971, J IMMUNOL, V107, P1672; SADAN N, 1969, NEW ENGL J MED, V280, P623, DOI 10.1056/NEJM196903202801201; SCHWARTZ HA, 1973, J IMMUNOL, V110, P1638; SHERMAN WILLIAM B., 1940, JOUR ALLERGY, V11, P225, DOI 10.1016/S0021-8707(40)90568-8; TADA T, 1971, J IMMUNOL, V106, P1002; TAKATSU K, 1976, J IMMUNOL, V116, P1257; VAZ NM, 1970, SCIENCE, V168, P852, DOI 10.1126/science.168.3933.852	17	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	2					120	127		10.1016/0091-6749(77)90213-5	http://dx.doi.org/10.1016/0091-6749(77)90213-5			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CV622	833380				2022-12-18	WOS:A1977CV62200005
J	ROSENBERG, M; PATTERSON, R; KELLY, JF; HARRIS, KE				ROSENBERG, M; PATTERSON, R; KELLY, JF; HARRIS, KE			ACUTE URTICARIA AND BRONCHOSPASM FOLLOWING RADIOGRAPHIC CONTRAST-MEDIA IN A DOG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NORTHWESTERN UNIV,DEPT MED,ALLERGY IMMUNOL SECT,CHICAGO,IL 60611; MCGAW MED CTR,CHICAGO,IL	Northwestern University								AKCASU A, 1960, INT ARCH ALLER A IMM, V16, P326, DOI 10.1159/000229102; FISCHER HW, 1972, RADIOLOGY, V103, P497, DOI 10.1148/103.3.497; LASSER EC, 1971, RADIOLOGY, V100, P683, DOI 10.1148/100.3.683; LASSER EC, 1968, RADIOLOGY, V91, P63, DOI 10.1148/91.1.63; LASSER EC, 1976, RADIOLOGY, V119, P91, DOI 10.1148/119.1.91; MANN MR, 1961, P ROY SOC MED, V54, P473; PENDERGRASS HP, 1958, RADIOLOGY, V71, P1; SCHATZ M, 1975, J ALLERGY CLIN IMMUN, V55, P358, DOI 10.1016/0091-6749(75)90007-X; ZWEIMAN B, 1975, ANN INTERN MED, V83, P159, DOI 10.7326/0003-4819-83-2-159	9	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	4					339	340		10.1016/0091-6749(77)90057-4	http://dx.doi.org/10.1016/0091-6749(77)90057-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DB886	66244	Bronze			2022-12-18	WOS:A1977DB88600011
J	SCHATZ, M				SCHATZ, M			APPROACH TO DIAGNOSIS AND TREATMENT IN MIGRANT ALLERGIC POPULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USN,REG MED CTR,DEPT INTERNAL MED,DIV ALLERGY,SAN DIEGO,CA 92134; USN,REG MED CTR,CTR CLIN INVEST,SAN DIEGO,CA 92134	United States Department of Defense; United States Navy; United States Department of Defense; United States Navy								AUGUSTIN R, 1959, IMMUNOLOGY, V2, P148; AUGUSTIN R, 1953, NATURE, V172, P307, DOI 10.1038/172307a0; AUGUSTIN R, 1962, IMMUNOLOGY, V5, P424; BERLIN L, 1972, INT ARCH ALLERGY, V42, P300; BERNSTEIN IL, 1976, J ALLERGY CLIN IMMUN, V57, P141, DOI 10.1016/0091-6749(76)90033-6; Brown A, 1927, J IMMUNOL, V13, P73; CHABOT R, 1929, J IMMUNOL, V16, P281; CHANG WWY, 1972, ALLERGIC DISEASES DI, P125; Coca AF, 1925, J IMMUNOL, V10, P445; COOKE ROBERT A., 1935, JOUR ALLERGY, V6, P311, DOI 10.1016/S0021-8707(35)90086-7; FEINBERG JG, 1960, INT ARCH ALLER A IMM, V16, P1; FITZGERALD JDL, 1949, J ALLERGY, V20, P286, DOI 10.1016/0021-8707(49)90042-8; FRANKLAND AW, 1955, INT ARCH ALLER A IMM, V6, P45, DOI 10.1159/000228145; FRICK OL, 1960, J ALLERGY, V31, P216, DOI 10.1016/0021-8707(60)90050-2; GOSSELIN M L, 1953, Acta Allergol, V6, P96, DOI 10.1111/j.1398-9995.1953.tb03473.x; GRUBB GLENN D., 1938, JOUR ALLERGY, V9, P211, DOI 10.1016/S0021-8707(38)90213-8; HEIJER A, 1968, ACTA ALLERGOL, V23, P146, DOI 10.1111/j.1398-9995.1968.tb03714.x; HOET J. J., 1952, ACTA ALLERGOL, V5, P239, DOI 10.1111/j.1398-9995.1952.tb03456.x; Lamson RW, 1928, J LAB CLIN MED, V13, P1129; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P140, DOI 10.1016/0091-6749(76)90149-4; LEIFERMAN KM, 1976, J ALLERGY CLIN IMMUN, V58, P129, DOI 10.1016/0091-6749(76)90148-2; MARSH DG, 1970, J ALLERGY, V46, P107, DOI 10.1016/0021-8707(70)90078-X; MILNER F H, 1972, Clinical Allergy, V2, P83, DOI 10.1111/j.1365-2222.1972.tb01271.x; MUNTZ PA, 1974, FLORA SO CALIFORNIA, P109; NELSON R, 1975, POLLEN GUIDE ALLERGY, P2; PINESS G, 1930, J ALLERGY, V1, P483; PRINCE HOMER E., 1939, JOUR ALLERGY, V10, P537, DOI 10.1016/S0021-8707(39)90248-0; RACKEMANN FM, 1936, J ALLERGY, V7, P319; SAMTER M, 1955, REGIONAL ALLERGY US; SEGAL AT, 1970, J ALLERGY, V45, P120; SELLERS ERLE D., 1932, JOUR ALLERGY, V3, P166, DOI 10.1016/S0021-8707(32)90376-1; SOLOMON WR, 1967, MANUAL CLIN ALLERGY, P340; SPAIN WC, 1930, J ALLERGY, V1, P209; STEINBERG L, 1952, J ALLERGY, V23, P163; STULL ARTHUR, 1932, JOUR ALLERGY, V3, P120, DOI 10.1016/S0021-8707(32)90371-2; STULL ARTHUR, 1932, JOUR ALLERGY, V3, P352, DOI 10.1016/S0021-8707(32)90231-7; WASTON SH, 1930, J ALLERGY CLIN IMMUN, V1, P483; WODEHOUSE ROGER P., 1948, ANN ALLERGY, V6, P358; WODEHOUSE RP, 1955, INT ARCH ALLER A IMM, V6, P65, DOI 10.1159/000228150; Wodehouse RP, 1971, HAY FEVER PLANTS, V2nd; YOO TJ, 1975, ANN ALLERGY, V34, P87; ZETTERST.O, 1972, ACTA ALLERGOL, V27, P15, DOI 10.1111/j.1398-9995.1972.tb01638.x	42	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	3					254	262		10.1016/0091-6749(77)90159-2	http://dx.doi.org/10.1016/0091-6749(77)90159-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CZ249	65374				2022-12-18	WOS:A1977CZ24900012
J	BACH, FH				BACH, FH			DIFFERENTIAL CELLULAR IMMUNE RESPONSIVENESS TO SYSTEMS OF MAJOR HISTOCOMPATIBILITY COMPLEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT SURG,MADISON,WI 53706; IMMUNOBIOL RES CTR,1150 UNIV AVE,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								ALTER BJ, 1973, J EXP MED, V137, P1303, DOI 10.1084/jem.137.5.1303; ALTER BJ, 1974, J EXP MED, V140, P1410, DOI 10.1084/jem.140.5.1410; AMOS DB, 1968, J EXP MED, V128, P623, DOI 10.1084/jem.128.4.623; APT AS, 1975, IMMUNOGENETICS, V1, P444; BACH FH, 1972, J EXP MED, V136, P1430, DOI 10.1084/jem.136.6.1430; BACH FH, 1973, TRANSPLANT P, V5, P23; BACH FH, 1973, SCIENCE, V180, P403, DOI 10.1126/science.180.4084.403; BACH FH, 1972, SCIENCE, V176, P1024, DOI 10.1126/science.176.4038.1024; BACH FH, 1973, TRANSPLANT P, V5, P1717; BACH FH, 1967, SCIENCE, V156, P1506, DOI 10.1126/science.156.3781.1506; BACH FH, 1969, TRANSPL P, V1, P339; BACH FH, IN PRESS; BONNARD GD, 1973, TRANSPLANT P, V5, P1679; DAVID CS, 1973, P NATL ACAD SCI USA, V70, P2509, DOI 10.1073/pnas.70.9.2509; DUTTON RW, 1966, J EXP MED, V123, P665, DOI 10.1084/jem.123.4.665; EGOROV IK, 1974, IMMUNOGENETICS, V1, P97, DOI 10.1007/BF01564050; EIJSVOOGEL VP, 1973, TRANSPL P, V5, P1675; EIJSVOOGEL VP, 1973, TRANSPL P, V5, P1301; EIJSVOOGEL VP, 1972, HISTOCOMPATIBILITY T, P501; ELKINS WL, 1973, TRANSPLANT P, V5, P1759; FESTENSTEIN H, 1972, TRANSPL P, V4, P219; FORMAN J, 1973, J EXP MED, V138, P672, DOI 10.1084/jem.138.3.672; GOTZE D, 1973, J EXP MED, V138, P1003, DOI 10.1084/jem.138.4.1003; KLEIN J, 1973, J EXP MED, V137, P1213, DOI 10.1084/jem.137.5.1213; KLEIN J, 1974, J EXP MED, V140, P1127, DOI 10.1084/jem.140.4.1127; LINDAHL KF, 1975, NATURE, V254, P607, DOI 10.1038/254607a0; LIVNAT S, 1973, NATURE-NEW BIOL, V243, P42; MEO T, 1973, TRANSPL P, V5, P377; MEO T, 1973, TRANSPL P, V5, P1507; MEO T, 1975, TRANSPL P, V7, P127; PECK AB, 1973, J IMMUNOL METHODS, V3, P147, DOI 10.1016/0022-1759(73)90030-6; PECK AB, 1973, TRANSPLANT P, V5, P1611; PECK AJ, IN PRESS; PLATE JM, 1970, HISTOCOMPATIBILITY T, P531; SACHS DH, 1973, J EXP MED, V138, P1289, DOI 10.1084/jem.138.6.1289; SCHENDEL DJ, 1974, J EXP MED, V140, P1534, DOI 10.1084/jem.140.6.1534; SCHENDEL DJ, 1973, TRANSPLANT P, V5, P1651; SCHENDEL DJ, TO BE PUBLISHED; SILVERS WK, 1967, SCIENCE, V155, P703, DOI 10.1126/science.155.3763.703; THORSBY E, 1973, TRANSPL P, V5, P1523; VANLEEUW.A, 1973, TRANSPL P, V5, P1539; WIDMER MB, 1973, NATURE-NEW BIOL, V242, P239, DOI 10.1038/newbio242239a0; WIDMER MB, 1973, TRANSPLANT P, V5, P1501; WILSON DB, 1967, J EXP MED, V126, P655, DOI 10.1084/jem.126.4.655; YUNIS EJ, 1971, P NATL ACAD SCI USA, V68, P3031, DOI 10.1073/pnas.68.12.3031; ZOSCHKE DC, 1970, SCIENCE, V170, P1404, DOI 10.1126/science.170.3965.1404	46	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	2					95	111		10.1016/0091-6749(76)90029-4	http://dx.doi.org/10.1016/0091-6749(76)90029-4			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BE952	55429	Bronze			2022-12-18	WOS:A1976BE95200002
J	COOPER, BJ; PATTERSON, R				COOPER, BJ; PATTERSON, R			CORTICOSTEROID DOSE GRAPH - USE IN DETERMINATION OF CORTICOSTEROID REQUIREMENTS, CHARACTERIZATION OF PATIENTS, AND PREVENTION OF SEASONAL EXACERBATION IN CORTICOSTEROID-DEPENDENT PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT MED,CHICAGO,IL 60611	Northwestern University								AVIADO DM, 1970, J CLIN PHARMACOL N D, V10, P3; BOOTH BH, 1972, ALLERGIC DISEASES, pCH3; BROWN HM, 1972, BRIT MED J, V1, P585, DOI 10.1136/bmj.1.5800.585; CHAI H, 1973, AM J DIS CHILD, V125, P757, DOI 10.1001/archpedi.1973.04160050095021; ELLIS EF, 1974, PEDIATR ANN, V3, P92; FALLIERS CJ, 1972, J ALLERGY CLIN IMMUN, V49, P156, DOI 10.1016/0091-6749(72)90109-1; GREGG I, 1970, DISODIUM CROMOGLYCAT, pCH16; JACOBY NM, 1966, LANCET, V2, P1354; LIEBERMAN P, 1972, J ALLERGY CLIN IMMUN, V49, P329, DOI 10.1016/0091-6749(72)90131-5; MAUNSELL K, 1968, BMJ-BRIT MED J, V1, P661, DOI 10.1136/bmj.1.5593.661; MEYER SL, 1975, DATA ANALYSIS SCIENT; OH SH, 1974, J ALLERGY CLIN IMMUN, V53, P345, DOI 10.1016/0091-6749(74)90118-3; SCHATZ M, 1975, JAMA-J AM MED ASSOC, V233, P804, DOI 10.1001/jama.233.7.804	13	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	6					635	646		10.1016/0091-6749(76)90175-5	http://dx.doi.org/10.1016/0091-6749(76)90175-5			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CP077	993478	Bronze			2022-12-18	WOS:A1976CP07700002
J	GUPTA, S; ROSS, GD; GOOD, RA; SIEGAL, FP				GUPTA, S; ROSS, GD; GOOD, RA; SIEGAL, FP			SURFACE CHARACTERISTICS OF HUMAN EOSINOPHILS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					189	189						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000001
J	MOORE, VL; BOREN, MN; ABRAMOFF, P				MOORE, VL; BOREN, MN; ABRAMOFF, P			IMMUNOLOGICAL RESPONSE OF PATIENTS WITH PIGEON BREEDERS DISEASE TO A PURIFIED ANTIGEN FROM PIGEON DROPPING EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					225	225						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000088
J	NAKAZAWA, H; ADOLPHSON, R; CHAPERON, E; HOBDAY, J; TOWNLEY, R; PAULI, J				NAKAZAWA, H; ADOLPHSON, R; CHAPERON, E; HOBDAY, J; TOWNLEY, R; PAULI, J			INVIVO AND INVITRO EFFECTS OF CHRONIC PROPRANOLOL ADMINISTRATION ON IMMUNE-RESPONSE IN MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					200	200						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000027
J	PEDDECORD, KM; NORTHEY, WT; GOODMAN, DH				PEDDECORD, KM; NORTHEY, WT; GOODMAN, DH			STUDIES ON DETERIORATION OF ANTIGEN-E IN EXTRACTS OF AMBROSIA-ELATIOR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ALLERGY & ASTHMA CLIN,PHOENIX,AZ; ARIZONA STATE UNIV,DEPT BOT & MICROBIOL,TEMPE,AZ 85281	Arizona State University; Arizona State University-Tempe				Peddecord, Michael/0000-0003-4107-8050				BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; Bliss CI, 1967, STAT BIOL STAT METHO, V1, P152; CHASE MW, 1972, APR ANN M AM SOC MIC; GOLDFARB AR, 1967, J ALLERGY, V40, P237, DOI 10.1016/0021-8707(67)90086-X; HAMPTON SF, 1949, J ALLERGY, V20, P19, DOI 10.1016/0021-8707(49)90080-5; KING TP, 1962, BIOCHEMISTRY-US, V1, P709, DOI 10.1021/bi00910a027; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KING TP, 1967, BIOCHEMISTRY-US, V6, P1992, DOI 10.1021/bi00859a017; STULL ARTHUR, 1933, JOUR ALLERGY, V4, P455, DOI 10.1016/S0021-8707(33)90098-2; WADSWORTH C, 1957, INT ARCH ALLER A IMM, V10, P355, DOI 10.1159/000228394; WOOLF CM, 1968, PRINCIPLES BIOMETRY, P83; 1970, FED REG            2, V35	12	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	1					56	61		10.1016/0091-6749(76)90079-8	http://dx.doi.org/10.1016/0091-6749(76)90079-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BC141	1245682				2022-12-18	WOS:A1976BC14100007
J	ROSENFELD, GB; MURPHEY, WH				ROSENFELD, GB; MURPHEY, WH			ALPHA-1-ANTITRYPSIN HETEROZYGOSITY AND SPIROMETRIC FUNCTION IN CHRONIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					218	219						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000072
J	ROSENTHAL, RR; KORDANSKY, DW; ROSENBERG, GL; NORMAN, PS				ROSENTHAL, RR; KORDANSKY, DW; ROSENBERG, GL; NORMAN, PS			ROLE OF ALPHA-ADRENERGIC RECEPTORS IN ALLERGIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					223	223						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000083
J	WEBB, DR				WEBB, DR			TRIAMCINOLONE ACETONIDE (TA) BY AEROSOL FOR CHRONIC BRONCHIAL-ASTHMA - EFFECTS ON ADRENAL-FUNCTION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					257	257						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000166
J	BEWTRA, A; LONGO, F; ADOLPHSON, R; TOWNLEY, R				BEWTRA, A; LONGO, F; ADOLPHSON, R; TOWNLEY, R			QUANTITATIVE-DETERMINATION OF ALPHA-ADRENERGIC RECEPTOR ACTIVITY IN HUMAN TRACHEA INVITRO	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					93	93						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800062
J	BICE, DE; SALVAGGIO, JE; HOFFMANN, E				BICE, DE; SALVAGGIO, JE; HOFFMANN, E			PASSIVE TRANSFER OF EXPERIMENTAL HYPERSENSITIVITY PNEUMONITIS WITH LYMPHOID-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					71	71						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800006
J	GLEICH, GJ; JACOB, GL				GLEICH, GJ; JACOB, GL			MEASUREMENT OF QUANTITY OF IGE ANTIBODIES TO RAGWEED ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					83	83						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800036
J	LARSON, JB; GLEICH, GJ				LARSON, JB; GLEICH, GJ			CHANGES IN ANTIGENIC COMPOSITION OF SHORT RAGWEED PLANT DURING MATURATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO MED SCH,DEPT MED,ALLERGIC DIS RES LAB,ROCHESTER,MN; MAYO MED SCH,DEPT IMMUNOL,ROCHESTER,MN; MAYO MED SCH,DEPT MICROBIOL,ROCHESTER,MN	Mayo Clinic; Mayo Clinic; Mayo Clinic								BIANCHI D. E., 1959, BOT GAZ, V120, P235, DOI 10.1086/336030; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; KING TP, 1962, BIOCHEMISTRY-US, V1, P709, DOI 10.1021/bi00910a027; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KING TP, 1967, BIOCHEMISTRY-US, V6, P1992, DOI 10.1021/bi00859a017; KNOX RB, 1970, J CELL SCI, V6, P1; KNOX RB, 1970, NATURE, V225, P1066, DOI 10.1038/2251066a0; KNOX RB, 1971, CYTOBIOS, V4, P13; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LOWELL FC, 1973, J ALLERGY CLIN IMMUN, V51, P187, DOI 10.1016/0091-6749(73)90024-9; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; OGDEN EC, 1969, AM J BOT, V56, P16, DOI 10.2307/2440389; REISMAN RE, 1969, J ALLERGY, V44, P82, DOI 10.1016/0021-8707(69)90004-5; SHAFIEE A, 1973, J PHARM SCI, V62, P1654, DOI 10.1002/jps.2600621015; SHAFIEE A, 1973, IN VITRO CELL DEV B, V9, P19; YUNGINGER JW, 1972, J ALLERGY CLIN IMMUN, V50, P326, DOI 10.1016/0091-6749(72)90036-X	16	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	2					112	116		10.1016/0091-6749(75)90115-3	http://dx.doi.org/10.1016/0091-6749(75)90115-3			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AM325	1151007	Bronze			2022-12-18	WOS:A1975AM32500004
J	OKAZAKI, T; ILEA, V; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE				OKAZAKI, T; ILEA, V; OKAZAKI, A; REISMAN, RE; ARBESMAN, CE			EFFECT OF TRIS-BUFFERED MEDIA AND TYRODE PHYSIOLOGIC SALINE SOLUTION ON ANTIGENIC RELEASE OF HISTAMINE FROM HUMAN LEUKOCYTES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY, DEPT MED, BUFFALO, NY USA; SUNY, DEPT MICROBIOL, BUFFALO, NY USA; BUFFALO GEN HOSP, ALLERGY RES LAB, 100 HIGH ST, BUFFALO, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; Buffalo General Medical Center								ATTALLAH AA, 1973, PROSTAG OTH LIPID M, V4, P479, DOI 10.1016/S0090-6980(73)80002-4; AUSTEN KF, 1973, ASTHMA PHYSIOLOGY IM, P111; Becker E L, 1973, Adv Immunol, V17, P93, DOI 10.1016/S0065-2776(08)60732-4; BROCKELHURST WE, 1967, HDB EXPT IMMUNOLOGY, P1152; CHAKRAVARTY N, 1973, ACTA PHYSIOL SCAND, V88, P469, DOI 10.1111/j.1748-1716.1973.tb05476.x; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; GILLESPI.E, 1974, FED PROC, V33, P762; HARPER HA, 1971, REV PHYSL CHEM, P392; LICHTENSTEIN L M, 1973, P91; LICHTENSTEIN LM, 1971, J IMMUNOL, V107, P1122; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LICHTENSTEIN LM, 1967, FED PROC, V26, P309; LICHTENSTEIN LM, 1972, PROSTAGLANDINS CELLU, P293; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MONGAR JL, 1972, BRIT J PHARMACOL, V46, P741, DOI 10.1111/j.1476-5381.1972.tb06899.x; OKAZAKI T, TO BE PUBLISHED; ORANGE RP, 1973, J IMMUNOL, V110, P760; ORANGE RP, 1971, BIOCHEMISTRY ACUTE A, P189; SCHILD HO, 1968, BIOCHEMISTRY ACUTE A, P99; STECHSCHULTE DJ, 1973, J IMMUNOL, V111, P1585; TAUBER AI, 1973, J IMMUNOL, V111, P27; UNGER WG, 1972, J PHARM PHARMACOL, V24, P470, DOI 10.1111/j.2042-7158.1972.tb09034.x; VONREDLICH D, 1969, ANAL BIOCHEM, V29, P167, DOI 10.1016/0003-2697(69)90021-9; 106B SIGM TECHN B	24	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	1					27	32		10.1016/0091-6749(75)90031-7	http://dx.doi.org/10.1016/0091-6749(75)90031-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AH615	48525				2022-12-18	WOS:A1975AH61500003
J	SHIMIZU, M; YAGURA, T; YAMAMURA, Y				SHIMIZU, M; YAGURA, T; YAMAMURA, Y			DETECTION OF IGG ANTIBODY TO DEOXYRIBONUCLEIC-ACID BY RADIOALLERGOSORBENT TEST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									OSAKA UNIV,MED SCH,DEPT INTERN MED 3,OSAKA,JAPAN	Osaka University								AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0; BERG T, 1971, INT ARCH ALLER A IMM, V40, P770, DOI 10.1159/000230461; CLARK C, 1972, J IMMUNOL, V109, P1143; FRANKLIN EC, 1960, J CLIN INVEST, V39, P1933, DOI 10.1172/JCI104218; KISHIMOTO T, 1971, J IMMUNOL, V107, P1567; LICHTENSTEIN LM, 1973, J CLIN INVEST, V52, P472, DOI 10.1172/JCI107204; MATSUOKA Y, 1971, IMMUNOCHEMISTRY, V8, P759, DOI 10.1016/0019-2791(71)90444-7; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; PLAUT A G, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P318, DOI 10.1073/pnas.65.2.318; POONIAN MS, 1971, BIOCHEMISTRY-US, V10, P424, DOI 10.1021/bi00779a011; TAN M, 1973, J LAB CLIN MED, V81, P122; THOMPSON RA, 1973, INT ARCH ALLER A IMM, V45, P170, DOI 10.1159/000231022; WIDE L, 1967, LANCET, V2, P1105; YUNGINGER JW, 1972, J ALLERGY CLIN IMMUN, V50, P109, DOI 10.1016/0091-6749(72)90006-1	15	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	5					356	363		10.1016/0091-6749(75)90129-3	http://dx.doi.org/10.1016/0091-6749(75)90129-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW330	1181353				2022-12-18	WOS:A1975AW33000005
J	SPRENKLE, AC; VANARSDEL, PP; BIERMAN, CW				SPRENKLE, AC; VANARSDEL, PP; BIERMAN, CW			NEW CLASS OF ANTIALLERGIC COMPOUNDS EFFECTIVE IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					118	118						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800122
J	WARREN, P; CHERNIACK, RM; TSE, KS				WARREN, P; CHERNIACK, RM; TSE, KS			ABNORMAL FUNCTION OF SMALL AIRWAYS IN HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					69	70						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800003
J	BUSSE, W; REED, CE; LICHTENS.LW; REISMAN, RE				BUSSE, W; REED, CE; LICHTENS.LW; REISMAN, RE			PROTECTION FOLLOWING HONEYBEE VENOM IMMUNOTHERAPY IN A CASE OF BEE-STING ANAPHYLAXIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					104	104						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000099
J	DEBANNE, MT; DOLOVICH, J				DEBANNE, MT; DOLOVICH, J			ANTIGENIC REACTIVITY OF INACTIVATED BACILLUS-SUBTILIS ENZYME PREPARATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MCMASTER UNIV,DEPT PEDIAT,HAMILTON,ONTARIO,CANADA	McMaster University								BELIN L, 1970, LANCET, V2, P1153; BERSON SA, 1971, NEW ENGL J MED, V284, P688, DOI 10.1056/NEJM197104012841302; DEBANNE MT, 1973, INT ARCH ALLER A IMM, V44, P854, DOI 10.1159/000230988; DEBANNE MT, 1971, J ALLERGY CLIN IMMUN, V48, P212, DOI 10.1016/0091-6749(71)90067-4; DOLOVICH J, 1972, J ALLERGY CLIN IMMUN, V49, P43, DOI 10.1016/0091-6749(72)90122-4; DOLOVICH J, 1971, J LAB CLIN MED, V77, P951; FLINDT MLH, 1969, LANCET, V1, P1177; FRANZ T, 1971, J ALLERGY, V47, P170, DOI 10.1016/S0091-6749(71)80295-6; GREENBERG M, 1970, BMJ-BRIT MED J, V2, P629, DOI 10.1136/bmj.2.5710.629; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; LITTLE DC, 1973, CAN MED ASSOC J, V108, P1120; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; NEWHOUSE ML, 1970, LANCET, V1, P689; PEPYS J, 1969, LANCET, V1, P1181; POLGAR L, 1967, BIOCHEMISTRY-US, V6, P610, DOI 10.1021/bi00854a032; SLAVIN RG, 1971, J ALLERGY CLIN IMMUN, V48, P262, DOI 10.1016/0091-6749(71)90026-1; WICHER V, 1973, IMMUNOCHEMISTRY, V10, P239, DOI 10.1016/0019-2791(73)90200-0; WICHER V, 1971, INT ARCH ALLER A IMM, V40, P779, DOI 10.1159/000230462; WICHER V, 1972, J ALLERGY CLIN IMMUN, V49, P59, DOI 10.1016/0091-6749(72)90124-8	19	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	4					205	212		10.1016/0091-6749(74)90082-7	http://dx.doi.org/10.1016/0091-6749(74)90082-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S6732	4209101				2022-12-18	WOS:A1974S673200003
J	ROTHSTEI.RJ; PINNEY, MA; BUCKLEY, JM; COTTON, EK				ROTHSTEI.RJ; PINNEY, MA; BUCKLEY, JM; COTTON, EK			EVALUATION OF REACTIVE AIRWAY DISEASE IN ATOPIC CYSTIC-FIBROSIS PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					100	101						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000090
J	SWEET, L; YANARI, S; RINGWALD, U; ANDERSON, J; CALLIES, Q				SWEET, L; YANARI, S; RINGWALD, U; ANDERSON, J; CALLIES, Q			COMPARISON OF RADIOALLERGOSORBENT TEST (RAST) WITH STANDARD ALLERGY DIAGNOSTIC PROCEDURES IN 100 UNSELECTED PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					82	82						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000043
J	THOMAS, AR; RHODES, ML; RICHERSON, HB				THOMAS, AR; RHODES, ML; RICHERSON, HB			ULTRASTRUCTURAL STUDIES OF ACUTE HYPERSENSITIVITY PNEUMONITIS IN RABBITS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV IOWA, COLL MED, DEPT INTERN MED, ALLERGY IMMUNOL DIV, IOWA CITY, IA USA; UNIV IOWA, COLL MED, DEPT INTERN MED, PULM DIV, IOWA CITY, IA USA	University of Iowa; University of Iowa								ANDERSON TF, 1951, T NEW YORK ACAD SCI, V13, P130, DOI 10.1111/j.2164-0947.1951.tb01007.x; GRONIOWSKI J, 1972, J ULTRA MOL STRUCT R, V38, P473, DOI 10.1016/0022-5320(72)90085-8; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KUHN C, 1972, J ULTRA MOL STRUCT R, V38, P161, DOI 10.1016/S0022-5320(72)90090-1; Luft JH, 1961, BIOPHYS BIOCHEM CYTO, V9, P409; NIDEN AH, 1972, CHEST, V62, P384, DOI 10.1378/chest.62.4.384; NOWELL JA, 1971, AM REV RESPIR DIS, V103, P313; NOWELL JA, 1972, SCANNING ELECTRON MI; RICHERSON HB, 1971, AM REV RESPIR DIS, V104, P568; RICHERSON HB, 1972, J LAB CLIN MED, V79, P745; RICHERSON HB, 1974, ANN NY ACAD SCI, V221, P340, DOI 10.1111/j.1749-6632.1974.tb28236.x; Wang N S, 1970, Hum Pathol, V1, P227, DOI 10.1016/S0046-8177(70)80036-3	12	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	3					147	156		10.1016/0091-6749(74)90051-7	http://dx.doi.org/10.1016/0091-6749(74)90051-7			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U0308	4855304				2022-12-18	WOS:A1974U030800003
J	FINK, J; HENSLEY, GT; BARBORIAK, JJ				FINK, J; HENSLEY, GT; BARBORIAK, JJ			PRIMATE MODEL OF HYPERSENSITIVITY PNEUMONITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					125	126		10.1016/S0091-6749(73)80101-0	http://dx.doi.org/10.1016/S0091-6749(73)80101-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300101
J	GOODFRIEND, L; LAPKOFF, CB; MARSH, DG				GOODFRIEND, L; LAPKOFF, CB; MARSH, DG			RAGWEED POLLEN ALLERGEN RA5 - ISOLATION, CHEMICAL PROPERTIES, AND GENETIC BASIS FOR ITS CUTANEOUS ACTIVITY IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					81	82		10.1016/S0091-6749(73)80011-9	http://dx.doi.org/10.1016/S0091-6749(73)80011-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300011
J	HARDEGRE.MC; SINGER, SH; GERONE, PJ				HARDEGRE.MC; SINGER, SH; GERONE, PJ			EFFECT OF ALLERGENIC EXTRACTS OF HOUSE DUST AND BACTERIAL VACCINE ON RESPIRATORY-INFECTIONS OF MICE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FDA,DEPT HEW,BUREAU BIOL,ROCKVILLE,MD 20852	US Food & Drug Administration (FDA)								AAS K, 1963, ACTA PAEDIATR, V52, P338, DOI 10.1111/j.1651-2227.1963.tb03789.x; BARR SE, 1965, J ALLERGY, V36, P47, DOI 10.1016/0021-8707(65)90032-8; Berrens L, 1970, Prog Allergy, V14, P259, DOI 10.1159/000289384; CLUFF LE, 1970, J INFECT DIS, V122, P205, DOI 10.1093/infdis/122.3.205; COLBY C, 1971, ANNU REV MICROBIOL, V25, P333, DOI 10.1146/annurev.mi.25.100171.002001; DECLERCQ E, 1969, P SOC EXP BIOL MED, V132, P699, DOI 10.3181/00379727-132-34291; DECLERCQ E, 1970, ANNU REV MED, V21, P17; DEGRE M, 1971, P SOC EXP BIOL MED, V137, P233, DOI 10.3181/00379727-137-35551; Diehl HS, 1938, J AMER MED ASSOC, V111, P1168, DOI 10.1001/jama.1938.02790390024008; FONTANA VJ, 1965, J AMER MED ASSOC, V193, P895, DOI 10.1001/jama.1965.03090110033009; GERONE PJ, 1971, INFECT IMMUN, V3, P323, DOI 10.1128/IAI.3.2.323-327.1971; GLEDHILL AW, 1964, BACTERIAL ENDOTOXINS, P410; GUNDY JE, 1957, J PEDIATR-US, V51, P516, DOI 10.1016/S0022-3476(57)80069-9; HILL DA, 1969, B WORLD HEALTH ORGAN, V41, P689; HILLEMAN MR, 1970, J INFECT DIS, V121, P196, DOI 10.1093/infdis/121.2.196; HO M, 1964, SCIENCE, V146, P1472, DOI 10.1126/science.146.3650.1472; HUANG K, 1971, INFECT IMMUN, V4, P581, DOI 10.1128/IAI.4.5.581-588.1971; KLEINSCHMIDT WJ, 1971, INFECT IMMUN, V4, P738, DOI 10.1128/IAI.4.6.738-741.1971; MUELLER HL, 1969, J AMER MED ASSOC, V208, P1379, DOI 10.1001/jama.208.8.1379; PETERSON RD, 1964, J ALLERGY, V35, P134, DOI 10.1016/0021-8707(64)90027-9; PINDAK FF, 1971, P SOC EXP BIOL MED, V138, P317; REINHOLD RB, 1971, P SOC EXP BIOL MED, V137, P334, DOI 10.3181/00379727-137-35572; ROBINSON RQ, 1969, DIAGNOSTIC PROCEDURE, P414; ROWLEY D, 1964, BACTERIAL ENDOTOXINS, P359; SHARPE TJ, 1971, J GEN VIROL, V12, P331, DOI 10.1099/0022-1317-12-3-331; SINGER SH, 1971, J ALLERGY, V47, P332, DOI 10.1016/S0091-6749(71)80137-9; STINEBRING WR, 1964, NATURE, V204, P712, DOI 10.1038/204712a0; 1944, J AM MED ASS, V26, P895	28	6	6	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	1					1	10		10.1016/0091-6749(73)90002-X	http://dx.doi.org/10.1016/0091-6749(73)90002-X			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O5651	4345105				2022-12-18	WOS:A1973O565100001
J	KOLOTKIN, BM; LEE, CK; TOWNLEY, RG				KOLOTKIN, BM; LEE, CK; TOWNLEY, RG			DURATION AND SPECIFICITY OF SODIUM CROMOLYN ON ALLERGEN INHALATION CHALLENGES IN ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					87	88		10.1016/S0091-6749(73)80022-3	http://dx.doi.org/10.1016/S0091-6749(73)80022-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913					2022-12-18	WOS:A1973O791300022
J	ROSENTHAL, RR; NORMAN, PS				ROSENTHAL, RR; NORMAN, PS			PRIMING PHENOMENON IN LUNG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	2					95	95		10.1016/S0091-6749(73)80038-7	http://dx.doi.org/10.1016/S0091-6749(73)80038-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O7913		Bronze			2022-12-18	WOS:A1973O791300038
J	SHERBELL, S; LYONS, HA				SHERBELL, S; LYONS, HA			EFFECTS OF ISOPROTERENOL MISTOMETER, WITH RECOMMENDED USE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY, DOWNSTATE MED CTR,DEPT MED,PULM DIS DIV, 450 CLARKSON AVE, BROOKLYN, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College								ALTOUNYAN R. E. C., 1964, THORAX, V19, P406, DOI 10.1136/thx.19.5.406; CAPLIN I, 1969, ANN ALLERGY, V27, P65; CROSBIE W A, 1971, Journal of Asthma Research, V8, P99, DOI 10.3109/02770907109108366; EISENSTADT WS, 1969, ANN ALLERGY, V27, P283; FERRER MI, 1971, CIRCULATION, V43, P528, DOI 10.1161/01.CIR.43.4.528; FIELD GB, 1967, CLIN SCI, V32, P279; GAZIOGLU K, 1971, AM REV RESPIR DIS, V104, P188; INGRAM RH, 1970, AM REV RESPIR DIS, V101, P364; KNUDSON RJ, 1967, J APPL PHYSIOL, V22, P402, DOI 10.1152/jappl.1967.22.3.402; KRASNOW N, 1964, AM J MED, V37, P514, DOI 10.1016/0002-9343(64)90065-8; MUSHIN GJ, 1967, THORAX, V22, P538, DOI 10.1136/thx.22.6.538; PALMER KNV, 1967, LANCET, V2, P1232; PALMER KNV, 1967, LANCET, V2, P383; PALMER KNV, 1970, BRIT MED J, V2, P23, DOI 10.1136/bmj.2.5700.23; PALMER KNV, 1968, LANCET, V1, P1972; PIERSON RN, 1969, AM REV RESPIR DIS, V100, P533; TAI E, 1967, THORAX, V22, P543, DOI 10.1136/thx.22.6.543; WADDELL JA, 1967, BRIT MED J, V2, P402, DOI 10.1136/bmj.2.5549.402; WARRELL DA, 1970, BMJ-BRIT MED J, V1, P65, DOI 10.1136/bmj.1.5688.65; 1962, AM REV RESP DIS, P85; 1971, AMA DRUG EVALUATIONS; 1962, AM REV RESP DIS, P762	22	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	6					321	327		10.1016/0091-6749(73)90090-0	http://dx.doi.org/10.1016/0091-6749(73)90090-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R5074	4752930				2022-12-18	WOS:A1973R507400001
J	PHILLS, JA; PERELMUTTER, L; LIAKOPOULOU, A				PHILLS, JA; PERELMUTTER, L; LIAKOPOULOU, A			EMPLOYMENT OF RAT MAST-CELL TECHNIQUE TO SEPARATE IMMUNOLOGICAL FROM NONIMMUNOLOGIC TYPES OF ALLERGIC REACTIONS TO ASPIRIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					97	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700027
J	SOLINGER, A; BERNSTEIN, IL; GLUECK, HI				SOLINGER, A; BERNSTEIN, IL; GLUECK, HI			EFFECT OF EPINEPHRINE ON PLATELET AGGREGATION IN NORMAL AND ATOPIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					107	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700047
J	TUFT, DS; VANARSDE.PP; FAIRCHILD, GA; GIDDENS, WE				TUFT, DS; VANARSDE.PP; FAIRCHILD, GA; GIDDENS, WE			MECHANISM OF HYPERSENSITIVITY PNEUMONITIS IN RABBIT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	6	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	49	2					103	+						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5997					2022-12-18	WOS:A1972L599700038
J	VAUGHAN, JH				VAUGHAN, JH			EMERGING CONCEPT OF CLINICAL IMMUNOLOGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BEESON PB, 1962, YEARBOOK MEDICINE, P226; BIANCO C, 1970, J EXP MED, V132, P702, DOI 10.1084/jem.132.4.702; CALLERAME ML, 1971, NEW ENGL J MED, V284, P459, DOI 10.1056/NEJM197103042840902; CONSTANTOULAKIS M, 1963, J CLIN INVEST, V42, P1790, DOI 10.1172/JCI104864; COOMBS RRA, 1969, LANCET, V2, P1157; PERNIS B., 1963, REUMATISMO, V15, P187; RABELLINO E, 1971, J EXP MED, V133, P156, DOI 10.1084/jem.133.1.156; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; Vaughan J H, 1968, Trans Assoc Am Physicians, V81, P231; WATERHOUSE C, 1971, TRANSPL P, V3, P1343	10	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	5					294	&		10.1016/0091-6749(72)90028-0	http://dx.doi.org/10.1016/0091-6749(72)90028-0			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N9856	4403940				2022-12-18	WOS:A1972N985600005
J	CAMPBELL, SG				CAMPBELL, SG			MILK PROTEINS RESPONSIBLE FOR MILK ALLERGY, AN AUTOALLERGIC DISEASE OF CATTLE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BREWER R L, 1957, J Am Vet Med Assoc, V130, P181; CAMPBELL SG, 1970, CORNELL VET, V60, P684; Duke WW, 1932, J AMER MED ASSOC, V98, P1445, DOI 10.1001/jama.1932.27320430003008b; HOULLIER, 1903, J MED VET, V54, P352; Lewis JH, 1934, J INFECT DIS, V55, P168, DOI 10.1093/infdis/55.2.168; LYSTER RLJ, 1967, J DAIRY RES, V34, P27, DOI 10.1017/S0022029900012103; Mullins J., 1960, New Zealand Veterinary Journal, V8, P68, DOI 10.1080/00480169.1960.33380	7	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	4					230	&		10.1016/0091-6749(71)90070-4	http://dx.doi.org/10.1016/0091-6749(71)90070-4			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5566	4106083				2022-12-18	WOS:A1971K556600006
J	DEBANNE, MT; WICHER, V; DOLOVICH, J				DEBANNE, MT; WICHER, V; DOLOVICH, J			ANTIGENIC COMPOSITIONS OF ENZYME-CONTAINING PREPARATIONS OF BACILLUS-SUBTILIS ORIGINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BERSON SA, 1966, AM J MED, V40, P676, DOI 10.1016/0002-9343(66)90148-3; DOLOVICH J, 1971, J LAB CLIN MED, V77, P951; DOLOVICH J, UNPUBLISHED DATA; FLINDT MLH, 1969, LANCET, V1, P1177; GUNTELBERG A. V., 1954, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P27; HAGEMAN JH, 1970, ARCH BIOCHEM BIOPHYS, V139, P67, DOI 10.1016/0003-9861(70)90045-7; KEAY L, 1970, BIOTECHNOL BIOENG, V12, P213, DOI 10.1002/bit.260120206; KEAY L, 1970, BIOTECHNOL BIOENG, V12, P179, DOI 10.1002/bit.260120205; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; MANCINI G, 1964, PROTIDES BIOLOGICAL, P370; OTTESEN M, 1960, CR TRAV LAB CARLSB, V32, P63; PEPYS J, 1969, LANCET, V1, P1181; SUGAE KI, 1960, J BIOCHEM-TOKYO, V47, P170, DOI 10.1093/oxfordjournals.jbchem.a127049; URIEL J, 1963, ANN NY ACAD SCI, V103, P956, DOI 10.1111/j.1749-6632.1963.tb53748.x; WICHER V, 1971, INT ARCH ALLER A IMM, V40, P779, DOI 10.1159/000230462	15	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	4					212	&		10.1016/0091-6749(71)90067-4	http://dx.doi.org/10.1016/0091-6749(71)90067-4			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K5566	4999249				2022-12-18	WOS:A1971K556600003
J	VIRTUE, CM; WITTIG, HJ; COOK, TJ				VIRTUE, CM; WITTIG, HJ; COOK, TJ			LYMPHOCYTE TRANSFORMATION WITH BACTERIAL ANTIGENS IN INTRINSIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BACH ML, 1970, 4 P INT HIST WORKSH; BAKER AG, 1959, AM PRACTIT, V9, P591; BATES DV, 1964, RESPIRATORY FUNCTION, P151; BERGMAN S, 1955, Acta Allergol, V8, P163, DOI 10.1111/j.1398-9995.1955.tb03563.x; BRITTON S, 1969, IMMUNOLOGY, V16, P513; COWLING DC, 1965, J PATHOL BACTERIOL, V89, P63, DOI 10.1002/path.1700890108; CRIEP LH, 1962, CLINICAL IMMUNOLOGY, P291; Dresser D W, 1968, Adv Immunol, V8, P129, DOI 10.1016/S0065-2776(08)60466-6; FEINBERG SM, 1946, ALLERGY PRACTICE; FRANCIS TC, 1967, 3RD P ANN LEUK CULT, P501; GLYNN A. A., 1960, THORAX, V15, P142, DOI 10.1136/thx.15.2.142; Hall R, 1966, Clin Exp Immunol, V1, P285; HAMPTON SF, 1965, IMMUNOLOGICAL DISEAS, P593; HEILMAN DH, 1970, INT ARCH ALLER A IMM, V39, P415, DOI 10.1159/000230369; LANDY M, 1965, J EXP MED, V122, P483, DOI 10.1084/jem.122.3.483; MOLLER G, 1969, CLIN EXP IMMUNOL, V4, P65; MULDER J, 1956, Proc R Soc Med, V49, P773; NOWELL PC, 1961, CANCER RES, V21, P1518; OPPENHEIM JJ, 1965, P SOC EXP BIOL MED, V118, P1014, DOI 10.3181/00379727-118-30033; RACKEMANN FM, 1931, CLINICAL ALLERGY HAY; TORMEY DC, 1967, NATURE, V213, P281, DOI 10.1038/213281a0; WARWICK MT, 1970, CLIN EXP IMMUNOL, V7, P31	22	6	6	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1971	48	6					321	&		10.1016/0091-6749(71)90078-9	http://dx.doi.org/10.1016/0091-6749(71)90078-9			0	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L0384	4399176				2022-12-18	WOS:A1971L038400001
J	Arock, M; Hoermann, G; Sotlar, K; Hermine, O; Sperr, WR; Hartmann, K; Brockow, K; Akin, C; Triggiani, M; Broesby-Olsen, S; Reiter, A; Gotlib, J; Horny, HP; Orfao, A; Metcalfe, DD; Valent, P				Arock, Michel; Hoermann, Gregor; Sotlar, Karl; Hermine, Olivier; Sperr, Wolfgang R.; Hartmann, Karin; Brockow, Knut; Akin, Cem; Triggiani, Massimo; Broesby-Olsen, Sigurd; Reiter, Andreas; Gotlib, Jason; Horny, Hans-Peter; Orfao, Alberto; Metcalfe, Dean D.; Valent, Peter			Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Mastocytosis; KIT mutations; genetic variants; hereditary alpha-tryptasemia; next-generation sequencing; diagnostic algorithm	ADVANCED SYSTEMIC MASTOCYTOSIS; C-KIT MUTATION; BONE-MARROW; PEDIATRIC MASTOCYTOSIS; TYROSINE KINASE; D816V; DIAGNOSIS; DISEASE; SURVIVAL; LINEAGE	Mast cell neoplasms are an emerging challenge in the fields of internal medicine, allergy, immunology, dermatology, laboratory medicine, and pathology. In this review, we discuss the current standards for the diagnosis and prognostication of mast cell neoplasms with special reference to clinically relevant germline and somatic gene variants. In patients with cutaneous mastocytosis or with indolent systemic mastocytosis (SM), various KIT-activating mutations act as key molecular drivers of the disease. In adults, KIT p.D816V is by far the most prevalent driver, whereas other KIT mutants are detected in nearly 40% of children. In advanced SM, including aggressive SM, SM with an associated hematological neoplasm, and mast cell leukemia, additional somatic mutations in other genes, such as SRSF2, JAK2, RUNX1, ASXL1, or RAS, may be detected. These drivers-are more frequently detected in SM with an associated hematological neoplasm, particularly in male patients. Recently, hereditary alpha-tryptasemia has been identified as a genetic trait more prevalent in SM compared with healthy controls. Moreover, hereditary alpha-tryptasemia is more frequent in patients with SM with Hymenoptera venom allergy and severe mediator-related symptoms than in patients with SM without symptoms. On the basis of this knowledge, we propose a diagnostic algorithm in which genetic markers are applied together with clinical and histopathologic criteria to establish the diagnosis and prognosis in SM.	[Arock, Michel] Sorbonne Univ, Pitie Salpetriere Charles Foix Hosp, AP HP, Dept Hematol Biol, Paris, France; [Hoermann, Gregor; Sperr, Wolfgang R.; Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria; [Hoermann, Gregor] MLL Munich Leukemia Lab, Max Lebsche Pl 31, D-81377 Munich, Germany; [Sotlar, Karl] Paracelsus Med Univ, Univ Hosp Salzburg, Inst Pathol, Salzburg, Austria; [Hermine, Olivier] Univ Paris 05, Imagine Inst, Sorbonne Paris Cite, Ctr Natl Reference Mastocytoses, Paris, France; [Sperr, Wolfgang R.; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria; [Hartmann, Karin] Univ Hosp Basel, Div Allergy, Dept Dermatol, Basel, Switzerland; [Hartmann, Karin] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Hartmann, Karin] Univ Basel, Basel, Switzerland; [Brockow, Knut] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, Munich, Germany; [Akin, Cem] Univ Michigan, Div Allergy & Clin Immunol, Ann Arbor, MI USA; [Triggiani, Massimo] Univ Salerno, Div Allergy & Clin Immunol, Salerno, Italy; [Broesby-Olsen, Sigurd] Odense Univ Hosp, Dept Dermatol, Odense, Denmark; [Broesby-Olsen, Sigurd] Odense Univ Hosp, Allergy Ctr, Odense, Denmark; [Reiter, Andreas] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Gotlib, Jason] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA USA; [Horny, Hans-Peter] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Orfao, Alberto] Univ Salamanca, Serv Cent Citometria NUCLEUS, Ctr Invest Canc IBMCC, Inst Biosanitario Salamanca IBSAL,CIBERONC, Salamanca, Spain; [Orfao, Alberto] Univ Salamanca, CSIC USAL, CIBERONC, Inst Biosanitario Salamanca IBSAL, Salamanca, Spain; [Orfao, Alberto] Univ Salamanca, Dept Med, Salamanca, Spain; [Metcalfe, Dean D.] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ludwig Boltzmann Institute; Medical University of Vienna; MLL Munich Leukemia Laboratory; Paracelsus Private Medical University; UDICE-French Research Universities; Universite Paris Cite; Medical University of Vienna; University of Basel; University of Basel; University of Basel; Technical University of Munich; University of Michigan System; University of Michigan; University of Salerno; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Ruprecht Karls University Heidelberg; Stanford Cancer Institute; Stanford University; University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hoermann, G (corresponding author), MLL Munich Leukemia Lab, Max Lebsche Pl 31, D-81377 Munich, Germany.; Arock, M (corresponding author), Sorbonne Univ, Pitie Salpetriere Charles Foix Hosp, AP HP, Lab Hematol, 47-83 Bd Hop, F-75013 Paris, France.	michel.arock@aphp.fr; gregor.hoermann@mll.com	Hartmann, Karin/N-4865-2015; Hoermann, Gregor/B-8832-2016	Hartmann, Karin/0000-0002-4595-8226; Hoermann, Gregor/0000-0002-7374-4380; Sperr, Wolfgang/0000-0003-3288-8027; Valent, Peter/0000-0003-0456-5095	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Austrian Science Funds (FWF) [F4701-B20, F4704-B20]	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Funds (FWF)(Austrian Science Fund (FWF))	D.D.M. was supported by the Division of Intramural Research, National Institute of Al-lergy and Infectious Diseases, National Institutes of Health. P.V. was supported by the Austrian Science Funds (FWF) (projects F4701-B20 and F4704-B20) .	Aberer E, 2021, J INVEST DERMATOL, V141, P1719, DOI 10.1016/j.jid.2020.12.030; Alvarez-Twose I, 2017, ONCOTARGET, V8, P68950, DOI 10.18632/oncotarget.10711; Alvarez-Twose I, 2016, J ALLERGY CLIN IMMUN, V137, P168, DOI 10.1016/j.jaci.2015.05.008; Arock M, 2015, LEUKEMIA, V29, P1223, DOI 10.1038/leu.2015.24; Arock M, 2020, LEUKEMIA LYMPHOMA, V61, P1075, DOI 10.1080/10428194.2019.1703974; Bibi S, 2014, IMMUNOL ALLERGY CLIN, V34, P239, DOI 10.1016/j.iac.2014.01.009; Bischoff SC, 1996, GUT, V38, P104, DOI 10.1136/gut.38.1.104; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Chollet MB, 2022, J ALLERGY CLIN IMMUN, V149, P728, DOI 10.1016/j.jaci.2021.06.017; Czarny J, 2021, INT J DERMATOL, V60, P1253, DOI 10.1111/ijd.15542; Damaj G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085362; DeAngelo DJ, 2018, LEUKEMIA, V32, P470, DOI 10.1038/leu.2017.234; DeAngelo DJ, 2021, NAT MED, V27, P2183, DOI 10.1038/s41591-021-01538-9; DeBruin EJ, 2015, METHODS MOL BIOL, V1220, P93, DOI 10.1007/978-1-4939-1568-2_7; Dobrea C, 2012, ROM J MORPHOL EMBRYO, V53, P197; Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003; Frieri M, 2013, PEDIAT ALLER IMM PUL, V26, P175, DOI 10.1089/ped.2013.0275; Fuchs D, 2021, J ALLER CL IMM-PRACT, V9, P1705, DOI 10.1016/j.jaip.2020.12.022; Galata G, 2021, AM J HUM GENET, V108, P284, DOI 10.1016/j.ajhg.2020.12.007; GALLI SJ, 1993, AM J PATHOL, V142, P965; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Garcia-Montero AC, 2016, BLOOD, V127, P761, DOI 10.1182/blood-2015-07-655100; Georgin-Lavialle S, 2013, BLOOD, V121, P1285, DOI 10.1182/blood-2012-07-442400; Georgin-Lavialle S, 2012, EUR J HAEMATOL, V89, P47, DOI 10.1111/j.1600-0609.2012.01761.x; Gotlib J, 2021, NAT MED, V27, P2192, DOI 10.1038/s41591-021-01539-8; Greco M, 2020, INDIAN J HEMATOL BLO, V36, P442, DOI 10.1007/s12288-019-01225-3; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Greiner G, 2020, HAEMATOLOGICA, V105, P366, DOI 10.3324/haematol.2019.217950; Greiner G, 2018, CLIN CHEM, V64, P547, DOI 10.1373/clinchem.2017.277897; Hanssens K, 2014, HAEMATOLOGICA, V99, P830, DOI 10.3324/haematol.2013.095133; Hartmann K, 2005, GASTROENTEROLOGY, V129, P1042, DOI 10.1053/j.gastro.2005.06.060; Henriques A, 2022, BLOOD, V139, P572, DOI 10.1182/blood.2021012694; Hoermann G, 2014, ALLERGY, V69, P810, DOI 10.1111/all.12409; Jawhar M, 2016, LEUKEMIA, V30, P2342, DOI 10.1038/leu.2016.190; Jawhar M, 2016, LEUKEMIA, V30, P136, DOI 10.1038/leu.2015.284; Jawhar M, 2015, LEUKEMIA, V29, P1115, DOI 10.1038/leu.2015.4; Jawhar M, 2019, J CLIN ONCOL, V37, P2846, DOI 10.1200/JCO.19.00640; Jawhar M, 2019, LEUKEMIA, V33, P1124, DOI 10.1038/s41375-018-0346-z; Jawhar M, 2016, EUR J CLIN INVEST, V46, P392, DOI 10.1111/eci.12607; Jordan JH, 2002, LEUKEMIA LYMPHOMA, V43, P575, DOI 10.1080/10428190290012065; Ke HN, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0120-8; Kluin-Nelemans HC, 2021, THERANOSTICS, V11, P292, DOI 10.7150/thno.51872; Lange M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052586; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Luskin KT, 2021, J ALLER CL IMM-PRACT, V9, P2235, DOI 10.1016/j.jaip.2021.03.005; Lyons JJ, 2021, ANN ALLERG ASTHMA IM, V127, P420, DOI 10.1016/j.anai.2021.06.019; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Martinelli G, 2018, LEUKEMIA, V32, P139, DOI 10.1038/leu.2017.183; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; Monnier J, 2016, ONCOTARGET, V7, P66299, DOI 10.18632/oncotarget.11812; Munoz-Gonzalez JI, 2021, LANCET HAEMATOL, V8, pE194, DOI 10.1016/S2352-3026(20)30400-2; Munoz-Gonzalez JI, 2019, BLOOD, V134, P456, DOI 10.1182/blood.2018886507; Munoz-Gonzalez JI, 2018, BLOOD ADV, V2, P2814, DOI 10.1182/bloodadvances.2018020628; Naumann N, 2021, BRIT J HAEMATOL, V194, P344, DOI 10.1111/bjh.17567; Naumann N, 2018, GENE CHROMOSOME CANC, V57, P252, DOI 10.1002/gcc.22526; Nedoszytko B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010411; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pardanani A, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0189-5; Pardanani A, 2018, BLOOD ADV, V2, P2964, DOI 10.1182/bloodadvances.2018026245; Pardanani A, 2016, AM J HEMATOL, V91, P888, DOI 10.1002/ajh.24426; Pardanani AD, 2016, BRIT J HAEMATOL, V175, P534, DOI 10.1111/bjh.13865; Polivka L, 2021, J ALLER CL IMM-PRACT, V9, P1695, DOI 10.1016/j.jaip.2020.12.019; Pollard WL, 2015, PEDIATR DERMATOL, V32, P267, DOI 10.1111/pde.12381; Reiter A, 2020, BLOOD, V135, P1365, DOI 10.1182/blood.2019000932; Reszka E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062964; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Sabato V, 2018, J CLIN IMMUNOL, V38, P457, DOI 10.1007/s10875-018-0506-y; Schwaab J, 2020, J ALLER CL IMM-PRACT, V8, P3121, DOI 10.1016/j.jaip.2020.05.005; Schwaab J, 2015, AM J HEMATOL, V90, P774, DOI 10.1002/ajh.24075; Schwaab J, 2013, BLOOD, V122, P2460, DOI 10.1182/blood-2013-04-496448; Shah S, 2018, AM J HEMATOL, V93, P1461, DOI 10.1002/ajh.25265; Sotlar K, 2008, J MOL DIAGN, V10, P58, DOI 10.2353/jmoldx.2008.070061; Sotlar K, 2010, J PATHOL, V220, P586, DOI 10.1002/path.2677; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Sperr WR, 2019, LANCET HAEMATOL, V6, pE638, DOI 10.1016/S2352-3026(19)30166-8; Sperr WR, 2012, EXPERT REV HEMATOL, V5, P261, DOI [10.1586/EHM.12.12, 10.1586/ehm.12.12]; Tan A, 2006, CLIN CHEM, V52, P2250, DOI 10.1373/clinchem.2006.068205; Tanasi I, 2021, BRIT J HAEMATOL, V193, P845, DOI 10.1111/bjh.17405; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Trizuljak J, 2020, ALLERGY, V75, P1927, DOI 10.1111/all.14248; Ustun C, 2016, HAEMATOLOGICA, V101, P1133, DOI 10.3324/haematol.2016.146563; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; VALENT P, 1992, BLOOD, V80, P2237; Valent P, 1995, Exp Dermatol, V4, P255, DOI 10.1111/j.1600-0625.1995.tb00254.x; Valent P, 2020, THERANOSTICS, V10, P10743, DOI 10.7150/thno.46719; Valent P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122976; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Valent P, 2015, HEMATOL-AM SOC HEMAT, P98, DOI 10.1182/asheducation-2015.1.98; Valent P, 2013, AM J CANCER RES, V3, P159; WILLHEIM M, 1995, J IMMUNOL METHODS, V182, P115, DOI 10.1016/0022-1759(95)00034-8; Yang Y, 2010, BLOOD, V116, P1114, DOI 10.1182/blood-2009-06-226027; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015	93	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1855	1865		10.1016/j.jaci.2022.04.004	http://dx.doi.org/10.1016/j.jaci.2022.04.004			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35430191				2022-12-18	WOS:000833525500005
J	Levi-Schaffer, F; Gibbs, BF; Hallgren, J; Pucillo, C; Redegeld, F; Siebenhaar, F; Vitte, J; Mezouar, S; Michel, M; Puzzovio, PG; Maurer, M				Levi-Schaffer, Francesca; Gibbs, Bernhard F.; Hallgren, Jenny; Pucillo, Carlo; Redegeld, Frank; Siebenhaar, Frank; Vitte, Joana; Mezouar, Soraya; Michel, Moiese; Puzzovio, Pier Giorgio; Maurer, Marcus			Selected recent advances in understanding the role of human mast cells in health and disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Allergy; cancer; human mast cells; receptors; signal transduction	KINASE INHIBITOR R112; TYROSINE KINASE; ACTIVATION; EOSINOPHILS; IGE; MASTOCYTOSIS; RESPONSES; RECEPTOR; TRYPTASE; SURVIVAL	Mast cells are highly granular tissue-resident cells and key drivers of inflammation, particularly in allergies as well as in other inflammatory diseases. Most mast cell research was initially conducted in rodents but has increasingly shifted to the human system, with the advancement of research technologies and methodologies. Today we can analyze primary human cells including rare subpopulations, we can produce and maintain mast cells isolated from human tissues, and there are several human mast cell lines. These tools have substantially facilitated our understanding of their role and function in different organs in both health and disease. We can now define more clearly where human mast cells originate from, how they develop, which mediators they store, produce de novo, and release, how they are activated and by which receptors, and which neighboring cells they interact with and by which mechanisms. Considerable progress has also been made regarding the potential contribution of mast cells to disease, which, in turn, has led to the development of novel approaches for preventing key pathogenic effects of mast cells, heralding the era of mast cell-targeted therapeutics. In this review, we present and discuss a selection of some of the most significant advancements and remaining gaps in our understanding of human mast cells during the last 25 years, with a focus on clinical relevance.	[Levi-Schaffer, Francesca; Puzzovio, Pier Giorgio] Hebrew Univ Jerusalem, Pharmacol & Expt Therapeut Unit, Inst Drug Res, Sch Pharm,Fac Med, POB 12272, IL-91120 Jerusalem, Israel; [Gibbs, Bernhard F.] Carl von Ossietzky Univ Oldenburg, Dept Human Med, Oldenburg, Germany; [Hallgren, Jenny] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Pucillo, Carlo] Univ Udine, Lab Immunol, Dept Med, Udine, Italy; [Redegeld, Frank] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Siebenhaar, Frank; Maurer, Marcus] Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany; [Siebenhaar, Frank; Maurer, Marcus] Free Univ Berlin, Berlin, Germany; [Siebenhaar, Frank; Maurer, Marcus] Humboldt Univ, Berlin, Germany; [Siebenhaar, Frank; Maurer, Marcus] Fraunhofer Inst Translat Med & Pharmacol, ITMP Allergol & Immunol, Berlin, Germany; [Vitte, Joana; Michel, Moiese] Aix Marseille Univ, AP HM, IRD, MEPHI, Marseille, France; [Vitte, Joana] IDESP, INSERM UA 11, Montpellier, France; [Mezouar, Soraya] Aix Marseille Univ, IRD, MEPHI, Marseille, France; [Michel, Moiese] CHU Nimes, Immunol Lab, Nimes, France	Hebrew University of Jerusalem; Carl von Ossietzky Universitat Oldenburg; Uppsala University; University of Udine; Utrecht University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU de Nimes	Levi-Schaffer, F (corresponding author), Hebrew Univ Jerusalem, Pharmacol & Expt Therapeut Unit, Inst Drug Res, Sch Pharm,Fac Med, POB 12272, IL-91120 Jerusalem, Israel.; Maurer, M (corresponding author), Charite Univ Med Berlin, Inst Allergol, Charitepl 1, D-10117 Berlin, Germany.	francescal@ekmd.huji.ac.il; marcus.maurer@charite.de	Maurer, Marcus/ABG-2174-2020; Hallgren Martinsson, Jenny/AAZ-6356-2021; Sumbayev, Vadim/HCH-7696-2022; Vitte, Joana/G-2572-2013	Maurer, Marcus/0000-0002-4121-481X; Vitte, Joana/0000-0002-3344-9408; Levi-Schaffer, Francesca/0000-0003-0620-2810; mezouar, soraya/0000-0002-2285-7051	European Mast Cell and Basophil Research Network	European Mast Cell and Basophil Research Network	This review benefited from the support of the European Mast Cell and Basophil Research Network (www.embrn.eu).	Afrin LB, 2020, INT J INFECT DIS, V100, P327, DOI 10.1016/j.ijid.2020.09.016; Altrichter S, 2020, J ALLERGY CLIN IMMUN, V145, P1510, DOI 10.1016/j.jaci.2020.03.005; Andersson CK, 2009, THORAX, V64, P297, DOI 10.1136/thx.2008.101683; Babina M, 2004, J LEUKOCYTE BIOL, V75, P244, DOI 10.1189/jlb.0403157; Babina M, 2019, J INVEST DERMATOL, V139, P1516, DOI 10.1016/j.jid.2019.01.013; Babina M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030525; Bachelet I, 2006, J ALLERGY CLIN IMMUN, V117, P1314, DOI 10.1016/j.jaci.2006.04.031; Bagher M, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0269-3; Boyden SE, 2016, NEW ENGL J MED, V374, P656, DOI 10.1056/NEJMoa1500611; Cahill KN, 2019, AM J RESP CRIT CARE, V200, P704, DOI 10.1164/rccm.201809-1755OC; Carroll-Portillo A, 2015, J CELL BIOL, V210, P851, DOI 10.1083/jcb.201412074; Caughey GH, 2016, EUR J PHARMACOL, V778, P44, DOI 10.1016/j.ejphar.2015.04.045; Cheret J, 2021, EXP DERMATOL, V30, P418, DOI 10.1111/exd.14245; Choi HW, 2018, SCIENCE, V362, P656, DOI 10.1126/science.aao0666; Chollet MB, 2022, J ALLERGY CLIN IMMUN, V149, P728, DOI 10.1016/j.jaci.2021.06.017; Church MK, 1997, J ALLERGY CLIN IMMUN, V99, P155, DOI 10.1016/S0091-6749(97)70089-7; Cildir G, 2019, IMMUNITY, V51, P949, DOI 10.1016/j.immuni.2019.09.021; Cop N, 2018, CYTOM PART B-CLIN CY, V94, P405, DOI 10.1002/cyto.b.21547; D'Inca F, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00073; Dahlin JS, 2017, BLOOD, V130, P1785, DOI 10.1182/blood-2017-03-773374; Dahlin JS, 2016, BLOOD, V127, P383, DOI 10.1182/blood-2015-06-650648; Dellon ES, 2020, NEW ENGL J MED, V383, P1624, DOI 10.1056/NEJMoa2012047; Desai A, 2016, J ALLERGY CLIN IMMUN, V137, P1863, DOI 10.1016/j.jaci.2015.09.059; Dickson MC, 2021, BRIT J CLIN PHARMACO, V87, P4797, DOI 10.1111/bcp.14923; Dispenza MC, 2020, J CLIN INVEST, V130, P4759, DOI 10.1172/JCI138448; Divoux A, 2012, J CLIN ENDOCR METAB, V97, pE1677, DOI 10.1210/jc.2012-1532; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Dudeck A, 2011, EUR J IMMUNOL, V41, P1883, DOI 10.1002/eji.201040994; Dwyer DF, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb7221; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Edelson BT, 2004, BLOOD, V103, P2214, DOI 10.1182/blood-2003-08-2978; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Elishmereni M, 2011, ALLERGY, V66, P376, DOI 10.1111/j.1398-9995.2010.02494.x; Falduto GH, 2021, PHARMACOL THERAPEUT, V220, DOI 10.1016/j.pharmthera.2020.107718; Feuser K, 2012, CYTOKINE, V58, P178, DOI 10.1016/j.cyto.2012.01.001; Finlin BS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45136-9; Franke K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073580; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Galdiero MR, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00103; Garvey LH, 2019, ALLERGY, V74, P1872, DOI 10.1111/all.13820; Giannetti MP, 2021, J ALLER CL IMM-PRACT, V9, P2083, DOI 10.1016/j.jaip.2021.02.023; Gibbs BF, 2012, INT J BIOCHEM CELL B, V44, P1739, DOI 10.1016/j.biocel.2012.06.019; Gleixner KV, 2011, BLOOD, V118, P1885, DOI 10.1182/blood-2010-06-289959; Grootens J, 2020, ALLERGY, V75, P211, DOI 10.1111/all.13981; Gulen T, 2021, J ALLERGY CLIN IMMUN, V148, P889, DOI 10.1016/j.jaci.2021.02.023; Guyer BJ, 2006, ALLERGY ASTHMA PROC, V27, P208, DOI 10.2500/aap.2006.27.2861; Harrison CA, 2007, BRIT J PHARMACOL, V150, P509, DOI 10.1038/sj.bjp.0707002; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Jiao QQ, 2019, EXP DERMATOL, V28, P749, DOI 10.1111/exd.13907; Jin ML, 2016, INTEGR BIOL-UK, V8, P968, DOI 10.1039/c6ib00097e; KALINER MA, 1979, NEW ENGL J MED, V301, P498, DOI 10.1056/NEJM197908303010910; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kato T, 2017, EUR J PHARMACOL, V801, P1, DOI 10.1016/j.ejphar.2017.02.048; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410; Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P388, DOI 10.1007/s12016-020-08785-7; Koziol-White CJ, 2016, BRIT J PHARMACOL, V173, P3080, DOI 10.1111/bph.13550; Kuhn H, 2021, J ALLERGY CLIN IMMUN, V147, P456, DOI 10.1016/j.jaci.2020.08.027; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Li F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3623898; Linnemann LC, 2020, PLOS NEGL TROP DIS, V14, P1; Lorentz A, 2005, J IMMUNOL, V174, P6751, DOI 10.4049/jimmunol.174.11.6751; Lotfi-Emran S, 2018, J ALLERGY CLIN IMMUN, V141, P311, DOI 10.1016/j.jaci.2017.02.048; Lu FL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00363; Lv YP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0493-1; MacGlashan D, 2011, INT IMMUNOPHARMACOL, V11, P475, DOI 10.1016/j.intimp.2010.12.018; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Martins PR, 2015, PARASITOL RES, V114, P1847, DOI 10.1007/s00436-015-4371-9; Matsui H, 2011, J MED MICROBIOL, V60, P128, DOI 10.1099/jmm.0.020495-0; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Mendez-Enriquez E, 2022, J ALLERGY CLIN IMMUN, V149, P1458, DOI 10.1016/j.jaci.2021.08.019; Merluzzi S, 2010, BLOOD, V115, P2810, DOI 10.1182/blood-2009-10-250126; Metz M, 2021, NAT MED, V27, P1961, DOI 10.1038/s41591-021-01537-w; Mezouar S, 2019, MBIO, V10, DOI [10.1128/mBio.02669-18, 10.1128/mbio.02669-18]; Mion F, 2014, J IMMUNOL, V193, P4568, DOI 10.4049/jimmunol.1302593; Mizrahi S, 2014, J ALLERGY CLIN IMMUN, V134, P230, DOI 10.1016/j.jaci.2014.03.031; Molina CR, 2019, BRIT J PHARMACOL, V176, P1135, DOI 10.1111/bph.14610; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Motta JD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.574862; Msallam R, 2020, SCIENCE, V370, P941, DOI 10.1126/science.aba0864; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Naranjo AN, 2020, J INVEST DERMATOL, V140, P2210, DOI 10.1016/j.jid.2020.03.936; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; OMI T, 1991, Japanese Journal of Allergology, V40, P1407; Patou J, 2011, RHINOLOGY, V49, P100, DOI 10.4193/Rhino09.147; Piliponsky AM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122851; Plum T, 2020, IMMUNITY, V52, P404, DOI 10.1016/j.immuni.2020.01.012; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Le QT, 2019, J EXP MED, V216, P2348, DOI 10.1084/jem.20190701; Rathore APS, 2020, CURR OPIN IMMUNOL, V66, P74, DOI 10.1016/j.coi.2020.05.003; Redegeld FA, 2018, IMMUNOL REV, V282, P87, DOI 10.1111/imr.12629; RILEY JF, 1954, LANCET, V1, P841; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Salazar-Terreros M, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-119029; Salomonsson M, 2020, ALLERGY, V75, P456, DOI 10.1111/all.14004; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Schuster C, 2012, J INVEST DERMATOL, V132, P2581, DOI 10.1038/jid.2012.187; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; Shimokawa C, 2017, IMMUNITY, V46, P863, DOI 10.1016/j.immuni.2017.04.017; Siebenhaar F, 2007, AM J PATHOL, V170, P1910, DOI 10.2353/ajpath.2007.060770; Siiskonen H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00422; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Smiljkovic D, 2017, ALLERGY, V72, P1666, DOI 10.1111/all.13166; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; Sprinzl B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052458; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Sumbayev VV, 2009, EUR J IMMUNOL, V39, P3511, DOI 10.1002/eji.200939370; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; Suurmond J, 2015, CLIN EXP ALLERGY, V45, P788, DOI 10.1111/cea.12509; Tancowny BP, 2010, IMMUNOLOGY, V131, P220, DOI 10.1111/j.1365-2567.2010.03296.x; Thapaliya M, 2021, CURR ALLERGY ASTHM R, V21, DOI 10.1007/s11882-020-00979-5; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; Valent P, 2020, J ALLERGY CLIN IMMUN, V146, P300, DOI 10.1016/j.jaci.2020.06.009; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; Velin D, 2005, GASTROENTEROLOGY, V129, P142, DOI 10.1053/j.gastro.2005.04.010; Vitte J, 2021, J ALLER CL IMM-PRACT, V9, P2994, DOI 10.1016/j.jaip.2021.03.011; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang Z, 2022, J INVEST DERMATOL, V142, P414, DOI 10.1016/j.jid.2021.07.153; Wang Z, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040341; Weiler CR, 2019, J ALLERGY CLIN IMMUN, V144, P883, DOI 10.1016/j.jaci.2019.08.023; Wenzel SE, 2021, AM J RESP CRIT CARE, V203, P809, DOI 10.1164/rccm.202009-3631CI; West PW, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615236; Youngblood BA, 2019, INT ARCH ALLERGY IMM, V180, P91, DOI 10.1159/000501637; Yu YX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02138; Yu YX, 2016, EUR J PHARMACOL, V778, P33, DOI 10.1016/j.ejphar.2015.07.017; Zhao XO., 2021, J ALLERGY CLIN IMMUN, V149, P718, DOI DOI 10.1016/J.JACI.2021.07.020; Zimmermann C, 2019, P NATL ACAD SCI USA, V116, P20500, DOI 10.1073/pnas.1908816116; Zuberbier T, 2001, J ALLERGY CLIN IMMUN, V108, P275, DOI 10.1067/mai.2001.116865	135	5	5	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1833	1844		10.1016/j.jaci.2022.01.030	http://dx.doi.org/10.1016/j.jaci.2022.01.030			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35276243				2022-12-18	WOS:000833525500003
J	Williams, HC; Schmitt, J; Thomas, KS; Spuls, PI; Simpson, EL; Apfelbacher, CJ; Chalmers, JR; Furue, M; Katoh, N; Gerbens, LAA; Leshem, YA; Howells, L; Singh, JA; Boers, M				Williams, Hywel C.; Schmitt, Jochen; Thomas, Kim S.; Spuls, Phyllis, I; Simpson, Eric L.; Apfelbacher, Christian J.; Chalmers, Joanne R.; Furue, Masutaka; Katoh, Norito; Gerbens, Louise A. A.; Leshem, Yael A.; Howells, Laura; Singh, Jasvinder A.; Boers, Maarten		HOME Initiative	The HOME Core outcome set for clinical trials of atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Atopic dermatitis; eczema; core outcome sets; clinical trials	LIFE MEASUREMENT INSTRUMENTS; ORIENTED ECZEMA MEASURE; OMERACT FILTER; CONSENSUS; QUALITY; SEVERITY; SCORAD; RECOMMENDATION; VALIDATION; STATEMENT	Core outcome sets are critically important outcomes that should be measured in clinical trials. Their absence in atopic dermatitis is a form of research waste and impedes combining evidence to inform patient care. Here, we articulate the rationale for core outcome sets in atopic dermatitis and review the work of the international Harmonising Outcome Measures for Eczema group from its inception in Munich, 2010. We describe core domain determination (what should be measured), to instrument selection (how domains should be measured), culminating in the complete core outcome measurement set in Tokyo, 2019. Using a "road map,'' Harmonising Outcome Measures for Eczema includes diverse research methods including Delphi and nominal group techniques informed by systematic reviews of properties of candidate instruments. The 4 domains and recommended instruments for including in all clinical trials of atopic dermatitis are patient symptoms, measured by Patient-Oriented Eczema Measure and peak Numerical Rating Scale 11 for itch intensity over 24 hours, clinical signs measured using the Eczema Area and Severity Index, quality of life measured by the Dermatology Life Quality Index series for adults, children, and infants, and long-term control measured by either Recap of atopic eczema or Atopic Dermatitis Control Tool.	[Williams, Hywel C.; Thomas, Kim S.; Chalmers, Joanne R.; Howells, Laura] Univ Nottingham, Ctr Evidence Based Dermatol, Sch Med, Nottingham, England; [Schmitt, Jochen] Med Fac Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Spuls, Phyllis, I; Gerbens, Louise A. A.] Univ Amsterdam, Locat Acad Med Ctr, Amsterdam Publ Hlth Infect & Immun, Dept Dermatol,Amsterdam UMC, Amsterdam, Netherlands; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Apfelbacher, Christian J.] Otto von Guericke Univ, Inst Social Med & Hlth Syst Res, Magdeburg, Germany; [Apfelbacher, Christian J.] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Singapore, Singapore; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan; [Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto, Japan; [Leshem, Yael A.] Rabin Med Ctr, Div Dermatol, Petah Tiqwa, Israel; [Leshem, Yael A.] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Singh, Jasvinder A.] VA Med Ctr, Med Serv, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Singh, Jasvinder A.] UAB Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Singh, Jasvinder A.] Vrije Univ, Dept Epidemiol & Data Sci, Amsterdam UMC, Amsterdam, Netherlands	University of Nottingham; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Amsterdam; Oregon Health & Science University; Otto von Guericke University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Kyushu University; Kyoto Prefectural University of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Amsterdam; Vrije Universiteit Amsterdam	Williams, HC (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England.	Hywel.Williams@nottingham.ac.uk		Thomas, Kim/0000-0001-7785-7465; williams, hywel/0000-0002-5646-3093	National Institute for Health and Care Research Senior Investigator award [RE 2374]; National Institute for Health and Care Research Programme Grant for Applied Research [RP-PG-0407-10177]; NIH NIAMS A Community-based Assessment of Skin Care, Allergies, and Eczema [5 R01 AR071057-05]; British Skin Foundation [8016]; National Institute for Health & Care Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0407-10177]	National Institute for Health and Care Research Senior Investigator award; National Institute for Health and Care Research Programme Grant for Applied Research; NIH NIAMS A Community-based Assessment of Skin Care, Allergies, and Eczema; British Skin Foundation; National Institute for Health & Care Research (NIHR) under its Programme Grants for Applied Research funding scheme	The following additional funding sources contributed to facilitating the HOME COS development:; National Institute for Health and Care Research Senior Investigator award to Prof Hywel Williams (RE 2374) funded travel costs to enable UK patients to participate in HOME meetings; National Institute for Health and Care Research Programme Grant for Applied Research RP-PG-0407-10177 "Setting Priorities and Reducing Uncertainties for the Prevention and Treatment of Skin Disease (SPRUSD)'' was used to support completion of the some of the systematic reviews, the cost of meetings and patient and public involvement (Prof Kim Thomas); NIH NIAMS A Community-based Assessment of Skin Care, Allergies, and Eczema: The CASCADE Trial grant number 5 R01 AR071057-05 and Oregon Clinical and Translational Research Institute (OCTRI) assisted with outcome evaluations and associated travel costs (Prof Eric Simpson); Laura Howells received a PhD studentship from the British Skin Foundation (Ref: 8016) for studies that informed this work; This study presents independent research commissioned by the National Institute for Health & Care Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10177). The views expressed in this study are those of the author(s) and are not necessarily those of the NHS, the NIHR or the Department of Health.	Barbarot S, 2016, J AM ACAD DERMATOL, V75, P1038, DOI 10.1016/j.jaad.2016.05.043; Bellamy N, 1997, J RHEUMATOL, V24, P799; Boers M, 1998, J RHEUMATOL, V25, P198; Boers M, 2014, J CLIN EPIDEMIOL, V67, P745, DOI 10.1016/j.jclinepi.2013.11.013; Chalmers JR, 2018, BRIT J DERMATOL, V178, pE332, DOI 10.1111/bjd.16543; Chalmers JR, 2016, BRIT J DERMATOL, V175, P69, DOI 10.1111/bjd.14773; Chalmers JR, 2014, BRIT J DERMATOL, V171, P1318, DOI 10.1111/bjd.13237; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Charman CR, 1999, BRIT J DERMATOL, V140, P109; Chopra R, 2017, J ALLERGY CLIN IMMUN, V140, P1708, DOI 10.1016/j.jaci.2017.04.052; COMET Initiative, COR OUTC MEAS EFF TR; comet-initiative, COR OUTC SET DEV RES; Coutanceau C, 2014, DERMATOLOGY, V229, P248, DOI 10.1159/000365075; Drucker AM, 2020, JAMA DERMATOL, V156, P659, DOI 10.1001/jamadermatol.2020.0796; Esaa F, 2021, ARCH DERMATOL RES, V313, P17, DOI 10.1007/s00403-020-02074-1; Gabes M, 2021, J EUR ACAD DERMATOL, V35, P458, DOI 10.1111/jdv.16848; Gabes M, 2020, J EUR ACAD DERMATOL, V34, P1773, DOI 10.1111/jdv.16362; Gabes M, 2020, PEDIAT ALLERG IMM-UK, V31, P66, DOI 10.1111/pai.13120; George SMC, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003871.pub3; Gerbens LAA, 2017, ALLERGY, V72, P146, DOI 10.1111/all.12959; Grinich EE, 2018, BRIT J DERMATOL, V179, P540, DOI 10.1111/bjd.16732; Heinl D, 2017, BRIT J DERMATOL, V176, P878, DOI 10.1111/bjd.14966; Heinl D, 2016, ALLERGY, V71, P358, DOI 10.1111/all.12806; Heinl D, 2016, ACTA DERM-VENEREOL, V96, P596, DOI 10.2340/00015555-2322; homeforeczema, HARM OUTC MEAS ECZ H; Howells L, 2019, J EUR ACAD DERMATOL, V33, P1124, DOI 10.1111/jdv.15475; Howells LM, 2020, BRIT J DERMATOL, V183, P524, DOI 10.1111/bjd.18780; Howells LM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017731; Howells LM, 2020, THESIS U NOTTINGHAM; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kantor R, 2016, ALLERGY, V71, P1480, DOI 10.1111/all.12982; Kirkham JJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002447; Langan SM, 2014, BRIT J DERMATOL, V170, P548, DOI 10.1111/bjd.12747; Lange T, 2021, J EUR ACAD DERMATOL, V35, P523, DOI 10.1111/jdv.16854; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; Leshem YA, 2020, J AM ACAD DERMATOL, V82, P1181, DOI 10.1016/j.jaad.2019.12.055; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Musters AH, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013870.pub2; Nankervis H, 2016, SCOPING SYSTEMATIC R; nihr, NAT I HLTH CAR RES H; nottingham, POEM PAT OR ECZ MEAS; Pariser DM, 2020, CURR MED RES OPIN, V36, P367, DOI 10.1080/03007995.2019.1699516; Patient-Reported Outcomes Measurement Information System (PROMIS), NAT I HLTH OFF STRAT; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; Rehal B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017520; Schmitt J, 2010, Br J Dermatol, V163, P1166, DOI 10.1111/j.1365-2133.2010.10054.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schmitt J, 2019, J INVEST DERMATOL, V139, P1045, DOI 10.1016/j.jid.2018.11.019; Schmitt J, 2015, J INVEST DERMATOL, V135, P24, DOI 10.1038/jid.2014.320; Schmitt J, 2014, J ALLERGY CLIN IMMUN, V134, P800, DOI 10.1016/j.jaci.2014.07.043; Schmitt J, 2013, J ALLERGY CLIN IMMUN, V132, P1337, DOI 10.1016/j.jaci.2013.07.008; Schmitt J, 2012, ALLERGY, V67, P1111, DOI 10.1111/j.1398-9995.2012.02874.x; Schmitt J, 2011, J INVEST DERMATOL, V131, P623, DOI 10.1038/jid.2010.303; Schoch D, 2017, J INVEST DERMATOL, V137, P2069, DOI 10.1016/j.jid.2017.05.020; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Simpson E, 2019, BMC DERMATOL, V19, DOI 10.1186/s12895-019-0095-3; skin.cochrane, COR OUTC SET IN CS C; Spuls PI, 2017, BRIT J DERMATOL, V176, P979, DOI 10.1111/bjd.15179; Stuart BL, 2021, J EUR ACAD DERMATOL, V35, P1987, DOI 10.1111/jdv.17335; Thomas KS, 2021, BRIT J DERMATOL, V185, P139, DOI 10.1111/bjd.19751; Topp J, 2022, J INVEST DERMATOL, V142, P343, DOI 10.1016/j.jid.2021.06.032; Topp J, 2019, ACTA DERM-VENEREOL, V99, P211, DOI 10.2340/00015555-3063; Vermeulen FM, 2019, BRIT J DERMATOL, V181, P492, DOI 10.1111/bjd.17715; Veysey EC, 2021, BRIT J DERMATOL, V184, P987, DOI 10.1111/bjd.20050; Vincent R, 2020, BRIT J DERMATOL, V183, P566, DOI 10.1111/bjd.19030; von Kobyletzki LB, 2017, ACTA DERM-VENEREOL, V97, P86, DOI 10.2340/00015555-2480; Yosipovitch G, 2019, BRIT J DERMATOL, V181, P761, DOI 10.1111/bjd.17744	70	5	5	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2022	149	6					1899	1911		10.1016/j.jaci.2022.03.017	http://dx.doi.org/10.1016/j.jaci.2022.03.017			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3J6SZ	35351441	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000833525500008
J	Guttman-Yassky, E; Pavel, AB; Diaz, A; Zhang, N; Del Duca, E; Estrada, Y; King, B; Banerjee, A; Banfield, C; Cox, LA; Dowty, ME; Page, K; Vincent, MS; Zhang, WD; Zhu, L; Peeva, E				Guttman-Yassky, Emma; Pavel, Ana B.; Diaz, Aisleen; Zhang, Ning; Del Duca, Ester; Estrada, Yeriel; King, Brett; Banerjee, Anindita; Banfield, Christopher; Cox, Lori Ann; Dowty, Martin E.; Page, Karen; Vincent, Michael S.; Zhang, Weidong; Zhu, Linda; Peeva, Elena			Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Alopecia areata; scalp; Janus kinase inhibitors; JAK; tyrosine kinase; cytokines; inflammation; biomarkers	JANUS KINASE INHIBITORS; TOFACITINIB; PATHOGENESIS; REGROWTH; PATIENT; HAIR	Background: Janus kinase (JAK) inhibitors have shown encouraging results in the treatment of alopecia areata (AA), an autoimmune form of hair loss, in small, uncontrolled studies and case reports. Objective: We conducted a biopsy substudy during the randomized, double-blind, placebo-controlled first 24 weeks of a phase 2a clinical trial that evaluated the efficacy and safety of ritlecitinib, an inhibitor of JAK3 and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family, and brepocitinib, an inhibitor of tyrosine kinase 2 (TYK2)/JAK1 in the treatment of AA. Methods: Change in biomarkers in lesional scalp biopsy samples between baseline and weeks 12 and 24 was an exploratory end point, and 46 patients participated from the ritlecitinib (n = 18), brepocitinib (n = 16), and placebo (n = 12) groups. Correlations of biomarkers with hair regrowth, measured using the Severity of Alopecia Tool (SALT) score, were also evaluated. Clinical Trial Registration: NCT02974868. Results: At week 24, both ritlecitinib and brepocitinib demonstrated improvement exceeding 100% in the lesional scalp transcriptome toward a nonlesional profile. At week 12, the improvements in scalp tissue were greater with brepocitinib than ritlecitinib; however, at week 24, the improvements were greater with ritlecitinib. Conclusions: For both ritlecitinib and brepocitinib, improvement in the SALT scores was positively associated with expression of T(H)1 markers and negatively associated with expression of hair keratins. Larger, long-term clinical trials are warranted.	[Guttman-Yassky, Emma; Pavel, Ana B.; Diaz, Aisleen; Zhang, Ning; Del Duca, Ester; Estrada, Yeriel] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Pavel, Ana B.] Univ Mississippi, University, MS 38677 USA; [Diaz, Aisleen] Ponce Hlth Sci Univ, Sch Med, Ponce, PR USA; [King, Brett] Yale Univ, Sch Med, New Haven, CT USA; [Banerjee, Anindita; Banfield, Christopher; Dowty, Martin E.; Page, Karen; Vincent, Michael S.; Zhang, Weidong; Zhu, Linda; Peeva, Elena] Pfizer, Cambridge, MA USA; [Cox, Lori Ann] Pfizer, Basking Ridge, NJ USA	Icahn School of Medicine at Mount Sinai; University of Mississippi; Ponce Health Sciences University; Yale University; Pfizer; Pfizer	Guttman-Yassky, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Dermatol, 5 East 98th St, New York, NY 10029 USA.; Guttman-Yassky, E (corresponding author), Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, 5 East 98th St, New York, NY 10029 USA.	Emma.Guttman@mountsinai.org			Pfizer	Pfizer(Pfizer)	This study was funded by Pfizer. Pfizer designed the study in consultation with all authors, and Pfizer collected the data. All authors had full access to the data and participated in data analysis and interpretation and in writing the report. The corresponding author had final responsibility for the decision to submit for publication. Upon request, and subject to certain criteria, conditions, and exceptions (see https://www.pfizer.com/science/clinical-trials/trial-data-and-results for more information), Pfizer will provide access to individual deidentified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines, and medical devices (1) for indications that have been approved in the United States and/or the European Union, or (2) in programs that have been terminated (ie, development for all indications has been discontinued). Pfizer will also consider requests for the protocol, data dictionary, and statistical analysis plan. Data may be requested from Pfizer trials 24 months after study completion. The deidentified participant data will be made available to researchers whose proposals meet the research criteria and other conditions, and for which an exception does not apply, via a secure portal. To gain access, data requestors must enter into a data access agreement with Pfizer.	Abedini Robabeh, 2018, Int J Womens Dermatol, V4, P91, DOI 10.1016/j.ijwd.2017.07.001; Akdogan N, 2019, DERMATOL THER, V32, DOI 10.1111/dth.13118; Almutairi N, 2019, DERMATOLOGY, V235, P130, DOI 10.1159/000494613; Bain KA, 2020, BRIT J DERMATOL, V182, P130, DOI 10.1111/bjd.18008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bissonnette R, 2019, J ALLERGY CLIN IMMUN, V144, P1274, DOI 10.1016/j.jaci.2019.06.047; Brunner PM, 2019, J ALLERGY CLIN IMMUN, V143, P142, DOI 10.1016/j.jaci.2018.07.028; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; Chan JNE, 2020, EUR J IMMUNOL, V50, P1663, DOI 10.1002/eji.201948521; Crispin MK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89776; Czarnowicki T, 2018, ALLERGY, V73, P713, DOI 10.1111/all.13346; Dainichi T, 2017, J DERMATOL SCI, V86, P3, DOI 10.1016/j.jdermsci.2016.10.004; de Jong A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121949; Velez-Muniz RD, 2019, SKIN APPENDAGE DISOR, V5, P293, DOI 10.1159/000497166; Rota DD, 2021, J COSMET DERMATOL-US, V20, P3026, DOI 10.1111/jocd.13966; Erduran F, 2017, ACTA DERMATOVEN ALP, V26, P47, DOI 10.15570/actaapa.2017.15; Fensome A, 2018, J MED CHEM, V61, P8597, DOI 10.1021/acs.jmedchem.8b00917; Ferreira RB, 2019, CLIN CASE REP, V7, P2539, DOI 10.1002/ccr3.2484; Fuentes-Duculan J, 2016, EXP DERMATOL, V25, P282, DOI 10.1111/exd.12918; Gautam RK, 2020, J COSMET DERMATOL-US, V19, P234, DOI 10.1111/jocd.12970; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Glickman JW, 2021, ALLERGY, V76, P3053, DOI 10.1111/all.14814; Glickman JW, 2021, J AM ACAD DERMATOL, V84, P370, DOI 10.1016/j.jaad.2020.04.138; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V143, P155, DOI 10.1016/j.jaci.2018.08.022; Guttman-Yassky E, 2016, J ALLERGY CLIN IMMUN, V137, P301, DOI 10.1016/j.jaci.2015.11.001; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Howell MD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02342; Jabbari A, 2018, J INVEST DERMATOL, V138, P1539, DOI 10.1016/j.jid.2018.01.032; Jabbari A, 2016, EXP DERMATOL, V25, P642, DOI 10.1111/exd.13060; Jabbari A, 2015, EBIOMEDICINE, V2, P351, DOI 10.1016/j.ebiom.2015.02.015; King B, 2021, J AM ACAD DERMATOL, V85, P379, DOI 10.1016/j.jaad.2021.03.050; Lind L, 2015, ATHEROSCLEROSIS, V242, P205, DOI 10.1016/j.atherosclerosis.2015.07.023; Liu LY, 2017, J AM ACAD DERMATOL, V76, P22, DOI 10.1016/j.jaad.2016.09.007; Olamiju Brianna, 2019, JAAD Case Rep, V5, P892, DOI 10.1016/j.jdcr.2019.07.005; Park HS, 2017, J AM ACAD DERMATOL, V77, P978, DOI 10.1016/j.jaad.2017.06.027; Park H, 2019, J DERMATOL, V46, P724, DOI 10.1111/1346-8138.14986; Pavel AB, 2019, J ALLERGY CLIN IMMUN, V144, P1011, DOI 10.1016/j.jaci.2019.07.013; Ramot Y, 2018, SKIN APPENDAGE DISOR, V4, P122, DOI 10.1159/000479722; Renert-Yuval Y, 2017, ADV THER, V34, P1594, DOI 10.1007/s12325-017-0542-7; Sanyal RD, 2019, ANN ALLERG ASTHMA IM, V122, P99, DOI 10.1016/j.anai.2018.08.024; Shivanna Chandrashekar Byalekere, 2018, Int J Trichology, V10, P103, DOI 10.4103/ijt.ijt_21_18; Song T, 2018, J ALLERGY CLIN IMMUN, V142, P1631, DOI 10.1016/j.jaci.2018.06.029; Strazzulla LC, 2018, J AM ACAD DERMATOL, V78, P1, DOI 10.1016/j.jaad.2017.04.1141; Szilveszter KP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01862; Triyangkulsri K, 2018, DRUG DES DEV THER, V12, P2323, DOI 10.2147/DDDT.S172638; Wambier CG, 2021, J AM ACAD DERMATOL, V85, P743, DOI 10.1016/j.jaad.2019.08.080; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Xu H, 2019, ACS CHEM BIOL, V14, P1235, DOI 10.1021/acschembio.9b00188; Zhang ZG, 2019, INDIAN J DERMATOL, V64, P1, DOI 10.4103/ijd.IJD_68_18	49	5	5	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1318	1328		10.1016/j.jaci.2021.10.036	http://dx.doi.org/10.1016/j.jaci.2021.10.036			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	34863853	hybrid			2022-12-18	WOS:000840331500023
J	Marzano, AV; Maronese, CA; Genovese, G; Ferrucci, S; Moltrasio, C; Asero, R; Cugno, M				Marzano, Angelo Valerio; Maronese, Carlo Alberto; Genovese, Giovanni; Ferrucci, Silvia; Moltrasio, Chiara; Asero, Riccardo; Cugno, Massimo			Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Urticaria; vasculitis; anti-C1q autoantibodies; complement	CONSENSUS CONFERENCE NOMENCLATURE; LEUKOCYTOCLASTIC VASCULITIS; DIRECT IMMUNOFLUORESCENCE; CUTANEOUS VASCULITIS; ERYTHEMA MULTIFORME; VIRUS-INFECTION; WELLS-SYNDROME; FEATURES; AUTOANTIBODIES; SPECTRUM	Urticarial vasculitis (UV) is a rare cutaneous vasculitis of small vessels characterized by recurrent episodes of wheal-like lesions that tend to last more than 24 hours, healing with a residual ecchymotic postinflammatory hyperpigmentation. The histopathologic pattern of UV is that of leukocytoclastic vasculitis, consisting of fibrinoid necrosis of dermal vessels' walls and neutrophil-rich perivascular inflammatory infiltrates. Although its etiopahogenesis remains still undefined, UV is now regarded as an immune complex-driven disease with activation of the complement cascade, leading to exaggerated production of anaphylatoxins that are responsible for neutrophil recruitment and activation. This condition can be categorized into 2 main entities according to serum complement levels: normocomplementemic UV and hypocomplementemic UV, the latter being associated with circulating anti-C1q autoantibodies and possible extracutaneous manifestations. Systemic multiorgan involvement may be seen particularly in syndromic hypocomplementemic UV, also known as McDuffie syndrome. This review summarizes the clinicopathological and laboratory features as well as the underlying pathophysiological mechanisms of UV. A focus on its main differential diagnoses is provided, that is, chronic spontaneous urticaria, bullous pemphigoid, IgA (Henoch-Schonlein purpura) and IgM/IgG immune complex vasculitis, lupus erythematous tumidus, Wells syndrome, erythema multiforme, cutaneous mastocytosis, cryopyrin-associated periodic syndromes, and coronavirus disease 2019-associated and anti-severe acute respiratory syndrome coronavirus 2-vaccine-associated urticarial eruptions.	[Marzano, Angelo Valerio; Maronese, Carlo Alberto; Genovese, Giovanni; Ferrucci, Silvia; Moltrasio, Chiara] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy; [Marzano, Angelo Valerio; Maronese, Carlo Alberto; Genovese, Giovanni; Cugno, Massimo] Univ Milan, Dept Pathophysiol & Transplantat, Via Francesco Sforza 35, I-20122 Milan, Italy; [Moltrasio, Chiara] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Asero, Riccardo] Clin San Carlo, Ambulatorio Allergol, Paderno Dugnano, Italy; [Cugno, Massimo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cugno, M (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Via Francesco Sforza 35, I-20122 Milan, Italy.	massimo.cugno@unimi.it	Cugno, Massimo/K-8106-2016	Cugno, Massimo/0000-0002-9918-0763				AFEKENSTAM E, 1984, ARCH DERMATOL, V120, P484; Al Musalhi BH, 2021, J AM ACAD DERMATOL, V85, P1617, DOI 10.1016/j.jaad.2020.12.031; Alomari M, 2019, CLIN RHEUMATOL, V38, P1691, DOI 10.1007/s10067-019-04548-8; Arora A, 2014, MAYO CLIN PROC, V89, P1515, DOI 10.1016/j.mayocp.2014.04.015; Asero R, 2020, CLIN EXP IMMUNOL, V200, P242, DOI 10.1111/cei.13428; Ataya A, 2015, CHEST, V147, pE44, DOI 10.1378/chest.14-1193; Barrera-Godinez A, 2021, J EUR ACAD DERMATOL, V35, P1865, DOI 10.1111/jdv.17381; Berggren MAM, 2007, J MED VIROL, V79, P963, DOI 10.1002/jmv.20893; Bianchi L, 2021, ALLERGY, V76, P2605, DOI 10.1111/all.14839; Black AK, 1996, CLIN EXP DERMATOL, V21, P424, DOI 10.1111/j.1365-2230.1996.tb00146.x; Bonnekoh H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00546; Booshehri LM, 2019, J CLIN IMMUNOL, V39, P277, DOI 10.1007/s10875-019-00638-z; Boyer A, 2020, NEPHROL THER, V16, P124, DOI 10.1016/j.nephro.2019.09.004; Bracken SJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00627; BREHMERANDERSSON E, 1986, ACTA DERM-VENEREOL, V66, P213; Bruschi M, 2020, J RHEUMATOL, V47, P377, DOI 10.3899/jrheum.181232; Buck Andrew, 2012, J Clin Aesthet Dermatol, V5, P36; BUSHKELL LL, 1980, J INVEST DERMATOL, V74, P372, DOI 10.1111/1523-1747.ep12543806; CALLEN JP, 1982, BRIT J DERMATOL, V107, P87, DOI 10.1111/j.1365-2133.1982.tb00295.x; Caputo R, 2006, ARCH DERMATOL, V142, P1157, DOI 10.1001/archderm.142.9.1157; CARDOSO PA, 1990, ALLERGOL IMMUNOPATH, V18, P191; Catala A, 2022, BRIT J DERMATOL, V186, P142, DOI 10.1111/bjd.20639; Chang SY, 2007, ALLERGY ASTHMA PROC, V28, P97, DOI 10.2500/aap.2007.28.2972; Criado PR, 2021, J EUR ACAD DERMATOL, V35, pE563, DOI 10.1111/jdv.17391; Cribier B, 2006, CLIN REV ALLERG IMMU, V30, P25, DOI 10.1385/CRIAI:30:1:025; Csorba K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02619; Cugno M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091011; Cugno M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129456; Damman J, 2020, AM J DERMATOPATH, V42, P399, DOI 10.1097/DAD.0000000000001501; Dash S, 2021, DERMATOL THER, V34, DOI 10.1111/dth.15093; David C, 2020, J ALLER CL IMM-PRACT, V8, P3222, DOI 10.1016/j.jaip.2020.05.031; Davis MDP, 1998, J AM ACAD DERMATOL, V38, P899; de Perosanz-Lobo D, 2020, J EUR ACAD DERMATOL, V34, pE566, DOI 10.1111/jdv.16713; Degirmentepe EN, 2019, ANN DERMATOL, V31, P335, DOI 10.5021/ad.2019.31.3.335; Di Raimondo C, 2021, AUSTRALAS J DERMATOL, V62, pE1, DOI 10.1111/ajd.13443; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dincy CVP, 2008, J EUR ACAD DERMATOL, V22, P789, DOI 10.1111/j.1468-3083.2007.02641.x; Freeman EE, 2020, J AM ACAD DERMATOL, V83, P1118, DOI 10.1016/j.jaad.2020.06.1016; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Gambichler T, 2022, J EUR ACAD DERMATOL, V36, P172, DOI 10.1111/jdv.17744; Garcia-Garcia B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63146-w; Gellrich FF, SCHNITZLER SYNDROME, DOI [10.1007/s00105-019-4434-4, DOI 10.1007/S00105-019-4434-4]; Gerfaud-Valentin M, 2014, AUTOIMMUN REV, V13, P708, DOI 10.1016/j.autrev.2014.01.058; Giang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00639; Gimenez-Arnau AM, 2021, J ALLER CL IMM-PRACT, V9, P2195, DOI 10.1016/j.jaip.2021.03.033; Gu Stephanie L, 2021, Int J Womens Dermatol, V7, P290, DOI 10.1016/j.ijwd.2021.01.021; Gusdorf L, 2018, ANN DERMATOL VENER, V145, P735, DOI 10.1016/j.annder.2018.06.010; Hamid S, 1998, J AM ACAD DERMATOL, V39, P278, DOI 10.1016/S0190-9622(98)70089-1; Holers VM, 2004, J CLIN INVEST, V114, P616, DOI 10.1172/JCI200422820; Imbalzano E, 2016, ALLERGY ASTHMA PROC, V37, P18, DOI 10.2500/aap.2016.37.3915; Ion O, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072131; Jachiet M, 2015, ARTHRITIS RHEUMATOL, V67, P527, DOI 10.1002/art.38956; Jara Luis J, 2009, Curr Rheumatol Rep, V11, P410; Jayakanthan K, 2017, INT J HEALTH SCI-IJH, V11, P3; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Johnson EF, 2017, J EUR ACAD DERMATOL, V31, P544, DOI 10.1111/jdv.13952; Kallenberg CGM, 2008, AUTOIMMUN REV, V7, P612, DOI 10.1016/j.autrev.2008.06.006; Kamyab K, 2019, INT J DERMATOL, V58, P825, DOI 10.1111/ijd.14387; Kaya G, 2020, DERMATOPATHOL-BASEL, V7, P3, DOI 10.3390/dermatopathology7010002; Kolkhir P, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100107; Krause K, 2013, J ALLERGY CLIN IMMUN, V132, P751, DOI 10.1016/j.jaci.2013.04.008; Kuhn A, 2009, AUTOIMMUN REV, V8, P441, DOI 10.1016/j.autrev.2008.12.010; Lath K, 2018, AM J DERMATOPATH, V40, P661, DOI 10.1097/DAD.0000000000001170; Lee JSS, 2007, J AM ACAD DERMATOL, V56, P994, DOI 10.1016/j.jaad.2006.10.962; Lerch M, 2018, CLIN REV ALLERG IMMU, V54, P177, DOI 10.1007/s12016-017-8667-7; Lin Jaimie, 2021, JAAD Case Rep, V11, P33, DOI 10.1016/j.jdcr.2021.02.019; Lipsker D, 2013, JAMA DERMATOL, V149, P1244, DOI 10.1001/jamadermatol.2013.5480; Liu E, 2020, CUREUS, V12, DOI 10.7759/cureus.8305; Liu TM, 2021, J ASTHMA ALLERGY, V14, P433, DOI 10.2147/JAA.S304099; Loricera J, 2014, MEDICINE, V93, P53, DOI 10.1097/MD.0000000000000013; Magen E, 2022, ALLERGY ASTHMA PROC, V43, P30, DOI [10.2500/aap.2022.43.210111, 10.2500/aap.2022.43.210111)]; Martensson U, 1996, SCAND J IMMUNOL, V43, P314, DOI 10.1046/j.1365-3083.1996.d01-48.x; Marzano AV, 2015, GIORN ITAL DERMAT V, V150, P41; Marzano AV, 2021, J AM ACAD DERMATOL, V84, P175, DOI 10.1016/j.jaad.2020.04.060; Marzano AV, 2020, AM J CLIN DERMATOL, V21, P525, DOI 10.1007/s40257-020-00520-4; Marzano Angelo Valerio, 2018, Clin Exp Rheumatol, V36 Suppl 110, P32; Marzano AV, J AM ACAD DERMATOL, V84, P1356; MCDUFFIE FC, 1973, MAYO CLIN PROC, V48, P340; McMahon DE, 2022, J AM ACAD DERMATOL, V86, P113, DOI 10.1016/j.jaad.2021.09.002; McMahon DE, 2021, J AM ACAD DERMATOL, V85, P46, DOI 10.1016/j.jaad.2021.03.092; Mehregan DR, 1998, ARCH DERMATOL, V134, P88, DOI 10.1001/archderm.134.1.88; MEHREGAN DR, 1992, J AM ACAD DERMATOL, V26, P441, DOI 10.1016/0190-9622(92)70069-R; Messiaen T, 2000, CLIN NEPHROL, V54, P409; Mohta Alpana, 2021, Indian Dermatol Online J, V12, P687, DOI 10.4103/idoj.IDOJ_127_21; Moreno-Suarez F, 2013, ACTAS DERMO-SIFILOGR, V104, P579, DOI [10.1016/j.ad.2012.12.004, 10.1016/j.adengl.2012.12.005]; Nasiri S, 2020, INT J DERMATOL, V59, P1285, DOI 10.1111/ijd.15112; Nazzaro G, 2022, DERMATOL THER, V35, DOI 10.1111/dth.15282; ODONNELL B, 1995, INT ANGIOL, V14, P166; Ozcakar ZB, 2013, ARTHRITIS RHEUM-US, V65, P2183, DOI 10.1002/art.38010; Patsinakidis N, 2019, CLIN COSMET INV DERM, V12, P707, DOI 10.2147/CCID.S166723; Peroni A, 2010, J AM ACAD DERMATOL, V62, P541, DOI 10.1016/j.jaad.2009.11.686; PETEIRO C, 1989, AM J DERMATOPATH, V11, P528, DOI 10.1097/00000372-198912000-00003; Puhl V, 2021, CLIN TRANSL ALLERGY, V11, DOI 10.1002/clt2.12031; Raoufi M, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.285.8168; Rattananukrom T, 2020, ASIAN PAC J ALLERGY, V38, P286, DOI 10.12932/AP-050918-0402; Rongioletti F, 2021, CLIN DERMATOL, V39, P149, DOI 10.1016/j.clindermatol.2020.12.004; Saeki T, 2001, NEPHRON, V88, P174, DOI 10.1159/000045981; SANCHEZ NP, 1982, J AM ACAD DERMATOL, V7, P599, DOI 10.1016/S0190-9622(82)70139-2; Satapathy A, 2020, CUREUS, V12, DOI 10.7759/cureus.11489; Schmetzer O, 2018, J ALLERGY CLIN IMMUN, V142, P876, DOI 10.1016/j.jaci.2017.10.035; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; SCHWARTZ HR, 1982, MAYO CLIN PROC, V57, P231; Serarslan G, 2021, NORTH CLIN ISTANB, V8, P513, DOI 10.14744/nci.2020.55476; Sjowall C, 2018, RHEUMATOLOGY, V57, P1400, DOI 10.1093/rheumatology/key110; Sokumbi O, 2012, INT J DERMATOL, V51, P889, DOI 10.1111/j.1365-4632.2011.05348.x; SOTER NA, 1977, NEW ENGL J MED, V296, P1440, DOI 10.1056/NEJM197706232962505; Sunderkotter CH, 2018, ARTHRITIS RHEUMATOL, V70, P171, DOI 10.1002/art.40375; Teng MC, 2012, J MICROBIOL IMMUNOL, V45, P22, DOI 10.1016/j.jmii.2011.09.024; Tosoni C, 2009, CLIN EXP DERMATOL, V34, P166, DOI 10.1111/j.1365-2230.2008.02891.x; Toumi A, 2021, STATPEARLS; Tsai CC, 2018, J FORMOS MED ASSOC, V117, P452, DOI 10.1016/j.jfma.2018.01.022; Venzor J, 2002, CLIN REV ALLERG IMMU, V23, P201, DOI 10.1385/CRIAI:23:2:201; Wedi Bettina, 2009, Allergy Asthma Clin Immunol, V5, P10, DOI 10.1186/1710-1492-5-10; Welzel T, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010128; WISNIESKI JJ, 1992, J IMMUNOL, V148, P1396; WISNIESKI JJ, 1995, MEDICINE, V74, P24, DOI 10.1097/00005792-199501000-00003; Wong U, 2016, CASE REP GASTROINTES, V2016, DOI 10.1155/2016/8603679; ZEISS CR, 1980, AM J MED, V68, P867, DOI 10.1016/0002-9343(80)90216-8; Zuberbier HCT, 2014, IMMUNOL ALLERGY CLIN, V34, P141, DOI 10.1016/j.iac.2013.09.007	119	5	5	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1137	1149		10.1016/j.jaci.2022.02.007	http://dx.doi.org/10.1016/j.jaci.2022.02.007			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	3T5RO	35396080				2022-12-18	WOS:000840331500002
J	Pinkerton, JW; Kim, RY; Brown, AC; Rae, BE; Donovan, C; Mayall, JR; Carroll, OR; Ali, MK; Scott, HA; Berthon, BS; Baines, KJ; Starkey, MR; Kermani, NZ; Guo, YK; Robertson, AAB; O'Neill, LAJ; Adcock, IM; Cooper, MA; Gibson, PG; Wood, LG; Hansbro, PM; Horvat, JC				Pinkerton, James W.; Kim, Richard Y.; Brown, Alexandra C.; Rae, Brittany E.; Donovan, Chantal; Mayall, Jemma R.; Carroll, Olivia R.; Ali, Md. Khadem; Scott, Hayley A.; Berthon, Bronwyn S.; Baines, Katherine J.; Starkey, Malcolm R.; Kermani, Nazanin Z.; Guo, Yi-Ke; Robertson, Avril A. B.; O'Neill, Luke A. J.; Adcock, Ian M.; Cooper, Matthew A.; Gibson, Peter G.; Wood, Lisa G.; Hansbro, Philip M.; Horvat, Jay C.			Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; obesity; IL-5; IL-13; NLRP3 inflammasomes	ALLERGIC AIRWAY DISEASE; INNATE LYMPHOID-CELLS; BODY-MASS INDEX; NLRP3 INFLAMMASOME; EOSINOPHILIC INFLAMMATION; SYSTEMIC INFLAMMATION; BARIATRIC SURGERY; SPUTUM; INDIVIDUALS; OVERWEIGHT	Background: Obesity is a risk factor for asthma, and obese asthmatic individuals are more likely to have severe, steroid-insensitive disease. How obesity affects the pathogenesis and severity of asthma is poorly understood. Roles for increased inflammasome-mediated neutrophilic responses, type 2 immunity, and eosinophilic inflammation have been described. Objective: We investigated how obesity affects the pathogenesis and severity of asthma and identified effective therapies for obesity-associated disease. Methods: We assessed associations between body mass index and inflammasome responses with type 2 (T2) immune responses in the sputum of 25 subjects with asthma. Functional roles for NLR family, pyrin domain-containing (NLRP) 3 inflammasome and T2 cytokine responses in driving key features of disease were examined in experimental high-fat diet- induced obesity and asthma. Results: Body mass index and inflammasome responses positively correlated with increased IL-5 and IL-13 expression as well as C-C chemokine receptor type 3 expression in the sputum of subjects with asthma. High-fat diet-induced obesity resulted in steroid-insensitive airway hyperresponsiveness in both the presence and absence of experimental asthma. High-fat diet- induced obesity was also associated with increased NLRP3 inflammasome responses and eosinophilic inflammation in airway tissue, but not lumen, in experimental asthma. Inhibition of NLRP3 inflammasome responses reduced steroid-insensitive airway hyperresponsiveness but had no effect on IL-5 or IL-13 responses in experimental asthma. Depletion of IL-5 and IL-13 reduced obesity-induced NLRP3 inflammasome responses and steroid-insensitive airway hyperresponsiveness in experimental asthma. Conclusion: We found a relationship between T2 cytokine and NLRP3 inflammasome responses in obesity-associated asthma, highlighting the potential utility of T2 cytokine-targeted biologics and inflammasome inhibitors. (J Allergy Clin Immunol 2022;149:1270-80.)	[Pinkerton, James W.; Kim, Richard Y.; Brown, Alexandra C.; Rae, Brittany E.; Donovan, Chantal; Mayall, Jemma R.; Carroll, Olivia R.; Ali, Md. Khadem; Scott, Hayley A.; Berthon, Bronwyn S.; Baines, Katherine J.; Starkey, Malcolm R.; Gibson, Peter G.; Wood, Lisa G.; Hansbro, Philip M.; Horvat, Jay C.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, Australia; [Pinkerton, James W.; Adcock, Ian M.] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Kim, Richard Y.; Donovan, Chantal; Hansbro, Philip M.] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, Australia; [Ali, Md. Khadem] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA USA; [Starkey, Malcolm R.] Hunter Med Res Inst, Prior Res Ctr GrowUpWell, Newcastle, Australia; [Kermani, Nazanin Z.; Guo, Yi-Ke] Imperial Coll London, Data Sci Inst, Dept Comp, London, England; [Robertson, Avril A. B.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Australia; [O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Australia; [Horvat, Jay C.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Pinkerton, James W.; Kim, Richard Y.; Brown, Alexandra C.; Rae, Brittany E.; Donovan, Chantal; Mayall, Jemma R.; Carroll, Olivia R.; Ali, Md. Khadem; Scott, Hayley A.; Berthon, Bronwyn S.; Baines, Katherine J.; Starkey, Malcolm R.; Gibson, Peter G.; Wood, Lisa G.; Hansbro, Philip M.; Horvat, Jay C.] Univ Newcastle, Newcastle, Australia; [Kim, Richard Y.; Donovan, Chantal; Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Dept Immunol & Pathol, Sydney, Australia	Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Technology Sydney; Stanford University; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Queensland; Trinity College Dublin; University of Queensland; University of Newcastle; University of Newcastle; University of Sydney; Centenary Institute; University of Technology Sydney	Horvat, JC (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Jay.horvat@newcastle.edu.au	郭, 伊可/GYD-3212-2022; kermani, nazanin/HGA-6347-2022; Hansbro, Phil/G-7486-2013; Ali, Khadem/R-2746-2018	Hansbro, Phil/0000-0002-4741-3035; Ali, Khadem/0000-0003-1305-0413; Horvat, Jay/0000-0002-8526-0631; Starkey, Malcolm/0000-0002-7359-7464; Mayall, Jemma/0000-0002-0915-5020; Adcock, Ian/0000-0003-2101-8843; Kim, Richard/0000-0002-8709-5270; Zounemat Kermani, Nazanin/0000-0003-2479-3861				Akinbami Lara J, 2016, NCHS Data Brief, P1; Ali MK, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01340-2019; Beckett WS, 2001, AM J RESP CRIT CARE, V164, P2045, DOI 10.1164/ajrccm.164.11.2004235; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Silva FMDE, 2020, CLIN EXP ALLERGY, V50, P244, DOI 10.1111/cea.13533; de Vries A, 2009, CLIN EXP ALLERGY, V39, P731, DOI 10.1111/j.1365-2222.2008.03179.x; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Dixon AE, 2018, EXPERT REV RESP MED, V12, P755, DOI 10.1080/17476348.2018.1506331; Essilfie AT, 2015, THORAX, V70, P458, DOI 10.1136/thoraxjnl-2014-206067; Everaere L, 2016, J ALLERGY CLIN IMMUN, V138, P1309, DOI 10.1016/j.jaci.2016.03.019; Farahi N, 2018, J ALLERGY CLIN IMMUN, V142, P1659, DOI 10.1016/j.jaci.2018.07.011; Ford ES, 2004, EUR RESPIR J, V24, P740, DOI 10.1183/09031936.04.00088003; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Fulkerson PC, 2006, P NATL ACAD SCI USA, V103, P16418, DOI 10.1073/pnas.0607863103; Ge XN, 2013, EXP LUNG RES, V39, P365, DOI 10.3109/01902148.2013.829537; Gibeon D, 2013, CHEST, V143, P406, DOI 10.1378/chest.12-0872; Gibson Peter G, 2013, Ann Am Thorac Soc, V10 Suppl, pS138, DOI 10.1513/AnnalsATS.201302-038AW; Hakala K, 2000, CHEST, V118, P1315, DOI 10.1378/chest.118.5.1315; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kim RY, 2017, J ALLERGY CLIN IMMUN, V139, P519, DOI 10.1016/j.jaci.2016.04.038; Kim RY, 2015, THORAX, V70, P1199, DOI 10.1136/thoraxjnl-2014-206736; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Lefaudeux D, 2016, J ALLERGY CLIN IMMUN; Lefaudeux D, 2017, J ALLERGY CLIN IMMUN, V139, P1797, DOI 10.1016/j.jaci.2016.08.048; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Marijsse GS, 2014, AM J RESP CRIT CARE, V189, P1284, DOI 10.1164/rccm.201311-2011LE; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004; Pinkerton JW, 2017, MOL IMMUNOL, V86, P44, DOI 10.1016/j.molimm.2017.01.014; Reddy RC, 2011, OBES SURG, V21, P200, DOI 10.1007/s11695-010-0155-6; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Scott HA, 2016, ALLERGY, V71, P1037, DOI 10.1111/all.12891; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Shen HH, 2006, ACTA PHARMACOL SIN, V27, P1594, DOI 10.1111/j.1745-7254.2006.00446.x; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; Tashiro H, 2019, ALLERGOL INT, V68, P135, DOI 10.1016/j.alit.2018.10.004; Telenga ED, 2012, ALLERGY, V67, P1060, DOI 10.1111/j.1398-9995.2012.02855.x; van der Wiel E, 2014, AM J RESP CRIT CARE, V189, P1281, DOI 10.1164/rccm.201310-1841LE; van Huisstede A, 2015, THORAX, V70, P659, DOI 10.1136/thoraxjnl-2014-206712; Wood LG, 2019, J ALLERGY CLIN IMMUN, V143, P305, DOI 10.1016/j.jaci.2018.04.037; Wood LG, 2012, AM J CLIN NUTR, V96, P534, DOI 10.3945/ajcn.111.032623; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036; World Health Organization, 2020, PREVALENCE OBESITY A	50	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2022	149	4					1270	1280		10.1016/j.jaci.2021.10.003	http://dx.doi.org/10.1016/j.jaci.2021.10.003			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	0Z8PK	34678326	Green Submitted			2022-12-18	WOS:000791333500006
J	Chang, X; March, M; Mentch, F; Nguyen, K; Glessner, J; Qu, HQ; Liu, YC; Furuta, G; Aceves, S; Gonsalves, N; Nadeau, K; Cianferoni, A; Spergel, J; Sleiman, P; Hakonarson, H				Chang, Xiao; March, Michael; Mentch, Frank; Nguyen, Kenny; Glessner, Joseph; Qu, Huiqi; Liu, Yichuan; Furuta, Glen; Aceves, Seema; Gonsalves, Nirmala; Nadeau, Kari; Cianferoni, Antonella; Spergel, Jonathan; Sleiman, Patrick; Hakonarson, Hakon			A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; genetic variants; genetic correlation; GWAS	RISK VARIANTS; HAY-FEVER; DISEASE; RECOMMENDATIONS; ACTIVATION; RESPONSES; CHILDREN; ASTHMA; GENES	Background: Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder of the esophagus marked by eosinophilic infiltration. Cumulative evidence indicates that the risk of EoE involves the complex interplay of both genetic and environmental factors. Because only a few genetic loci have been identified in EoE, the genetic underpinning of EoE remains largely elusive. Objective: We sought to identify genetic loci associated with EoE. Methods: Four EoE cohorts were genotyped using the Illumina single nucleotide polymorphism array platform, totaling 1,930 cases and 13,634 controls of European ancestry. Genotype imputation was performed with the Michigan Imputation Server using the Trans-Omics for Precision Medicine reference panel including whole-genome sequencing data from more than 100,000 individuals. Meta-analysis was conducted to identify potential novel genetic loci associated with EoE. Results: Our study identified 11 new genome-wide significant loci, of which 6 are common variant loci, including 5q31.1 (rs2106984, P = 4.16 x 10(-8); odds ratio [OR], 1.26, RAD50), 15q22.2 (rs2279293, P = 1.23 x 10(-10); OR, 0.69, RORA), and 15q23 (rs56062135, P = 2.91 x 10(-11); OR, 1.29, SMAD3), which have been previously associated with allergic conditions. Interestingly, a low-frequency synonymous mutation within the MATN2 gene was identified as the most significant single nucleotide polymorphism at the 8q22.1 locus. We also identified 5 sex-specific loci in the EoE cases, including an inflammatory bowel disease-associated locus at 9p24.1 (rs62541556, P = 4.4 x 10(-8); OR, 1.11, JAK2). Conclusions: Our findings demonstrate shared genetic underpinnings between EoE and other immune-mediated diseases and provide novel candidate genes for therapeutic target identification and prioritization.	[Chang, Xiao; March, Michael; Mentch, Frank; Nguyen, Kenny; Glessner, Joseph; Qu, Huiqi; Liu, Yichuan; Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, 3615 Civ Ctr Blvd,Rm 1216E, Philadelphia, PA 19104 USA; [Furuta, Glen] Univ Colorado, Digest Hlth Inst, Sect Pediat Gastroenterol Hepatol & Nutr, Childrens Hosp Colorado,Sch Med, Aurora, CO USA; [Furuta, Glen] Univ Colorado, Dept Pediat, Mucosal Inflammat Program, Gastrointestinal Eosinophil Dis Program,Sch Med, Aurora, CO USA; [Aceves, Seema] Univ Calif San Diego, Dept Pediat & Med, Div Allergy Immunol, San Diego, CA USA; [Aceves, Seema] Rady Childrens Hosp, San Diego, CA USA; [Gonsalves, Nirmala] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL USA; [Nadeau, Kari] Stanford Univ, Sch Med, Lucile Packard Childrens Hosp, Stanford Hosp & Clin,Div Allergy Immunol & Rheuma, Palo Alto, CA 94304 USA; [Cianferoni, Antonella; Spergel, Jonathan; Sleiman, Patrick; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cianferoni, Antonella; Spergel, Jonathan] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Northwestern University; Feinberg School of Medicine; Lucile Packard Children's Hospital (LPCH); Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iceland	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, 3615 Civ Ctr Blvd,Rm 1216E, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Qu, Hui-Qi/B-4719-2009	Qu, Hui-Qi/0000-0001-9317-4488; LIU, YICHUAN/0000-0003-2023-072X	Institutional Development Funds from The Children's Hospital of Philadelphia (CHOP); CHOP's Endowed Chair in Genomic Research; National Human Genome Research Institute (NHGRI) [U01-HG006830]	Institutional Development Funds from The Children's Hospital of Philadelphia (CHOP); CHOP's Endowed Chair in Genomic Research; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by Institutional Development Funds from The Children's Hospital of Philadelphia (CHOP) , by CHOP's Endowed Chair in Genomic Research (to H.H.) , and by National Human Genome Research Institute (NHGRI) -sponsored Electronic Medical Records and Genomics Network (grant no. U01-HG006830 to H.H.) .	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Alexander ES, 2014, J ALLERGY CLIN IMMUN, V134, P1084, DOI 10.1016/j.jaci.2014.07.021; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chi YF, 2015, INFLAMM RES, V64, P833, DOI 10.1007/s00011-015-0867-0; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P589, DOI 10.1016/j.cgh.2013.09.008; Eluri S, 2015, CURR OPIN GASTROEN, V31, P309, DOI 10.1097/MOG.0000000000000185; Fadista J, 2016, EUR J HUM GENET, V24, P1202, DOI 10.1038/ejhg.2015.269; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Ferreira MAR, 2019, AM J HUM GENET, V104, P665, DOI 10.1016/j.ajhg.2019.02.022; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Fischer TA, 2001, J BIOL CHEM, V276, P5967, DOI 10.1074/jbc.M009781200; Franko A, 2018, METABOLISM, V88, P22, DOI 10.1016/j.metabol.2018.09.001; Gerner MC, 2020, FASEB J, V34, P8367, DOI 10.1096/fj.201902664; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Iotchkova V, 2019, NAT GENET, V51, P343, DOI 10.1038/s41588-018-0322-6; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V142, P32, DOI 10.1016/j.jaci.2018.04.015; Jensen ET, 2018, J ALLERGY CLIN IMMUN, V141, P632, DOI 10.1016/j.jaci.2017.07.010; Jonas A, 2014, J CLIN INVEST, V124, P5042, DOI 10.1172/JCI71385; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Kottyan LC, 2021, J ALLERGY CLIN IMMUN, V147, P255, DOI 10.1016/j.jaci.2020.10.018; Kottyan LC, 2020, J ALLERGY CLIN IMMUN, V145, P9, DOI 10.1016/j.jaci.2019.11.013; Kottyan LC, 2019, GENES IMMUN, V20, P281, DOI 10.1038/s41435-018-0034-z; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kowalski MH, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008500; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Limketkai BN, 2019, GUT, V68, P2152, DOI 10.1136/gutjnl-2018-318074; Lo BC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8864; Lucendo AJ, 2017, UNITED EUR GASTROENT, V5, P335, DOI 10.1177/2050640616689525; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Martinez-Riano A, 2018, EMBO REP, V19, DOI 10.15252/embr.201846016; Martino D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05608-4; Mehta A, 2015, J EXP MED, V212, P1679, DOI 10.1084/jem.20150489; Panda SK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00861; Peterson K, 2016, AM J GASTROENTEROL, V111, P926, DOI 10.1038/ajg.2016.185; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajput C, 2017, AM J PHYSIOL-LUNG C, V312, pL983, DOI 10.1152/ajplung.00368.2016; Rauscher R, 2018, BIOCHEM SOC T, V46, P937, DOI 10.1042/BST20170422; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Salas A, 2020, NAT REV GASTRO HEPAT, V17, P323, DOI 10.1038/s41575-020-0273-0; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Sleiman PMA, 2015, BEST PRACT RES CL GA, V29, P701, DOI 10.1016/j.bpg.2015.09.003; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Spergel JM, 2009, J PEDIATR GASTR NUTR, V48, P30, DOI 10.1097/MPG.0b013e3181788282; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; Wang L, 2019, HUM CELL, V32, P411, DOI 10.1007/s13577-019-00266-0; Wang L, 2019, INT ARCH ALLERGY IMM, V178, P119, DOI 10.1159/000493803; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Xu H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17097-5; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	60	5	5	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					988	998		10.1016/j.jaci.2021.08.018	http://dx.doi.org/10.1016/j.jaci.2021.08.018			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34506852				2022-12-18	WOS:000765938100028
J	Mateja, A; Wang, QL; Chovanec, J; Kim, J; Wilson, KJ; Schwartz, LB; Glover, SC; Carter, MC; Metcalfe, DD; Brittain, E; Lyons, JJ				Mateja, Allyson; Wang, Qinlu; Chovanec, Jack; Kim, Jiwon; Wilson, Kenneth J.; Schwartz, Lawrence B.; Glover, Sarah C.; Carter, Melody C.; Metcalfe, Dean D.; Brittain, Erica; Lyons, Jonathan J.			Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Anaphylaxis; mast cell activation; tryptase; hereditary alpha-tryptasemia	MAST-CELL ACTIVATION; HEREDITARY ALPHA-TRYPTASEMIA	Background: Acute increases of >= 20% + 2 ng/mL (20 + 2 rule) over basal serum tryptase (BST) is the recommended threshold supporting a clinical diagnosis of anaphylaxis. Prospective studies have demonstrated high sensitivity for this algorithm after parenteral exposure, but specificity has not been evaluated. Objective: We sought to define a serum tryptase change that distinguishes baseline variability from anaphylaxis on the basis of intraindividual variation in BST. Methods: Ninety-three total subjects with atopy (n = 62) or hereditary alpha-tryptasemia (H alpha T) (n = 31) and >= 2 BST measurements were identified. Sequential BST variability measurements were modeled and threshold ratios that optimized sensitivity and/or specificity determined. Models were tested in 22 individuals with physician-diagnosed anaphylaxis and validated in independent cohorts of individuals with H alpha T (n = 33), indolent systemic mastocytosis (ISM) (n = 52), and ISM + H alpha T (n = 12). Mature tryptase levels were measured in H alpha T (n = 19) and ISM (n = 20). An online application was developed for clinical use. Results: As a result of BST variability, 9.7% (9/93) of primary cohort patients, and 18% (6/33) of H alpha T, 30% (16/53) of ISM, and 25% (3/12) of ISM 1 H alpha T patients from validation cohorts met the 20 + 2 rule despite absent immediate hypersensitivity symptoms; mature tryptase was noncontributory among individuals with H alpha T or ISM at baseline. A ratio of acute tryptase/BST exceeding 1.685 provided the optimized diagnostic rule for jointly maximizing sensitivity and specificity. Statistically significant improvement in specificity relative to the 20 + 2 rule was observed among individuals with elevated BST caused by H alpha T and ISM. Conclusions: Using an acute tryptase/BST ratio of 1.685 improves specificity of measured changes among individuals with H alpha T and ISM while maintaining high sensitivity for confirmation of anaphylaxis.	[Mateja, Allyson] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Bethesda, MD USA; [Wang, Qinlu] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chovanec, Jack; Kim, Jiwon; Carter, Melody C.; Metcalfe, Dean D.; Lyons, Jonathan J.] NIH, Lab Allerg Dis, Bldg 10, Bethesda, MD 20892 USA; [Wilson, Kenneth J.; Glover, Sarah C.] Univ Mississippi, Med Ctr, Dept Med, Div Digest Dis, Jackson, MS 39216 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA USA; [Glover, Sarah C.] Univ Florida, Dept Med, Div Gastroenterol, Gainesville, FL USA; [Brittain, Erica] NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; University of Mississippi; University of Mississippi Medical Center; Virginia Commonwealth University; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lyons, JJ (corresponding author), NIAID, NIH, LAD, 9000 Rockville Pike,Bldg 29B,Room 5NN18,MSC 1889, Bethesda, MD 20892 USA.	jonathan.lyons@nih.gov		Glover, Sarah/0000-0002-9899-0473	Division of Intramural Research of the NIAID, NIH; National Cancer Institute, National Institutes of Health [75N910D00024, 75N91019F00130]; US Public Health Service grant NIH [R21DE028378]	Division of Intramural Research of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service grant NIH	This project was funded in whole or in part with federal funds from the Division of Intramural Research of the NIAID, NIH, and the National Cancer Institute, National Institutes of Health, under contract 75N910D00024, task order 75N91019F00130. S.C.G. is supported by US Public Health Service grant NIH R21DE028378. The con-tent of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services; nor does mention of trade names, commer-cial products, or organizations imply endorsement by the US government.	Baretto RL, 2017, ALLERGY, V72, P2031, DOI 10.1111/all.13226; Carter MC, 2018, J ALLERGY CLIN IMMUN, V141, P180, DOI 10.1016/j.jaci.2017.05.036; Dua S, 2018, J ALLER CL IMM-PRACT, V6, P1692, DOI 10.1016/j.jaip.2018.01.006; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Giannetti MP, 2021, ANN ALLERG ASTHMA IM, V126, P655, DOI 10.1016/j.anai.2021.01.016; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Hox V, 2015, J ALLERGY CLIN IMMUN, V135, P729, DOI 10.1016/j.jaci.2014.11.003; Lyons JJ, 2020, MASTOCYTOSIS COMPREH, P35; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Lyons JJ, 2018, IMMUNOL ALLERGY CLIN, V38, P483, DOI 10.1016/j.iac.2018.04.003; Lyons JJ, 2016, NAT GENET, V48, P1564, DOI 10.1038/ng.3696; Sabato V, 2018, J CLIN IMMUNOL, V38, P457, DOI 10.1007/s10875-018-0506-y; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; Schwartz LB, 2003, J IMMUNOL, V170, P5667, DOI 10.4049/jimmunol.170.11.5667; Shimabukuro TT, 2021, JAMA-J AM MED ASSOC, V325, P1101, DOI 10.1001/jama.2021.1967; Sivagnanam S, 2003, CRIT CARE, V7, P119, DOI 10.1186/cc1871; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Valent P, 2019, INT ARCH ALLERGY IMM, V180, P44, DOI 10.1159/000501079; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Vitte J, 2019, ALLERGY, V74, P1157, DOI 10.1111/all.13752; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wongkaewpothong P, 2014, ALLERGY ASTHMA IMMUN, V6, P304, DOI 10.4168/aair.2014.6.4.304	23	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					1010	+		10.1016/j.jaci.2021.08.007	http://dx.doi.org/10.1016/j.jaci.2021.08.007			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34425177				2022-12-18	WOS:000765938100030
J	Pivniouk, V; Pivniouk, O; DeVries, A; Uhrlaub, JL; Michael, A; Pivniouk, D; VanLinden, SR; Conway, MY; Hahn, S; Malone, SP; Ezeh, P; Churko, JM; Anderson, D; Kraft, M; Nikolich-Zugich, J; Vercelli, D				Pivniouk, Vadim; Pivniouk, Oksana; DeVries, Avery; Uhrlaub, Jennifer L.; Michael, Ashley; Pivniouk, Denis; VanLinden, Sydney R.; Conway, Michelle Y.; Hahn, Seongmin; Malone, Sean P.; Ezeh, Peace; Churko, Jared M.; Anderson, Dayna; Kraft, Monica; Nikolich-Zugich, Janko; Vercelli, Donata			The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						COVID-19; SARS-CoV-2; bacterial lysate; OM-85; epithelial cells; ACE2; TMPRSS2	RESPIRATORY-TRACT; RNA; CHILDREN; VECTORS; TMPRSS2; ACE2	Background: Treatments for coronavirus disease 2019, which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are urgently needed but remain limited. SARS-CoV-2 infects cells through interactions of its spike (S) protein with angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) on host cells. Multiple cells and organs are targeted, particularly airway epithelial cells. OM-85, a standardized lysate of human airway bacteria with strong immunomodulating properties and an impeccable safety profile, is widely used to prevent recurrent respiratory infections. We found that airway OM-85 administration inhibits Ace2 and Tmprss2 transcription in the mouse lung, suggesting that OM-85 might hinder SARS-CoV-2/host cell interactions. Objectives: We sought to investigate whether and how OM-85 treatment protects nonhuman primate and human epithelial cells against SARS-CoV-2. Methods: ACE2 and TMPRSS2 mRNA and protein expression, cell binding of SARS-CoV-2 S1 protein, cell entry of SARS-CoV-2 S protein-pseudotyped lentiviral particles, and SARS-CoV-2 cell infection were measured in kidney, lung, and intestinal epithelial cell lines, primary human bronchial epithelial cells, and ACE2-transfected HEK293T cells treated with OM-85 in vitro. Results: OM-85 significantly downregulated ACE2 and TMPRSS2 transcription and surface ACE2 protein expression in epithelial cell lines and primary bronchial epithelial cells. OM-85 also strongly inhibited SARS-CoV-2 S1 protein binding to, SARS-CoV-2 S protein-pseudotyped lentivirus entry into, and SARS-CoV-2 infection of epithelial cells. These effects of OM-85 appeared to depend on SARS-CoV-2 receptor downregulation. Conclusions: OM-85 inhibits SARS-CoV-2 epithelial cell infection in vitro by downregulating SARS-CoV-2 receptor expression. Further studies are warranted to assess whether OM-85 may prevent and/or reduce the severity of coronavirus disease 2019.	[Pivniouk, Vadim; Churko, Jared M.; Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Pivniouk, Vadim; Pivniouk, Oksana; DeVries, Avery; Michael, Ashley; VanLinden, Sydney R.; Hahn, Seongmin; Malone, Sean P.; Ezeh, Peace; Anderson, Dayna; Vercelli, Donata] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA; [Pivniouk, Vadim; DeVries, Avery; Churko, Jared M.; Kraft, Monica; Nikolich-Zugich, Janko; Vercelli, Donata] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Uhrlaub, Jennifer L.; Nikolich-Zugich, Janko] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Conway, Michelle Y.; Kraft, Monica] Univ Arizona, Dept Med, Tucson, AZ 85721 USA; [Vercelli, Donata] Univ Arizona, Arizona Ctr Biol Complex Dis, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Vercelli, D (corresponding author), Univ Arizona, 1657 E Helen St, Tucson, AZ 85721 USA.	donata@arizona.edu			OM Pharma SA; NIH [T32 ES007091]; BIO5 Institute;  [T32 HL007249];  [P01AI148104];  [R21AI144722];  [R25HL126140]	OM Pharma SA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIO5 Institute; ; ; ; 	This work was funded in part by a research grant provided by OM Pharma SA to the University of Arizona. Support was also provided by postdoctoral NIH fellowships from T32 ES007091 and the BIO5 Institute (to A.D.V.), a predoctoral T32 HL007249 fellowship (to S.R.V.L.), and P01AI148104, R21AI144722, and R25HL126140 (to D.V.).	Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cao CQ, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13981; Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065; Cohen MS, 2021, NEW ENGL J MED, V384, P289, DOI 10.1056/NEJMe2034495; COVID-19 Vaccine Resource Center, NEW ENGL J MED; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Dittmar M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108959; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Drayman N, 2021, SCIENCE, V373, P931, DOI 10.1126/science.abg5827; Esposito S, 2018, CURR OPIN ALLERGY CL, V18, P198, DOI 10.1097/ACI.0000000000000433; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Guimaraes PO, 2021, NEW ENGL J MED, V385, P406, DOI 10.1056/NEJMoa2101643; Gutierrez-Tarango MD, 2001, CHEST, V119, P1742, DOI 10.1378/chest.119.6.1742; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Johansen MD, 2020, MUCOSAL IMMUNOL, V13, P877, DOI 10.1038/s41385-020-00340-z; Kimura H, 2020, J ALLERGY CLIN IMMUN, V146, P80, DOI 10.1016/j.jaci.2020.05.004; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Kyriakidis NC, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00292-w; Larenas-Linnemann D, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100476; Li J, 2021, J ENZYM INHIB MED CH, V36, P903, DOI 10.1080/14756366.2021.1906663; Liu Y, 2021, CELL, V184, P18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Q, 2021, IMMUNITY, V54, P1304, DOI 10.1016/j.immuni.2021.05.006; Mahoney M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2108728118; Neises JZ, 2021, J MED VIROL, V93, P6611, DOI 10.1002/jmv.27224; Pardo Joe, 2020, Drugs Context, V9, DOI 10.7573/dic.2020-4-14; Pasquali C, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00041; Pivniouk V, 2022, J ALLERGY CLIN IMMUN, V149, P943, DOI 10.1016/j.jaci.2021.09.013; Pontali E, 2021, J ALLERGY CLIN IMMUN, V147, P1217, DOI 10.1016/j.jaci.2021.01.024; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Riva L, 2020, NATURE, V586, P113, DOI 10.1038/s41586-020-2577-1; Roth M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188010; Rubin EJ, 2021, NEW ENGL J MED, V384, P1564, DOI 10.1056/NEJMe2103108; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schaad UB, 2002, CHEST, V122, P2042, DOI 10.1378/chest.122.6.2042; Suarez N, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00545; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang C, 2021, ACS NANO, V15, P6340, DOI 10.1021/acsnano.0c06836; White SM, 1999, J VIROL, V73, P2832, DOI 10.1128/JVI.73.4.2832-2840.1999; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu CA, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13060953; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	56	5	6	3	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2022	149	3					923	+		10.1016/j.jaci.2021.11.019	http://dx.doi.org/10.1016/j.jaci.2021.11.019			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZO7WJ	34902435	Green Published			2022-12-18	WOS:000765938100022
J	Georas, SN; Wright, RJ; Ivanova, A; Israel, E; LaVange, LM; Akuthota, P; Carr, TF; Denlinger, LC; Fajt, ML; Kumar, R; O'Neal, WK; Phipatanakul, W; Szefler, SJ; Aronica, MA; Bacharier, LB; Burbank, AJ; Castro, M; Alexander, LC; Bamdad, J; Cardet, JC; Comhair, SAA; Covar, RA; DiMango, EA; Erwin, K; Erzurum, SC; Fahy, JV; Gaffin, JM; Gaston, B; Gerald, LB; Hoffman, EA; Holguin, F; Jackson, DJ; James, J; Jarjour, NN; Kenyon, NJ; Khatri, S; Kirwan, JP; Kraft, M; Krishnan, JA; Liu, AH; Liu, MC; Marquis, MA; Martinez, F; Mey, J; Moore, WC; Moy, JN; Ortega, VE; Peden, DB; Pennington, E; Peters, MC; Ross, K; Sanchez, M; Smith, LJ; Sorkness, RL; Wechsler, ME; Wenzel, SE; White, SR; Zein, J; Zeki, AA; Noel, P				Georas, Steve N.; Wright, Rosalind J.; Ivanova, Anastasia; Israel, Elliot; LaVange, Lisa M.; Akuthota, Praveen; Carr, Tara F.; Denlinger, Loren C.; Fajt, Merritt L.; Kumar, Rajesh; O'Neal, Wanda K.; Phipatanakul, Wanda; Szefler, Stanley J.; Aronica, Mark A.; Bacharier, Leonard B.; Burbank, Allison J.; Castro, Mario; Alexander, Laura Crotty; Bamdad, Julie; Cardet, Juan Carlos; Comhair, Suzy A. A.; Covar, Ronina A.; DiMango, Emily A.; Erwin, Kim; Erzurum, Serpil C.; Fahy, John, V; Gaffin, Jonathan M.; Gaston, Benjamin; Gerald, Lynn B.; Hoffman, Eric A.; Holguin, Fernando; Jackson, Daniel J.; James, John; Jarjour, Nizar N.; Kenyon, Nicholas J.; Khatri, Sumita; Kirwan, John P.; Kraft, Monica; Krishnan, Jerry A.; Liu, Andrew H.; Liu, Mark C.; Marquis, M. Alison; Martinez, Fernando; Mey, Jacob; Moore, Wendy C.; Moy, James N.; Ortega, Victor E.; Peden, David B.; Pennington, Emily; Peters, Michael C.; Ross, Kristie; Sanchez, Maria; Smith, Lewis J.; Sorkness, Ronald L.; Wechsler, Michael E.; Wenzel, Sally E.; White, Steven R.; Zein, Joe; Zeki, Amir A.; Noel, Patricia		PrecISE Study Team	The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe asthma; precision medicine; adaptive clinical trial design; asthma exacerbation; type 2 asthma; non-type 2 asthma; patient advisory committee; biomarker	S-NITROSOGLUTATHIONE REDUCTASE; AIRWAY SMOOTH-MUSCLE; STEM-CELL FACTOR; TRANSCRIPTION FACTOR 6; REGULATORY T-CELLS; C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; INDUCED SPUTUM; NITRIC-OXIDE; MAST-CELLS	Asthma is a heterogeneous disease, with multiple underlying inflammatory pathways and structural airway abnormalities that impact disease persistence and severity. Recent progress has been made in developing targeted asthma therapeutics, especially for subjects with eosinophilic asthma. However, there is an unmet need for new approaches to treat patients with severe and exacerbation-prone asthma, who contribute disproportionately to disease burden. Extensive deep phenotyping has revealed the heterogeneous nature of severe asthma and identified distinct disease subtypes. A current challenge in the field is to translate new and emerging knowledge about different pathobiologic mechanisms in asthma into patient-specific therapies, with the ultimate goal of modifying the natural history of disease. Here, we describe the Precision Interventions for Severe and/or Exacerbation-Prone Asthma (PrecISE) Network, a groundbreaking collaborative effort of asthma researchers and biostatisticians from around the United States. The PrecISE Network was designed to conduct phase II/proof-of-concept clinical trials of precision interventions in the population with severe asthma, and is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health. Using an innovative adaptive platform trial design, the PrecISE Network will evaluate up to 6 interventions simultaneously in biomarker-defined subgroups of subjects. We review the development and organizational structure of the PrecISE Network, and choice of interventions being studied. We hope that the PrecISE Network will enhance our understanding of asthma subtypes and accelerate the development of therapeutics for severe asthma.	[Georas, Steve N.] Univ Rochester, Dept Med, Div Pulm & Crit Care Med, Med Ctr, Rochester, NY 14620 USA; [Wright, Rosalind J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ivanova, Anastasia; LaVange, Lisa M.; James, John; Marquis, M. Alison; Sanchez, Maria] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Div Allergy & Immunol, Boston, MA 02115 USA; [Akuthota, Praveen; Alexander, Laura Crotty] Univ Calif San Diego, Dept Med, Pulm Div, La Jolla, CA 92093 USA; [Carr, Tara F.; Gerald, Lynn B.; Kraft, Monica; Martinez, Fernando] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Denlinger, Loren C.; Jackson, Daniel J.; Jarjour, Nizar N.; Sorkness, Ronald L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA; [Fajt, Merritt L.; Wenzel, Sally E.] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Kumar, Rajesh] Lurie Childrens Hosp, Chicago, IL USA; [O'Neal, Wanda K.; Burbank, Allison J.; Peden, David B.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Phipatanakul, Wanda; Gaffin, Jonathan M.] Boston Childrens Hosp, Boston, MA USA; [Phipatanakul, Wanda; Gaffin, Jonathan M.] Harvard Med Sch, Boston, MA 02115 USA; [Szefler, Stanley J.; Liu, Andrew H.; Wechsler, Michael E.] Childrens Hosp Colorado, Aurora, CO USA; [Szefler, Stanley J.; Holguin, Fernando; Liu, Andrew H.; Wechsler, Michael E.] Univ Colorado, Sch Med, Aurora, CO USA; [Aronica, Mark A.; Comhair, Suzy A. A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Bacharier, Leonard B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Castro, Mario] Univ Kansas, Sch Med, Kansas City, KS USA; [Bamdad, Julie; Noel, Patricia] NHLBI, Div Lung Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [Cardet, Juan Carlos] Univ S Florida, Allergy & Immunol, Tampa, FL 33620 USA; [Covar, Ronina A.] Natl Jewish Hlth, Denver, CO USA; [DiMango, Emily A.] Columbia Univ, Med Ctr, New York, NY USA; [Erwin, Kim] Univ Illinois, Inst Healthcare Delivery Design, Chicago, IL USA; [Fahy, John, V; Peters, Michael C.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Gaston, Benjamin] Indiana Univ, Wells Ctr Pediat Res, Indianapolis, IN 46204 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Kenyon, Nicholas J.; Zeki, Amir A.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA; [Khatri, Sumita; Zein, Joe] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Kirwan, John P.; Mey, Jacob] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Krishnan, Jerry A.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Liu, Mark C.] Johns Hopkins Univ, Dept Med, Pulm & Crit Care Med, Baltimore, MD USA; [Moore, Wendy C.; Ortega, Victor E.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Moy, James N.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Pennington, Emily; Ross, Kristie] Cleveland Clin, Cleveland, OH 44106 USA; [Smith, Lewis J.] Northwestern Univ, Chicago, IL 60611 USA; [White, Steven R.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Ross, Kristie] UH Rainbow Babies & Childrens Hosp, Cleveland, OH USA	University of Rochester; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Diego; University of Arizona; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ann & Robert H. Lurie Children's Hospital of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cleveland Clinic Foundation; Vanderbilt University; University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; University of South Florida; National Jewish Health; Columbia University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa; University of California System; University of California Davis; Cleveland Clinic Foundation; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center; Rush University; Cleveland Clinic Foundation; Northwestern University; University of Chicago; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Georas, SN (corresponding author), Univ Rochester, Med Ctr, KMRB 2-9617,601 Elmwood Ave, Rochester, NY 14620 USA.	Steve_Georas@urmc.rochester.edu	Nouraie, Seyed Mehdi/O-4071-2018; Fain, Sean/K-4260-2016	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Hoffman, Eric/0000-0001-8456-9437; Mey, Jacob/0000-0001-6826-7762; Francisco, Dave/0000-0003-1206-7424; GAFFIN, JONATHAN/0000-0003-2213-4504; Fain, Sean/0000-0001-5461-0646	National Heart, Lung, and Blood Institute, National Institutes of Health [U24 HL138998, 1UG1HL139054, 1UG1HL139098, 1UG1HL139106, 1UG1HL139117, 1UG1HL139118, 1UG1HL139119, 1UG1HL139123, 1UG1HL139124, 1UG1HL139125, 1UG1HL139126]; National Institutes of Health Clinical & Translational Science Award grants [UL1TR002451, UL1TR000427, UL1TR002366, UL1TR002389, UL1TR002489, UL1TR001857, UL1TR001442, UL1TR001872]; Duke/Vanderbilt Trial Innovation Center [5U24TR001608]; Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research; William W. and Judith H. Busse Professor of Allergy & Asthma Research; Walter and Carmina Parkes Family Endowed Professorship	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Clinical & Translational Science Award grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke/Vanderbilt Trial Innovation Center; Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research; William W. and Judith H. Busse Professor of Allergy & Asthma Research; Walter and Carmina Parkes Family Endowed Professorship	The PrecISE study is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (grant nos. U24 HL138998, 1UG1HL139054, 1UG1HL139098, 1UG1HL139106, 1UG1HL139117, 1UG1HL139118, 1UG1HL139119, 1UG1HL139123, 1UG1HL139124, 1UG1HL139125, and 1UG1HL139126). Support for site institutional infrastructure came from National Institutes of Health Clinical & Translational Science Award grants (grant no. UL1TR002451 [Harvard], grant no. UL1TR000427 [University of Wisconsin], grant no. UL1TR002366 [University of Kansas], grant no. UL1TR002389 [University of Chicago], grant no. UL1TR002489 [University of North Carolina], grant no. UL1TR001857 [University of Pittsburgh], grant no. UL1TR001442 [University of California, San Diego], and grant no. UL1TR001872 [University of California, San Francisco]). The single institutional review board is supported by the Duke/Vanderbilt Trial Innovation Center (grant no. 5U24TR001608). The following endowed chair positions contributed additional support: Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research (E.I.), William W. and Judith H. Busse Professor of Allergy & Asthma Research (L.C.D.), and Walter and Carmina Parkes Family Endowed Professorship (S.N.G.). The study also gratefully acknowledges receiving contributed product from Vitaeris, owned and operated by the CSL group (clazakizumab), Vitaflo (MCT), Sun Pharma (imatinib), OM Pharma, a Vifor Pharma Group Company (OM-85, Broncho-Vaxom), Incyte (itacitinib), Laurel Venture (Cavosonstat), and GlaxoSmithKline (Advair Diskus and Ventolin).	Abe S, 2020, J NUTR, V150, P2383, DOI 10.1093/jn/nxaa186; Aguilar-Pimentel A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178563; Al-Muhsen SZ, 2004, CLIN EXP ALLERGY, V34, P911, DOI 10.1111/j.1365-2222.2004.01975.x; Aletaha D, 2017, LANCET, V389, P1206, DOI 10.1016/S0140-6736(17)30401-4; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; [Anonymous], 2018, GLEEVEC PRODUCT MONO; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Asosingh K, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.127801; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Barnes PJ, 2016, PHARMACOL REV, V68, P788, DOI 10.1124/pr.116.012518; Barnes PJ, 1995, RES IMMUNOL, V146, P698, DOI 10.1016/0923-2494(96)84921-2; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bissonnette R, 2016, J DERMATOL TREAT, V27, P332, DOI 10.3109/09546634.2015.1115819; Blonder JP, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-3; Braithwaite IE, 2021, J ALLERGY CLIN IMMUN, V148, P783, DOI 10.1016/j.jaci.2021.02.042; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Brightling CE, 2003, THORAX, V58, P528, DOI 10.1136/thorax.58.6.528; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brown JK, 2002, AM J PHYSIOL-LUNG C, V282, pL197, DOI 10.1152/ajplung.2002.282.2.L197; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Cardet JC, 2016, EUR RESPIR J, V48, P403, DOI 10.1183/13993003.00246-2016; Cardinale F, 2020, EXPERT REV RESP MED, V14, P1019, DOI 10.1080/17476348.2020.1793673; Cerny-Reiterer S, 2015, ONCOTARGET, V6, P3071, DOI 10.18632/oncotarget.3074; Choi S, 2013, J APPL PHYSIOL, V115, P730, DOI 10.1152/japplphysiol.00113.2013; Choudhry S, 2010, PHARMACOGENET GENOM, V20, P351, DOI 10.1097/FPC.0b013e328337f992; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; CLAMAN DM, 1994, J ALLERGY CLIN IMMUN, V94, P861, DOI 10.1016/0091-6749(94)90154-6; Cohen SB, 2017, ANN RHEUM DIS, V76, P1253, DOI 10.1136/annrheumdis-2016-210457; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI 10.1089/ARS.2008.2425; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Da Silva CA, 2006, FUND CLIN PHARMACOL, V20, P21, DOI 10.1111/j.1472-8206.2005.00390.x; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Donaldson SH, 2017, J CYST FIBROS, V16, P371, DOI 10.1016/j.jcf.2017.01.009; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Dweik RA, 1998, J CLIN INVEST, V101, P660, DOI 10.1172/JCI1378; ELLIOTT HW, 1971, CLIN PHARMACOL THER, V12, P468; Emeryk A, 2018, PEDIAT ALLERG IMM-UK, V29, P394, DOI 10.1111/pai.12894; Esty B, 2019, J ALLER CL IMM-PRACT, V7, P1639, DOI 10.1016/j.jaip.2019.02.043; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; FAHY JV, 1994, J ALLERGY CLIN IMMUN, V93, P1031, DOI 10.1016/S0091-6749(94)70052-4; FAHY JV, 1993, AM REV RESPIR DIS, V147, P1126, DOI 10.1164/ajrccm/147.5.1126; Fajt Merritt L, 2013, Ann Am Thorac Soc, V10 Suppl, pS158, DOI 10.1513/AnnalsATS.201303-064AW; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; Farha S, 2014, PULM CIRC, V4, P452, DOI 10.1086/677359; Fleming TR, 2020, JAMA-J AM MED ASSOC, V324, P33, DOI 10.1001/jama.2020.9286; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Forsythe LP, 2019, HEALTH AFFAIR, V38, P359, DOI 10.1377/hlthaff.2018.05067; Frank L, 2020, J GEN INTERN MED, V35, P307, DOI 10.1007/s11606-019-05436-2; Fuhlbrigge AL, 2017, LANCET RESP MED, V5, P577, DOI 10.1016/S2213-2600(17)30218-7; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Ghaffar O, 2000, CLIN EXP ALLERGY, V30, P86; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Greenwald R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011919; Growing Protocol Design Complexity Stresses Investigators Volunteers, 2008, GROWING PROTOCOL DES, V10, P1; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3; Hastie AT, 2018, CLIN EXP ALLERGY, V48, P787, DOI 10.1111/cea.13129; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Hsieh MM, 2007, ANN INTERN MED, V146, P486, DOI 10.7326/0003-4819-146-7-200704030-00004; Hufnagl K, 2020, SEMIN IMMUNOPATHOL, V42, P75, DOI 10.1007/s00281-019-00775-y; Israel E, 2021, J ALLERGY CLIN IMMUN, V147, P1594, DOI 10.1016/j.jaci.2021.01.037; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Ivanova A, 2020, J BIOPHARM STAT, V30, P1026, DOI 10.1080/10543406.2020.1821705; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper Elizabeth F, 2005, Health Qual Life Outcomes, V3, P58, DOI 10.1186/1477-7525-3-58; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kirby M, 2017, RESPIRATION, V94, P336, DOI 10.1159/000478865; Kirkpatrick SI, 2016, J NUTR, V146, P2567, DOI 10.3945/jn.116.237271; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kraft M, 2003, CHEST, V124, P42, DOI 10.1378/chest.124.1.42; Kuperman DA, 2008, CURR MOL MED, V8, P384, DOI 10.2174/156652408785161032; Levy BD, 2015, AM J RESP CRIT CARE, V192, P1366, DOI 10.1164/rccm.201505-0963WS; Lim EM, 2010, INT J LAB HEMATOL, V32, P590, DOI 10.1111/j.1751-553X.2010.01223.x; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Makowska Joanna S, 2009, BMC Pulm Med, V9, P27, DOI 10.1186/1471-2466-9-27; Marozkina NV, 2015, ANNU REV PHYSIOL, V77, P431, DOI 10.1146/annurev-physiol-021113-170352; Marozkina NV, 2015, EUR RESPIR J, V45, P87, DOI 10.1183/09031936.00042414; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mease PJ, 2016, ARTHRITIS RHEUMATOL, V68, P2163, DOI 10.1002/art.39700; Mensah GA, 2019, GLOB HEART, V14, P191, DOI 10.1016/j.gheart.2019.06.005; Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Moore PE, 2009, PEDIATR PULM, V44, P649, DOI 10.1002/ppul.21033; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Mullins CD, 2012, JAMA-J AM MED ASSOC, V307, P1587, DOI 10.1001/jama.2012.442; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Ostridge K, 2019, ANN AM THORAC SOC, V16, P990, DOI 10.1513/AnnalsATS.201810-669OC; Pan L, 2015, J CLIN PHARMACOL, V55, P1086, DOI 10.1002/jcph.518; Peters MC, 2020, AM J RESP CRIT CARE, V202, P973, DOI 10.1164/rccm.201909-1813OC; Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC; Peters MC, 2016, EUR RESPIR J, V48, P291, DOI 10.1183/13993003.01132-2016; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Picado C, 1999, ALLERGY, V54, P569, DOI 10.1034/j.1398-9995.1999.00024.x; Pinnock H, 2005, J CLIN EPIDEMIOL, V58, P809, DOI 10.1016/j.jclinepi.2005.01.010; Pottel H, 2017, CLIN KIDNEY J, V10, P545, DOI 10.1093/ckj/sfx026; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramos CHI, 2021, CURR PROTEIN PEPT SC, V22, P192, DOI 10.2174/1389203721666201111160925; Ray A, 2016, J CLIN INVEST, V126, P2394, DOI 10.1172/JCI84144; Razi CH, 2010, J ALLERGY CLIN IMMUN, V126, P763, DOI 10.1016/j.jaci.2010.07.038; Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Roy AS., 2012, STIFLING NEW CURES T, V5, P5; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Saville BR, 2016, CLIN TRIALS, V13, P358, DOI 10.1177/1740774515626362; Schaad UB, 2010, WORLD J PEDIATR, V6, P5, DOI 10.1007/s12519-010-0001-x; Schatz M, 2014, J ALLERGY CLIN IMMUN, V133, P1549, DOI 10.1016/j.jaci.2013.10.006; Schroeder MA, 2020, BLOOD ADV, V4, P1656, DOI 10.1182/bloodadvances.2019001043; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Siddiqui S, 2008, J ALLERGY CLIN IMMUN, V122, P335, DOI 10.1016/j.jaci.2008.05.020; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Sutherland ER, 2014, J ALLERGY CLIN IMMUN, V133, P34, DOI 10.1016/j.jaci.2013.10.025; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Teng M, 2020, NUTR REV, V78, P249, DOI 10.1093/nutrit/nuz074; Thakur N, 2021, AM J RESP CRIT CARE, V204, P26; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5; Ward C, 2001, AM J RESP CRIT CARE, V164, P1718, DOI 10.1164/ajrccm.164.9.2102039; Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249; Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; WHO, 2011, WHO TECH REP SER, V959, P1; Winnica D, 2019, ANTIOXID REDOX SIGN, V31, P673, DOI 10.1089/ars.2018.7627; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Xu WL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183066; Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925; Xu WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132007; Zein JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133490	160	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2022	149	2					488	+		10.1016/j.jaci.2021.10.035	http://dx.doi.org/10.1016/j.jaci.2021.10.035			38	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YV3IA	34848210	Green Published, Green Accepted			2022-12-18	WOS:000752623200004
J	Atanasio, A; Franklin, MC; Kamat, V; Hernandez, AR; Badithe, A; Ben, LH; Jones, J; Bautista, J; Yancopoulos, GD; Olson, W; Murphy, AJ; Sleeman, MA; Orengo, JM				Atanasio, Amanda; Franklin, Matthew C.; Kamat, Vishal; Hernandez, Annabel Romero; Badithe, Ashok; Ben, Li-Hong; Jones, Jennifer; Bautista, Joannie; Yancopoulos, George D.; Olson, William; Murphy, Andrew J.; Sleeman, Matthew A.; Orengo, Jamie M.			Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Bet v 1; birch pollen allergy; mAbs; IgE; x-ray crystal-lography; cryo-electron microscopy	POLLEN ALLERGEN; GRASS-POLLEN; ASTHMA EXACERBATIONS; MAJOR ALLERGEN; IGE EPITOPES; OAK POLLEN; IMMUNOTHERAPY; BINDING; RHINITIS; IGG4	Background: Blocking the major cat allergen, Fel d 1, with mAbs was effective in preventing an acute cat allergic response. Objectives: This study sought to extend the allergen-specific antibody approach and demonstrate that a combination of mAbs targeting Bet v 1, the immunodominant and most abundant allergenic protein in birch pollen, can prevent the birch allergic response. Methods: Bet v 1-specific mAbs, REGN5713, REGN5714, and REGN5715, were isolated using the VelocImmune platform. Surface plasmon resonance, x-ray crystallography, and cryoelectron microscopy determined binding kinetics and structural data. Inhibition of IgE-binding, basophil activation, and mast cell degranulation were assessed via blocking ELISA, flow cytometry, and the passive cutaneous anaphylaxis mouse model. Results: REGN5713, REGN5714, and REGN5715 bind with high affinity and noncompetitively to Bet v 1. A cocktail of all 3 antibodies, REGN5713/14/15, blocks IgE binding to Bet v 1 and inhibits Bet v 1- and birch pollen extract-induced basophil activation ex vivo and mast cell degranulation in vivo. Crystal structures of the complex of Bet v 1 with immunoglobulin antigen-binding fragments of REGN5713 or REGN5715 show distinct interaction sites on Bet v 1. Cryo-electron microscopy reveals a planar and roughly symmetrical complex formed by REGN5713/14/15 bound to Bet v 1. Conclusions: These data confirm the immunodominance of Bet v 1 in birch allergy and demonstrate blockade of the birch allergic response with REGN5713/14/15. Structural analyses show simultaneous binding of REGN5713, REGN5714, and REGN5715 with substantial areas of Bet v 1 exposed, suggesting that targeting specific epitopes is sufficient to block the allergic response. (J Allergy Clin Immunol 2022;149:200-11.)	[Atanasio, Amanda; Franklin, Matthew C.; Kamat, Vishal; Hernandez, Annabel Romero; Badithe, Ashok; Ben, Li-Hong; Jones, Jennifer; Bautista, Joannie; Yancopoulos, George D.; Olson, William; Murphy, Andrew J.; Sleeman, Matthew A.; Orengo, Jamie M.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Regeneron	Orengo, JM (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	jamie.orengo@regeneron.com		Kamat, Vishal/0000-0002-6299-7024; Orengo, Jamie/0000-0002-2695-6508	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	This study was funded by Regeneron Pharmaceuticals, Inc.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Arvidsson MB, 2002, J ALLERGY CLIN IMMUN, V109, P777, DOI 10.1067/mai.2002.123868; Asrat S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aav8402; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Ciprandi G, 2008, EUR ANN ALLERGY CLIN, V40, P77; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Elisyutina O, 2019, ALLERGY, V74, P2525, DOI 10.1111/all.13931; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Francis JN, 2008, J ALLERGY CLIN IMMUN, V121, P1120, DOI 10.1016/j.jaci.2008.01.072; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gergen PJ, 2002, J PEDIATR-US, V141, P631, DOI 10.1067/mpd.2002.127510; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Gevaert P, 2022, J ALLERGY CLIN IMMUN, V149, P189, DOI 10.1016/j.jaci.2021.05.039; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GROTE M, 1991, J HISTOCHEM CYTOCHEM, V39, P1395, DOI 10.1177/39.10.1940310; Guilbert A, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0378-x; Hansen I, 2004, CURR OPIN ALLERGY CL, V4, P159, DOI 10.1097/01.all.0000129444.81350.23; Ito K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0057-0; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Kamat V, 2020, ANAL BIOCHEM, V593, DOI 10.1016/j.ab.2020.113580; Laffer S, 1996, J IMMUNOL, V157, P4953; Levin M, 2014, CLIN EXP ALLERGY, V44, P288, DOI 10.1111/cea.12230; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Moote W, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0282-5; Mueller GA, 2020, J IMMUNOL, V205, P1999, DOI 10.4049/jimmunol.2000295; Mueller GA, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0848-4; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Neumann JE, 2019, GEOHEALTH, V3, P11, DOI 10.1029/2018GH000153; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V102, P579, DOI 10.1016/S0091-6749(98)70273-8; Orengo JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03636-8; Pablos I, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0603-z; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Pomes A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02067; Price Alexandra, 2015, Dermatitis, V26, P78, DOI 10.1097/DER.0000000000000087; Schappi GF, 1997, J ALLERGY CLIN IMMUN, V100, P656, DOI 10.1016/S0091-6749(97)70170-2; Schenk MF, 2011, J PROTEOMICS, V74, P1290, DOI 10.1016/j.jprot.2011.03.021; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Shamji MH, 2006, J IMMUNOL METHODS, V317, P71, DOI 10.1016/j.jim.2006.09.004; Shamji MH, 2021, AM J RESP CRIT CARE, V204, P23, DOI 10.1164/rccm.202011-4107OC; Sheffield Perry E, 2011, ISRN Allergy, V2011, P537194, DOI 10.5402/2011/537194; Sun XZ, 2016, SCI TOTAL ENVIRON, V544, P185, DOI 10.1016/j.scitotenv.2015.11.100; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Wallace DV, 2017, ANN INTERN MED, V167, P876, DOI 10.7326/M17-2203; Wallace DV, 2017, CURR OPIN ALLERGY CL, V17, P286, DOI 10.1097/ACI.0000000000000375; Wang XW, 2000, J IMMUNOL METHODS, V244, P217, DOI 10.1016/S0022-1759(00)00260-X; Wickman M, 2005, ALLERGY, V60, P14, DOI 10.1111/j.1398-9995.2005.00852.x; Winther L, 2006, CLIN EXP ALLERGY, V36, P254, DOI 10.1111/j.1365-2222.2006.02340.x; Wu S, 2010, EXPERT REV VACCINES, V9, P631, DOI 10.1586/ERV.10.59; Wurth MA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123387; Yang XY, 2014, CURR OPIN BIOTECH, V30, P225, DOI 10.1016/j.copbio.2014.09.001; Zhang Q, 2018, ANAL CHEM, V90, P11315, DOI 10.1021/acs.analchem.8b01864; Zhang Y, 2014, INT J BIOMETEOROL, V58, P909, DOI 10.1007/s00484-013-0674-7; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	64	5	5	8	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					200	211		10.1016/j.jaci.2021.05.038	http://dx.doi.org/10.1016/j.jaci.2021.05.038			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YE9QV	34126155				2022-12-18	WOS:000741453800003
J	Crowley, TB; Campbell, IM; Liebling, EJ; Lambert, MP; Katz, LEL; Heimall, J; Bailey, A; McGinn, DE; McGinn, DMM; Sullivan, KE				Crowley, T. Blaine; Campbell, Ian M.; Liebling, Emily J.; Lambert, Michele P.; Katz, Lorraine E. Levitt; Heimall, Jennifer; Bailey, Alice; McGinn, Daniel E.; McGinn, Donna M. McDonald; Sullivan, Kathleen E.			Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						DiGeorge; homeostatic proliferation; autoimmunity; atopy; dysregulation	IMMUNOLOGICAL FEATURES; IGA DEFICIENCY; ABNORMALITIES; AUTOIMMUNITY; COHORT	Background: Identification of biomarkers associated with immune-mediated diseases in 22q11.2 deletion syndrome is an evolving field. Objectives: We sought to use a carefully phenotyped cohort to study immune parameters associated with autoimmunity and atopy in 22q11.2 deletion syndrome to define biomarkers associated with immune-mediated disease in this syndrome. Methods: Chart review validated autoimmune disease and atopic condition diagnoses. Laboratory data were extracted for each subcohort and plotted according to age. A random-effects model was used to define statistical significance. Results: CD19, CD4, and CD4/45RA lymphocyte populations were not different from the general cohort for patients with atopic conditions. CD4/45RA T cells were significantly lower in the subjects with immune thrombocytopenia compared with the general cohort, and CD4 T-cell counts were lower in patients with autoimmune thyroid disease. Conclusions: The mechanisms of autoimmunity in cytopenias may be distinct from those of solid-organ autoimmunity in 22q11.2 deletion syndrome. This study identifies potential biomarkers for risk stratification among commonly obtained laboratory studies. (J Allergy Clin Immunol 2022;149:445-50.)	[Crowley, T. Blaine; Campbell, Ian M.; Bailey, Alice; McGinn, Daniel E.; McGinn, Donna M. McDonald] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Human Genet,Dept Pediat, Philadelphia, PA 19104 USA; [Campbell, Ian M.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Liebling, Emily J.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Rheumatol,Dept Pediat, Philadelphia, PA 19104 USA; [Lambert, Michele P.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Hematol,Dept Pediat, Philadelphia, PA 19104 USA; [Katz, Lorraine E. Levitt] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Endocrinol & Diabet,Dept Pediat, Philadelphia, PA 19104 USA; [Heimall, Jennifer; Sullivan, Kathleen E.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Allergy & Immunol,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sullivan, KE (corresponding author), Childrens Hosp Philadelphia, Allergy Immunol, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	sullivank@cho.edu		McDonald-McGinn, Donna/0000-0003-4077-250X	National Institutes of Health [119737-02, 070454-11, 125757-02]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants: 119737-02; 070454-11; 125757-02. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.	Arnason JE, 2012, BLOOD, V119, P5016, DOI 10.1182/blood-2011-09-381020; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Cirillo E, 2020, J ALLER CL IMM-PRACT, V8, P3112, DOI 10.1016/j.jaip.2020.06.051; Crowley B, 2018, AM J MED GENET A, V176, P2082, DOI 10.1002/ajmg.a.38597; Deshpande DR, 2021, J CLIN IMMUNOL, V41, P29, DOI 10.1007/s10875-020-00854-y; Fischer A, 2017, J ALLERGY CLIN IMMUN, V140, P1388, DOI 10.1016/j.jaci.2016.12.978; Framme JL, 2014, J CLIN IMMUNOL, V34, P514, DOI 10.1007/s10875-014-0002-y; Fronkova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114514; Fung WLA, 2015, GENET MED, V17, P599, DOI 10.1038/gim.2014.175; Gennery AR, 2002, ARCH DIS CHILD, V86, P422, DOI 10.1136/adc.86.6.422; Giardino G, 2019, BLOOD, V133, P2586, DOI 10.1182/blood.2018885244; Jawad AF, 2011, J CLIN IMMUNOL, V31, P927, DOI 10.1007/s10875-011-9569-8; Jawad AF, 2001, J PEDIATR-US, V139, P715, DOI 10.1067/mpd.2001.118534; Ludvigsson JF, 2014, J CLIN IMMUNOL, V34, P444, DOI 10.1007/s10875-014-0009-4; Mahe P, 2019, AM J MED GENET A, V179, P2207, DOI 10.1002/ajmg.a.61336; Marcovecchio GE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00447; McDonald-McGinn DM, 1999, GENET COUNSEL, V10, P11; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Montin D, 2019, J ALLER CL IMM-PRACT, V7, P2369, DOI 10.1016/j.jaip.2019.03.014; Morsheimer M, 2017, AM J MED GENET A, V173, P2366, DOI 10.1002/ajmg.a.38319; Schindewolf E, 2018, AM J MED GENET A, V176, P1735, DOI 10.1002/ajmg.a.38665; Staple L, 2005, PEDIAT ALLERG IMM-UK, V16, P226, DOI 10.1111/j.1399-3038.2005.00259.x; Taddei I, 2001, P NATL ACAD SCI USA, V98, P11428, DOI 10.1073/pnas.201127298; Tison BE, 2011, J ALLERGY CLIN IMMUN, V128, P1115, DOI 10.1016/j.jaci.2011.06.043; Urm SH, 2013, MAYO CLIN PROC, V88, P813, DOI 10.1016/j.mayocp.2013.05.021	25	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					445	450		10.1016/j.jaci.2021.06.007	http://dx.doi.org/10.1016/j.jaci.2021.06.007			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	34144109				2022-12-18	WOS:000747922700014
J	Haimel, M; Pazmandi, J; Heredia, RJ; Dmytrus, J; Bal, SK; Zoghi, S; van Daele, P; Briggs, TA; Wouters, C; Bader-Meunier, B; Aeschlimann, FA; Caorsi, R; Eleftheriou, D; Hoppenreijs, E; Salzer, E; Bakhtiar, S; Derfalvi, B; Saettini, F; Kusters, MAA; Elfeky, R; Truck, J; Riviere, JG; van der Burg, M; Gattorno, M; Seidel, MG; Burns, S; Warnatz, K; Hauck, F; Brogan, P; Gilmour, KC; Schuetz, C; Simon, A; Bock, C; Hambleton, S; de Vries, E; Robinson, PN; van Gijn, M; Boztug, K				Haimel, Matthias; Pazmandi, Julia; Heredia, Raul Jimenez; Dmytrus, Jasmin; Bal, Sevgi Koestel; Zoghi, Samaneh; van Daele, Paul; Briggs, Tracy A.; Wouters, Carine; Bader-Meunier, Brigitte; Aeschlimann, Florence A.; Caorsi, Roberta; Eleftheriou, Despina; Hoppenreijs, Esther; Salzer, Elisabeth; Bakhtiar, Shahrzad; Derfalvi, Beata; Saettini, Francesco; Kusters, Maaike A. A.; Elfeky, Reem; Truck, Johannes; Riviere, Jacques G.; van der Burg, Mirjam; Gattorno, Marco; Seidel, Markus G.; Burns, Siobhan; Warnatz, Klaus; Hauck, Fabian; Brogan, Paul; Gilmour, Kimberly C.; Schuetz, Catharina; Simon, Anna; Bock, Christoph; Hambleton, Sophie; de Vries, Esther; Robinson, Peter N.; van Gijn, Marielle; Boztug, Kaan			Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HPO; ontology; phenotype; rare diseases; inborn errors of immunity; immunodeficiencies; disease classification; diagnostic support; patient matching; genetic analysis	UNDIAGNOSED DISEASES; HEALTH; DISCOVERY; DIAGNOSIS; PLATFORM; WORKING	Background: Accurate, detailed, and standardized phenotypic descriptions are essential to support diagnostic interpretation of genetic variants and to discover new diseases. The Human Phenotype Ontology (HPO), extensively used in rare disease research, provides a rich collection of vocabulary with standardized phenotypic descriptions in a hierarchical structure. However, to date, the use of HPO has not yet been widely implemented in the field of inborn errors of immunity (IEIs), mainly due to a lack of comprehensive IEI-related terms. Objectives: We sought to systematically review available terms in HPO for the depiction of IEIs, to expand HPO, yielding more comprehensive sets of terms, and to reannotate IEIs with HPO terms to provide accurate, standardized phenotypic descriptions. Methods: We initiated a collaboration involving expert clinicians, geneticists, researchers working on IEIs, and bioinformaticians. Multiple branches of the HPO tree were restructured and extended on the basis of expert review. Our ontology-guided machine learning coupled with a 2-tier expert review was applied to reannotate defined subgroups of IEIs. Results: We revised and expanded 4 main branches of the HPO tree. Here, we reannotated 73 diseases from 4 International Union of Immunological Societies-defined IEI disease subgroups with HPO terms. We achieved a 4.7-fold increase in the number of phenotypic terms per disease. Given the new HPO annotations, we demonstrated improved ability to computationally match selected IEI cases to their known diagnosis, and improved phenotype-driven disease classification. Conclusions: Our targeted expansion and reannotation presents enhanced precision of disease annotation, will enable superior HPO-based IEI characterization, and hence benefit both IEI diagnostic and research activities.	[Haimel, Matthias; Pazmandi, Julia; Heredia, Raul Jimenez; Dmytrus, Jasmin; Bal, Sevgi Koestel; Zoghi, Samaneh; Aeschlimann, Florence A.; Salzer, Elisabeth; Bock, Christoph; Boztug, Kaan] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Zimmermannpl 10, A-1090 Vienna, Austria; [Haimel, Matthias; Pazmandi, Julia; Heredia, Raul Jimenez; Dmytrus, Jasmin; Bal, Sevgi Koestel; Zoghi, Samaneh; Aeschlimann, Florence A.; Salzer, Elisabeth; Boztug, Kaan] St Anna Childrens Canc Res Inst CCRI, Zimmermannpl 10, A-1090 Vienna, Austria; [Haimel, Matthias; Pazmandi, Julia; Heredia, Raul Jimenez; Dmytrus, Jasmin; Bal, Sevgi Koestel; Zoghi, Samaneh; Aeschlimann, Florence A.; Salzer, Elisabeth; Bock, Christoph; Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [van Daele, Paul] Erasmus MC, Dept Clin Immunol, Rotterdam, Netherlands; [Briggs, Tracy A.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, NW Genom Lab Hub, Manchester, Lancs, England; [Briggs, Tracy A.] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England; [Wouters, Carine] Katholieke Univ Leuven, Dept Microbiol & Immunol, Immunobiol, Leuven, Belgium; [Wouters, Carine] Univ Hosp Leuven, Dept Pediat, Div Pediat Rheumatol, Leuven, Belgium; [Bader-Meunier, Brigitte] Necker Hosp Sick Children, AP HP, Pediat Immunohematol & Rheumatol Unit, Paris, France; [Bader-Meunier, Brigitte] Reference Ctr Rheumat Autoimmune & Syst Dis Child, Paris, France; [Caorsi, Roberta; Gattorno, Marco] IRCCS Ist Giannina Gaslini, Ctr Autoinflammatory Dis & Immunodeficiency, Genoa, Italy; [Eleftheriou, Despina; Kusters, Maaike A. A.; Elfeky, Reem; Brogan, Paul] UCL, Great Ormond St Inst Child Hlth, London, England; [Eleftheriou, Despina; Kusters, Maaike A. A.; Elfeky, Reem; Brogan, Paul; Gilmour, Kimberly C.] Great Ormond St GOS Hosp Children NHS Fdn Trust, Dept Immunol, London, England; [Hoppenreijs, Esther] Radboud Univ Nijmegen Med Ctr, Dept Paediat Rheumatol, Nijmegen, Netherlands; [Bakhtiar, Shahrzad] Goethe Univ, Dept Children & Adolescents, Div Stem Cell Transplantat, Immunol & Intens Care Unit, Frankfurt, Germany; [Derfalvi, Beata] Dalhousie Univ, Dept Pediat, Div Immunol, IWK Hlth Ctr Halifax, Halifax, NS, Canada; [Saettini, Francesco] Univ Milano Bicocca, Fdn MBBM, Pediat Hematol Dept, Via Pergolesi 33, Monza, Italy; [Truck, Johannes] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Riviere, Jacques G.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Jeffrey Model Fdn Excellence Ctr, Vall dHebron Res Inst, Barcelona, Spain; [Riviere, Jacques G.] Jeffrey Model Fdn Excellence Ctr, Barcelona, Spain; [van der Burg, Mirjam] Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [van der Burg, Mirjam] Leiden Univ Med Ctr, Dept Pediat, Lab Pediat Immunol, Leiden, Netherlands; [Seidel, Markus G.] Med Univ Graz, Dept Pediat & Adolescent Med, Div Pediat Hematooncol, Res Unit Pediat Hematol & Immunol, Graz, Austria; [Burns, Siobhan] Royal Free Hosp NHS Fdn Trust, UCL Inst Immun & Transplantat, Dept Immunol, London, England; [Warnatz, Klaus] Univ Freiburg, Fac Med, Dept Rheumatol & Clin Immunol, Div Immunodeficiency,Med Ctr, Freiburg, Germany; [Warnatz, Klaus] Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Fac Med, Freiburg, Germany; [Hauck, Fabian] Ludwig Maximilian Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Hauck, Fabian] Ludwig Maximilian Univ Munchen, Univ Hosp, Munich Ctr Rare Dis M ZSE LMU, Munich, Germany; [Schuetz, Catharina] Tech Univ Dresden, Dept Pediat, Med Fak Carl Gustav Carus, Dresden, Germany; [Simon, Anna] Radboud Univ Nijmegen, Radboudumc Expertise Ctr Immunodeficiency & Autoi, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Bock, Christoph] Med Univ Vienna, Inst Artificial Intelligence & Decis Support, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Hambleton, Sophie] Newcastle Univ, Immun & Inflammat Theme Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [de Vries, Esther] Tilburg Univ, Tranzo, Tilburg, Netherlands; [de Vries, Esther] Elisabeth Tweesteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT USA; [van Gijn, Marielle] Univ Med Ctr Groningen, Dept Genet, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Aeschlimann, Florence A.; Salzer, Elisabeth; Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, St Anna Childrens Hosp, Vienna, Austria	Saint Anna Children's Hospital; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Erasmus University Rotterdam; Erasmus MC; University of Manchester; University of Manchester; KU Leuven; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS Istituto Giannina Gaslini; University of London; University College London; Radboud University Nijmegen; Goethe University Frankfurt; Dalhousie University; University of Milano-Bicocca; University Children's Hospital Zurich; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Medical University of Graz; University of London; University College London; University of Freiburg; University of Freiburg; University of Munich; University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Radboud University Nijmegen; Medical University of Vienna; Newcastle University - UK; Tilburg University; Elisabeth-TweeSteden Ziekenhuis (ETZ); Jackson Laboratory; University of Groningen; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital	Boztug, K (corresponding author), Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Zimmermannpl 10, A-1090 Vienna, Austria.; Boztug, K (corresponding author), St Anna Childrens Canc Res Inst CCRI, Zimmermannpl 10, A-1090 Vienna, Austria.; van Gijn, M (corresponding author), Univ Med Ctr Groningen, Dept Genet, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	m.e.van.gijn@umcg.nl	Bock, Christoph/AAE-7618-2019; Ba, Sha/HGB-9711-2022; Rivière, Jacques G./ABH-8867-2020; Seidel, Markus G/N-9951-2017	Bock, Christoph/0000-0001-6091-3088; Rivière, Jacques G./0000-0003-1055-2063; de Vries, Esther/0000-0003-4311-3550; Seidel, Markus G/0000-0003-0981-8661; Haimel, Matthias/0000-0002-0320-0214; Wouters, Carine/0000-0002-6426-8845; Kusters, Maaike/0000-0001-7601-9822; Brogan, Paul/0000-0001-6178-6893; Briggs, Tracy/0000-0001-5208-2691; Jimenez Heredia, Raul/0000-0002-1406-0608	European Research Council (ERC) [820074]; Austrian Science Fund (FWF) [P 29951-B30]; European Union's Horizon 2020 research and innovation program under the EJP RD COFUND-EJP [N8 825575]; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases; European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA); European Society for Immunodeficiencies (ESID)	European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union's Horizon 2020 research and innovation program under the EJP RD COFUND-EJP; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases; European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA); European Society for Immunodeficiencies (ESID)	This work was supported by the European Research Council (ERC Consolidator Grant no. 820074 ``iDysChart'' to K.B.), by the Austrian Science Fund (FWF) project P 29951-B30 (to K.B.), and by funding from the European Union's Horizon 2020 research and innovation program under the EJP RD COFUND-EJP N8 825575 (to C.B.). Additional financial support for the workshops was granted by the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, the European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN-RITA), and the European Society for Immunodeficiencies (ESID).	Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Arbabi A, 2019, JMIR MED INF, V7, P191, DOI 10.2196/12596; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; Chinn IK, 2020, J ALLERGY CLIN IMMUN, V145, P46, DOI 10.1016/j.jaci.2019.09.009; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gall T, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00062; Gasteiger LM, 2020, J ALLER CL IMM-PRACT, V8, P1778, DOI 10.1016/j.jaip.2020.02.019; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Greene D, 2017, BIOINFORMATICS, V33, P1104, DOI 10.1093/bioinformatics/btw763; Hernandez-Ibarburu G, 2019, INT J MED INFORM, V129, P189, DOI 10.1016/j.ijmedinf.2019.06.010; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Lehne M, 2019, STUD HEALTH TECHNOL, V267, P52, DOI 10.3233/SHTI190805; Martin AR, 2019, NAT GENET, V51, P1560, DOI 10.1038/s41588-019-0528-2; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Pavan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170365; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Rae W, 2018, CLIN GENET, V93, P647, DOI 10.1111/cge.13163; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schriml LM, 2019, NUCLEIC ACIDS RES, V47, pD955, DOI 10.1093/nar/gky1032; Seidel MG, 2019, J ALLER CL IMM-PRACT, V7, P1763, DOI 10.1016/j.jaip.2019.02.004; Shefchek KA, 2020, NUCLEIC ACIDS RES, V48, pD704, DOI 10.1093/nar/gkz997; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003; Thompson R, 2014, J GEN INTERN MED, V29, pS780, DOI 10.1007/s11606-014-2908-8; Westbury SK, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0151-5; Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194	29	5	5	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2022	149	1					369	378		10.1016/j.jaci.2021.04.033	http://dx.doi.org/10.1016/j.jaci.2021.04.033			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YO4PH	33991581	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-18	WOS:000747922700006
J	Rebuli, ME; Brocke, SA; Jaspers, I				Rebuli, Meghan E.; Brocke, Stephanie A.; Jaspers, Ilona			Impact of inhaled pollutants on response to viral infection in controlled exposures	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Viral infection; pollution; inhaled	NASAL EPITHELIAL-CELLS; INDOOR AIR-POLLUTION; ATTENUATED INFLUENZA; SMOKE EXPOSURE; WOOD SMOKE; ALVEOLAR MACROPHAGES; ANTIVIRAL IMMUNITY; LUNG-FUNCTION; SURFACTANT; INFLAMMATION	Air pollutants are a major source of increased risk of disease, hospitalization, morbidity, and mortality worldwide. The respiratory tract is a primary target of potential concurrent exposure to both inhaled pollutants and pathogens, including viruses. Although there are various associative studies linking adverse outcomes to co- or subsequent exposures to inhaled pollutants and viruses, knowledge about causal linkages and mechanisms by which pollutant exposure may alter human respiratory responses to viral infection is more limited. In this article, we review what is known about the impact of pollutant exposure on antiviral host defense responses and describe potential mechanisms by which pollutants can alter the viral infection cycle. This review focuses on evidence from human observational and controlled exposure, ex vivo, and in vitro studies. Overall, there are a myriad of points throughout the viral infection cycle that inhaled pollutants can alter to modulate appropriate host defense responses. These alterations may contribute to observed increases in rates of viral infection and associated morbidity and mortality in areas of the world with high ambient pollution levels or in people using tobacco products. Although the understanding of mechanisms of interaction is advancing through controlled in vivo and in vitro exposure models, more studies are needed because emerging infectious pathogens, such as severe acute respiratory syndrome coronavirus 2, present a significant threat to public health.	[Rebuli, Meghan E.; Brocke, Stephanie A.; Jaspers, Ilona] Univ N Carolina, Curriculum Toxicol & Environm Med, Chapel Hill, NC 27515 USA; [Rebuli, Meghan E.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Rebuli, Meghan E.; Jaspers, Ilona] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jaspers, I (corresponding author), 116 Manning Dr,Campus Box 7325, Chapel Hill, NC 27599 USA.	ilona_jaspers@med.unc.edu		Brocke, Stephanie/0000-0002-1916-799X; Rebuli, Meghan/0000-0003-1918-2257	National Institute of Environmental Health Sciences of the National Institutes of Health [P30ES010126]; University of North Carolina Center for Environmental Health and Susceptibility [R01 ES013611, R01 HL095163, T32ES007126]; US Environmental Protection Agency [U.S. EPA CR83578501]	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of North Carolina Center for Environmental Health and Susceptibility; US Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under award number P30ES010126 (M.E.R. and I.J.), to the University of North Carolina Center for Environmental Health and Susceptibility (grant nos. R01 ES013611, R01 HL095163, and T32ES007126 to I.J.), and a cooperative agreement from the US EPA (U.S. EPA CR83578501). The information in this document has been funded by the US Environmental Protection Agency. It has been subjected to review by the National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views and policies of the agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.	Ali N, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.580057; Alon R, 2021, NAT REV IMMUNOL, V21, P49, DOI 10.1038/s41577-020-00470-2; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Backinger Cathy L, 2016, Tob Regul Sci, V2, P290, DOI 10.18001/TRS.2.3.8; Bauer CMT, 2008, J INTERF CYTOK RES, V28, P167, DOI 10.1089/jir.2007.0054; Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Brake SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030841; Brewington JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99385; Cai GS, 2020, AM J RESP CRIT CARE, V201, P1557, DOI 10.1164/rccm.202003-0693LE; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Garcia-Sancho MC, 2009, REV INVEST CLIN, V61, P392; Ciencewicki J, 2007, INHAL TOXICOL, V19, P1135, DOI 10.1080/08958370701665434; Ciencewicki J, 2007, INHAL TOXICOL, V19, P1121, DOI 10.1080/08958370701665426; Clapp PW, 2017, AM J PHYSIOL-LUNG C, V313, pL278, DOI 10.1152/ajplung.00452.2016; Comer DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032924; Croft DP, 2017, ENVIRON RES, V154, P352, DOI 10.1016/j.envres.2017.01.027; Domingo JL, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109650; Duffney PF, 2018, AM J PHYSIOL-LUNG C, V314, pL505, DOI 10.1152/ajplung.00406.2017; El-Shimy IA, 2021, PHARMACOL RES PERSPE, V9, DOI 10.1002/prp2.698; Fuller CH, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0270-0; Fullerton DG, 2011, INT J TUBERC LUNG D, V15, P391; Ghosh A, 2019, AM J RESP CRIT CARE, V200, P1392, DOI 10.1164/rccm.201903-0615OC; Glencross DA, 2020, FREE RADICAL BIO MED, V151, P56, DOI 10.1016/j.freeradbiomed.2020.01.179; Gowdy KM, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-34; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Han S, 2015, ANN AM THORAC SOC, V12, P765, DOI 10.1513/AnnalsATS.201411-507FR; Harb H, 2021, IMMUNITY, V54, P1186, DOI 10.1016/j.immuni.2021.04.002; HARRIS JO, 1975, AM REV RESPIR DIS, V111, P579; Heymann PW, 2020, J ALLERGY CLIN IMMUN, V146, P545, DOI 10.1016/j.jaci.2020.01.035; Hiura TS, 1999, J IMMUNOL, V163, P5582; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Jarjour NN, 2000, J ALLERGY CLIN IMMUN, V105, P1169, DOI 10.1067/mai.2000.106376; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Jaspers I, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-22; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kim JH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228410; Lawal AO, 2017, TOXICOL LETT, V270, P88, DOI 10.1016/j.toxlet.2017.01.017; Lee K-H, 2015, J IMMUNOL, V194; Liu JC, 2016, CLIMATIC CHANGE, V138, P655, DOI 10.1007/s10584-016-1762-6; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; Lozhkov AA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9120989; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Meyer M, 2015, AM J PHYSIOL-LUNG C, V308, pL1189, DOI 10.1152/ajplung.00028.2015; Meyer M, 2014, AM J PHYSIOL-LUNG C, V306, pL269, DOI 10.1152/ajplung.00290.2013; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Mishra R, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115148; Mishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240; Modestou MA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-64; Molnar P, 2005, ATMOS ENVIRON, V39, P2643, DOI 10.1016/j.atmosenv.2005.01.016; Noah TL, 2012, AM J RESP CRIT CARE, V185, P179, DOI 10.1164/rccm.201103-0465OC; Noah TL, 2011, ENVIRON HEALTH PERSP, V119, P78, DOI 10.1289/ehp.1002258; Oloyede IP, 2013, J TROP PEDIATRICS, V59, P399, DOI 10.1093/tropej/fmt033; Opotowsky Alexander R, 2008, Medscape J Med, V10, P22; Perez-Padilla R, 2001, INT J TUBERC LUNG D, V5, P441; Proud D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040762; Purkayastha A, 2020, CELL STEM CELL, V27, P869, DOI 10.1016/j.stem.2020.11.010; Rager JE, 2013, AM J PHYSIOL-LUNG C, V305, pL432, DOI 10.1152/ajplung.00116.2013; Rebuli ME., SEX BASED DIFF LUNG, V2021, P291; Rebuli ME, 2021, AM J RESP CELL MOL, V64, P126, DOI 10.1165/rcmb.2020-0164OC; Rebuli ME, 2019, AM J RESP CRIT CARE, V199, P996, DOI 10.1164/rccm.201807-1287OC; Ryu MH, 2020, THORAX, V75, P640, DOI 10.1136/thoraxjnl-2020-214561; Sharif-Askari NS, 2020, MOL THER-METH CLIN D, V18, P1, DOI 10.1016/j.omtm.2020.05.013; Silveyra P, SEX BASED DIFF LUNG, V2021, P251; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; TAKAHASHI H, 1993, AM REV RESPIR DIS, V147, P1562, DOI 10.1164/ajrccm/147.6_Pt_1.1562; Tang T, 2021, ACS INFECT DIS, V7, P264, DOI 10.1021/acsinfecdis.0c00701; Tao RJ, 2020, MOL IMMUNOL, V125, P178, DOI 10.1016/j.molimm.2020.07.001; Thurston GD, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00419-2016; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Vo Thao, 2020, bioRxiv, DOI 10.1101/2020.11.10.377408; Voinsky I, 2020, DRUG DEVELOP RES, V81, P1073, DOI 10.1002/ddr.21729; Watzky M, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2020.110317; WEITZ JI, 1987, ANN INTERN MED, V107, P680, DOI 10.7326/0003-4819-107-5-680; World Health Organization, 2018, GLOB DAT HOUS POLL M; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	81	5	5	2	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1420	1429		10.1016/j.jaci.2021.07.002	http://dx.doi.org/10.1016/j.jaci.2021.07.002		DEC 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	34252446	Bronze, Green Published			2022-12-18	WOS:000728634000006
J	Ladjemi, MZ; Di Candia, L; Heddebaut, N; Techoueyres, C; Airaud, E; Soussan, D; Dombret, MC; Hamidi, F; Guillou, N; Mordant, P; Castier, Y; Letuve, S; Taille, C; Aubier, M; Pretolani, M				Ladjemi, Maha Zohra; Di Candia, Leonarda; Heddebaut, Nicolas; Techoueyres, Camille; Airaud, Eloise; Soussan, David; Dombret, Marie-Christine; Hamidi, Fatima; Guillou, Noelline; Mordant, Pierre; Castier, Yves; Letuve, Sverine; Taille, Camille; Aubier, Michel; Pretolani, Marina			Clinical and histopathologic predictors of therapeutic response to bronchial thermoplasty in severe refractory asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Bronchial epithelium; T2-type inflammation; MUC5AC; IL-33; mast cells; IFN-alpha/beta exacerbations; asthma control; bronchial thermoplasty	AIRWAY SMOOTH-MUSCLE; PEDIATRIC SEVERE ASTHMA; TYPE-2 INFLAMMATION; MUCUS HYPERSECRETION; EXPRESSION; MUC5AC; SAFETY; EXACERBATIONS; NEUTROPHILS; EPITHELIUM	Background: Phenotypes and endotypes predicting optimal response to bronchial thermoplasty (BT) in patients with severe asthma remain elusive. Objective: Our aim was to compare the clinical characteristics and hallmarks of airway inflammation and remodeling before and after BT in responder and partial responder patients with severe asthma refractory to oral steroids and to omalizumab. Methods: In all, 23 patients with severe refractory asthma were divided into BT responders (n = 15) and BT partial responders (n = 8), according to the decrease in asthma exacerbations at 12 months after BT. Clinical parameters were compared at baseline and 12 months after BT, and hallmarks of airway inflammation and remodeling were analyzed by immunohistochemistry in bronchial biopsy specimens before and 3 months after BT. Results: At baseline, the BT responders were around 8 years younger than the BT partial responders (P = .02) and they had a greater incidence of atopy, higher numbers of blood eosinophils (both P = .03) and IgE levels, higher epithelial IFN-alpha expression, and higher numbers of mucosal eosinophils and IL-33-positive cells (P <= .05). A reduction in blood eosinophil count, serum IgE level, type 2 airway inflammation, and numbers of mucosal IL-33-positive cells and mast cells associated with augmented epithelial MUC5AC and IFN-alpha/beta immunostaining was noted after BT in responders, whereas the numbers of mucosal IL-33-positive cells were augmented in BT partial responders. Most of these changes were correlated with clinical parameters. Subepithelial membrane thickening and airway smooth muscle area were similar in the 2 patient groups at baseline and after BT. Conclusion: By reducing allergic type 2 inflammation and increasing epithelial MUC5AC and anti-viral IFN-alpha/beta expression, BT may enhance host immune responses and thus attenuate exacerbations and symptoms in BT responders. Instead, targeting IL-33 may provide a clinical benefit in BT partial responders.	[Ladjemi, Maha Zohra; Di Candia, Leonarda; Heddebaut, Nicolas; Techoueyres, Camille; Airaud, Eloise; Soussan, David; Dombret, Marie-Christine; Hamidi, Fatima; Guillou, Noelline; Mordant, Pierre; Castier, Yves; Letuve, Sverine; Taille, Camille; Aubier, Michel; Pretolani, Marina] Univ Paris, INSERM, UMR1152, Fac Med,Physiopathol & Epidemiol Malad Resp, Paris, France; [Ladjemi, Maha Zohra; Di Candia, Leonarda; Heddebaut, Nicolas; Techoueyres, Camille; Airaud, Eloise; Soussan, David; Dombret, Marie-Christine; Hamidi, Fatima; Guillou, Noelline; Mordant, Pierre; Castier, Yves; Letuve, Sverine; Taille, Camille; Aubier, Michel; Pretolani, Marina] Univ Sorbonne Paris Cite, IN FLAMEX, Lab Excellence, Paris, France; [Ladjemi, Maha Zohra; Di Candia, Leonarda; Heddebaut, Nicolas; Techoueyres, Camille; Airaud, Eloise; Soussan, David; Dombret, Marie-Christine; Hamidi, Fatima; Guillou, Noelline; Mordant, Pierre; Castier, Yves; Letuve, Sverine; Taille, Camille; Aubier, Michel; Pretolani, Marina] DHU FIRE, Paris, France; [Dombret, Marie-Christine; Taille, Camille] Hop Bichat Claude Bernard, Dept Pneumol A, Paris, France; [Mordant, Pierre; Castier, Yves] Hop Bichat Claude Bernard, Dept Chirurg Thorac, Paris, France; [Dombret, Marie-Christine; Mordant, Pierre; Castier, Yves; Taille, Camille] AP HP, Paris, France; [Ladjemi, Maha Zohra] Univ Paris, CNRS, UMR8104, Inst Cochin,INSERM,U1016, Paris, France; [Di Candia, Leonarda] Scinopsis, Frejus, France; [Guillou, Noelline] Univ Paris 06, CNRS, UMR1135, Ctr Immunol & Malad Infect CIMI,INSERM,ERL8255, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Pretolani, M (corresponding author), Univ Paris, INSERM, UMR1152, Fac Med, 16 Rue Henri Huchard, F-75018 Paris, France.	marina.pretolani@inserm.fr		Taille, Camille/0000-0001-9768-5728	Boston Scientific, Marlborough, Mass; AstraZeneca, Gaithersburg, Md; Legs Poix, Chancellerie des Universites, Paris, France	Boston Scientific, Marlborough, Mass; AstraZeneca, Gaithersburg, Md(AstraZeneca); Legs Poix, Chancellerie des Universites, Paris, France	Supported by Boston Scientific, Marlborough, Mass; AstraZeneca, Gaithersburg, Md; and Legs Poix, Chancellerie des Universites, Paris, France.	Andersson CK, 2017, J ALLERGY CLIN IMMUN, V139, P1819, DOI 10.1016/j.jaci.2016.09.022; Aubier M, 2016, J ALLERGY CLIN IMMUN, V138, P729, DOI 10.1016/j.jaci.2015.12.1332; Bonser LR, 2019, ADV IMMUNOL, V142, P1, DOI 10.1016/bs.ai.2019.05.001; Bonser LR, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120112; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chakir J, 2015, ANN AM THORAC SOC, V12, P1612, DOI 10.1513/AnnalsATS.201504-208OC; Chen YJ, 2006, AM J RESP CELL MOL, V34, P338, DOI 10.1165/rcmb.2005-0176OC; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Crawford B, 2008, RESP MED, V102, P1545, DOI 10.1016/j.rmed.2008.06.009; d'Hooghe JNS, 2018, PHARMACOL THERAPEUT, V181, P101, DOI 10.1016/j.pharmthera.2017.07.015; Denner DR, 2015, ANN AM THORAC SOC, V12, P1302, DOI 10.1513/AnnalsATS.201502-082OC; Denney L, 2018, BIOMED J, V41, P218, DOI 10.1016/j.bj.2018.08.004; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fernandes J, 2018, J INFECT DIS, V218, P1306, DOI 10.1093/infdis/jiy298; Hansel TT, 2017, EBIOMEDICINE, V19, P128, DOI 10.1016/j.ebiom.2017.03.033; Hirahara K, 2018, J LEUKOCYTE BIOL, V104, P895, DOI 10.1002/JLB.MR1117-456R; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Kaur D, 2015, ALLERGY, V70, P556, DOI 10.1111/all.12593; Kroes JA, 2020, BIOCHEM PHARMACOL, V179, DOI 10.1016/j.bcp.2020.113978; Lachowicz-Scroggins ME, 2016, AM J RESP CRIT CARE, V194, P1296; MacDowell AL, 2007, CURR ALLERGY ASTHM R, V7, P464, DOI 10.1007/s11882-007-0071-6; Mainardi AS, 2019, CLIN CHEST MED, V40, P193, DOI 10.1016/j.ccm.2018.10.015; Martinez-Rivera C, 2018, RESP MED, V135, P22, DOI 10.1016/j.rmed.2017.12.013; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Norbiato G, 1997, PSYCHONEUROENDOCRINO, V22, pS19, DOI 10.1016/S0306-4530(97)00011-5; Pavord ID, 2007, AM J RESP CRIT CARE, V176, P1185, DOI 10.1164/rccm.200704-571OC; Pretolani M, 2017, J ALLERGY CLIN IMMUN, V139, P1176, DOI 10.1016/j.jaci.2016.08.009; Pretolani M, 2014, AM J RESP CRIT CARE, V190, P1452, DOI 10.1164/rccm.201407-1374LE; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Ravanetti L, 2019, J ALLERGY CLIN IMMUN, V143, P1355, DOI 10.1016/j.jaci.2018.08.051; Ridley C, 2018, BIOCHEM SOC T, V46, P1099, DOI 10.1042/BST20170402; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Safholm J, 2019, J ALLERGY CLIN IMMUN, V144, P984, DOI 10.1016/j.jaci.2019.04.031; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Salem IH, 2019, AM J RESP CRIT CARE, V199, P536, DOI 10.1164/rccm.201811-2064LE; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Seibold MA, 2018, ANN AM THORAC SOC, V15, pS98, DOI 10.1513/AnnalsATS.201711-868MG; Sun QZ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.003OO-2019; Tan LD, 2019, J ALLER CL IMM-PRACT, V7, P71, DOI 10.1016/j.jaip.2018.08.017; Thomson NC, 2019, J ASTHMA ALLERGY, V12, P375, DOI 10.2147/JAA.S200912; Verstockt B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02983; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; Werder RB, 2018, J ALLERGY CLIN IMMUN, V141, P1607, DOI 10.1016/j.jaci.2017.07.051; Xia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098915; Yang SJ, 2019, FASEB J, V33, P3746, DOI 10.1096/fj.201801285R; Zhu J, 2019, J ALLERGY CLIN IMMUN, V143, P114, DOI 10.1016/j.jaci.2018.04.003	51	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1227	+		10.1016/j.jaci.2020.12.642	http://dx.doi.org/10.1016/j.jaci.2020.12.642		NOV 2021	15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV7LX	33453288				2022-12-18	WOS:000717415000021
J	Lyons, JJ				Lyons, Jonathan J.			On the complexities of tryptase genetics and impact on clinical phenotypes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Lyons, Jonathan J.] NIAID, Translat Allerg Immunopathol Unit, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lyons, JJ (corresponding author), NIAID, Translat Allerg Immunopathol Unit, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jonathan.lyons@nih.gov		Lyons, Jonathan/0000-0002-2346-8189	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Hu-man Services, nor does mention of trade names, commercial products, or organiza-tions imply endorsement by the US Government.	Chollet, 2021, J ALLERGY CLIN IMMUN, V148, P889; Glover SC, 2021, ANN ALLERG ASTHMA IM, V127, P638, DOI 10.1016/j.anai.2021.08.009; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; Le QT, 2019, J EXP MED, V216, P2348, DOI 10.1084/jem.20190701	5	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2021	148	5					1342	1343		10.1016/j.jaci.2021.08.011	http://dx.doi.org/10.1016/j.jaci.2021.08.011		NOV 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WV8FQ	34489125	Bronze			2022-12-18	WOS:000717466600005
J	Yamamoto, Y; Otsuka, A; Ishida, Y; San Wong, L; Seidel, JA; Nonomura, Y; Nakashima, C; Nakajima, S; Kitoh, A; Nomura, T; Dainichi, T; Honda, T; Amano, W; Konishi, N; Hayashi, M; Matsushita, M; Kabashima, K				Yamamoto, Yasuo; Otsuka, Atsushi; Ishida, Yoshihiro; San Wong, Lai; Seidel, Judith A.; Nonomura, Yumi; Nakashima, Chisa; Nakajima, Saeko; Kitoh, Akihiko; Nomura, Takashi; Dainichi, Teruki; Honda, Tetsuya; Amano, Wataru; Konishi, Noriko; Hayashi, Mikio; Matsushita, Mutsuyoshi; Kabashima, Kenji			Pituitary adenylate cyclase-activating polypeptide promotes cutaneous dendritic cell functions in contact hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PACAP; denervation; dendritic cells; contact hypersen-sitivity; resiniferatoxin; neuropeptides; peripheral sensory nerves	GENE-RELATED PEPTIDE; SENSORY NEURONS; SIGNALING PATHWAYS; T-CELLS; SKIN; INFLAMMATION; NEUROPEPTIDES; SENSITIZATION; MIGRATION; RESPONSES	Background: Sensory nerves regulate cutaneous local inflammation indirectly through induction of pruritus and directly by acting on local immune cells. The underlying mechanisms for how sensory nerves influence cutaneous acquired immune responses remain to be clarified. Objective: This study aimed to explore the effect of peripheral nerves on cutaneous immune cells in cutaneous acquired immune responses. Methods: We analyzed contact hypersensitivity (CHS) responses as a murine model of delayed-type hypersensitivity in absence or presence of resiniferatoxin-induced sensory nerve denervation. We conducted ear thickness measurements, flow cytometric analyses, and mRNA expression analyses in CHS. Results: CHS responses were attenuated in mice that were denervated during the sensitization phase of CHS. By screening neuropeptides, we found that pituitary adenylate cyclaseactivating polypeptide (PACAP) mRNA expression was decreased in the dorsal root ganglia after denervation. Administration of PACAP restored attenuated CHS response in resiniferatoxin-treated mice, and pharmacological inhibition of PACAP suppressed CHS. Flow cytometric analysis of skin draining lymph nodes showed that cutaneous dendritic cell migration and maturation were reduced in both denervated mice and PACAP antagonist-treated mice. The expression of chemokine receptors CCR7 and CXCR4 of dendritic cell s was enhanced by addition of PACAP in vitro. Conclusion: These findings indicate that a neuropeptide PACAP promotes the development of CHS responses by inducing cutaneous dendritic cell functions during the sensitization phase. (J Allergy Clin Immunol 2021;148:858-66.)	[Yamamoto, Yasuo; Otsuka, Atsushi; Ishida, Yoshihiro; San Wong, Lai; Seidel, Judith A.; Nonomura, Yumi; Nakashima, Chisa; Nakajima, Saeko; Kitoh, Akihiko; Nomura, Takashi; Dainichi, Teruki; Honda, Tetsuya; Amano, Wataru; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Translat Res Dept Skin & Brain Dis, Kyoto, Japan; [Yamamoto, Yasuo; Amano, Wataru; Konishi, Noriko; Hayashi, Mikio; Matsushita, Mutsuyoshi] Japan Tobacco, Cent Pharmaceut Res Inst, Takatsuki, Osaka, Japan; [Otsuka, Atsushi] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Otsuka, Atsushi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [San Wong, Lai] Biopolis, Singapore Immunol Network & Skin Res Inst Singapo, Technol & Res, Singapore, Singapore	Kyoto University; Kyoto University; Japan Tobacco Inc.; Chang Gung Memorial Hospital; Chang Gung University	Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawara Cho, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp		Nakajima, Saeko/0000-0003-0831-1447; Ishida, Yoshihiro/0000-0002-6210-5903	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development (AMED) [JP19gm1210006h0001]; Japan Tobacco Inc	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Tobacco Inc(Japan Tobacco Inc.)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan (to K.K.) and the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) under grant JP19gm1210006h0001 (to A.O. and K.K.), and a research grand from Japan Tobacco Inc (to K.K.).	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; De Smedt T, 1998, J IMMUNOL, V161, P4476; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Engel MA, 2011, NEUROPEPTIDES, V45, P229, DOI 10.1016/j.npep.2011.03.005; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Hanakawa S, 2019, J ALLERGY CLIN IMMUN, V144, P1343, DOI 10.1016/j.jaci.2019.05.033; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Hoyer D, 2012, CHEM BIODIVERS, V9, P2367, DOI 10.1002/cbdv.201200288; Inan S, 2009, EUR J PHARMACOL, V616, P141, DOI 10.1016/j.ejphar.2009.06.026; Joseph T, 2005, BRIT J DERMATOL, V152, P185, DOI 10.1111/j.1365-2133.2005.06330.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kemeny A, 2010, J MOL NEUROSCI, V42, P443, DOI 10.1007/s12031-010-9368-3; Kish DD, 2012, J IMMUNOL, V188, P1761, DOI 10.4049/jimmunol.1100928; Kodali S, 2003, EUR J IMMUNOL, V33, P3070, DOI 10.1002/eji.200324085; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Maruyama K, 2018, ISCIENCE, V6, P306, DOI 10.1016/j.isci.2018.08.007; May V, 2010, J BIOL CHEM, V285, P9749, DOI 10.1074/jbc.M109.043117; McMahon SB, 2015, NAT REV NEUROSCI, V16, P389, DOI 10.1038/nrn3946; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Mori T, 2008, J INVEST DERMATOL, V128, P1719, DOI 10.1038/jid.2008.5; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Niizeki H, 1999, J INVEST DERMATOL, V112, P437, DOI 10.1046/j.1523-1747.1999.00534.x; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Otsuka A, 2015, ALLERGY, V70, P131, DOI 10.1111/all.12526; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Roy A, 2013, AM J PHYSIOL-REG I, V304, pR1070, DOI 10.1152/ajpregu.00465.2012; Rudecki AP, 2016, TRENDS ENDOCRIN MET, V27, P620, DOI 10.1016/j.tem.2016.04.008; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Scholzen T, 1998, EXP DERMATOL, V7, P81, DOI 10.1111/j.1600-0625.1998.tb00307.x; Shioda S, 2016, ANAT SCI INT, V91, P313, DOI 10.1007/s12565-016-0351-0; Shiratori-Hayashi M, 2015, NAT MED, V21, P927, DOI 10.1038/nm.3912; Siebenhaar F, 2008, J ALLERGY CLIN IMMUN, V121, P955, DOI 10.1016/j.jaci.2007.11.013; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xu ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22373	47	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					858	866		10.1016/j.jaci.2021.02.005	http://dx.doi.org/10.1016/j.jaci.2021.02.005		SEP 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	33609627				2022-12-18	WOS:000695242900034
J	Kim, JY; Lim, S; Lim, HS; Kim, YS; Eun, KM; Khalmuratova, R; Seo, Y; Kim, JK; Kim, YS; Kim, MK; Jin, SY; Han, SC; Pyo, S; Hong, SN; Park, JW; Shin, HW; Kim, DW				Kim, Jin Youp; Lim, Suha; Lim, Hee-Suk; Kim, Yi-Sook; Eun, Kyoung Mi; Khalmuratova, Roza; Seo, Yuju; Kim, Joon Kon; Kim, Young Seok; Kim, Min-Kyung; Jin, Siyeon; Han, Seung Cheol; Pyo, Suyeon; Hong, Seung-No; Park, Jong-Wan; Shin, Hyun-Woo; Kim, Dae Woo			Bone morphogenetic protein-2 as a novel biomarker for refractory chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal polyp; bone morphogenetic proteins; sinusitis; osteitis; biomarker	MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; OSTEITIS; POLYPOGENESIS; SINUSITIS; MARKER; ASTHMA; BMP-2	Background: Bone morphogenetic proteins (BMPs), which are members of the TGF-beta superfamily, regulate bone remodeling by stimulating osteoblasts and osteoclasts. Although the association between osteitis and poor surgical outcomes is well known in patients with chronic rhinosinusitis (CRS), BMPs have not been fully investigated as potential biomarkers for the prognosis of CRS. Objective: Our aim was to investigate the role of BMPs in osteitis in patients with CRS with nasal polyps (NPs) (CRSwNPs), as well as associations between BMPs and inflammatory markers in sinonasal tissues from patients with CRSwNP. Methods: We investigated the expression of 6 BMPs (BMP-2, BMP-4, BMP-6, BMP-7, BMP-9, and BMP-10) and their cellular origins in NPs of human subjects by using immunohistochemistry and ELISA of NP tissues. Exploratory factor analysis was performed to identify associations between BMPs and inflammatory markers. Air-liquid interface cell culture of human nasal epithelial cells was performed to evaluate the induction of the epithelial-mesenchymal transition by BMPs. Results: Of the 6 BMPs studied, BMP-2 and BMP-7 were associated with refractoriness. Only BMP-2 concentrations were higher in patients with severe osteitis and advanced disease extent according to the computed tomography findings. Eosinophils and some macrophages were identified as cellular sources of BMP-2 in immunofluorescence analysis. An in vitro experiment revealed that BMP-2 induced epithelialmesenchymal transition in air-liquid interface-cultured human nasal epithelial cells, particularly in a T(H)2 milieu. Conclusion: BMP-2 could reflect the pathophysiology of mucosa and bone remodeling and may be a novel biomarker for refractory CRSwNP.	[Kim, Jin Youp; Lim, Hee-Suk; Eun, Kyoung Mi; Seo, Yuju; Kim, Joon Kon; Kim, Young Seok; Kim, Min-Kyung; Jin, Siyeon; Han, Seung Cheol; Pyo, Suyeon; Hong, Seung-No; Kim, Dae Woo] Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Coll Med, Seoul, South Korea; [Kim, Jin Youp] Seoul Natl Univ, Coll Med, Interdisciplinary Program Med Informat, Seoul, South Korea; [Lim, Suha; Kim, Yi-Sook; Khalmuratova, Roza; Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Obstruct Upper Airway Res Lab, Dept Pharmacol, Seoul, South Korea; [Lim, Suha; Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Lim, Suha; Kim, Yi-Sook; Park, Jong-Wan; Shin, Hyun-Woo] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Shin, Hyun-Woo] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DW (corresponding author), Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 425 Shindaebang 2 Dong, Seoul 07061, South Korea.; Shin, HW (corresponding author), Seoul Natl Univ, Dept Pharmacol, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.	charlie@snu.ac.kr; kicubi73@gmail.com		Kim, Young Seok/0000-0002-5042-6048; Han, Seung Cheol/0000-0003-1981-9334	National Research Foundation of Korea [NRF-2019R1A2C2087170, 2020R1A4A2002903]; Seoul Metropolitan Government Seoul National University Boramae Medical Center [03-2019-1]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI17C1669]	National Research Foundation of Korea(National Research Foundation of Korea); Seoul Metropolitan Government Seoul National University Boramae Medical Center; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea	Supported by the National Research Foundation of Korea (grant NRF-2019R1A2C2087170 [to D.W.K.] and grant 2020R1A4A2002903 [to H.W.S.] ) , the Seoul Metropolitan Government Seoul National University Boramae Medical Center (focused clinical research grant-in-aid 03-2019-1 [to D.W.K.] ) , and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant HI17C1669 to [H.W.S.] ) .	Bae JS, 2020, THORAX, V75, P982, DOI 10.1136/thoraxjnl-2019-213916; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Bhandarkar ND, 2011, INT FORUM ALLERGY RH, V1, P372, DOI 10.1002/alr.20068; Blackwell Debra L, 2014, Vital Health Stat 10, P1; Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X; Dituri F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101130; Donoso O, 2015, J CELL BIOCHEM, V116, P1267, DOI 10.1002/jcb.25082; Dube PR, 2017, BIOCHEM BIOPH RES CO, V491, P154, DOI 10.1016/j.bbrc.2017.07.065; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens WJ, 2020, RHINOLOGY, V58, P1, DOI 10.4193/Rhin20.401; Georgalas C, 2010, CLIN OTOLARYNGOL, V35, P455, DOI 10.1111/j.1749-4486.2010.02218.x; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Husson F., 2016, MULTIVARIATE EXPLORA, V96, P698; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Khalmuratova R, 2021, CLIN EXP OTORHINOLAR, V14, P43, DOI 10.21053/ceo.2020.00416; Khalmuratova R, 2020, ALLERGY ASTHMA IMMUN, V12, P306, DOI 10.4168/aair.2020.12.2.306; Khalmuratova R, 2019, EBIOMEDICINE, V46, P330, DOI 10.1016/j.ebiom.2019.07.035; Kim DW, 2017, J ALLERGY CLIN IMMUN, V139, P1692, DOI 10.1016/j.jaci.2016.09.026; Kim DK, 2019, ALLERGY ASTHMA IMMUN, V12, P980; Kim DK, 2020, ALLERGY ASTHMA IMMUN, V12, P42, DOI 10.4168/aair.2020.12.1.42; Kim DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111352; Kim JY, 2019, YONSEI MED J, V60, P578, DOI 10.3349/ymj.2019.60.6.578; Kim YS, 2011, AM J RHINOL ALLERGY, V25, pE117, DOI 10.2500/ajra.2011.25.3630; Konnecke M, 2017, ARCH IMMUNOL THER EX, V65, P157, DOI 10.1007/s00005-016-0409-7; Lee JT, 2006, AM J RHINOL, V20, P278, DOI 10.2500/ajr.2006.20.2857; Lee M, 2019, MUCOSAL IMMUNOL, V12, P601, DOI 10.1038/s41385-019-0149-1; Lee M, 2016, J ALLERGY CLIN IMMUN, V137, P87, DOI 10.1016/j.jaci.2015.07.026; Lee SN, 2015, AM J RESP CELL MOL, V52, P749, DOI 10.1165/rcmb.2014-0029OC; Leung N, 2016, EUR ARCH OTO-RHINO-L, V273, P2917, DOI 10.1007/s00405-015-3817-0; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo DD, 2010, AM J PATHOL, V176, P1139, DOI 10.2353/ajpath.2010.090459; McCormack N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-36; Mehta V, 2008, MAYO CLIN PROC, V83, P671, DOI 10.4065/83.6.671; Minor DM, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0595-9; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nam YH, 2015, ALLERGY ASTHMA RESPI, V3, P47, DOI 10.4168/aard.2015.3.1.47; NORLANDER T, 1994, ACTA OTO-LARYNGOL, P38; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Rosendahl A, 2002, AM J RESP CELL MOL, V27, P160, DOI 10.1165/ajrcmb.27.2.4779; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Ryu G, 2021, CURR OPIN ALLERGY CL, V21, P30, DOI 10.1097/ACI.0000000000000701; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Shin HW, 2012, AM J RESP CRIT CARE, V185, P944, DOI 10.1164/rccm.201109-1706OC; Singla DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147897; Snidvongs K, 2012, RHINOLOGY, V50, P299, DOI [10.4193/Rhin12.022, 10.4193/Rhino12.022]; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; TOVI F, 1992, LARYNGOSCOPE, V102, P426, DOI 10.1288/00005537-199204000-00010; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wang ZC, 2018, INT FORUM ALLERGY RH, V8, P1323, DOI 10.1002/alr.22218; WESTRIN KM, 1992, ACTA OTO-LARYNGOL, V112, P107, DOI 10.3109/00016489209100791; Wu DW, 2019, LARYNGOSCOPE, V129, pE102, DOI 10.1002/lary.27581; Xiao WM, 2016, FRONT ORAL BIOL, V18, P9, DOI 10.1159/000351895; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhao RW, 2018, J APPL TOXICOL, V38, P678, DOI 10.1002/jat.3573; Zuo WL, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02553-2017	56	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					461	+		10.1016/j.jaci.2021.02.027	http://dx.doi.org/10.1016/j.jaci.2021.02.027		AUG 2021	25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33667477				2022-12-18	WOS:000684625700023
J	Lowe, AA; Gerald, JK; Clemens, CJ; Stern, DA; Gerald, LB				Lowe, Ashley A.; Gerald, Joe K.; Clemens, Conrad J.; Stern, Debra A.; Gerald, Lynn B.			Managing respiratory emergencies at school: A county-wide stock inhaler program	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Health policy; schools; asthma; albuterol; school nursing	PUBLIC-HEALTH IMPACT; BUDESONIDE-FORMOTEROL; ASTHMA; MAINTENANCE; INTERVENTIONS; PERFORMANCE; MEDICATION; THERAPY	Background: A total of 15 states allow schools to manage respiratory emergencies among multiple students by using a single albuterol inhaler (stock inhaler) paired with a disposable holding chamber. Objective: Our aim was to evaluate implementation barriers and facilitators, as well as satisfaction with a stock inhaler program across K through12 schools in Pima County, Arizona. Methods: All public, charter, private, and parochial schools were offered supplies, web-based training, and technical assistance at no cost. The RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework was used to evaluate program implementation. School documentation logs were reviewed, school health personnel were surveyed, and a convenience sample of health personnel were interviewed. Chi-square tests evaluated categoric outcomes and Poisson hurdle regression examined stock inhaler use by school organization type, grade levels served, and type of school health personnel employed. Results: In all, 229 schools (68%) participated, reaching 82% of students in the county. A total of 152 schools (66%) used a stock inhaler, accounting for 1038 events. The mean number of puffs administered was 2.7 (SD = 1.2) per event, and most events (79%) involved students with asthma. Although most events (83.9%) resulted in the student returning to class, 15.6% resulted in students being sent home. Only 6 events resulted in 911 calls, and 5 of these led to an ambulance transport. School health personnel reported high levels of satisfaction, and all schools renewed participation for a second year. Program costs were $156 per school. Conclusion: With technical assistance, stock inhaler programs can be feasibly implemented by schools in a wide range of settings, thereby increasing their capacity to safely managerespiratory emergencies.	[Lowe, Ashley A.; Clemens, Conrad J.; Gerald, Lynn B.] Univ Arizona, Coll Med, Dept Hlth Promot Sci, Tucson, AZ USA; [Lowe, Ashley A.; Gerald, Joe K.; Stern, Debra A.; Gerald, Lynn B.] Univ Arizona, Coll Med, Mel & Enid Zuckerman Coll Publ Hlth, Dept Community Environm & Policy, Tucson, AZ USA; [Gerald, Joe K.] Univ Arizona, Coll Med, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Clemens, Conrad J.] Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Lowe, AA (corresponding author), Univ Arizona, Asthma & Airway Dis Res Ctr, 1501 N Campbell Ave,Box 245030,Rm 2351-B, Tucson, AZ 85724 USA.	aaray@arizona.edu	Lowe, Ashley A./AAS-6438-2021	Lowe, Ashley A./0000-0001-6252-0368	Thayer Medical Corporation; Banner University Medical Center-Tucson Campus; Mel and Enid Zuckerman Family Foundation	Thayer Medical Corporation; Banner University Medical Center-Tucson Campus; Mel and Enid Zuckerman Family Foundation	Program materials and supplies were funded by or graciously donated from the following foundations and program stakeholders: the Thayer Medical Corporation, the Banner University Medical Center-Tucson Campus, and the Mel and Enid Zuckerman Family Foundation.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Asthma and Allergy Foundation of America, ALB SCH 2017; Basch CE, 2011, J SCHOOL HEALTH, V81, P606, DOI 10.1111/j.1746-1561.2011.00634.x; Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Beasley R, 2019, NEW ENGL J MED, V380, P2020, DOI 10.1056/NEJMoa1901963; Buscemi J, 2017, J BEHAV MED, V40, P203, DOI 10.1007/s10865-016-9773-3; Children's Action Alliance, 2014, AR KIDS COUNT DAT BO; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; Crump C, 2013, ANN EPIDEMIOL, V23, P179, DOI 10.1016/j.annepidem.2013.01.001; Food Allergy Research & Education, 2016, SCH ACC EP MAP 2016; Frakt A, 2019, JAMA PEDIATR, V173, P130, DOI 10.1001/jamapediatrics.2018.4540; Gerald JK, 2012, PEDIAT ALLER IMM PUL, V25, P11, DOI 10.1089/ped.2011.0118; Gerald LB, 2018, ANN AM THORAC SOC, V15, P413, DOI 10.1513/AnnalsATS.201708-639HP; Gerald LB, 2016, ANN AM THORAC SOC, V13, P295, DOI 10.1513/AnnalsATS.201510-683LE; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Greiling AK, 2005, J SCHOOL HEALTH, V75, P286, DOI 10.1111/j.1746-1561.2005.00039.x; Kliff S, 2019, NEW YORK TIMES; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; Kwan BM, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00345; LegiScan, 2017, AR HOUS BILL 2208; Liberty K, 2010, CHEST, V2010, P1249; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; Moonie S, 2008, J SCHOOL HEALTH, V78, P140, DOI 10.1111/j.1746-1561.2007.00276.x; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Murphy KR, 2006, ANN ALLERG ASTHMA IM, V96, P398, DOI 10.1016/S1081-1206(10)60906-4; National Asthma Education and Prevention Program, 2007, GUID DIAGN MAN ASTHM; Nwaru BI, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01872-2019; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Osborne L, 2014, STATE LAW PERMITTING; Papp EM, 2019, AM J PUBLIC HEALTH, V109, P1528, DOI 10.2105/AJPH.2019.305314; Reddel HK, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01046-2019; Shaker MS, 2019, JAMA PEDIATR, V173, P169, DOI 10.1001/jamapediatrics.2018.4275; Stanford RH, 2012, ANN ALLERG ASTHMA IM, V109, P403, DOI 10.1016/j.anai.2012.08.014; United States Census Bureau, 2018, QUICK FACTS PIM COUN	37	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					420	+		10.1016/j.jaci.2021.01.028	http://dx.doi.org/10.1016/j.jaci.2021.01.028		AUG 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	TZ7BX	33581200				2022-12-18	WOS:000684625700019
J	Yahia, SA; Audousset, C; Alvarez-Simon, D; Vorng, H; Togbe, D; Marquillies, P; Delacre, M; Rose, S; Bouscayrol, H; Rifflet, A; Quesniaux, V; Boneca, IG; Chamaillard, M; Tsicopoulos, A				Yahia, Saliha Ait; Audousset, Camille; Alvarez-Simon, Daniel; Vorng, Han; Togbe, Dieudonnee; Marquillies, Philippe; Delacre, Myriam; Rose, Stephanie; Bouscayrol, Helene; Rifflet, Aline; Quesniaux, Valerie; Boneca, Ivo Gomperts; Chamaillard, Mathias; Tsicopoulos, Anne			NOD1 sensing of house dust mite-derived microbiota promotes allergic experimental asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; allergy; house dust mite; NOD1; peptidoglycan; epithelial cells; microbiota; T(H)2 cells	INDUCED AIRWAY INFLAMMATION; MURAMYL DIPEPTIDE; EARLY-LIFE; T-CELL; PEPTIDOGLYCAN; RECOGNITION; LIPOPOLYSACCHARIDE; EXACERBATION; SEVERITY	Background: Asthma severity has been linked to exposure to gram-negative bacteria from the environment that are recognized by NOD1 receptor and are present in house dust mite (HDM) extracts. NOD1 polymorphism has been associated with asthma. Objective: We sought to evaluate whether either host or HDMderived microbiota may contribute to NOD1-dependent disease severity. Methods: A model of HDM-induced experimental asthma was used and the effect of NOD1 deficiency was evaluated. Contribution of host microbiota was evaluated by fecal transplantation. Contribution of HDM-derived microbiota was assessed by 16S ribosomal RNA sequencing, mass spectrometry analysis, and peptidoglycan depletion of the extracts. Results: In this model, loss of the bacterial sensor NOD1 and its adaptor RIPK2 improved asthma features. Such inhibitory effect was not related to dysbiosis caused by NOD1 deficiency, as shown by fecal transplantation of Nod1-deficient microbiota to wild-type germ-free mice. The 16S ribosomal RNA gene sequencing and mass spectrometry analysis of HDM allergen, revealed the presence of some muropeptides from gram-negative bacteria that belong to the Bartonellaceae family. While such HDM-associated muropeptides were found to activate NOD1 signaling in epithelial cells, peptidoglycan-depleted HDM had a decreased ability to instigate asthma in vivo. Conclusions: These data show that NOD1-dependent sensing of HDM-associated gram-negative bacteria aggravates the severity of experimental asthma, suggesting that inhibiting the NOD1 signaling pathway may be a therapeutic approach to treating asthma. (J Allergy Clin Immunol 2021;148:394-406.)	[Yahia, Saliha Ait; Audousset, Camille; Alvarez-Simon, Daniel; Vorng, Han; Marquillies, Philippe; Delacre, Myriam; Chamaillard, Mathias; Tsicopoulos, Anne] Univ Lille, Ctr Natl Rech Sci CNRS, Inst Natl Sante & Rech Med, Ctr Hosp Univ Lille,Inst Pasteur Lille,U1019 Unit, Lille, France; [Togbe, Dieudonnee; Rose, Stephanie; Bouscayrol, Helene; Quesniaux, Valerie] UMR 7355 CNRS Univ Orleans, Lab Expt & Mol Immunol & Neurogenet, Orleans, France; [Rifflet, Aline; Boneca, Ivo Gomperts] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Paris, France; [Rifflet, Aline; Boneca, Ivo Gomperts] CNRS, UMR 2001, Paris, France; [Rifflet, Aline; Boneca, Ivo Gomperts] Inst Natl Sante & Rech Med, Equipe Avenir, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tsicopoulos, A (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, U1019 Pulm Immun, 1 Rue Prof Calmette, F-59019 Lille, France.	anne.tsicopoulos@pasteur-lille.fr	Alvarez-Simón, Daniel/AAD-3351-2021; Boneca, Ivo G/H-1677-2014; TSICOPOULOS, Anne/C-2260-2019	Alvarez-Simón, Daniel/0000-0002-3464-0909; Boneca, Ivo G/0000-0001-8122-509X; Audousset, Camille/0000-0003-2554-8286; TSICOPOULOS, Anne/0000-0002-1579-2763	Institut Pasteur; Agence Nationale de Recherche [18-CE14-0020]; CNRS of Orleans (France); European funding in Region Centre-Val de Loire (Fonds Europeens de Developpement Regional) [201600110366 BIO-TARGET, EX005756 BIO-TARGET II]; Investissement d'Avenir program, Laboratoire d'Excellence ''Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]	Institut Pasteur(European Commission); Agence Nationale de Recherche(French National Research Agency (ANR)); CNRS of Orleans (France); European funding in Region Centre-Val de Loire (Fonds Europeens de Developpement Regional); Investissement d'Avenir program, Laboratoire d'Excellence ''Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR))	Supported by grants from Projets Transversaux de Recherche (18-16) from Institut Pasteur (to A.T., M.C., and I.G.B.), by Agence Nationale de Recherche 18-CE14-0020 (to A.T., M.C., and I.G.B.), and by CNRS of Orleans (France) and European funding in Region Centre-Val de Loire (Fonds Europeens de Developpement Regional no. 201600110366 BIO-TARGETand EX005756 BIO-TARGET II). A.R. was supported by Investissement d'Avenir program, Laboratoire d'Excellence ''Integrative Biology of Emerging Infectious Diseases'' (ANR-10-LABX-62-IBEID).	Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Banskar S, 2019, J IMMUNOL, V203, P3113, DOI 10.4049/jimmunol.1900711; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Everaere L, 2016, J ALLERGY CLIN IMMUN, V138, P1309, DOI 10.1016/j.jaci.2016.03.019; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Groneberg DA, 2001, AM J PATHOL, V158, P707, DOI 10.1016/S0002-9440(10)64013-8; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Huang ZX, 2019, NAT MICROBIOL, V4, P766, DOI 10.1038/s41564-019-0381-1; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Kim TH, 2014, ALLERGY ASTHMA IMMUN, V6, P163, DOI 10.4168/aair.2014.6.2.163; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Lee J, 2019, J ALLERGY CLIN IMMUN, V143, P1620, DOI 10.1016/j.jaci.2018.10.062; Li X, 2018, CELL HOST MICROBE, V24, P847, DOI 10.1016/j.chom.2018.11.003; Lu MF, 2016, INNATE IMMUN-LONDON, V22, P307, DOI 10.1177/1753425916644675; Mellado M, 2008, J PHARMACOL EXP THER, V324, P769, DOI 10.1124/jpet.107.128538; Miller MH, 2018, J LEUKOCYTE BIOL, V104, P447, DOI 10.1002/JLB.4HI0118-017RR; Molinaro R, 2019, J BIOL CHEM, V294, P9007, DOI 10.1074/jbc.RA119.007997; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park SY, 2013, J IMMUNOL, V190, P3480, DOI 10.4049/jimmunol.1202675; Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; Tang VH, 2015, FEBS OPEN BIO, V5, P813, DOI 10.1016/j.fob.2015.09.004; Thorsen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12989-7; Tran LS, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12826; Valerio CR, 2005, J ALLERGY CLIN IMMUN, V116, P1296, DOI 10.1016/j.jaci.2005.09.046; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Yahia SA, 2014, AM J RESP CRIT CARE, V189, P899, DOI 10.1164/rccm.201310-1827OC; Yao XL, 2013, AM J RESP CELL MOL, V49, P902, DOI 10.1165/rcmb.2013-0001OC; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200; Zhou YJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13698-x	43	5	5	4	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					394	406		10.1016/j.jaci.2020.12.649	http://dx.doi.org/10.1016/j.jaci.2020.12.649		AUG 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33508265	Green Submitted			2022-12-18	WOS:000684625700017
J	Almeida, L; Dhillon-LaBrooy, A; Carriche, G; Berod, L; Sparwasser, T				Almeida, Luis; Dhillon-LaBrooy, Ayesha; Carriche, Guilhermina; Berod, Luciana; Sparwasser, Tim			CD4(+) T-cell differentiation and function: Unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T cell; CD4; metabolism; immunometabolism; antibiotics; polyamine; fatty acid oxidation; arginine; mitochondria	REGULATORY T; TRANSCRIPTION-FACTOR; METABOLIC CHECKPOINT; TUMOR MICROENVIRONMENT; EFFECTOR RESPONSES; DEPENDENT HISTONE; PATHOGENIC TH17; ACTIVATION; EXPRESSION; INDUCTION	The progression through different steps of T-cell development, activation, and effector function is tightly bound to specific cellular metabolic processes. Previous studies established that T-effector cells have a metabolic bias toward aerobic glycolysis, whereas naive and regulatory T cells mainly rely on oxidative phosphorylation. More recently, the field of immunometabolism has drifted away from the notion that mitochondrial metabolism holds little importance in T-cell activation and function. Of note, T cells possess metabolic promiscuity, which allows them to adapt their nutritional requirements according to the tissue environment. Altogether, the integration of these metabolic pathways culminates in the generation of not only energy but also intermediates, which can regulate epigenetic programs, leading to changes in T-cell fate. In this review, we discuss the recent literature on how glycolysis, amino acid catabolism, and fatty acid oxidation work together with the tricarboxylic acid cycle in the mitochondrion. We also emphasize the importance of the electron transport chain for T-cell immunity. We also discuss novel findings highlighting the role of key enzymes, accessory pathways, and posttranslational protein modifications that distinctively regulate T-cell function and might represent prominent candidates for therapeutic purposes.& nbsp;	[Almeida, Luis; Dhillon-LaBrooy, Ayesha; Carriche, Guilhermina; Sparwasser, Tim] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany; [Almeida, Luis; Dhillon-LaBrooy, Ayesha; Carriche, Guilhermina] Inst Infect Immunol, TWINCORE, Ctr Expt & Clin Infect Res, Hannover, Germany; [Berod, Luciana] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med Mainz, D-55122 Mainz, Germany; [Berod, Luciana; Sparwasser, Tim] Univ Med Ctr Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center for Infection Research; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Sparwasser, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany.; Berod, L (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med Mainz, D-55122 Mainz, Germany.	berod@uni-mainz.de; sparwasser@uni-mainz.de	Sparwasser, Tim D/AAA-4306-2022	Almeida, Luis/0000-0002-2605-4280	Deutsche Forschungsgemeinschaft [CRC156, CRC1292]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (grant nos. CRC156 and CRC1292).	Akdis M, 2012, J ALLERGY CLIN IMMUN, V129, P1438, DOI 10.1016/j.jaci.2012.05.003; Almeida L, 2021, IMMUNITY, V54, P68, DOI 10.1016/j.immuni.2020.11.001; Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Anderson KA, 2017, BBA-BIOENERGETICS, V1858, P991, DOI 10.1016/j.bbabio.2017.09.005; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Angiari S, 2020, CELL METAB, V31, P391, DOI 10.1016/j.cmet.2019.10.015; Araujo LF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31170-6; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Bedoya AM, 2014, GYNECOL ONCOL, V135, P74, DOI 10.1016/j.ygyno.2014.07.096; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Bron L, 2013, INT J CANCER, V132, pE85, DOI 10.1002/ijc.27728; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Broom AJ, 2016, TOXICOL RES-UK, V5, P136, DOI 10.1039/c5tx00197h; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Bystrzycka W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122666; Carriche GM, 2021, J ALLERGY CLIN IMMUN, V147, P335, DOI 10.1016/j.jaci.2020.04.037; Casteleyn C, 2010, LAB ANIM-UK, V44, P176, DOI 10.1258/la.2009.009112; Castro CN, 2015, MOL IMMUNOL, V68, P575, DOI 10.1016/j.molimm.2015.07.025; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Colaco HG, 2019, 833269 BIORXIV; Comito G, 2019, ONCOGENE, V38, P3681, DOI 10.1038/s41388-019-0688-7; CROFFORD OB, 1995, NEW ENGL J MED, V333, P588, DOI 10.1056/NEJM199508313330910; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Czystowska-Kuzmicz M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10979-3; D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; de Boniface J, 2012, ONCOIMMUNOLOGY, V1, P1305, DOI 10.4161/onci.21678; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Deng YX, 2017, HUM IMMUNOL, V78, P120, DOI 10.1016/j.humimm.2016.12.010; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Divakaruni AS, 2018, CELL METAB, V28, P490, DOI 10.1016/j.cmet.2018.06.001; Dong L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111450; Duan W, 2019, AM J TRANSL RES, V11, P2393; Duncan KD, 2019, ANALYST, V144, P782, DOI 10.1039/c8an01581c; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; El-Hattab AW, 1993, **DROPPED REF**; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Franchi L, 2017, J IMMUNOL, V198, P2735, DOI 10.4049/jimmunol.1600810; Franchina DG, 2018, TRENDS CANCER, V4, P138, DOI 10.1016/j.trecan.2017.12.006; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu Z, 2019, CELL REP, V28, P159, DOI 10.1016/j.celrep.2019.06.024; Gammage PA, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0668-y; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gong F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02918; Grabon W, 2009, CLIN BIOCHEM, V42, P353, DOI 10.1016/j.clinbiochem.2008.11.018; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Guan XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107729; He NH, 2017, P NATL ACAD SCI USA, V114, P12542, DOI 10.1073/pnas.1715363114; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Howie D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89160; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jambhekar A, 2019, NAT REV MOL CELL BIO, V20, P625, DOI 10.1038/s41580-019-0151-1; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Konjar S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01683; Kono M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127395; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Kunisada Y, 2017, EBIOMEDICINE, V25, P154, DOI 10.1016/j.ebiom.2017.10.009; Kunkl M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020482; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Leber A, 2017, J IMMUNOL, V198, P2260, DOI 10.4049/jimmunol.1601547; Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Li J, 2017, ACTA BIOCH BIOPH SIN, V49, P792, DOI 10.1093/abbs/gmx079; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lim HW, 2015, J EXP MED, V212, P607, DOI 10.1084/jem.20132378; Liu MY, 2020, SHOCK, V53, P103, DOI 10.1097/SHK.0000000000001333; Liu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02689-5; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma HH, 2019, NEUROCHEM INT, V125, P136, DOI 10.1016/j.neuint.2019.02.012; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Mak TW, 2017, IMMUNITY, V46, P1089, DOI 10.1016/j.immuni.2017.06.009; Makowski L, 2020, IMMUNOL REV, V295, P5, DOI 10.1111/imr.12858; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Merkley SD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02914; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mocholi E, 2018, CELL REP, V24, P1136, DOI 10.1016/j.celrep.2018.06.065; Moro L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111983; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Nelson DL., 2005, PRINCIPLES BIOCH; O'Connor RS, 2020, METHODS MOL BIOL, V2097, P83, DOI 10.1007/978-1-0716-0203-4_5; O'Connor RS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24676-6; O'Sullivan D, 2019, NAT REV IMMUNOL, V19, P324, DOI 10.1038/s41577-019-0140-9; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Ozay EI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01284; Pacella I, 2018, P NATL ACAD SCI USA, V115, pE6546, DOI 10.1073/pnas.1720113115; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Priyadharshini B, 2018, J IMMUNOL, V201, P2215, DOI 10.4049/jimmunol.1800311; Procaccini C, 2016, IMMUNITY, V44, P712, DOI 10.1016/j.immuni.2016.02.022; Proserpio V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0957-5; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Pucino V, 2019, CELL METAB, V30, P1055, DOI 10.1016/j.cmet.2019.10.004; Puntel RL, 2013, TOXICOL IN VITRO, V27, P59, DOI 10.1016/j.tiv.2012.10.011; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Raud B, 2018, IMMUNOL REV, V283, P213, DOI 10.1111/imr.12655; Richter-Dennerlein R, 2015, NAT REV MOL CELL BIO, V16, P586, DOI 10.1038/nrm4051; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Roy S, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03036; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin BY, 2020, CELL REP, V30, P1898, DOI 10.1016/j.celrep.2020.01.022; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986; Song WZ, 2019, IMMUNOL REV, V288, P85, DOI 10.1111/imr.12740; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun FF, 2020, LANCET RHEUMATOL, V2, pE210, DOI 10.1016/S2665-9913(20)30004-7; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tang CY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00837; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; TeSlaa T, 2016, CELL METAB, V24, P485, DOI 10.1016/j.cmet.2016.07.002; Neildez-Nguyen TMA, 2015, IMMUNOLOGY, V144, P431, DOI 10.1111/imm.12388; Timmons Jennifer, 2012, J Gastrointest Dig Syst, V2; Tindemans I, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010110; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Tseng CH, 2021, J CROHNS COLITIS, V15, P64, DOI 10.1093/ecco-jcc/jjaa136; Uda K, 2003, J GASTROEN HEPATOL, V18, P554, DOI 10.1046/j.1440-1746.2003.03020.x; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wada J, 2008, ANTICANCER RES, V28, P2401; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wilson CS, 2020, IMMUNOMETABOLISM, V2; Wu Bowen, 2020, Immunometabolism, V2, DOI 10.20900/immunometab20200017; Wu D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15876; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xie X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005251; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yabu M, 2011, INT IMMUNOL, V23, P29, DOI 10.1093/intimm/dxq455; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Cong-Hui, 2018, PLoS Biol, V16, pe2003782, DOI 10.1371/journal.pbio.2003782; Zheng WP, 2014, MEDCHEMCOMM, V5, P297, DOI 10.1039/c3md00325f; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zielinski LP, 2016, MITOCHONDRION, V31, P45, DOI 10.1016/j.mito.2016.09.003; Zuo H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010005	193	5	5	6	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					16	32		10.1016/j.jaci.2021.03.033	http://dx.doi.org/10.1016/j.jaci.2021.03.033		JUL 2021	17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33966898				2022-12-18	WOS:000669906700002
J	Turi, KN; McKennan, C; Gebretsadik, T; Snyder, B; Seroogy, CM; Lemanske, RF; Zoratti, E; Havstad, S; Ober, C; Lynch, S; McCauley, K; Yu, C; Jackson, DJ; Gern, JE; Hartert, TV				Turi, Kedir N.; McKennan, Christopher; Gebretsadik, Tebeb; Snyder, Brittney; Seroogy, Christine M.; Lemanske, Robert F., Jr.; Zoratti, Edward; Havstad, Suzanne; Ober, Carole; Lynch, Susan; McCauley, Kathyrn; Yu, Chang; Jackson, Daniel J.; Gern, James E.; Hartert, Tina V.		ECHO CREW Investigators	Unconjugated bilirubin is associated with protection from early-life wheeze and childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Wheeze; asthma; metabolomics; bilirubin; lipid mediators	SECRETORY PHOSPHOLIPASE A(2); LYSOPHOSPHATIDIC ACID; NEONATAL PHOTOTHERAPY; SERUM BILIRUBIN; RISK; METABOLOMICS; INFLAMMATION; INHIBITION; ALLERGIES; JAUNDICE	Background: Wheeze and allergic sensitization are the strongest early-life predictors of childhood asthma development; the molecular origins of these early-life phenotypes are poorly understood. Objectives: We sought to identify metabolites associated with early-life wheeze, allergic sensitization, and childhood asthma. Methods: We conducted a nested case-control study using Environmental influences on Child Health Outcomes Program cohorts for discovery and independent replication. Wheeze and allergic sensitization were defined by number of wheeze episodes and positive specific IgE at age 1 year, respectively. Asthma was defined as physician diagnosis of asthma at age 5 or 6 years. We used untargeted metabolomics, controlling for observed and latent confounding factors, to assess associations between the plasma metabolome and early-life wheeze, allergy, and childhood asthma. Results: Eighteen plasma metabolites were associated with first year wheeze in the discovery cohort (n = 338). Z,Z unconjugated bilirubin (UCB) and its related metabolites exhibited a dose-response relationship with wheeze frequency; UCB levels were 13% (beta = 0.87; 95% CI, 0.74-1.02) and 22% (beta = 0.78; 95% CI, 0.68-0.91) lower in children with 1 to 3 and 41 wheeze episodes compared with those who never wheezed, respectively. UCB levels were also associated with childhood asthma (beta = 0.82; 95% CI, 0.68-0.98). Similar trends were observed in 2 independent cohorts. UCB was significantly negatively correlated with eicosanoid- and oxidative stress-related metabolites. There were no significant associations between metabolites and allergic sensitization. Conclusions: We identified a novel inverse, dose-dependent association between UCB and recurrent wheeze and childhood asthma. Inflammatory lipid mediators and oxidative stress byproducts inversely correlated with UCB, suggesting that UCB modulates pathways critical to the development of early-life recurrent wheeze and childhood asthma.	[Turi, Kedir N.; Snyder, Brittney; Hartert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [McKennan, Christopher] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA; [Gebretsadik, Tebeb; Yu, Chang] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Seroogy, Christine M.; Lemanske, Robert F., Jr.; Jackson, Daniel J.; Gern, James E.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Zoratti, Edward] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA; [Havstad, Suzanne] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Lynch, Susan; McCauley, Kathyrn] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Chicago; University of California System; University of California San Francisco	Hartert, TV (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West End Ave,Ste 450, Nashville, TN 37203 USA.; Gern, JE (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, K4-918 CSC,600 Highland Ave, Madison, WI 53792 USA.	gern@medicine.wisc.edu; tina.hartert@vumc.org	Snyder, Brittney/Y-5788-2019	Snyder, Brittney/0000-0001-8356-3965; Turi, Kedir/0000-0002-3853-9357	National Institutes of Health (NIH) [UG3 OD023282, UL1 TR002373, UM1AI114271, U19AI095230, K24 AI 077930, T32 HL087738, K12 HD04348318, K01HL149989]; Childhood Origins of Asthma Study [P01 HL070831, U10 HL064305, R01 HL061879]; Infant Susceptibility to Pulmonary Infections and Asthma following RSV Exposure [U19 AI 095227, UL1 RR 024975, R21 HD087864]; Wisconsin Infant Study Cohort [2U19AI104317]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Childhood Origins of Asthma Study; Infant Susceptibility to Pulmonary Infections and Asthma following RSV Exposure; Wisconsin Infant Study Cohort	This work was supported by the National Institutes of Health (NIH) grant numbers UG3 OD023282, UL1 TR002373, UM1AI114271, U19AI095230, K24 AI 077930, T32 HL087738, K12 HD04348318, and K01HL149989. The Environmental influences on Child Health Outcomes-Children's Respiratory and Environmental Workgroup cohorts are supported as follows: Childhood Origins of Asthma Study (grant nos. P01 HL070831, U10 HL064305, and R01 HL061879), Infant Susceptibility to Pulmonary Infections and Asthma following RSV Exposure (grant nos. U19 AI 095227, UL1 RR 024975, and R21 HD087864), and Wisconsin Infant Study Cohort (grant no. 2U19AI104317).	Abdala-Valencia H, 2007, AM J PHYSIOL-LUNG C, V292, pL1111, DOI 10.1152/ajplung.00208.2006; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Aspberg S, 2007, PEDIAT ALLERG IMM-UK, V18, P313, DOI 10.1111/j.1399-3038.2006.00518.x; Aspberg S, 2010, PEDIAT ALLERG IMM-UK, V21, pE733, DOI 10.1111/j.1399-3038.2010.01038.x; Barlotta A, 2019, J INFECT DIS, V219, P1216, DOI 10.1093/infdis/jiy659; Bartel J, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301009; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Castro-Rodriguez JA, 2010, J ALLERGY CLIN IMMUN, V126, P212, DOI 10.1016/j.jaci.2010.06.032; DiNicolantonio JJ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2018-000914; Esther CR, 2016, EUR RESPIR J, V48, P1612, DOI 10.1183/13993003.00524-2016; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; Gern JE, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1088-9; Horsfall LJ, 2011, JAMA-J AM MED ASSOC, V305, P691, DOI 10.1001/jama.2011.124; Huang LS, 2013, AM J EPIDEMIOL, V178, P1691, DOI 10.1093/aje/kwt248; Itoh S, 2001, ANN CLIN BIOCHEM, V38, P323, DOI 10.1258/0004563011900821; Jameel NM, 2005, MOL CELL BIOCHEM, V276, P219, DOI 10.1007/s11010-005-4441-x; Jasprova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148126; Joshi V, 2016, ARCH BIOCHEM BIOPHYS, V598, P28, DOI 10.1016/j.abb.2016.04.003; Kelly RS, 2017, CHEST, V151, P262, DOI 10.1016/j.chest.2016.10.008; Kim DE, 2017, BIOMATERIALS, V140, P37, DOI 10.1016/j.biomaterials.2017.06.014; Kuzniewicz MW, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0662; Larkin EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0040-0; Leem AY, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0814-z; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Lessig J, 2010, LIPIDS, V45, P37, DOI 10.1007/s11745-009-3365-8; MCDONAGH AF, 1980, SCIENCE, V208, P145, DOI 10.1126/science.7361112; McKennan C, 2020, ANN APPL STAT, V14, P789, DOI [10.1214/20-AOAS1328, 10.1214/20-aoas1328]; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIGLIORISI G, 1987, AM J PATHOL, V127, P157; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Perry R, 2019, PHARMACOECONOMICS, V37, P155, DOI 10.1007/s40273-018-0726-2; Rubner FJ, 2017, J ALLERGY CLIN IMMUN, V139, P501, DOI 10.1016/j.jaci.2016.03.049; Seroogy CM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4448-0; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun HL, 2013, AM J RHINOL ALLERGY, V27, P192, DOI 10.2500/ajra.2013.27.3874; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang HHF, 2018, ELIFE, V7, DOI 10.7554/eLife.35856; Taylor JA, 2015, PEDIATRICS, V135, P224, DOI 10.1542/peds.2014-1919; THUNBERG T, 1980, ARCH TOXICOL, V45, P273, DOI 10.1007/BF00293808; Turi KN, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1431-z; Turi KN, 2018, J ALLERGY CLIN IMMUN, V141, P1191, DOI 10.1016/j.jaci.2017.04.021; Wei CC, 2015, PEDIATR RES, V78, P223, DOI 10.1038/pr.2015.89; Zahran HS, 2018, MMWR-MORBID MORTAL W, V67, P149, DOI 10.15585/mmwr.mm6705e1; Zamboni N, 2015, MOL CELL, V58, P699, DOI 10.1016/j.molcel.2015.04.021	48	5	6	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2021	148	1					128	138		10.1016/j.jaci.2020.12.639	http://dx.doi.org/10.1016/j.jaci.2020.12.639		JUL 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TE3IE	33434532	Green Accepted			2022-12-18	WOS:000669906700021
J	Gotlib, J; George, TI; Carter, MC; Austen, KF; Bochner, B; Dwyer, DF; Lyons, JJ; Hamilton, MJ; Butterfield, J; Bonadonna, P; Weiler, C; Galli, SJ; Schwartz, LB; Elberink, HO; Maitland, A; Theoharides, T; Ustun, C; Horny, HP; Orfao, A; Deininger, M; Radia, D; Jawhar, M; Kluin-Nelemans, H; Metcalfe, DD; Arock, M; Sperr, WR; Valent, P; Castells, M; Akin, C				Gotlib, Jason; George, Tracy I.; Carter, Melody C.; Austen, K. Frank; Bochner, Bruce; Dwyer, Daniel F.; Lyons, Jonathan J.; Hamilton, Matthew J.; Butterfield, Joseph; Bonadonna, Patrizia; Weiler, Catherine; Galli, Stephen J.; Schwartz, Lawrence B.; Elberink, Hanneke Oude; Maitland, Anne; Theoharides, Theoharis; Ustun, Celalettin; Horny, Hans-Peter; Orfao, Alberto; Deininger, Michael; Radia, Deepti; Jawhar, Mohamad; Kluin-Nelemans, Hanneke; Metcalfe, Dean D.; Arock, Michel; Sperr, Wolfgang R.; Valent, Peter; Castells, Mariana; Akin, Cem			Proceedings from the Inaugural American Initiative in Mast Cell Diseases(AIM) Investigator Conference	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Systemic mastocytosis; siglec-8; mast cell activation syndrome; hereditary alpha-tryptasemia; anaphylaxis; European Competence Network on Mastocytosis (ECNM); American Initiative in Mast Cell Diseases (AIM)	BASAL SERUM TRYPTASE; EUROPEAN COMPETENCE NETWORK; IRRITABLE-BOWEL-SYNDROME; SYSTEMIC MASTOCYTOSIS; CONNECTIVE-TISSUE; ACTIVATION SYNDROME; ONSET MASTOCYTOSIS; HUMAN EOSINOPHILS; ANAPHYLAXIS; CLASSIFICATION	The American Initiative in Mast Cell Diseases (AIM) held its inaugural investigator conference at Stanford University School of Medicine in May 2019. The overarching goal of this meeting was to establish a Pan-American organization of physicians and scientists with multidisciplinary expertise in mast cell disease. To serve this unmet need, AIM envisions a network where basic, translational, and clinical researchers could establish collaborations with both academia and biopharma to support the development of new diagnostic methods, enhanced understanding of the biology of mast cells in human health and disease, and the testing of novel therapies. In these AIM proceedings, we highlight selected topics relevant to mast cell biology and provide updates regarding the recently described hereditary alpha-tryptasemia. In addition, we discuss the evaluation and treatment of mast cell activation (syndromes), allergy and anaphylaxis in mast cell disorders, and the clinical and biologic heterogeneity of the more indolent forms of mastocytosis. Because mast cell disorders are relatively rare, AIM hopes to achieve a coordination of scientific efforts not only in the Americas but also in Europe by collaborating with the well-established European Competence Network on Mastocytosis.	[Gotlib, Jason] Stanford Univ, Sch Med, Div Hematol, Stanford Canc Inst, Stanford, CA 94305 USA; [George, Tracy I.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Carter, Melody C.; Lyons, Jonathan J.; Metcalfe, Dean D.] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Austen, K. Frank; Dwyer, Daniel F.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Bochner, Bruce] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Hamilton, Matthew J.] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Butterfield, Joseph; Weiler, Catherine] Mayo Clin, Div Allerg Dis, Rochester, MN USA; [Bonadonna, Patrizia] Verona Univ Hosp, Allergy Unit, Verona, Italy; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA USA; [Elberink, Hanneke Oude] Univ Groningen, Univ Med Ctr Groningen, Sect Allergol, Internal Med, Groningen, Netherlands; [Maitland, Anne] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Theoharides, Theoharis] Tufts Univ, Sch Med, Dept Immunol, Boston, MA 02111 USA; [Ustun, Celalettin] Rush Univ, Dept Med, Div Hematol Oncol & Cellular Therapy, Chicago, IL 60612 USA; [Horny, Hans-Peter] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Orfao, Alberto] Univ Salamanca, Serv Cent Citometria, Ctr Invest Canc IBMCC CSIC USAL, IBSAL,CIBERONC, Salamanca, Spain; [Orfao, Alberto] Univ Salamanca, Dept Med, Salamanca, Spain; [Deininger, Michael] Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA; [Deininger, Michael] Huntsman Canc Inst, Salt Lake City, UT USA; [Radia, Deepti] Guys & St Thomas NHS Hosp, Dept Clin Haematol, London, England; [Jawhar, Mohamad] Heidelberg Univ, Univ Hosp Mannheim, Heidelberg, Germany; [Kluin-Nelemans, Hanneke] Univ Groningen, Univ Med Ctr Groningen, Dept Haematol, Groningen, Netherlands; [Arock, Michel] Hop La Pitie Salpetriere, Haematol Lab, Paris, France; [Sperr, Wolfgang R.; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Sperr, Wolfgang R.; Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria; [Castells, Mariana] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA; [Castells, Mariana] Harvard Med Sch, Boston, MA 02115 USA; [Akin, Cem] Univ Michigan, Div Allergy & Immunol, Ann Arbor, MI 48109 USA	Stanford Cancer Institute; Stanford University; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Stanford University; Stanford University; Virginia Commonwealth University; University of Groningen; Icahn School of Medicine at Mount Sinai; Tufts University; Rush University; University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Ruprecht Karls University Heidelberg; University of Groningen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Gotlib, J (corresponding author), Stanford Canc Inst, 875 Blake Wilbur Dr,Rm 2324, Stanford, CA 94305 USA.	jason.gotlib@stanford.edu	ustun, celalettin/AEM-2670-2022; George, Tracy I./GRY-0951-2022	Valent, Peter/0000-0003-0456-5095; Sperr, Wolfgang/0000-0003-3288-8027	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [R13TR002722]; Mast Cell Disease Society, Inc (TMS), a national 501c3 nonprofit; Charles and Ann Johnson Foundation; Stanford Cancer Institute Innovation Fund; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH; Asthma and Allergic Diseases Cooperative Research Centers Opportunity Fund (NIH) [U19AI07053]; Austrian Science Fund (FWF) [F4701-B20, F4704-B20, P32470-B]	National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); Mast Cell Disease Society, Inc (TMS), a national 501c3 nonprofit; Charles and Ann Johnson Foundation; Stanford Cancer Institute Innovation Fund; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Asthma and Allergic Diseases Cooperative Research Centers Opportunity Fund (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) (award no. R13TR002722 to J.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank The Mast Cell Disease Society, Inc (TMS), a national 501c3 nonprofit, for their partnership and support of AIM, for patient-centered research, and for sponsoring international physicians at this inaugural meeting. J.G. expresses gratitude for the support of the Charles and Ann Johnson Foundation, the staff of the Stanford Mastocytosis Center, and the Stanford Cancer Institute Innovation Fund. M.C., J.J.L., and D.D.M. are supported in part by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH. D.F.D. is supported by the Asthma and Allergic Diseases Cooperative Research Centers Opportunity Fund (award no. U19AI07053 from the NIH). P.V. has been supported by the Austrian Science Fund (FWF) (grant nos. F4701-B20, F4704-B20, and P32470-B).	Akin C, 2004, ANNU REV MED, V55, P419, DOI 10.1146/annurev.med.55.091902.103822; Akin C, 2017, J ALLERGY CLIN IMMUN, V140, P349, DOI 10.1016/j.jaci.2017.06.007; Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alvarez-Twose I, 2016, J ALLERGY CLIN IMMUN, V137, P168, DOI 10.1016/j.jaci.2015.05.008; Aniceto V, 2019, INT ARCH ALLERGY IMM, V179, P201, DOI 10.1159/000497235; Ben-Amitai D, 2005, ISR MED ASSOC J, V7, P320; Berezowska S, 2014, MODERN PATHOL, V27, P19, DOI 10.1038/modpathol.2013.117; Bochner BS, 2016, GLYCOBIOLOGY, V26, P546, DOI 10.1093/glycob/cww024; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Bonadonna P, 2018, J ALLER CL IMM-PRACT, V6, P1368, DOI 10.1016/j.jaip.2017.11.025; Bonadonna P, 2018, IMMUNOL ALLERGY CLIN, V38, P455, DOI 10.1016/j.iac.2018.04.010; Bonadonna P, 2014, IMMUNOL ALLERGY CLIN, V34, P397, DOI 10.1016/j.iac.2014.01.014; Boyden SE, 2016, NEW ENGL J MED, V374, P656, DOI 10.1056/NEJMoa1500611; Brockow K, 2003, J AM ACAD DERMATOL, V48, P508, DOI 10.1067/mjd.2003.98; Broesby-Olsen S, 2018, ALLERGY, V73, P230, DOI 10.1111/all.13237; Butterfield J, 2020, J ALLER CL IMM-PRACT, V8, P2533, DOI 10.1016/j.jaip.2020.02.021; Butterfield JH, 2010, PROSTAG OTH LIPID M, V92, P73, DOI 10.1016/j.prostaglandins.2010.03.003; CAPLAN RM, 1963, ARCH DERMATOL, V87, P146, DOI 10.1001/archderm.1963.01590140008002; Carter MC, 2015, J ALLERGY CLIN IMMUN, V136, P1673, DOI 10.1016/j.jaci.2015.04.024; Castells M, 2019, J ALLER CL IMM-PRACT, V7, P1097, DOI 10.1016/j.jaip.2019.02.002; Caughey GH, 2006, J ALLERGY CLIN IMMUN, V117, P1411, DOI 10.1016/j.jaci.2006.02.026; Dahlin JS, 2016, BLOOD, V127, P383, DOI 10.1182/blood-2015-06-650648; de Olano DG, 2007, CLIN EXP ALLERGY, V37, P1547, DOI 10.1111/j.1365-2222.2007.02804.x; Distler M, 2020, DERMATOLOGY, V236, P529, DOI 10.1159/000504842; Divekar R, 2015, ALLERGY, V70, P1230, DOI 10.1111/all.12668; Doyle LA, 2014, AM J SURG PATHOL, V38, P832, DOI 10.1097/PAS.0000000000000190; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Fellinger C, 2014, ALLERGOL IMMUNOPATH, V42, P544, DOI 10.1016/j.aller.2014.05.002; Galen BT, 2014, BLOOD, V123, P1127, DOI 10.1182/blood-2013-11-538355; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Gonzalez-Gil A, 2018, GLYCOBIOLOGY, V28, P786, DOI 10.1093/glycob/cwy057; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Greenhawt M, 2007, CURR OPIN ALLERGY CL, V7, P387, DOI 10.1097/ACI.0b013e3282a6443e; Greiner G, 2021, BLOOD, V137, P238, DOI 10.1182/blood.2020006157; Gulen T, 2014, CLIN EXP ALLERGY, V44, P121, DOI 10.1111/cea.12225; GURISH MF, 1995, IMMUNITY, V3, P175, DOI 10.1016/1074-7613(95)90087-X; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Haeberli G, 2003, CLIN EXP ALLERGY, V33, P1216, DOI 10.1046/j.1365-2222.2003.01755.x; Hamilton MJ, 2011, J ALLERGY CLIN IMMUN, V128, P147, DOI 10.1016/j.jaci.2011.04.037; Hanjra P, 2018, J ALLER CL IMM-PRACT, V6, P687, DOI 10.1016/j.jaip.2017.08.022; Hartmann K, 2000, HEMATOL ONCOL CLIN N, V14, P625, DOI 10.1016/S0889-8588(05)70299-9; Hartmann K, 2016, J ALLERGY CLIN IMMUN, V137, P35, DOI 10.1016/j.jaci.2015.08.034; Horny HP, 2017, WHO CLASSIFICATION T, V3, P61; Hudson SA, 2011, J CLIN IMMUNOL, V31, P1045, DOI 10.1007/s10875-011-9589-4; Jendoubi F, 2020, CLIN EXP ALLERGY, V50, P654, DOI 10.1111/cea.13592; Khokhar D, 2020, MED CLIN N AM, V104, P177, DOI 10.1016/j.mcna.2019.09.002; Kluin-Nelemans HC, 2020, LEUKEMIA, V34, P1090, DOI 10.1038/s41375-019-0632-4; Knuplez E, 2020, J LEUKOCYTE BIOL, V108, P43, DOI 10.1002/JLB.3HI0120-381R; Kucharewicz I, 2007, J INVEST ALLERG CLIN, V17, P65; Kutty GR, 2019, DIGEST DIS SCI, V64, P152, DOI 10.1007/s10620-018-5298-7; Lange M, 2012, ARCH MED SCI, V8, P533, DOI 10.5114/aoms.2012.29409; Lanternier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001906; Lemal R, 2019, J ALLER CL IMM-PRACT, V7, P2387, DOI 10.1016/j.jaip.2019.03.039; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Lueke AJ, 2016, CLIN BIOCHEM, V49, P979, DOI 10.1016/j.clinbiochem.2016.02.007; Lyons JJ, 2021, J ALLERGY CLIN IMMUN, V147, P622, DOI 10.1016/j.jaci.2020.06.035; Lyons JJ, 2018, IMMUNOL ALLERGY CLIN, V38, P483, DOI 10.1016/j.iac.2018.04.003; Lyons JJ, 2016, NAT GENET, V48, P1564, DOI 10.1038/ng.3696; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Ma DQ, 2014, HISTOPATHOLOGY, V64, P218, DOI 10.1111/his.12212; Maun HR, 2019, CELL, V179, P417, DOI 10.1016/j.cell.2019.09.009; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; METCALFE DD, 1991, J INVEST DERMATOL, V96, pS2, DOI 10.1111/1523-1747.ep12468882; Nycholat CM, 2019, J AM CHEM SOC, V141, P14032, DOI 10.1021/jacs.9b05769; O'Sullivan JA, 2020, J LEUKOCYTE BIOL, V108, P73, DOI 10.1002/JLB.2MR0120-352RR; O'Sullivan JA, 2018, J ALLERGY CLIN IMMUN, V141, P1774, DOI 10.1016/j.jaci.2017.06.028; O'Sullivan JA, 2018, J LEUKOCYTE BIOL, V104, P11, DOI 10.1002/JLB.2HI0917-391R; Orsolini G, 2017, CALCIFIED TISSUE INT, V100, P595, DOI 10.1007/s00223-017-0241-z; Le QT, 2019, J EXP MED, V216, P2348, DOI 10.1084/jem.20190701; Ravi A, 2014, J ALLER CL IMM-PRACT, V2, P775, DOI 10.1016/j.jaip.2014.06.011; Rossini M, 2016, OSTEOPOROSIS INT, V27, P2411, DOI 10.1007/s00198-016-3539-1; Sabato V, 2018, J CLIN IMMUNOL, V38, P457, DOI 10.1007/s10875-018-0506-y; Sagher F, 1967, MASTOCYTOSIS MAST CE, P14; Sahiner UM, 2014, ALLERGY, V69, P265, DOI 10.1111/all.12317; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; Schwartz LB, 2003, J IMMUNOL, V170, P5667, DOI 10.4049/jimmunol.170.11.5667; Siles R, 2013, ACTA DERM-VENEREOL, V93, P354, DOI 10.2340/00015555-1486; Slapnicar C, 2019, CASE REP HEMATOL, V2019, DOI 10.1155/2019/3787586; Smiljkovic D, 2020, J ALLER CL IMM-PRACT, V8, P2761, DOI 10.1016/j.jaip.2020.04.030; SOTER NA, 1991, J INVEST DERMATOL, V96, pS32, DOI 10.1111/1523-1747.ep12468973; Soucie E, 2015, MOL IMMUNOL, V63, P55, DOI 10.1016/j.molimm.2014.03.013; Sperr WR, 2009, EUR J CLIN INVEST, V39, P914, DOI 10.1111/j.1365-2362.2009.02184.x; Sperr WR, 2019, LANCET HAEMATOL, V6, pE638, DOI 10.1016/S2352-3026(19)30166-8; Sperr WR, 2015, AM J CANCER RES, V5, P354; Sperr WR, 2001, BLOOD, V98, P2200, DOI 10.1182/blood.V98.7.2200; Torrelo A, 2012, CURR OPIN PEDIATR, V24, P480, DOI 10.1097/MOP.0b013e328355b248; Trizuljak J, 2020, ALLERGY, V75, P1927, DOI 10.1111/all.14248; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2004, WIEN KLIN WOCHENSCHR, V116, P647, DOI 10.1007/s00508-004-0253-3; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2019, INT ARCH ALLERGY IMM, V180, P44, DOI 10.1159/000501079; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P1125, DOI 10.1016/j.jaip.2019.01.006; Valent P, 2019, J ALLER CL IMM-PRACT, V7, P81, DOI 10.1016/j.jaip.2018.09.024; Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893; Valent P, 2017, CANCER RES, V77, P1261, DOI 10.1158/0008-5472.CAN-16-2234; Valent P, 2012, WIEN KLIN WOCHENSCHR, V124, P807, DOI 10.1007/s00508-012-0293-z; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5; Wei YD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010019; Weiler CR, 2019, J ALLERGY CLIN IMMUN, V144, P883, DOI 10.1016/j.jaci.2019.08.023; Wiechers T, 2015, J ALLERGY CLIN IMMUN, V136, P1581, DOI 10.1016/j.jaci.2015.05.034; Wolff K, 2001, LEUKEMIA RES, V25, P519, DOI 10.1016/S0145-2126(01)00044-3; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yanagihori H, 2005, J MOL DIAGN, V7, P252, DOI 10.1016/S1525-1578(10)60552-1; Yokoi H, 2008, J ALLERGY CLIN IMMUN, V121, P499, DOI 10.1016/j.jaci.2007.10.004; Youngblood BA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010019; Youngblood BA, 2019, INT ARCH ALLERGY IMM, V180, P91, DOI 10.1159/000501637; Youngblood BA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126219; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	111	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2043	2052		10.1016/j.jaci.2021.03.008	http://dx.doi.org/10.1016/j.jaci.2021.03.008		JUN 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33745886	Green Published, Green Accepted			2022-12-18	WOS:000657814800006
J	Mobus, L; Rodriguez, E; Harder, I; Schwarz, A; Wehkamp, U; Stolzl, D; Boraczynski, N; Gerdes, S; Litman, T; Kleinheinz, A; Abraham, S; Heratizadeh, A; Handrick, C; Haufe, E; Schmitt, J; Werfel, T; Weidinger, S				Moebus, Lena; Rodriguez, Elke; Harder, Inken; Schwarz, Agatha; Wehkamp, Ulrike; Stoelzl, Dora; Boraczynski, Nicole; Gerdes, Sascha; Litman, Thomas; Kleinheinz, Andreas; Abraham, Susanne; Heratizadeh, Annice; Handrick, Christiane; Haufe, Eva; Schmitt, Jochen; Werfel, Thomas; Weidinger, Stephan		TREATgermany Study Grp	Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; natural killer cells; skin transcriptome; RNA-Sequencing; gene expression	NATURAL-KILLER; RECEPTOR EXPRESSION; READ ALIGNMENT; SUBSETS; SKIN	Background: Altered quantities, activity, and composition of natural killer (NK) cells in blood as well as expression changes of genes involved in NK-cell function in skin lesions of patients with atopic dermatitis (AD) were recently reported. Objectives: We sought to comprehensively analyze cutaneous NK-cell transcriptomic signatures in AD, and to examine changes under treatment. Methods: We analyzed NK-cell signatures in skin transcriptome data from 57 patients with moderate to severe AD and 31 healthy controls. In addition, changes after 12 weeks of systemic treatment (dupilumab n = 21, cyclosporine n = 8) were analyzed. Deconvolution of leucocyte fractions was conducted. Immunofluorescence staining of NK cells was performed on paraffin-embedded skin sections. Results: Immunofluorescence staining revealed a relatively high abundance of both NK cells and CD3(+)CD56(+) cells in lesional as compared with nonlesional and healthy skin. Lesional and to a lesser extent nonlesional skin showed a strong upregulation of NK-cell markers together with a dysbalanced expression of inhibitory and activating receptors, which was not reverted under treatment. Digital cytometry showed a decrease in activated and an increase in resting NK cells in both lesional and nonlesional skin, which was reverted by both treatment with dupilumab and cyclosporine. The NK-cell transcriptomic signature remained upregulated after treatment, but there was a shift on the qualitative level, indicating a compositional change in NK-cell subsets toward CD56(bright) NK cells. Conclusions: Lesional AD skin shows a NK-cell dysregulation, which despite clinical improvement under systemic therapy was only partially reverted, and which may represent a yet underappreciated disease mechanism.	[Moebus, Lena; Rodriguez, Elke; Harder, Inken; Schwarz, Agatha; Wehkamp, Ulrike; Stoelzl, Dora; Boraczynski, Nicole; Gerdes, Sascha; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Venereol & Allergol, Campus Kiel, Kiel, Germany; [Litman, Thomas] LEO Pharma AS, Explorat Biol, Ballerup, Denmark; [Kleinheinz, Andreas] Elbe Med Ctr, Dept Dermatol, Buxtehude, Germany; [Abraham, Susanne] Carl Gustav Carus Univ, TU Dresden, Med Ctr, Univ Allergy Ctr, Dresden, Germany; [Heratizadeh, Annice; Werfel, Thomas] Hannover Med Sch, Dept Dermatol Allergol & Venereol, Div Immunodermatol & Allergy Res, Hannover, Germany; [Handrick, Christiane] Dr Med Christiane Handrick, Practice Dermatol & Venereol, Berlin, Germany; [Haufe, Eva; Schmitt, Jochen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Ctr Evidence Based Hlth Care ZEGV, Dresden, Germany	University of Kiel; Schleswig Holstein University Hospital; LEO Pharma; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hannover Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Weidinger, S (corresponding author), Arnold Heller Str 3, D-24105 Kiel, Germany.	sweidinger@dermatology.uni-kiel.de	Gerdes, Sascha/J-4308-2017	Gerdes, Sascha/0000-0002-6667-7757; Litman, Thomas/0000-0002-6068-901X; Schmitt, Jochen/0000-0003-0264-0960; Rodriguez, Elke/0000-0003-3692-3950; Mobus, Lena/0000-0003-0685-0893; Sander, Nicole/0000-0001-9084-7069	Sanofi-Aventis Deutschland GmbH; BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) - Innovative Medicines Initiative 2 Joint Undertaking [821511]; European Union's Horizon 2020 research and innovation programme; European Federation of Pharmaceutical Industries and Associations (EFPIA); DFG Cluster of Excellence "Precision Medicine in Inflammation'' [EXC2167]	Sanofi-Aventis Deutschland GmbH(Sanofi-Aventis); BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) - Innovative Medicines Initiative 2 Joint Undertaking; European Union's Horizon 2020 research and innovation programme; European Federation of Pharmaceutical Industries and Associations (EFPIA); DFG Cluster of Excellence "Precision Medicine in Inflammation''(German Research Foundation (DFG))	TREATgermany is financially supported by Sanofi-Aventis Deutschland GmbH. This work also received support through BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis), a project funded by the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement no. 821511). The Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Infrastructure support was provided through the DFG Cluster of Excellence "Precision Medicine in Inflammation'' (grant no. EXC2167).	Aktas E, 2005, CLIN EXP IMMUNOL, V140, P301, DOI 10.1111/j.1365-2249.2005.02777.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ben-Moshe NB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11257-y; Bryceson Y. T., 2006, IMMUNOL REV, V29, P997; Buentke E, 2002, J INVEST DERMATOL, V119, P850, DOI 10.1046/j.1523-1747.2002.00132.x; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Heratizadeh A, 2020, J EUR ACAD DERMATOL, V34, P1263, DOI 10.1111/jdv.16078; JENSEN JR, 1984, J INVEST DERMATOL, V82, P30, DOI 10.1111/1523-1747.ep12259055; Kabashima K, 2020, J ALLERGY CLIN IMMUN, V146, P276, DOI 10.1016/j.jaci.2020.04.052; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiselevsky DB, 2020, BIOCHEMISTRY-MOSCOW+, V85, P131, DOI 10.1134/S0006297920020017; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LEVER RS, 1985, CLIN ALLERGY, V15, P479, DOI 10.1111/j.1365-2222.1985.tb02298.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luci C, 2012, BRIT J DERMATOL, V166, P789, DOI 10.1111/j.1365-2133.2012.10814.x; Mack MR, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1005; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mobus L, 2021, J ALLERGY CLIN IMMUN, V147, P213, DOI 10.1016/j.jaci.2020.06.012; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Peng H, 2017, SEMIN IMMUNOL, V31, P3, DOI 10.1016/j.smim.2017.07.006; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; WEHRMANN W, 1990, INT ARCH ALLER A IMM, V92, P318, DOI 10.1159/000235196; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895	31	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1959	+		10.1016/j.jaci.2020.11.022	http://dx.doi.org/10.1016/j.jaci.2020.11.022		MAY 2021	9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZE	33390269	Green Published			2022-12-18	WOS:000651594000004
J	Jakiela, B; Soja, J; Sladek, K; Przybyszowski, M; Plutecka, H; Gielicz, A; Rebane, A; Bochenek, G				Jakiela, Bogdan; Soja, Jerzy; Sladek, Krzysztof; Przybyszowski, Marek; Plutecka, Hanna; Gielicz, Anna; Rebane, Ana; Bochenek, Grazyna			Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; NSAID-exacerbated respiratory disease; airway inflammation; asthma endotypes; biomarkers		Background: Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) asthma is characterized by chronic rhinosinusitis and intolerance of aspirin and other COX1 inhibitors. Clinical data point to a heterogeneity within the N-ERD phenotype. Objective: Our aim was to investigate immune mediator profiles in the lower airways of patients with N-ERD. Methods: Levels of cytokines (determined by using Luminex assay) and eicosanoids (determined by using mass spectrometry) were measured in bronchoalveolar lavage fluid (BALF) from patients with N-ERD (n = 22), patients with NSAID-tolerant asthma (n = 21), and control subjects (n = 11). mRNA expression in BALF cells was quantified by using TaqMan low-density arrays. Results: Lower airway eosinophilia was more frequent in N-ERD (54.5%) than in NSAID-tolerant asthma (9.5% [P = .009]). The type-2 (T2) immune signature of BALF cells was more pronounced in the eosinophilic subphenotype of N-ERD. Similarly, BALF concentrations of periostin and CCL26 were significantly increased in eosinophilic N-ERD and correlated with T2 signature in BALF cells. Multiparameter analysis of BALF mediators of all patients with asthma revealed the presence of 2 immune endotypes: T2-like (with an elevated level of periostin in BALF) and non-T2/proinflammatory (with higher levels of matrix metalloproteinases and inflammatory cytokines). Patients with N-ERD were classified mostly as having the T2 endotype (68%). Changes in eicosanoid profile (eg, increased leukotriene E-4 level) were limited to patients with N-ERD with airway eosinophilia. Blood eosinophilia appeared to be a useful predictor of airway T2 signature (area under the curve [AUC] = 0.83); however, surrogate biomarkers had moderate performance in distinguishing eosinophilic N-ERD (for blood eosinophils, AUC = 0.72; for periostin, AUC = 0.75). Conclusions: Lower airway immune profiles show considerable heterogeneity of N-ERD, with skewing toward T2 response and eosinophilic inflammation. Increased production of leukotriene E-4 was restricted to a subgroup of patients with eosinophilia in the lower airway.	[Jakiela, Bogdan; Soja, Jerzy; Sladek, Krzysztof; Przybyszowski, Marek; Plutecka, Hanna; Gielicz, Anna; Bochenek, Grazyna] Jagiellonian Univ, Coll Med, Fac Med, Dept Internal Med, Jakubowskiego 2, PL-30688 Krakow, Poland; [Rebane, Ana] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia	Jagiellonian University; Collegium Medicum Jagiellonian University; University of Tartu	Bochenek, G (corresponding author), Jagiellonian Univ, Coll Med, Fac Med, Dept Internal Med, Jakubowskiego 2, PL-30688 Krakow, Poland.	mmbochen@cyf-kr.edu.pl	Rebane, Ana/D-4279-2013; Jakiela, Bogdan/CAA-1861-2022	Rebane, Ana/0000-0001-6051-1361; Jakiela, Bogdan/0000-0003-0444-981X; Bochenek, Grazyna/0000-0003-2455-7041	Polish National Science Center [UMO-2014/15/B/NZ5/01539]; Estonian Research Council [PUT1669]	Polish National Science Center; Estonian Research Council(Estonian Research Council)	Supported by the Polish National Science Center (grant UMO-2014/15/B/NZ5/01539 [to G.B.]) and a personal research grant from the Estonian Research Council (grant number PUT1669 [to A.R.]).	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Adamjee J, 2006, J PATHOL, V209, P392, DOI 10.1002/path.1979; Allinne J, 2019, J ALLERGY CLIN IMMUN, V144, P1624, DOI 10.1016/j.jaci.2019.08.039; Balbi B, 2007, EUR RESPIR J, V30, P769, DOI 10.1183/09031936.00112306; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; Bochenek G, 2014, J ALLERGY CLIN IMMUN, V133, P98, DOI 10.1016/j.jaci.2013.07.004; Brooks CR, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0511-6; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Eastman JJ, 2017, J ALLERGY CLIN IMMUN, V140, P101, DOI 10.1016/j.jaci.2016.11.023; Elston WJ, 2004, EUR RESPIR J, V24, P375, DOI 10.1183/09031936.04.00063003; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P53, DOI 10.1164/ajrccm.152.1.7599862; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Gorska K, 2016, POL ARCH MED WEWN, V126, P124, DOI 10.20452/pamw.3299; Grootendorst DC, 1997, CLIN EXP ALLERGY, V27, P769, DOI 10.1111/j.1365-2222.1997.tb01211.x; Grunwell JR, 2019, J ALLER CL IMM-PRACT, V7, P516, DOI 10.1016/j.jaip.2018.08.024; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Heron M, 2012, CLIN EXP IMMUNOL, V167, P523, DOI 10.1111/j.1365-2249.2011.04529.x; Higashi A, 2012, INT ARCH ALLERGY IMM, V158, P299, DOI 10.1159/000331433; Ishida A, 2012, ALLERGOL INT, V61, P589, DOI 10.2332/allergolint.11-OA-0370; Izuhara K, 2016, AM J RESP CRIT CARE, V193, P949, DOI 10.1164/rccm.201510-2032PP; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Kim MA, 2014, ANN ALLERG ASTHMA IM, V113, P314, DOI 10.1016/j.anai.2014.06.014; Kowalski ML, 2002, ALLERGY, V57, P493, DOI 10.1034/j.1398-9995.2002.13508.x; Lee HY, 2017, ALLERGY, V72, P616, DOI 10.1111/all.13075; Lefaudeux D, 2017, J ALLERGY CLIN IMMUN, V139, P1797, DOI 10.1016/j.jaci.2016.08.048; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; Li Y, 2018, J IMMUNOL, V200, P2253, DOI 10.4049/jimmunol.1701455; Lim HF, 2018, SEMIN RESP CRIT CARE, V39, P56, DOI 10.1055/s-0037-1606217; MAESTRELLI P, 1995, AM J RESP CRIT CARE, V152, P1926, DOI 10.1164/ajrccm.152.6.8520757; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Mastalerz L, 2015, CLIN EXP ALLERGY, V45, P1779, DOI 10.1111/cea.12654; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nasser SMS, 1996, AM J RESP CRIT CARE, V153, P90, DOI 10.1164/ajrccm.153.1.8542168; Park HS, 1998, ANN ALLERG ASTHMA IM, V81, P219, DOI 10.1016/S1081-1206(10)62815-3; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Rutgers SR, 2000, EUR RESPIR J, V15, P109, DOI 10.1183/09031936.00.15110900; Sanak M, 2011, J ALLERGY CLIN IMMUN, V127, P1141, DOI 10.1016/j.jaci.2010.12.1108; SLADEK K, 1994, AM J RESP CRIT CARE, V149, P940, DOI 10.1164/ajrccm.149.4.8143059; Sousa AR, 1997, AM J RESP CRIT CARE, V156, P1384, DOI 10.1164/ajrccm.156.5.9702072; Steinke JW, 2014, J IMMUNOL, V193, P41, DOI 10.4049/jimmunol.1301753; Szczeklik A, 1996, AM J RESP CRIT CARE, V154, P1608, DOI 10.1164/ajrccm.154.6.8970343; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Tulic MK, 2001, RESP RES, V2, P333, DOI 10.1186/rr83; Varga EM, 1999, EUR RESPIR J, V14, P610, DOI 10.1034/j.1399-3003.1999.14c21.x; Wagener AH, 2015, THORAX, V70, P115, DOI 10.1136/thoraxjnl-2014-205634; Wei Y, 2018, J THORAC DIS, V10, P6585, DOI 10.21037/jtd.2018.11.12; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	51	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1269	1280		10.1016/j.jaci.2020.08.007	http://dx.doi.org/10.1016/j.jaci.2020.08.007		APR 2021	12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	32810516				2022-12-18	WOS:000637368900017
J	Shilts, MH; Rosas-Salazar, C; Turi, KN; Rajan, D; Rajagopala, SV; Patterson, MF; Gebretsadik, T; Anderson, LJ; Peebles, RS; Hartert, TV; Das, SR				Shilts, Meghan H.; Rosas-Salazar, Christian; Turi, Kedir N.; Rajan, Devi; Rajagopala, Seesandra V.; Patterson, Megan F.; Gebretsadik, Tebeb; Anderson, Larry J.; Peebles, R. Stokes, Jr.; Hartert, Tina V.; Das, Suman R.			Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; CHILDREN; ASSOCIATION; VALIDATION; RISK		[Shilts, Meghan H.; Rajagopala, Seesandra V.; Das, Suman R.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA; [Turi, Kedir N.; Patterson, Megan F.; Peebles, R. Stokes, Jr.; Hartert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Rosas-Salazar, Christian] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Allergy Immunol & Pulm Med, Nashville, TN 37232 USA; [Gebretsadik, Tebeb] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Das, Suman R.] Vanderbilt Univ, Med Ctr, Dept Otolaryngol, Nashville, TN 37232 USA; [Das, Suman R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Rajan, Devi; Anderson, Larry J.] Emory Univ, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Das, SR (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA.; Hartert, TV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA.; Das, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Otolaryngol, Nashville, TN 37232 USA.; Das, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.	tina.hartert@vanderbilt.edu; suman.r.das@vumc.org	Rosas-Salazar, Christian/AAC-8571-2021	Rosas-Salazar, Christian/0000-0001-6644-5780; Das, Suman/0000-0003-2496-9724	National Institute of Allergy and Infectious Diseases [U19AI095227, K24AI77930, HHSN272200900007C, R21AI142321, U19AI110819]; National Heart, Lung, and Blood Institute [K23HL148638, R01HL146401]; Parker B. Francis Fellowship Program; Vanderbilt Institute for Clinical and Translational Research (National Center for Advancing Translational Sciences) [UL1TR000445]; Vanderbilt Technologies for Advanced Genomics Core (National Institutes of Health) [UL1RR024975, P30CA68485, P30EY08126, G20RR030956]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Fellowship Program; Vanderbilt Institute for Clinical and Translational Research (National Center for Advancing Translational Sciences); Vanderbilt Technologies for Advanced Genomics Core (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by funds from the National Institute of Allergy and Infectious Diseases (under awards U19AI095227, K24AI77930, HHSN272200900007C, R21AI142321, and U19AI110819); the National Heart, Lung, and Blood Institute (under awards K23HL148638 and R01HL146401); the Parker B. Francis Fellowship Program; the Vanderbilt Institute for Clinical and Translational Research (grant support from the National Center for Advancing Translational Sciences under award UL1TR000445); and the Vanderbilt Technologies for Advanced Genomics Core (grant support from the National Institutes of Health under awards UL1RR024975, P30CA68485, P30EY08126, and G20RR030956).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2015, GENES ENVIRONMENTS A; [Anonymous], 2020, MGI FREEZE2 PHEWEB; [Anonymous], 2018, GWAS ROUND 2 RESULTS; Bellinghausen C, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0382-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Desideria D, 2007, RECENT PATENTS INFLA, V1, P237, DOI 10.2174/187221307782418847; Ederveen THA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0395-y; Gulraiz F, 2015, FASEB J, V29, P849, DOI 10.1096/fj.14-254359; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kang H.M, 2016, EPACTS EFFICIENT PAR; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mansbach JM, 2019, J INFECT DIS, V219, P1804, DOI 10.1093/infdis/jiy741; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Reeves SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34021-6; Rosas-Salazar C, 2018, J ALLERGY CLIN IMMUN, V142, P1447, DOI 10.1016/j.jaci.2017.10.049; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobota RS, 2015, ANN HUM GENET, V79, P136, DOI 10.1111/ahg.12095; Sonawane AR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50217-w; Turi KN, 2018, AM J RESP CRIT CARE, V198, P1064, DOI 10.1164/rccm.201711-2348OC; UKBiobank ICD PheWeb, 2020, ANAL 1403 ICD BASED; Westergren-Thorsson G, 2010, CLIN RESPIR J, V4, P1, DOI 10.1111/j.1752-699X.2010.00190.x; White MJ, 2016, IMMUNOGENETICS, V68, P391, DOI 10.1007/s00251-016-0914-1	31	5	5	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1097	+		10.1016/j.jaci.2020.06.023	http://dx.doi.org/10.1016/j.jaci.2020.06.023		MAR 2021	16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32628963	Bronze, Green Published			2022-12-18	WOS:000635524300016
J	Kutukculer, N; Seeholzer, T; O'Neill, TJ; Grass, C; Aykut, A; Karaca, NE; Durmaz, A; Cogulu, O; Aksu, G; Gehring, T; Gewies, A; Krappmann, D				Kutukculer, Necil; Seeholzer, Thomas; O'Neill, Thomas J.; Grass, Carina; Aykut, Ayca; Karaca, Neslihan Edeer; Durmaz, Asude; Cogulu, Ozgur; Aksu, Guzide; Gehring, Torben; Gewies, Andreas; Krappmann, Daniel			Human immune disorder associated with homozygous hypomorphic mutation affecting MALT1B splice variant	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNODEFICIENCY		[Kutukculer, Necil; Karaca, Neslihan Edeer; Aksu, Guzide] Ege Univ, Fac Med, Dept Pediat Immunol, Izmir, Turkey; [Aykut, Ayca; Durmaz, Asude; Cogulu, Ozgur] Ege Univ, Fac Med, Dept Med Genet, Izmir, Turkey; [Seeholzer, Thomas; O'Neill, Thomas J.; Grass, Carina; Gehring, Torben; Gewies, Andreas; Krappmann, Daniel] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Cellular Signal Integrat, Neuherberg, Germany	Ege University; Ege University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kutukculer, N (corresponding author), Ege Univ, Fac Med, Dept Pediat Immunol, Izmir, Turkey.	necil.kutukculer@ege.edu.tr; daniel.krappmann@helmholtz-muenchen.de	Krappmann, Daniel/ABF-4038-2021; Aykut, Ayca/B-1698-2018; Krappmann, Daniel/AAT-4354-2021	Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; O'Neill, Thomas/0000-0003-2253-3118; Seeholzer, Thomas/0000-0002-1115-3358; Gewies, Andreas/0000-0002-7606-6482	Jeffrey Modell Foundation; Deutsche Forschungsgemeinschaft [SFB 1054/A04, SFB 1335/P07]	Jeffrey Modell Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Caspar Ohnmacht for technical support. Our work in Turkey was supported by the Jeffrey Modell Foundation. The work by D.K. was supported by the Deutsche Forschungsgemeinschaft (grants SFB 1054/A04 and SFB 1335/P07).	Aksu G, 2005, TURKISH J PEDIATR, V47, P19; Frizinsky S, 2019, J CLIN IMMUNOL, V39, P401, DOI 10.1007/s10875-019-00629-0; Kverneland AH, 2016, CYTOM PART A, V89A, P543, DOI 10.1002/cyto.a.22855; Lu HY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02078; McKinnon ML, 2014, J ALLERGY CLIN IMMUN, V133, P1458, DOI 10.1016/j.jaci.2013.10.045; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Quancard J, 2019, NAT CHEM BIOL, V15, P304, DOI 10.1038/s41589-018-0222-1; Schnappauf O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01745; Zotti T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02167	9	5	5	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					775	+		10.1016/j.jaci.2020.07.034	http://dx.doi.org/10.1016/j.jaci.2020.07.034		FEB 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32858082	Bronze, Green Published			2022-12-18	WOS:000616665800049
J	Morice, A; Birring, S; Dicpinigaitis, P; McGarvey, L; Pavord, I; Smith, J; La Rosa, C; Li, Q; Nguyen, AM; Schelfhout, J; Tzontcheva, A; Muccino, D				Morice, Alyn; Birring, Surinder; Dicpinigaitis, Peter; McGarvey, Lorcan; Pavord, Ian; Smith, Jaclyn; La Rosa, Carmen; Li, Qing; Nguyen, Allison Martin; Schelfhout, Jonathan; Tzontcheva, Anjela; Muccino, David			Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									[Morice, Alyn] Univ Hull, Kingston Upon Hull, N Humberside, England; [Birring, Surinder] Kings Coll London, London, England; [Dicpinigaitis, Peter] Jack D Weiler Hosp, Bronx, NY USA; [Pavord, Ian] Univ Oxford, Oxford, England; [Smith, Jaclyn] Univ Manchester, Manchester, Lancs, England; [La Rosa, Carmen; Li, Qing; Nguyen, Allison Martin; Schelfhout, Jonathan; Tzontcheva, Anjela; Muccino, David] Merck & Co Inc, Kenilworth, NJ USA	University of Hull; University of London; King's College London; University of Oxford; University of Manchester; Merck & Company			Birring, Surinder/GWU-6967-2022						0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2		S		188	AB61	AB61						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QX2DK					2022-12-18	WOS:000629158000189
J	Lipworth, B; Chan, R; Kuo, CR				Lipworth, Brian; Chan, Rory; Kuo, Chris RuiWen			Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Lipworth, Brian; Chan, Rory; Kuo, Chris RuiWen] Univ Dundee, Scottish Ctr Resp Res, Ninewells Hosp & Med Sch, Rhinol Mega Clin, Dundee, Scotland	University of Dundee	Lipworth, B (corresponding author), Univ Dundee, Scottish Ctr Resp Res, Ninewells Hosp & Med Sch, Rhinol Mega Clin, Dundee, Scotland.			Lipworth, Brian/0000-0002-8140-2014	Genentech, Inc; Novartis Pharma AG; Novartis Pharmaceuticals Corporation; Roche Group	Genentech, Inc(Roche HoldingGenentech); Novartis Pharma AG; Novartis Pharmaceuticals Corporation(Novartis); Roche Group	The original study was funded by Genentech, Inc, a member of the Roche Group, and Novartis Pharma AG. Third-party writing assistance was provided by Jack Pike, PhD, CMPP, of Envision Pharma, Inc, and funded by Genentech, Inc, a member of the Roche Group, and Novartis Pharmaceuticals Corporation.	Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Cardell LO, 2020, J ALLERGY CLIN IMMUN, V145, P752, DOI 10.1016/j.jaci.2020.01.019; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Corren J, 2020, J ALLER CL IMM-PRACT, V8, P516, DOI 10.1016/j.jaip.2019.08.050; Gevaert P, 2020, J ALLERGY CLIN IMMUN, V146, P595, DOI 10.1016/j.jaci.2020.05.032	5	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					413	414		10.1016/j.jaci.2020.09.024	http://dx.doi.org/10.1016/j.jaci.2020.09.024		JAN 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	33160644	Bronze			2022-12-18	WOS:000607781700021
J	Peters, RL; Barret, DY; Soriano, VX; McWilliam, V; Lowe, AJ; Ponsonby, AL; Tang, MLK; Dharmage, SC; Gurrin, LC; Koplin, JJ; Perrett, KP				Peters, Rachel L.; Barret, Danny Ye; Soriano, Victoria X.; McWilliam, Vicki; Lowe, Adrian J.; Ponsonby, Anne-Louise; Tang, Mimi L. K.; Dharmage, Shyamali C.; Gurrin, Lyle C.; Koplin, Jennifer J.; Perrett, Kirsten P.			No cashew allergy in infants introduced to cashew by age 1 year	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RISK		[Peters, Rachel L.; Barret, Danny Ye; Soriano, Victoria X.; McWilliam, Vicki; Lowe, Adrian J.; Ponsonby, Anne-Louise; Tang, Mimi L. K.; Dharmage, Shyamali C.; Koplin, Jennifer J.; Perrett, Kirsten P.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Peters, Rachel L.; Barret, Danny Ye; Soriano, Victoria X.; Tang, Mimi L. K.; Koplin, Jennifer J.; Perrett, Kirsten P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [McWilliam, Vicki; Tang, Mimi L. K.; Perrett, Kirsten P.] Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic, Australia; [Lowe, Adrian J.; Dharmage, Shyamali C.; Gurrin, Lyle C.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Ponsonby, Anne-Louise] Florey Inst, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Perrett, KP (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Perrett, KP (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.; Perrett, KP (corresponding author), Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic, Australia.	kirsten.perrett@rch.org.au	; Perrett, Kirsten/P-8813-2019	Koplin, Jennifer/0000-0002-7576-5142; Tang, Mimi/0000-0002-3839-5293; Peters, Rachel/0000-0002-2411-6628; Perrett, Kirsten/0000-0002-5683-996X; Soriano, Victoria Ximena/0000-0002-8412-5657	National Health and Medical Research Council (NHMRC) of Australia [491233, 1006215]; Ilhan Food Allergy Foundation; AnaphylaxiStop; Charles and Sylvia Viertel Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program; NHMRC Centre for Food and Allergy Research; NHMRC; NHMRC fellowships; Melbourne Children's Clinician-Scientist Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ilhan Food Allergy Foundation; AnaphylaxiStop; Charles and Sylvia Viertel Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program; NHMRC Centre for Food and Allergy Research(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Children's Clinician-Scientist Fellowship	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia project grants (491233 and 1006215), Ilhan Food Allergy Foundation, AnaphylaxiStop, the Charles and Sylvia Viertel Medical Research Foundation, the Victorian Government's Operational Infrastructure Support Program, and the NHMRC Centre for Food and Allergy Research. V.X.S. is supported by a PhD scholarship from the NHMRC-funded Centre for Food and Allergy Research. R.L.P., A.-L.P., A.J.L., S.C.D., J.J.K., and K.P.P. hold or held NHMRC fellowships during data collection for this article. K.P.P. is supported by a Melbourne Children's Clinician-Scientist Fellowship. The researchers were independent of the funders.	Australian Society of Clinical Immunolgy and Allergy, 2016, INF FEED ALL PREV; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Koplin JJ, 2015, INT J EPIDEMIOL, V44, P1161, DOI 10.1093/ije/dyu261; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; McWilliam V, 2019, J ALLERGY CLIN IMMUN, V143, P644, DOI 10.1016/j.jaci.2018.07.038; Mullins RJ, 2016, CLIN EXP ALLERGY, V46, P1099, DOI 10.1111/cea.12748; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					383	384		10.1016/j.jaci.2020.07.003	http://dx.doi.org/10.1016/j.jaci.2020.07.003		JAN 2021	2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32693093	Bronze			2022-12-18	WOS:000607781700011
J	Kumar, R; Ferrie, RP; Balmert, LC; Kienzl, M; Rifas-Shiman, SL; Gold, DR; Sordillo, JE; Kleinman, K; Camargo, CA; Litonjua, AA; Oken, E; Cook-Mills, JM				Kumar, Rajesh; Ferrie, Ryan P.; Balmert, Lauren C.; Kienzl, Matthew; Rifas-Shiman, Sheryl L.; Gold, Diane R.; Sordillo, Joanne E.; Kleinman, Ken; Camargo, Carlos A., Jr.; Litonjua, Augusto A.; Oken, Emily; Cook-Mills, Joan M.			Associations of alpha- and gamma-tocopherol during early life with lung function in childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Tocopherol isoforms; lung function; child	MATERNAL PREPREGNANCY OBESITY; VITAMIN-E ISOFORMS; CELLS IN-UTERO; DENDRITIC CELLS; WEIGHT-GAIN; ALLERGIC INFLAMMATION; INFANT FORMULA; UNITED-STATES; ASTHMA; CHILDREN	Background: Tocopherol isoforms may regulate child lung growth and spirometric measures. Objective: Our aim was to determine the extent to which plasma alpha-tocopherol (alpha-T) or g-tocopherol (gamma-T) isoform levels in early childhood or in utero are associated with childhood lung function. Methods: We included 622 participants in the Project Viva cohort who had lung function at a mid-childhood visit (age 6-10 years). Maternal and child tocopherol isoform levels were measured by HPLC at the second trimester and 3 years of age, respectively. Multivariable linear regression models (adjusted for mid-childhood body mass index z scores, maternal education, smoking in pregnancy, and prenatal particulate matter with diameter of <2.5 micrometers (PM2.5) particulate exposure) stratified by tertiles of child gamma-T level were used to assess the association of alpha-T levels with FEV1 and forced vital capacity (FVC) percent predicted. Similarly, models stratified by child alpha-T tertile evaluated associations of g-T levels with lung function. We performed similar analyses with maternal second trimester tocopherol isoform levels. Results: The median maternal second trimester alpha-T level was 63 mM (interquartile range = 47-82). The median early-childhood level was 25 mM (interquartile range = 20-33 mM). In the lowest tertile of early-childhood gamma-T, children with a higher alpha-T level (per 10 mM) had a higher mid-childhood FEV1 percent predicted (beta = 3.09; 95% CI = 0.58-5.59 and a higher FVC percent predicted (beta = 2.77; 95% CI = 0.47-5.06). This protective association of alpha-T was lost at higher gamma-T levels. We did not see any consistent associations of second trimester levels of either alpha-T or gamma-T with mid-childhood FEV1 or FVC. Conclusion: When gamma-T levels were in the lowest tertile, a higher early-childhood alpha-T level was associated with better lung function at mid-childhood. Second trimester maternal plasma alpha-T concentration was 3-fold higher than in the adult nonpregnant female population.	[Kumar, Rajesh] Lurie Childrens Hosp, Chicago, IL USA; [Kumar, Rajesh; Ferrie, Ryan P.; Balmert, Lauren C.; Kienzl, Matthew] Northwestern Univ, Chicago, IL 60611 USA; [Rifas-Shiman, Sheryl L.; Sordillo, Joanne E.; Oken, Emily] Harvard Med Sch, Dept Populat Med, Div Chron Dis Res Lifecourse, Boston, MA 02115 USA; [Rifas-Shiman, Sheryl L.; Sordillo, Joanne E.; Oken, Emily] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Gold, Diane R.; Camargo, Carlos A., Jr.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Kleinman, Ken] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Camargo, Carlos A., Jr.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Litonjua, Augusto A.] Univ Rochester, Med Ctr, Div Pediat Pulm Med, Rochester, NY 14642 USA; [Cook-Mills, Joan M.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Van Nuys Med Sci Bldg MS 2059,635 Barnhill Dr, Indianapolis, IN 46202 USA; [Cook-Mills, Joan M.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Microbiol, Indianapolis, IN 46202 USA; [Cook-Mills, Joan M.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Immunol, Indianapolis, IN 46202 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Rochester; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Cook-Mills, JM (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Van Nuys Med Sci Bldg MS 2059,635 Barnhill Dr, Indianapolis, IN 46202 USA.	joancook@iu.edu	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Kumar, Rajesh/0000-0002-1962-7108	National Institutes of Health (NIH), United States [R01AI127695];  [HHSN2752011300013C];  [U19AR06952];  [UG1HL139125];  [R01HD034568];  [R01AI102960];  [UH3OD023286]	National Institutes of Health (NIH), United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; 	J. M. Cook-Mills was supported by National Institutes of Health (NIH) grant R01AI127695, United States. R. Kumar was supported by NIH grant R01AI127695, as well as by grants HHSN2752011300013C, U19AR06952, and UG1HL139125, United States. Project Viva is supported by grants R01HD034568, R01AI102960, and UH3OD023286, United States.	Abdala-Valencia H, 2016, AM J PHYSIOL-LUNG C, V310, pL759, DOI 10.1152/ajplung.00301.2015; Abdala-Valencia H, 2014, AM J PHYSIOL-LUNG C, V307, pL482, DOI 10.1152/ajplung.00132.2014; Abdala-Valencia H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041054; Akinbami LJ, 2001, NCHS DATA BRIEF, V2012, P1; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Arlt O, 2014, CELL PHYSIOL BIOCHEM, V34, P27, DOI 10.1159/000362982; Backman K, 2018, CLIN EXP ALLERGY, V48, P138, DOI 10.1111/cea.13062; Barcelo-Coblijn G, 2007, BBA-MOL BASIS DIS, V1772, P556, DOI 10.1016/j.bbadis.2006.12.008; Berdnikovs S, 2009, J IMMUNOL, V182, P4395, DOI 10.4049/jimmunol.0803659; Bloise E, 2016, HUM REPROD UPDATE, V22, P164, DOI 10.1093/humupd/dmv049; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Boyle FG, 1996, ANN NUTR METAB, V40, P234, DOI 10.1159/000177927; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Buschard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052639; Chan JYC, 2015, PEDIATRICS, V135, P607, DOI 10.1542/peds.2014-3060; Chatkin Moema Nudilemon, 2008, J. bras. pneumol., V34, P764, DOI 10.1590/S1806-37132008001000003; CHATTERJEE S, 1984, LIPIDS, V19, P363, DOI 10.1007/BF02534789; Chu SY, 2009, MATERN CHILD HLTH J, V13, P614, DOI 10.1007/s10995-008-0388-3; CLARKE JTR, 1981, CAN J BIOCHEM CELL B, V59, P412, DOI 10.1139/o81-057; Cook-Mills J, 2016, THORAX, V71, P954, DOI 10.1136/thoraxjnl-2016-208494; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Cook-Mills Joan M., 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P348; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Fedulov AV, 2011, AM J RESP CELL MOL, V44, P285, DOI 10.1165/rcmb.2009-0400OC; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Friebele E, 1996, ENVIRON HEALTH PERSP, V104, P22, DOI 10.2307/3432754; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P532, DOI 10.1016/j.jaci.2011.06.037; Halonen M, 2013, AM J RESP CRIT CARE, V188, P35, DOI 10.1164/rccm.201207-1265OC; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hollams EM, 2014, AM J RESP CRIT CARE, V189, P401, DOI 10.1164/rccm.201302-0323OC; Hyvarinen MK, 2007, ACTA PAEDIATR, V96, P1464, DOI 10.1111/j.1651-2227.2007.00458.x; Ilan Y, 2009, CLIN EXP IMMUNOL, V158, P300, DOI 10.1111/j.1365-2249.2009.04030.x; Joseph-Bowen J, 2004, AM J RESP CRIT CARE, V169, P850, DOI 10.1164/rccm.200304-556OC; Khare A, 2015, J IMMUNOL, V195, P431, DOI 10.4049/jimmunol.1500474; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kumar R, 2010, PEDIAT ALLER IMM PUL, V23, P183, DOI 10.1089/ped.2010.0032; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Legutko A, 2011, J IMMUNOL, V187, P4517, DOI 10.4049/jimmunol.1101493; Leme AS, 2006, J IMMUNOL, V176, P762, DOI 10.4049/jimmunol.176.2.762; Leonard SW, 2002, AM J CLIN NUTR, V75, P555, DOI 10.1093/ajcn/75.3.555; Levkau B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00243; Lim RH, 2009, AM J REPROD IMMUNOL, V61, P1, DOI 10.1111/j.1600-0897.2008.00671.x; Litonjua AA, 2006, AM J CLIN NUTR, V84, P903, DOI 10.1093/ajcn/84.4.903; Lowe A, 2011, J ALLERGY CLIN IMMUN, V128, P1107, DOI 10.1016/j.jaci.2011.08.025; Luisi F, 2012, J BRAS PNEUMOL, V38, P158, DOI 10.1590/S1806-37132012000200003; Lundstrom SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033780; Marchese ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-31; Marchese ME, 2012, BIOCHEMISTRY-US, V51, P8235, DOI 10.1021/bi300925r; Martinez FD, 2007, EUR RESPIR J, V29, P179, DOI 10.1183/09031936.00087906; McCary CA, 2012, BIOCHEM J, V441, P189, DOI 10.1042/BJ20111318; McCary CA, 2011, J IMMUNOL, V186, P3674, DOI 10.4049/jimmunol.1003037; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nelson SE, 1996, AM J CLIN NUTR, V64, P291, DOI 10.1093/ajcn/64.3.291; Otto C, 2018, QUAL LIFE RES, V27, P879, DOI 10.1007/s11136-017-1753-8; Palmer LJ, 2001, AM J RESP CRIT CARE, V163, P37, DOI 10.1164/ajrccm.163.1.2005013; Patel SP, 2012, J EPIDEMIOL COMMUN H, V66, P809, DOI 10.1136/jech.2011.133777; Pike KC, 2013, THORAX, V68, P372, DOI 10.1136/thoraxjnl-2012-202556; Podda M, 1996, J LIPID RES, V37, P893; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rapp KI, 2018, HEALTH PROMOT PRACT, V19, P233, DOI 10.1177/1524839917740126; Reichman NE, 2008, MATERN CHILD HLTH J, V12, P725, DOI 10.1007/s10995-007-0292-2; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; Strait RT, 2016, EXPERT REV RESP MED, V10, P881, DOI 10.1080/17476348.2016.1184090; Sullivan PW, 2017, ANN ALLERG ASTHMA IM, V119, P246, DOI 10.1016/j.anai.2017.07.002; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; UAUY R, 1994, J PEDIATR-US, V124, P612, DOI 10.1016/S0022-3476(05)83144-0; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; van Schayck CP, 2005, EUR RESPIR J, V26, P647, DOI 10.1183/09031936.05.00019805; Vollmer WM, 1998, AM J RESP CRIT CARE, V157, P1079, DOI 10.1164/ajrccm.157.4.9704140; Wang WH, 2011, OTOLARYNG HEAD NECK, V144, P506, DOI 10.1177/0194599810396133; Wolf G, 2006, NUTR REV, V64, P295, DOI [10.1111/j.1753-4887.2006.tb00213.x, 10.1301/nr.2006.jun.295-299]; Zha KX, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0092-4	75	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6								10.1016/j.jaci.2020.04.019	http://dx.doi.org/10.1016/j.jaci.2020.04.019			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32344059	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000596937900016
J	Lipworth, B; Kuo, CR; Chan, R				Lipworth, Brian; Kuo, Chris RuiWen; Chan, Rory			2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (FENO) in asthma management	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; fractional exhaled nitric oxide; inhaled corticosteroid; IL-13; type 2 inflammation			[Lipworth, Brian; Kuo, Chris RuiWen; Chan, Rory] Univ Dundee, Scottish Ctr Resp Res, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, B (corresponding author), Univ Dundee, Scottish Ctr Resp Res, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland.	b.j.lipworth@dundee.ac.uk		Lipworth, Brian/0000-0002-8140-2014				Anderson WJ, 2012, CHEST, V142, P1553, DOI 10.1378/chest.12-1310; Bardsley G, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0836-6; Bateman ED, 2010, J ALLERGY CLIN IMMUN, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Colak Y, 2018, EUR RESPIR J, V52; Kuo CR, 2019, RESP MED, V155, P54, DOI 10.1016/j.rmed.2019.07.010; Manoharan A, 2014, CLIN EXP ALLERGY, V44, P1240, DOI 10.1111/cea.12352; Petsky HL, 2018, THORAX, V73, P1110, DOI 10.1136/thoraxjnl-2018-211540; Price DB, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0282-7; Price DB, 2018, LANCET RESP MED, V6, P29, DOI 10.1016/S2213-2600(17)30424-1; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7	10	5	6	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1281	1282		10.1016/j.jaci.2020.03.006	http://dx.doi.org/10.1016/j.jaci.2020.03.006			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	33280711	Bronze			2022-12-18	WOS:000596937900005
J	Steiman, CA; Evans, MD; Lee, KE; Lasarev, MR; Gangnon, RE; Olson, BF; Barnes, KL; Bendixsen, CG; Seroogy, CM; Gern, JE				Steiman, Cheryl A.; Evans, Michael D.; Lee, Kristine E.; Lasarev, Michael R.; Gangnon, Ronald E.; Olson, Brent F.; Barnes, Kathrine L.; Bendixsen, Casper G.; Seroogy, Christine M.; Gern, James E.			Patterns of farm exposure are associated with reduced incidence of atopic dermatitis in early life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; farm effect; children; birth cohort; latent class analysis	HAY-FEVER; ALLERGIC RHINITIS; CHILDHOOD ASTHMA; SKIN BARRIER; CHILDREN; RISK; ECZEMA; ENVIRONMENTS; DISEASES; INFLAMMATION	Background: Farm exposures may reduce the risk of atopic dermatitis (AD) in children, but this is controversial and US data are limited. Objective: This study was conducted to identify patterns of farm exposure in Wisconsin family farms that modify AD incidence and prevalence in early childhood. Methods: Environmental exposures, health history, and clinical outcomes were prospectively recorded for 111 farm families and 129 non-farm families enrolled in the Wisconsin Infant Study Cohort birth cohort study. Exposures from the prenatal and early postnatal (2-month) visits were evaluated together with parental report of AD diagnosis by a health care provider through age 24 months. Latent class analysis was performed with prenatal and early postnatal farm-exposure variables to assign farm children to 3 classes. Results: Overall, children of farm families had reduced AD incidence (P = .03). Within farm families, exposures including poultry (3% vs 28%; P = .003), pig (4% vs 25%; P = .04), feed grain (13% vs 34%; P = .02), and number of animal species were inversely associated with AD incidence. Among the latent class groups, children in families with diverse or more intense farm exposures (classes A and B) had reduced AD incidence, whereas low-exposure (class C) infants had AD incidence similar to that in nonfarm children. Conclusions: Infants in Wisconsin farm families had reduced AD incidence, and patterns of farm exposures further defined AD risk. These findings suggest that exposure to diverse farm animals, feed, and bedding during the prenatal period and in early infancy reduce the risk of early-onset AD, a phenotype associated with multiple other atopic diseases.	[Steiman, Cheryl A.; Evans, Michael D.; Lee, Kristine E.; Lasarev, Michael R.; Gangnon, Ronald E.; Seroogy, Christine M.; Gern, James E.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Olson, Brent F.; Barnes, Kathrine L.; Bendixsen, Casper G.] Marshfield Clin Res Inst, Natl Farm Med Ctr, Marshfield, WI USA	University of Wisconsin System; University of Wisconsin Madison	Gern, JE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Allergy Immunol & Rheumatol, Dept Pediat, 600 Highland Ave,K4-918 CSC, Madison, WI 53792 USA.; Gern, JE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Allergy Immunol & Rheumatol, Dept Med, 600 Highland Ave,K4-918 CSC, Madison, WI 53792 USA.	gern@medicine.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714; Evans, Michael/0000-0001-7449-3993; Gern, James/0000-0002-6667-4708	National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases [U19 AI104317, 5T32AI007635-18]; NIH-National Center for Advancing Translational Sciences [UL1TR000427]; NIH Office of the Director [UG3/UH3 OD023282]; Marshfield Clinic Research Institute	National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-National Center for Advancing Translational Sciences; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshfield Clinic Research Institute	This study was funded by the National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (grant nos. U19 AI104317 and 5T32AI007635-18), NIH-National Center for Advancing Translational Sciences (grant no. UL1TR000427), NIH Office of the Director (grant no. UG3/UH3 OD023282), and the Marshfield Clinic Research Institute.	Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Brick T, 2016, J ALLERGY CLIN IMMUN, V137, P1699, DOI 10.1016/j.jaci.2015.10.042; COX DR, 1972, J R STAT SOC B, V34, P187; De Benedetto A, 2012, J INVEST DERMATOL, V132, P949, DOI 10.1038/jid.2011.435; Douwes J, 2008, EUR RESPIR J, V32, P603, DOI 10.1183/09031936.00033707; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Frei R, 2018, J ALLERGY CLIN IMMUN, V141, P382, DOI 10.1016/j.jaci.2017.04.051; Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Horak E, 2014, WIEN KLIN WOCHENSCHR, V126, P532, DOI 10.1007/s00508-014-0571-z; Huang YJ, 2017, J ALLERGY CLIN IMMUN, V139, P1099, DOI 10.1016/j.jaci.2017.02.007; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Kilpelainen M, 2000, CLIN EXP ALLERGY, V30, P201, DOI 10.1046/j.1365-2222.2000.00800.x; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Ludka-Gaulke T, 2018, J ALLERGY CLIN IMMUN, V141, P454, DOI 10.1016/j.jaci.2017.07.032; LUOMA R, 1983, ALLERGY, V38, P339, DOI 10.1111/j.1398-9995.1983.tb04128.x; Peters M, 2010, J ALLERGY CLIN IMMUN, V126, P648, DOI 10.1016/j.jaci.2010.05.011; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roduit C, 2017, JAMA PEDIATR, V171, P655, DOI 10.1001/jamapediatrics.2017.0556; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schneider L, 2013, J ALLERGY CLIN IMMUN, V131, P295, DOI 10.1016/j.jaci.2012.12.672; Seroogy CM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4448-0; Silverberg JI, 2019, ANN ALLERG ASTHMA IM, V123, P144, DOI 10.1016/j.anai.2019.04.020; Singh AM, 2010, J ALLERGY CLIN IMMUN, V125, P491, DOI 10.1016/j.jaci.2009.11.026; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tsakok T, 2016, J ALLERGY CLIN IMMUN, V137, P1071, DOI 10.1016/j.jaci.2015.10.049; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Mutius E, 2010, CLIN EXP IMMUNOL, V160, P130, DOI 10.1111/j.1365-2249.2010.04138.x; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Waser M, 2007, CLIN EXP ALLERGY, V37, P661, DOI 10.1111/j.1365-2222.2006.02640.x; Wickens K, 2002, ALLERGY, V57, P1171, DOI 10.1034/j.1398-9995.2002.t01-1-23644.x; Williams MR, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0567-4	42	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6								10.1016/j.jaci.2020.06.025	http://dx.doi.org/10.1016/j.jaci.2020.06.025			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32650021	Green Accepted			2022-12-18	WOS:000596937900019
J	Szefler, SJ				Szefler, Stanley J.			Update on the NAEPPCC Asthma Guidelines: The wait is over, or is it?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma guidelines; bronchial thermoplasty; inhaled corticosteroids; long-acting beta-agonists; long-acting muscarinic agents; short-acting beta-agonists; tiotropium		As an asthma specialist, one is often asked to discuss the asthma guidelines. The challenge that one faces is deciding which guidelines to use as a resource for discussion or presentation. It often comes down to the following questions: What is the question? What message does one want to deliver? Where is the most current information? and Who is the target audience? This commentary will help answer those questions as it guides the reader through the new update of the National Heart, Lung and Blood Institute/National Asthma Education and Prevention Program guidelines and then outlines differences between 2 widely used strategies for the management of asthma: the Global Initiative for Asthma and the National Heart, Lung and Blood Institute/National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of Asthma.	[Szefler, Stanley J.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Sect Pediat Pulm & Sleep Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Szefler, SJ (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA.; Szefler, SJ (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Sect Pediat Pulm & Sleep Med, Aurora, CO USA.; Szefler, SJ (corresponding author), Childrens Hosp Colorado, Breathing Inst, Sect Pediat & Sleep Pulm Med, 13123 E 16th Ave,Box B395, Aurora, CO 80045 USA.	Stanley.Szefler@childrenscolorado.org		Szefler, Stanley/0000-0002-6911-3199				Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Chan WV, 2017, J AM COLL CARDIOL, V69, P1076, DOI 10.1016/j.jacc.2016.11.004; Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003; D'Anci KE, 2017, AHRQ COMP EFFECTIVEN; Gibbons GH, 2013, J AM COLL CARDIOL, V62, P1396, DOI 10.1016/j.jacc.2013.08.003; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Global Initiative for Asthma, 2019, DIFF TO TREAT SEV AS; Guyatt G. H., 2008, EVIDENCE BASED MED W; Institute of Medicine, 2011, PRACT GUID WE CAN TR; Leas BF, 2018, J ALLERGY CLIN IMMUN, V141, P1854, DOI 10.1016/j.jaci.2018.02.001; Lin SY, 2018, AHRQ PUBLICATION; Mensah GA, 2018, J ALLERGY CLIN IMMUN, V142, P744, DOI 10.1016/j.jaci.2018.07.004; National Asthma Education and Prevention Program, 2007, 3 US NATL HART LUNG; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Sobieraj DM, 2018, COMP EFFECTIVENESS R; Szefler SJ, 2018, J ALLERGY CLIN IMMUN, V142, P773, DOI 10.1016/j.jaci.2018.03.010; Wang Z, 2018, MAYO CLIN PROC, V93, P191, DOI 10.1016/j.mayocp.2017.11.012	17	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1275	1280		10.1016/j.jaci.2020.01.025	http://dx.doi.org/10.1016/j.jaci.2020.01.025			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32004522	Bronze			2022-12-18	WOS:000596937900004
J	Broderick, L; Hoffman, HM				Broderick, Lori; Hoffman, Hal M.			Pediatric recurrent fever and autoinflammation from the perspective of an allergist/immunologist	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pediatrics; recurrent fever; periodic fever; autoinflammation	PERIODIC FEVER; DISEASES; DIAGNOSIS	Autoinflammatory diseases are monogenic and polygenic disorders due to dysregulation of the innate immune system. The inherited conditions have been clustered with primary immunodeficiencies in the latest practice parameters; however, these diseases have unique clinical presentations, genetics, and available therapies. Given the presentation of fevers, rashes, and mucosal symptoms observed in many of these syndromes, patients are likely to present to an allergist/immunologist. Although there has been attention in the literature to diagnosis and treatment of rare, genetically defined autoinflammatory disorders, physicians are challenged by increasing numbers of patients with intermittent or periodic fevers who face unnecessary morbidities due to a lack of a diagnosis. The broad differential of diseases presenting with fever includes autoinflammatory syndromes, infections associated with immunodeficiency and/or allergies complicated by infection, and less commonly, autoimmune disorders or malignancy. To address this challenge, we review the history of the medical approach to fever, current diagnostic paradigms, and controversies in management. We describe the spectrum of disorders referred to a recurrent fever disorders clinic established in an Allergy/Immunology division at a tertiary pediatric care center. Finally, we provide practical recommendations including historical features and initial laboratory investigations that can help clinicians appropriately manage these patients.	[Broderick, Lori; Hoffman, Hal M.] Univ Calif San Diego, Div Allergy Immunol & Rheumatol, Dept Pediat, Rady Childrens Hosp, San Diego, CA 92103 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Broderick, L (corresponding author), 9500 Gilman Dr,Mail Code 0760, La Jolla, CA 92093 USA.	lbroderick@ucsd.edu		Broderick, Lori/0000-0001-6147-7097	National Institutes of Health [1K08HD075830-01A1]; Thrasher Research Fund; Hartwell Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; Hartwell Foundation	L.B. was supported by the National Institutes of Health (grant no. 1K08HD075830-01A1), Thrasher Research Fund, The Hartwell Foundation, and A.P. Giannini.	Barbi E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090081; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Broderick L., 2013, PRIMARY IMMUNODEFICI; Chuamanochan M, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100019; Colvin JM, 2012, PEDIATRICS, V130, pE1455, DOI 10.1542/peds.2012-1391; Erbis G, 2018, PEDIATR RHEUMATOL, V16, DOI 10.1186/s12969-018-0300-7; Federici S, 2014, BEST PRACT RES CL RH, V28, P263, DOI 10.1016/j.berh.2014.05.005; Grob GN, 2007, J HIST MED ALL SCI, V62, P383, DOI 10.1093/jhmas/jrm003; Hausmann JS, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0902-7; Heimall JR, 2018, J CLIN IMMUNOL, V38, P320, DOI 10.1007/s10875-018-0489-8; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Holzinger D, 2015, NAT REV RHEUMATOL, V11, P573, DOI 10.1038/nrrheum.2015.79; Kraszewska-Glomba B, 2016, BOSNIAN J BASIC MED, V16, P157, DOI 10.17305/bjbms.2016.974; Kuemmerle-Deschner JB, 2017, ARTHRITIS RHEUMATOL, V69, P2233, DOI 10.1002/art.40208; Kuemmerle-Deschner JB, 2017, ANN RHEUM DIS, V76, P942, DOI 10.1136/annrheumdis-2016-209686; Landry A, 2017, CAN FAM PHYSICIAN, V63, pE316; Lantto U, 2016, J PEDIATR-US, V179, P172, DOI 10.1016/j.jpeds.2016.08.097; Luu I, 2020, J CLIN IMMUNOL, V40, P179, DOI 10.1007/s10875-019-00724-2; Manthiram K, 2020, P NATL ACAD SCI USA, V117, P14405, DOI 10.1073/pnas.2002051117; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Massin MM, 2006, ACTA CLIN BELG, V61, P161, DOI 10.1179/acb.2006.027; Papa R, 2020, RHEUMATOLOGY, V59, P344, DOI 10.1093/rheumatology/kez270; Schnappauf O, 2019, RHEUMATOLOGY, V58, P44, DOI 10.1093/rheumatology/kez294; Statler VA, 2016, J PEDIAT INF DIS SOC, V5, P249, DOI 10.1093/jpids/piv008; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; Thomas KT, 1999, J PEDIATR-US, V135, P15, DOI 10.1016/S0022-3476(99)70321-5; Vaz LE, 2014, PEDIATRICS, V133, P375, DOI 10.1542/peds.2013-2903; Wallenstein MB, 2013, CLIN PEDIATR, V52, P254, DOI 10.1177/0009922812472252; Weintraub B, 2015, PEDIATR REV, V36, P554, DOI 10.1542/pir.36-12-554; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114	30	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					960	+		10.1016/j.jaci.2020.09.019	http://dx.doi.org/10.1016/j.jaci.2020.09.019			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	33002514	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000588153700032
J	Wong, GS; Redes, JL; Balenga, N; McCullough, M; Fuentes, N; Gokhale, A; Koziol-White, C; Jude, JA; Madigan, LA; Chan, EC; Jester, WH; Biardel, S; Flamand, N; Panettieri, RA; Druey, KM				Wong, Gordon S.; Redes, Jamie L.; Balenga, Nariman; McCullough, Morgan; Fuentes, Nathalie; Gokhale, Ameya; Koziol-White, Cynthia; Jude, Joseph A.; Madigan, Laura A.; Chan, Eunice C.; Jester, William H.; Biardel, Sabrina; Flamand, Nicolas; Panettieri, Reynold A.; Druey, Kirk M.			RGS4 promotes allergen- and aspirin-associated airway hyperresponsiveness by inhibiting PGE2 biosynthesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; aspirin sensitivity; G proteins; PGE2; aspirin-exacerbated respiratory disease; regulators of G protein signaling protein	RECEPTOR EXPRESSION; SIGNAL-TRANSDUCTION; SEVERE ASTHMA; PATHOGENESIS; ACTIVATION; REGULATOR; DISEASE; RELAXATION; RESPONSES; PATHWAYS	Background: Allergens elicit host production of mediators acting on G-protein-coupled receptors to regulate airway tone. Among these is prostaglandin E2 (PGE2), which, in addition to its role as a bronchodilator, has anti-inflammatory actions. Some patients with asthma develop bronchospasm after the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs, a disorder termed aspirin-exacerbated respiratory disease. This condition may result in part from abnormal dependence on the bronchoprotective actions of PGE2. Objective: We sought to understand the functions of regulator of G protein signaling 4 (RGS4), a cytoplasmic protein expressed in airway smooth muscle and bronchial epithelium that regulates the activity of G-protein-coupled receptors, in asthma. Methods: We examined RGS4 expression in human lung biopsies by immunohistochemistry. We assessed airways hyperresponsiveness (AHR) and lung inflammation in germline and airway smooth muscle-specific Rgs4(-/-) mice and in mice treated with an RGS4 antagonist after challenge with Aspergillus fumigatus. We examined the role of RGS4 in nonsteroidal anti-inflammatory drug-associated bronchoconstriction by challenging aspirin-exacerbated respiratory disease-like (ptges1(-/-)) mice with aspirin. Results: RGS4 expression in respiratory epithelium is increased in subjects with severe asthma. Allergen-induced AHR was unexpectedly diminished in Rgs4(-/-) mice, a finding associated with increased airway PGE2 levels. RGS4 modulated allergen-induced PGE2 secretion in human bronchial epithelial cells and prostanoid-dependent bronchodilation. The RGS4 antagonist CCG203769 attenuated AHR induced by allergen or aspirin challenge of wild-type or ptges1(-/-) mice, respectively, in association with increased airway PGE2 levels. Conclusions: RGS4 may contribute to the development of AHR by reducing airway PGE2 biosynthesis in allergen- and aspirininduced asthma.	[Wong, Gordon S.; Redes, Jamie L.; Balenga, Nariman; McCullough, Morgan; Fuentes, Nathalie; Madigan, Laura A.; Chan, Eunice C.; Druey, Kirk M.] NIAID, Lung & Vasc Inflammat Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gokhale, Ameya] NIAID, Food Allergy Res Unit, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Koziol-White, Cynthia; Jude, Joseph A.; Jester, William H.; Panettieri, Reynold A.] Rutgers State Univ, Rutgers Inst Translat Med & Sci, Child Hlth Inst New Jersey, Sch Med, New Brunswick, NJ USA; [Biardel, Sabrina; Flamand, Nicolas] Univ Laval, Fac Med, Ctr Rech IUCPQ, Dept Med, Quebec City, PQ, Canada; [Balenga, Nariman] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Div Gen & Oncol Surg,Dept Surg, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center; Laval University; University System of Maryland; University of Maryland Baltimore	Druey, KM (corresponding author), 10 Ctr Dr,Rm 11N238A, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Flamand, Nicolas/H-5823-2019; Balenga, Nariman/A-5895-2011	Flamand, Nicolas/0000-0001-5944-7200; Balenga, Nariman/0000-0002-2741-9595; Jester Jr., William/0000-0002-2872-6095	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [Z01-AI-000746, Z01-AI-000943];  [CTSA-UL1TR003017];  [2P01HL114471-06]	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; 	Funding for this study was provided in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (project nos. Z01-AI-000746 and Z01-AI-000943) and by grants CTSA-UL1TR003017 (CTSA) and 2P01HL114471-06 (PPG) to R.A.P. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the US government.	Balenga NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7763; Balenga NA, 2014, J ALLERGY CLIN IMMUN, V134, P451, DOI 10.1016/j.jaci.2014.01.019; Basu T, 2018, J ALLERGY CLIN IMMUN, V141, P423, DOI 10.1016/j.jaci.2017.07.034; Bodle CR, 2017, ANAL BIOCHEM, V522, P10, DOI 10.1016/j.ab.2017.01.013; Boonpiyathad T, 2019, SEMIN IMMUNOL, V46, DOI 10.1016/j.smim.2019.101333; Carr R, 2016, MOL PHARMACOL, V89, P94, DOI 10.1124/mol.115.100339; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Cho JL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1370; Chow JM, 2000, BRIT J PHARMACOL, V131, P1584, DOI 10.1038/sj.bjp.0703738; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Damera G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028504; Druey KM, 2017, ADV IMMUNOL, V136, P315, DOI 10.1016/bs.ai.2017.05.001; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Enilari O, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2412; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; FitzPatrick M, 2014, PULM PHARMACOL THER, V28, P68, DOI 10.1016/j.pupt.2013.11.005; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Garvy BA, 2000, J IMMUNOL, V165, P6480, DOI 10.4049/jimmunol.165.11.6480; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; George T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170269; Gon Y, 2018, ALLERGOL INT, V67, P12, DOI 10.1016/j.alit.2017.08.011; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; Jo-Watanabe A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143580; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kawabata A, 2004, J PHARMACOL EXP THER, V311, P402, DOI 10.1124/jpet.104.068387; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Komi DEA, 2019, CLIN REV ALLERG IMMU, V56, P234, DOI 10.1007/s12016-018-8720-1; Koziol-White C, 2020, AM J PHYSIOL-LUNG C, V318, pL345, DOI 10.1152/ajplung.00393.2019; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Lan RS, 2001, BRIT J PHARMACOL, V132, P93, DOI 10.1038/sj.bjp.0703776; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Madigan LA, 2018, AM J RESP CELL MOL, V58, P89, DOI 10.1165/rcmb.2017-0109OC; Maric J, 2018, J ALLERGY CLIN IMMUN, V141, P1761, DOI 10.1016/j.jaci.2017.09.050; Masaki K, 2017, ANN ALLERG ASTHMA IM, V119, P253, DOI 10.1016/j.anai.2017.07.008; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Morello S, 2005, BIOCHEM PHARMACOL, V71, P223, DOI 10.1016/j.bcp.2005.10.016; Narayanankutty A, 2013, CLIN BIOCHEM, V46, P566, DOI 10.1016/j.clinbiochem.2012.12.005; Noti M, 2018, CURR OPIN IMMUNOL, V54, P130, DOI 10.1016/j.coi.2018.07.001; Peebles RS, 2019, CLIN CHEST MED, V40, P29, DOI 10.1016/j.ccm.2018.10.014; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Ricciardolo FLM, 2018, EUR J PHARMACOL, V827, P181, DOI 10.1016/j.ejphar.2018.03.017; Rusznak M, 2019, CURR OPIN ALLERGY CL, V19, P38, DOI 10.1097/ACI.0000000000000498; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Torres R, 2015, MOL IMMUNOL, V63, P61, DOI 10.1016/j.molimm.2014.03.007; Wang MA, 2010, J PHARMACOL EXP THER, V334, P63, DOI 10.1124/jpet.110.166678; Xie Y, 2012, J ALLERGY CLIN IMMUN, V130, P968, DOI 10.1016/j.jaci.2012.05.004; Xue XT, 2017, ONCOTARGET, V8, P78530, DOI 10.18632/oncotarget.20825; Yamauchi K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071733; Yang Z, 2011, J BIOL CHEM, V286, P11444, DOI [10.1074/jbc.M110.212480, 10.1074/jbc.M111.229344]; Ying S, 2006, J ALLERGY CLIN IMMUN, V117, P312, DOI 10.1016/j.jaci.2005.10.037; Zaidman NA, 2017, AM J PHYSIOL-CELL PH, V313, pC68, DOI 10.1152/ajpcell.00043.2017	57	5	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1152	+		10.1016/j.jaci.2020.03.004	http://dx.doi.org/10.1016/j.jaci.2020.03.004			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32199913	Green Accepted, hybrid			2022-12-18	WOS:000588153700018
J	Zhu, J; Mallia, P; Footitt, J; Qiu, YS; Message, SD; Kebadze, T; Aniscenko, J; Barnes, PJ; Adcock, IM; Kon, OM; Johnson, M; Contoli, M; Stanciu, LA; Papi, A; Jeffery, PK; Johnston, SL				Zhu, Jie; Mallia, Patrick; Footitt, Joseph; Qiu, Yusheng; Message, Simon D.; Kebadze, Tatiana; Aniscenko, Julia; Barnes, Peter J.; Adcock, Ian M.; Kon, Onn M.; Johnson, Malcolm; Contoli, Marco; Stanciu, Luminita A.; Papi, Alberto; Jeffery, Peter K.; Johnston, Sebastian L.			Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Rhinovirus infection; eosinophils; inflammation; chronic obstructive pulmonary disease exacerbation	OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW LIMITATION; SEVERE EXACERBATIONS; GENE-EXPRESSION; INDUCED SPUTUM; T-LYMPHOCYTES; EOSINOPHILIA; BIOPSIES; AIRWAYS; IDENTIFICATION	Background: Respiratory viral infection causes chronic obstructive pulmonary disease (COPD) exacerbations. We previously reported increased bronchial mucosa eosinophil and neutrophil inflammation in patients with COPD experiencing naturally occurring exacerbations. But it is unclear whether virus per se induces bronchial mucosal inflammation, nor whether this relates to exacerbation severity. Objectives: We sought to determine the extent and nature of bronchial mucosal inflammation following experimental rhinovirus (RV)-16-induced COPD exacerbations and its relationship to disease severity. Methods: Bronchial mucosal inflammatory cell phenotypes were determined at preinfection baseline and following experimental RV infection in 17 Global Initiative for Chronic Obstructive Lung Disease stage II subjects with COPD and as controls 20 smokers and 11 nonsmokers with normal lung function. No subject had a history of asthma/allergic rhinitis: all had negative results for aeroallergen skin prick tests. Results: RV infection increased the numbers of bronchial mucosal eosinophils and neutrophils only in COPD and CD8(+) T lymphocytes in patients with COPD and nonsmokers. Monocytes/macrophages, CD4(+) T lymphocytes, and CD20(+) B lymphocytes were increased in all subjects. At baseline, compared with nonsmokers, subjects with COPD and smokers had increased numbers of bronchial mucosal monocytes/ macrophages and CD8(+) T lymphocytes but fewer numbers of CD4(+) T lymphocytes and CD20(+) B lymphocytes. The virusinduced inflammatory cells in patients with COPD were positively associated with virus load, illness severity, and reductions in lung function. Conclusions: Experimental RV infection induces bronchial mucosal eosinophilia and neutrophilia only in patients with COPD and monocytes/macrophages and lymphocytes in both patients with COPD and control subjects. The virus-induced inflammatory cell phenotypes observed in COPD positively related to virus load and illness severity. Antiviral/antiinflammatory therapies could attenuate bronchial inflammation and ameliorate virus-induced COPD exacerbations.	[Zhu, Jie; Mallia, Patrick; Footitt, Joseph; Qiu, Yusheng; Message, Simon D.; Kebadze, Tatiana; Aniscenko, Julia; Barnes, Peter J.; Adcock, Ian M.; Kon, Onn M.; Contoli, Marco; Stanciu, Luminita A.; Jeffery, Peter K.; Johnston, Sebastian L.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Mallia, Patrick; Footitt, Joseph; Message, Simon D.; Kon, Onn M.; Johnston, Sebastian L.] Imperial Coll Healthcare NHS Trust, London, England; [Johnson, Malcolm] GlaxoSmithKline, Uxbridge, Middx, England; [Contoli, Marco; Papi, Alberto] Univ Ferrara, Res Ctr Asthma & COPD, Ferrara, Italy	Imperial College London; Imperial College London; GlaxoSmithKline; University of Ferrara	Johnston, SL (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, St Marys Campus,Norfolk Pl, London W2 1PG, England.	s.johnstou@imperial.ac.uk		Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018	Academy of Medical Sciences; Wellcome Trust [083,567/Z/07/Z]; European Respiratory Society fellowship; Medical Research Council [G0600879]; British Medical Association H.C. Roscoe Fellowships; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program [P00/2]; National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme; GlaxoSmithKline; Pfizer UK; NIHR Clinical Lecturer funding scheme; Wellcome Trust; Medical Research Council; MRC [G0600879] Funding Source: UKRI	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome Trust); European Respiratory Society fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Medical Association H.C. Roscoe Fellowships; British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program; National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme(National Institute for Health Research (NIHR)); GlaxoSmithKline(GlaxoSmithKline); Pfizer UK(Pfizer); NIHR Clinical Lecturer funding scheme; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an Academy of Medical Sciences and Wellcome Trust Starter Grant award (P.M.), a European Respiratory Society fellowship (M.C.), a Medical Research Council Clinical Research Fellowship (S.D.M.) and Medical Research Council Program Grant G0600879 (P.J.B., I.M.A., and S.L.J.), British Medical Association H.C. Roscoe Fellowships (J.F., S.D.M., and P.M.), British Lung Foundation/Severin Wunderman Family Foundation Lung Research Program Grant P00/2 (S.L.J.), Wellcome Trust Grant 083,567/Z/07/Z for the Centre for Respiratory Infection, Imperial College and the National Institute for Health Research (NIHR) Biomedical Research Centre funding scheme, and the NIHR Clinical Lecturer funding scheme; an unrestricted grant from GlaxoSmithKline; and a grant from Pfizer UK. Spirometers were provided by Micro Medical Ltd, Rochester, UK.	[Anonymous], 1994, Respir Med, V88, P165; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bardin PG, 1996, EUR RESPIR J, V9, P2250, DOI 10.1183/09031936.96.09112250; Camp J, 2018, MED SCI BASEL, V6; Caramori G, 2009, SOUTH MED J, V102, P277, DOI 10.1097/SMJ.0b013e3181836b73; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Criner GJ, 2019, NEW ENGL J MED, V381, P1023, DOI 10.1056/NEJMoa1905248; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Footitt J, 2016, CHEST, V149, P62, DOI 10.1378/chest.14-2637; Fujimoto K, 2005, EUR RESPIR J, V25, P640, DOI 10.1183/09031936.05.00047504; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hayden FG, 2003, CLIN INFECT DIS, V36, P1523, DOI 10.1086/375069; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; Johnston SL, 1995, DIAGNOSTIC PROCEDURE, P553; Lams BEA, 2000, EUR RESPIR J, V15, P512, DOI 10.1034/j.1399-3003.2000.15.14.x; Lokwani R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024330; MacDonald M, 2011, RESPIROLOGY, V16, P264, DOI 10.1111/j.1440-1843.2010.01908.x; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mallia P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-116; Mallia P, 2012, AM J RESP CRIT CARE, V186, P1117, DOI 10.1164/rccm.201205-0806OC; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Marcos PJ, 2018, MED SCI BASEL, V6; MULLEN JBM, 1985, BMJ-BRIT MED J, V291, P1235, DOI 10.1136/bmj.291.6504.1235; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Papadopoulos NG, 1999, J VIROL METHODS, V80, P179, DOI 10.1016/S0166-0934(99)00045-2; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Roche N, 2017, AM J RESP CRIT CARE, V195, P1189, DOI 10.1164/rccm.201701-0193OC; Rohde G, 2008, INFECTION, V36, P427, DOI 10.1007/s15010-008-7327-5; Rutgers SR, 2000, EUR RESPIR J, V15, P109, DOI 10.1183/09031936.00.15110900; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; SAETTA M, 1994, AM J RESP CRIT CARE, V150, P1646, DOI 10.1164/ajrccm.150.6.7952628; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Singh D, 2014, EUR RESPIR J, V44, P1697, DOI 10.1183/09031936.00162414; Sivapalan P, 2019, LANCET RESP MED, V7, P699, DOI 10.1016/S2213-2600(19)30176-6; Soter S, 2013, INFLAMMATION, V36, P1178, DOI 10.1007/s10753-013-9653-8; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Zhu J, 2001, AM J RESP CRIT CARE, V164, P109, DOI 10.1164/ajrccm.164.1.2007050; Zhu J, 2012, CHEST, V142, P347, DOI 10.1378/chest.11-1581	49	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					840	+		10.1016/j.jaci.2020.03.021	http://dx.doi.org/10.1016/j.jaci.2020.03.021			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32283204	Green Published, hybrid			2022-12-18	WOS:000582395800015
J	Khan, DA; Phillips, EJ				Khan, David A.; Phillips, Elizabeth J.			Pharmacogenomic biomarkers in allergy and immunology practice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						HLA; pharmacogenomics; cytochrome P450; off-target; on-target; adverse drug reaction			[Khan, David A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Allergy & Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Phillips, Elizabeth J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University	Khan, DA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Allergy & Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Dave.Khan@UTSouthwestern.edu			National Institutes of Health [R34AI134569]; National Health and Medical Research Council of Australia	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	E.J.P. receives funding from the National Institutes of Health (grant nos. 1P50GM115305-01, R21AI139021, R34AI136815, and 1 R01 HG010863-01) and the National Health and Medical Research Council of Australia. D.A.K. and E.J.P. receive funding from the National Institutes of Health (grant no. R34AI134569).	[Anonymous], 2020, TABL PHARM BIOM DRUG; Farzan N, 2017, CLIN EXP ALLERGY, V47, P271, DOI 10.1111/cea.12844; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; Herr TM, 2019, J AM MED INFORM ASSN, V26, P143, DOI 10.1093/jamia/ocy156; Karnes JH, 2019, ANNU REV PHARMACOL, V59, P463, DOI 10.1146/annurev-pharmtox-010818-021818; Konvinse KC, 2019, J ALLERGY CLIN IMMUN, V144, P183, DOI 10.1016/j.jaci.2019.01.045; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Stainsby CM, 2019, PHARMACOTHERAPY, V39, P40, DOI 10.1002/phar.2196; Weitzel KW, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-015-0162-5	9	5	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					509	512		10.1016/j.jaci.2020.05.050	http://dx.doi.org/10.1016/j.jaci.2020.05.050			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NO0HS	32533972	Bronze, Green Accepted			2022-12-18	WOS:000569168900004
J	Gelardi, M; Cassano, M; Ciprandi, G				Gelardi, Matteo; Cassano, Michele; Ciprandi, Giorgio			The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Gelardi, Matteo; Cassano, Michele] Univ Foggia, Dept Otolaryngol, Foggia, Italy; [Ciprandi, Giorgio] Casa Cura Villa Montallegro, Allergy Clin, Genoa, Italy	University of Foggia	Ciprandi, G (corresponding author), Casa Cura Villa Montallegro, Allergy Clin, Genoa, Italy.	gio.cip@libero.it	Ciprandi, Giorgio/G-7462-2012	Ciprandi, Giorgio/0000-0001-7016-8421				Ciprandi G, 2019, ANN ALLERG ASTHMA IM, V123, P213, DOI 10.1016/j.anai.2019.05.006; Fokkens WJ, 2020, RHINOLOGY, V58, P1, DOI 10.4193/Rhin20.401; Fokkens WJ, 2019, ALLERGY, V74, P2312, DOI 10.1111/all.13875; Gelardi M, 2019, ACTA OTORHINOLARYNGO, V39, P329, DOI 10.14639/0392-100X-2426; Gelardi M, 2017, ACTA OTORHINOLARYNGO, V37, P38, DOI 10.14639/0392-100X-1417; Gelardi M, 2010, Int J Immunopathol Pharmacol, V23, P45; Mullol J, 2020, J ALLERGY CLIN IMMUN, V145, P773, DOI 10.1016/j.jaci.2020.01.024	7	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					462	463		10.1016/j.jaci.2020.04.049	http://dx.doi.org/10.1016/j.jaci.2020.04.049			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32593490	Green Published, Bronze			2022-12-18	WOS:000558835000043
J	Kabashima, K; Weidinger, S				Kabashima, Kenji; Weidinger, Stephan			NK cells as a possible new player in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						NK cells; atopic dermatitis; CD56; IL-15; group 2 innate lymphoid cells; IL-4; IFN-gamma			[Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Skin Res Inst Singapore SRIS, Biopolis, Singapore, Singapore; [Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Arnold Heller Str 3, D-24105 Kiel, Germany	Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); University of Kiel; Schleswig Holstein University Hospital	Weidinger, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol & Allergy, Arnold Heller Str 3, D-24105 Kiel, Germany.; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp; sweidinger@dermatology.uni-kiel.de						Bi JC, 2017, J IMMUNOL, V198, P3336, DOI 10.4049/jimmunol.1601830; Brar K, 2016, EXPERT OPIN BIOL TH, V16, P507, DOI 10.1517/14712598.2016.1135898; Dainichi T, 2018, NAT IMMUNOL, V19, P1286, DOI 10.1038/s41590-018-0256-2; Guo Y, 2015, J IMMUNOL, V195, P2353, DOI 10.4049/jimmunol.1500300; Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V143, P155, DOI 10.1016/j.jaci.2018.08.022; Kabata H, 2018, IMMUNOL REV, V286, P37, DOI 10.1111/imr.12706; Mack MR, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay1005; Nakajima S, 2019, J ALLERGY CLIN IMMUN, V143, P13, DOI 10.1016/j.jaci.2018.11.014; Weidinger S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0001-z	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					276	277		10.1016/j.jaci.2020.04.052	http://dx.doi.org/10.1016/j.jaci.2020.04.052			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32439430	Bronze			2022-12-18	WOS:000558835000009
J	Kuo, CY; Kohn, DB				Kuo, Caroline Y.; Kohn, Donald B.			Overview of the current status of gene therapy for primary immune deficiencies (PIDs)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Primary immune deficiencies; gene therapy; lentiviral vectors; gene editing; autologous hematopoietic stem cell transplantation	SEVERE COMBINED IMMUNODEFICIENCY; ADENOSINE-DEAMINASE DEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; HEMATOPOIETIC STEM; CELLS	Over 3 decades, gene therapy has advanced from a logical idea to becoming a clinical reality for several of the most severe primary immune deficiencies, as well as other inherited disorders. The first gene therapy medicines have been licensed for marketing and several more are advancing toward that goal to make them widely available, beyond clinical trials. Although common platforms of cells, vectors, or editing reagents are used for these disorders, each individual genetic cause of an immune deficiency requires its own vector or editing tools and a package of preclinical data on efficacy and safety to initiate clinical trials. One-by-one, gene therapy for primary immune deficiencies is being brought to the clinic and hopefully will provide safe and effective therapies.	[Kuo, Caroline Y.; Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kohn, DB (corresponding author), 3163 Terasaki Life Sci Bldg,610 Charles E Young D, Los Angeles, CA 90095 USA.	dkohn1@mednet.ucla.edu		Kuo, Caroline/0000-0002-9302-0187				Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; ANDERSON WF, 1980, NEW ENGL J MED, V303, P1293, DOI 10.1056/NEJM198011273032210; [Anonymous], 2016, STRIMVELISTM REC E1R; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bauer TR, 2000, CURR OPIN MOL THER, V2, P383; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cavazzana M, 2016, HUM GENE THER, V27, P108, DOI 10.1089/hum.2015.137; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cicalese MP, 2018, MOL THER, V26, P917, DOI 10.1016/j.ymthe.2017.12.022; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kang EM, 2010, BLOOD, V115, P783, DOI 10.1182/blood-2009-05-222760; KANTOFF PW, 1986, P NATL ACAD SCI USA, V83, P6563, DOI 10.1073/pnas.83.17.6563; Kohn D, 2020, MOL THER, V28, P56; Kohn DB, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123432; Kohn DB, 2020, MOL THER, V28, P554; Kohn DB, 2020, NAT MED, V26, P200, DOI 10.1038/s41591-019-0735-5; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Malech HL, 1997, P NATL ACAD SCI USA, V94, P12133, DOI 10.1073/pnas.94.22.12133; Malech HL, 1998, BLOOD, V92, p690A; Mamcarz E, N ENGL J MED, V380, P1525; Morgan RA, 2017, CELL STEM CELL, V21, P574, DOI 10.1016/j.stem.2017.10.010; Muul LM, 2003, BLOOD, V101, P2563, DOI 10.1182/blood-2002-09-2800; Punwani D, 2017, HUM GENE THER, V28, P112, DOI 10.1089/hum.2016.064; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Shaw KL, 2017, J CLIN INVEST, V127, P1689, DOI 10.1172/JCI90367; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; STEINBERG MH, 1984, AM J MED SCI, V288, P169, DOI 10.1097/00000441-198411000-00004; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; WILSON JT, 1977, SCIENCE, V196, P200, DOI 10.1126/science.847468	37	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					229	233		10.1016/j.jaci.2020.05.024	http://dx.doi.org/10.1016/j.jaci.2020.05.024			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32771134	Bronze			2022-12-18	WOS:000558835000001
J	Han, YY; Forno, E; Rosser, F; Celedon, JC				Han, Yueh-Ying; Forno, Erick; Rosser, Franziska; Celedon, Juan C.			Serum folate metabolites, asthma, and lung function in a nationwide US study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FOLIC-ACID; ATOPY		[Han, Yueh-Ying; Forno, Erick; Rosser, Franziska; Celedon, Juan C.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Pulm Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Celedon, JC (corresponding author), Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Pulm Med, Pittsburgh, PA 15260 USA.	juan.celedon@chp.edu	Forno, Erick/I-1476-2019	Forno, Erick/0000-0001-6497-9885	US National Institutes of Health [HL125666, KL2TR001856, HL117191, HL119952, MD011764]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the US National Institutes of Health (grant HL125666 [to E.F.]; grant KL2TR001856 [to F.R.]; and grants HL117191, HL119952, and MD011764 (to J.C.C.]).	Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Blatter J, 2013, AM J RESP CRIT CARE, V188, P12, DOI 10.1164/rccm.201302-0317PP; Kelly P, 1997, AM J CLIN NUTR, V65, P1790, DOI 10.1093/ajcn/65.6.1790; Luers JC, 2020, LARYNGO RHINO OTOL, V99, P287, DOI 10.1055/a-1095-2344; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; McGowan EC, 2020, J ALLER CL IMM-PRACT, V8, P132, DOI 10.1016/j.jaip.2019.06.017; Neurology BoDotSSo, 2020, NEUROLOGY BODOTSSO; Nicholson A, 2017, RESP MED, V133, P29, DOI 10.1016/j.rmed.2017.10.026; Paniz C, 2017, J NUTR, V147, P1684, DOI 10.3945/jn.117.247445; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Thuesen BH, 2010, ALLERGY, V65, P1446, DOI 10.1111/j.1398-9995.2010.02378.x; Zhang JJ, 2020, ALLERGY, V75, P1809, DOI 10.1111/all.14316	12	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2020	146	1					220	+		10.1016/j.jaci.2020.01.034	http://dx.doi.org/10.1016/j.jaci.2020.01.034			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OC5BB	32018028	Green Accepted, Bronze			2022-12-18	WOS:000579170500036
J	Novak, T; Hall, MW; McDonald, DR; Newhams, MM; Mistry, AJ; Panoskaltsis-Mortari, A; Mourani, PM; Loftis, LL; Weiss, SL; Tarquinio, KM; Markovitz, B; Hartman, ME; Schwarz, A; Junger, WG; Randolph, AG				Novak, Tanya; Hall, Mark W.; McDonald, Douglas R.; Newhams, Margaret M.; Mistry, Anushay J.; Panoskaltsis-Mortari, Angela; Mourani, Peter M.; Loftis, Laura L.; Weiss, Scott L.; Tarquinio, Keiko M.; Markovitz, Barry; Hartman, Mary E.; Schwarz, Adam; Junger, Wolfgang G.; Randolph, Adrienne G.		PALISI Pediat Intensive Care Influ	RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Polyinosinic:polycytidylic acid; LPS; IFN-alpha; TNF-alpha; influenza; pediatric; suppression; Toll-like receptor 4; retinoic acid inducible gene-I; critical care	VIRUS-INFECTION; INTERFERON; MECHANISMS; EXHAUSTION; CHILDREN; RISK	Background: Decreased TNF-alpha production in whole blood after ex vivo LPS stimulation indicates suppression of the Toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether antiviral immune signaling pathways are also suppressed in these patients is unclear. Objectives: We sought to evaluate suppression of the TLR4 and the antiviral retinoic acid inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection. Methods: In this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand polyinosinic-polycytidylic acid-low-molecular-weight/LyoVec and LPS to evaluate IFN-alpha and TNF-alpha production capacities (RIG-I and TLR4 pathways, respectively). Results: Suppression of either IFN-alpha or TNF-alpha production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to have prolonged (>7 days) multiple-organ dysfunction syndrome (30.3% vs 8.6%; P = .004) or prolonged hypoxemic respiratory failure (39.4% vs 11.4%; P = .001) compared with those with single- or no pathway suppression. Conclusions: Suppression of both RIG-I and TLR4 signaling pathways, essential for respective antiviral and antibacterial responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial coinfection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.	[Novak, Tanya; Newhams, Margaret M.; Mistry, Anushay J.; Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Novak, Tanya; Junger, Wolfgang G.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Novak, Tanya; Randolph, Adrienne G.] Harvard Med Sch, Dept Anesthesia, Boston, MA 02115 USA; [Hall, Mark W.] Nationwide Childrens Hosp, Dept Pediat, Div Crit Care Med, Columbus, OH USA; [McDonald, Douglas R.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [McDonald, Douglas R.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Panoskaltsis-Mortari, Angela] Univ Minnesota, Dept Pediat, Cytokine Reference Lab, Minneapolis, MN 55455 USA; [Mourani, Peter M.] Univ Colorado, Sect Crit Care Med, Dept Pediat, Sch Med, Aurora, CO USA; [Mourani, Peter M.] Childrens Hosp Colorado, Aurora, CO USA; [Loftis, Laura L.] Texas Childrens Hosp, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA; [Weiss, Scott L.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Tarquinio, Keiko M.] Emory Univ, Div Pediat Crit Care Med, Dept Pediat, Childrens Healthcare Atlanta Egleston,Sch Med, Atlanta, GA 30322 USA; [Markovitz, Barry] Childrens Hosp Los Angeles, Dept Anesthesiol Crit Care Med, Los Angeles, CA 90027 USA; [Hartman, Mary E.] St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; [Schwarz, Adam] Childrens Hosp Orange Cty, Dept Pediat, Orange, CA 92668 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Hospital Los Angeles; St. Louis Children's Hospital; Washington University (WUSTL); Childrens Hospital of Orange County	Randolph, AG (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Bader 634, Boston, MA 02115 USA.; Randolph, AG (corresponding author), Harvard Med Sch, Dept Anesthesiol Crit Care & Pain Med, 300 Longwood Ave,Bader 634, Boston, MA 02115 USA.	adrienne.randolph@childrens.harvard.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Weiss, Scott/0000-0002-7040-3281; Randolph, Adrienne/0000-0002-3084-3071; NOVAK, TANYA/0000-0002-7115-7545; sapru, anil/0000-0003-1528-8249; Gedeit, Rainer/0000-0003-2420-9493	National Institutes of Health [R01AI084011, R21HD095228, 5T32GM103702-05, R01HD098363]; Anesthesia Trailblazer Award from the Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anesthesia Trailblazer Award from the Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital	Financial support was provided by the National Institutes of Health (grant nos. R01AI084011 and R21HD095228 to A.G.R.; grant no. 5T32GM103702-05 to W.G.J. and T.N.; and grant no. R01HD098363 to W.G.J. and A.G.R.) and the Anesthesia Trailblazer Award from the Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital (to T.N.).	Alsharifi M, 2006, J IMMUNOL, V177, P3235, DOI 10.4049/jimmunol.177.5.3235; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOCCI V, 1988, IMMUNOLOGY, V64, P1; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chu M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00862; Coffin SE, 2007, PEDIATRICS, V119, P740, DOI 10.1542/peds.2006-2679; Cornell TT, 2012, J THORAC CARDIOV SUR, V143, P1160, DOI 10.1016/j.jtcvs.2011.09.011; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Fiore-Gartland A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01423; Furuya Y, 2013, SCAND J IMMUNOL, V78, P395, DOI 10.1111/sji.12107; Hall MW, 2013, CRIT CARE MED, V41, P224, DOI 10.1097/CCM.0b013e318267633c; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Muszynski JA, 2018, AM J RESP CRIT CARE, V198, P361, DOI 10.1164/rccm.201710-2006OC; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Paul F, 2015, GENE, V567, P132, DOI 10.1016/j.gene.2015.04.087; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Postal M, 2012, CLINICS, V67, P157, DOI 10.6061/clinics/2012(02)11; Randolph AG, 2019, CLIN INFECT DIS, V68, P365, DOI 10.1093/cid/ciy495; Randolph AG, 2016, PEDIATR CRIT CARE ME, V17, P279, DOI 10.1097/PCC.0000000000000661; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Reder AT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00281; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Shahin D, 2011, EGYPT J MED HUM GENE, V12, P139; Tang BM, 2019, INTENS CARE MED, V45, P1012, DOI 10.1007/s00134-019-05582-5; Tian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041879; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Warnking K, 2015, CELL MICROBIOL, V17, P303, DOI 10.1111/cmi.12375; WONG JP, 1995, ANTIMICROB AGENTS CH, V39, P2574, DOI 10.1128/AAC.39.11.2574; Wu J, 2014, J VIROL, V88, P10421, DOI 10.1128/JVI.00996-14	36	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2020	145	6					1673	+		10.1016/j.jaci.2020.01.040	http://dx.doi.org/10.1016/j.jaci.2020.01.040			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LW4ZZ	32035159	Green Accepted, Bronze			2022-12-18	WOS:000539157800022
J	Vocanson, M; Naisbitt, DJ; Nicolas, JF				Vocanson, Marc; Naisbitt, Dean J.; Nicolas, Jean-Francois			Current perspective of the etiopathogenesis of delayed-type, and T-cell-mediated drug-related skin diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Drug hypersensitivity; drug allergy; cytotoxic CD8(+) T cells; TCR recognition; genetics; tolerance; danger signals; heterologous immunity	ACTIVATION		[Vocanson, Marc; Nicolas, Jean-Francois] Univ Claude Bernard Lyon 1, Univ Lyon, Ecole Normale Super Lyon,U1111, CIRI,Ctr Int Rech Infectiol,INSERM,CNRS,UMR 5308, Lyon, France; [Naisbitt, Dean J.] Univ Liverpool, Dept Clin & Mol Pharmacol, MRC Ctr Drug Safety Sci, Liverpool, Merseyside, England; [Nicolas, Jean-Francois] Lyon Sud Univ Hosp, Allergol & Clin Immunol Dept, Pierre Benite, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Liverpool; CHU Lyon	Vocanson, M (corresponding author), CIRI INSERM U1111, 21 Ave Tony Garnier, F-69007 Lyon, France.	marc.vocanson@inserm.fr	Nicolas, Jean-François/AAW-9289-2020; Vocanson, Marc/G-5431-2017	Vocanson, Marc/0000-0002-0181-8862; Naisbitt, Dean/0000-0003-4107-7832				Almeida CA, 2019, J ALLERGY CLIN IMMUN, V144, P608, DOI 10.1016/j.jaci.2019.05.009; Cardone M, 2018, J CLIN INVEST, V128, P2819, DOI 10.1172/JCI99321; Chen CB, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6431694; Elzagallaai AA, 2020, J CLIN PHARMACOL, V60, P409, DOI 10.1002/jcph.1535; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Meng XL, 2017, J IMMUNOL, V198, P4217, DOI 10.4049/jimmunol.1700209; Pan RY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11396-2; Pichler WJ, 2019, ALLERGY, V74, P1457, DOI 10.1111/all.13765; Redwood AJ, 2018, HLA, V91, P3, DOI 10.1111/tan.13183; Toksoy A, 2017, J BIOL CHEM, V292, P2805, DOI 10.1074/jbc.M116.749473	10	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1142	1144		10.1016/j.jaci.2020.01.030	http://dx.doi.org/10.1016/j.jaci.2020.01.030			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	32018033	Bronze			2022-12-18	WOS:000523633400008
J	Lee, JS; An, Y; Yoon, CJ; Kim, JY; Kim, KH; Freeman, AF; Yim, JJ; Shin, EC; Holland, SM; Lee, EY; Ju, YS				Lee, Jeong Seok; An, Yohan; Yoon, Christopher J.; Kim, Jeong Yeon; Kim, Kyung Hwan; Freeman, Alexandra F.; Yim, Jae-Joon; Shin, Eui-Cheol; Holland, Steven M.; Lee, Eun Young; Ju, Young Seok			Germline gain-of-function mutation of STAT1 rescued by somatic mosaicism in immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like disorder	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CD8 T-CELLS		[Lee, Jeong Seok; Kim, Jeong Yeon; Lee, Eun Young] Seoul Natl Univ, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Jeong Seok; Kim, Kyung Hwan; Shin, Eui-Cheol; Ju, Young Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [An, Yohan; Ju, Young Seok] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea; [Yoon, Christopher J.] Korea Adv Inst Sci & Technol, Res Ctr Nat Sci, Daejeon, South Korea; [Yoon, Christopher J.] Washington Univ, Dept Med, St Louis, MO USA; [Freeman, Alexandra F.; Holland, Steven M.] NIH, Allergy & Infect Dis, Bldg 10, Bethesda, MD 20892 USA; [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Seoul National University (SNU)	Lee, EY (corresponding author), Seoul Natl Univ, Div Rheumatol, Dept Internal Med, Coll Med, Seoul, South Korea.	elee@snu.ac.kr; ysju@kaist.ac.kr	Ju, Young Seok/E-1324-2012	Ju, Young Seok/0000-0002-5514-4189; Yoon, Christopher/0000-0001-5714-7087; Yim, Jae-Joon/0000-0002-9605-0074	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare, Republic of Korea [HI14C1277, HI17C1836]; KREONET (Korea Research Environment Open NETwork)	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); KREONET (Korea Research Environment Open NETwork)	Support was provided by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI14C1277 to E.Y.L. and grant no. HI17C1836 to Y.S.J.). Y.S.J. is supported by KREONET (Korea Research Environment Open NETwork) which is managed and operated by Korea Institute of Science and Technology Information, Republic of Korea.	Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Leiding JW, 2018, J ALLERGY CLIN IMMUN, V141, P704, DOI 10.1016/j.jaci.2017.03.049; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Quigley M, 2008, J IMMUNOL, V180, P2158, DOI 10.4049/jimmunol.180.4.2158; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Toubiana J, 2016, BLOOD, V127, P3154, DOI 10.1182/blood-2015-11-679902; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102	9	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1017	1021		10.1016/j.jaci.2019.11.028	http://dx.doi.org/10.1016/j.jaci.2019.11.028			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31805313	hybrid			2022-12-18	WOS:000518756700045
J	Pouzolles, M; Machado, A; Guilbaud, M; Irla, M; Gailhac, S; Barennes, P; Cesana, D; Calabria, A; Benedicenti, F; Serge, A; Raman, I; Li, QZ; Montini, E; Klatzmann, D; Adjali, O; Taylor, N; Zimmermann, VS				Pouzolles, Marie; Machado, Alice; Guilbaud, Mickael; Irla, Magali; Gailhac, Sarah; Barennes, Pierre; Cesana, Daniela; Calabria, Andrea; Benedicenti, Fabrizio; Serge, Arnauld; Raman, Indu; Li, Quan-Zhen; Montini, Eugenio; Klatzmann, David; Adjali, Oumeya; Taylor, Naomi; Zimmermann, Valerie S.			Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe combined immunodeficiency; gene therapy; zeta-associated protein of 70kDa; thymus; intrathymic gene transfer; medulla formation; T-cell reconstitution; humoral immunity	SEVERE COMBINED IMMUNODEFICIENCY; HEMATOPOIETIC STEM-CELLS; WISKOTT-ALDRICH-SYNDROME; IN-VIVO; TRANSGENE EXPRESSION; IMMUNE-RESPONSES; AAV VECTORS; INSERTIONAL MUTAGENESIS; HELPER VIRUS; CANINE MODEL	Background: Patients with T-cell immunodeficiencies are generally treated with allogeneic hematopoietic stem cell transplantation, but alternatives are needed for patients without matched donors. An innovative intrathymic gene therapy approach that directly targets the thymus might improve outcomes. Objective: We sought to determine the efficacy of intrathymic adeno-associated virus (AAV) serotypes to transduce thymocyte subsets and correct the T-cell immunodeficiency in a zeta-associated protein of 70 kDa (ZAP-70)-deficient murine model. Methods: AAV serotypes were injected intrathymically into wild-type mice, and gene transfer efficiency was monitored. ZAP-70(-/-) mice were intrathymically injected with an AAV8 vector harboring the ZAP70 gene. Thymus structure, immunophenotyping, T-cell receptor clonotypes, T-cell function, immune responses to transgenes and autoantibodies, vector copy number, and integration were evaluated. Results: AAV8, AAV9, and AAV10 serotypes all transduced thymocyte subsets after in situ gene transfer, with transduction of up to 5% of cells. Intrathymic injection of an AAV8-ZAP-70 vector into ZAP-70(-/-) mice resulted in a rapid thymocyte differentiation associated with the development of a thymic medulla. Strikingly, medullary thymic epithelial cells expressing the autoimmune regulator were detected within 10 days of gene transfer, correlating with the presence of functional effector and regulatory T-cell subsets with diverse T-cell receptor clonotypes in the periphery. Although thymocyte reconstitution was transient, gene-corrected peripheral T cells harboring approximately 1 AAV genome per cell persisted for more than 40 weeks, and AAV vector integration was detected. Conclusions: Intrathymic AAV-transduced progenitors promote a rapid restoration of the thymic architecture, with a single wave of thymopoiesis generating long-term peripheral T-cell function.	[Pouzolles, Marie; Machado, Alice; Gailhac, Sarah; Taylor, Naomi; Zimmermann, Valerie S.] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Guilbaud, Mickael; Adjali, Oumeya] Univ Nantes, CHU Nantes, INSERM UMR1089, Nantes, France; [Irla, Magali] Aix Marseille Univ UM2, CIML, INSERM U1104, CNRS UMR7280, Marseille, France; [Barennes, Pierre; Klatzmann, David] Sorbonne Univ, INSERM, I3, Paris, France; [Cesana, Daniela; Calabria, Andrea; Benedicenti, Fabrizio; Montini, Eugenio] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy SR Tiget, IRCCS, Milan, Italy; [Serge, Arnauld] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, INSERM,CRCM, Marseille, France; [Raman, Indu; Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA; [Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Klatzmann, David] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France; [Klatzmann, David] Inflammat Immunopathol Biotherapy Dept i2B, Paris, France; [Taylor, Naomi] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Adjali, O; Taylor, N; Zimmermann, VS (corresponding author), Inst Genet Mol Montpellier, 1919 Route Mende, F-34293 Montpellier 5, France.	oumeya.adjali@univ-nantes.fr; taylorn4@mail.nih.gov; zimmermann@igmm.cnrs.fr	Montini, Eugenio/L-1152-2016; Taylor, Naomi/H-4016-2014; Serge, Arnauld/AAP-1525-2020; IRLA, Magali/AAH-7941-2019; Serge, Arnauld/B-4642-2017	Montini, Eugenio/0000-0003-1771-6067; Serge, Arnauld/0000-0002-1280-6277; IRLA, Magali/0000-0001-8803-9708; Serge, Arnauld/0000-0003-4271-3706; , Valerie/0000-0001-8919-0071	LABEX EpiGenMed; FRM; INSERM; National Institutes of Health; CNRS; AFM from the National Institute of Allergy and Infectious Diseases [R01AI059349]; ANR; ARC; INCA; ERC-Advanced TRiPoD [322856]	LABEX EpiGenMed; FRM(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM from the National Institute of Allergy and Infectious Diseases; ANR(French National Research Agency (ANR)); ARC(Australian Research Council); INCA(Institut National du Cancer (INCA) France); ERC-Advanced TRiPoD	M.P. was supported by a PhD fellowship from the LABEX EpiGenMed and the FRM. M.I. and O.A. are supported by INSERM, N.T. was supported by INSERM and the National Institutes of Health, and V.S.Z. is supported by CNRS. This work was funded by the AFM, grant R01AI059349 from the National Institute of Allergy and Infectious Diseases, and the ANR, ARC, FRM, INCA, and ERC-Advanced TRiPoD (#322856 to D.K.).	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320; Abramson J, 2016, EUR J IMMUNOL, V46, P22, DOI 10.1002/eji.201545792; Adjali O, 2005, P NATL ACAD SCI USA, V102, P13586, DOI 10.1073/pnas.0504268102; Adjali O, 2005, J CLIN INVEST, V115, P2287, DOI 10.1172/JCI23966; Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Ariga T, 2001, BLOOD, V97, P2896, DOI 10.1182/blood.V97.9.2896; Au-Yeung BB, 2018, ANNU REV IMMUNOL, V36, P127, DOI 10.1146/annurev-immunol-042617-053335; Awong G, 2013, BLOOD, V122, P4210, DOI 10.1182/blood-2012-12-472803; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; Brown N, 2017, HUM GENE THER, V28, P450, DOI 10.1089/hum.2017.038; Buning H, 2015, CURR OPIN PHARMACOL, V24, P94, DOI 10.1016/j.coph.2015.08.002; Calcedo R, 2017, P NATL ACAD SCI USA, V114, P1655, DOI 10.1073/pnas.1617726114; Capo V, 2018, J ALLERGY CLIN IMMUN, V142, P928, DOI 10.1016/j.jaci.2017.11.015; Castiello MC, 2015, J ALLERGY CLIN IMMUN, V136, P692, DOI 10.1016/j.jaci.2015.01.035; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; Colella P, 2018, MOL THER-METH CLIN D, V8, P87, DOI 10.1016/j.omtm.2017.11.007; Corti M, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.33; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Davis BR, 2008, BLOOD, V111, P5064, DOI 10.1182/blood-2007-06-095299; Davis BR, 2010, CLIN IMMUNOL, V135, P72, DOI 10.1016/j.clim.2009.12.011; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; De Barros SC, 2013, STEM CELLS, V31, P1245, DOI 10.1002/stem.1378; de Barros SC, 2013, BLOOD, V121, P2144, DOI 10.1182/blood-2012-08-447417; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; DeMatteo RP, 1997, J VIROL, V71, P5330, DOI 10.1128/JVI.71.7.5330-5335.1997; Dudakov JA, 2017, BLOOD, V130, P933, DOI 10.1182/blood-2017-01-762658; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Dudakov JA, 2011, BEST PRACT RES CL HA, V24, P467, DOI 10.1016/j.beha.2011.05.003; Elverman M, 2017, MUSCLE NERVE, V56, P943, DOI 10.1002/mus.25658; Etzensperger R, 2017, NAT IMMUNOL, V18, P1218, DOI 10.1038/ni.3847; Firouzi S, 2014, GENOME MED, V6, DOI 10.1186/gm568; Fischer A, 2013, GENE, V525, P170, DOI 10.1016/j.gene.2013.03.092; Fischer A, 2011, HEMATOL ONCOL CLIN N, V25, P89, DOI 10.1016/j.hoc.2010.11.007; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; FREY JR, 1992, J EXP MED, V175, P1067, DOI 10.1084/jem.175.4.1067; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Gernoux G, 2017, HUM GENE THER, V28, P338, DOI 10.1089/hum.2017.022; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Goldberg GL, 2010, J IMMUNOL, V184, P6014, DOI 10.4049/jimmunol.0802445; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Han SO, 2015, HUM GENE THER, V26, P26, DOI 10.1089/hum.2014.115; Han ZC, 2008, HUM GENE THER, V19, P267, DOI 10.1089/hum.2007.161; Hargrove PW, 1997, BLOOD, V89, P2167, DOI 10.1182/blood.V89.6.2167; Heimall J, 2017, BIOL BLOOD MARROW TR, V23, P379, DOI 10.1016/j.bbmt.2016.12.619; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huser D, 2017, J VIROL, V91, DOI 10.1128/JVI.02137-16; Irla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052591; Irla M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002059; Kaplitt MG, 1996, ANN THORAC SURG, V62, P1669, DOI 10.1016/S0003-4975(96)00946-0; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kelly RM, 2010, BLOOD, V115, P1088, DOI 10.1182/blood-2009-05-223198; Kimura MY, 2016, NAT IMMUNOL, V17, P1415, DOI 10.1038/ni.3560; Kumar SRP, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.34; Le Bec C, 2006, GENE THER, V13, P805, DOI 10.1038/sj.gt.3302724; Le Guiner C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16105; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Ling C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35495; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Lopes N, 2017, EMBO MOL MED, V9, P835, DOI 10.15252/emmm.201607176; Lopes N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00365; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Mack DL, 2017, MOL THER, V25, P839, DOI 10.1016/j.ymthe.2017.02.004; Maina N, 2008, HUM GENE THER, V19, P376, DOI 10.1089/hum.2007.143; Malik P, 1997, J VIROL, V71, P1776, DOI 10.1128/JVI.71.3.1776-1783.1997; Mamcarz E, 2019, NEW ENGL J MED, V380, P1525, DOI 10.1056/NEJMoa1815408; Manna S, 2016, METHODS MOL BIOL, V1323, P203, DOI 10.1007/978-1-4939-2809-5_17; Marodon G, 2006, BLOOD, V108, P2972, DOI 10.1182/blood-2006-03-010900; Martino AT, 2011, METHODS MOL BIOL, V807, P259, DOI 10.1007/978-1-61779-370-7_11; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McIntosh JH, 2012, GENE THER, V19, P78, DOI 10.1038/gt.2011.64; Mendoza SD, 2017, J NEUROPHYSIOL, V117, P2004, DOI 10.1152/jn.00780.2016; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Moreau A, 2009, MOL THER, V17, P472, DOI 10.1038/mt.2008.272; Mueller C, 2013, J CLIN INVEST, V123, P5310, DOI 10.1172/JCI70314; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Nathwani AC, 2000, GENE THER, V7, P183, DOI 10.1038/sj.gt.3301068; Nishikomori R, 2004, BLOOD, V103, P4565, DOI 10.1182/blood-2003-10-3655; Nowrouzi A, 2012, MOL THER, V20, P1177, DOI 10.1038/mt.2012.47; Pala F, 2015, J CLIN INVEST, V125, P3941, DOI 10.1172/JCI82249; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; Perera J, 2015, CELL MOL LIFE SCI, V72, P2657, DOI 10.1007/s00018-015-1895-1; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Reichel FF, 2018, INVEST OPHTH VIS SCI, V59, P1910, DOI 10.1167/iovs.17-22494; Reichel FF, 2017, MOL THER, V25, P2648, DOI 10.1016/j.ymthe.2017.08.018; Reimann C, 2012, STEM CELLS, V30, P1771, DOI 10.1002/stem.1145; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Rossi SW, 2007, BLOOD, V109, P3803, DOI 10.1182/blood-2006-10-049767; Rucci F, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00015; Russell DW, 2007, MOL THER, V15, P1740, DOI 10.1038/sj.mt.6300299; Salvetti A, 1998, HUM GENE THER, V9, P695, DOI 10.1089/hum.1998.9.5-695; Schuhmann NK, 2010, EXP HEMATOL, V38, P707, DOI 10.1016/j.exphem.2010.04.016; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Serge A, 2015, J IMMUNOL METHODS, V424, P32, DOI 10.1016/j.jim.2015.04.019; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Shaw KL, 2017, J CLIN INVEST, V127, P1689, DOI 10.1172/JCI90367; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Smith LJ, 2014, MOL THER, V22, P1625, DOI 10.1038/mt.2014.107; Smith MJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92056; Sondhi D, 2005, GENE THER, V12, P1618, DOI 10.1038/sj.gt.3302549; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Speckmann C, 2008, BLOOD, V112, P4090, DOI 10.1182/blood-2008-04-153361; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Thordardottir S, 2014, STEM CELLS DEV, V23, P955, DOI 10.1089/scd.2013.0521; Thrasher AJ, 2006, NATURE, V443, pE5, DOI 10.1038/nature05219; Tone Y, 2007, BLOOD, V109, P1182, DOI 10.1182/blood-2006-08-039057; Tuckett AZ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0478-z; Tuckett AZ, 2014, BLOOD, V123, P2797, DOI 10.1182/blood-2013-10-535401; Uzel G, 2008, BLOOD, V111, P209, DOI 10.1182/blood-2007-04-082552; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; Vandamme C, 2017, HUM GENE THER, V28, P1061, DOI 10.1089/hum.2017.150; Velardi E, 2014, J EXP MED, V211, P2341, DOI 10.1084/jem.20131289; Veldwijk MR, 2010, CYTOTHERAPY, V12, P107, DOI 10.3109/14653240903348293; Vicente R, 2010, BLOOD, V115, P1913, DOI 10.1182/blood-2009-06-229724; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2003, J CLIN INVEST, V111, P1389, DOI 10.1172/JCI200315485; Walter JE, 2016, J CLIN INVEST, V126, P4389, DOI 10.1172/JCI91162; Wang CY, 2016, INT J ONCOL, V48, P2247, DOI 10.3892/ijo.2016.3492; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Xiao WD, 2000, MOL THER, V1, P323, DOI 10.1006/mthe.2000.0045; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Zhang SL, 2014, BLOOD, V124, P296, DOI 10.1182/blood-2014-01-552794	145	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					679	+		10.1016/j.jaci.2019.08.029	http://dx.doi.org/10.1016/j.jaci.2019.08.029			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31513879	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000512887400029
J	Tanimoto, S; Simons, FE; Lockey, R; Lieberman, P; Kaliner, M; Lowenthal, R				Tanimoto, Sarina; Simons, F. Estelle; Lockey, Richard; Lieberman, Phillip; Kaliner, Michael; Lowenthal, Richard			A Phase 1, Five-Period, Five-Treatment, Randomized Crossover Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Epinephrine After Administration of Intranasal (IN) ARS-1 and Intramuscular (IM) Epinephrine to Healthy Volunteers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 13-16, 2020	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Tanimoto, Sarina; Lowenthal, Richard] ARS Pharmaceut Inc, San Diego, CA USA; [Simons, F. Estelle] Univ Manitoba, Winnipeg, MB, Canada; [Lockey, Richard] Univ S Florida, Tampa, FL 33620 USA; [Lieberman, Phillip] Allergy & Asthma Associates, San Jose, CA USA; [Kaliner, Michael] Inst Asthma & Allergy, Chevy Chase, MD USA	University of Manitoba; State University System of Florida; University of South Florida									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2		S		239	AB77	AB77						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	KQ7IJ					2022-12-18	WOS:000517092700239
J	Simon, D; Simon, HU				Simon, Dagmar; Simon, Hans-Uwe			Relationship of skin barrier breakdown and eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Atopic dermatitis; eosinophilic esophagitis; epithelial barrier defect; type 2 inflammation	FC-EPSILON-RI; ATOPIC-DERMATITIS; LANGERHANS CELLS; EPITHELIAL BARRIER; FILAGGRIN; DIFFERENTIATION; EXPRESSION; IGE; ASSOCIATION; ACTIVATION	Eosinophilic esophagitis (EoE) is strongly associated with allergic diseases, such as asthma, allergic rhinitis, and atopic dermatitis (AD). Although atopic diseases affect different organs, they share a number of characteristics, such as eosinophil tissue infiltration; T(H)2-biased inflammation involving innate and adaptive immune responses; increased peripheral blood total IgE levels, including specific IgE to environmental allergens; and a chronic disease course.(1) They exhibit a genetic predisposition.(1) Previous observations that airway allergies usually occur before EoE manifestation,(E1) the fact that a challenge to the upper airways in a mouse model leads to eosinophilia in the esophagus,(2,3 )and our recognition that medications effective in asthmatic patients are helpful in patients with EoE(E2,E3) had already placed EoE close to asthma and allergic rhinitis. Although patients with EoE are less frequently affected by AD compared with allergic airway diseases,(2,E1) there are several observations that suggest a close relationship between these 2 different clinical entities because they both share both an impaired epithelial barrier and type 2 inflammation. The main purpose of this article is to emphasize that both AD and EoE exhibit barrier defects contributing to disease development and to address the question of whether skin barrier disruption might contribute to EoE pathogenesis.	[Simon, Dagmar] Bern Univ Hosp, Inselspital, Dept Dermatol, Bern, Switzerland; [Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Simon, Hans-Uwe] Sechenov Univ, Dept Clin Immunol & Allergol, Moscow, Russia	University of Bern; University Hospital of Bern; University of Bern; Sechenov First Moscow State Medical University	Simon, D (corresponding author), Inselspital Bern, Dept Dermatol, CH-3010 Bern, Switzerland.	dagmar.simon@insel.ch	Simon, Hans-Uwe/AAU-7410-2020	Simon, Hans-Uwe/0000-0002-9404-7736	Swiss National Science Foundation [310030_166473]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	H.-U. Simon is supported by the Swiss National Science Foundation (grant no. 310030_166473).	Akdis CA, 1999, J INVEST DERMATOL, V113, P628, DOI 10.1046/j.1523-1747.1999.00720.x; Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Azouz NP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9736; Bieber T, 1996, J DERMATOL SCI, V13, P71, DOI 10.1016/0923-1811(95)00504-8; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Brunner PM, 2018, J ALLERGY CLIN IMMUN, V141, P2094, DOI 10.1016/j.jaci.2018.02.040; BRUYNZEELKOOMEN C, 1988, CLIN EXP IMMUNOL, V74, P137; Chandramouleeswaran PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150968; D'Mello RJ, 2016, MUCOSAL IMMUNOL, V9, P744, DOI 10.1038/mi.2015.98; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Fortugno P, 2012, HUM MOL GENET, V21, P4187, DOI 10.1093/hmg/dds243; Hill DA, 2018, J ALLER CL IMM-PRACT, V6, P1528, DOI 10.1016/j.jaip.2018.05.010; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Katzka DA, 2014, CLIN GASTROENTEROL H, V12, P1824, DOI 10.1016/j.cgh.2014.02.039; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Martin LJ, 2018, J ALLERGY CLIN IMMUN, V141, P1690, DOI 10.1016/j.jaci.2017.09.046; Masterson JC, 2019, J CLIN INVEST, V129, P3224, DOI 10.1172/JCI126744; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Muller S, 2009, PEDIAT ALLERG IMM-UK, V20, P358, DOI 10.1111/j.1399-3038.2008.00808.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Rochman M, 2018, J ALLERGY CLIN IMMUN, V142, P10, DOI 10.1016/j.jaci.2018.05.008; Rochman M, 2017, J ALLERGY CLIN IMMUN, V140, P738, DOI 10.1016/j.jaci.2016.11.042; Roedl D, 2009, J EUR ACAD DERMATOL, V23, P1263, DOI 10.1111/j.1468-3083.2009.03302.x; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Simon D, 2005, J ALLERGY CLIN IMMUN, V115, P1090, DOI 10.1016/j.jaci.2005.01.017; Simon D, 2018, ALLERGY, V73, P239, DOI 10.1111/all.13244; Simon D, 2016, ALLERGY, V71, P611, DOI 10.1111/all.12846; Simon D, 2015, ALLERGY, V70, P443, DOI 10.1111/all.12570; Simon D, 2014, ALLERGY, V69, P125, DOI 10.1111/all.12351; Simon D, 2013, ALLERGY, V68, P945, DOI 10.1111/all.12157; Simon D, 2019, INT ARCH ALLERGY IMM, V178, P207, DOI 10.1159/000497383; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Venturelli N, 2016, J ALLERGY CLIN IMMUN, V138, P1367, DOI 10.1016/j.jaci.2016.02.034; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Yen EH, 2010, J PEDIATR GASTR NUTR, V51, P584, DOI 10.1097/MPG.0b013e3181de7685; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001; Zhu YN, 2017, J ALLERGY CLIN IMMUN, V140, P1310, DOI 10.1016/j.jaci.2017.01.025	48	5	5	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					90	+		10.1016/j.jaci.2019.11.005	http://dx.doi.org/10.1016/j.jaci.2019.11.005			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31738992	Bronze			2022-12-18	WOS:000505590800009
J	Karta, MR; Cavagnero, K; Miller, M; Badrani, J; Naji, L; Doherty, TA; Broide, DH				Karta, Maya R.; Cavagnero, Kellen; Miller, Marina; Badrani, Jana; Naji, Luay; Doherty, Taylor A.; Broide, David H.			Platelets attach to lung type 2 innate lymphoid cells (ILC2s) expressing P-selectin glycoprotein ligand 1 and influence ILC2 function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RECRUITMENT; TRAFFICKING; NEUTROPHILS		[Karta, Maya R.; Cavagnero, Kellen; Miller, Marina; Badrani, Jana; Naji, Luay; Doherty, Taylor A.; Broide, David H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Broide, DH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dbroide@ucsd.edu	Badrani, Jana/GVR-9659-2022	Cavagnero, Kellen J/0000-0003-4160-6394; Broide, David/0000-0001-8405-9090	National Institutes of Health (NIH) [AI 070535, AI 107779, AI 242236, AI 038425]; NIH [AI 070535, AI 114585, T32 AI 007469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R01AI107779, R01AI114585] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health (NIH) grants AI 070535, AI 107779, AI 242236, and AI 038425 (to D.H.B.). T.A.D. is supported by NIH grants AI 114585 and AI 070535. M.R.K. was supported by T32 AI 007469.	Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Doherty TA, 2018, J ALLERGY CLIN IMMUN, V141, P1587, DOI 10.1016/j.jaci.2018.02.034; Doherty TA, 2017, J ALLERGY CLIN IMMUN, V139, P1465, DOI 10.1016/j.jaci.2016.12.003; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Karta MR, 2018, J ALLERGY CLIN IMMUN, V141, P329, DOI 10.1016/j.jaci.2017.03.010; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lund SJ, 2017, J IMMUNOL, V199, P1096, DOI 10.4049/jimmunol.1601569; Michelson AD, 2007, BLOOD, V110, P794, DOI 10.1182/blood-2007-05-089078; O'Sullivan TE, 2018, METHODS MOL BIOL, V1799, P109, DOI 10.1007/978-1-4939-7896-0_10; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Pitchford SC, 2003, J ALLERGY CLIN IMMUN, V112, P109, DOI 10.1067/mai.2003.1514; Rigas D, 2017, J ALLERGY CLIN IMMUN, V139, P1468, DOI 10.1016/j.jaci.2016.08.034; Shah SA, 2017, FRONT MED, V4, P1; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Woltmann G, 2000, BLOOD, V95, P3146	20	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1112	+		10.1016/j.jaci.2019.06.001	http://dx.doi.org/10.1016/j.jaci.2019.06.001			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31201889	Green Accepted, Bronze			2022-12-18	WOS:000488803900025
J	Uhel, F; Azzaoui, I; Le Gallou, S; Fest, T; Tarte, K; Roussel, M				Uhel, Fabrice; Azzaoui, Imane; Le Gallou, Simon; Fest, Thierry; Tarte, Karin; Roussel, Mikael			Early-stage myeloid-derived suppressor cell count: Basophil exclusion matters	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Uhel, Fabrice] CHU Rennes, Malad Infect & Reanimat Med, Rennes, France; [Uhel, Fabrice; Azzaoui, Imane; Le Gallou, Simon; Fest, Thierry; Tarte, Karin; Roussel, Mikael] INSERM, Rennes, France; [Azzaoui, Imane; Le Gallou, Simon; Fest, Thierry; Tarte, Karin; Roussel, Mikael] CHU Rennes, Pole Biol, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes	Roussel, M (corresponding author), INSERM, Rennes, France.; Roussel, M (corresponding author), CHU Rennes, Pole Biol, Rennes, France.	mikael.roussel@chu-rennes.fr	Roussel, Mikael/C-3080-2017; Uhel, Fabrice/AAF-4238-2020; tarte, karin/GXV-1815-2022	Roussel, Mikael/0000-0002-9741-0668; tarte, karin/0000-0002-6809-917X; Azzaoui, Imane/0000-0001-5603-6780	National Institute of Cancer (INCa Recherche Translationnelle 2010); Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang; Lymphoma Study Association group; Nuovo-Soldati Foundation	National Institute of Cancer (INCa Recherche Translationnelle 2010); Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang; Lymphoma Study Association group; Nuovo-Soldati Foundation	This work was supported by a research grant from the National Institute of Cancer (INCa Recherche Translationnelle 2010), by the Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang, and by the Lymphoma Study Association group. M.R. is a recipient of a fellowship from the Nuovo-Soldati Foundation.	Azzaoui I, 2016, BLOOD, V128, P1081, DOI 10.1182/blood-2015-08-662783; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Fleming V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00398; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Lang S, 2018, CLIN CANCER RES, V24, P4834, DOI 10.1158/1078-0432.CCR-17-3726; Martinelli S, 2018, AM J HUM GENET, V102, P309, DOI 10.1016/j.ajhg.2017.12.015; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Najjar YG, 2017, CLIN CANCER RES, V23, P2346, DOI 10.1158/1078-0432.CCR-15-1823; Okla K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00691; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Toba K, 1999, CYTOMETRY, V35, P249, DOI 10.1002/(SICI)1097-0320(19990301)35:3<249::AID-CYTO8>3.0.CO;2-O; Uhel F, 2017, AM J RESP CRIT CARE, V196, P315, DOI 10.1164/rccm.201606-1143OC; Varricchi G, 2018, IMMUNOL REV, V282, P8, DOI 10.1111/imr.12627; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852	15	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2019	144	4					1125	+		10.1016/j.jaci.2019.06.027	http://dx.doi.org/10.1016/j.jaci.2019.06.027			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JB8FZ	31279012	Green Accepted, Bronze			2022-12-18	WOS:000488803900029
J	Gao, LQ; Mo, S; Xie, J; Chen, SS; Wen, X; Long, XR; Ren, L; Zang, N; Xie, XH; Deng, Y; Luo, J; Luo, ZX; Fu, Z; Smyth, RL; Liu, EM				Gao, Leiqiong; Mo, Shi; Xie, Jun; Chen, Sisi; Wen, Xiang; Long, Xiaoru; Ren, Luo; Zang, Na; Xie, Xiaohong; Deng, Yu; Luo, Jian; Luo, Zhengxiu; Fu, Zhou; Smyth, Rosalind L.; Liu, Enmei			Respiratory syncytial virus nonstructural protein 1 downregulates glucocorticoid receptor expression through miR-29a	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Gao, Leiqiong; Mo, Shi; Xie, Jun; Chen, Sisi; Wen, Xiang; Long, Xiaoru; Ren, Luo] Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing, Minist Educ, Key Lab Child Dev & Disorders,Pediat Res Inst, CSTC2009CA5002, Chongqing, Peoples R China; [Zang, Na; Xie, Xiaohong; Deng, Yu; Luo, Jian; Luo, Zhengxiu; Fu, Zhou; Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Smyth, Rosalind L.] UCL, Inst Child Hlth, Great Ormond St, London, England	Chongqing Medical University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Liu, EM (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	emliu186@126.com			National Natural Science Foundation of China [8130007, 81670011, 91642107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants from the National Natural Science Foundation of China (8130007, 81670011, and 91642107).	Bailey MT, 2009, J IMMUNOL, V182, P7888, DOI 10.4049/jimmunol.0800891; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Fernandes RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004878.pub4; Glantschnig C, 2018, DIABETOL STOFFWECHS, V13, pLBFV7; Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Wang HM, 2017, J CANCER RES CLIN, V143, P1005, DOI 10.1007/s00432-017-2388-4; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Xie J, 2018, J INFECT DIS, V217, P35, DOI 10.1093/infdis/jix445	9	5	8	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					854	857		10.1016/j.jaci.2019.05.014	http://dx.doi.org/10.1016/j.jaci.2019.05.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31128120	Bronze			2022-12-18	WOS:000485222300029
J	Cook-Mills, JM; Kaplan, MH; Turner, MJ; Kloepfer, KM; Kumar, R				Cook-Mills, Joan M.; Kaplan, Mark H.; Turner, Matthew J.; Kloepfer, Kirsten M.; Kumar, Rajesh			Exposure: Staphylococcus aureus skin colonization predisposes to food allergy in the Learning Early about Allergy to Peanut (LEAP) and LEAP-On studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy; Staphylococcus aureus; eczema; peanut; egg; milk; IgE; skin; nasal; environment	SENSITIZATION		[Cook-Mills, Joan M.; Kaplan, Mark H.; Turner, Matthew J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Cook-Mills, Joan M.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, Div Pulm Allergy & Sleep Med, Indianapolis, IN 46202 USA; [Turner, Matthew J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Turner, Matthew J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Kloepfer, Kirsten M.] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA; [Kumar, Rajesh] Lurie Childrens Hosp, Chicago, IL USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago	Cook-Mills, JM (corresponding author), Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, VanNuys Med Sci Bldg MS 2059,635 Barnhill Dr, Indianapolis, IN 46202 USA.	joancook@iu.edu		Kumar, Rajesh/0000-0002-1962-7108	NIAID NIH HHS [L40 AI096442, K23 AI135094] Funding Source: Medline; CSRD VA [IK2 CX001019] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI135094] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001019] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSRD VA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)		Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P1343, DOI 10.1016/j.jaci.2017.09.034; Fukutomi Y, 2015, ALLERGOL INT, V64, P321, DOI 10.1016/j.alit.2015.05.007; Jones AL, 2016, J ALLERGY CLIN IMMUN, V137, P1247, DOI 10.1016/j.jaci.2016.01.010; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Totte JEE, 2016, BRIT J DERMATOL, V175, P687, DOI 10.1111/bjd.14566; Tsilochristou O, 2019, J ALLERGY CLIN IMMUN, V144, P494, DOI 10.1016/j.jaci.2019.04.025; Walker MT, 2018, J ALLERGY CLIN IMMUN, V141, P1711, DOI 10.1016/j.jaci.2018.02.003; Xian M, 2016, J ALLERGY CLIN IMMUN, V138, P890, DOI 10.1016/j.jaci.2016.07.003	10	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					404	406		10.1016/j.jaci.2019.06.014	http://dx.doi.org/10.1016/j.jaci.2019.06.014			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31255642	Green Submitted			2022-12-18	WOS:000478789300007
J	Hansen, R; Gerasimidis, K; Turner, S				Hansen, Richard; Gerasimidis, Kostas; Turner, Steve			Asthma causation and the gastrointestinal microbiome and metabolome: Might there be a signal, or is it just noise?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; child; gastrointestinal tract; metabolome; microbiome	CHILDHOOD ASTHMA; CROHNS-DISEASE; CHILDREN		[Hansen, Richard] Royal Hosp Children, Dept Paediat Gastroenterol, Glasgow, Lanark, Scotland; [Gerasimidis, Kostas] Univ Glasgow, Human Nutr, Glasgow, Lanark, Scotland; [Turner, Steve] Univ Aberdeen, Child Hlth, Aberdeen, Scotland	University of Glasgow; University of Aberdeen	Turner, S (corresponding author), Royal Aberdeen Childrens Hosp, Child Hlth, Aberdeen AB25 2ZG, Scotland.	s.w.turner@abdn.ac.uk		Gerasimidis, Konstantinos/0000-0001-9432-2200; Hansen, Richard/0000-0002-3944-6646				Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Chan-Yeung M, 2005, J ALLERGY CLIN IMMUN, V116, P49, DOI 10.1016/j.jaci.2005.03.029; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Holbrook JT, 2012, JAMA-J AM MED ASSOC, V307, P373, DOI 10.1001/jama.2011.2035; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Kevans D, 2016, J CROHNS COLITIS, V10, P209, DOI 10.1093/ecco-jcc/jjv197; Lee-Sarwar KA, 2019, J ALLERGY CLIN IMMUN, V144, P442, DOI 10.1016/j.jaci.2019.02.032; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150	10	5	5	5	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					401	403		10.1016/j.jaci.2019.04.026	http://dx.doi.org/10.1016/j.jaci.2019.04.026			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31078572	Green Accepted, Bronze			2022-12-18	WOS:000478789300006
J	Eriksson, D; Bacchetta, R; Gunnarsson, HI; Chan, A; Barzaghi, F; Ehl, S; Hallgren, A; van Gool, F; Sardh, F; Lundqvist, C; Laakso, SM; Ronnblom, A; Ekwall, O; Makitie, O; Bensing, S; Husebye, ES; Anderson, M; Kampe, O; Landegren, N				Eriksson, Daniel; Bacchetta, Rosa; Gunnarsson, Hordur Ingi; Chan, Alice; Barzaghi, Federica; Ehl, Stephan; Hallgren, Asa; van Gool, Frederic; Sardh, Fabian; Lundqvist, Christina; Laakso, Saila M.; Ronnblom, Anders; Ekwall, Olov; Makitie, Outi; Bensing, Sophie; Husebye, Eystein S.; Anderson, Mark; Kampe, Olle; Landegren, Nils			The autoimmune targets in IPEX are dominated by gut epithelial proteins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AUTOANTIBODIES; IDENTIFICATION		[Eriksson, Daniel; Gunnarsson, Hordur Ingi; Hallgren, Asa; Sardh, Fabian; Husebye, Eystein S.; Kampe, Olle; Landegren, Nils] Karolinska Inst, Dept Med Solna, Ctr Mol Med, Stockholm, Sweden; [Eriksson, Daniel; Kampe, Olle] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Stockholm, Sweden; [Bacchetta, Rosa] Stanford Univ, Dept Pediat, Sch Med, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA 94305 USA; [Chan, Alice] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Barzaghi, Federica] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy; [Ehl, Stephan] Univ Freiburg, Freiburg Univ Hosp, Ctr Chron Immunodeficiency, Fac Med, Freiburg, Germany; [van Gool, Frederic; Anderson, Mark] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Lundqvist, Christina; Ekwall, Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Laakso, Saila M.; Makitie, Outi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Laakso, Saila M.; Makitie, Outi] Helsinki Univ Hosp, Helsinki, Finland; [Ronnblom, Anders] Uppsala Univ, Dept Med Sci, Gastroenterol, Uppsala, Sweden; [Ekwall, Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Makitie, Outi; Bensing, Sophie] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Makitie, Outi] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Makitie, Outi] Folkhalsan Inst Genet, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Helsinki, Finland; [Husebye, Eystein S.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Husebye, Eystein S.] Haukeland Hosp, Dept Med, Bergen, Norway; [Husebye, Eystein S.; Kampe, Olle] KG Jebsen Ctr Autoimmune Disorders, Bergen, Norway; [Landegren, Nils] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stanford University; University of California System; University of California San Francisco; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Freiburg; University of California System; University of California San Francisco; University of Gothenburg; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Uppsala University; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Bergen; University of Bergen; Haukeland University Hospital; Uppsala University	Eriksson, D (corresponding author), Karolinska Inst, Dept Med Solna, Ctr Mol Med, Stockholm, Sweden.; Eriksson, D (corresponding author), Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Stockholm, Sweden.	daniel.eriksson@ki.se	Laakso, Saila/ABD-1476-2021; Anderson, Mark/AAZ-4992-2020; Eriksson, Daniel/AAT-5860-2021; Ehl, Stephan/AAM-6006-2020	Laakso, Saila/0000-0002-5588-7855; Anderson, Mark/0000-0002-3093-4758; Eriksson, Daniel/0000-0001-5473-3312; Bacchetta, Rosa/0000-0002-0606-6268; Ekwall, Olov/0000-0002-4506-9955; Lundqvist, Christina/0000-0002-2256-4072; Ehl, Stephan/0000-0002-9265-2721	Swedish Research Council; Torsten and Ragnar Soderberg foundations; Novo Nordisk Foundation; Academy of Finland; Crafoord Foundation; Folkhalsan Research Foundation; Helmsley Charitable Trust; KG Jebsen Foundation; Marcus Borgstrom Foundation; Stockholm County Council; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg foundations; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Crafoord Foundation; Folkhalsan Research Foundation; Helmsley Charitable Trust; KG Jebsen Foundation; Marcus Borgstrom Foundation; Stockholm County Council(Stockholm County Council); Swedish Society for Medical Research	This study was funded by the Swedish Research Council, the Torsten and Ragnar Soderberg foundations, the Novo Nordisk Foundation, the Academy of Finland, the Crafoord Foundation, the Folkhalsan Research Foundation, the Helmsley Charitable Trust, the KG Jebsen Foundation, the Marcus Borgstrom Foundation, the Stockholm County Council, and the Swedish Society for Medical Research.	BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Huter EN, 2010, J INVEST DERMATOL, V130, P1391, DOI 10.1038/jid.2010.16; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; Kobayashi I, 2011, CLIN IMMUNOL, V141, P83, DOI 10.1016/j.clim.2011.05.010; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Rosenberg JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00544; Russler-Germain EV, 2017, MUCOSAL IMMUNOL, V10, P1375, DOI 10.1038/mi.2017.65; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419	16	5	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					327	+		10.1016/j.jaci.2019.02.031	http://dx.doi.org/10.1016/j.jaci.2019.02.031			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	31027649	Green Published, hybrid			2022-12-18	WOS:000473432800039
J	Polak, D; Samadi, N; Vizzardelli, C; Acosta, GS; Rosskopf, S; Steinberger, P; Jahn-Schmid, B; Bohle, B				Polak, Dominika; Samadi, Nazanin; Vizzardelli, Caterina; Acosta, Gabriela Sanchez; Rosskopf, Sandra; Steinberger, Peter; Jahn-Schmid, Beatrice; Bohle, Barbara			Neutrophils promote T-cell-mediated inflammation in allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LIGAND; CD2		[Polak, Dominika; Samadi, Nazanin; Vizzardelli, Caterina; Acosta, Gabriela Sanchez; Jahn-Schmid, Beatrice; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Rosskopf, Sandra; Steinberger, Peter] Med Univ Vienna, Inst Immunol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Bohle, B (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	barbara.bohle@meduniwien.ac.at		Vizzardelli, Caterina/0000-0001-9262-6710; Bohle, Barbara/0000-0002-5105-7985; Steinberger, Peter/0000-0001-6848-4097	Austrian Science funds (FWF) [W1248, SFB F4610]; Medical University of Vienna	Austrian Science funds (FWF)(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Austrian Science funds (FWF), projects W1248 and SFB F4610, and by the Medical University of Vienna.	BIERER BE, 1988, J IMMUNOL, V140, P3358; Calzetti F, 2017, J ALLERGY CLIN IMMUN, V139, P352, DOI 10.1016/j.jaci.2016.06.025; GIMMI CD, 1993, P NATL ACAD SCI USA, V90, P6586, DOI 10.1073/pnas.90.14.6586; Kitzmuller C, 2015, J ALLERGY CLIN IMMUN, V136, P151, DOI 10.1016/j.jaci.2014.12.1928; KUIJPERS TW, 1991, BLOOD, V78, P1105; Leitner J, 2015, J IMMUNOL, V195, P477, DOI 10.4049/jimmunol.1401917; Polak D, 2019, J ALLERGY CLIN IMMUN, V143, P1143, DOI 10.1016/j.jaci.2018.06.005; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; Vizzardelli C, 2018, ALLERGY, V73, P851, DOI 10.1111/all.13363; 2012, J ALLERGY CLIN IMMUN, V129, P521	11	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1923	+		10.1016/j.jaci.2018.11.035	http://dx.doi.org/10.1016/j.jaci.2018.11.035			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30578884				2022-12-18	WOS:000466784600027
J	Tamehiro, N; Nishida, K; Sugita, Y; Hayakawa, K; Oda, H; Nitta, T; Nakano, M; Nishioka, A; Yanobu-Takanashi, R; Goto, M; Okamura, T; Adachi, R; Kondo, K; Morita, A; Suzuki, H				Tamehiro, Norimasa; Nishida, Kyoko; Sugita, Yu; Hayakawa, Kunihiro; Oda, Hiroyo; Nitta, Takeshi; Nakano, Miwa; Nishioka, Akiko; Yanobu-Takanashi, Reiko; Goto, Motohito; Okamura, Tadashi; Adachi, Reiko; Kondo, Kazunari; Morita, Akimichi; Suzuki, Harumi			Ras homolog gene family H (RhoH) deficiency induces psoriasis-like chronic dermatitis by promoting T(H)17 cell polarization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Psoriasis; T cell; T(H)17; IL-22 binding protein; retinoic acid-related orphan receptor gamma t; Nr2f6; T-cell receptor signaling	PAPILLOMAVIRUS TYPE 5; DELTA T-CELLS; IFN-GAMMA; IL-22; INTERLEUKIN-22; SUSCEPTIBILITY; TCR; INFLAMMATION; CYCLOSPORINE; ARTHRITIS	Background: Ras homolog gene family H (RhoH) is a membrane-bound adaptor protein involved in proximal T-cell receptor signaling. Therefore RhoH plays critical roles in the differentiation of T cells; however, the function of RhoH in the effecter phase of the T-cell response has not been fully characterized. Objective: We sought to explore the role of RhoH in inflammatory immune responses and investigated the involvement of RhoH in the pathogenesis of psoriasis. Methods: We analyzed effector T-cell and systemic inflammation in wild-type and RhoH-null mice. RhoH expression in T cells in human PBMCs was quantified by using RT-PCR. Results: RhoH deficiency in mice induced T(H)17 polarization during effector T-cell differentiation, thereby inducing psoriasis-like chronic dermatitis. Ubiquitin protein ligase E3 component N-recognin 5 (Ubr5) and nuclear receptor subfamily 2 group F member 6 (Nr2f6) expression levels decreased in RhoH-deficient T cells, resulting in increased protein levels and DNA binding activity of retinoic acid-related orphan receptor gt. The consequential increase in IL-17 and IL-22 production induced T cells to differentiate into T(H)17 cells. Furthermore, IL-22 binding protein/Fc chimeric protein reduced psoriatic inflammation in RhoH-deficient mice. Expression of RhoH in T cells was lower in patients with psoriasis with very severe symptoms. Conclusion: Our results indicate that RhoH inhibits T(H)17 differentiation and thereby plays a role in the pathogenesis of psoriasis. Additionally, IL-22 binding protein has therapeutic potential for the treatment of psoriasis.	[Tamehiro, Norimasa; Nishida, Kyoko; Sugita, Yu; Hayakawa, Kunihiro; Oda, Hiroyo; Nitta, Takeshi; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Chiba 2728516, Japan; [Nakano, Miwa] Natl Ctr Global Hlth & Med, Communal Lab, Res Inst, Chiba, Japan; [Yanobu-Takanashi, Reiko; Goto, Motohito; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Lab Anim Med, Res Inst, Chiba, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Chiba, Japan; [Nishida, Kyoko] Tokyo Med & Dent Univ, Dept Immunol, Tokyo, Japan; [Nishioka, Akiko; Morita, Akimichi] Nagoya City Univ, Dept Geriatr & Environm Dermatol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Tamehiro, Norimasa; Adachi, Reiko; Kondo, Kazunari] Natl Inst Hlth Sci, Dept Biochem, Kawasaki, Kanagawa, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Medical & Dental University (TMDU); Nagoya City University; National Institute of Health Sciences - Japan	Suzuki, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Chiba 2728516, Japan.	hsuzuki@ri.ncgm.go.jp	kondo, kazunari/AGE-0558-2022; Suzuki, Harumi/L-1271-2013	kondo, kazunari/0000-0002-2662-4626; Suzuki, Harumi/0000-0003-3616-9361; HAYAKAWA, Kunihiro/0000-0002-8053-746X; yuan ren, hou teng/0000-0001-6288-4583	National Center for Global Health and Medicine [25-103, 26-106]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	Supported by grants from the National Center for Global Health and Medicine (25-103 and 26-106).	Abdallah MA, 2009, CUTIS, V84, P163; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chae HD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013970; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; da Rocha LF, 2012, J RHEUMATOL, V39, P1320, DOI 10.3899/jrheum.111027; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; ELLIS CN, 1986, JAMA-J AM MED ASSOC, V256, P3110, DOI 10.1001/jama.256.22.3110; Favre M, 1998, J INVEST DERMATOL, V110, P311, DOI 10.1046/j.1523-1747.1998.00164.x; GRIFFITHS CEM, 1987, LANCET, V1, P806; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Gunderson AJ, 2013, J INVEST DERMATOL, V133, P955, DOI 10.1038/jid.2012.390; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hermann-Kleiter N, 2015, CELL REP, V12, P2072, DOI 10.1016/j.celrep.2015.08.035; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koga T, 2002, EUR J DERMATOL, V12, P20; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Martin JCJ, 2014, MUCOSAL IMMUNOL, V7, P101, DOI 10.1038/mi.2013.28; Moniaga CS, 2013, J DERMATOL SCI, V71, P76, DOI 10.1016/j.jdermsci.2013.03.011; Muro R, 2018, J CLIN INVEST, V128, P415, DOI 10.1172/JCI95837; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Nikamo P, 2014, J INVEST DERMATOL, V134, P1535, DOI 10.1038/jid.2014.5; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Oda H, 2013, IMMUNOL LETT, V151, P1, DOI 10.1016/j.imlet.2013.02.007; Oda H, 2009, J IMMUNOL, V182, P957, DOI 10.4049/jimmunol.182.2.957; Pan HF, 2009, CLIN CHIM ACTA, V401, P179, DOI 10.1016/j.cca.2008.11.009; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Saeki H, 2013, J DERMATOL SCI, V71, P148, DOI 10.1016/j.jdermsci.2013.04.002; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tamehiro N, 2017, IMMUNOL CELL BIOL, V95, P729, DOI 10.1038/icb.2017.27; Tamehiro N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131047; Troeger A, 2013, EXP CELL RES, V319, P2375, DOI 10.1016/j.yexcr.2013.07.002; Troeger A, 2012, BLOOD, V119, P4708, DOI 10.1182/blood-2011-12-395939; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	57	5	7	2	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1878	1891		10.1016/j.jaci.2018.09.032	http://dx.doi.org/10.1016/j.jaci.2018.09.032			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30339851	Bronze			2022-12-18	WOS:000466784600023
J	Xiao, N; He, K; Gong, F; Xie, Q; Peng, J; Su, X; Lu, YP; Xia, XF; Lin, G; Cheng, LM				Xiao, Na; He, Ke; Gong, Fei; Xie, Qi; Peng, Jing; Su, Xian; Lu, Yeping; Xia, Xuefeng; Lin, Ge; Cheng, Lamei			Altered subsets and activities of B lymphocytes in polycystic ovary syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Xiao, Na; He, Ke; Gong, Fei; Xie, Qi; Peng, Jing; Su, Xian; Lin, Ge; Cheng, Lamei] Cent South Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Hunan, Peoples R China; [Xiao, Na; Lu, Yeping; Lin, Ge; Cheng, Lamei] Natl Engn Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China; [Xiao, Na; Gong, Fei; Lin, Ge] Reprod & Genet Hosp CITIC Xiangya, Changsha, Hunan, Peoples R China; [Xia, Xuefeng] Houston Methodist Res Inst, Houston, TX USA	Central South University; Central South University; The Methodist Hospital System; The Methodist Hospital - Houston	Cheng, LM (corresponding author), Cent South Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Hunan, Peoples R China.; Cheng, LM (corresponding author), Natl Engn Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China.	LameiCheng@csu.edu.cn			National Natural Science Foundation of China [81460244, 81270868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by grants from the National Natural Science Foundation of China (no. 81460244 to L.C. and no. 81270868 to X.X.).	Deng C, 2016, DIABETES CARE, V39, P434, DOI 10.2337/dc15-1765; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Hefler-Frischmuth K, 2010, FERTIL STERIL, V93, P2291, DOI 10.1016/j.fertnstert.2009.01.056; Jeannin P, 2000, IMMUNITY, V13, P303, DOI 10.1016/S1074-7613(00)00030-3; Krishna MB, 2015, J CLIN ENDOCR METAB, V100, P282, DOI 10.1210/jc.2014-2401; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Yuan XX, 2016, P NATL ACAD SCI USA, V113, P2708, DOI 10.1073/pnas.1523236113	9	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1943	+		10.1016/j.jaci.2019.01.007	http://dx.doi.org/10.1016/j.jaci.2019.01.007			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30677479	Bronze			2022-12-18	WOS:000466784600034
J	Beziat, V; Jouanguy, E; Puel, A				Beziat, Vivien; Jouanguy, Emmanuelle; Puel, Anne			Dominant negative CARD11 mutations: Beyond atopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						CARD11; primary immunodeficiency; inborn error of immunity; atopic diseases	FAMILY		[Beziat, Vivien; Jouanguy, Emmanuelle; Puel, Anne] Necker Hosp Sick Children, INSERM, UMR 1163, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Beziat, Vivien; Jouanguy, Emmanuelle; Puel, Anne] Paris Descartes Univ, Imagine Inst, Paris, France; [Jouanguy, Emmanuelle; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University	Puel, A (corresponding author), Imagine Inst, Lab Human Genet Infect Dis, 24 Blvd Montparnasse, F-75015 Paris, France.	anne.puel@inserm.fr	Puel, Anne/H-7305-2017; Béziat, Vivien/AAT-4097-2021; Béziat, Vivien/G-2971-2011	Puel, Anne/0000-0003-2603-0323; Béziat, Vivien/0000-0002-4020-824X; Béziat, Vivien/0000-0002-4020-824X				Bedsaul JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02105; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Dadi H, 2018, J ALLERGY CLIN IMMUN, V141, P1818, DOI 10.1016/j.jaci.2017.06.047; Dorjbal B, 2019, J ALLERGY CLIN IMMUN, V143, P1482, DOI 10.1016/j.jaci.2018.08.013; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Gupta M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01049; Ma CA, 2017, NAT GENET, V49, P1192, DOI 10.1038/ng.3898; Snow AL, 2012, J EXP MED, V209, P2247, DOI 10.1084/jem.20120831; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050	9	5	7	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1345	1347		10.1016/j.jaci.2018.12.1006	http://dx.doi.org/10.1016/j.jaci.2018.12.1006			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30659853	Bronze			2022-12-18	WOS:000463348900009
J	Ege, MJ; Schuetz, C; Jacobsen, EM; Muller-Langer, SM; Furlan, I; Sirin, M; Pannicke, U; Schwarz, K; Debatin, KM; Honig, M; Schulz, A; Friedrich, W				Ege, Markus J.; Schuetz, Catharina; Jacobsen, Eva-Maria; Mueller-Langer, Susanna M.; Furlan, Ingrid; Sirin, Mehtap; Pannicke, Ulrich; Schwarz, Klaus; Debatin, Klaus-Michael; Hoenig, Manfred; Schulz, Ansgar; Friedrich, Wilhelm			Late thymic deficiency after HLA-haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RECONSTITUTION; CHILDREN		[Ege, Markus J.] Univ Childrens Hosp Munich, Munich, Germany; [Ege, Markus J.] German Ctr Lung Res, Giessen, Germany; [Schuetz, Catharina; Jacobsen, Eva-Maria; Mueller-Langer, Susanna M.; Furlan, Ingrid; Sirin, Mehtap; Debatin, Klaus-Michael; Hoenig, Manfred; Schulz, Ansgar; Friedrich, Wilhelm] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Pannicke, Ulrich; Schwarz, Klaus] Univ Med Ctr Ulm, Inst Transfus Med, Ulm, Germany	University of Munich; Ulm University; Ulm University	Friedrich, W (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany.	wilhelm-friedrich@t-online.de	Ege, Markus/C-1962-2012; Debatin, Klaus-Michael/J-9704-2014	Ege, Markus/0000-0001-6643-3923; Debatin, Klaus-Michael/0000-0002-8397-1886	German Center for Lung Research (DZL)	German Center for Lung Research (DZL)	This work has been supported by the German Center for Lung Research (DZL).	Borghans JA, 2006, BLOOD, V108, P763, DOI 10.1182/blood-2006-01-009241; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Friedrich W, 2007, IMMUNOL RES, V38, P165, DOI 10.1007/s12026-007-0030-2; Heimall J, 2017, BLOOD, V130, P2718, DOI 10.1182/blood-2017-05-781849; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; REISNER Y, 1983, BLOOD, V61, P341; Savic RM, 2013, BIOL BLOOD MARROW TR, V19, P1608, DOI 10.1016/j.bbmt.2013.08.014; Schuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003	13	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1623	+		10.1016/j.jaci.2018.11.027	http://dx.doi.org/10.1016/j.jaci.2018.11.027			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30529243	Bronze			2022-12-18	WOS:000463348900038
J	Matsuda, A; Asada, Y; Suita, N; Iwamoto, S; Hirakata, T; Yokoi, N; Ohkawa, Y; Okada, Y; Yokomizo, T; Ebihara, N				Matsuda, Akira; Asada, Yosuke; Suita, Naomasa; Iwamoto, Satoshi; Hirakata, Toshiaki; Yokoi, Norihiko; Ohkawa, Yasuyuki; Okada, Yukinori; Yokomizo, Takehiko; Ebihara, Nobuyuki			Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DERMATITIS		[Matsuda, Akira; Asada, Yosuke; Iwamoto, Satoshi; Hirakata, Toshiaki; Ebihara, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Lab Ocular Atop Dis, Tokyo, Japan; [Suita, Naomasa; Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka, Japan; [Hirakata, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan; [Yokoi, Norihiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Fukuoka, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Osaka, Japan; [Ebihara, Nobuyuki] Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Urayasu, Japan	Juntendo University; Osaka University; Juntendo University; Kyoto Prefectural University of Medicine; Kyushu University; Osaka University; Juntendo University	Matsuda, A (corresponding author), Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Lab Ocular Atop Dis, Tokyo, Japan.	akimatsu@juntendo.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Yokomizo, Takehiko/P-5673-2016; Matsuda, Akira/A-9981-2010	Ohkawa, Yasuyuki/0000-0001-6440-9954; Yokomizo, Takehiko/0000-0002-5219-1553; Matsuda, Akira/0000-0002-0792-3663	Japanese Society for the Promotion of Science [15H05904, 15H04708, 16K11303, 16K20333, 16K20334, 18H02627, 18K16966]; Foundation of Strategic Research Projects in Private Universities [S1311011]; Institute for Environmental and Gender-Specific Medicine, Juntendo University; NOVARTIS Foundation for the Promotion of Science	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation of Strategic Research Projects in Private Universities; Institute for Environmental and Gender-Specific Medicine, Juntendo University; NOVARTIS Foundation for the Promotion of Science	This study was supported by Grants-in-Aid from the Japanese Society for the Promotion of Science (grant nos. 15H05904, 15H04708, 16K11303, 16K20333, 16K20334, 18H02627, and 18K16966), the Foundation of Strategic Research Projects in Private Universities (grant no. S1311011), the Institute for Environmental and Gender-Specific Medicine, Juntendo University, and the NOVARTIS Foundation for the Promotion of Science.	Bielory B, 2010, IMMUNOL ALLERGY CLIN, V30, P323, DOI 10.1016/j.iac.2010.06.004; Chen JJ, 2014, J AM ACAD DERMATOL, V70, P569, DOI 10.1016/j.jaad.2013.10.036; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fujishima H, 2016, J ALLERGY CLIN IMMUN, V138, P459, DOI 10.1016/j.jaci.2015.11.039; HENRIQUEZ AS, 1979, ARCH OPHTHALMOL-CHIC, V97, P473; Matsuda A, 2010, J ALLERGY CLIN IMMUN, V126, P1310, DOI 10.1016/j.jaci.2010.06.001; Miyazaki D, 2017, OPHTHALMOLOGY, V124, P287, DOI 10.1016/j.ophtha.2016.11.002; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Wang WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26604	9	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1610	+		10.1016/j.jaci.2018.11.007	http://dx.doi.org/10.1016/j.jaci.2018.11.007			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30471305				2022-12-18	WOS:000463348900035
J	Zeki, AA; Flayer, CH; Haczku, A				Zeki, Amir A.; Flayer, Cameron H.; Haczku, Angela			A burning need to redefine airways disease: Biomass smoke exposure identified as a unique risk factor for asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							COPD OVERLAP; LUNG		[Zeki, Amir A.; Flayer, Cameron H.; Haczku, Angela] Univ Calif Davis, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA	University of California System; University of California Davis	Haczku, A (corresponding author), Univ Calif Davis, Sch Med, 6510 GBSF,One Shields Ave, Davis, CA 95616 USA.	haczku@ucdavis.edu	Haczku, Angela/A-8486-2013	Haczku, Angela/0000-0002-1301-4941	TRDRP [556126/2018A, T32 HL007013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER	TRDRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by TRDRP 556126/2018A (to A.H. and A.A.Z.) and T32 HL007013 (to C.H.F.).	Assad NA, 2016, CURR OPIN PULM MED, V22, P150, DOI 10.1097/MCP.0000000000000246; Chung JW, 2014, INT J CHRONIC OBSTR, V9, P795, DOI 10.2147/COPD.S61093; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Henriksen AH, 2018, COPD, V15, P27, DOI 10.1080/15412555.2017.1408580; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Morgan BW, 2019, J ALLERGY CLIN IMMUN, V143, P1598, DOI 10.1016/j.jaci.2018.06.052; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Woodruff PG, 2017, AM J RESP CRIT CARE, V196, P375, DOI 10.1164/rccm.201705-0973WS	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1339	1341		10.1016/j.jaci.2018.11.020	http://dx.doi.org/10.1016/j.jaci.2018.11.020			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30529450	Bronze, Green Accepted			2022-12-18	WOS:000463348900007
J	Finotto, S				Finotto, Susetta			B lymphocyte-induced maturation protein 1 (Blimp-1), a negative regulator of T(H)9 development, orchestrates the resolution of airway inflammation in patients with allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						B lymphocyte-induced maturation protein 1; allergic asthma; IL-9	TRANSCRIPTION FACTORS BLIMP-1; IMMUNE-RESPONSES; TGF-BETA; DIFFERENTIATION; DEPENDS		[Finotto, Susetta] Friedrich Alexander Univ Erlangen Nurnberg, Dept Mol Pneumol, Univ Klinikum Erlangen, D-91052 Erlangen, Germany	University of Erlangen Nuremberg	Finotto, S (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Mol Pneumol, Labs Cellular & Mol Lung Immunol, Hartmannstr 14, D-91052 Erlangen, Germany.	susetta.finotto@uk-erlangen.de	Finotto, Susetta/AAL-3503-2020					Benevides L, 2019, J ALLERGY CLIN IMMUN, V143, P1119, DOI 10.1016/j.jaci.2018.06.046; Bielor C, 2017, J ALLERGY CLIN IMMUN, V140, P283, DOI 10.1016/j.jaci.2016.10.049; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Graser A, 2016, MUCOSAL IMMUNOL, V9, P1183, DOI 10.1038/mi.2015.130; Gross NJ, 2017, AM J RESP CRIT CARE, V195, P159, DOI 10.1164/rccm.201610-2074PP; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410	11	5	6	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					937	939		10.1016/j.jaci.2018.07.039	http://dx.doi.org/10.1016/j.jaci.2018.07.039			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30193841	Bronze			2022-12-18	WOS:000460272900013
J	Goleva, E; Babineau, DC; Gill, MA; Jackson, LP; Shao, BM; Hu, Z; Liu, AH; Visness, CM; Sorkness, CA; Leung, DYM; Togias, A; Busse, WW				Goleva, Elena; Babineau, Denise C.; Gill, Michelle A.; Jackson, Leisa P.; Shao, Baomei; Hu, Zheng; Liu, Andrew H.; Visness, Cynthia M.; Sorkness, Christine A.; Leung, Donald Y. M.; Togias, Alkis; Busse, William W.			Expression of corticosteroid-regulated genes by PBMCs in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; steroid resistance; corticosteroids; glucocorticoid receptor	GLUCOCORTICOID-RECEPTOR-BETA; NUCLEAR TRANSLOCATION; CHILDHOOD ASTHMA; OMALIZUMAB; PHENOTYPES; MODULATION; BIOMARKERS; THERAPY; DISEASE; HEALTH	Background: Variability in response to inhaled corticosteroids (ICSs) can result in less than optimal asthma control. Development of biomarkers assessing the therapeutic efficacy of corticosteroids is important. Objective: We sought to examine whether in vitro PBMC responses to corticosteroids relate to the clinical ICS response. Methods: PBMCs were collected from 125 children with asthma (6-17 years) at enrollment (visit 0 [V0]) and after 1 year of bimonthly guidelines-based management visits (visit 6 [V6]). Difficult-to-control and easy-to-control asthma were defined as requiring daily therapy with 500 mu g or more of fluticasone propionate (FLU) with or without a long-acting beta-agonist versus 100 mu g or less of FLU in at least 4 visits. mRNA levels of glucocorticoid receptor alpha and corticosteroid transactivation (FK506-binding protein 5) and transrepression markers (IL-8 and TNF-alpha) were measured by using RT-PCR in freshly isolated cells and in response to 10(-8) mol/L FLU. Results: Compared with PBMCs from patients with easy-tocontrol asthma, PBMCs from those with difficult-to-control asthma had significantly lower glucocorticoid receptor a levels at V0 (P = .05). A 30% increase in IL-8 suppression by FLU (P = .04) and a trend for increased TNF-alpha suppression by FLU between V0 and V6 (P = .07) were observed in patients with easy-to-control asthma. In contrast, no changes between V0 and V6 in IL-8 and TNF-alpha suppression by FLU were observed in patients with difficult-to-control asthma. Corticosteroidmediated transactivation (FK506-binding protein 5 induction by FLU) increased in the PBMCs of patients with difficult-tocontrol and easy-to-control asthma between V0 and V6 (P = .05 and P = .03, respectively). Conclusions: PBMCs of children with difficult-to-control asthma treated with guidelines-based therapy and requiring high-dose ICSs had reduced in vitro responsiveness to corticosteroids.	[Goleva, Elena; Jackson, Leisa P.; Liu, Andrew H.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Babineau, Denise C.; Visness, Cynthia M.] Rho Fed Syst Div, Chapel Hill, NC USA; [Gill, Michelle A.; Shao, Baomei; Hu, Zheng] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Sorkness, Christine A.; Busse, William W.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Togias, Alkis] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Jewish Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Goleva, E (corresponding author), Natl Jewish Hlth, 1400 Jackson St,K1016A, Denver, CO 80206 USA.	golevae@njhealth.org			National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200900052C, HHSN272201000052I, 1UM1AI114271-01]; National Center for Research Resources (NCRR), NIH [NCRR/NIH UL1TR001079, UL1TR000451, UL1RR025780, UL1TR000075]; National Center for Advancing Translational Sciences, NIH [NCATS/NIH UL1TR000154, UL1TR001082, UL1TR000077-04, UL1TR000040, UL1TR000150, UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105, UL1TR001082, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI114271] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services; National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in whole or in part by federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under contract numbers HHSN272200900052C, HHSN272201000052I, and 1UM1AI114271-01. Additional support was provided by the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences, NIH, under grants NCRR/NIH UL1TR001079, UL1TR000451, UL1RR025780, UL1TR000075 and NCATS/NIH UL1TR000154, UL1TR001082, UL1TR000077-04, UL1TR000040, UL1TR000150, and UL1TR001105. GlaxoSmithKline provided Ventolin, Flovent, Advair, and Flonase under a clinical trial agreement with the NIH/NIAID; GlaxoSmithKline did not have a role in the development or approval of the protocol, conduct of the trial, data analysis, manuscript preparation, or the decision to submit for publication.	ADCOCK IM, 1995, J EXP MED, V182, P1951, DOI 10.1084/jem.182.6.1951; Alonso AM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00154; Barsky EE, 2018, ANN AM THORAC SOC, V15, P399, DOI 10.1513/AnnalsATS.201708-637FR; Berry A, 2016, J ALLERGY CLIN IMMUN, V137, P1317, DOI 10.1016/j.jaci.2016.03.009; Bigler J, 2017, AM J RESP CRIT CARE, V195, P1311, DOI 10.1164/rccm.201604-0866OC; Bossley CJ, 2016, J ALLERGY CLIN IMMUN, V138, P413, DOI 10.1016/j.jaci.2015.12.1347; Brown KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180778; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chachi L, 2017, ALLERGY, V72, P126, DOI 10.1111/all.13003; Chang TS, 2014, J ALLERGY CLIN IMMUN, V133, P363, DOI 10.1016/j.jaci.2013.09.002; Esquivel A, 2017, AM J RESP CRIT CARE, V196, P985, DOI 10.1164/rccm.201701-0120OC; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Fitzpatrick AM, 2017, J ALLER CL IMM-PRACT, V5, P901, DOI 10.1016/j.jaip.2017.05.015; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Hapgood JP, 2016, PHARMACOL THERAPEUT, V165, P93, DOI 10.1016/j.pharmthera.2016.06.002; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Li LB, 2006, J LEUKOCYTE BIOL, V79, P818, DOI 10.1189/jlb.0805466; Liu AH, 2016, J ALLERGY CLIN IMMUN, V138, P1042, DOI 10.1016/j.jaci.2016.06.060; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Pongracic JA, 2016, J ALLERGY CLIN IMMUN, V138, P1030, DOI 10.1016/j.jaci.2016.06.059; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Robertson S, 2013, STEROIDS, V78, P182, DOI 10.1016/j.steroids.2012.10.016; Romens SE, 2015, CHILD DEV, V86, P303, DOI 10.1111/cdev.12270; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Stempel DA, 2016, NEW ENGL J MED, V375, P840, DOI 10.1056/NEJMoa1606356; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zoratti EM, 2016, J ALLERGY CLIN IMMUN, V138, P1016, DOI 10.1016/j.jaci.2016.06.061	45	5	6	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					940	+		10.1016/j.jaci.2018.06.043	http://dx.doi.org/10.1016/j.jaci.2018.06.043			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30059697	Bronze, Green Accepted			2022-12-18	WOS:000460272900014
J	Koppelman, SJ; Peillon, A; Agbotounou, W; Sampson, HA; Martin, L				Koppelman, Stef J.; Peillon, Aurelie; Agbotounou, Wenceslas; Sampson, Hugh A.; Martin, Laurent			Epicutaneous immunotherapy for peanut allergy modifies IgG(4) responses to major peanut allergens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IGE		[Koppelman, Stef J.; Peillon, Aurelie; Agbotounou, Wenceslas; Martin, Laurent] DBV Technol, Montrouge, France; [Sampson, Hugh A.] DBV Technol, New York, NY USA		Koppelman, SJ (corresponding author), DBV Technol, Montrouge, France.	stef.koppelman@dbv-technologies.com			DBV Technologies	DBV Technologies	This study was funded by DBV Technologies.	Ballmer-Weber BK, 2015, ALLERGY, V70, P391, DOI 10.1111/all.12574; Burk CM, 2016, CLIN EXP ALLERGY, V46, P347, DOI 10.1111/cea.12635; Koppelman SJ, 2005, CLIN EXP ALLERGY, V35, P490, DOI 10.1111/j.1365-2222.2005.02204.x; Koppelman SJ, 2016, FOOD CHEM TOXICOL, V91, P82, DOI 10.1016/j.fct.2016.02.016; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Nozawa A, 2014, PEDIAT ALLERG IMM-UK, V25, P323, DOI 10.1111/pai.12243; Sampson HA, 2017, JAMA-J AM MED ASSOC, V318, P1798, DOI 10.1001/jama.2017.16591; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048; Zhuang YH, 2013, IMMUNOL RES, V55, P125, DOI 10.1007/s12026-012-8355-x	9	5	5	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1218	+		10.1016/j.jaci.2018.10.025	http://dx.doi.org/10.1016/j.jaci.2018.10.025			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30389411	hybrid			2022-12-18	WOS:000460272900042
J	Lombardi, E; Stern, DA; Sherrill, D; Morgan, WJ; Wright, AL; Garcia-Aymerich, J; Pons, IS; Guerra, S; Martinez, FD				Lombardi, Enrico; Stern, Debra A.; Sherrill, Duane; Morgan, Wayne J.; Wright, Anne L.; Garcia-Aymerich, Judith; Serra Pons, Ignasi; Guerra, Stefano; Martinez, Fernando D.			Peak flow variability in childhood and body mass index in adult life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INCIDENT ASTHMA; DIAGNOSED ASTHMA; OBESITY; RISK; OVERWEIGHT; METAANALYSIS; ONSET; AGE; SYMPTOMS; SMOKING		[Lombardi, Enrico] Anna Meyer Pediat Univ Hosp, Pediat Pulm Unit, Florence, Italy; [Stern, Debra A.; Sherrill, Duane; Morgan, Wayne J.; Wright, Anne L.; Guerra, Stefano; Martinez, Fernando D.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA; [Garcia-Aymerich, Judith; Serra Pons, Ignasi; Guerra, Stefano] ISGlobal Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Garcia-Aymerich, Judith; Guerra, Stefano] Univ Pompeu Fabra, Barcelona, Spain	University of Arizona; ISGlobal; Pompeu Fabra University	Martinez, FD (corresponding author), Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA.	fdmartin@email.arizona.edu	Lombardi, Enrico/K-3356-2016; J, Garcia-Aymerich/G-6867-2014	Lombardi, Enrico/0000-0003-4749-9091; J, Garcia-Aymerich/0000-0002-7097-4586	National Heart, Lung, and Blood Institute [132523]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132523] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Brown H., 1999, APPL MIXED MODELS ME; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Chen ZH, 2017, AM J RESP CRIT CARE, V195, P1181, DOI 10.1164/rccm.201608-1691OC; Chinn S, 2001, THORAX, V56, P845, DOI 10.1136/thorax.56.11.845; Egan KB, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-121; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Frey U, 2015, ALLERGY, V70, P26, DOI 10.1111/all.12525; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Global Initiative for Asthma (GINA) NHLaBI National Institutes of Health, GINA REP GLOB STRAT; Gold DR, 2003, PEDIATR PULM, V36, P514, DOI 10.1002/ppul.10376; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Guibas GV, 2013, ALLERGY, V68, P1298, DOI 10.1111/all.12245; Gump A, 2001, J APPL PHYSIOL, V90, P2306, DOI 10.1152/jappl.2001.90.6.2306; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; HIGGINS BG, 1992, AM REV RESPIR DIS, V145, P588, DOI 10.1164/ajrccm/145.3.588; Huovinen E, 2003, RESP MED, V97, P273, DOI 10.1053/rmed.2003.1419; Jindal SL, 2002, J ASTHMA, V39, P363, DOI 10.1081/JAS-120004029; Kuczmarski R.J., 2000, CDC GROWTH CHARTS US; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P85, DOI [DOI 10.1016/HACI.2008.03.005, 10.1016/j.jaci.2008.03.005]; Litonjua AA, 2008, J ALLERGY CLIN IMMUN, V121, P1075, DOI 10.1016/j.jaci.2008.03.005; Luder E, 2004, RESP MED, V98, P29, DOI 10.1016/j.rmed.2003.08.004; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Permaul P, 2014, ANN ALLERG ASTHMA IM, V113, P244, DOI 10.1016/j.anai.2014.07.001; PERUMAUL P, 2002, J ASTHMA, V39, P363; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; SIERSTED HC, 1994, AM J RESP CRIT CARE, V149, P598, DOI 10.1164/ajrccm.149.3.8118624; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Strine TW, 2007, J ASTHMA, V44, P651, DOI 10.1080/02770900701554896; Stukus DR, 2015, J ALLERGY CLIN IMMUN, V135, P894, DOI 10.1016/j.jaci.2014.11.002; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Willeboordse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077574	41	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1224	+		10.1016/j.jaci.2018.10.035	http://dx.doi.org/10.1016/j.jaci.2018.10.035			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30414860	Green Accepted, Bronze			2022-12-18	WOS:000460272900044
J	Morita, H; Tamari, M; Fujiwara, M; Motomura, K; Koezuka, Y; Ichien, G; Matsumoto, K; Ishizaka, K; Saito, H				Morita, Hideaki; Tamari, Masato; Fujiwara, Masako; Motomura, Kenichiro; Koezuka, Yasuhiko; Ichien, Go; Matsumoto, Kenji; Ishizaka, Kimishige; Saito, Hirohisa			IgE-class-specific immunosuppression in offspring by administration of anti-IgE to pregnant mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LIFE		[Morita, Hideaki; Tamari, Masato; Fujiwara, Masako; Motomura, Kenichiro; Matsumoto, Kenji; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan; [Tamari, Masato] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Koezuka, Yasuhiko; Ichien, Go] Hubit Genomix, Tokyo, Japan; [Ishizaka, Kimishige] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	National Center for Child Health & Development - Japan; Jikei University; La Jolla Institute for Immunology	Saito, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan.	saito-hr@ncchd.go.jp	Morita, Hideaki/ADL-2008-2022; Morita, Hideaki/S-2214-2016	Morita, Hideaki/0000-0003-0928-8322; Saito, Hirohisa/0000-0002-6630-8337	Japan Society for the Promotion of Science [18H0285]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was funded mainly by a Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (grant no. 18H0285 to H.S.), and was funded in part by a grant from Hubit Genomix to H.S.	CHEN SS, 1983, J EXP MED, V157, P772, DOI 10.1084/jem.157.2.772; Laffleur B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01277; Lawrence MG, 2017, J ALLERGY CLIN IMMUN, V139, P422, DOI 10.1016/j.jaci.2016.04.056; Namazy J, 2015, J ALLERGY CLIN IMMUN, V135, P407, DOI 10.1016/j.jaci.2014.08.025; Reynolds LA, 2017, NAT REV IMMUNOL, V17, P518, DOI 10.1038/nri.2017.39; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Susanto NH, 2017, ENVIRON RES, V157, P198, DOI 10.1016/j.envres.2017.05.026; Tumas DB, 2001, J ALLERGY CLIN IMMUN, V107, P1025, DOI 10.1067/mai.2001.115625; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1261	+		10.1016/j.jaci.2018.11.008	http://dx.doi.org/10.1016/j.jaci.2018.11.008			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30471303	hybrid			2022-12-18	WOS:000460272900057
J	Zhao, ZT; Reimann, S; Wang, S; Wang, YJ; Zuberbier, T				Zhao, Zuotao; Reimann, Sascha; Wang, Shan; Wang, Yuhan; Zuberbier, Torsten			Ordinary vibratory angioedema is not generally associated with ADGRE2 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHOLINERGIC URTICARIA		[Zhao, Zuotao; Wang, Shan; Wang, Yuhan] Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing, Peoples R China; [Zhao, Zuotao; Wang, Shan; Wang, Yuhan] Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China; [Reimann, Sascha; Zuberbier, Torsten] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, Berlin, Germany	Peking University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zhao, ZT (corresponding author), Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing, Peoples R China.; Zhao, ZT (corresponding author), Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China.	zhaozuotaotao@163.com		Zuberbier, Torsten/0000-0002-1466-8875	National Natural Science Foundation of China; Deutsche Forschungsgemeinschaft [GZ901]; European Centre for Allergy Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Centre for Allergy Research Foundation	This work was supported in part by Joint Sino-Germany Research Project by the National Natural Science Foundation of China and Deutsche Forschungsgemeinschaft (GZ901) and the European Centre for Allergy Research Foundation.	Boyden SE, 2016, NEW ENGL J MED, V374, P656, DOI 10.1056/NEJMoa1500611; KAPLAN AP, 1976, J INVEST DERMATOL, V67, P327, DOI 10.1111/1523-1747.ep12514352; METZGER WJ, 1976, J ALLERGY CLIN IMMUN, V57, P605, DOI 10.1016/0091-6749(76)90012-9; Patruno C, 2009, DERMATITIS, V20, P346, DOI 10.2310/6620.2009.09034; Sarmast Shehnaz A, 2014, Cutis, V93, pE10; ZUBERBIER T, 1994, J AM ACAD DERMATOL, V31, P978, DOI 10.1016/S0190-9622(94)70267-5; Zuberbier T, 2018, ALLERGY, V73, P1393, DOI 10.1111/all.13397; Zuberbier T, 2014, ALLERGY, V69, P868, DOI 10.1111/all.12313; Zuberbier T, 1998, URTICARIA CLIN DIAGN	9	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1246	+		10.1016/j.jaci.2018.10.049	http://dx.doi.org/10.1016/j.jaci.2018.10.049			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30445064				2022-12-18	WOS:000460272900052
J	Birring, S; Muccino, D; Bacci, ED; Vernon, MK; Nguyen, AM				Birring, Surinder; Muccino, David; Bacci, Elizabeth D.; Vernon, Margaret K.; Nguyen, Allison M.			Defining Minimal Clinically Important Differences (MCID) on the Leicester Cough Questionnaire (LCQ): Analyses of a Phase 2 Randomized Controlled Trial in Chronic Cough	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Birring, Surinder] Kings Coll London, Leicester, Leics, England; [Muccino, David; Nguyen, Allison M.] Merck Sharp & Dohme Corp, Kenilworth, NJ USA; [Bacci, Elizabeth D.] Evidera, Seattle, WA USA; [Vernon, Margaret K.] Evidera, Bethesda, MD USA	Merck & Company; Evidera; Evidera			Birring, Surinder/GWU-6967-2022						0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		156	AB53	AB53						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200156
J	Busse, WW; Maspero, JF; Hanania, NA; Fitz-Gerald, JM; Ford, LB; Rice, M; Lu, YF; Rowe, P; Staudinger, H; Amin, N; Ruddy, M; Graham, NMH; Teper, A				Busse, William W.; Maspero, Jorge F.; Hanania, Nicola A.; Fitz-Gerald, J. Mark; Ford, Linda B.; Rice, Megan; Lu, Yufang; Rowe, Paul; Staudinger, Heribert; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M. H.; Teper, Ariel			Dupilumab Improves Lung Function and Reduces Severe Exacerbation Rate in Patients With Uncontrolled, Moderate-to-Severe Asthma With or Without Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Fitz-Gerald, J. Mark] Univ British Columbia, Vancouver, BC, Canada; [Ford, Linda B.] Asthma & Allergy Ctr, Bellevue, NE USA; [Rice, Megan; Rowe, Paul; Staudinger, Heribert; Teper, Ariel] Sanofi, Bridgewater, NJ USA; [Lu, Yufang; Amin, Nikhil; Ruddy, Marcella; Graham, Neil M. H.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; University of British Columbia; Sanofi-Aventis; Regeneron			Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		293	AB97	AB97		10.1016/j.jaci.2018.12.296	http://dx.doi.org/10.1016/j.jaci.2018.12.296			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200290
J	Corren, J; Bousquet, J; Busse, WW; Maspero, JF; Hanania, NA; Ford, LB; Rice, M; Lu, YF; Rowe, P; Harel, S; Staudinger, H; Ruddy, M; Graham, NMH; Amin, N; Teper, A				Corren, Jonathan; Bousquet, Jean; Busse, William W.; Maspero, Jorge F.; Hanania, Nicola A.; Ford, Linda B.; Rice, Megan; Lu, Yufang; Rowe, Paul; Harel, Sivan; Staudinger, Heribert; Ruddy, Marcella; Graham, Neil M. H.; Amin, Nikhil; Teper, Ariel			Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bousquet, Jean] MACVIA France Malad Chron Vieillissement Actif Fr, Montpellier, France; [Bousquet, Jean] Fdn FMC VIA LR, Montpellier, France; [Busse, William W.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Ford, Linda B.] Asthma & Allergy Ctr, Bellevue, NE USA; [Rice, Megan; Rowe, Paul; Staudinger, Heribert; Teper, Ariel] Sanofi, Bridgewater, NJ USA; [Lu, Yufang; Harel, Sivan; Ruddy, Marcella; Graham, Neil M. H.; Amin, Nikhil] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite de Montpellier; Universite de Montpellier; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; Sanofi-Aventis; Regeneron			Bousquet, Jean/O-4221-2019; Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		294	AB97	AB97		10.1016/j.jaci.2018.12.297	http://dx.doi.org/10.1016/j.jaci.2018.12.297			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200291
J	Hellberg, S; Mehta, RB; Forsberg, A; Berg, G; Brynhildsen, J; Winqvist, O; Jenmalm, MC; Ernerudh, J				Hellberg, Sandra; Mehta, Ratnesh B.; Forsberg, Anna; Berg, Goran; Brynhildsen, Jan; Winqvist, Ola; Jenmalm, Maria C.; Ernerudh, Jan			Maintained thymic output of conventional and regulatory T cells during human pregnancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EMIGRANTS; TRANSPLANTATION; PECAM-1		[Hellberg, Sandra; Mehta, Ratnesh B.; Forsberg, Anna; Jenmalm, Maria C.] Linkoping Univ, Dept Clin & Expt Med, Unit Autoimmun & Immune Regulat, Div Neuro & Inflammat Sci, Linkoping, Sweden; [Berg, Goran; Brynhildsen, Jan] Linkoping Univ, Dept Clin & Expt Med, Div Obstet & Gynecol, Linkoping, Sweden; [Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden; [Ernerudh, Jan] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Ernerudh, Jan] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University; Karolinska Institutet; Linkoping University; Linkoping University	Hellberg, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Unit Autoimmun & Immune Regulat, Div Neuro & Inflammat Sci, Linkoping, Sweden.	sandra.hellberg@liu.se	Forsberg, Anna/ABD-2423-2020	Forsberg, Anna/0000-0001-6896-4867; Hellberg, Sandra/0000-0002-8713-7434; winqvist, Ola/0000-0003-0842-4441	Swedish Research Council [K2013-61X-22310-01-4]; Medical Research Council of Southeast Sweden [FORSS-315121, FORSS-161101]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Swedish Research Council (grant no. K2013-61X-22310-01-4) and the Medical Research Council of Southeast Sweden (grant no. FORSS-315121, FORSS-161101).	Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; CLARKE AG, 1994, IMMUNOL TODAY, V15, P545, DOI 10.1016/0167-5699(94)90212-7; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Luley L, 2015, AM J REPROD IMMUNOL, V73, P417, DOI 10.1111/aji.12348; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mjosberg J, 2009, J IMMUNOL, V183, P759, DOI 10.4049/jimmunol.0803654; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Nobile M, 2004, BLOOD, V104, P470, DOI 10.1182/blood-2003-12-4265; Sairafi D, 2012, CLIN IMMUNOL, V142, P343, DOI 10.1016/j.clim.2011.12.001; Steinborn A, 2003, AM J OBSTET GYNECOL, V188, P473, DOI 10.1067/mob.2003.55; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; Swami S, 2012, OBSTET MED, V5, P130, DOI 10.1258/om.2011.110077; Tanaskovic S, 2010, IMMUNOL CELL BIOL, V88, P321, DOI 10.1038/icb.2009.108; Wagner MI, 2015, IMMUNOL CELL BIOL, V93, P858, DOI 10.1038/icb.2015.51	17	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					771	+		10.1016/j.jaci.2018.09.023	http://dx.doi.org/10.1016/j.jaci.2018.09.023			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30312712	Bronze, Green Submitted			2022-12-18	WOS:000457718700037
J	Pease, JE; Williams, TJ				Pease, James E.; Williams, Timothy J.			Tipping the balance: A biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergic inflammation; asthma; biased antagonist; CCR3; eosinophil; inflammation	CHEMOKINE; INHIBITION; EOTAXIN		[Pease, James E.; Williams, Timothy J.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Imperial College London	Pease, JE (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Inflammat Repair & Dev Sect, Fac Med, South Kensington Campus,Rm 353, London SW7 2AZ, England.	j.pease@imperial.ac.uk	Pease, James/X-4521-2018	Pease, James/0000-0003-3749-0341	Medical Research Council [G1000758] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Grozdanovic M, 2019, J ALLERGY CLIN IMMUN, V143, P669, DOI 10.1016/j.jaci.2018.05.003; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Neighbour H, 2014, CLIN EXP ALLERGY, V44, P508, DOI 10.1111/cea.12244; Pease JE, 2014, EXPERT OPIN DRUG DIS, V9, P467, DOI 10.1517/17460441.2014.897324; Phillips RM, 2003, J IMMUNOL, V170, P6190, DOI 10.4049/jimmunol.170.12.6190; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Zimmermann N, 1999, J BIOL CHEM, V274, P12611, DOI 10.1074/jbc.274.18.12611	10	5	6	3	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					552	553		10.1016/j.jaci.2018.10.052	http://dx.doi.org/10.1016/j.jaci.2018.10.052			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30452926	Bronze, Green Submitted			2022-12-18	WOS:000457718700012
J	Prazma, CM; Albers, F; Mallett, S; Llanos-Ackert, JP; Yancey, SW				Prazma, Charlene M.; Albers, Frank; Mallett, Stephen; Llanos-Ackert, Jean-Pierre; Yancey, Steven W.			Mepolizumab improves patient outcomes and reduces exacerbations in severe asthma patients with comorbid upper airways disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Prazma, Charlene M.] GlaxoSmithKline, Durham, NC USA; [Albers, Frank] GSK, Resp Med Franchise, Res Triangle Pk, NC USA; [Mallett, Stephen] GSK, Biostat, Stockley Pk, Uxbridge, Middx, England; [Llanos-Ackert, Jean-Pierre] GlaxoSmithKline, Res Triangle Pk, NC USA; [Yancey, Steven W.] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline					GSK [MEA112997, NCT01000506, MEA115588, NCT01691521, MEA115575 (NCT01842607), 200862 (NCT02281318)]	GSK(GlaxoSmithKline)	GSK [MEA112997 (NCT01000506), MEA115588 (NCT01691521), MEA115575 (NCT01842607), 200862 (NCT02281318)]		0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		283	AB94	AB94		10.1016/j.jaci.2018.12.286	http://dx.doi.org/10.1016/j.jaci.2018.12.286			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO		Bronze			2022-12-18	WOS:000457771200280
J	Schmaier, AH; Bauer, KA; Cicardi, M; Hebert, J; Johnston, DT; Busse, PJ; Paes, K; Sexton, DJ; Kenniston, J; Nurse, C; Zaragoza, RH				Schmaier, Alvin H.; Bauer, Kenneth A.; Cicardi, Marco; Hebert, Jacques; Johnston, Douglas T.; Busse, Paula J.; Paes, Kim; Sexton, Daniel J.; Kenniston, Jon; Nurse, Christina; Zaragoza, Rafael H.			Effect of Lanadelumab on Coagulation Parameters in Patients With Hereditary Angioedema: Findings From The Phase 3 HELP Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Schmaier, Alvin H.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Schmaier, Alvin H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Cicardi, Marco] Univ Milan, Dept Biomed & Clin Sci, Luigi Sacco Hosp, ASST Fatebenefratelli Sacco, Milan, Italy; [Hebert, Jacques] Ctr Rech Appl Allergie Quebec, Quebec City, PQ, Canada; [Johnston, Douglas T.] Clin Res Charlotte, Charlotte, NC USA; [Busse, Paula J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Paes, Kim; Sexton, Daniel J.; Kenniston, Jon; Nurse, Christina] Shire, Lexington, MA USA; [Zaragoza, Rafael H.] Soc Alergol, San Juan, PR USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Harvard University; Beth Israel Deaconess Medical Center; University of Milan; Luigi Sacco Hospital; Icahn School of Medicine at Mount Sinai; Shire Pharmaceuticals Limited			Schmaier, Alvin/AAM-1063-2020	Schmaier, Alvin/0000-0002-3884-6234					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		121	AB42	AB42						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200121
J	Tsao, L; Otani, IM; Bove, R				Tsao, Lulu; Otani, Iris M.; Bove, Riley			Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 22-25, 2019	San Francisco, CA	Amer Acad Allergy, Asthma & Immunol					[Tsao, Lulu] UCSF, Dept Med, San Francisco, CA USA; [Otani, Iris M.] UCSF, Dept Internal Med, Div Allergy & Immunol, San Francisco, CA USA; [Bove, Riley] UCSF, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2		S		49	AB17	AB17						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	HK2VO					2022-12-18	WOS:000457771200049
J	Hoshino, A; Yang, X; Tanita, K; Yoshida, K; Ono, T; Nishida, N; Okuno, Y; Kanzaki, T; Goi, K; Fujino, H; Ohshima, K; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Ogawa, S; Kojima, S; Morio, T; Kanegane, H				Hoshino, Akihiro; Yang, Xi; Tanita, Kay; Yoshida, Kenichi; Ono, Toshiaki; Nishida, Naonori; Okuno, Yusuke; Kanzaki, Takeyuki; Goi, Kumiko; Fujino, Hisanori; Ohshima, Koichi; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Ogawa, Seishi; Kojima, Seiji; Morio, Tomohiro; Kanegane, Hirokazu			Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FLOW-CYTOMETRIC ASSAY; READ ALIGNMENT; DISEASE; LYMPHOCYTES; DEFICIENCY; MUTATIONS		[Hoshino, Akihiro; Tanita, Kay; Ono, Toshiaki; Morio, Tomohiro; Kanegane, Hirokazu] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hoshino, Akihiro; Yang, Xi; Nishida, Naonori; Kanegane, Hirokazu] Univ Toyama, Dept Pediat, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Yang, Xi] Chongqing Med Univ, Div Immunol, Childrens Hosp, Chongqing, Peoples R China; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Grad Sch Med, Kyoto, Japan; [Okuno, Yusuke; Kojima, Seiji] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi, Japan; [Kanzaki, Takeyuki] Yamanashi Prefectural Cent Hosp, Dept Rheumatol, Kofu, Yamanashi, Japan; [Goi, Kumiko] Univ Yamanashi, Dept Pediat, Sch Med, Kofu, Yamanashi, Japan; [Fujino, Hisanori] Japanese Red Cross Osaka Hosp, Dept Pediat, Osaka, Japan; [Ohshima, Koichi] Kurume Univ, Dept Pathol, Sch Med, Kurume, Fukuoka, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Lab Sequence Anal, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Kanegane, Hirokazu] Tokyo Med & Dent Univ, Dept Child Hlth & Dev, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Toyama; Chongqing Medical University; Kyoto University; Nagoya University; University of Yamanashi; Kurume University; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Kanegane, H (corresponding author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med & Dent Sci, Tokyo, Japan.; Kanegane, H (corresponding author), Univ Toyama, Dept Pediat, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.; Kanegane, H (corresponding author), Tokyo Med & Dent Univ, Dept Child Hlth & Dev, Grad Sch Med & Dent Sci, Tokyo, Japan.	hkanegane.ped@tmd.ac.jp	Ogawa, Seishi/AAE-7088-2019; Okuno, Yusuke/C-9082-2009	Okuno, Yusuke/0000-0003-3139-9272; Miyano, Satoru/0000-0002-1753-6616	Research on Measures for Intractable Disease Project; Ministry of Education, Culture, Sports, Science and Technology of Japan [H23-TA012]; JSPS KAKENHI [JP26461570, JP17K10099, JP17K17692]	Research on Measures for Intractable Disease Project; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research on Measures for Intractable Disease Project and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. H23-TA012 to S.K.) and JSPS KAKENHI (grant nos. JP26461570 and JP17K10099 to H.K. and grant no. JP17K17692 to A.H.).	Ban SA, 2014, J CLIN IMMUNOL, V34, P941, DOI 10.1007/s10875-014-0088-2; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Bonilla FA, 2013, PRIMARY IMMUNODEFICI, P780; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Gerdemann U, 2012, MOL THER, V20, P1622, DOI 10.1038/mt.2012.130; Kanegane H, 2012, PEDIAT ALLERG IMM-UK, V23, P488, DOI 10.1111/j.1399-3038.2012.01282.x; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Palendira U, 2012, J EXP MED, V209, P911, DOI 10.1084/jem.20112391; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Rivat C, 2013, BLOOD, V121, P1073, DOI 10.1182/blood-2012-07-445858; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhao M, 2011, CYTOM PART B-CLIN CY, V80B, P8, DOI 10.1002/cyto.b.20552	17	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					421	+		10.1016/j.jaci.2018.07.044	http://dx.doi.org/10.1016/j.jaci.2018.07.044			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30342818	Bronze			2022-12-18	WOS:000454918300051
J	Frew, AJ; Ljorring, C; Wolf, H; Wustenberg, E; Durham, SR; Corrigan, CJ; Powell, RJ; Pfaar, O				Frew, Anthony J.; Ljorring, Christian; Wolf, Hendrik; Wuestenberg, Eike; Durham, Stephen R.; Corrigan, Christopher J.; Powell, Richard J.; Pfaar, Oliver			UK Immunotherapy Study: Reanalysis by a combined symptom and medication score	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							GRASS-POLLEN IMMUNOTHERAPY; STANDARDIZATION; RECOMMENDATIONS; ALLERGY; TRIALS		[Frew, Anthony J.] Royal Sussex Cty Hosp, Dept Resp Med, Brighton, E Sussex, England; [Ljorring, Christian] ALK Abello, Global Clin Dev, Horsholm, Denmark; [Wolf, Hendrik; Wuestenberg, Eike] ALK Abello Arzneimittel GmbH, Clin Dev Med Dept, Hamburg, Germany; [Wuestenberg, Eike] Univ Klinikum Carl Gustav Carus, Clin Otolaryngol, Dresden, Germany; [Durham, Stephen R.] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, Allergy & Clin Immunol,Sect Inflammat Repair & De, London, England; [Corrigan, Christopher J.] Guys Hosp, Dept Allergy, London, England; [Corrigan, Christopher J.] Kings Coll London, Fac Life Sci & Med, London, England; [Powell, Richard J.] Univ Nottingham, Fac Med & Hlth Sci, Sch Mol Med Sci, Nottingham, England; [Pfaar, Oliver] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany; [Pfaar, Oliver] Ctr Rhinol & Allergol, Wiesbaden, Germany	University of Brighton; ALK-Abello AS; ALK-Abello AS; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham; Ruprecht Karls University Heidelberg	Pfaar, O (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany.; Pfaar, O (corresponding author), Ctr Rhinol & Allergol, Wiesbaden, Germany.	oliver@pfaar.org			ALK-Abello, Horsholm, Denmark	ALK-Abello, Horsholm, Denmark	Supported by ALK-Abello, Horsholm, Denmark.	Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383; Pfaar O, 2014, ALLERGO J, V23, P28, DOI 10.1007/s15007-014-0707-5; Roberts G, 2006, J ALLERGY CLIN IMMUN, V117, P263, DOI 10.1016/j.jaci.2005.09.054; Roberts G, 2018, ALLERGY, V73, P765, DOI 10.1111/all.13317; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; VARNEY VA, 1991, BRIT MED J, V302, P265, DOI 10.1136/bmj.302.6771.265	9	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1998	+		10.1016/j.jaci.2018.07.034	http://dx.doi.org/10.1016/j.jaci.2018.07.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30149039	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000452315800040
J	Sitarik, AR; Kasmikha, NS; Kim, H; Wegienka, G; Havstad, S; Ownby, D; Zoratti, E; Johnson, CC				Sitarik, Alexandra Rene; Kasmikha, Nena Sabri; Kim, Haejin; Wegienka, Ganesa; Havstad, Suzanne; Ownby, Dennis; Zoratti, Edward; Johnson, Christine Cole			Breast-feeding and delivery mode modify the association between maternal atopy and childhood allergic outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ASTHMA; RISK; IGE		[Sitarik, Alexandra Rene; Wegienka, Ganesa; Havstad, Suzanne; Johnson, Christine Cole] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Kasmikha, Nena Sabri; Kim, Haejin; Zoratti, Edward] Henry Ford Hlth Syst, Dept Internal Med, Div Allergy & Immunol, Detroit, MI USA; [Ownby, Dennis] Augusta Univ, Dept Pediat, Augusta, GA USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University	Sitarik, AR (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA.	asitari1@hfhs.org		Sitarik, Alexandra/0000-0001-8957-389X	National Institutes of Health [P01 AI089473, R01AI051598]; Fund for Henry Ford Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051598, P01AI089473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Henry Ford Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (grant nos. P01 AI089473 and R01AI051598) and the Fund for Henry Ford Hospital. Disclosure of potential conflict of interest: The authors declare	Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bertelsen RJ, 2017, CLIN EXP ALLERGY, V47, P627, DOI 10.1111/cea.12906; Levin AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31775; Magne F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00192; Munblit D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080894; Nwaru BI, 2013, CLIN EXP ALLERGY, V43, P1263, DOI 10.1111/cea.12180; Perry LM, 2009, ANN ALLERG ASTHMA IM, V103, P342, DOI 10.1016/S1081-1206(10)60535-2; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Xu RY, 2015, J ASTHMA ALLERGY, V8, P51, DOI 10.2147/JAA.S80245	9	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					2002	+		10.1016/j.jaci.2018.08.012	http://dx.doi.org/10.1016/j.jaci.2018.08.012			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30170122	Green Accepted, Bronze			2022-12-18	WOS:000452315800042
J	van Wijk, RG				van Wijk, Roy Gerth			Diagnosis of dog allergy: Beware of the dog	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Dog; allergy; diagnosis; nasal provocation test; children; molecular diagnostic techniques			[van Wijk, Roy Gerth] Erasmus MC, Dept Internal Med, Sect Allergol, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Wijk, RG (corresponding author), Erasmus MC, Dept Internal Med, Sect Allergol, Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	r.gerthvanwijk@erasmusmc.nl						Auge J, 2018, ALLERGY, V73, P1597, DOI 10.1111/all.13416; AVMA, 2012, US PET OWN STAT AVMA; Curin M, 2011, INT ARCH ALLERGY IMM, V154, P258, DOI 10.1159/000321113; Haahtela T, 2014, CLIN EXP ALLERGY, V44, P407, DOI 10.1111/cea.12240; Kack U, 2018, J ALLERGY CLIN IMMUN, V142, P1113, DOI 10.1016/j.jaci.2018.05.012; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; McBride D, 2012, PEDIAT ALLERG IMM-UK, V23, P230, DOI 10.1111/j.1399-3038.2011.01254.x; Smith HE, 2009, J ALLERGY CLIN IMMUN, V123, P646, DOI 10.1016/j.jaci.2008.11.005	8	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1058	1059		10.1016/j.jaci.2018.08.006	http://dx.doi.org/10.1016/j.jaci.2018.08.006			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	30144473	Bronze			2022-12-18	WOS:000446327300005
J	Chirumbolo, S; Biorklund, G; Vella, A				Chirumbolo, Salvaore; Biorklund, Geir; Vella, Antonio			Mast cell activation test versus basophil activation test and related competing issues	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHYMASE; MASTOCYTOSIS; ALLERGY; ASTHMA; GENE		[Chirumbolo, Salvaore] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Biorklund, Geir] Council Nutr & Environm Med, Mo I Rana, Norway; [Vella, Antonio] AOUI Policlin GB Rossi, Immunol Sect, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Chirumbolo, S (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	salvatore.chirumbolo@univr.it	Bjorklund, Geir/B-7319-2014	Bjorklund, Geir/0000-0003-2632-3935				Bahri R, 2018, J ALLERGY CLIN IMMUN, V142, P485, DOI 10.1016/j.jaci.2018.01.043; Bonadonna P, 2010, CURR OPIN ALLERGY CL, V10, P347, DOI 10.1097/ACI.0b013e32833b280c; Chirumbolo S, 2018, HUM VACC IMMUNOTHER, V14, P815, DOI 10.1080/21645515.2017.1417711; Escribano L, 2004, CYTOM PART B-CLIN CY, V58B, P1, DOI 10.1002/cyto.b.10072; Frossi B, 2018, IMMUNOL REV, V282, P35, DOI 10.1111/imr.12636; Hermes B, 2000, J INVEST DERMATOL, V114, P51, DOI 10.1046/j.1523-1747.2000.00837.x; Iwanaga T, 2004, CLIN EXP ALLERGY, V34, P1037, DOI 10.1111/j.1365-2222.2004.02000.x; Kinney SRM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132467; Sharma S, 2005, J HUM GENET, V50, P276, DOI 10.1007/s10038-005-0252-x	9	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					1018	1019		10.1016/j.jaci.2018.06.020	http://dx.doi.org/10.1016/j.jaci.2018.06.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	30055831	Bronze			2022-12-18	WOS:000443726500044
J	Adamko, DJ; Khamis, MM; Steacy, LM; Regush, S; Bryce, R; Ellis, AK				Adamko, Darryl J.; Khamis, Mona M.; Steacy, Lisa M.; Regush, Shana; Bryce, Rhonda; Ellis, Anne K.			Severity of allergic rhinitis assessed by using urine metabolomic profiling: Proof of concept	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SYNCYTIAL VIRUS-INFECTION; PHENOME-WIDE ASSOCIATION; AIRWAY HYPERRESPONSIVENESS; EXPRESSION; DISEASE; REVEAL; ASTHMA		[Adamko, Darryl J.; Regush, Shana] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Adamko, Darryl J.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Adamko, Darryl J.; Khamis, Mona M.] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada; [Bryce, Rhonda] Univ Saskatchewan, Clin Res Support Unit, Saskatoon, SK, Canada; [Steacy, Lisa M.; Ellis, Anne K.] Kingston Gen Hosp, Allergy Res Unit, Kingston, ON, Canada; [Ellis, Anne K.] Queens Univ, Dept Med, Kingston, ON, Canada	University of Alberta; University of Alberta; University of Saskatchewan; University of Saskatchewan; Queens University - Canada; Queens University - Canada	Adamko, DJ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.; Adamko, DJ (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Adamko, DJ (corresponding author), Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada.	darryl.adamko@usask.ca			AllerGen; NCE; Magnetic Resonance Diagnostic Centre (MRDC); Canadian Institutes for Health Research (CIHR); CIHR; Genome Prairie; Genome Canada; AHFMR; Canadian National High Field NMR Centre (NANUC); Natural Science and Engineering Research Council of Canada (NSERC); University of Alberta Hospital Foundation; Alberta Science and Research Authority (ASRA); Western Economic Development (WED); Allergy Research Trust of the Kingston General Hospital Research Institute	AllerGen; NCE; Magnetic Resonance Diagnostic Centre (MRDC); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Genome Prairie; Genome Canada(Genome Canada); AHFMR(Alberta Heritage Foundation for Medical Research); Canadian National High Field NMR Centre (NANUC); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta Hospital Foundation(University of Alberta); Alberta Science and Research Authority (ASRA); Western Economic Development (WED); Allergy Research Trust of the Kingston General Hospital Research Institute	Supported by AllerGen, NCE, the Magnetic Resonance Diagnostic Centre (MRDC), and the Canadian Institutes for Health Research (CIHR). The MRDC has received funding from CIHR, Genome Prairie, Genome Canada, an establishment grant from AHFMR, the Canadian National High Field NMR Centre (NANUC), the Natural Science and Engineering Research Council of Canada (NSERC), the University of Alberta Hospital Foundation, the Alberta Science and Research Authority (ASRA), and Western Economic Development (WED) and was supported in kind by the Allergy Research Trust of the Kingston General Hospital Research Institute.	Adamko DJ, 2015, J ALLERGY CLIN IMMUN, V136, P571, DOI 10.1016/j.jaci.2015.05.022; [Anonymous], 2011, GUIDE CARE USE LAB A; Bates JT, 2013, J IMMUNOL, V190, P3732, DOI 10.4049/jimmunol.1202964; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dulek DE, 2014, J VIROL, V88, P9655, DOI 10.1128/JVI.03299-13; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Larkin EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0040-0; Newcomb DC, 2015, J ALLERGY CLIN IMMUN, V136, P1025, DOI 10.1016/j.jaci.2015.05.046; Peebles RS, 1999, J MED VIROL, V57, P186, DOI 10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q; Peebles RS, 2001, J MED VIROL, V63, P178, DOI 10.1002/1096-9071(20000201)63:2<178::AID-JMV1013>3.3.CO;2-F; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40	17	5	5	2	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					687	689		10.1016/j.jaci.2018.02.051	http://dx.doi.org/10.1016/j.jaci.2018.02.051			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29678748	Bronze			2022-12-18	WOS:000440664400039
J	Miller, M; Vuong, C; Garcia, MF; Rosenthal, P; Das, S; Weng, N; Pham, A; Kim, YJ; Broide, DH				Miller, Marina; Vuong, Christine; Garcia, Meghan Farrell; Rosenthal, Peter; Das, Sudipta; Weng, Ning; Pham, Alexa; Kim, Yu Jin; Broide, David H.			Does reduced zona pellucida binding protein 2 (ZPBP2) expression on chromosome 17q21 protect against asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RECESSIVE DSG1 MUTATIONS; MULTIPLE ALLERGIES; SEVERE DERMATITIS; AIRWAY RESPONSIVENESS; ORMDL3; DOMINANT; GSDMB		[Miller, Marina; Vuong, Christine; Garcia, Meghan Farrell; Rosenthal, Peter; Das, Sudipta; Weng, Ning; Pham, Alexa; Kim, Yu Jin; Broide, David H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Broide, DH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dbroide@ucsd.edu		Broide, David/0000-0001-8405-9090	National Institutes of Health [AI 070535, AI 107779, AI 124236, AI 038425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R37AI038425, R01AI038425, R01AI107779, R01AI124236, T32AI007469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants AI 070535, AI 107779, AI 124236, and AI 038425 (to D.H.B.).	Boyden LM, 2016, HUM MOL GENET, V25, P348, DOI 10.1093/hmg/ddv481; Cavalli M, 2017, BRIT J HAEMATOL, V177, P588, DOI 10.1111/bjh.14616; Chen J, 2017, J ALLERGY CLIN IMMUN; Cheng RH, 2016, J DERMATOL, V43, P1201, DOI 10.1111/1346-8138.13431; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Danescu S, 2017, J EUR ACAD DERMATOL, V31, pE144, DOI 10.1111/jdv.13967; Das S, 2017, ADV IMMUNOL, V135, P1, DOI 10.1016/bs.ai.2017.06.001; Das S, 2016, P NATL ACAD SCI USA, V113, P13132, DOI 10.1073/pnas.1610433113; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Green H, 1977, Prog Clin Biol Res, V17, P493; Has C, 2015, BRIT J DERMATOL, V172, P257, DOI 10.1111/bjd.13247; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Loser S, 2017, J ALLERGY CLIN IMMUN, V139, P1496, DOI 10.1016/j.jaci.2016.07.033; McAleer MA, 2015, J ALLERGY CLIN IMMUN, V136, P1268, DOI 10.1016/j.jaci.2015.05.002; Miller M, 2017, J IMMUNOL, V198, P3017, DOI 10.4049/jimmunol.1601848; Miller M, 2017, J ALLERGY CLIN IMMUN, V139, P1373, DOI 10.1016/j.jaci.2016.08.053; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Schlipf NA, 2016, BRIT J DERMATOL, V174, P444, DOI 10.1111/bjd.14079; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007	22	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					706	+		10.1016/j.jaci.2018.04.011	http://dx.doi.org/10.1016/j.jaci.2018.04.011			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29709669	Green Accepted			2022-12-18	WOS:000440664400045
J	Kim, DK; Beaven, MA; Metcalfe, DD; Olivera, A				Kim, Do-Kyun; Beaven, Michael A.; Metcalfe, Dean D.; Olivera, Ana			Interaction of DJ-1 with Lyn is essential for IgE-mediated stimulation of human mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human mast cells; IgE receptor; Lyn activation; DJ-1; signaling; reactive oxygen species; spleen tyrosine kinase	FC-EPSILON-RI; REGULATING KINASE 1; PARKINSONS-DISEASE; OXIDATIVE DAMAGE; ACTIVATION; APOPTOSIS; RECEPTOR; PROTEIN; DEGRANULATION; MICRODOMAINS	Background: DJ-1 is a redox-sensitive protein with multiple roles in cell homeostasis, levels of which are altered in patients with mast cell (MC)-related disorders. However, whether DJ-1 can regulate human MC function is unknown. Objective: We sought to investigate the potential role of DJ-1 in the responses of human MCs to antigen stimulation. Methods: DJ-1 was silenced in human CD34(+)-derived MCs and in the LAD2 MC line by using lentiviral short hairpin RNA constructs. Release of beta-hexosaminidase, prostaglandin D-2, and GM-CSF and changes in reactive oxygen species levels were measured after Fc epsilon RI engagement. Enzymatic assays, sucrose density gradient centrifugation, immunoprecipitation, dot and Western blotting, and confocal imaging were performed for signaling, cellular localization, and coassociation studies. Results: DJ-1 knockdown substantially reduced mediator release, as well as Lyn kinase and spleen tyrosine kinase activation and signaling through mechanisms that appeared largely unrelated to DJ-1 antioxidant activity. Following Fc epsilon RI activation, nonoxidized rather than oxidized DJ-1 translocated to lipid rafts, where it associated with Lyn, an interaction that appeared critical for maximal Lyn activation and initiation of signaling. Using purified recombinant proteins, we demonstrated that DJ-1 directly bound toLyn but not to other Src kinases, and this interactionwas specific for human but not mouse proteins. In addition, DJ-1 reduced Src homology 2 domain-containing phosphatase 2 phosphatase activity by scavenging reactive oxygen species, thus preventing spleen tyrosine kinase dephosphorylation and perpetuating MC signaling. Conclusion: We demonstrate a novel role for DJ-1 in the early activation of Lyn by Fc epsilon RI, which is essential for human MC responses and provides the basis for an alternative target in allergic disease therapy.	[Kim, Do-Kyun; Metcalfe, Dean D.; Olivera, Ana] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Olivera, A (corresponding author), NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, Bldg 10,Rm 11N240,10 Ctr Dr, Bethesda, MD 20892 USA.	ana.olivera@nih.gov			Division of Intramural Research Programs within the National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute/National Institutes of Health; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000965] Funding Source: NIH RePORTER	Division of Intramural Research Programs within the National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research Programs within the National Institute of Allergy and Infectious Diseases and National Heart, Lung, and Blood Institute/National Institutes of Health. D.-K. K. was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) and funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI14C1175).	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Cao J, 2015, BIOCHEM PHARMACOL, V93, P241, DOI 10.1016/j.bcp.2014.11.012; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Costello PS, 1996, ONCOGENE, V13, P2595; Deeg S, 2010, J CELL BIOL, V188, P505, DOI 10.1083/jcb.200904103; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Hammond S, 2009, J STRUCT BIOL, V168, P161, DOI 10.1016/j.jsb.2009.04.012; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kim DK, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004098; Kim DK, 2013, J ALLERGY CLIN IMMUN, V131, P1653, DOI 10.1016/j.jaci.2012.10.012; Kim JH, 2013, NEUROBIOL DIS, V60, P1, DOI 10.1016/j.nbd.2013.08.007; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kirshenbaum Arnold S, 2006, Methods Mol Biol, V315, P105; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; Ma J, 2014, BIOCHEM J, V462, P489, DOI 10.1042/BJ20140235; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Poderycki M, 2010, J IMMUNOL, V184, P84, DOI 10.4049/jimmunol.0901590; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Shelby SA, 2016, MOL BIOL CELL, V27, P3645, DOI 10.1091/mbc.E16-06-0425; Shim E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161835; Siegel AM, 2013, J ALLERGY CLIN IMMUN, V132, P1388, DOI 10.1016/j.jaci.2013.08.045; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Takahashi-Niki K, 2015, J BIOL CHEM, V290, P17838, DOI 10.1074/jbc.M115.666271; Tsuboi Y, 2008, FEBS LETT, V582, P2643, DOI 10.1016/j.febslet.2008.06.043; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang S, 2016, ONCOTARGET, V7, P65758, DOI 10.18632/oncotarget.11613	45	5	5	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					195	+		10.1016/j.jaci.2017.08.030	http://dx.doi.org/10.1016/j.jaci.2017.08.030			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29031599	Bronze, Green Accepted			2022-12-18	WOS:000437837500023
J	Bird, JA; Fleischer, DM; Groetch, M; Nowak-Wegrzyn, A; Sicherer, S; Young, MC				Bird, J. Andrew; Fleischer, David M.; Groetch, Marion; Nowak-Wegrzyn, Anna; Sicherer, Scott; Young, Michael C.			Additional oral food challenge considerations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Bird, J. Andrew] Univ Texas Southwestern Med Sch, Dallas, TX 75235 USA; [Fleischer, David M.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Fleischer, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Groetch, Marion; Nowak-Wegrzyn, Anna; Sicherer, Scott] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Young, Michael C.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Icahn School of Medicine at Mount Sinai; Harvard University; Boston Children's Hospital; Harvard Medical School	Bird, JA (corresponding author), Univ Texas Southwestern Med Sch, Dallas, TX 75235 USA.	drew.bird@utsouthwestern.edu		Nowak-Wegrzyn, Anna/0000-0002-0960-9854	Food Allergy Research and Education; Aimmune Therapeutics; DBV Technologies; Nestle Nutrition Institute; American College of Allergy, Asthma, and Immunology; Nutricia North America; Mead Johnson; National Institutes of Health/National Institute of Allergy and Infectious Diseases; Astellas Pharma; Nutricia; Nestle; Thermo Fisher; Thermofisher; Merck; UpToDate; Johns Hopkins University Press; American Academy of Allergy, Asthma Immunology; HAL Allergy	Food Allergy Research and Education; Aimmune Therapeutics; DBV Technologies; Nestle Nutrition Institute(Nestle SA); American College of Allergy, Asthma, and Immunology; Nutricia North America(Danone Nutricia); Mead Johnson; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Astellas Pharma(Astellas Pharmaceuticals); Nutricia(Danone Nutricia); Nestle(Nestle SA); Thermo Fisher; Thermofisher; Merck(Merck & Company); UpToDate; Johns Hopkins University Press; American Academy of Allergy, Asthma Immunology; HAL Allergy(HAL Allergy Group)	J. A. Bird has received personal fees from Food Allergy Research and Education, Aimmune Therapeutics, and DBV Technologies, and has received grants from Aimmune Therapeutics and DBV Technologies. D. M. Fleischer has received travel support from the American College of Allergy, Asthma, and Immunology and Nestle Nutrition; is on the scientific advisory council for the National Peanut Board; serves on the FAACT Medical Advisory Board and FARE Clinical Advisory Board; has consultant arrangements with DBV Technologies, Aimmune Therapeutics, Monsanto, Kaleo Pharma, INSYS Therapeutics, and BEFORE Brands; is employed by University of Colorado Medicine; has received grants from Nestle Nutrition Institute, DBV Technologies, and Aimmune Therapeutics; has received payment for lectures from Nestle Nutrition Institute and the American College of Allergy, Asthma, and Immunology; has received payment for manuscript preparation from the Nestle Nutrition Institute; and has received royalties from UpToDate. M. Groetch has received personal fees from Nutricia North America and Mead Johnson. A. Nowak-Wegrzyn has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, Nutricia, Nestle, and Thermo Fisher, and has received personal fees from Nutricia, Nestle, Thermofisher, Merck, and UpToDate. S. Sicherer has received personal fees from UpToDate, Johns Hopkins University Press, and the American Academy of Allergy, Asthma & Immunology and has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases and HAL Allergy. M. C. Young declares no relevant conflicts of interest.	Akuete K, 2017, ANN ALLERG ASTHMA IM, V119, P339, DOI 10.1016/j.anai.2017.07.028; Ballmer-Weber BK, 2018, J ALLERGY CLIN IMMUN, V141, P69, DOI 10.1016/j.jaci.2017.06.038; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Pongracic JA, 2012, J ALLERGY CLIN IMMUN, V129, P564, DOI 10.1016/j.jaci.2011.09.024; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Simberloff T, 2017, J ALLER CL IMM-PRACT, V5, P335, DOI 10.1016/j.jaip.2016.05.021; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010	7	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2322	2322		10.1016/j.jaci.2018.02.037	http://dx.doi.org/10.1016/j.jaci.2018.02.037			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29692338	Bronze			2022-12-18	WOS:000434701600050
J	Garn, H				Garn, Holger			Is 9 more than 2 also in allergic airway inflammation?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergic airway inflammation; inflammation; CD4(+); T cells; T(H)1; T(H)2; interleukins	T-CELLS		[Garn, Holger] Philipps Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem, Marburg, Germany; [Garn, Holger] German Ctr Lung Res, Giessen, Germany	Philipps University Marburg	Garn, H (corresponding author), Philipps Univ Marburg, Inst Lab Med & Pathobiochem, Fac Med, Ctr Tumor & Immunobiol ZTI, Hans Meerwein Str 3, D-35043 Marburg, Germany.	garn@staff.uni-marburg.de		Garn, Holger/0000-0002-5178-4023				Carrascosa LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15366; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Muehling LM, 2017, J ALLERGY CLIN IMMUN, V140, P1523, DOI 10.1016/j.jaci.2017.02.025; Neurath MF, 2016, CYTOKINE GROWTH F R, V29, P93, DOI 10.1016/j.cytogfr.2016.02.002; Pepper AN, 2017, J ALLER CL IMM-PRACT, V5, P909, DOI 10.1016/j.jaip.2017.04.038; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Wang P, 2018, J ALLERGY CLIN IMMUN, V141, P2168, DOI 10.1016/j.jaci.2017.06.026; Yao WG, 2011, J ALLERGY CLIN IMMUN, V128, P1357, DOI 10.1016/j.jaci.2011.06.019	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2024	2026		10.1016/j.jaci.2018.04.002	http://dx.doi.org/10.1016/j.jaci.2018.04.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29680450	Bronze			2022-12-18	WOS:000434701600009
J	Unni, MNM; Elfeky, R; Rao, K; Nademi, Z; Chiesa, R; Amrolia, P; Skinner, R; Slater, O; Worth, A; Flood, T; Abinun, M; Hambleton, S; Qasim, W; Gaspar, HB; Cant, AJ; Gennery, AR; Veys, P; Slatter, MA				Unni, Mohamed Najib Mohamed; Elfeky, Reem; Rao, Kanchan; Nademi, Zohreh; Chiesa, Robert; Amrolia, Persis; Skinner, Roderick; Slater, Olga; Worth, Austen; Flood, Terence; Abinun, Mario; Hambleton, Sophie; Qasim, Waseem; Gaspar, Hubert B.; Cant, Andrew J.; Gennery, Andrew R.; Veys, Paul; Slatter, Mary A.			Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MARROW TRANSPLANTATION; CARCINOMA; SURVIVAL; DISEASES; CHILDREN; CANCERS; BLOOD		[Unni, Mohamed Najib Mohamed; Nademi, Zohreh; Skinner, Roderick; Flood, Terence; Abinun, Mario; Hambleton, Sophie; Cant, Andrew J.; Gennery, Andrew R.; Slatter, Mary A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Childrens Haemopoiet Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Elfeky, Reem; Rao, Kanchan; Chiesa, Robert; Amrolia, Persis; Slater, Olga; Worth, Austen; Qasim, Waseem; Gaspar, Hubert B.; Veys, Paul] Great Ormond St Hosp NHS Trust, London, England; [Hambleton, Sophie; Gennery, Andrew R.; Slatter, Mary A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle University - UK	Slatter, MA (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Childrens Haemopoiet Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England.; Slatter, MA (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	mary.slatter@nuth.nhs.uk		QASIM, WASEEM/0000-0001-8353-4494; Hambleton, Sophie/0000-0001-7954-3267; Skinner, Rod/0000-0002-1162-675X	National Institute of Health Research; Wellcome Clinical Research; GOSH Childrens Charity; BioTest UK; Jules Thorn Trust; Wellcome Trust; BioTest; National Institute for Health Research; Autolus Ltd; Novartis; JAZZ Pharma	National Institute of Health Research(National Institute for Health Research (NIHR)); Wellcome Clinical Research; GOSH Childrens Charity; BioTest UK; Jules Thorn Trust; Wellcome Trust(Wellcome TrustEuropean Commission); BioTest; National Institute for Health Research(National Institute for Health Research (NIHR)); Autolus Ltd; Novartis(Novartis); JAZZ Pharma(Jazz Pharmaceuticals)	R. Elfeky reports employment with Bellicum Pharmaceutical running phase I/II trials with BPX-501. A. Worth reports institutional grants pending from the National Institute of Health Research, Wellcome Clinical Research, and the GOSH Childrens Charity; institutional payments for advisory board work for BioTest UK; employment as an immunology consultant at the Great Ormond Street Hospital; and receiving fees for a commissioned review article for the British Journal of Haematology. S. Hambleton reports institutional consultant fees from UCB Celltech and has grants pending from the Jules Thorn Trust and the Wellcome Trust; speaking fees from BioTest; and travel support from the Medical Research Council, the Wellcome Trust, ESID, BSI, UKPIN, Harvard Medical School, the National Institutes of Health, and Oxford University. W. Qasim reports institutional grant funding from the National Institute for Health Research; consultancy fees from Autolus Ltd and to his institution from Servier; and CAR Advisory Board membership at Novartis. Hubert B. B. Gaspar reports board membership and consulting work for Orchard Therapeutics outside the scope of this study. P. Veys reports consultancy fees from Novartis and JAZZ Pharma. The rest of the authors declare that they have no relevant conflicts of interest.	Bomken S, 2015, CHILDREN-BASEL, V2, P146, DOI 10.3390/children2020146; Cancer Research UK, CHILDR CANC STAT; Cotterill S, 2000, BRIT J CANCER, V83, P397, DOI 10.1054/bjoc.2000.1313; Eapen M, 2012, BIOL BLOOD MARROW TR, V18, P1438, DOI 10.1016/j.bbmt.2012.03.003; Hertenstein B, 2005, HAEMATOLOGICA, V90, P969; Kamani NR, 2011, BIOL BLOOD MARROW TR, V17, P1783, DOI 10.1016/j.bbmt.2011.05.008; McClain K L, 1997, Cancer Treat Res, V92, P39; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Nelson AS, 2017, PEDIATR BLOOD CANCER, V64, P197, DOI 10.1002/pbc.26219; Rizzo JD, 2009, BLOOD, V113, P1175, DOI 10.1182/blood-2008-05-158782; Shimoni A, 2013, LEUKEMIA, V27, P829, DOI 10.1038/leu.2012.299; Socie G, 2000, J CLIN ONCOL, V18, P348, DOI 10.1200/JCO.2000.18.2.348; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Wojenski DJ, 2015, TRANSPL INFECT DIS, V17, P250, DOI 10.1111/tid.12367	14	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2018	141	6					2319	+		10.1016/j.jaci.2018.02.038	http://dx.doi.org/10.1016/j.jaci.2018.02.038			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GI7SD	29524534	Green Accepted, Bronze			2022-12-18	WOS:000434701600049
J	Bourdin, A; Suehs, CM; Marin, G; Vachier, I; Matzner-Lober, E; Chanez, P; Molinari, N				Bourdin, Arnaud; Suehs, Carey M.; Marin, Gregory; Vachier, Isabelle; Matzner-Lober, Eric; Chanez, Pascal; Molinari, Nicolas		COBRA Consortium	Asthma, COPD, and overlap in a national cohort: ACO on a gradient	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Bourdin, Arnaud; Suehs, Carey M.; Vachier, Isabelle] Montpellier Univ Hosp, Arnaud Villeneuve Hosp, Dept Resp Dis, Montpellier, France; [Bourdin, Arnaud; Molinari, Nicolas] Arnaud Villeneuve Hosp, INSERM U 1046, Crastes Paulet Bldg, Montpellier, France; [Suehs, Carey M.; Marin, Gregory; Molinari, Nicolas] Montpellier Univ Hosp, La Colombiere Hosp, Dept Med Informat, Montpellier, France; [Matzner-Lober, Eric] Rennes Univ 2, Continuing Educ ENSAE ENSAI CEPE, Rennes, France; [Chanez, Pascal] Nord Hosp, Publ Assistance Hosp Marseilles, Dept Resp Dis, Chemin Bourrely, Marseille, France; [Chanez, Pascal] Aix Marseille Univ, INSERM CNRS U1067 UMR7733, Marseille, France; [Molinari, Nicolas] Montpellier Univ, CNRS, Alexander Grothendieck Inst Montpellier, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Bourdin, A (corresponding author), Montpellier Univ Hosp, Arnaud Villeneuve Hosp, Dept Resp Dis, Montpellier, France.; Bourdin, A (corresponding author), Arnaud Villeneuve Hosp, INSERM U 1046, Crastes Paulet Bldg, Montpellier, France.	a-bourdin@chu-montpellier.fr	Suehs, Carey/AAE-5806-2019; matzner-lober, eric/Z-5974-2019; molinari, nicolas/Y-9681-2019	Suehs, Carey/0000-0002-2175-3496; matzner-lober, eric/0000-0002-9187-8390; chanez, pascal/0000-0003-4059-0917	Inserm; CHU de Nimes; LEGS POIX; GSK; AstraZeneka; Chiesi	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nimes; LEGS POIX; GSK(GlaxoSmithKline); AstraZeneka; Chiesi(Chiesi Pharmaceuticals Inc)	The COBRA cohort was financed by Inserm, CHU de Nimes, LEGS POIX, GSK, AstraZeneka, and Chiesi. These funding sources played no part in the present analysis.	Barrecheguren M, 2015, COPD RES PRACT; Chanez P, 1997, AM J RESP CRIT CARE, V155, P1529, DOI 10.1164/ajrccm.155.5.9154853; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Global Initiative for Chronic Obstructive Lung Diseases, 2015, GINA GOLD DIAGN DIS; Hahn D, 2010, EUR RESPIR J, V35, P459, DOI 10.1183/09031936.00156709; Magnussen H, 2014, RESP MED, V108, P593, DOI 10.1016/j.rmed.2014.01.002; Pavord ID, 2008, LANCET, V372, P1017, DOI 10.1016/S0140-6736(08)61421-X; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863	8	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1516	1519		10.1016/j.jaci.2017.11.049	http://dx.doi.org/10.1016/j.jaci.2017.11.049			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29355677	Bronze, Green Submitted			2022-12-18	WOS:000429197800046
J	Wolf, M; Aglas, L; Twaroch, TE; Steiner, M; Huber, S; Hauser, M; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Wallner, M; Ferreira, F				Wolf, Martin; Aglas, Lorenz; Twaroch, Teresa E.; Steiner, Markus; Huber, Sara; Hauser, Michael; Hofer, Heidi; Parigiani, Maria A.; Ebner, Christof; Bohle, Barbara; Briza, Peter; Neubauer, Angela; Stolz, Frank; Wallner, Michael; Ferreira, Fatima			Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							STANDARDIZATION		[Wolf, Martin; Aglas, Lorenz; Steiner, Markus; Huber, Sara; Hauser, Michael; Hofer, Heidi; Parigiani, Maria A.; Briza, Peter; Wallner, Michael; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Salzburg, Austria; [Twaroch, Teresa E.; Neubauer, Angela] Biomay AG, Vienna Competence Ctr, Vienna, Austria; [Steiner, Markus] Paracelsus Med Univ, Lab Immunol & Mol, Ctr Res, Salzburg, Austria; [Ebner, Christof] Allergy Clin Reumannpl, Vienna, Austria; [Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Wolf, Martin] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Inst Expt & Clin Cell Therapy, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Medical University of Vienna; Paracelsus Private Medical University	Ferreira, F (corresponding author), Salzburg Univ, Dept Mol Biol, Salzburg, Austria.	fatima.ferreira@sbg.ac.at	Ferreira, Fatima/AAB-4321-2019; Wolf, Martin/AGX-0301-2022; Ferreira, Fatima/E-4889-2011; Hauser, Michael/P-6148-2017; Briza, Peter/D-7309-2012; Huber, Sara/AAG-6474-2019; Aglas, Lorenz/L-3996-2015	Ferreira, Fatima/0000-0003-0989-2335; Wolf, Martin/0000-0002-4795-8086; Ferreira, Fatima/0000-0003-0989-2335; Hauser, Michael/0000-0001-6558-755X; Briza, Peter/0000-0002-4941-6782; Huber, Sara/0000-0003-3589-4924; Aglas, Lorenz/0000-0002-1236-5934; Bohle, Barbara/0000-0002-5105-7985	Austrian Science Funds (FWF) International PhD Program "Immunity in Cancer and Allergy'' [W1213]; FWF [SFB F4610]; Christian Doppler Research Association (Christian Doppler Laboratory for Allergy Diagnosis and Therapy); priority program "Allergy-Cancer-BioNano Research Centre'' of the University of Salzburg	Austrian Science Funds (FWF) International PhD Program "Immunity in Cancer and Allergy''; FWF(Austrian Science Fund (FWF)); Christian Doppler Research Association (Christian Doppler Laboratory for Allergy Diagnosis and Therapy); priority program "Allergy-Cancer-BioNano Research Centre'' of the University of Salzburg	This study was supported by the Austrian Science Funds (FWF) International PhD Program "Immunity in Cancer and Allergy'' (Project W1213), the FWF SFB F4610, the Christian Doppler Research Association (Christian Doppler Laboratory for Allergy Diagnosis and Therapy), and the priority program "Allergy-Cancer-BioNano Research Centre'' of the University of Salzburg.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Freier R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12707; Gomez-Casado C, 2016, ARCH IMMUNOL THER EX, V64, P339, DOI 10.1007/s00005-016-0401-2; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; Jahn-Schmid B, 2010, J ALLERGY CLIN IMMUN, V126, P1068, DOI 10.1016/j.jaci.2010.05.038; Machado Y, 2016, J ALLERGY CLIN IMMUN, V137, P1525, DOI 10.1016/j.jaci.2015.09.026; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wolf M, 2017, ALLERGY, V72, P1874, DOI 10.1111/all.13196; YODER MD, 1990, J BIOL CHEM, V265, P11429; Zheng WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09131	13	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1488	+		10.1016/j.jaci.2017.10.027	http://dx.doi.org/10.1016/j.jaci.2017.10.027			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29157946	hybrid			2022-12-18	WOS:000429197800037
J	Austen, KF				Austen, K. Frank			Mentoring: An art and a responsibility	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Mentoring; allergy			[Austen, K. Frank] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Bldg Transformat Med,60 Fenwood Rd,5th Floor, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Austen, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Bldg Transformat Med,60 Fenwood Rd,5th Floor, Boston, MA 02115 USA.	fausten@research.bwh.harvard.edu							0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					880	881		10.1016/j.jaci.2018.01.004	http://dx.doi.org/10.1016/j.jaci.2018.01.004			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29382599	Bronze			2022-12-18	WOS:000426974800006
J	Knobloch, J; Jungck, D; Charron, C; Stoelben, E; Ito, K; Koch, A				Knobloch, Juergen; Jungck, David; Charron, Catherine; Stoelben, Erich; Ito, Kazuhiro; Koch, Andrea			Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CD8 T-CELLS; ASTHMA; WHEEZE; EXPOSURE; RECEPTOR; RELEASE; STRESS; BLOOD; BIRTH; COPD		[Knobloch, Juergen; Jungck, David] Bergmannsheil Univ Hosp, Med Clin Pneumol 3, Allergol Sleep & Resp Med, Bochum, Germany; [Jungck, David] Bethel Teaching Hosp, Dept Internal Med Pneumol Allergol & Resp Med 2, Berlin, Germany; [Charron, Catherine; Ito, Kazuhiro] RespiVert Ltd, London, England; [Stoelben, Erich] Univ Witten Herdecke, Hosp Cologne, Lungenklin, Dept Thorac Surg, Witten, Germany; [Koch, Andrea] Klinikum Ludwig Maximilians Univ, Med Klin & Poliklin 5, Munich, Germany; [Koch, Andrea] German Ctr Lung Res DZL, Munich, Germany	Ruhr University Bochum; Witten Herdecke University; University of Munich	Koch, A (corresponding author), Klinikum Ludwig Maximilians Univ, Med Klin & Poliklin 5, Munich, Germany.; Koch, A (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	andrea.koch@med.uni-muenchen.de	Ito, Kazuhiro/AAF-5994-2019	Knobloch, Jurgen/0000-0001-6868-0055				Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Burgess SL, 2016, RESP MED, V110, P53, DOI 10.1016/j.rmed.2015.11.009; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Kerzel S, 2012, J PEDIATR-US, V161, P1172, DOI 10.1016/j.jpeds.2012.07.051; Knobloch J, 2013, AM J RESP CELL MOL, V49, P114, DOI 10.1165/rcmb.2012-0287OC; Knobloch J, 2010, J PHARMACOL EXP THER, V335, P788, DOI 10.1124/jpet.110.166843; Latorre M, 2015, PULM PHARMACOL THER, V30, P44, DOI 10.1016/j.pupt.2014.10.006; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; Marcais A, 2006, EUR J IMMUNOL, V36, P2745, DOI 10.1002/eji.200636259; Martin RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074730; Norman P, 2014, EXPERT OPIN THER PAT, V24, P1397, DOI 10.1517/13543776.2014.967213; Onions ST, 2016, J MED CHEM, V59, P1727, DOI 10.1021/acs.jmedchem.5b01029; Patel MM, 2011, ENVIRON RES, V111, P1222, DOI 10.1016/j.envres.2011.08.004; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Rosa MJ, 2011, RESP MED, V105, P869, DOI 10.1016/j.rmed.2010.11.022; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Ueng TH, 2005, TOXICOL SCI, V87, P483, DOI 10.1093/toxsci/kfi251; Walzer T, 2003, J IMMUNOL, V170, P1615, DOI 10.4049/jimmunol.170.4.1615; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691	24	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1122	+		10.1016/j.jaci.2017.09.026	http://dx.doi.org/10.1016/j.jaci.2017.09.026			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29079133				2022-12-18	WOS:000426974800033
J	Corren, J; Parnes, JR; Wang, LW; Mo, M; Roseti, SL; Griffiths, JM; O'Quinn, S; van der Merwe, R				Corren, Jonathan; Parnes, Jane R.; Wang, Liangwei; Mo, May; Roseti, Stephanie L.; Griffiths, Janet M.; O'Quinn, Sean; van der Merwe, Rene			Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Corren, Jonathan] Allergy Med Clin, Los Angeles, CA USA; [Parnes, Jane R.; Mo, May] Amgen Inc, Thousand Oaks, CA USA; [Wang, Liangwei; Roseti, Stephanie L.; Griffiths, Janet M.] MedImmune, Gaithersburg, MD USA; [O'Quinn, Sean] AstraZeneca, Gaithersburg, MD USA; [van der Merwe, Rene] MedImmune, Cambridge, England	Amgen; AstraZeneca; Medimmune; AstraZeneca; AstraZeneca; Medimmune									0	5	6	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		257	AB80	AB80		10.1016/j.jaci.2017.12.259	http://dx.doi.org/10.1016/j.jaci.2017.12.259			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700257
J	Vercelli, D				Vercelli, Donata			Are we what our mothers made us? Lessons from epigenetics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Childhood asthma; epigenetics; DNA methylation; maternal exposure; phthalates; transgenerational inheritance	ASTHMA		[Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Arizona Ctr Biol Complex Dis, Tucson, AZ USA; [Vercelli, Donata] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA	University of Arizona; University of Arizona	Vercelli, D (corresponding author), BIO5 Inst,Rm 339,1657 Helen St, Tucson, AZ 85721 USA.	donata@email.arizona.edu		Vercelli, Donata/0000-0001-5276-8976	Johnson and Johnson; VIFOR PHARMA	Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); VIFOR PHARMA	D. Vercelli's institution received grants from Johnson and Johnson and VIFOR PHARMA for other works.	DeVries A, 2017, J ALLERGY CLIN IMMUN, V140, P534, DOI 10.1016/j.jaci.2016.10.041; DeVries A, 2017, EPIGENOMICS-UK, V9, P585, DOI 10.2217/epi-2016-0149; Inoue A, 2017, NATURE, V547, P419, DOI 10.1038/nature23262; Jahreis S, 2018, J ALLERGY CLIN IMMUN, V141, P741, DOI 10.1016/j.jaci.2017.03.017; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Robinson Lacey, 2015, Curr Environ Health Rep, V2, P379, DOI 10.1007/s40572-015-0066-8; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Wang IJ, 2017, INT J ENV RES PUBLIC, V14	10	5	5	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2					525	526		10.1016/j.jaci.2017.12.973	http://dx.doi.org/10.1016/j.jaci.2017.12.973			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FV2PQ	29274413				2022-12-18	WOS:000424410800008
J	Puche, LV; Lopez-Sanchez, D; Blanca-Lopez, N; Somoza-Alvarez, ML; Diaz, EH; Diaz-Perales, A; Canto, MG; Blanca, M				Victorio Puche, Laura; Lopez-Sanchez, Damian; Blanca-Lopez, Natalia; Luisa Somoza-Alvarez, Maria; Haroun Diaz, Elisa; Diaz-Perales, Araceli; Gabriela Canto, Maria; Blanca, Miguel			Peach pollen sensitisation is highly prevalent in areas of great extension of peach tree cultivar	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Victorio Puche, Laura; Lopez-Sanchez, Damian] Virgen de la Arrixaca Univ Gen Hosp, Allergy Unit, Murcia, Spain; [Blanca-Lopez, Natalia; Luisa Somoza-Alvarez, Maria; Haroun Diaz, Elisa; Gabriela Canto, Maria; Blanca, Miguel] Infanta Leonor Univ Hosp, Allergy Unit, Madrid, Spain; [Diaz-Perales, Araceli] Ctr Plant Biotechnol & Genom UPM INIA, Madrid, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitario Infanta Leonor; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP)			Díaz-Perales, Araceli/D-8433-2016	Díaz-Perales, Araceli/0000-0002-1093-3627					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		97	AB31	AB31		10.1016/j.jaci.2017.12.099	http://dx.doi.org/10.1016/j.jaci.2017.12.099			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX		Bronze			2022-12-18	WOS:000429306700097
J	Parpaleix, A; Boyer, L; Wiedemann, A; Lacabaratz, C; Margarit, L; Enouf, V; Le Corvoisier, P; Lino, A; Covali-Noroc, A; Housset, B; Chouaid, C; Maitre, B; Levy, Y; Lelievre, JD; Adnot, S				Parpaleix, Aurelien; Boyer, Laurent; Wiedemann, Aurelie; Lacabaratz, Christine; Margarit, Laurent; Enouf, Vincent; Le Corvoisier, Philippe; Lino, Anne; Covali-Noroc, Ala; Housset, Bruno; Chouaid, Christos; Maitre, Bernard; Levy, Yves; Lelievre, Jean-Daniel; Adnot, Serge			Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EXACERBATIONS		[Parpaleix, Aurelien; Boyer, Laurent; Wiedemann, Aurelie; Lacabaratz, Christine; Levy, Yves; Lelievre, Jean-Daniel; Adnot, Serge] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France; [Parpaleix, Aurelien; Boyer, Laurent; Adnot, Serge] Univ Paris Est UPEC, Creteil, France; [Boyer, Laurent; Margarit, Laurent; Lino, Anne; Covali-Noroc, Ala; Maitre, Bernard; Adnot, Serge] Hop Henri Mondor, APHP, Dept Physiol Explorat Fonct, Creteil, France; [Wiedemann, Aurelie; Lacabaratz, Christine; Levy, Yves; Lelievre, Jean-Daniel] Univ Paris Est UPEC, Fac Med, DHU VIC, Creteil, France; [Wiedemann, Aurelie; Lacabaratz, Christine; Levy, Yves; Lelievre, Jean-Daniel] Vaccine Res Inst, Creteil, France; [Enouf, Vincent] Inst Pasteur, CNR IPP, Unite Genet Mol Virus ARN, Paris, France; [Le Corvoisier, Philippe] Hop Henri Mondor, INSERM, Ctr Invest Clin 1430, Creteil, France; [Housset, Bruno; Chouaid, Christos; Maitre, Bernard] Ctr Hosp Intercommunal, Dept Pneumol & Pathol Profess, Creteil, France; [Levy, Yves; Lelievre, Jean-Daniel] Hop Henri Mondor, APHP, Dept Immunol Clin, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Boyer, L (corresponding author), Inst Mondor Rech Biomed, INSERM, U955, Creteil, France.; Boyer, L (corresponding author), Univ Paris Est UPEC, Creteil, France.; Boyer, L (corresponding author), Hop Henri Mondor, APHP, Dept Physiol Explorat Fonct, Creteil, France.	laurent.boyer@aphp.fr	le corvoisier, philippe/AAO-2862-2020; , Lelievre/AAB-1398-2020; christos, chouaid/R-4477-2018	christos, chouaid/0000-0002-4290-5524; Boyer, Laurent/0000-0002-2608-6696; Wiedemann, Aurelie/0000-0002-4224-3137; Maitre, Bernard/0000-0002-8061-1252; Lelievre, Jean-Daniel/0000-0002-8182-3628; Lacabaratz, Christine/0000-0001-6925-0225; Le Corvoisier, Philippe/0000-0003-0402-9591	Institut national de la sante et de la recherche medicale [C09-11]	Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	This study was supported by a grant from the Institut national de la sante et de la recherche medicale (C09-11).	Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Nath KD, 2014, INT J CHRONIC OBSTR, V9, P51, DOI 10.2147/COPD.S53590; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Shahid Z, 2010, VACCINE, V28, P6145, DOI 10.1016/j.vaccine.2010.07.036; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Zwaans WAR, 2014, J CLIN VIROL, V61, P181, DOI 10.1016/j.jcv.2014.06.025	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1754	+		10.1016/j.jaci.2017.07.038	http://dx.doi.org/10.1016/j.jaci.2017.07.038			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28889955	Bronze			2022-12-18	WOS:000417206000045
J	Renz, H				Renz, Harald			Autophagy: Nobel Prize 2016 and allergy and asthma research	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Autophagy	MUTANTS		[Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Baldingerstr, D-35043 Marburg, Germany	Philipps University Marburg	Renz, H (corresponding author), Philipps Univ Marburg, Inst Lab Med, Baldingerstr, D-35043 Marburg, Germany.	harald.renz@uk-gm.de						Ban GY, 2016, CLIN EXP ALLERGY, V46, P48, DOI 10.1111/cea.12585; Cao Zu, 2014, Zhonghua Jie He He Hu Xi Za Zhi, V37, P507; Cho IH, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0211-9; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Radonjic-Hoesli S, 2017, J ALLERGY CLIN IMMUN, V140, P1632, DOI 10.1016/j.jaci.2017.01.044; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; ZEKI AA, 2014, AM J RESP CRIT CARE, V189; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	13	5	6	2	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1548	1549		10.1016/j.jaci.2017.03.021	http://dx.doi.org/10.1016/j.jaci.2017.03.021			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28400114	Green Published, Bronze			2022-12-18	WOS:000417206000008
J	Ovadia, A; Schejter, YD; Grunebaum, E; Kim, VHD; Reid, B; Schechter, T; Pope, E; Roifman, CM				Ovadia, Adi; Schejter, Yael Dinur; Grunebaum, Eyal; Kim, Vy Hong-Diep; Reid, Brenda; Schechter, Tal; Pope, Elena; Roifman, Chaim M.			Hematopoietic stem cell transplantation for RelB deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANHIDROTIC ECTODERMAL DYSPLASIA; NF-KAPPA-B; NEMO MUTATION; IMMUNODEFICIENCY; DIAGNOSIS; PATHWAY; CHILD; SCT		[Ovadia, Adi; Schejter, Yael Dinur; Grunebaum, Eyal; Kim, Vy Hong-Diep; Reid, Brenda; Roifman, Chaim M.] Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Toronto, ON, Canada; [Ovadia, Adi; Schejter, Yael Dinur; Grunebaum, Eyal; Kim, Vy Hong-Diep; Reid, Brenda; Roifman, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Ovadia, Adi; Schejter, Yael Dinur; Roifman, Chaim M.] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada; [Ovadia, Adi; Schejter, Yael Dinur; Roifman, Chaim M.] Hosp Sick Children, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada; [Schechter, Tal] Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada; [Pope, Elena] Hosp Sick Children, Dermatol Paediat Med Div, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Roifman, CM (corresponding author), Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Toronto, ON, Canada.; Roifman, CM (corresponding author), Univ Toronto, Toronto, ON, Canada.; Roifman, CM (corresponding author), Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada.; Roifman, CM (corresponding author), Hosp Sick Children, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada.	chaim.roifman@sickkids.ca			Immunodeficiency Canada Distinguished Professorship in Immunology (CMR); Program for Immunogenomics; Canadian Centre for Primary Immunodeficiency; Jeffrey Modell Foundation; Immunodeficiency Canada	Immunodeficiency Canada Distinguished Professorship in Immunology (CMR); Program for Immunogenomics; Canadian Centre for Primary Immunodeficiency; Jeffrey Modell Foundation; Immunodeficiency Canada	This work was supported by the Immunodeficiency Canada Distinguished Professorship in Immunology (CMR), the Program for Immunogenomics, the Canadian Centre for Primary Immunodeficiency, the Jeffrey Modell Foundation, and Immunodeficiency Canada.	Abbott JK, 2014, BONE MARROW TRANSPL, V49, P1446, DOI 10.1038/bmt.2014.157; Arva NC, 2016, PEDIATR DEVEL PATHOL, V19, P132, DOI 10.2350/15-05-1627-CR.1; Beattie B, 2016, J ALLERGY CLIN IMMUN, V137, P1890, DOI 10.1016/j.jaci.2015.10.025; Chandrakasan S, 2017, J ALLERGY CLIN IMMUN, V139, P1040, DOI 10.1016/j.jaci.2016.08.039; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Dupuis-Girod S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e97; Dupuis-Girod S, 2006, PEDIATRICS, V118, pE205, DOI 10.1542/peds.2005-2661; Fish JD, 2009, BONE MARROW TRANSPL, V43, P217, DOI 10.1038/bmt.2008.308; Granados EL, 2008, HUM MUTAT, V29, P861, DOI 10.1002/humu.20740; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Imamura M, 2011, J CLIN IMMUNOL, V31, P802, DOI 10.1007/s10875-011-9568-9; Kawai T, 2012, BLOOD, V119, P5458, DOI 10.1182/blood-2011-05-354167; Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446; Klemann C, 2016, CLIN IMMUNOL, V164, P52, DOI 10.1016/j.clim.2016.01.010; Mancini AJ, 2008, ARCH DERMATOL, V144, P342, DOI 10.1001/archderm.144.3.342; Merico D, 2015, LYMPHOSIGN J, V2, P147, DOI DOI 10.14785/LPSN-2015-0005; Nagasawa M, 2017, J CLIN IMMUNOL, V37, P413, DOI 10.1007/s10875-017-0375-9; Paciolla M, 2015, GENES IMMUN, V16, P239, DOI 10.1038/gene.2015.3; Pai Sung-Yun, 2008, J Allergy Clin Immunol, V122, P1113, DOI 10.1016/j.jaci.2008.08.026; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Schimke LF, 2013, J CLIN IMMUNOL, V33, P1088, DOI 10.1007/s10875-013-9906-1; Sharfe N, 2015, J AUTOIMMUN, V65, P90, DOI 10.1016/j.jaut.2015.09.001; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tono C, 2007, BONE MARROW TRANSPL, V39, P801, DOI 10.1038/sj.bmt.1705658; Yoshioka T, 2013, J CLIN IMMUNOL, V33, P1165, DOI 10.1007/s10875-013-9924-z	27	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1199	+		10.1016/j.jaci.2017.05.007	http://dx.doi.org/10.1016/j.jaci.2017.05.007			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28552761	Bronze			2022-12-18	WOS:000412172900045
J	Tacquard, C; Boudjedir, K; Carlier, M; Muller, JY; Gomis, P; Mertes, PM				Tacquard, Charles; Boudjedir, Karim; Carlier, Monique; Muller, Jean-Yves; Gomis, Philippe; Mertes, Paul Michel			Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BLOOD-DONORS		[Tacquard, Charles; Mertes, Paul Michel] Nouvel Hop Civil, Hop Univ Strasbourg, Dept Anesthesia & Intens Care, Strasbourg, France; [Boudjedir, Karim] French Natl Agcy Med & Hlth Prod Safety ANSM, St Denis, Reunion, France; [Carlier, Monique] Ctr Hosp, Dept Anesthesia & Intens Care, Chalons Sur Marne, France; [Muller, Jean-Yves] Soc Francaise Transfus Sanguine, Paris, France; [Gomis, Philippe] CHU Reims, Hop Maison Blanche, Dept Anaesthesiol & Intens Care, Reims, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Reims; Universite de Reims Champagne-Ardenne	Mertes, PM (corresponding author), Nouvel Hop Civil, Hop Univ Strasbourg, Dept Anesthesia & Intens Care, Strasbourg, France.	paul-michel.mertes@chru-strasbourg.fr						Anani W, 2014, VOX SANG, V107, P389, DOI 10.1111/vox.12192; CLARK JA, 1983, AM J CLIN PATHOL, V80, P210, DOI 10.1093/ajcp/80.2.210; Comite d'hemovigilance du Quebec, 2010, QUEBECHEMOVIGILANCE; FROMMEL D, 1973, VOX SANG, V25, P513, DOI 10.1111/j.1423-0410.1973.tb03545.x; Hirayama F, 2013, BRIT J HAEMATOL, V160, P434, DOI 10.1111/bjh.12150; Sandler SG, 2015, TRANSFUSION, V55, P199, DOI 10.1111/trf.12796; Sandler SG, 2006, TRANSFUSION, V46, P10, DOI 10.1111/j.1537-2995.2006.00686.x; Steering Group, UK HEM REP 2011 2012; VYAS GN, 1968, LANCET, V2, P312	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					884	885		10.1016/j.jaci.2017.03.029	http://dx.doi.org/10.1016/j.jaci.2017.03.029			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28414063	Bronze			2022-12-18	WOS:000409241500035
J	Huo, YL; Patel, K; Scott, GB; van Dyke, RB; Siberry, GK; Burchett, SK; Shearer, WT				Huo, Yanling; Patel, Kunjal; Scott, Gwendolyn B.; van Dyke, Russell B.; Siberry, George K.; Burchett, Sandra K.; Shearer, William T.			Lymphocyte subsets in HIV-exposed uninfected infants and HIV-unexposed uninfected infants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-LYMPHOCYTES; CHILDREN; MOTHERS; TRANSMISSION; BORN		[Huo, Yanling; Patel, Kunjal] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Scott, Gwendolyn B.] Univ Miami, Miller Sch Med, Div Pediat Infect Dis & Immunol, Miami, FL 33136 USA; [van Dyke, Russell B.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Siberry, George K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Burchett, Sandra K.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Burchett, Sandra K.] Harvard Med Sch, Boston, MA USA; [Shearer, William T.] Texas Childrens Hosp, Baylor Coll Med, Dept Immunol Allergy Rheumatol, Houston, TX 77030 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; Tulane University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine	Huo, YL (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA.	yhuo@sdac.harvard.edu		Shearer, William/0000-0002-2483-2130	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); Baylor College of Medicine-University of Texas Center for AIDS Research [P1009 (AI36211)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068616, UM1AI068632, UM1AI068616, UM1AI106716] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Baylor College of Medicine-University of Texas Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under award nos. UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), and UM1AI106716 (IMPAACT LC), with cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The Baylor College of Medicine-University of Texas Center for AIDS Research provided support for P1009 (AI36211). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Afran L, 2014, CLIN EXP IMMUNOL, V176, P11, DOI 10.1111/cei.12251; Borges-Almeida E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-38; Bunders M, 2010, AIDS RES HUM RETROV, V26, P967, DOI 10.1089/aid.2009.0241; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120; Kuhn L, 2001, AIDS, V15, P1, DOI 10.1097/00002030-200101050-00003; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Ono E, 2008, BRAZ J MED BIOL RES, V41, P700, DOI 10.1590/S0100-879X2008000800011; Romano MF, 2006, VIRAL IMMUNOL, V19, P363, DOI 10.1089/vim.2006.19.363	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					605	+		10.1016/j.jaci.2017.01.033	http://dx.doi.org/10.1016/j.jaci.2017.01.033			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28279682	Green Accepted, Bronze			2022-12-18	WOS:000406855500040
J	Gavino, C; Landekic, M; Zeng, JB; Wu, N; Jung, SM; Zhong, MC; Cohen-Blanchet, A; Langelier, M; Neyret, O; Lejtenyi, D; Rochefort, C; Cotton-Montpetit, J; McCusker, C; Mazer, B; Veillette, A; Vinh, DC				Gavino, Christina; Landekic, Marija; Zeng, Jibin; Wu, Ning; Jung, Sungmi; Zhong, Ming-Chao; Cohen-Blanchet, Alexis; Langelier, Melanie; Neyret, Odile; Lejtenyi, Duncan; Rochefort, Claudia; Cotton-Montpetit, Judith; McCusker, Christine; Mazer, Bruce; Veillette, Andre; Vinh, Donald C.			Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-CELLS; ZAP-70-DEFICIENT PATIENTS; ZAP-70 DEFICIENCY; PERIPHERAL-BLOOD; ANTIGEN RECEPTOR; LYMPHOCYTES; FRAMEWORK; ABSENCE; HUMANS; GENOME		[Gavino, Christina; Landekic, Marija; Zeng, Jibin; Langelier, Melanie; Rochefort, Claudia; Vinh, Donald C.] MUHC, Infect Dis Susceptibil Program, Montreal, PQ, Canada; [Gavino, Christina; Landekic, Marija; Zeng, Jibin; Langelier, Melanie; Rochefort, Claudia; Vinh, Donald C.] RI MUHC, Montreal, PQ, Canada; [Wu, Ning; Zhong, Ming-Chao; Veillette, Andre; Vinh, Donald C.] IRCM, Lab Mol Oncol, Montreal, PQ, Canada; [Jung, Sungmi; Mazer, Bruce] MUHC, Dept Pathol, Montreal, PQ, Canada; [Cohen-Blanchet, Alexis; Neyret, Odile; Cotton-Montpetit, Judith] IRCM, Bioinformat & Mol Biol Core Facil, Montreal, PQ, Canada; [Lejtenyi, Duncan; McCusker, Christine] MUHC, Dept Pediat, Div Allergy & Clin Immunol, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Vinh, DC (corresponding author), MUHC, Infect Dis Susceptibil Program, Montreal, PQ, Canada.; Vinh, DC (corresponding author), RI MUHC, Montreal, PQ, Canada.; Vinh, DC (corresponding author), IRCM, Lab Mol Oncol, Montreal, PQ, Canada.	donald.vinh@mcgill.ca		VINH, DONALD/0000-0003-1347-7767	McGill University Health Centre (MUHC) (Department of Medicine); Research Institute-MUHC (Merck Sharpe Dohme award); CSL Behring Canada; La Fondation du Grand Defi Pierre Lavoie; Rare Disease Foundation; BC Children's Hospital Foundation; Fonds de recherche du Quebec-Sante (FRQS); Canadian Institutes of Health Research	McGill University Health Centre (MUHC) (Department of Medicine); Research Institute-MUHC (Merck Sharpe Dohme award); CSL Behring Canada; La Fondation du Grand Defi Pierre Lavoie; Rare Disease Foundation; BC Children's Hospital Foundation; Fonds de recherche du Quebec-Sante (FRQS); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by research funds from McGill University Health Centre (MUHC) (Department of Medicine), Research Institute-MUHC (Merck Sharpe & Dohme award), CSL Behring Canada, La Fondation du Grand Defi Pierre Lavoie, and the Rare Disease Foundation and the BC Children's Hospital Foundation, as well as salary support to D.C.V. from the Fonds de recherche du Quebec-Sante (FRQS). A.V. has been supported by a grant from the Canadian Institutes of Health Research and is holder of Canada Research Chair in Immune Cell Signaling.	ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chan AY, 2016, J EXP MED, V213, P155, DOI 10.1084/jem.20150888; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Elder ME, 2001, J IMMUNOL, V166, P656, DOI 10.4049/jimmunol.166.1.656; Gavino C, 2014, CLIN INFECT DIS, V59, P81, DOI 10.1093/cid/ciu215; GELFAND EW, 1995, J EXP MED, V182, P1057, DOI 10.1084/jem.182.4.1057; Honig M, 2012, BONE MARROW TRANSPL, V47, P305, DOI 10.1038/bmt.2011.71; Karaca E, 2013, GENE, V512, P189, DOI 10.1016/j.gene.2012.10.062; Katamura K, 1999, CLIN EXP IMMUNOL, V115, P124; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matsuda S, 1999, J BIOL CHEM, V274, P34515, DOI 10.1074/jbc.274.49.34515; Mazer B, 1997, CLIN IMMUNOL IMMUNOP, V84, P129, DOI 10.1006/clin.1997.4365; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meinl E, 2000, J IMMUNOL, V165, P3578, DOI 10.4049/jimmunol.165.7.3578; MONAFO WJ, 1992, CLIN EXP IMMUNOL, V90, P390; Newell A, 2011, J ALLERGY CLIN IMMUN, V127, P517, DOI 10.1016/j.jaci.2010.09.016; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; ROIFMAN CM, 1989, J EXP MED, V170, P2177, DOI 10.1084/jem.170.6.2177; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Toyabe S, 2001, IMMUNOLOGY, V103, P164, DOI 10.1046/j.1365-2567.2001.01246.x; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Vinh DC, 2011, CLIN INFECT DIS, V52, pE99, DOI 10.1093/cid/ciq215; Winkler J, 2013, THER DELIV, V4, P791, DOI [10.4155/TDE.13.47, 10.4155/tde.13.47]	33	5	5	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1688	+		10.1016/j.jaci.2017.02.002	http://dx.doi.org/10.1016/j.jaci.2017.02.002			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28216435	Bronze, Green Published			2022-12-18	WOS:000400465300034
J	Marlu, R; Deroux, A; Du-Thanh, A; Boccon-Gibod, I; Launay, D; Bouillet, L				Marlu, Raphael; Deroux, Alban; Du-Thanh, Aurelie; Boccon-Gibod, Isabelle; Launay, David; Bouillet, Laurence			Normal PAI-2 level in French FXII-HAE patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACTIVATOR INHIBITOR TYPE-2		[Marlu, Raphael] Univ Hosp, Hemostasis Unit, Grenoble, France; [Deroux, Alban; Boccon-Gibod, Isabelle; Bouillet, Laurence] Univ Hosp, Internal Med Med Dept, Grenoble, France; [Du-Thanh, Aurelie] Univ Hosp, Dept Dermatol, Montpellier, France; [Launay, David] Univ Hosp, Internal Med Med Dept, Lille, France; [Marlu, Raphael; Deroux, Alban; Du-Thanh, Aurelie; Boccon-Gibod, Isabelle; Launay, David; Bouillet, Laurence] French Natl Reference Ctr Angioedema CREAK, Grenoble, France	CHU Grenoble Alpes; CHU Grenoble Alpes; Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille	Bouillet, L (corresponding author), Univ Hosp, Internal Med Med Dept, Grenoble, France.; Bouillet, L (corresponding author), French Natl Reference Ctr Angioedema CREAK, Grenoble, France.	lbouillet@chu-grenoble.fr	Launay, David/H-1674-2016; DEROUX, Alban/AGN-3318-2022; Launay, David/A-5270-2018; Marlu, Raphael/M-7680-2014	Launay, David/0000-0003-1840-1817; DEROUX, Alban/0000-0002-9098-7368; Launay, David/0000-0003-1840-1817; Bouillet, laurence/0000-0001-8245-4767; Du-Thanh, Aurelie/0000-0003-1508-1977; Marlu, Raphael/0000-0002-3462-2006; boccon-gibod, isabelle/0000-0002-5774-8429				Joseph K, 2016, J ALLERGY CLIN IMMUN, V137, P1822, DOI 10.1016/j.jaci.2015.07.041; Li X, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0150-y; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810	4	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1719	1720		10.1016/j.jaci.2016.12.982	http://dx.doi.org/10.1016/j.jaci.2016.12.982			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28318558	Bronze			2022-12-18	WOS:000400465300047
J	Das, M; Galeotti, C; Stephen-Victor, E; Karnam, A; Kaveri, SV; Bayry, J				Das, Mrinmoy; Galeotti, Caroline; Stephen-Victor, Emmanuel; Karnam, Anupama; Kaveri, Srini V.; Bayry, Jagadeesh			Human basophils may not undergo modulation by DC-SIGN and mannose receptor-targeting immunotherapies due to absence of receptors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS; LIGAND		[Das, Mrinmoy; Galeotti, Caroline; Stephen-Victor, Emmanuel; Karnam, Anupama; Kaveri, Srini V.; Bayry, Jagadeesh] Inst Natl Sante & Rech Med, Unite 1138, Paris, France; [Das, Mrinmoy; Galeotti, Caroline; Stephen-Victor, Emmanuel; Karnam, Anupama; Kaveri, Srini V.; Bayry, Jagadeesh] Sorbonne Univ, UPMC Univ Paris 06, UMR S 1138, Paris, France; [Das, Mrinmoy; Galeotti, Caroline; Stephen-Victor, Emmanuel; Karnam, Anupama; Kaveri, Srini V.; Bayry, Jagadeesh] Ctr Rech Cordeliers, Equipe Immunopathol & Immuno Intervent therapeut, Paris, France; [Galeotti, Caroline] CHU Bicetre, Natl Referral Ctr Auto Inflammatory Dis, Dept Pediat Rheumatol, Le Kremlin Bicetre, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bayry, J (corresponding author), Inst Natl Sante & Rech Med, Unite 1138, Paris, France.; Bayry, J (corresponding author), Sorbonne Univ, UPMC Univ Paris 06, UMR S 1138, Paris, France.; Bayry, J (corresponding author), Ctr Rech Cordeliers, Equipe Immunopathol & Immuno Intervent therapeut, Paris, France.; Bayry, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Paris, France.	jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011; Das, Mrinmoy/AAS-5750-2021; Stephen Victor, Emmanuel/HDN-0252-2022	Bayry, Jagadeesh/0000-0003-0498-9808; Das, Mrinmoy/0000-0002-5785-5697; Stephen Victor, Emmanuel/0000-0001-5049-7017; Kaveri, Srini/0000-0002-0837-4053	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie; Universite Paris Descartes; CSL Behring, Switzerland; La Fondation pour la Recherche Medicale, France [FDM20150633674]; Indo-French Center for Promotion of Advanced Research	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Universite Paris Descartes; CSL Behring, Switzerland; La Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); Indo-French Center for Promotion of Advanced Research	This study was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Pierre et Marie Curie, Universite Paris Descartes, and CSL Behring, Switzerland. C.G. is a recipient of fellowship from La Fondation pour la Recherche Medicale (FDM20150633674), France, and E.S.-V. and A.K. are recipients of fellowships from the Indo-French Center for Promotion of Advanced Research.	Bates EEM, 1999, J IMMUNOL, V163, P1973; Divekar A, 2012, J IMMUNOL, V188; Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092; Oettgen HC, 2016, J ALLERGY CLIN IMMUN, V137, P1631, DOI 10.1016/j.jaci.2016.04.009; Sirvent S, 2016, J ALLERGY CLIN IMMUN, V138, P558, DOI 10.1016/j.jaci.2016.02.029; Suurmond J, 2014, EUR J IMMUNOL, V44, P386, DOI 10.1002/eji.201343617; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427	7	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1403	+		10.1016/j.jaci.2016.09.062	http://dx.doi.org/10.1016/j.jaci.2016.09.062			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	28088336	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000398771800043
J	Hershko, AY				Hershko, Alon Y.			Insights into the mast cell-microbiome connection in the skin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Mast cell; skin microbiome; lipoteichoic acid; stem cell factor; Toll-like receptor 2	DERMATITIS; TOLERANCE		[Hershko, Alon Y.] Meir Med Ctr, Dept Med, Lab Allergy & Clin Immunol, Kefar Sava, Israel; [Hershko, Alon Y.] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Hershko, AY (corresponding author), Meir Med Ctr, Dept Med, IL-44281 Kefar Sava, Israel.	alon.hershko@clalit.org.il						Chen YE, 2013, J AM ACAD DERMATOL, V69, P143, DOI 10.1016/j.jaad.2013.01.016; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019; Wang ZP, 2012, J IMMUNOL, V189, P1551, DOI 10.4049/jimmunol.1200471; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424	10	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1137	1139		10.1016/j.jaci.2016.11.016	http://dx.doi.org/10.1016/j.jaci.2016.11.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	28087228	Bronze			2022-12-18	WOS:000398771800008
J	Casavecchia, G; Gravina, M; Correale, M; Totaro, A; Macarini, L; Di Biase, M; Brunetti, ND				Casavecchia, Grazia; Gravina, Matteo; Correale, Michele; Totaro, Antonio; Macarini, Luca; Di Biase, Matteo; Brunetti, Natale Daniele			Cardiac magnetic resonance imaging for the diagnosis and follow-up of Loeffler's endocarditis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ENDOMYOCARDIAL DISEASE		[Casavecchia, Grazia; Correale, Michele] Univ Foggia, Dept Cardiol, Foggia, Italy; [Gravina, Matteo] Univ Foggia, Dept Radiol, Foggia, Italy; [Totaro, Antonio; Macarini, Luca; Di Biase, Matteo; Brunetti, Natale Daniele] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy	University of Foggia; University of Foggia; University of Foggia	Brunetti, ND (corresponding author), Univ Foggia, Dept Med & Surg Sci, Foggia, Italy.	natale.brunetti@unifg.it	Totaro, Antonio/AAW-3879-2020; Totaro, Antonio/GNW-4036-2022; Correale, Michele/R-3080-2019; Brunetti, Natale Daniele/S-9131-2019	Totaro, Antonio/0000-0003-4333-0782; Brunetti, Natale Daniele/0000-0001-9610-7408; CORREALE, MICHELE/0000-0002-7863-253X				Deb K, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-21; FELICE PV, 1993, ANGIOLOGY, V44, P869, DOI 10.1177/000331979304401104; Ichikawa Y, 2003, J CARDIOVASC MAGN R, V5, P333, DOI 10.1081/JCMR-120019422; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Pillar N, 2012, CAN J CARDIOL, V28, DOI 10.1016/j.cjca.2012.01.003; Salanitri GC, 2005, AM J ROENTGENOL, V184, P1432, DOI 10.2214/ajr.184.5.01841432; Stirrat J, 2013, CAN J CARDIOL, V29, P329, DOI 10.1016/j.cjca.2012.11.033; Syed IS, 2008, INT J CARDIOL, V126, pE50, DOI 10.1016/j.ijcard.2007.01.019; Vogelsberg H, 2008, J AM COLL CARDIOL, V51, P1022, DOI 10.1016/j.jacc.2007.10.049	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1055	1057		10.1016/j.jaci.2016.07.044	http://dx.doi.org/10.1016/j.jaci.2016.07.044			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27746234	Bronze			2022-12-18	WOS:000397295800045
J	Chandrakasan, S; Marsh, RA; Uzel, G; Holland, SM; Shah, KN; Bleesing, J				Chandrakasan, Shanmuganathan; Marsh, Rebecca A.; Uzel, Gulbu; Holland, Steven M.; Shah, Kara N.; Bleesing, Jack			Outcome of patients with NEMO deficiency following allogeneic hematopoietic cell transplant	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CORD BLOOD TRANSPLANTATION; ECTODERMAL DYSPLASIA; MUTATION; IMMUNODEFICIENCY		[Chandrakasan, Shanmuganathan] Emory Univ, Aflac Canc & Blood Disorder Ctr, Sch Med, Dept Pediat,Div Bone Marrow Transplantat, Atlanta, GA 30322 USA; [Marsh, Rebecca A.; Bleesing, Jack] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Def, Cincinnati, OH 45229 USA; [Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shah, Kara N.] Cincinnati Childrens Hosp Med Ctr, Div Dermatol, Cincinnati, OH 45229 USA	Emory University; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cincinnati Children's Hospital Medical Center	Chandrakasan, S (corresponding author), Emory Univ, Aflac Canc & Blood Disorder Ctr, Sch Med, Dept Pediat,Div Bone Marrow Transplantat, Atlanta, GA 30322 USA.	Shanmuganathan.chandrakasan@emory.edu	Shah, Kara/AAC-9512-2020; Chandrakasan, Shanmuganathan/AAM-3430-2020	chandrakasan, shanmuganathan/0000-0001-8007-9932	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Abbott JK, 2014, BONE MARROW TRANSPL, V49, P1446, DOI 10.1038/bmt.2014.157; Beattie B, 2016, J ALLERGY CLIN IMMUN, V137, P1890, DOI 10.1016/j.jaci.2015.10.025; Fish JD, 2009, BONE MARROW TRANSPL, V43, P217, DOI 10.1038/bmt.2008.308; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Horwitz ME, 2003, BLOOD, V102, P2692, DOI 10.1182/blood-2003-04-1268; Imamura M, 2011, J CLIN IMMUNOL, V31, P802, DOI 10.1007/s10875-011-9568-9; Minakawa S, 2009, CLIN EXP DERMATOL, V34, pe441, DOI 10.1111/j.1365-2230.2009.03473.x; Pai Sung-Yun, 2008, J Allergy Clin Immunol, V122, P1113, DOI 10.1016/j.jaci.2008.08.026; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Tono C, 2007, BONE MARROW TRANSPL, V39, P801, DOI 10.1038/sj.bmt.1705658	10	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1040	1043		10.1016/j.jaci.2016.08.039	http://dx.doi.org/10.1016/j.jaci.2016.08.039			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27744027	Bronze			2022-12-18	WOS:000397295800040
J	Jakob, T; Spillner, E				Jakob, Thilo; Spillner, Edzard			Comparing sensitivity of Hymenoptera allergen components on different diagnostic assay systems: Comparing apples and oranges?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VENOM ALLERGY; BEE		[Jakob, Thilo] Justus Liebig Univ Giessen, Univ Med Ctr Giessen & Marburg, Dept Dermatol & Allergol, Camous Giessen, Giessen, Germany; [Jakob, Thilo] Univ Med Cntr Freiburg, Dept Dermatol, Allergy Res Grp, Freiburg, Germany; [Spillner, Edzard] Aarhus Univ, Immunol Engn, Dept Engn, Aarhus, Denmark	Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University of Freiburg; Aarhus University	Jakob, T (corresponding author), Justus Liebig Univ Giessen, Univ Med Ctr Giessen & Marburg, Dept Dermatol & Allergol, Camous Giessen, Giessen, Germany.; Jakob, T (corresponding author), Univ Med Cntr Freiburg, Dept Dermatol, Allergy Res Grp, Freiburg, Germany.	thilo.jakob@derma.med.uni-giessen.de		spillner, edzard/0000-0003-0999-5254	Thermo Fisher Scientific; ALK-Abello; Allergy Therapeutics; Novartis; Allergopharma; Stallergenes	Thermo Fisher Scientific; ALK-Abello; Allergy Therapeutics; Novartis(Novartis); Allergopharma; Stallergenes	T. Jakob has received a grant, consulting fees, and travel support from Thermo Fisher Scientific; has a board membership with the German Society of Allergy and Clinical Immunology; has consultant arrangements with ALK-Abello, Allergy Therapeutics, Novartis, Leti GmbH, Stallergenes, and Allergopharma; is editor of Allergo Journal International; and has received payment for lectures from ALK-Abello, Allergy Therapeutics, Novartis, Allergopharma, Stallergenes, and Thermo Fisher Scientific. E. Spillner declares no relevant conflicts of interest.	Jakob T, 2012, J ALLERGY CLIN IMMUN, V130, P276, DOI 10.1016/j.jaci.2012.03.048; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Sato K., 2010, JPN J MED TECHNOL, V59, P929; Schrautzer C, 2016, J ALLERGY CLIN IMMUN, V137, P1603, DOI 10.1016/j.jaci.2015.10.041; Selb J, 2016, CLIN EXP ALLERGY, V46, P621, DOI 10.1111/cea.12639; Szecsi PB, 2013, INT ARCH ALLERGY IMM, V162, P33, DOI 10.1159/000353276; Wood RA, 2007, ANN ALLERG ASTHMA IM, V99, P34, DOI 10.1016/S1081-1206(10)60618-7	7	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1066	1067		10.1016/j.jaci.2016.09.058	http://dx.doi.org/10.1016/j.jaci.2016.09.058			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	28062118	Bronze			2022-12-18	WOS:000397295800051
J	Djupesland, PG; Messina, J; Mahmoud, R				Djupesland, Per G.; Messina, John, Jr.; Mahmoud, Ramy			New Exhalation Delivery Systems (EDS) Enhance Topical Steroid Delivery In Chronic Rhinosinusitis With Nasal Polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Djupesland, Per G.] OptiNose, Oslo, Norway; [Messina, John, Jr.; Mahmoud, Ramy] OptiNose, Yardley, PA USA										0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		206	AB65	AB65		10.1016/j.jaci.2016.12.260	http://dx.doi.org/10.1016/j.jaci.2016.12.260			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF					2022-12-18	WOS:000401699800109
J	Jose, J; Ishmael, FT				Jose, Jaison; Ishmael, Faoud Terrence			A Drug Allergy Education Handout Is an Easy and Effective Method to Improve Patient Awareness of Penicillin Allergy and Increase Penicillin Testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Jose, Jaison] Penn State Milton S Hershey Med Ctr, Hershey, PA USA; [Ishmael, Faoud Terrence] Penn State Hershey Med Ctr, Palmyra, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health									0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		98	AB29	AB29		10.1016/j.jaci.2016.12.053	http://dx.doi.org/10.1016/j.jaci.2016.12.053			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EO8NM		Bronze			2022-12-18	WOS:000396946000099
J	Litonjua, AA; Weiss, ST				Litonjua, Augusto A.; Weiss, Scott T.			Vitamin D status through the first 10 years of life: A vital piece of the puzzle in asthma inception	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; childhood; vitamin D; incidence; prevention	RANDOMIZED CLINICAL-TRIAL; D DEFICIENCY; SUPPLEMENTATION; DISEASE; RISK		[Litonjua, Augusto A.; Weiss, Scott T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Litonjua, AA (corresponding author), Brigham & Womens Hosp, Dept Med, 181 Longwood Ave, Boston, MA 02130 USA.	augusto.litonjua@channing.harvard.edu			National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [HL091528]; NIH [1UG3OD023268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091528, U01HL091528] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023268] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute grant HL091528 and NIH grant 1UG3OD023268.	Cantorna MT, 2014, EXP BIOL MED, V239, P1524, DOI 10.1177/1535370214523890; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Deluca Hector F, 2014, Bonekey Rep, V3, P479, DOI 10.1038/bonekey.2013.213; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Hollams EM, 2017, J ALLERGY CLIN IMMUN, V139, P472, DOI 10.1016/j.jaci.2016.07.032; Lasky-Su J, 2012, HUM GENET, V131, P1495, DOI 10.1007/s00439-012-1185-z; LITONJUA AA, 2012, VITAMIN D LUNG MECH; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Litonjua AA, 2012, CURR OPIN ALLERGY CL, V12, P179, DOI 10.1097/ACI.0b013e3283507927; Rappaport BZ, 1934, J ALLERGY, V5, P541, DOI [DOI 10.1016/S0021-8707(34)90130-1, 10.1016/S0021-8707(34)90130-1]; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sordillo JE, 2016, J ALLERGY CLIN IMMUN; Wei R, 2015, NUTRIENTS, V7, P8251, DOI 10.3390/nu7105392; Weiss ST, 2016, EXPERT REV RESP MED, V10, P1039, DOI 10.1080/17476348.2016.1227257; Weiss ST, 2015, THORAX, V70, P919, DOI 10.1136/thoraxjnl-2015-207334; Wolsk HM, 2016, AM THOR SOC INT C 20	17	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					459	461		10.1016/j.jaci.2016.11.019	http://dx.doi.org/10.1016/j.jaci.2016.11.019			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27993535	Green Accepted, Bronze			2022-12-18	WOS:000397002400011
J	Naclerio, RM; Hamilos, DL; Ferguson, BJ; Bachert, C; Hellings, PW; Mullol, J; Gevaert, P; Zhang, D; Khan, A; Fan, CP; Joish, VN; Amin, N; Pirozzi, G; Graham, NM; Staudinger, HW; Grabher, A; Mannent, L				Naclerio, Robert M.; Hamilos, Daniel L.; Ferguson, Berrylin J.; Bachert, Claus; Hellings, Peter W.; Mullol, Joaquim; Gevaert, Philippe; Zhang, Donghui; Khan, Asif; Fan, Chunpeng; Joish, Vijay N.; Amin, Nikhil; Pirozzi, Gianluca; Graham, Neil Mh.; Staudinger, Heribert W.; Grabher, Annette; Mannent, Leda			Dupilumab Improves Sense of Smell and Reduces Anosmia Among Patients with Nasal Polyposis and Chronic Sinusitis: Results from a Phase 2a Trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Naclerio, Robert M.] Univ Chicago, Chicago, IL 60637 USA; [Hamilos, Daniel L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ferguson, Berrylin J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Bachert, Claus; Gevaert, Philippe] Ghent Univ Hosp, Ghent, Belgium; [Hellings, Peter W.] Univ Hosp Leuven, Leuven, Belgium; [Mullol, Joaquim] Hosp Clin IDIBAPS, Barcelona, Catalonia, Spain; [Zhang, Donghui; Fan, Chunpeng; Staudinger, Heribert W.] Sanofi R&D, Bridgewater, NJ USA; [Khan, Asif; Mannent, Leda] Sanofi R&D, Chilly Mazarin, France; [Joish, Vijay N.; Amin, Nikhil] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Graham, Neil Mh.] Regeneron Pharmaceut, Tarrytown, NY USA; [Grabher, Annette] Sanofi R&D, Berlin, Germany	University of Chicago; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Regeneron; Regeneron; Sanofi-Aventis			Khan, Asif H/GRJ-1775-2022; Hellings, Peter W/I-4068-2018; Gevaert, Philippe/AAP-1892-2020; Bachert, Claus/J-8825-2012; Gevaert, Philippe/ABA-4588-2021	Khan, Asif H/0000-0001-9158-0116; Hellings, Peter W/0000-0001-6898-688X; Gevaert, Philippe/0000-0002-1629-8468; 					0	5	7	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		286	AB90	AB90		10.1016/j.jaci.2016.12.245	http://dx.doi.org/10.1016/j.jaci.2016.12.245			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF					2022-12-18	WOS:000401699800189
J	Sly, PD; Varghese, J; Noor, F; Tang, MLK; Laing, I; Oo, S; Prastanti, F; LeSouef, PN; Holt, PG				Sly, Peter D.; Varghese, Julie; Noor, Farhana; Tang, Mimi L. K.; Laing, Ingrid; Oo, Steve; Prastanti, Franciska; LeSouef, Peter N.; Holt, Patrick G.			Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CLINICAL-PRACTICE; CHILDREN		[Sly, Peter D.; Varghese, Julie; Noor, Farhana] Univ Queensland, Childrens Hlth Queensland, Brisbane, Qld, Australia; [Sly, Peter D.; Varghese, Julie; Noor, Farhana] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Tang, Mimi L. K.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Laing, Ingrid; Prastanti, Franciska; Holt, Patrick G.] Telethon Kids Inst, Perth, WA, Australia; [Laing, Ingrid; Oo, Steve; Prastanti, Franciska; LeSouef, Peter N.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [Oo, Steve; Holt, Patrick G.] Princess Margaret Hosp, Resp & Sleep Dept, Perth, WA, Australia	University of Queensland; University of Queensland; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Telethon Kids Institute; University of Western Australia; University of Western Australia	Sly, PD (corresponding author), Univ Queensland, Childrens Hlth Queensland, Brisbane, Qld, Australia.; Sly, PD (corresponding author), Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia.	p.sly@uq.edu.au	Le Souef, Peter N/H-5256-2014; Laing, Ingrid/I-7092-2013; Tang, Mimi/ABD-8350-2020; Sly, Peter D/F-1486-2010; Holt, Patrick/H-1548-2011	Laing, Ingrid/0000-0002-1641-9899; Tang, Mimi/0000-0002-3839-5293; Sly, Peter D/0000-0001-6305-2201; Le Souef, Peter/0000-0003-0930-1654; Holt, Patrick/0000-0003-1193-0935				Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008	9	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					703	+		10.1016/j.jaci.2016.07.035	http://dx.doi.org/10.1016/j.jaci.2016.07.035			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27637383	Bronze			2022-12-18	WOS:000397002400042
J	Soteres, DF; Messina, J; Carothers, J; Mahmoud, R; Djupesland, PG				Soteres, Daniel F.; Messina, John, Jr.; Carothers, Jennifer; Mahmoud, Ramy; Djupesland, Per G.			NAVIGATE I: A Randomized Double-Blind Trial of a Fluticasone Propionate Exhalation Delivery System (FLU-EDS) for Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Soteres, Daniel F.] Asthma & Allergy Associates PC, Colorado Springs, CO USA; [Messina, John, Jr.; Carothers, Jennifer; Mahmoud, Ramy] OptiNose, Yardley, PA USA; [Djupesland, Per G.] OptiNose, Oslo, Norway										0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		208	AB66	AB66		10.1016/j.jaci.2016.12.262	http://dx.doi.org/10.1016/j.jaci.2016.12.262			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800111
J	Tashkin, DP; Kim, HJ; Zeidler, M; Kleerup, E; Goldin, J				Tashkin, Donald P.; Kim, Hyun J.; Zeidler, Michelle; Kleerup, Eric; Goldin, Jonathan			Evaluating small-airways disease in asthmatic patients: The utility of quantitative computed tomography	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Quantitative computed tomography; small airways; asthma; air trapping; methacholine challenge	CT		[Tashkin, Donald P.; Zeidler, Michelle; Kleerup, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Kim, Hyun J.; Goldin, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tashkin, DP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	dtashkin@mednet.ucla.edu		Goldin, Jonathan/0000-0003-3007-9947	US Public Health Service grant [R01 HL080343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080343] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by a US Public Health Service grant (R01 HL080343).	Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Goldin JG, 1998, RADIOLOGY, V208, P321, DOI 10.1148/radiology.208.2.9680554; Gono H, 2003, EUR RESPIR J, V22, P965, DOI 10.1183/09031936.03.00085302; Hartley R, 2015, EXPERT REV CLIN IMMU, V11, P1147, DOI 10.1586/1744666X.2015.1072049; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; STERN EJ, 1995, AM J ROENTGENOL, V165, P813, DOI 10.2214/ajr.165.4.7676972; Tunon-de-Lara JM, 2007, J ALLERGY CLIN IMMUN, V119, P583, DOI 10.1016/j.jaci.2006.11.005; Ueda T, 2006, J ALLERGY CLIN IMMUN, V118, P1019, DOI 10.1016/j.jaci.2006.07.032; Zeidler MR, 2006, J ALLERGY CLIN IMMUN, V118, P1075, DOI 10.1016/j.jaci.2006.06.042; Zeidler MR, 2006, EUR RESPIR J, V27, P307, DOI 10.1183/09031936.06.00005605	11	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					49	+		10.1016/j.jaci.2016.11.010	http://dx.doi.org/10.1016/j.jaci.2016.11.010			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	27884601	Bronze			2022-12-18	WOS:000393996800005
J	Mannurita, SC; Vignoli, M; Colarusso, G; Tucci, F; Veltroni, M; Frenos, S; Tintori, V; Arico, M; Bigley, V; Collin, M; Favre, C; Gambineri, E				Mannurita, Sara Ciullini; Vignoli, Marina; Colarusso, Gloria; Tucci, Fabio; Veltroni, Marinella; Frenos, Stefano; Tintori, Veronica; Arico, Maurizio; Bigley, Venetia; Collin, Matthew; Favre, Claudio; Gambineri, Eleonora			Timely follow-up of a GATA2 deficiency patient allows successful treatment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MYELOID-LEUKEMIA; MYELODYSPLASIA; MUTATIONS		[Mannurita, Sara Ciullini; Vignoli, Marina; Colarusso, Gloria; Gambineri, Eleonora] Univ Florence, Dept NEUROFARBA, Sect Childs Hlth, Florence, Italy; [Tucci, Fabio; Veltroni, Marinella; Frenos, Stefano; Tintori, Veronica; Arico, Maurizio; Gambineri, Eleonora] Anna Meyer Childrens Hos, Dept Hematol Oncol, Florence, Italy; [Bigley, Venetia; Collin, Matthew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Florence; Newcastle University - UK	Gambineri, E (corresponding author), Univ Florence, Dept NEUROFARBA, Sect Childs Hlth, Florence, Italy.; Gambineri, E (corresponding author), Anna Meyer Childrens Hos, Dept Hematol Oncol, Florence, Italy.	eleonora.gambineri@unifi.it	Bigley, Venetia/AAU-9738-2020; Gambineri, Eleonora/J-8747-2016; Mannurita, Sara Ciullini/AAA-5395-2019; Arico, Maurizio/S-3039-2019	Bigley, Venetia/0000-0002-3017-2474; Gambineri, Eleonora/0000-0002-4676-6541; Mannurita, Sara Ciullini/0000-0002-4498-6209; Arico, Maurizio/0000-0002-1908-6671				Collin M, 2015, BRIT J HAEMATOL, V169, P173, DOI 10.1111/bjh.13317; de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Grossman J, 2014, BIOL BLOOD MARROW TR, V20, P1940, DOI 10.1016/j.bbmt.2014.08.004; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Hsu AP, 2015, CURR OPIN ALLERGY CL, V15, P104, DOI 10.1097/ACI.0000000000000126; Mir MA, 2015, CANCER MED-US, V4, P490, DOI 10.1002/cam4.384; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528	11	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1480	+		10.1016/j.jaci.2016.06.004	http://dx.doi.org/10.1016/j.jaci.2016.06.004			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27481672	Bronze			2022-12-18	WOS:000389542700039
J	Horner, CC; Dula, C; Bacharier, LB; Garbutt, JM; Gonzalez, C; Deych, E; Shannon, WD; Strunk, RC				Horner, Caroline C.; Dula, Courtney; Bacharier, Leonard B.; Garbutt, Jane M.; Gonzalez, Carlos; Deych, Elena; Shannon, William D.; Strunk, Robert C.			Daily global stress is associated with nocturnal asthma awakenings in school-age children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MORBIDITY		[Horner, Caroline C.; Bacharier, Leonard B.; Garbutt, Jane M.; Strunk, Robert C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Horner, Caroline C.; Bacharier, Leonard B.; Garbutt, Jane M.; Strunk, Robert C.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Dula, Courtney] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Garbutt, Jane M.; Gonzalez, Carlos; Deych, Elena; Shannon, William D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Horner, CC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; Horner, CC (corresponding author), St Louis Childrens Hosp, St Louis, MO 63178 USA.	horner_k@kids.wustl.edu		Bacharier, Leonard/0000-0003-0432-2704	NCATS NIH HHS [UL1 TR002345, UL1 TR000448] Funding Source: Medline; NCRR NIH HHS [UL1 RR024992] Funding Source: Medline; NHLBI NIH HHS [L40 HL110190] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Busse WW, 2012, CHEM IMMUNOL ALLERGY, V98, P14, DOI 10.1159/000336495; Horner CC, 2011, J ALLERGY CLIN IMMUN, V128, P977, DOI 10.1016/j.jaci.2011.07.018; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Reynolds CR, 2008, REVISED CHILDRENS MA, V2nd; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Theoharides TC, 2012, ANN ALLERG ASTHMA IM, V109, P14, DOI 10.1016/j.anai.2012.03.003; Varni JW, 1996, J BEHAV MED, V19, P515, DOI 10.1007/BF01904901; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625	9	5	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1196	1199		10.1016/j.jaci.2016.01.054	http://dx.doi.org/10.1016/j.jaci.2016.01.054			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27246525	Green Accepted, Bronze			2022-12-18	WOS:000385499400028
J	Grunebaum, E; Kim, VHD; Somers, GR; Shammas, A; Roifman, CM				Grunebaum, Eyal; Kim, Vy Hong-Diep; Somers, Gino R.; Shammas, Amer; Roifman, Chaim M.			Bone marrow transplantation for monoallelic signal transducer and activator of transcription 1 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC MUCOCUTANEOUS CANDIDIASIS; FUNCTION STAT1 MUTATIONS		[Grunebaum, Eyal; Kim, Vy Hong-Diep; Roifman, Chaim M.] Dept Pediat, Div Immunol & Allergy, Toronto, ON, Canada; [Grunebaum, Eyal; Kim, Vy Hong-Diep; Somers, Gino R.; Shammas, Amer; Roifman, Chaim M.] Hosp Sick Children, Toronto, ON, Canada; [Grunebaum, Eyal; Kim, Vy Hong-Diep; Somers, Gino R.; Shammas, Amer; Roifman, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Somers, Gino R.] Dept Pediat Lab Med, Div Pathol, Toronto, ON, Canada; [Shammas, Amer] Dept Diagnost Imaging, Div Nucl Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Grunebaum, E (corresponding author), Dept Pediat, Div Immunol & Allergy, Toronto, ON, Canada.; Grunebaum, E (corresponding author), Hosp Sick Children, Toronto, ON, Canada.; Grunebaum, E (corresponding author), Univ Toronto, Toronto, ON, Canada.	eyal.grunebaum@sickkids.ca		Grunebaum, Eyal/0000-0002-2586-6391				Atkinson A, 2008, J ALLERGY CLIN IMMUN, V122, P1215, DOI 10.1016/j.jaci.2008.06.023; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Aldave JC, 2013, J CLIN IMMUNOL, V33, P1273, DOI 10.1007/s10875-013-9947-5; Dalal, 2014, LYMPHOSIGN J, V1, P97; Grunebaum E, 2006, JAMA-J AM MED ASSOC, V295, P508, DOI 10.1001/jama.295.5.508; Hoh MC, 1996, BONE MARROW TRANSPL, V18, P797; Naqvi, 2014, LYMPHOSIGN J, V1, P87, DOI DOI 10.14785/LPSN-2014-0004; Roifman, 2014, LYMPHOSIGN J, V1, P57; Sharfe N, 2014, J ALLERGY CLIN IMMUN, V133, P807, DOI 10.1016/j.jaci.2013.09.032; Soltesz B, 2013, J MED GENET, V50, P567, DOI 10.1136/jmedgenet-2013-101570; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054	12	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					612	615		10.1016/j.jaci.2016.02.009	http://dx.doi.org/10.1016/j.jaci.2016.02.009			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27061251	Bronze			2022-12-18	WOS:000380835800042
J	Khan, S; Kuruvilla, M; Hagin, D; Wakeland, B; Liang, CY; Vishwanathan, K; Gatti, RA; Torgersen, TR; Abraham, RS; Wakeland, EK; van Oers, NSC; de la Morena, MT				Khan, Shaheen; Kuruvilla, Merin; Hagin, David; Wakeland, Benjamin; Liang, Chaoying; Vishwanathan, Kasthuribhai; Gatti, Richard A.; Torgersen, Troy R.; Abraham, Roshini S.; Wakeland, Edward K.; van Oers, Nicolai S. C.; de la Morena, M. Teresa			RNA sequencing reveals the consequences of a novel insertion in dedicator of cytokinesis-8	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOCK8; IMMUNODEFICIENCY		[Khan, Shaheen; Wakeland, Benjamin; Liang, Chaoying; Vishwanathan, Kasthuribhai; Wakeland, Edward K.; van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr, Dept Immunol, Dallas, TX USA; [Kuruvilla, Merin; de la Morena, M. Teresa] Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.; de la Morena, M. Teresa] Univ Texas Southwestern Med Ctr, Dept Pediat, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr, Dept Microbiol, Dallas, TX USA; [Kuruvilla, Merin; de la Morena, M. Teresa] Univ Texas Southwestern Med Ctr, Div Allergy & Immunol, Dallas, TX 75390 USA; [Hagin, David; Torgersen, Troy R.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Gatti, Richard A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Gatti, Richard A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Abraham, Roshini S.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [de la Morena, M. Teresa] Childrens Heath, Childrens Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Seattle Children's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mayo Clinic	de la Morena, MT (corresponding author), Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.; de la Morena, MT (corresponding author), Univ Texas Southwestern Med Ctr, Dept Pediat, Dallas, TX 75390 USA.; de la Morena, MT (corresponding author), Univ Texas Southwestern Med Ctr, Div Allergy & Immunol, Dallas, TX 75390 USA.; de la Morena, MT (corresponding author), Childrens Heath, Childrens Med Ctr, Dallas, TX 75235 USA.	maite.delamorena@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021; Kuruvilla, Merin/AAH-8832-2019; Hagin, David/GRS-3442-2022	van Oers, Nicolai/0000-0002-6545-8405; Khan, Shaheen/0000-0002-1472-8129				Al-Herz W, 2012, CLIN IMMUNOL, V143, P266, DOI 10.1016/j.clim.2012.03.002; Alsum Z, 2013, J CLIN IMMUNOL, V33, P55, DOI 10.1007/s10875-012-9769-x; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Dinwiddie DL, 2013, J ALLERGY CLIN IMMUN, V131, P594, DOI 10.1016/j.jaci.2012.10.062; Engelhardt KR, 2015, J ALLERGY CLIN IMMUN, V136, P402, DOI 10.1016/j.jaci.2014.12.1945; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Jing H, 2014, J ALLERGY CLIN IMMUN, V133, P1667, DOI 10.1016/j.jaci.2014.03.025; Sanal O, 2012, J CLIN IMMUNOL, V32, P698, DOI 10.1007/s10875-012-9664-5; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					289	292		10.1016/j.jaci.2015.11.033	http://dx.doi.org/10.1016/j.jaci.2015.11.033			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26883462	Bronze			2022-12-18	WOS:000379659100034
J	Lukkarinen, M; Jartti, T				Lukkarinen, Minna; Jartti, Tuomas			The first rhinovirus-wheeze acts as a marker for later asthma in hig-hrisk children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EARLY-LIFE; PREDNISOLONE; EPISODE		[Lukkarinen, Minna; Jartti, Tuomas] Univ Turku, Dept Pediat, Turku, Finland; [Lukkarinen, Minna; Jartti, Tuomas] Turku Univ Hosp, Turku, Finland	University of Turku; University of Turku	Lukkarinen, M (corresponding author), Univ Turku, Dept Pediat, Turku, Finland.; Lukkarinen, M (corresponding author), Turku Univ Hosp, Turku, Finland.	mimapo@utu.fi						Bonnelykke K, 2015, J ALLERGY CLIN IMMUN, V136, P81, DOI 10.1016/j.jaci.2015.02.024; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jartti T, 2015, J ALLERGY CLIN IMMUN, V135, P691, DOI 10.1016/j.jaci.2014.07.001; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Kusel MMH, 2012, EUR RESPIR J, V39, P876, DOI 10.1183/09031936.00193310; Lukkarinen M, 2013, PEDIAT ALLERG IMM-UK, V24, P237, DOI 10.1111/pai.12046; Turunen R, 2014, PEDIAT ALLERG IMM-UK, V25, P796, DOI 10.1111/pai.12318	7	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1								10.1016/j.jaci.2016.01.040	http://dx.doi.org/10.1016/j.jaci.2016.01.040			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	27084406				2022-12-18	WOS:000379659100043
J	Reid, B; Girodet, PO; Boomer, JS; Abdel-Gadir, A; Zheng, K; Wechsler, ME; Bacharier, LB; Kunselman, SJ; King, TS; Israel, E; Castro, M; Cernadas, M; Green, JM				Reid, Brandy; Girodet, Pierre-Olivier; Boomer, Jonathan S.; Abdel-Gadir, Azza; Zheng, Kathy; Wechsler, Michael E.; Bacharier, Leonard B.; Kunselman, Susan J.; King, Tonya S.; Israel, Elliot; Castro, Mario; Cernadas, Manuela; Green, Jonathan M.			Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							REGULATORY T-CELLS; RESISTANT ASTHMA		[Reid, Brandy; Boomer, Jonathan S.; Castro, Mario; Green, Jonathan M.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Green, Jonathan M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Girodet, Pierre-Olivier; Zheng, Kathy; Israel, Elliot; Cernadas, Manuela] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Girodet, Pierre-Olivier] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, Dept Pharmacol, Bordeaux, France; [Abdel-Gadir, Azza] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Wechsler, Michael E.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Kunselman, Susan J.; King, Tonya S.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School; UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Boston Children's Hospital; National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Green, JM (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.; Green, JM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	jgreen@wustl.edu	Wechsler, Michael/AAC-5506-2019	Green, Jonathan/0000-0002-7449-4387; Bacharier, Leonard/0000-0003-0432-2704; Abdel-Gadir, Azza/0000-0003-4210-9445; Girodet, Pierre-Olivier/0000-0002-9298-9711	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098075, U10HL098102, U10HL098115] Funding Source: NIH RePORTER; NHLBI NIH HHS [U10 HL098115, U10 HL064313, U10 HL098075, U10 HL098102] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gupta A, 2014, THORAX, V69, P508, DOI 10.1136/thoraxjnl-2013-203421; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	9	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					286	289		10.1016/j.jaci.2015.11.030	http://dx.doi.org/10.1016/j.jaci.2015.11.030			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	26874367	Bronze, Green Accepted			2022-12-18	WOS:000379659100033
J	Munitz, A; Karo-Atar, D; Foster, PS				Munitz, Ariel; Karo-Atar, Danielle; Foster, Paul S.			Asthma diagnosis: MicroRNAs to the rescue	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; microRNA; biomarker; eosinophil; neutrophil	ALLERGIC AIRWAYS DISEASE; ANTAGONISM; TARGETS		[Munitz, Ariel] Tel Aviv Univ, Sackler Sch Med, Dept Microbiol & Clin Immunol, Ramat Aviv, Israel; [Karo-Atar, Danielle] Augman Nano Ltd, Biotherapeut Cluster, Ness Ziona, Israel; [Foster, Paul S.] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Newcastle, NSW 2009, Australia; [Foster, Paul S.] Hunter Med Res Inst, New Lambton Hts, Australia	Tel Aviv University; Sackler Faculty of Medicine; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Foster, PS (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, DMB523,David Maddison Clin Sci Bldg, Newcastle, NSW 2009, Australia.; Foster, PS (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2009, Australia.	arielm@post.tau.ac.il; danielle.augmanity@gmail.com; Paul.Foster@newcastle.edu.au	Foster, Paul/G-5057-2013	Karo-Atar, Danielle/0000-0002-0225-8836; , Paul/0000-0002-0827-8299	Medical Research Council [MR/K006584/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Maes T, 2016, J ALLERGY CLIN IMMUN, V137, P1433, DOI 10.1016/j.jaci.2016.02.018; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Postma DS, 2015, J ALLERGY CLIN IMMUN, V136, P521, DOI 10.1016/j.jaci.2015.06.018; Tay HL, 2014, ANN MED, V46, P633, DOI 10.3109/07853890.2014.958196; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	11	5	6	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1447	1448		10.1016/j.jaci.2016.02.013	http://dx.doi.org/10.1016/j.jaci.2016.02.013			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	27155036	Bronze			2022-12-18	WOS:000376180200019
J	Forbes, D; Johnston, L; Gardner, J; MacCallum, SF; Campbell, LE; Dinkova-Kostova, AT; McLean, WHI; Ibbotson, SH; Dawe, RS; Brown, SJ				Forbes, Deborah; Johnston, Leona; Gardner, June; MacCallum, Stephanie F.; Campbell, Linda E.; Dinkova-Kostova, Albena T.; McLean, W. H. Irwin; Ibbotson, Sally H.; Dawe, Robert S.; Brown, Sara J.			Filaggrin genotype does not determine the skin's threshold to UV-induced erythema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPIC-DERMATITIS; BARRIER FUNCTION; SENSITIVITY		[Forbes, Deborah] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Johnston, Leona; Gardner, June; Ibbotson, Sally H.; Dawe, Robert S.] Univ Dundee, Ninewells Hosp & Med Sch, Photobiol Unit, Dept Dermatol, Dundee DD1 9SY, Scotland; [Dinkova-Kostova, Albena T.] Univ Dundee, Ninewells Hosp & Med Sch, Jacqui Wood Canc Ctr, Div Canc Res,Med Res Inst, Dundee DD1 9SY, Scotland; [MacCallum, Stephanie F.; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Dermatol & Genet Med, Coll Life Sci, Dundee, Scotland; [MacCallum, Stephanie F.; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [Brown, Sara J.] Univ Dundee, Ninewells Hosp & Med Sch, Dermatol & Genet Med, Med Res Inst,Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Brown, SJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dermatol & Genet Med, Med Res Inst,Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland.	s.j.brown@dundee.ac.uk		Dinkova-Kostova, Albena/0000-0003-0316-9859; Forbes, Deborah/0000-0003-2584-0236	MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: Medline; Wellcome Trust [086398/Z/08/Z, 098439/Z/12/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dyer RK, 2012, J INVEST DERMATOL, V132, P2544, DOI 10.1038/jid.2012.227; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Tajima T, 1998, J DERMATOL SCI, V17, P101, DOI 10.1016/S0923-1811(97)00080-7; ten Berge O, 2009, AM J CLIN DERMATOL, V10, P119, DOI 10.2165/00128071-200910020-00004	10	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1280	1282		10.1016/j.jaci.2015.11.022	http://dx.doi.org/10.1016/j.jaci.2015.11.022			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26830116	Green Published, hybrid			2022-12-18	WOS:000373351200047
J	Poposki, JA; Keswani, A; Kim, JK; Klingler, AI; Suh, LA; Norton, J; Carter, RG; Peters, AT; Hulse, KE; Grammer, LC; Tan, BK; Conley, DB; Jaen, JC; Schall, TJ; Kern, RC; Kato, A				Poposki, Julie A.; Keswani, Anjeni; Kim, Julie K.; Klingler, Aiko I.; Suh, Lydia A.; Norton, James; Carter, Roderick G.; Peters, Anju T.; Hulse, Kathryn E.; Grammer, Leslie C.; Tan, Bruce K.; Conley, David B.; Jaen, Juan C.; Schall, Thomas J.; Kern, Robert C.; Kato, Atsushi			Tissue proteases convert CCL23 into potent monocyte chemoattractants in patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NASAL POLYPS; CHEMOKINES; ACTIVATION; BINDING; CCR1		[Poposki, Julie A.; Keswani, Anjeni; Kim, Julie K.; Klingler, Aiko I.; Suh, Lydia A.; Norton, James; Carter, Roderick G.; Peters, Anju T.; Hulse, Kathryn E.; Grammer, Leslie C.; Kern, Robert C.; Kato, Atsushi] Northwestern Univ, Dept Med, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Tan, Bruce K.; Conley, David B.; Kern, Robert C.; Kato, Atsushi] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jaen, Juan C.; Schall, Thomas J.] ChemoCentryx, Mountain View, CA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kato, A (corresponding author), Northwestern Univ, Dept Med, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.; Kato, A (corresponding author), Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA.	a-kato@northwestern.edu		Grammer, Leslie/0000-0001-6860-2014; Kato, Atsushi/0000-0001-9144-3138	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546, R21HL113913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104733, U19AI106683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC012067] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL113913, R37 HL068546] Funding Source: Medline; NIAID NIH HHS [R01 AI104733, U19 AI106683] Funding Source: Medline; NICHD NIH HHS [K12 HD055884] Funding Source: Medline; NIDCD NIH HHS [K23 DC012067] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Berkhout TA, 2000, BIOCHEM PHARMACOL, V59, P591, DOI 10.1016/S0006-2952(99)00354-8; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Poposki JA, 2015, CLIN EXP ALLERGY, V45, P384, DOI 10.1111/cea.12471; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609	9	5	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2016	137	4					1274	+		10.1016/j.jaci.2015.09.029	http://dx.doi.org/10.1016/j.jaci.2015.09.029			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DI2TG	26560043	Green Accepted, Bronze			2022-12-18	WOS:000373351200045
J	Salter, BM; Nusca, G; Tworek, D; Oliveria, JP; Smith, SG; Watson, RM; Scime, T; Obminski, C; Sehmi, R; Gauvreau, GM				Salter, Brittany M.; Nusca, Graeme; Tworek, Damian; Oliveria, John-Paul; Smith, Steve G.; Watson, Rick M.; Scime, Tara; Obminski, Catie; Sehmi, Roma; Gauvreau, Gail M.			Expression of activation markers in circulating basophils and the relationship to allergen-induced bronchoconstriction in subjects with mild allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Salter, Brittany M.; Nusca, Graeme; Tworek, Damian; Oliveria, John-Paul; Watson, Rick M.; Scime, Tara; Obminski, Catie; Gauvreau, Gail M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Smith, Steve G.; Sehmi, Roma] St Josephs, Firestone Inst Resp Hlth, Hamilton, ON, Canada	McMaster University; McMaster University	Gauvreau, GM (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	gauvreau@mcmaster.ca	Oliveria, John-Paul/AAH-8080-2020; Tworek, Damian Przemyslaw/S-9244-2016	Oliveria, John-Paul/0000-0002-7192-7634; Tworek, Damian Przemyslaw/0000-0001-9862-6703; Smith, Steven/0000-0001-9928-117X				Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; KIMURA I, 1975, Clinical Allergy, V5, P95, DOI 10.1111/j.1365-2222.1975.tb01840.x; MARUYAMA N, 1994, AM J RESP CRIT CARE, V150, P1086, DOI 10.1164/ajrccm.150.4.7921441; Nouri-Aria KT, 2001, J ALLERGY CLIN IMMUN, V108, P205, DOI 10.1067/mai.2001.117175; Ono E, 2010, J ALLERGY CLIN IMMUN, V125, P483, DOI 10.1016/j.jaci.2009.10.074; Salter BM, 2015, J ALLERGY CLIN IMMUN, V136, P1636, DOI 10.1016/j.jaci.2015.03.039	6	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					936	938		10.1016/j.jaci.2015.08.024	http://dx.doi.org/10.1016/j.jaci.2015.08.024			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26441227	Bronze			2022-12-18	WOS:000371897500041
J	Scarselli, A; Di Cesare, S; Di Matteo, G; De Matteis, A; Ariganello, P; Romiti, ML; Cascioli, S; De Vito, R; Bertaina, A; Locatelli, F; Gaspar, HB; Aiuti, A; Rossi, P; Gilmour, K; Cancrini, C				Scarselli, Alessia; Di Cesare, Silvia; Di Matteo, Gigliola; De Matteis, Arianna; Ariganello, Paola; Romiti, Maria Luisa; Cascioli, Simona; De Vito, Rita; Bertaina, Alice; Locatelli, Franco; Gaspar, H. Bobby; Aiuti, Alessandro; Rossi, Paolo; Gilmour, Kimberly; Cancrini, Caterina			Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IFN-GAMMA AUTOANTIBODIES; INTERFERON-GAMMA; PATIENT; MANIFESTATIONS; SUSCEPTIBILITY; INFECTION; RECURRENT; DEFECTS		[Scarselli, Alessia; Di Cesare, Silvia; Di Matteo, Gigliola; De Matteis, Arianna; Ariganello, Paola; Romiti, Maria Luisa; Aiuti, Alessandro; Rossi, Paolo; Cancrini, Caterina] Bambino Gesu Pediat Hosp, Unit Immune & Infect Dis, Univ Dept Pediat, DPUO, Rome, Italy; [Cascioli, Simona] Bambino Gesu Pediat Hosp, Immunol & Pharmacotherapy Area, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, Dept Pathol, Rome, Italy; [Bertaina, Alice; Locatelli, Franco] Bambino Gesu Pediat Hosp, Dept Pediat Hematol & Oncol, Rome, Italy; [Gaspar, H. Bobby] UCL, Inst Child Hlth, Ctr Immunodeficiency, Mol Immunol Unit, London, England; [Aiuti, Alessandro] Sci Inst HS Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy; [Gilmour, Kimberly] Great Ormond St Hosp Children NHS Fdn Trust, London, England	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of London; University College London; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Scarselli, A; Cancrini, C (corresponding author), Bambino Gesu Pediat Hosp, Unit Immune & Infect Dis, Univ Dept Pediat, DPUO, Rome, Italy.	alessia.scarselli@gmail.com; cancrini@med.uniroma2.it	Cascioli, Simona/AAH-9248-2019; Rossi, Paolo/K-5746-2016; DI CESARE, SILVIA/AAB-5754-2020; De Matteis, Arianna/ABD-5096-2021; AIUTI, ALESSANDRO/K-3918-2016; DI MATTEO, GIGLIOLA/AAB-5968-2020; scarselli, alessia/AAB-5815-2020	Rossi, Paolo/0000-0003-2620-7918; DI CESARE, SILVIA/0000-0002-9912-7997; De Matteis, Arianna/0000-0001-6705-4407; AIUTI, ALESSANDRO/0000-0002-5398-1717; Bertaina, Alice/0000-0002-3729-436X; DI MATTEO, GIGLIOLA/0000-0001-8344-5635; cancrini, caterina/0000-0001-8410-9617; De Vito, rita/0000-0002-7450-8398				Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Bertaina A, 2014, BLOOD, V124, P822, DOI 10.1182/blood-2014-03-563817; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Brugnoni D, 1998, BLOOD, V91, P949, DOI 10.1182/blood.V91.3.949.949_949_955; Cattaneo F, 2013, J ALLERGY CLIN IMMUN, V131, P1136, DOI 10.1016/j.jaci.2012.12.667; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Chu CC, 2004, HUM IMMUNOL, V65, P1123, DOI 10.1016/j.humimm.2004.08.138; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; Felgentreff K, 2011, CLIN IMMUNOL, V141, P73, DOI 10.1016/j.clim.2011.05.007; Frucht DM, 2001, GENES IMMUN, V2, P422, DOI 10.1038/sj.gene.6363802; Lee WI, 2013, IMMUNOBIOLOGY, V218, P762, DOI 10.1016/j.imbio.2012.08.281; Notorangelo LD, 2001, HUM MUTAT, V18, P255; O'Connell E, 2014, J CLIN IMMUNOL, V34, P928, DOI 10.1007/s10875-014-0073-9; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Smitt JHS, 2013, CURR OPIN PEDIATR, V25, P492, DOI 10.1097/MOP.0b013e3283623b9f; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; Walshe D, 2009, J ALLERGY CLIN IMMUN, V123, P505, DOI 10.1016/j.jaci.2008.11.041; [周雪莲 Zhou Xuelian], 2012, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V27, P198	19	5	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					948	951		10.1016/j.jaci.2015.09.017	http://dx.doi.org/10.1016/j.jaci.2015.09.017			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26545580	Bronze			2022-12-18	WOS:000371897500046
J	Wen, T; Rothenberg, ME; Wang, YH				Wen, Ting; Rothenberg, Marc E.; Wang, Yui-Hsi			Hematopoietic prostaglandin D synthase: Linking pathogenic effector CD4(+) T(H)2 cells to proeosinophilic inflammation in patients with gastrointestinal allergic disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Eosinophilic gastrointestinal disorders; immunology; pathogenic effector T(H)2 cells; type 2 innate lymphoid cells	INNATE LYMPHOID-CELLS; LUNG INFLAMMATION; CRTH2 ANTAGONIST; EOSINOPHILS; EXPRESSION; RECEPTOR; DIFFERENTIATION; LYMPHOPOIETIN; BASOPHILS; CYTOKINE	Eosinophilic gastrointestinal disorders (EGIDs) are characterized as gastrointestinal disorders associated with overproduction of local T(H)2 cytokines, including IL-4, IL-5, and IL-13.(1) Although recent studies have identified multiple hematopoietic cell types to be involved in adverse allergic immune responses in the gastrointestinal tract, the primary cellular sources of T(H)2 cytokines and their interactions in the pathogenesis of EGIDs remain elusive.(1) Mechanistically, IL-4 secretion results in immunoglobulin class-switching to IgE in B cells(2) and induction of alternatively activated macrophages.(3) Production of IL-5 promotes the development, function, and survival of eosinophils,(4) and IL-13 induces dysregulated expression of epithelial cell-derived genes, including eotaxin 3,(5) desmoglein-1,(6) and LRRC31,(7) which have been shown to be involved in eosinophil recruitment and esophageal epithelial barrier functions. In addition, epithelial cell-derived T(H)2-promoting cytokines, including thymic stromal lymphopoietin (TSLP), IL-25, and IL-33, are likely to be potential mediators involved in the induction of gastrointestinal allergic diseases.(8,9)	[Wen, Ting; Rothenberg, Marc E.; Wang, Yui-Hsi] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wang, YH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yui_hsi.wang@cchmc.org			NIAID NIH HHS [R01 AI112626, R37 AI045898, AI124355, AI112626-01, R01 AI124355] Funding Source: Medline; NIDDK NIH HHS [P30 DK078392] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124355, R01AI112626, R37AI045898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barlow JL, 2009, BIOFACTORS, V35, P178, DOI 10.1002/biof.24; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Claar D, 2015, EXPERT REV RESP MED, V9, P55, DOI 10.1586/17476348.2015.992783; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; D'Mello RJ, 2015, MUCOSAL IMMUNOL; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hall IP, 2015, PULM PHARMACOL THER, V32, P37, DOI 10.1016/j.pupt.2015.03.003; Han ST, 2014, AM J RESP CELL MOL, V50, P654, DOI 10.1165/rcmb.2013-0181OC; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moore ML, 2006, J ALLERGY CLIN IMMUN, V117, P1036, DOI 10.1016/j.jaci.2005.12.1314; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Straumann A, 2013, ALLERGY, V68, P375, DOI 10.1111/all.12096; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056	34	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					919	921		10.1016/j.jaci.2015.11.032	http://dx.doi.org/10.1016/j.jaci.2015.11.032			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26947983	Green Accepted, Bronze			2022-12-18	WOS:000371897500036
J	Blumenthal, KG; Lai, KH; Wickner, PG; Goss, FR; Seger, DL; Slight, SP; Topaz, M; Chang, FY; Zhou, L				Blumenthal, Kimberly G.; Lai, Kenneth H.; Wickner, Paige G.; Goss, Foster R.; Seger, Diane L.; Slight, Sarah P.; Topaz, Maxim; Chang, Frank Y.; Zhou, Li			Reported Incidence of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs in the Electronic Health Record	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 04-07, 2016	Los Angeles, CA	Amer Acad Allergy, Asthma & Immunol					[Blumenthal, Kimberly G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol,Dept Med, Boston, MA USA; [Blumenthal, Kimberly G.; Topaz, Maxim; Zhou, Li] Harvard Univ, Sch Med, Boston, MA USA; [Lai, Kenneth H.; Seger, Diane L.; Chang, Frank Y.] Partners HealthCare Syst, Boston, MA USA; [Wickner, Paige G.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Dept Med,Brigham & Womens Hosp, Chestnut Hill, MA USA; [Goss, Foster R.] Univ Colorado, Aurora, CO USA; [Seger, Diane L.; Slight, Sarah P.; Topaz, Maxim; Chang, Frank Y.; Zhou, Li] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Slight, Sarah P.] Univ Durham, Durham, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Durham University			Blumenthal, Kimberly/AAG-8290-2019; Topaz, Maxim/AAQ-7121-2021	Blumenthal, Kimberly/0000-0003-4773-9817; Topaz, Maxim/0000-0002-2358-9837					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2		S		639	AB196	AB196		10.1016/j.jaci.2015.12.772	http://dx.doi.org/10.1016/j.jaci.2015.12.772			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	DK6BI		Bronze			2022-12-18	WOS:000375005403085
J	Natsume, O; Kabashima, S; Nakasato, J; Yamamoto-Hanada, K; Narita, M; Kondo, M; Saito, M; Kishino, A; Inoue, E; Shinahara, W; Kido, H; Saito, H; Ohya, Y				Natsume, Osamu; Kabashima, Shigenori; Nakasato, Junko; Yamamoto-Hanada, Kiwako; Narita, Masami; Kondo, Mai; Saito, Mayako; Kishino, Ai; Inoue, Eisuke; Shinahara, Wakako; Kido, Hiroshi; Saito, Hirohisa; Ohya, Yukihiro			Early Introduction of Egg for Infants with Atopic Dermatitis to Prevent Egg Allergy: A Double-Blind Placebo-Controlled Randomized Clinical Trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 04-07, 2016	Los Angeles, CA	Amer Acad Allergy, Asthma & Immunol					[Natsume, Osamu; Kabashima, Shigenori; Nakasato, Junko; Yamamoto-Hanada, Kiwako; Narita, Masami; Kondo, Mai; Saito, Mayako; Kishino, Ai; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo, Japan; [Inoue, Eisuke] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Shinahara, Wakako; Kido, Hiroshi] Univ Tokushima, Tokushima, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tokushima University; National Center for Child Health & Development - Japan			Narita, Masami/AAF-1079-2019; Yamamoto-Hanada, Kiwako/GQH-6445-2022; Yamamoto-Hanada, Kiwako/AAR-3094-2020	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Saito-Abe, Mayako/0000-0002-8845-7034					0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2		S		319	AB98	AB98		10.1016/j.jaci.2015.12.445	http://dx.doi.org/10.1016/j.jaci.2015.12.445			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	DK6BI		Bronze			2022-12-18	WOS:000375005402010
J	Purath, U; Ibrahim, R; Zeitvogel, J; Renz, H; Runkel, F; Schmidts, T; Dobler, D; Werfel, T; Muller, A; Garn, H				Purath, Ulrich; Ibrahim, Rouba; Zeitvogel, Jana; Renz, Harald; Runkel, Frank; Schmidts, Thomas; Dobler, Dorota; Werfel, Thomas; Mueller, Anke; Garn, Holger			Efficacy of T-cell transcription factor-specific DNAzymes in murine skin inflammation models	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Purath, Ulrich; Mueller, Anke] Sterna Biol GmbH & Co KG, Marburg, Germany; [Ibrahim, Rouba; Renz, Harald; Garn, Holger] Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, Marburg, Germany; [Zeitvogel, Jana; Werfel, Thomas] Hannover Med Sch, Clin Dermatol Allergol & Venerol, Div Immunodermatol & Allergy Res, Hannover, Germany; [Runkel, Frank; Schmidts, Thomas; Dobler, Dorota] Tech Hsch Mittelhessen, Inst Bioprocessengn & Biopharmaceut Technol, Giessen, Germany	Philipps University Marburg; Hannover Medical School	Garn, H (corresponding author), Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, Marburg, Germany.	garn@staff.uni-marburg.de	Werfel, Thomas/B-6921-2012	Garn, Holger/0000-0002-5178-4023				Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nomura T, 2014, J DERMATOL SCI, V76, P3, DOI 10.1016/j.jdermsci.2014.07.010; Schmidts T, 2010, INT J PHARMACEUT, V398, P107, DOI 10.1016/j.ijpharm.2010.07.037; Schmidts T, 2011, INT J PHARMACEUT, V410, P75, DOI 10.1016/j.ijpharm.2011.03.023; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Yin Y, 2011, EUR J PHARMACOL, V651, P205, DOI 10.1016/j.ejphar.2010.10.068	9	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2					644	+		10.1016/j.jaci.2015.09.022	http://dx.doi.org/10.1016/j.jaci.2015.09.022			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DC5BN	26560045	Bronze			2022-12-18	WOS:000369235500045
J	Peden, DB; Bush, RK				Peden, David B.; Bush, Robert K.			Advances in environmental and occupational disorders in 2014	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Air pollution; allergens; anaphylaxis; viral infections; immune responses; asthma	ALLERGEN-SPECIFIC IGE; ASTHMA; IDENTIFICATION; RESPONSES; SENSITIZATION; RESISTANCE; CHILDREN; DISEASE; COMMON	In 2014, the Journal published a number of studies that have advanced our understanding of the effects of various environmental factors and immune responses in patients with allergic diseases. In this review we emphasize reports that have appeared in the Journal over the past year that deal with environmental and occupational respiratory disorders and novel approaches to their treatment. The review will focus on the effects of environmental factors and immune responses in allergic airway diseases, identification of new allergens, and risk factors in stinging insect allergy, development of asthma in different age groups, effects of viral infections, and benefits of new therapies.	[Peden, David B.] Univ N Carolina, Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, Chapel Hill, NC 27599 USA; [Bush, Robert K.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Allergy Immunol Pulm Crit Care & Sleep Med, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Peden, DB (corresponding author), Univ N Carolina, Sch Med, Dept Pediat, Div Allergy Immunol & Rheumatol, 104 Mason Hill Farm, Chapel Hill, NC 27599 USA.	david_peden@med.unc.edu		Peden, David/0000-0003-4526-4627				Agbetile J, 2014, J ALLERGY CLIN IMMUN, V134, P33, DOI 10.1016/j.jaci.2013.09.050; Bublin M, 2014, J ALLERGY CLIN IMMUN, V134, P521, DOI 10.1016/j.jaci.2014.04.015; Cabauatan CR, 2014, J ALLERGY CLIN IMMUN, V133, P910, DOI 10.1016/j.jaci.2013.10.004; Cho SH, 2014, J ALLERGY CLIN IMMUN, V133, P1465, DOI 10.1016/j.jaci.2013.11.009; Cifuentes L, 2014, J ALLERGY CLIN IMMUN, V133, P909, DOI 10.1016/j.jaci.2013.09.047; Curin M, 2014, J ALLERGY CLIN IMMUN, V133, P918, DOI 10.1016/j.jaci.2013.10.058; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Dubuis E, 2014, J ALLERGY CLIN IMMUN, V133, P1588, DOI 10.1016/j.jaci.2013.11.017; Focke-Tejkl M, 2014, J ALLERGY CLIN IMMUN, V133, P836, DOI 10.1016/j.jaci.2013.08.038; Gadermaier G, 2014, J ALLERGY CLIN IMMUN, V134, P472, DOI 10.1016/j.jaci.2014.02.016; Goldblum RM, 2014, J ALLERGY CLIN IMMUN, V134, P967, DOI 10.1016/j.jaci.2014.05.009; Hatchwell L, 2014, J ALLERGY CLIN IMMUN, V133, P1720, DOI 10.1016/j.jaci.2013.11.014; Hilger C, 2014, J ALLERGY CLIN IMMUN, V133, P759, DOI 10.1016/j.jaci.2013.04.034; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Howrylak JA, 2014, J ALLERGY CLIN IMMUN, V133, P1289, DOI 10.1016/j.jaci.2014.02.006; Hulse KE, 2014, J ALLERGY CLIN IMMUN, V133, P275, DOI 10.1016/j.jaci.2013.08.015; Hyde ER, 2014, J ALLERGY CLIN IMMUN, V133, P1220, DOI 10.1016/j.jaci.2013.10.049; Iwasaki J, 2014, J ALLERGY CLIN IMMUN, V134, P25, DOI 10.1016/j.jaci.2014.03.014; Koenderman L, 2014, J ALLERGY CLIN IMMUN, V134, P323, DOI 10.1016/j.jaci.2014.04.030; Lukkarinen H, 2014, J ALLERGY CLIN IMMUN, V133, P256, DOI 10.1016/j.jaci.2013.10.014; Marcon A, 2014, J ALLERGY CLIN IMMUN, V133, P104, DOI 10.1016/j.jaci.2013.03.040; Mas S, 2014, J ALLERGY CLIN IMMUN, V133, P923, DOI 10.1016/j.jaci.2013.10.061; Mendola P, 2014, J ALLERGY CLIN IMMUN, V133, P85, DOI 10.1016/j.jaci.2013.06.012; Milara J, 2014, J ALLERGY CLIN IMMUN, V134, P314, DOI 10.1016/j.jaci.2014.02.001; Miller RL, 2014, J ALLERGY CLIN IMMUN, V134, P1001, DOI 10.1016/j.jaci.2014.07.064; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Pillai P, 2014, J ALLERGY CLIN IMMUN, V133, P1770, DOI 10.1016/j.jaci.2014.03.027; Pravettoni V, 2014, J ALLERGY CLIN IMMUN, V133, P1218, DOI 10.1016/j.jaci.2013.10.033; Savage WJ, 2014, J ALLERGY CLIN IMMUN, V133, P1772, DOI 10.1016/j.jaci.2014.03.030; Sturm GJ, 2014, J ALLERGY CLIN IMMUN, V133, P1635, DOI 10.1016/j.jaci.2013.10.046	30	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					866	871		10.1016/j.jaci.2015.08.008	http://dx.doi.org/10.1016/j.jaci.2015.08.008			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	26449799	Green Accepted			2022-12-18	WOS:000362976300005
J	Kirak, O; Riethmuller, G				Kirak, Oktay; Riethmueller, Gert			A novel, nonanaphylactogenic, bispecific IgE-CD3 antibody eliminates IgE1(+) B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IGE; ASTHMA		[Kirak, Oktay; Riethmueller, Gert] Univ Munich, Inst Immunol, D-80539 Munich, Germany	University of Munich	Kirak, O (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	kirak@scripps.edu; gert.riethmueller@med.uni-muenchen.de	Kirak, Oktay/H-6347-2013	Kirak, Oktay/0000-0002-6524-4685				Avila PC, 2007, ANNU REV MED, V58, P185, DOI 10.1146/annurev.med.58.061705.145252; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Feichtner S, 2008, J IMMUNOL, V180, P5499, DOI 10.4049/jimmunol.180.8.5499; HABA S, 1994, J IMMUNOL, V152, P51; LUSTGARTEN J, 1995, EUR J IMMUNOL, V25, P2985, DOI 10.1002/eji.1830251041; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Rudolf MP, 2000, J IMMUNOL, V165, P813, DOI 10.4049/jimmunol.165.2.813; Talay O, 2013, NAT IMMUNOL, V14, P1302, DOI 10.1038/ni.2770; Zugmaier G, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.64	9	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					800	+		10.1016/j.jaci.2015.02.017	http://dx.doi.org/10.1016/j.jaci.2015.02.017			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25825213	Bronze			2022-12-18	WOS:000360913300034
J	Madritsch, C; Eckl-Dorna, J; Blatt, K; Ellinger, I; Kundi, M; Niederberger, V; Valent, P; Valenta, R; Flicker, S				Madritsch, Christoph; Eckl-Dorna, Julia; Blatt, Katharina; Ellinger, Isabella; Kundi, Michael; Niederberger, Verena; Valent, Peter; Valenta, Rudolf; Flicker, Sabine			Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GRASS-POLLEN ALLERGEN; HUMAN IGE; ASTHMA; INFLAMMATION; EXPRESSION		[Madritsch, Christoph; Valenta, Rudolf; Flicker, Sabine] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Eckl-Dorna, Julia; Niederberger, Verena] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [Blatt, Katharina; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria; [Ellinger, Isabella] Med Univ Vienna, Div Cellular & Mol Pathophysiol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Ctr Publ Hlth, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Madritsch, C (corresponding author), Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	sabine.flicker@meduniwien.ac.at	Ellinger, Isabella/AAV-9170-2020; Test, Test/Y-7921-2019; Eckl-Dorna, Julia/AAY-6371-2020; Valent, Peter/B-8533-2016; Test, PV/U-9451-2019; Gamperl, Susi/V-2715-2019	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Valenta, Rudolf/0000-0001-5944-3365; Flicker, Sabine/0000-0003-4768-8693; Ellinger, Isabella/0000-0001-6335-076X; Madritsch, Christoph/0000-0001-7044-7420; Eckl-Dorna, Julia/0000-0001-5981-1607	Austrian Science Fund FWF [F 4607, F 4613, F 4605] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Flicker S, 2002, EUR J IMMUNOL, V32, P2156, DOI 10.1002/1521-4141(200208)32:8<2156::AID-IMMU2156>3.0.CO;2-A; Gadermaier E, 2014, INT ARCH ALLERGY IMM, V163, P77, DOI 10.1159/000355947; Gorska-Ciebiada M, 2006, ANN ALLERG ASTHMA IM, V97, P66, DOI 10.1016/S1081-1206(10)61372-5; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00127; Linhart B, 2005, J ALLERGY CLIN IMMUN, V115, P1010, DOI 10.1016/j.jaci.2004.12.1142; Reisinger J, 2005, J ALLERGY CLIN IMMUN, V115, P973, DOI 10.1016/j.jaci.2005.01.021; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; Steinberger P, 1996, J BIOL CHEM, V271, P10967, DOI 10.1074/jbc.271.18.10967; Traub S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003520; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x	14	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					490	+		10.1016/j.jaci.2015.01.006	http://dx.doi.org/10.1016/j.jaci.2015.01.006			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25769914	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000359004900035
J	Thomas, AO; Jackson, DJ; Evans, MD; Rajamanickam, V; Gangnon, RE; Fain, SB; Sorkness, RL; Okupa, AY; Thomas, A; Gern, JE; Lemanske, RF				Thomas, Amy O.; Jackson, Daniel J.; Evans, Michael D.; Rajamanickam, Victoria; Gangnon, Ronald E.; Fain, Sean B.; Sorkness, Ronald L.; Okupa, Adesua Y.; Thomas, Alex; Gern, James E.; Lemanske, Robert F., Jr.			Sex-related differences in pulmonary physiologic outcome measures in a high-risk birth cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sex; gender; asthma; pulmonary physiology; spirometry; helium MRI; ventilation defects; mannitol; airway hyperreactivity; fractional exhaled nitric oxide	EXHALED NITRIC-OXIDE; CHILDHOOD ASTHMA; RHINOVIRUS ILLNESSES; CLINICAL-PRACTICE; LUNG-FUNCTION; CHILDREN; RATIO; AGE	Background: Sex influences the risk of wheezing illnesses and the prevalence of asthma throughout childhood. Objective: To better understand the mechanisms of these effects, we analyzed longitudinal relationships between sex, lung physiology, and asthma in the Childhood Origins of ASThma birth cohort study. Methods: Childhood Origins of ASThma birth cohort study children were followed prospectively from birth and assessed annually. Results of spirometry, fractional exhaled nitric oxide (FENO), mannitol provocation testing, and 3 He gas magnetic resonance imaging were assessed by sex using multivariate models including age, asthma diagnosis, and wheezing histories. Results: Girls had higher prebronchodilator forced expiratory volume in 0.5 seconds/forced vital capacity values than did boys (mean difference, 0.017; 95% CI, 0.000-0.034; P = .05) of equivalent age. Postbronchodilator findings were more pronounced, with boys demonstrating reduced forced expiratory volume in 0.5 seconds/forced vital capacity values than did girls of equivalent age (mean difference, 0.032; 95% CI, 0.014-0.049; P = .0005). Conversely, girls were noted to have higher ventilation defects on 3 He magnetic resonance imaging than did boys (P = .01). No differences were noted in the rate of positive responses to mannitol provocation or FENO measurements. Conclusions: Lower airflow values are present by spirometry for prepubertal boys than for age-matched girls; however, greater 3 He ventilation defects were noted in girls. This could represent a greater degree of subclinical air trapping in prepubertal girls because residual volumes are not detected on standard spirometric readings. No differences were noted between the 2 sexes with airway hyperresponsiveness (mannitol provocation testing) or inflammation (FENO). Prospective peripubertal follow-up will determine whether these differences persist or change with the de novo expression and remission of asthma based on sex and age.	[Thomas, Amy O.; Jackson, Daniel J.; Sorkness, Ronald L.; Okupa, Adesua Y.; Thomas, Alex; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Evans, Michael D.; Rajamanickam, Victoria; Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53792 USA; [Fain, Sean B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI 53792 USA; [Fain, Sean B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Phys, Madison, WI 53792 USA; [Sorkness, Ronald L.; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharm, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, DJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Sect Allergy Immunol & Rheumatol, Dept Pediat, K4-936 Clini Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	djj@medicine.wisc.edu	Fain, Sean B./K-4260-2016	Fain, Sean B./0000-0001-5461-0646; Gangnon, Ronald/0000-0003-2587-6714; Evans, Michael/0000-0001-7449-3993	National Institutes of Health (NIH) [P01 HL70831]; Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (NIH) (grant no. P01 HL70831) and by the Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences (grant no. UL1TR000427).	Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; Baraldi E, 2002, EUR RESPIR J, V20, P223, DOI 10.1183/09031936.02.00293102; Belgrave DCM, 2014, AM J RESP CRIT CARE, V189, P1101, DOI 10.1164/rccm.201309-1700OC; Buchvald F, 2005, J ALLERGY CLIN IMMUN, V115, P1130, DOI 10.1016/j.jaci.2005.03.020; Cadman RV, 2013, J ALLERGY CLIN IMMUN, V131, P369, DOI 10.1016/j.jaci.2012.10.032; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Eigen H, 2001, AM J RESP CRIT CARE, V163, P619, DOI 10.1164/ajrccm.163.3.2002054; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Loisel DA, 2011, J ALLERGY CLIN IMMUN, V128, P524, DOI 10.1016/j.jaci.2011.06.016; Quanjer PH, 2010, EUR RESPIR J, V36, P1391, DOI 10.1183/09031936.00164109; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sverrild A, 2009, J ALLERGY CLIN IMMUN, V124, P928, DOI 10.1016/j.jaci.2009.06.028; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Uekert SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1375, DOI 10.1016/j.jaci.2006.09.008; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204	21	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					282	287		10.1016/j.jaci.2014.12.1927	http://dx.doi.org/10.1016/j.jaci.2014.12.1927			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25678088	Green Accepted			2022-12-18	WOS:000359004900008
J	Leitch, CS; Chu, R; Ray, R; Holme, SA				Leitch, Claire S.; Chu, Roland; Ray, Ruth; Holme, Stephen A.		Edinburgh Dermatology Virtual Jour	Preventing atopic eczema from birth using emollients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Leitch, Claire S.; Chu, Roland; Ray, Ruth; Holme, Stephen A.] Royal Infirm Edinburgh NHS Trust, Dept Dermatol, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Leitch, CS (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Dermatol, Edinburgh, Midlothian, Scotland.	c.leitch@nhs.net						Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005	2	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1663	1664		10.1016/j.jaci.2015.01.051	http://dx.doi.org/10.1016/j.jaci.2015.01.051			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CK0ZC	26051953				2022-12-18	WOS:000355933400039
J	Stukus, DR				Stukus, David R.			Obesity and asthma: The chicken or the egg?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							MECHANISMS; OVERWEIGHT; CHILDREN; LINK		[Stukus, David R.] Nationwide Childrens Hosp, Sect Allergy & Immunol, Columbus, OH 43205 USA; [Stukus, David R.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Stukus, DR (corresponding author), Nationwide Childrens Hosp, Sect Allergy & Immunol, 700 Childrens Dr, Columbus, OH 43205 USA.	David.stukus@nationwidechildrens.org	Stukus, David/C-7512-2013					[Anonymous], 2007, J ALLERGY CLIN IMM S, V120, pS94; Danielewicz H, 2014, PEDIAT ALLER IMM PUL, V27, P104, DOI 10.1089/ped.2014.0360; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Korppi M, 2010, ACTA PAEDIATR, V99, P1290, DOI 10.1111/j.1651-2227.2010.01826.x; Lang JE, 2015, J ALLERGY CLIN IMMUN, V135, P886, DOI 10.1016/j.jaci.2014.08.029; Palmer DJ, 2014, IMMUNOL ALLERGY CLIN, V34, P825, DOI 10.1016/j.iac.2014.07.003; Papoutsakis C, 2013, J ACAD NUTR DIET, V113, P77, DOI 10.1016/j.jand.2012.08.025; Permaul P, 2014, ANN ALLERG ASTHMA IM, V113, P244, DOI 10.1016/j.anai.2014.07.001; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052	11	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					894	895		10.1016/j.jaci.2014.11.002	http://dx.doi.org/10.1016/j.jaci.2014.11.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25528362	Bronze			2022-12-18	WOS:000352238600008
J	Leiferman, KM				Leiferman, Kristin M.			Eosinophils and itch: Partners in crime or strange bedfellows?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Contact hypersensitivity; cutaneous innervation; eosinophil; itch; mast cell; PHIL mice; substance P; trimellitic anhydride	CONTACT HYPERSENSITIVITY; TRIMELLITIC ANHYDRIDE; MODEL		Univ Utah, Dept Dermatol, Sch Med 4A330, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Leiferman, KM (corresponding author), Univ Utah, Dept Dermatol, Sch Med 4A330, 30 N 1900 E, Salt Lake City, UT 84112 USA.	kristin.leiferman@hsc.utah.edu						Chai OH, 2005, EXP MOL MED, V37, P408, DOI 10.1038/emm.2005.51; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Lee JJ, 2015, J ALLERGY CLIN IMMUN, V135, P477, DOI 10.1016/j.jaci.2014.07.003; Leiferman KM, 2009, ATOPIC DERMATITIS, P195; Mjosberg J, 2012, EUR J IMMUNOL, V42, P1093, DOI 10.1002/eji.201242549; PATTERSON R, 1982, J ALLERGY CLIN IMMUN, V70, P19, DOI 10.1016/0091-6749(82)90196-8; Pichler WJ, 2003, ANN INTERN MED, V139, P683, DOI 10.7326/0003-4819-139-8-200310210-00012; Schneider C, 2009, J INVEST DERMATOL, V129, P899, DOI 10.1038/jid.2008.307; Spits H, 2013, IMMUNOL CELL BIOL, V91, P390, DOI 10.1038/icb.2013.24	11	5	6	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					488	490		10.1016/j.jaci.2014.11.036	http://dx.doi.org/10.1016/j.jaci.2014.11.036			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25662307				2022-12-18	WOS:000349372300022
J	Mather, MW; Hayhurst, H; Bacon, CM; Cole, TS; Pan-Hammarstrom, Q; Misbah, S; Gennery, AR				Mather, Michael W.; Hayhurst, Hannah; Bacon, Chris M.; Cole, Theresa S.; Pan-Hammarstrom, Qiang; Misbah, Siraj; Gennery, Andrew R.			Mutation of TNFRSF13B in a child with 22q11 deletion syndrome associated with granulomatous lymphoproliferation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; TACI MUTATION		[Mather, Michael W.; Hayhurst, Hannah; Cole, Theresa S.; Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bacon, Chris M.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bacon, Chris M.] Newcastle Tyne Hosp NHS Fdn Trust, North England Haematol Oncol Diagnost Serv, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pan-Hammarstrom, Qiang] Karolinska Univ, Huddinge Hosp, Stockholm, Sweden; [Misbah, Siraj] John Radcliffe Hosp, Oxford OX3 9DU, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital; University of Oxford	Mather, MW (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	a.r.gennery@ncl.ac.uk	hammarstrom, qiang pan/ABA-4589-2021; Cole, Theresa/AAX-7893-2021	Cole, Theresa/0000-0002-8272-4074; pan-hammarstrom, qiang/0000-0003-1990-8804; Bacon, Chris/0000-0002-8268-2812; Mather, Michael/0000-0001-7972-7111				Ardeniz O, 2009, CLIN IMMUNOL, V133, P198, DOI 10.1016/j.clim.2009.05.001; Berglund LJ, 2006, J ALLERGY CLIN IMMUN, V117, P870, DOI 10.1016/j.jaci.2006.01.004; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Garibyan L, 2007, J CLIN INVEST, V117, P1550, DOI 10.1172/JCI31023; McLean-Tooke A, 2007, SCAND J IMMUNOL, V66, P1, DOI 10.1111/j.1365-3083.2007.01949.x; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					559	561		10.1016/j.jaci.2014.07.025	http://dx.doi.org/10.1016/j.jaci.2014.07.025			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25174870	Bronze			2022-12-18	WOS:000349372300033
J	Rubner, FJ; Jackson, DJ; Tisler, CJ; Rajamanickam, V; Gern, JE; Lemanske, RF				Rubner, Frederick J.; Jackson, Daniel J.; Tisler, Christopher J.; Rajamanickam, Victoria; Gern, James E.; Lemanske, Robert F., Jr.			Relationships Among Eosinophils, Asthma, and Sex in a High-Risk Birth Cohort	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Rubner, Frederick J.; Tisler, Christopher J.; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Jackson, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Pediat, Madison, WI USA; [Rajamanickam, Victoria] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		738	AB228	AB228		10.1016/j.jaci.2014.12.1680	http://dx.doi.org/10.1016/j.jaci.2014.12.1680			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600737
J	Sanchez-Machin, I; Guedes, PP; Perez, RG; Matheu, V				Sanchez-Machin, Inmaculada; Poza Guedes, Paloma; Gonzalez Perez, Ruperto; Matheu, Victor			Experience in the Use of Social Media (whatsapp, e-Mail, facebook, website) By Patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 20-24, 2015	Houston, TX	Amer Acad Allergy, Asthma & Immunol					[Sanchez-Machin, Inmaculada] Clin Tecnosana Tenerife, El Rosario, Spain; [Sanchez-Machin, Inmaculada] Hosp Quiron, Santa Cruz De Tenerife, Spain; [Poza Guedes, Paloma; Gonzalez Perez, Ruperto] Alergocan, Santa Cruz De Tenerife, Spain; [Matheu, Victor] Hosp Quiron Tenerife, Santa Cruz De Tenerife, Spain				Matheu, Victor/AAU-3043-2020; Ruperto, González-Pérez/AAE-6200-2022; Machín, María Inmaculada Sánchez/ABF-6003-2020; Poza-Guedes, Paloma/AAE-6848-2022	Matheu, Victor/0000-0002-0469-800X; Poza-Guedes, Paloma/0000-0001-8516-6648; Sanchez-Machin, Inmaculada/0000-0003-0109-8735					0	5	5	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2		S		435	AB135	AB135		10.1016/j.jaci.2014.12.1374	http://dx.doi.org/10.1016/j.jaci.2014.12.1374			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	CR2BN					2022-12-18	WOS:000361129600435
J	Stewart, GA				Stewart, Geoffrey A.			Studies of house dust mites can now fully embrace the "-omics'' era	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Dermatophagoides farinae; genome; transcriptome; microbiome; Enterobacter cloacae; symbiosis; ubiquinol-cytochrome c reductase binding protein-like protein; amylase; Blo t 12; Blo t 19	DERMATOPHAGOIDES-PTERONYSSINUS; ALLERGEN; BACTERIA; IDENTIFICATION		Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia	University of Western Australia	Stewart, GA (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, M504,35 Stirling Highway, Nedlands, WA 6009, Australia.	geoff.stewart@uwa.edu.au						Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Hales BJ, 2007, CLIN EXP ALLERGY, V37, P1357, DOI 10.1111/j.1365-2222.2007.02786.x; Hubert J, 2012, MICROB ECOL, V63, P919, DOI 10.1007/s00248-011-9969-6; Kopecky J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112919; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; STEWART GA, 1992, EXP APPL ACAROL, V16, P165, DOI 10.1007/BF01201499; Thomas WR, 2003, CLIN EXP ALLERGY, V33, P416, DOI 10.1046/j.1365-2222.2003.01634.x; Valerio CR, 2005, J ALLERGY CLIN IMMUN, V116, P1296, DOI 10.1016/j.jaci.2005.09.046; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Zakzuk J, 2014, INT ARCH ALLERGY IMM, V163, P119, DOI 10.1159/000356482	12	5	5	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					549	550		10.1016/j.jaci.2014.12.934	http://dx.doi.org/10.1016/j.jaci.2014.12.934			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25662308				2022-12-18	WOS:000349372300029
J	Hamilton, RG; Scheer, DI; Gruchalla, R; Adkinson, NF; Sampson, HA				Hamilton, Robert G.; Scheer, David I.; Gruchalla, Rebecca; Adkinson, N. Franklin; Sampson, Hugh A.			Casein-related anaphylaxis after use of an Everlast kickboxing glove	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Hamilton, Robert G.; Adkinson, N. Franklin] Johns Hopkins Univ, Sch Med, Div Clin Immunol & Allergy, Baltimore, MD 21218 USA; [Scheer, David I.] Scheer & Co, New Haven, CT USA; [Gruchalla, Rebecca] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Pediat Allergy Div, New York, NY 10029 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai	Hamilton, RG (corresponding author), Johns Hopkins Univ, Sch Med, Div Clin Immunol & Allergy, Baltimore, MD 21218 USA.	rhamilt2@jhmi.edu						Benede S, 2014, FOOD CHEM, V143, P514, DOI 10.1016/j.foodchem.2013.07.110; HAMILTON RG, 2014, HANDBOOK OF FOOD ALL; PALOSUO T, 2008, D7427 ASTM; Rose RF, 2009, CONTACT DERMATITIS, V61, P129, DOI 10.1111/j.1600-0536.2009.01580.x; Ylitalo L, 1999, J ALLERGY CLIN IMMUN, V104, P177, DOI 10.1016/S0091-6749(99)70131-4	5	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					269	+		10.1016/j.jaci.2014.06.041	http://dx.doi.org/10.1016/j.jaci.2014.06.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25218287				2022-12-18	WOS:000347298200035
J	Scala, G; Sopo, SM				Scala, Guglielmo; Sopo, Stefano Miceli			When are serum specific IgE levels positive?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNOTHERAPY; CHILDREN		[Scala, Guglielmo] Loreto Crispi Hosp, Allergy Unit, Naples, Italy; [Sopo, Stefano Miceli] Univ Cattolica Sacro Cuore, Dept Pediat, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Scala, G (corresponding author), Loreto Crispi Hosp, Allergy Unit, Naples, Italy.	guglielmoscala@gmail.com		Miceli Sopo, Stefano/0000-0002-8175-6146				Stringari G, 2014, J ALLERGY CLIN IMMUN, V134, P75, DOI 10.1016/j.jaci.2014.01.042; Tripodi S, 2012, J ALLERGY CLIN IMMUN, V129, P834, DOI 10.1016/j.jaci.2011.10.045	2	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					291	292		10.1016/j.jaci.2014.10.008	http://dx.doi.org/10.1016/j.jaci.2014.10.008			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25457151				2022-12-18	WOS:000347298200048
J	Bateman, ED				Bateman, Eric D.			Treatment adherence in asthmatic patients: The last frontier?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; inhalers; adherence	RANDOMIZED CONTROLLED-TRIAL; ELECTRONIC MONITOR; EXACERBATIONS; MEDICATIONS; DEFINITION; INHALER		[Bateman, Eric D.] Univ Cape Town, Dept Med, Div Pulmonol, ZA-7700 Cape Town, South Africa	University of Cape Town	Bateman, ED (corresponding author), Univ Cape Town, Lung Inst, George St, ZA-7700 Cape Town, South Africa.	eric.bateman@uct.ac.za						Berg J, 1998, ANN BEHAV MED, V20, P36, DOI 10.1007/BF02893807; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Foster JM, 2014, J ALLERGY CLIN IMMUN, V134, P1260, DOI 10.1016/j.jaci.2014.05.041; Foster JM, 2012, J ASTHMA, V49, P657, DOI 10.3109/02770903.2012.684253; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Patel M, 2013, J ALLER CL IMM-PRACT, V1, P83, DOI 10.1016/j.jaip.2012.08.004; Patel M, 2013, LANCET RESP MED, V1, P32, DOI 10.1016/S2213-2600(13)70007-9; Patel M, 2013, RESPIROLOGY, V18, P546, DOI 10.1111/resp.12059; Perrin K, 2010, J ALLERGY CLIN IMMUN, V126, P505, DOI 10.1016/j.jaci.2010.06.033	12	5	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1269	1270		10.1016/j.jaci.2014.08.004	http://dx.doi.org/10.1016/j.jaci.2014.08.004			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW1UG	25258141				2022-12-18	WOS:000346075400007
J	Biagioni, BJ; Pui, MM; Fung, EK; Wong, S; Hosseini, A; Dybuncio, A; Alexis, NE; Carlsten, C				Biagioni, Bradly J.; Pui, Mandy M.; Fung, Elkie; Wong, SzeWing; Hosseini, Ali; Dybuncio, Anne; Alexis, Neil E.; Carlsten, Chris			Sputum adiponectin as a marker for western red cedar asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SERUM ADIPONECTIN		[Biagioni, Bradly J.; Pui, Mandy M.; Fung, Elkie; Wong, SzeWing; Hosseini, Ali; Dybuncio, Anne; Carlsten, Chris] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC V5Z 1M9, Canada; [Alexis, Neil E.] Univ N Carolina, Dept Pediat, Div Rheumatol Allergy & Immunol, Chapel Hill, NC USA	University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Biagioni, BJ (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC V5Z 1M9, Canada.	carlsten@mail.ubc.ca	Hosseini, Ahmad/AAC-3735-2022					Assad NA, 2012, BIOCHIMIE, V94, P2180, DOI 10.1016/j.biochi.2012.03.006; Carlsten C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057166; Dixon AE, 2011, J ASTHMA, V48, P811, DOI 10.3109/02770903.2011.613507; Holguin F, 2011, J ASTHMA, V48, P217, DOI 10.3109/02770903.2011.555033; Medoff BD, 2009, AM J RESP CELL MOL, V41, P397, DOI 10.1165/rcmb.2008-0415OC; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Sood A, 2008, THORAX, V63, P877, DOI 10.1136/thx.2007.090803; Sood A, 2014, J ASTHMA, V51, P459, DOI 10.3109/02770903.2014.882934; Sood A, 2009, CHEST, V135, P287, DOI 10.1378/chest.08-1705	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1446	1448		10.1016/j.jaci.2014.06.037	http://dx.doi.org/10.1016/j.jaci.2014.06.037			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW1UG	25129682	Bronze			2022-12-18	WOS:000346075400029
J	Rael, E; Lockey, RF				Rael, Efren; Lockey, Richard F.			Optimal duration of allergen immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Short case; subcutaneous immunotherapy; sublingual immunotherapy; immunotherapy duration; venom immunotherapy; clinical allergy pearls	GRASS-POLLEN IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; VENOM IMMUNOTHERAPY; FOLLOW-UP; EFFICACY; RHINOCONJUNCTIVITIS; TABLET		[Rael, Efren] Milton S Hershey Med Ctr, Penn State Coll Med, Dept Internal Med, Div Pulm Allergy & Crit Care,Sect Allergy Asthma, Hershey, PA 17033 USA; [Lockey, Richard F.] Univ S Florida, Coll Med, Div Allergy & Immunol, Tampa, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University System of Florida; University of South Florida	Rael, E (corresponding author), Milton S Hershey Med Ctr, C5804B,MCH0401,500 Univ Dr, Hershey, PA 17033 USA.	efrenrael@gmail.com		Rael, Efren/0000-0003-1709-3111				Aasbjerg K, 2014, CLIN EXP ALLERGY, V44, P417, DOI 10.1111/cea.12241; Cox L, 2010, J ALLERGY CLIN IMMUN, V125, P569, DOI 10.1016/j.jaci.2009.10.060; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Didier A, 2013, CLIN EXP ALLERGY, V43, P568, DOI 10.1111/cea.12100; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Eng PA, 2006, ALLERGY, V61, P198, DOI 10.1111/j.1398-9995.2006.01011.x; Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; HEDLIN G, 1991, J ALLERGY CLIN IMMUN, V87, P955, DOI 10.1016/0091-6749(91)90417-M; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; REISMAN RE, 1991, J ALLERGY CLIN IMMUN, V87, P618, DOI 10.1016/0091-6749(91)90378-2; Rueff F, 2014, CLIN EXP ALLERGY, V44, P736, DOI 10.1111/cea.12275	14	5	5	7	26	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1218	+		10.1016/j.jaci.2014.08.046	http://dx.doi.org/10.1016/j.jaci.2014.08.046			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25439231				2022-12-18	WOS:000344938900039
J	Matsumoto, K; Saito, H				Matsumoto, Kenji; Saito, Hirohisa			Eczematous sensitization, a novel pathway for allergic sensitization, can occur in an early stage of eczema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Eczema; erythema; sensitization; Langerhans cells; dendrite	FOOD ALLERGY; CELLS; RISK		[Matsumoto, Kenji; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan	National Center for Child Health & Development - Japan	Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	matsumoto-k@ncchd.go.jp		Saito, Hirohisa/0000-0002-6630-8337				Fleischer DM, 2013, J ALLER CL IMM-PRACT, V1, P29, DOI 10.1016/j.jaip.2012.09.003; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kumar R, 2010, PEDIAT ALLER IMM PUL, V23, P175, DOI 10.1089/ped.2010.0014; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Matsumoto K, 2013, ALLERGOL INT, V62, P291, DOI 10.2332/allergolint.13-RAI-0603; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Senti G, 2009, J ALLERGY CLIN IMMUN, V124, P997, DOI 10.1016/j.jaci.2009.07.019; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001	10	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					865	866		10.1016/j.jaci.2014.08.006	http://dx.doi.org/10.1016/j.jaci.2014.08.006			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ9GC	25282567				2022-12-18	WOS:000343155700012
J	Sherbourne, CD; Stucky, BD; Edelen, MO; Eberhart, NK; Kleerup, E; Lara, M				Sherbourne, Cathy D.; Stucky, Brian D.; Edelen, Maria Orlando; Eberhart, Nicole K.; Kleerup, Eric; Lara, Marielena			Assessing the validity of the RAND Negative Impact of Asthma on Quality of Life Short Forms	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Validity; asthma; quality of life; short forms	HEALTH-STATUS; VALIDATION; OUTCOMES; QUESTIONNAIRE; SEVERITY; RESPONSIVENESS; IMPAIRMENT; VERSION; SCORES; ADULTS	Background: In response to recommendations from the 2010 National Institutes of Health Asthma Outcomes Workshop, we developed a system for measuring the negative impact of asthma on quality of life (QoL), which was referred to as the RAND Negative Impact of Asthma on Quality of Life (RAND-IAQL) item bank. The bank contains 65 items that focus on the patient's perception of the impact or bother of asthma on his or her life. Objective: Evidence for the validity of 2 short forms, the RAND-IAQL 4-item and 12-item Short Forms, from the bank is presented. Methods: Using a sample of 2032 adults with asthma, we validated our short forms against the Asthma Quality of Life Questionnaire-Marks (AQLQ-M), the Asthma Control Test, and generic measures of QoL developed by the Patient-reported Outcomes Measurement Information System (PROMIS). Discriminant validity was examined by comparing scores of respondents who differed according to multiple health indicators. Results: Our sample ranged in age from 18 to 99 years (mean, 43 years), with 14% Hispanic, 11% Asian, 19% African American, and 56% non-Hispanic white race/ethnicity. Men had a significantly worse impact of asthma on QoL than women. The impact of asthma on QoL was greatest in African American and Hispanic subjects compared with that seen in non-Hispanic white subjects. Our measures correlated highly with the AQLQ-M and more strongly with the PROMIS global physical than mental scales. They differentiated between adults with asthma according to their perceived severity, level of control, presence or absence of exacerbations, and physical comorbidity. Conclusion: The RAND-IAQL item bank, measuring the impact of asthma on QoL, will complement other patient-reported outcomes, such as measures of asthma symptoms, functioning, and control.	[Sherbourne, Cathy D.; Stucky, Brian D.; Edelen, Maria Orlando; Eberhart, Nicole K.; Lara, Marielena] RAND Corp, Santa Monica, CA 90407 USA; [Kleerup, Eric] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sherbourne, CD (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	Cathy_Sherbourne@rand.org	Edelen, Maria/AAM-9195-2021		National Heart, Lung, and Blood Institute [R01HL107312]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107312] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grant R01HL107312 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aburuz S, 2007, RESPIROLOGY, V12, P227, DOI 10.1111/j.1440-1843.2006.01020.x; Adams RJ, 2006, CHEST, V129, P285, DOI 10.1378/chest.129.2.285; Adams RJ, 2000, J ASTHMA, V37, P131, DOI 10.3109/02770900009055436; Apter AJ, 1999, J ALLERGY CLIN IMMUN, V103, P72, DOI 10.1016/S0091-6749(99)70528-2; Barley EA, 1998, RESP MED, V92, P1207, DOI 10.1016/S0954-6111(98)90423-1; Bayliss MS, 2000, QUAL LIFE RES, V9, P451, DOI 10.1023/A:1008939328060; CDC, 2010, AM BREATH EAS 2010 C; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cherepanov D, 2011, OUTCOMES MEASUREMENT; Cohen J., 1988, STAT POWER ANAL BEHA; DeWitt EM, 2011, J CLIN EPIDEMIOL, V64, P794, DOI 10.1016/j.jclinepi.2010.10.012; Dorans NJ, 2000, J EDUC MEAS, V37, P281, DOI 10.1111/j.1745-3984.2000.tb01088.x; Eberhart NK, 2014, QUAL LIFE RES, V23, P837, DOI 10.1007/s11136-013-0510-x; Fuhlbrigge AL, 2002, AM J RESP CRIT CARE, V166, P1044, DOI 10.1164/rccm.2107057; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Graham DM, 2000, ALLERGY ASTHMA PROC, V21, P151, DOI 10.2500/108854100778148990; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; HYLAND ME, 1991, RESP MED, V85, P13, DOI 10.1016/S0954-6111(06)80163-0; HYLAND ME, 1995, BRIT J CLIN PSYCHOL, V34, P601, DOI 10.1111/j.2044-8260.1995.tb01494.x; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Katz PP, 1999, J CLIN EPIDEMIOL, V52, P667, DOI 10.1016/S0895-4356(99)00026-8; Magid DJ, 2004, ANN EMERG MED, V43, P551, DOI 10.1016/j.annemergmed.2003.11.021; MARKS GB, 1993, J CLIN EPIDEMIOL, V46, P1103, DOI 10.1016/0895-4356(93)90109-E; MARKS GB, 1992, J CLIN EPIDEMIOL, V45, P461, DOI 10.1016/0895-4356(92)90095-5; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Rosenzweig JRC, 2004, RESP MED, V98, P1157, DOI 10.1016/j.rmed.2004.04.001; Schatz M, 2005, J ALLERGY CLIN IMMUN, V115, P1049, DOI 10.1016/j.jaci.2005.02.008; Schatz M, 2007, QUAL LIFE RES, V16, P345, DOI 10.1007/s11136-006-9103-2; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Stahl E, 2003, PULM PHARMACOL THER, V16, P53, DOI 10.1016/S1094-5539(02)00171-2; Stucky BD, 2014, RESP MED, V108, P252, DOI 10.1016/j.rmed.2013.12.008; THISSEN D, 1995, APPL PSYCH MEAS, V19, P39, DOI 10.1177/014662169501900105; Thissen D, 2001, TEST SCORING, p[xii, 422]; Wallenstein GV, 2007, CURR MED RES OPIN, V23, P369, DOI 10.1185/030079906X167426; Ware JE, 1998, QUAL LIFE RES, V7, P235, DOI 10.1023/A:1024946316424; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988	40	5	5	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					900	907		10.1016/j.jaci.2014.03.002	http://dx.doi.org/10.1016/j.jaci.2014.03.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	AQ9GC	24746752	Green Accepted			2022-12-18	WOS:000343155700017
J	McGowan, EC; Savage, JH; Courneya, JP; Sterba, PM; Parihar, S; Lin, J; Gimenez, G; Sampson, HA; Schroeder, J; MacGlashan, D; Wood, RA; Hamilton, RG; Saini, S				McGowan, Emily C.; Savage, Jessica H.; Courneya, Jean-Paul; Sterba, Patricia M.; Parihar, Saitu; Lin, Jing; Gimenez, Gustavo; Sampson, Hugh A.; Schroeder, John; MacGlashan, Donald; Wood, Robert A.; Hamilton, Robert G.; Saini, Sarbjit			Relationship of IgE to basophil phenotypes in peanut-sensitized adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHALLENGE RESPONSES		[McGowan, Emily C.; Courneya, Jean-Paul; Sterba, Patricia M.; Parihar, Saitu; Schroeder, John; MacGlashan, Donald; Wood, Robert A.; Hamilton, Robert G.; Saini, Sarbjit] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Savage, Jessica H.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Lin, Jing; Gimenez, Gustavo; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Div Pediat Allergy & Immunol, New York, NY 10029 USA	Johns Hopkins University; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	McGowan, EC (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	ssaini1@jhmi.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, KL2TR001077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088604, U19AI070345] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001077, UL1 TR001079] Funding Source: Medline; NIAID NIH HHS [U19-AI070345, R21 AI088604, U01 AI100952, U19 AI070345] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Gernez Y, 2011, INT ARCH ALLERGY IMM, V154, P318, DOI 10.1159/000321824; Glaumann S, 2012, ALLERGY, V67, P242, DOI 10.1111/j.1398-9995.2011.02754.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; Paterniti M, 2011, CLIN EXP ALLERGY, V41, P963, DOI 10.1111/j.1365-2222.2011.03719.x; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2014	134	3					746	749		10.1016/j.jaci.2014.04.040	http://dx.doi.org/10.1016/j.jaci.2014.04.040			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GR	24985395	Green Accepted			2022-12-18	WOS:000341372400036
J	Cifuentes, L; Blank, S; Pennino, D; Michel, J; Darsow, U; Ring, J; Ollert, M				Cifuentes, Liliana; Blank, Simon; Pennino, Davide; Michel, Jana; Darsow, Ulf; Ring, Johannes; Ollert, Markus			Recombinant allergens rarely allow identification of Hymenoptera venom-allergic patients with negative specific IgE to whole venom preparations Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Cifuentes, Liliana; Michel, Jana; Darsow, Ulf; Ring, Johannes; Ollert, Markus] Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Blank, Simon] Tech Univ Munich, ZAUM Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany; [Blank, Simon] Helmholtz Ctr Munich, Munich, Germany; [Pennino, Davide] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; King's College London	Cifuentes, L (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany.	liliana.cifuentes@lrz.tu-muenchen.de	Blank, Simon/M-7708-2013; Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152; Ollert, Markus W./0000-0002-8055-0103				Cifuentes L, 2014, J ALLERGY CLIN IMMUN, V133, P909, DOI 10.1016/j.jaci.2013.09.047; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Ollert M, 2005, CLIN CHEM, V51, P1241, DOI 10.1373/clinchem.2004.046565; Rafei-Shamsabadi D, 2014, J ALLERGY CLIN IMMUN, V134, P493, DOI 10.1016/j.jaci.2014.05.035; Sturm GJ, 2011, J ALLERGY CLIN IMMUN, V128, P247, DOI 10.1016/j.jaci.2011.02.021	6	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					494	+		10.1016/j.jaci.2014.05.036	http://dx.doi.org/10.1016/j.jaci.2014.05.036			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	25087229				2022-12-18	WOS:000341370800038
J	Gao, ZW; Dosman, JA; Rennie, DC; Schwartz, DA; Yang, IV; Beach, J; Senthilselvan, A				Gao, Zhiwei; Dosman, James A.; Rennie, Donna C.; Schwartz, David A.; Yang, Ivana V.; Beach, Jeremy; Senthilselvan, Ambikaipakan			NOS3 polymorphism, lung function, and exposure in swine operations: Results of 2 studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NITRIC-OXIDE SYNTHASE; GENE POLYMORPHISMS; WORKERS; ASTHMA		[Gao, Zhiwei; Senthilselvan, Ambikaipakan] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Dosman, James A.; Rennie, Donna C.] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [Schwartz, David A.; Yang, Ivana V.] Univ Colorado, Dept Med, Denver, CO USA; [Beach, Jeremy] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Saskatchewan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta	Gao, ZW (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	sentil@ualberta.ca	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X	Canadian Institutes of Health Research [MOP-57907] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Gao ZW, 2013, ANN ALLERG ASTHMA IM, V110, P44, DOI 10.1016/j.anai.2012.11.003; Holla LI, 2002, CLIN EXP ALLERGY, V32, P1193, DOI 10.1046/j.1365-2745.2002.01445.x; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Lee YC, 2000, ALLERGY, V55, P959, DOI 10.1034/j.1398-9995.2000.00724.x; SHAUL PW, 1994, J CLIN INVEST, V94, P2231, DOI 10.1172/JCI117585; Vaporidi K, 2010, AM J PHYSIOL-LUNG C, V299, pL150, DOI 10.1152/ajplung.00341.2009; Von Essen SG, 1998, J TOXICOL-CLIN TOXIC, V36, P557, DOI 10.3109/15563659809028049	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2014	134	2					485	488		10.1016/j.jaci.2014.04.006	http://dx.doi.org/10.1016/j.jaci.2014.04.006			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GB	24865140				2022-12-18	WOS:000341370800034
J	Recher, M; Karjalainen-Lindsberg, ML; Lindlof, M; Soderlund-Venermo, M; Lanzi, G; Vaisanen, E; Kumar, A; Sadeghi, M; Berger, CT; Alitalo, T; Anttila, P; Kolehmainen, M; Franssila, R; Chen, TT; Siitonen, S; Delmonte, OM; Walter, JE; Pessach, I; Hess, C; Simpson, MA; Navarini, AA; Giliani, S; Hedman, K; Seppanen, M; Notarangelo, LD				Recher, Mike; Karjalainen-Lindsberg, Marja-Liisa; Lindlof, Mikael; Soderlund-Venermo, Maria; Lanzi, Gaetana; Vaisanen, Elina; Kumar, Arun; Sadeghi, Mohammadreza; Berger, Christoph T.; Alitalo, Tiina; Anttila, Pekka; Kolehmainen, Maija; Franssila, Rauli; Chen, Tingting; Siitonen, Sanna; Delmonte, Ottavia M.; Walter, Jolan E.; Pessach, Itai; Hess, Christoph; Simpson, Michael A.; Navarini, Alexander A.; Giliani, Silvia; Hedman, Klaus; Seppanen, Mikko; Notarangelo, Luigi D.			Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-CELLS; SLFN2		[Recher, Mike; Delmonte, Ottavia M.; Walter, Jolan E.; Pessach, Itai; Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Recher, Mike; Delmonte, Ottavia M.; Walter, Jolan E.; Pessach, Itai; Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Recher, Mike; Berger, Christoph T.; Hess, Christoph] Univ Basel Hosp, Med Outpatient Clin, Clin Primary Immunodeficiency, CH-4031 Basel, Switzerland; [Recher, Mike; Berger, Christoph T.; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, CH-4031 Basel, Switzerland; [Karjalainen-Lindsberg, Marja-Liisa; Lindlof, Mikael; Soderlund-Venermo, Maria; Vaisanen, Elina; Kumar, Arun; Sadeghi, Mohammadreza; Franssila, Rauli; Chen, Tingting; Siitonen, Sanna; Hedman, Klaus] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Karjalainen-Lindsberg, Marja-Liisa; Lindlof, Mikael; Soderlund-Venermo, Maria; Vaisanen, Elina; Kumar, Arun; Sadeghi, Mohammadreza; Franssila, Rauli; Chen, Tingting; Siitonen, Sanna; Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland; [Lanzi, Gaetana; Giliani, Silvia] Childrens Hosp, Angelo Nocivelli Inst Mol Med, Dept Pediat, Brescia, Italy; [Lanzi, Gaetana; Giliani, Silvia] Childrens Hosp, Dept Pathol, Lab Genet Disorders Childhood, Brescia, Italy; [Alitalo, Tiina] Univ Helsinki, Cent Hosp, Genet Lab, HUSLAB, Helsinki, Finland; [Anttila, Pekka; Kolehmainen, Maija] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Pessach, Itai] Chaim Sheba Med Ctr, Dept Pediat Crit Care, IL-52621 Tel Hashomer, Israel; [Pessach, Itai] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Simpson, Michael A.; Navarini, Alexander A.] Kings Coll London, Guys Hosp, Sch Med, Div Genet & Mol Med, London, England	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Basel; University of Basel; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Recher, M (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	recherm@uhbs.ch	Chen, Tingting/I-8274-2019; Notarangelo, Luigi D/F-9718-2016; Söderlund-Venermo, Maria/AAX-2112-2020; Berger, Christoph T/I-6126-2019; Giliani, Silvia/AAX-8843-2020; Hedman, Klaus/D-5379-2009; Simpson, Michael/F-4737-2011; Navarini, Alexander/C-5504-2014	Chen, Tingting/0000-0002-2227-3208; Notarangelo, Luigi D/0000-0002-8335-0262; Berger, Christoph T/0000-0002-1730-8824; Giliani, Silvia/0000-0001-8137-4642; Recher, Mike/0000-0002-9121-6936; Simpson, Michael/0000-0002-8539-8753; Seppanen, Mikko/0000-0001-9733-3650; Kumar, Arun/0000-0003-4483-7585; Hedman, Klaus/0000-0003-1779-7960; sadeghi, mohammad reza/0000-0002-2725-6407; Navarini, Alexander/0000-0001-7059-632X				Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Horton MR, 2010, NAT IMMUNOL, V11, P281, DOI 10.1038/ni0410-281; Xia ZQ, 2012, J IMMUNOL, V188, P3315, DOI 10.4049/jimmunol.1102775	8	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1462	U382		10.1016/j.jaci.2013.10.052	http://dx.doi.org/10.1016/j.jaci.2013.10.052			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24373355				2022-12-18	WOS:000335450700031
J	Beigelman, A; Zeiger, RS; Kelly, HW; Bacharier, LB				Beigelman, Avraham; Zeiger, Robert S.; Kelly, H. William; Bacharier, Leonard B.		Natl Heart Lung Blood Inst	The challenge of treating preschool wheezing episodes: The need for evidence-based approaches	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Lower respiratory tract illness; oral corticosteroids; preschool children; treatment strategies; recurrent wheezing	CHILDHOOD ASTHMA; ORAL PREDNISOLONE; CHILDREN; CORTICOSTEROIDS		[Beigelman, Avraham; Bacharier, Leonard B.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Beigelman, Avraham; Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO USA; [Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Allergy, San Diego, CA USA; [Zeiger, Robert S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kelly, H. William] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Kaiser Permanente; University of California System; University of California San Diego; University of New Mexico	Beigelman, A (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Allergy Immunol & Pulm Med, 660 S Euclid Ave,Campus Box 8116, St Louis, MO 63110 USA.	beigelman_a@kids.wustl.edu		Bacharier, Leonard/0000-0003-0432-2704; Zeiger, Robert/0000-0001-5788-5063	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000997, UL1RR025780, M01RR000051, M01RR000036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064305, U10HL064307, U10HL064287, U10HL064288, U10HL064295, U10HL064313] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000448, UL1 TR001082, KL2 TR000450] Funding Source: Medline; NCRR NIH HHS [5M01 RR00997, 1 UL1RR025780, M01 RR000036, M01 RR000997, M01 RR00051, M01 RR00036, UL1 RR025780, M01 RR000051] Funding Source: Medline; NHLBI NIH HHS [5U10HL064288, U10 HL064313, 5U10HL064313, 5U10HL064305, U10 HL064307, U10 HL064287, 5U10HL064307, 5U10HL064295, U10 HL064305, U10 HL064288, U10 HL064295, 5U10HL064287] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beigelman A, 2013, J ALLERGY CLIN IMMUN, V131, P1518, DOI 10.1016/j.jaci.2013.01.034; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Gergen PJ, 2013, J ALLERGY CLIN IMMUN, V131, P1526, DOI 10.1016/j.jaci.2013.03.011; GRANT CC, 1995, PEDIATRICS, V96, P224; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hasegawa K, 2013, J PEDIATR-US, V163, P1127, DOI 10.1016/j.jpeds.2013.05.002; Hewer SL, 1998, RESP MED, V92, P541, DOI 10.1016/S0954-6111(98)90305-5; Kayani S, 2002, CHEST, V122, P624, DOI 10.1378/chest.122.2.624; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; National Asthma Education and Prevention Program NH Lung and Blood Institute National Institutes of Health US Department of Health and Human Services., 2007, 3 US DEP HLTH HUM SE; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Rowe BH, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000195.pub2; Weinberger M, 2014, J ALLERGY CLIN IMMUN, V133, P1014, DOI 10.1016/j.jaci.2013.07.013	14	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1016	1017		10.1016/j.jaci.2014.01.005	http://dx.doi.org/10.1016/j.jaci.2014.01.005			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24529412	Green Accepted, Bronze			2022-12-18	WOS:000333531700010
J	Sheshadri, A; Hoffman, EA; Castro, M				Sheshadri, Ajay; Hoffman, Eric A.; Castro, Mario			Can computed tomography help us identify asthmatic phenotypes?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Endotype; biomarker; phenotype; asthma	AIRWAY WALL THICKNESS; CLUSTER-ANALYSIS; CT		[Sheshadri, Ajay; Castro, Mario] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA	Washington University (WUSTL); University of Iowa	Castro, M (corresponding author), Washington Univ, Sch Med, Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	castrom@wustl.edu	Sheshadri, Ajay/AAN-7427-2020	Sheshadri, Ajay/0000-0002-8091-0180; Hoffman, Eric/0000-0001-8456-9437				Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Castro M, 2011, J ALLERGY CLIN IMMUN, V107, P65; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Grenier P, 1996, EUR RADIOL, V6, P199; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Kasahara K, 2002, THORAX, V57, P242, DOI 10.1136/thorax.57.3.242; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518, DOI 10.1164/ajrccm.162.4.9909044; Park SW, 2012, RESP MED, V106, P786, DOI 10.1016/j.rmed.2012.02.012	14	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					739	740		10.1016/j.jaci.2013.12.1036	http://dx.doi.org/10.1016/j.jaci.2013.12.1036			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24472625	Bronze			2022-12-18	WOS:000332397600015
J	Pereira, DA; Tavera, MAU; Pereira, DA; Madrigal-Burgaleta, R; Berges-Gimeno, P; Alvarez-Cuesta, E				Angel Pereira, Denisse; Urena Tavera, Maria Alicia; Angel Pereira, Denisse; Madrigal-Burgaleta, Ricardo; Berges-Gimeno, Pilar; Alvarez-Cuesta, Emilio			Desensitization To Anakinra Case Report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Angel Pereira, Denisse; Urena Tavera, Maria Alicia; Angel Pereira, Denisse; Madrigal-Burgaleta, Ricardo; Berges-Gimeno, Pilar; Alvarez-Cuesta, Emilio] Ramon y Cajal Univ Hosp, Madrid, Spain	Hospital Universitario Ramon y Cajal			Madrigal-Burgaleta, Ricardo/AAF-3255-2019	Madrigal-Burgaleta, Ricardo/0000-0002-3358-3578					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		947	AB274	AB274						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241301263
J	Bernstein, JA; Saini, SS; Maurer, M; Hsieh, HJ; Chen, H; Canvin, J; Casale, TB; Kaplan, AP; Rosen, K				Bernstein, Jonathan A.; Saini, Sarbjit S.; Maurer, Marcus; Hsieh, Hsin-Ju; Chen, Hubert; Canvin, Janice; Casale, Thomas B.; Kaplan, Allen P.; Rosen, Karin			Efficacy Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria With Different Background Therapy: Post Hoc Analysis Of Asteria I, Asteria II, and Glacial Studies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Bernstein, Jonathan A.; Rosen, Karin] Univ Cincinnati, Med Ctr, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Saini, Sarbjit S.] Johns Hopkins Univ, Baltimore, MD USA; [Maurer, Marcus] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Hsieh, Hsin-Ju; Chen, Hubert] Genentech Inc, San Francisco, CA 94080 USA; [Canvin, Janice] Novartis Pharmaceut UK Ltd, Horsham, W Sussex, England; [Casale, Thomas B.] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Kaplan, Allen P.] Med Univ S Carolina, Charleston, SC 29425 USA	University System of Ohio; University of Cincinnati; Johns Hopkins University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding; Genentech; Novartis; State University System of Florida; University of South Florida; Medical University of South Carolina			Maurer, Marcus/ABG-2174-2020; Casale, Thomas B/K-4334-2013	Maurer, Marcus/0000-0002-4121-481X; Casale, Thomas B/0000-0002-3149-7377; Canvin, Janice/0000-0001-9609-7182					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		411	AB117	AB117		10.1016/j.jaci.2013.12.435	http://dx.doi.org/10.1016/j.jaci.2013.12.435			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO		Bronze			2022-12-18	WOS:000330241300408
J	Haddad, E; Allakhverdi, Z; Griffith, LM; Cowan, MJ; Notarangelo, LD				Haddad, Elie; Allakhverdi, Zoulfia; Griffith, Linda M.; Cowan, Morton J.; Notarangelo, Luigi D.			Survey on retransplantation criteria for patients with severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STEM-CELL TRANSPLANTATION; RECONSTITUTION		[Haddad, Elie] Univ Montreal, Dept Pediat, Div Pediat Immunol Allergy & Rheumatol, Montreal, PQ H3C 3J7, Canada; [Haddad, Elie; Allakhverdi, Zoulfia] CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Griffith, Linda M.] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA; [Cowan, Morton J.] Univ Calif San Francisco, Benioff Childrens Hosp, Div Pediat Allergy Immunol & Blood & Marrow Trans, San Francisco, CA 94143 USA; [Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Haddad, E (corresponding author), Univ Montreal, Dept Pediat, Div Pediat Immunol Allergy & Rheumatol, Montreal, PQ H3C 3J7, Canada.	elie.haddad@umontreal.ca	Allakhverdi, Zoulfia/AAG-1379-2019; Notarangelo, Luigi D/F-9718-2016; Haddad, Elie/AAQ-4971-2020	Notarangelo, Luigi D/0000-0002-8335-0262; Haddad, Elie/0000-0003-2446-6879	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI082973, R13AI094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS064808] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI082973, R13 AI094943] Funding Source: Medline; NINDS NIH HHS [U54 NS064808] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buckley RH, 2013, J CLIN IMMUNOL, V33, P96, DOI 10.1007/s10875-012-9797-6; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Griffith LM, 2014, J ALLERGY CLIN IMMUN, V133, P335, DOI 10.1016/j.jaci.2013.07.052; Haddad E, 1998, BLOOD, V91, P3646; Haddad E, 2013, J ALLERGY CLIN IMMUN, V131, P994, DOI 10.1016/j.jaci.2013.01.047; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Shearer WT, 2014, J ALLERGY C IN PRESS; Teigland CL, 2013, BONE MARROW TRANSPL, V48, P1050, DOI 10.1038/bmt.2013.6	10	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					597	599		10.1016/j.jaci.2013.10.022	http://dx.doi.org/10.1016/j.jaci.2013.10.022			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24331379	Green Accepted			2022-12-18	WOS:000332397100045
J	Nowak-Wegrzyn, AH; Strong, BD; Ananos, D; Sampson, HA				Nowak-Wegrzyn, Anna H.; Strong, Beth D.; Ananos, Diane; Sampson, Hugh A.			Long Term Follow Up Of Children Who Incorporated Extensively Heated (baked milk) In The Diet	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Nowak-Wegrzyn, Anna H.; Strong, Beth D.; Ananos, Diane; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		372	AB107	AB107		10.1016/j.jaci.2013.12.396	http://dx.doi.org/10.1016/j.jaci.2013.12.396			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO		Bronze			2022-12-18	WOS:000330241300370
J	Paggiaro, P; Halpin, DMG; Buhl, R; Engel, M; Zubek, V; Blahova, Z; Moroni-Zentgraf, P; Pizzichini, E				Paggiaro, Pierluigi; Halpin, David M. G.; Buhl, Roland; Engel, Michael; Zubek, Valentina; Blahova, Zuzana; Moroni-Zentgraf, Petra; Pizzichini, Emilio			Tiotropium Respimat (R) Add-On To Inhaled Corticosteroids Improves Lung Function In Patients With Symptomatic Mild Asthma: Results From A Phase III Trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Paggiaro, Pierluigi] Univ Pisa, Pisa, Italy; [Halpin, David M. G.] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Buhl, Roland] Mainz Univ Hosp, Mainz, Germany; [Engel, Michael; Moroni-Zentgraf, Petra] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Zubek, Valentina] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Blahova, Zuzana] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Pizzichini, Emilio] Univ Fed Santa Catarina, NUPAIVA Asthma Res Ctr, Florianopolis, SC, Brazil	University of Pisa; University of Exeter; University Hospital Mainz; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Universidade Federal de Santa Catarina (UFSC)			Pizzichini, Emilio/L-2252-2014	Pizzichini, Emilio/0000-0001-7046-9996					0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		15	AB4	AB4		10.1016/j.jaci.2013.12.039	http://dx.doi.org/10.1016/j.jaci.2013.12.039			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241300016
J	Shin, JI; Eisenhut, M				Shin, Jae Il; Eisenhut, Michael			A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: Just a B-cell depletion?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Shin, Jae Il] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea; [Eisenhut, Michael] NHS Fdn Trust, Luton & Dunstable Univ Hosp, Dept Pediat, Luton, Beds, England	Yonsei University; Yonsei University Health System; Oxford University Hospitals NHS Foundation Trust	Shin, JI (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea.	shinji@yuhs.ac; michael_eisenhut@yahoo.com	SHIN, JAE IL/ABD-9660-2021; SHIN, JAE IL/J-6922-2017	SHIN, JAE IL/0000-0003-2326-1820; SHIN, JAE IL/0000-0003-2326-1820				Navarrete AM, 2011, VACCINE, V29, P2649, DOI 10.1016/j.vaccine.2011.01.095; Scully M, 2012, HEMATOLOGY, V17, pS22, DOI 10.1179/102453312X13336169155178; Sfikakis PP, 2007, CLIN IMMUNOL, V123, P66, DOI 10.1016/j.clim.2006.12.006; Sorvillo N, 2012, BLOOD, V119, P3828, DOI 10.1182/blood-2011-09-377754; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; Toyoda H, 2013, J ALLERGY CLIN IMMUN, V132, P226, DOI 10.1016/j.jaci.2013.01.040	6	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					600	600		10.1016/j.jaci.2013.11.022	http://dx.doi.org/10.1016/j.jaci.2013.11.022			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24365135				2022-12-18	WOS:000332397100046
J	Swanson, BN; Wang, L; Ming, J; Hamilton, JD; Teper, A; Dicioccio, T; Li, YT; Graham, N; Pirozzi, G; Wenzel, SE				Swanson, Brian N.; Wang, Lin; Ming, Jeffrey; Hamilton, Jennifer D.; Teper, Ariel; Dicioccio, Thomas; Li, Yongtao; Graham, Neil; Pirozzi, Gianluca; Wenzel, Sally E.			Exhaled Nitric Oxide (FeNO) and T-Helper 2 Cell Biomarkers: Can They Predict Treatment Response To Dupilumab, An IL-4R alpha Antibody, In An Eosinophilic Asthma Population?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Swanson, Brian N.; Wang, Lin; Ming, Jeffrey; Teper, Ariel; Li, Yongtao; Pirozzi, Gianluca] Sanofi Rech, Bridgewater, NJ USA; [Hamilton, Jennifer D.; Dicioccio, Thomas; Graham, Neil] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Wenzel, Sally E.] Univ Pittsburgh, Med Ctr NW, Pittsburgh, PA USA	Sanofi-Aventis; Regeneron; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh									0	5	7	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		297	AB85	AB85		10.1016/j.jaci.2013.12.321	http://dx.doi.org/10.1016/j.jaci.2013.12.321			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241300295
J	Turner, S				Turner, Stephen			Predicting the future for recurrent respiratory symptoms in young children: Applying a dash of science to the art of medicine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; child; diagnosis; longitudinal studies; sensitivity	ASTHMA		Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Aberdeen AB25 2ZG, Scotland	University of Aberdeen	Turner, S (corresponding author), Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Foresterhill, Aberdeen AB25 2ZG, Scotland.	s.w.turner@abdn.ac.uk	Turner, Stephen/GXM-4654-2022					British Thoracic Society Scottish Intercollegiate Guidelines Network, BRIT GUID MAN ASTHM; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Pescatore AM, 2014, J ALLERGY CLIN IMMUN, V133, P111, DOI 10.1016/j.jaci.2013.06.002; SPEIGHT ANP, 1983, BRIT MED J, V286, P1253, DOI 10.1136/bmj.286.6373.1253	5	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					119	120		10.1016/j.jaci.2013.07.001	http://dx.doi.org/10.1016/j.jaci.2013.07.001			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	23910688				2022-12-18	WOS:000329105700016
J	Renz, H				Renz, Harald			Advances in in vitro diagnostics in allergy, asthma, and immunology in 2012	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunodeficiencies; neonatal screening; recombinant allergens; food allergy; rhinitis; insect venom allergies	SEVERE COMBINED-IMMUNODEFICIENCY; API M 1; BASOPHIL ACTIVATION TEST; WEIGHT-GLUTENIN SUBUNIT; DETECTABLE SPECIFIC IGE; NORTH-SOUTH DIFFERENCE; VES V 5; WASP VENOM; CLINICAL-RELEVANCE; PERIOSTIN	Laboratory tests play an increasing role in risk assessment, diagnostics, and disease monitoring. Great advances have been achieved lately, particularly in the field of clinical immunology and allergy. These include neonatal screening of immunodeficiencies and asthma biomarkers and investigation into the role of recombinant allergens in in vitro testing. The latter area has implications for the diagnostics of food allergy, pollen-induced allergies, asthma, and insect allergies.	Univ Marburg, Inst Lab Med, D-35043 Marburg, Germany	Philipps University Marburg	Renz, H (corresponding author), Univ Marburg, Inst Lab Med, Baldinger Str, D-35043 Marburg, Germany.	renzh@med.uni-marburg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB/TR22]; German Lung Center (DZL); LOEWE Center "Universities Giessen and Marburg Lung Center'' (UGMLC)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Lung Center (DZL); LOEWE Center "Universities Giessen and Marburg Lung Center'' (UGMLC)	Supported by the Deutsche Forschungsgemeinschaft (DFG; SFB/TR22), the German Lung Center (DZL), and the LOEWE Center "Universities Giessen and Marburg Lung Center'' (UGMLC).	Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Asarnoj A, 2012, J ALLERGY CLIN IMMUN, V130, P468, DOI 10.1016/j.jaci.2012.05.019; Azzari C, 2011, J ALLERGY CLIN IMMUN, V127, P1394, DOI 10.1016/j.jaci.2011.03.040; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Baker MW, 2010, PUBLIC HEALTH REP, V125, P88, DOI 10.1177/00333549101250S211; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Buckley RH, 2012, J ALLERGY CLIN IMMUN, V129, P597, DOI 10.1016/j.jaci.2011.12.964; Caubet JC, 2012, J ALLERGY CLIN IMMUN, V129, P739, DOI 10.1016/j.jaci.2011.11.053; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chinuki Y, 2012, J ALLERGY CLIN IMMUN, V129, P1404, DOI 10.1016/j.jaci.2012.02.049; Comeau AM, 2010, J INHERIT METAB DIS, V33, pS273, DOI 10.1007/s10545-010-9103-9; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cunningham-Rundles C, 2012, J ALLERGY CLIN IMMUN, V129, P1425, DOI 10.1016/j.jaci.2012.03.025; Dang TD, 2012, J ALLERGY CLIN IMMUN, V129, P1056, DOI 10.1016/j.jaci.2012.01.056; de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x; Eberlein B, 2012, J ALLERGY CLIN IMMUN, V130, P155, DOI 10.1016/j.jaci.2012.02.008; Fukutomi Y, 2012, J ALLERGY CLIN IMMUN, V129, P860, DOI 10.1016/j.jaci.2012.01.031; Gerstel-Thompson JL, 2010, CLIN CHEM, V56, P1466, DOI 10.1373/clinchem.2010.144915; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; Hale JE, 2010, J ALLERGY CLIN IMMUN, V126, P1073, DOI 10.1016/j.jaci.2010.08.043; Haneda Y, 2012, J ALLERGY CLIN IMMUN, V129, P1681, DOI 10.1016/j.jaci.2012.03.041; Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; Jakob T, 2012, J ALLERGY CLIN IMMUN, V130, P276, DOI 10.1016/j.jaci.2012.03.048; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Korosec P, 2012, J ALLERGY CLIN IMMUN, V130, P818, DOI 10.1016/j.jaci.2012.05.048; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kulis M, 2012, J ALLERGY CLIN IMMUN, V129, P1159, DOI 10.1016/j.jaci.2011.11.045; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Matsuo H, 2005, J IMMUNOL, V175, P8116, DOI 10.4049/jimmunol.175.12.8116; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Morita E, 2001, BRIT J DERMATOL, V145, P182, DOI 10.1046/j.1365-2133.2001.04314.x; Nair P, 2012, J ALLERGY CLIN IMMUN, V130, P655, DOI 10.1016/j.jaci.2012.07.021; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Palosuo K, 2003, J ALLERGY CLIN IMMUN, V111, P1386, DOI 10.1067/mai.2003.1498; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Puck JM, 2012, J ALLERGY CLIN IMMUN, V129, P607, DOI 10.1016/j.jaci.2012.01.032; Rachid R, 2012, J ALLERGY CLIN IMMUN, V129, P628, DOI 10.1016/j.jaci.2011.06.047; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Shearer WT, 2012, J ALLERGY CLIN IMMUN, V129, P619, DOI 10.1016/j.jaci.2011.12.992; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Sturm GJ, 2012, J ALLERGY CLIN IMMUN, V130, P817, DOI 10.1016/j.jaci.2012.05.047; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Takahashi H, 2012, CLIN EXP ALLERGY, V42, P1293, DOI 10.1111/j.1365-2222.2012.04039.x; Tripodi S, 2012, J ALLERGY CLIN IMMUN, V129, P834, DOI 10.1016/j.jaci.2011.10.045; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Uygungil B, 2012, J ALLERGY CLIN IMMUN, V129, P1692, DOI 10.1016/j.jaci.2012.03.043; Valcarcel MA, 2012, J ALLERGY CLIN IMMUN, V130, P1001, DOI 10.1016/j.jaci.2012.06.036; Verbsky J, 2012, J ALLERGY CLIN IMMUN, V129, P622, DOI 10.1016/j.jaci.2011.12.004	55	5	7	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1287	1292		10.1016/j.jaci.2013.08.043	http://dx.doi.org/10.1016/j.jaci.2013.08.043			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24139605				2022-12-18	WOS:000327538200007
J	Fernandez-Bertolin, L; Mullol, J; Fuentes-Prado, M; Alobid, I; Roca-Ferrer, J; Picado, C; Pujols, L				Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar; Pujols, Laura			Deficient glucocorticoid induction of anti-inflammatory genes in nasal polyp fibroblasts of asthmatic patients with and without aspirin intolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar; Pujols, Laura] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Fernandez-Bertolin, Laura; Mullol, Joaquim; Fuentes-Prado, Mireya; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar; Pujols, Laura] Univ Barcelona, Ctr Invest Resp Red Enfermedades Resp CIBERes, Barcelona, Spain; [Mullol, Joaquim; Alobid, Isam] Univ Barcelona, Hosp Clin, Unitat Rinol & Clin Olfacte, Serv Otorrinolaringol, Barcelona, Spain; [Picado, Cesar] Univ Barcelona, Hosp Clin, Serv Pneumol & Allergia Resp, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Fernandez-Bertolin, L (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	lpujols@clinic.ub.es	Fuentes, Mireya/J-5901-2017; /AAL-7347-2021; Roca-Ferrer, Jordi/AFQ-4652-2022; Pujols, Laura/G-8920-2015; /AFX-9519-2022	Fuentes, Mireya/0000-0002-1381-5589; Roca-Ferrer, Jordi/0000-0002-9527-2273; Pujols, Laura/0000-0003-3708-5098; 				Bachert C, 2010, CURR ALLERGY ASTHM R, V10, P194, DOI 10.1007/s11882-010-0096-0; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Fernandez-Bertolin L, 2011, RHINOLOGY, V49, P562, DOI 10.4193/Rhino11.036; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC	9	5	5	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2013	132	5					1243	1246		10.1016/j.jaci.2013.07.010	http://dx.doi.org/10.1016/j.jaci.2013.07.010			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	242JH	23998656				2022-12-18	WOS:000326235600037
J	Allen, KJ; Koplin, J; Ponsonby, AL; Vuillermin, P; Dharmage, SC				Allen, Katrina J.; Koplin, Jennifer; Ponsonby, Anne-Louise; Vuillermin, Peter; Dharmage, Shyamali C.		HealthNuts Study Invest	Vitamin D and food allergy in patients with severe atopic dermatitis Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OF-FUNCTION MUTATIONS; INFANTS		[Allen, Katrina J.; Koplin, Jennifer; Ponsonby, Anne-Louise; Vuillermin, Peter; Dharmage, Shyamali C.; HealthNuts Study Invest] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Allen, Katrina J.; Koplin, Jennifer; Ponsonby, Anne-Louise] Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia; [Dharmage, Shyamali C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia; [Allen, Katrina J.] Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic 3052, Australia; [Vuillermin, Peter] Barwon Hlth & Deakin Univ Geelong, Child Hlth Res Unit, Geelong, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Allen, KJ (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	katie.allen@rch.org.au	Ponsonby, Anne-Louise/AAE-4351-2019; Allen, Katrina/I-4361-2018; Matheson, Melanie C/O-4721-2015	Allen, Katrina/0000-0002-1921-4493; Matheson, Melanie C/0000-0002-5822-3499; Tang, Mimi/0000-0002-3839-5293; Dharmage, Shyamali/0000-0001-6063-1937; Koplin, Jennifer/0000-0002-7576-5142; Ponsonby, Anne-Louise/0000-0002-6581-3657				Allen KJ, 2013, J ALLERGY CLIN IMMUN, V131, P1109, DOI 10.1016/j.jaci.2013.01.017; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Koplin JJ, 2012, J ALLERGY CLIN IMMUN, V129, P1145, DOI 10.1016/j.jaci.2011.09.044; Mohiuddin MS, 2013, J ALLERGY CLIN IMMUN, V132, P1011, DOI 10.1016/j.jaci.2013.06.039; Tan HTT, 2012, J ALLERGY CLIN IMMUN, V130, P1211, DOI 10.1016/j.jaci.2012.07.022	5	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					1011	1012		10.1016/j.jaci.2013.06.040	http://dx.doi.org/10.1016/j.jaci.2013.06.040			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23954350				2022-12-18	WOS:000325096500043
J	von Berg, A; Koletzko, S; Filipiak-Pittroff, B; Heinrich, J; Bauer, CP; Kramer, U; Hoffmann, B; Berdel, D				von Berg, Andrea; Koletzko, Sibylle; Filipiak-Pittroff, Birgit; Heinrich, Joachim; Bauer, Carl-P.; Kraemer, Ursula; Hoffmann, Barbara; Berdel, Dietrich		German Infant Nutr Intervention	The German Infant Nutritional Intervention (GINI) study and formulation issues Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[von Berg, Andrea; Filipiak-Pittroff, Birgit; Berdel, Dietrich] Marien Hosp Wesel, Res Inst, Dept Pediat, Wesel, Germany; [Koletzko, Sibylle; Filipiak-Pittroff, Birgit] Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany; [Heinrich, Joachim] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munich, Inst Epidemiol 1, Neuherberg, Germany; [Bauer, Carl-P.] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Kraemer, Ursula; Hoffmann, Barbara] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany	St. Marien Hospital; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	von Berg, A (corresponding author), Marien Hosp Wesel, Res Inst, Dept Pediat, Wesel, Germany.	avb.rodehorst@gmx.de	Heinrich, Joachim/N-1720-2013	Heinrich, Joachim/0000-0002-9620-1629				Meaney JV, 2013, J ALLERGY CLIN IMMUN, V132, P770, DOI 10.1016/j.jaci.2013.05.009; Rzehak P, 2011, CLIN NUTR, V30, P339, DOI 10.1016/j.clnu.2010.11.002; von Berg A, 2013, J ALLERGY CLIN IMMUN, V131, P1565, DOI 10.1016/j.jaci.2013.01.006	3	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2013	132	3					770	771		10.1016/j.jaci.2013.05.010	http://dx.doi.org/10.1016/j.jaci.2013.05.010			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	207OS	23810765				2022-12-18	WOS:000323612000041
J	Marrs, T; du Toit, G; Fox, AT; Perkin, MR; Lack, G				Marrs, Tom; du Toit, George; Fox, Adam T.; Perkin, Michael R.; Lack, Gideon			Double-blind food challenges can be conducted effectively by using interspersed active and placebo doses among children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALLERGY; ADULTS		[Marrs, Tom; du Toit, George; Fox, Adam T.; Perkin, Michael R.; Lack, Gideon] Kings Coll London, Dept Paediat Allergy, London, England; [Marrs, Tom; du Toit, George; Fox, Adam T.; Perkin, Michael R.; Lack, Gideon] Guys & St Thomas Hosp, Dept Childrens Allergies, London SE1 9RT, England; [Perkin, Michael R.] Div Clin Dev Sci, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Marrs, T (corresponding author), Kings Coll London, Dept Paediat Allergy, London, England.	tommarrs@doctors.org.uk	Fox, Adam/O-3547-2015; Perkin, Michael/AID-7491-2022	Fox, Adam/0000-0002-3533-9798; Du Toit, George/0000-0002-0321-2928; Perkin, Michael/0000-0001-9272-2585; Lack, Gideon/0000-0001-7350-4021	Medical Research Council [G1000758B] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish; Medical Research Council [G1000758] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		HANSEN TK, 1992, ALLERGY, V47, P610, DOI 10.1111/j.1398-9995.1992.tb02383.x; Lucas JSA, 2004, CLIN EXP ALLERGY, V34, P1115, DOI 10.1111/j.1365-2222.2004.01982.x; Niggemann B, 2010, ALLERGY, V65, P2, DOI 10.1111/j.1398-9995.2009.02170.x; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Wensing M, 2002, CLIN EXP ALLERGY, V32, P1757, DOI 10.1046/j.1365-2222.2002.01555.x	5	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2013	132	2					502	502		10.1016/j.jaci.2013.04.040	http://dx.doi.org/10.1016/j.jaci.2013.04.040			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	194KL	23763972	Bronze			2022-12-18	WOS:000322631700038
J	Naclerio, RM; Baroody, FM; Pinto, JM				Naclerio, Robert M.; Baroody, Fuad M.; Pinto, Jayant M.			Should clinicians use omalizumab for the treatment of nasal polyps?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC RHINOSINUSITIS		[Naclerio, Robert M.; Baroody, Fuad M.; Pinto, Jayant M.] Univ Chicago Med & Biol Sci, Sect Otolaryngol Head & Neck Surg, Chicago, IL USA		Naclerio, RM (corresponding author), Univ Chicago Med & Biol Sci, Sect Otolaryngol Head & Neck Surg, Chicago, IL USA.	fbaroody@surgery.bsd.uchicago.edu						Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Kern RC, 2013, J ALLERGY CLIN IMMUN, V131, P117, DOI 10.1016/j.jaci.2012.11.021; Pinto JM, 2010, RHINOLOGY, V48, P318, DOI [10.4193/Rhin09.144, 10.4193/Rhino09.144]	3	5	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2013	132	1					247	247		10.1016/j.jaci.2013.04.001	http://dx.doi.org/10.1016/j.jaci.2013.04.001			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	173BF	23684073				2022-12-18	WOS:000321052300041
J	Gadermaier, E; Flicker, S; Lupinek, C; Steinberger, P; Valenta, R				Gadermaier, Elisabeth; Flicker, Sabine; Lupinek, Christian; Steinberger, Peter; Valenta, Rudolf			Determination of allergen specificity by heavy chains in grass pollen allergen-specific IgE antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; allergen; IgE antibodies; specificity; affinity	EFFECTOR CELL DEGRANULATION; PHLEUM-PRATENSE POLLEN; BETA-LACTOGLOBULIN ALLERGEN; MOLECULAR CHARACTERIZATION; ENCODING TRANSCRIPTOME; MAJOR ALLERGEN; CDNA CLONING; PLASMA-CELLS; P 5; REPERTOIRE	Background: Affinity and clonality of allergen-specific IgE antibodies are important determinants for the magnitude of IgE-mediated allergic inflammation. Objective: We sought to analyze the contribution of heavy and light chains of human allergen-specific IgE antibodies for allergen specificity and to test whether promiscuous pairing of heavy and light chains with different allergen specificity allows binding and might affect affinity. Methods: Ten IgE Fabs specific for 3 non-cross-reactive major timothy grass pollen allergens (Phl p 1, Phl p 2, and Phl p 5) obtained by means of combinatorial cloning from patients with grass pollen allergy were used to construct stable recombinant single chain variable fragments (ScFvs) representing the original Fabs and shuffled ScFvs in which heavy chains were recombined with light chains from IgE Fabs with specificity for other allergens by using the pCANTAB 5 E expression system. Possible ancestor genes for the heavy chain and light chain variable region-encoding genes were determined by using sequence comparison with the ImMunoGeneTics database, and their chromosomal locations were determined. Recombinant ScFvs were tested for allergen specificity and epitope recognition by means of direct and sandwich ELISA, and affinity by using surface plasmon resonance experiments. Results: The shuffling experiments demonstrate that promiscuous pairing of heavy and light chains is possible and maintains allergen specificity, which is mainly determined by the heavy chains. ScFvs consisting of different heavy and light chains exhibited different affinities and even epitope specificity for the corresponding allergen. Conclusion: Our results indicate that allergen specificity of allergen-specific IgE is mainly determined by the heavy chains. Different heavy and light chain pairings in allergen-specific IgE antibodies affect affinity and epitope specificity and thus might influence clinical reactivity to allergens. (J Allergy Clin Immunol 2013;131:1185-93.)	[Gadermaier, Elisabeth; Flicker, Sabine; Lupinek, Christian; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Vienna Gen Hosp, A-1090 Vienna, Austria; [Steinberger, Peter] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, A-1090 Vienna, Austria; [Valenta, Rudolf] Med Univ Vienna, Christian Doppler Lab Allergy Res, Dept Pathophysiol & Allergy Res, Div Immunopathol,Vienna Gen Hosp,Ctr Pathophysiol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Flicker, S (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol,Vienna Gen Hosp, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	sabine.flicker@meduniwien.ac.at	Lupinek, Christian/I-3311-2019	Lupinek, Christian/0000-0002-8612-8245; Valenta, Rudolf/0000-0001-5944-3365; Flicker, Sabine/0000-0003-4768-8693; Steinberger, Peter/0000-0001-6848-4097	Austrian Research Promotion Agency [813003]; Austria Science Fund (FWF) [P233-B11, F46]; Christian Doppler Research Association; Biomay, Vienna, Austria; Austrian Science Fund; Biomay; Phadia-Thermo Fisher; Austrian Science Fund (FWF) [P 23318] Funding Source: researchfish	Austrian Research Promotion Agency; Austria Science Fund (FWF)(Austrian Science Fund (FWF)); Christian Doppler Research Association; Biomay, Vienna, Austria; Austrian Science Fund(Austrian Science Fund (FWF)); Biomay; Phadia-Thermo Fisher; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Supported by grant 813003 from the Austrian Research Promotion Agency, grant P233-B11 and special research program F46 of the Austria Science Fund (FWF), the Christian Doppler Research Association, and a research grant from Biomay, Vienna, Austria.; R. Valenta has received research support from the Austrian Science Fund, the Christian Doppler Research Association, Biomay, and Phadia-Thermo Fisher and has received consultancy fees from Biomay and Phadia-Thermo Fisher. The rest of the authors declare that they have no relevant conflicts of interest.	Andreasson U, 2006, J MOL BIOL, V362, P212, DOI 10.1016/j.jmb.2006.06.062; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Casset A, 2012, INT ARCH ALLERGY IMM, V159, P253, DOI 10.1159/000337654; Christensen LH, 2010, J IMMUNOL, V184, P4966, DOI 10.4049/jimmunol.0904038; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Collins AM, 2003, PHARMACOL THERAPEUT, V100, P157, DOI 10.1016/j.pharmthera.2003.07.002; DOLECEK C, 1993, FEBS LETT, V335, P299, DOI 10.1016/0014-5793(93)80406-K; Eckl-Dorna J, 2012, CLIN EXP ALLERGY, V42, P1347, DOI 10.1111/j.1365-2222.2012.04030.x; Edwards MR, 2002, J IMMUNOL, V168, P6305, DOI 10.4049/jimmunol.168.12.6305; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; Flicker S, 2002, EUR J IMMUNOL, V32, P2156, DOI 10.1002/1521-4141(200208)32:8<2156::AID-IMMU2156>3.0.CO;2-A; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Focke M, 2008, CLIN EXP ALLERGY, V38, P1400, DOI 10.1111/j.1365-2222.2008.03031.x; Gadermaier E, 2010, INT ARCH ALLERGY IMM, V151, P17, DOI 10.1159/000232567; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gieras A, 2007, J ALLERGY CLIN IMMUN, V119, P384, DOI 10.1016/j.jaci.2006.09.034; Horst A, 2002, CLIN EXP IMMUNOL, V130, P370, DOI 10.1046/j.1365-2249.2002.02025.x; Jakobsen CG, 2004, MOL IMMUNOL, V41, P941, DOI 10.1016/j.molimm.2004.05.009; Jylha S, 2009, J IMMUNOL METHODS, V350, P63, DOI 10.1016/j.jim.2009.07.007; LAFFER S, 1994, J ALLERGY CLIN IMMUN, V94, P689, DOI 10.1016/0091-6749(94)90176-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laukkanen ML, 2003, J IMMUNOL METHODS, V278, P271, DOI 10.1016/S0022-1759(03)00070-X; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P100, DOI 10.1159/000049189; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P161, DOI 10.1159/000049195; Madritsch C, 2011, CLIN EXP ALLERGY, V41, P270, DOI 10.1111/j.1365-2222.2010.03666.x; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Marth K, 2010, MOL IMMUNOL, V47, P2323, DOI 10.1016/j.molimm.2010.05.285; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Persson H, 2007, J ALLERGY CLIN IMMUN, V120, P1186, DOI 10.1016/j.jaci.2007.06.041; Steinberger P, 1996, J BIOL CHEM, V271, P10967, DOI 10.1074/jbc.271.18.10967; Swoboda I, 2004, J IMMUNOL, V172, P6490, DOI 10.4049/jimmunol.172.10.6490; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENTA R, 1994, BIOCHEM BIOPH RES CO, V199, P106, DOI 10.1006/bbrc.1994.1201; Valenta R, 1997, IGE REGULATION MOL M, P225; van Neerven RJ, 2006, INT ARCH ALLERGY IMM, V141, P119, DOI 10.1159/000094714; VRTALA S, 1993, J IMMUNOL, V151, P4773; VRTALA S, 1993, INT ARCH ALLERGY IMM, V102, P160, DOI 10.1159/000236567	40	5	5	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1185	+		10.1016/j.jaci.2012.10.010	http://dx.doi.org/10.1016/j.jaci.2012.10.010			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23206656	Green Accepted			2022-12-18	WOS:000317187200029
J	Castro, M; Woods, J				Castro, Mario; Woods, Jason			Insights into pediatric asthma with hyperpolarized magnetic resonance imaging of the lung	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Pediatric asthma; hyperpolarized magnetic resonance imaging; lung imaging	CYSTIC-FIBROSIS; HE-3 MRI; DIFFUSION; GAS; VOLUNTEERS; CHILDHOOD; HEALTHY		Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Castro, M (corresponding author), Washington Univ, Sch Med, Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	castrom@wustl.edu						Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054; Cadman RV, 2013, J ALLERGY CLIN IMMUN, V131, P369, DOI 10.1016/j.jaci.2012.10.032; de Lange EE, 2007, J ALLERGY CLIN IMMUN, V119, P1072, DOI 10.1016/j.jaci.2006.12.659; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Fain SB, 2007, J MAGN RESON IMAGING, V25, P910, DOI 10.1002/jmri.20876; GUR D, 1981, J COMPUT ASSIST TOMO, V5, P678, DOI 10.1097/00004728-198110000-00015; Kauczor HU, 1997, JMRI-J MAGN RESON IM, V7, P538, DOI 10.1002/jmri.1880070314; Mentore K, 2005, ACAD RADIOL, V12, P1423, DOI 10.1016/j.acra.2005.07.008; Mugler JP, 2010, P NATL ACAD SCI USA, V107, P21707, DOI 10.1073/pnas.1011912107; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Parraga G, 2008, ACAD RADIOL, V15, P776, DOI 10.1016/j.acra.2008.03.003; Saam BT, 2000, MAGN RESON MED, V44, P174, DOI 10.1002/1522-2594(200008)44:2<174::AID-MRM2>3.0.CO;2-4; van Beek EJR, 2009, EUR RESPIR J, V34, P1311, DOI 10.1183/09031936.00138508; van Beek EJR, 2007, EUR RADIOL, V17, P1018, DOI 10.1007/s00330-006-0392-1; Wang CB, 2008, J MAGN RESON IMAGING, V28, P80, DOI 10.1002/jmri.21408; Woods JC, 2006, MAGN RESON MED, V56, P1293, DOI 10.1002/mrm.21076; Yablonskiy DA, 2009, J APPL PHYSIOL, V107, P1258, DOI 10.1152/japplphysiol.00386.2009	17	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					377	378		10.1016/j.jaci.2012.12.669	http://dx.doi.org/10.1016/j.jaci.2012.12.669			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23374266				2022-12-18	WOS:000314661500014
J	Gupta, R; Holdford, D; Bilaver, L; Dyer, A; Meltzer, D				Gupta, Ruchi; Holdford, David; Bilaver, Lucy; Dyer, Ashley; Meltzer, David			The High Economic Burden of Childhood Food Allergy in the United States	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Gupta, Ruchi; Bilaver, Lucy; Dyer, Ashley] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Gupta, Ruchi] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Holdford, David] Virginia Commonwealth Univ, Richmond, VA USA; [Bilaver, Lucy] No Illinois Univ, De Kalb, IL USA; [Meltzer, David] Univ Chicago, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Virginia Commonwealth University; Northern Illinois University; University of Chicago			Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393					0	5	5	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB223	AB223		10.1016/j.jaci.2012.12.1464	http://dx.doi.org/10.1016/j.jaci.2012.12.1464			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800793
J	Hafner, R; Couroux, P; Armstrong, K; Patel, D; Larche, M				Hafner, Rod; Couroux, Peter; Armstrong, Kristen; Patel, Deepen; Larche, Mark			1. Two Year Persistent Treatment Effect Achieved After 4 Doses of Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Hafner, Rod] Circassia, Oxford, England; [Couroux, Peter] Cetero Res, Mississauga, ON, Canada; [Armstrong, Kristen] Adiga Life Sci Inc, Hamilton, ON, Canada; [Patel, Deepen] Cetero Res, Mississauga, ON, Canada; [Larche, Mark] McMaster Univ St Josephs Healthcare, Hamilton, ON, Canada	McMaster University				Larche, Mark/0000-0002-1439-7593					0	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB147	AB147		10.1016/j.jaci.2012.12.1185	http://dx.doi.org/10.1016/j.jaci.2012.12.1185			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800518
J	Wallace, KL; Elias, MK; Butterfield, JH; Weiler, CR				Wallace, Kara L.; Elias, Martha K.; Butterfield, Joseph H.; Weiler, Catherine R.			Hypereosinophilic Syndrome and Thrombosis: A Retrospective Review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)	FEB 22-26, 2013	San Antonio, TX	Amer Acad Allergy, Asthma & Immunol (AAAAI)					[Wallace, Kara L.; Butterfield, Joseph H.; Weiler, Catherine R.] Mayo Clin, Rochester, MN USA; [Elias, Martha K.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Mayo Clinic; Dartmouth College									0	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2		S			AB122	AB122		10.1016/j.jaci.2012.12.1105	http://dx.doi.org/10.1016/j.jaci.2012.12.1105			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	111WC					2022-12-18	WOS:000316550800439
J	Abrahamsson, TR; Jakobsson, HE; Andersson, AF; Bjorksten, B; Engstrand, L; Jenmalm, MC				Abrahamsson, Thomas R.; Jakobsson, Hedvig E.; Andersson, Anders F.; Bjorksten, Bengt; Engstrand, Lars; Jenmalm, Maria C.			Gut microbiota diversity and atopic disease: Does breast-feeding play a role? Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Abrahamsson, Thomas R.; Jenmalm, Maria C.] Linkoping Univ, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Jenmalm, Maria C.] Linkoping Univ, Unit Autoimmun & Immune Regulat, Dept Clin & Expt Med, Div Clin Immunol, Linkoping, Sweden; [Jakobsson, Hedvig E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.; Engstrand, Lars] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Bjorksten, Bengt] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Bjorksten, Bengt] Karolinska Inst, Inst Environm Med, Stockholm, Sweden	Linkoping University; Linkoping University; Karolinska Institutet; Royal Institute of Technology; Orebro University; Karolinska Institutet	Abrahamsson, TR (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden.	thomas.abrahamsson@lio.se		Jenmalm, Maria/0000-0002-2117-5366; Andersson, Anders/0000-0002-3627-6899				Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Azad MB, 2013, J ALLERGY CLIN IMMUN, V131, P247, DOI 10.1016/j.jaci.2012.10.044; Bezirtzoglou E, 2011, ANAEROBE, V17, P478, DOI 10.1016/j.anaerobe.2011.03.009; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	6	5	5	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					248	249		10.1016/j.jaci.2012.10.045	http://dx.doi.org/10.1016/j.jaci.2012.10.045			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23199606	Green Submitted			2022-12-18	WOS:000312961200047
J	Durrani, SR; Kelly, JT				Durrani, Sandy R.; Kelly, John T.			Pancreatitis as a complication of aspirin desensitization for aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DIVISUM		[Durrani, Sandy R.; Kelly, John T.] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Durrani, SR (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.	john.kelly@deancare.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007635] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERNARD JP, 1990, PANCREAS, V5, P248, DOI 10.1097/00006676-199005000-00002; DELHAYE M, 1985, GASTROENTEROLOGY, V89, P951, DOI 10.1016/0016-5085(85)90193-3; Hope AP, 2009, J ALLERGY CLIN IMMUN, V123, P406, DOI 10.1016/j.jaci.2008.09.048; Hoyte FCL, 2012, J ALLERGY CLIN IMMUN, V129, P1684, DOI 10.1016/j.jaci.2011.12.003; Lehman G A, 1995, Gastrointest Endosc Clin N Am, V5, P145; Smotkin J, 2002, J CLIN GASTROENTEROL, V34, P459, DOI 10.1097/00004836-200204000-00018; Stevenson DD, 2012, J ALLERGY CLIN IMMUN, V129, P1687, DOI 10.1016/j.jaci.2012.04.016	7	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					244	246		10.1016/j.jaci.2012.10.006	http://dx.doi.org/10.1016/j.jaci.2012.10.006			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23146377				2022-12-18	WOS:000312961200044
J	Koponen, P; Karjalainen, MK; Korppi, M				Koponen, Petri; Karjalainen, Minna K.; Korppi, Matti			IL10 polymorphisms, rhinovirus-induced bronchiolitis, and childhood asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENE POLYMORPHISM; INFANCY; A/G		[Koponen, Petri; Korppi, Matti] Tampere Univ, Pediat Res Ctr, FIN-33101 Tampere, Finland; [Karjalainen, Minna K.] Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland	Tampere University; University of Oulu	Koponen, P (corresponding author), Tampere Univ, Pediat Res Ctr, FIN-33101 Tampere, Finland.	petri.koponen@uta.fi		Karjalainen, Minna K/0000-0003-3184-3775				Helminen M, 2008, PEDIATR PULM, V43, P391, DOI 10.1002/ppul.20793; Koponen P, 2012, EUR RESPIR J, V39, P76, DOI 10.1183/09031936.00040211; Koponen P, 2012, EUR SOC PED INF DIS; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Nie W, 2012, CYTOKINE, V60, P849, DOI 10.1016/j.cyto.2012.08.023; Nuolivirta K, 2009, PEDIATR INFECT DIS J, V28, P1121, DOI 10.1097/INF.0b013e3181af37ee; Raedler D, 2012, J ALLERGY CLIN IMMUN	7	5	6	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2013	131	1					249	250		10.1016/j.jaci.2012.10.049	http://dx.doi.org/10.1016/j.jaci.2012.10.049			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	062YR	23182169				2022-12-18	WOS:000312961200048
J	Szefler, SJ; Busse, WW				Szefler, Stanley J.; Busse, William W.			The long-acting beta-adrenergic agonist controversy in asthma: Troublesome times!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; asthma control; asthma guidelines; inhaled corticosteroids (ICSs); long-acting beta-adrenergic agonists (LABAs)	INHALED CORTICOSTEROIDS; SALMETEROL; THERAPY; SAFETY; TIOTROPIUM; ADULTS; METAANALYSIS; MORTALITY; CARE		[Szefler, Stanley J.] Natl Jewish Hlth, Div Pediat Clin Pharmacol, Dept Pediat, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Div Allergy & Immunol, Dept Pediat, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pediat & Pharmacol, Denver, CO USA; [Busse, William W.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Madison	Szefler, SJ (corresponding author), Natl Jewish Hlth, Div Pediat Clin Pharmacol, Dept Pediat, 1400 Jackson St,Rm J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199	NCRR NIH HHS [1 UL1 RR025780] Funding Source: Medline; NHLBI NIH HHS [HL-98075, HL-87811, HL-75416, HL-64288, HL-51834] Funding Source: Medline; NIAID NIH HHS [AI-90052] Funding Source: Medline; NIEHS NIH HHS [ES-18181] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064288, U10HL051834, U10HL098075, U01HL075416, R21HL087811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akinbami L. J., 2012, TRENDS ASTHMA PREVAL; [Anonymous], 3 NAT HEART LUNG BLO; Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Bel EH, 2012, NEW ENGL J MED, V367, P1257, DOI 10.1056/NEJMe1209381; Brozek JL, 2012, ARCH INTERN MED, P1; Calhoun WJ, 2012, JAMA-J AM MED ASSOC, V308, P987, DOI 10.1001/2012.jama.10893; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Chan CM, 2012, ARCH INTERN MED, P1; Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Global Initiative for Asthma National Heart Lung and Blood Institute, GLOB STRAT ASTHM MAN; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V126, P449, DOI 10.1016/j.jaci.2010.05.039; *NAT ASTHM ED PREV, 1997, NIH PUBL; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pearce N, 1998, EPIDEMIOL REV, V20, P173, DOI 10.1093/oxfordjournals.epirev.a017979; Pedersen S, 2012, J ALLERGY CLIN IMMUN, V129, P1280, DOI 10.1016/j.jaci.2012.02.048; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Rodrigo GJ, 2012, THORAX, V67, P342, DOI 10.1136/thx.2010.155648; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; Sears M R, 1998, Can Respir J, V5 Suppl A, p54A; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; STOLLEY PD, 1978, PREV MED, V7, P519, DOI 10.1016/0091-7435(78)90265-7; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; Szefler SJ, 2012, THORAX, V67, P450, DOI 10.1136/thoraxjnl-2012-201876; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010; Thomas A, 2011, J ALLERGY CLIN IMMUN, V128, P915, DOI 10.1016/j.jaci.2011.07.014	36	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2012	130	6					1256	1259		10.1016/j.jaci.2012.10.021	http://dx.doi.org/10.1016/j.jaci.2012.10.021			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	044RP	23195524				2022-12-18	WOS:000311641100003
J	Kerstan, A; Beyersdorf, N; Stoevesandt, J; Trautmann, A				Kerstan, Andreas; Beyersdorf, Niklas; Stoevesandt, Johanna; Trautmann, Axel			Wasp venom immunotherapy expands a sub-population of CD4(+)CD25(+) forkhead box protein 3-positive regulatory T cells expressing the T-cell receptor V beta 2 and V beta 5.1 chains	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Kerstan, Andreas; Stoevesandt, Johanna; Trautmann, Axel] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Beyersdorf, Niklas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Kerstan, A (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany.	kerstan_a@klinik.uni-wuerzburg.de	Beyersdorf, Niklas/S-3845-2016	Beyersdorf, Niklas/0000-0002-9236-5415; Kerstan, Andreas/0000-0001-6483-0191				Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; Kerstan A, 2011, J ALLERGY CLIN IMMUN, V127, P495, DOI 10.1016/j.jaci.2010.11.025; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Pacholczyk R, 2008, IMMUNOLOGY, V125, P450, DOI 10.1111/j.1365-2567.2008.02992.x; RING J, 1977, LANCET, V1, P466; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					994	996		10.1016/j.jaci.2012.05.010	http://dx.doi.org/10.1016/j.jaci.2012.05.010			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	22728086				2022-12-18	WOS:000309594800025
J	Kumar, R; Williams, LK; Kato, A; Peterson, EL; Favoreto, S; Hulse, K; Wang, DL; Beckman, K; Thyne, S; LeNoir, M; Meade, K; Lanfear, DE; Levin, AM; Favro, D; Yang, JJ; Weiss, K; Boushey, HA; Grammer, L; Avila, PC; Burchard, EG; Schleimer, R				Kumar, Rajesh; Williams, L. Keoki; Kato, Atsushi; Peterson, Edward L.; Favoreto, Silvio, Jr.; Hulse, Katie; Wang, Deli; Beckman, Kenneth; Thyne, Shannon; LeNoir, Michael; Meade, Kelley; Lanfear, David E.; Levin, Albert M.; Favro, David; Yang, James J.; Weiss, Kevin; Boushey, Homer A.; Grammer, Leslie; Avila, Pedro C.; Burchard, Esteban G.; Schleimer, Robert			Genetic variation in B cell-activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPITHELIAL-CELLS; RHINOVIRUS; CHILDREN; PATHWAYS; VIRUSES; SIGNALS; ADULTS		[Kumar, Rajesh] Childrens Mem Hosp, Div Allergy & Immunol, Chicago, IL 60614 USA; [Williams, L. Keoki; Lanfear, David E.; Favro, David] Henry Ford Hlth Syst, Ctr Hlth Serv Res, Detroit, MI USA; [Williams, L. Keoki; Lanfear, David E.; Levin, Albert M.] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Peterson, Edward L.; Yang, James J.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Kato, Atsushi; Favoreto, Silvio, Jr.; Hulse, Katie; Grammer, Leslie; Avila, Pedro C.; Schleimer, Robert] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Weiss, Kevin] Northwestern Univ, Dept Gen Internal Med, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Wang, Deli] Childrens Mem Hosp, Biostat Res Core, Chicago, IL 60614 USA; [Wang, Deli] Childrens Mem Res Ctr, Chicago, IL USA; [Beckman, Kenneth] Univ Minnesota, Biomed Genom Ctr, Minneapolis, MN USA; [Thyne, Shannon] Univ Calif San Francisco, Dept Pediat, San Francisco Gen Hosp, San Francisco, CA USA; [Boushey, Homer A.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco Gen Hosp, San Francisco, CA USA; [LeNoir, Michael] Bay Area Pediat, Oakland, CA USA; [Meade, Kelley] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Minnesota System; University of Minnesota Twin Cities; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Kumar, R (corresponding author), Childrens Mem Hosp, Div Allergy & Immunol, Chicago, IL 60614 USA.	rkumar@childrensmemorial.org		Grammer, Leslie/0000-0001-6860-2014; Hulse, Kathryn/0000-0003-0969-999X; Kato, Atsushi/0000-0001-9144-3138; Kumar, Rajesh/0000-0002-1962-7108	NHLBI NIH HHS [R01HL078885, U01HL072478, R37HL068546, R01HL088133, R37 HL068546, K23 HL093023, R01 HL079055, R01 HL078885, K23HL093023, U01 HL072478, R01HL079055, R01 HL088133] Funding Source: Medline; NIAID NIH HHS [R01 AI061774, R01AI072570, P01 AI50496, R01 AI079139, P01 AI050496, R21AI057506, U01AI082984, R01 AI072570, R01AI079139, R21 AI057506, R01AI61774, U01 AI082984] Funding Source: Medline; NIDDK NIH HHS [R01 DK064695, R01DK064695] Funding Source: Medline; NIEHS NIH HHS [R01ES015794, R01 ES015794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546, R01HL078885, U01HL072478, K23HL093023, R01HL088133, R01HL079055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984, R01AI079139, R01AI061774, R01AI072570, R21AI057506, P01AI050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Reed JL, 2009, J INFECT DIS, V199, P1128, DOI 10.1086/597386; Shalowitz MU, 2007, AMBUL PEDIATR, V7, P271, DOI 10.1016/j.ambp.2007.03.004; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695	12	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2012	130	4					996	999		10.1016/j.jaci.2012.04.047	http://dx.doi.org/10.1016/j.jaci.2012.04.047			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017MT	22728080	Green Accepted			2022-12-18	WOS:000309594800026
J	Korosec, P; Silar, M; Zidarn, M; Kosnik, M				Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Kosnik, Mitja			Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOUBLE POSITIVITY; VESPULA VENOM; ALLERGY; BEE; SENSITIVITY		[Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Kosnik, Mitja] Univ Clin Resp & Allerg Dis, Golnik, Slovenia		Korosec, P (corresponding author), Univ Clin Resp & Allerg Dis, Golnik, Slovenia.	peter.korosec@klinika-golnik.si	Košnik, Mitja/AAI-2295-2019	Košnik, Mitja/0000-0002-4701-7374; Zidarn, Mihaela/0000-0003-0515-5207; Korosec, Peter/0000-0002-0835-1599				Eberlein B, 2012, J ALLERGY CLIN IMMUN, V130, P155, DOI 10.1016/j.jaci.2012.02.008; Jakob T, 2012, J ALLERGY CLIN IMMUN, V130, P276, DOI 10.1016/j.jaci.2012.03.048; Korosec P, 2009, CLIN EXP ALLERGY, V39, P1730, DOI 10.1111/j.1365-2222.2009.03347.x; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Sturm GJ, 2012, J ALLERGY CLIN IMMUN, V130, P817, DOI 10.1016/j.jaci.2012.05.047; Sturm GJ, 2011, J ALLERGY CLIN IMMUN, V128, P247, DOI 10.1016/j.jaci.2011.02.021	9	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					818	819		10.1016/j.jaci.2012.05.048	http://dx.doi.org/10.1016/j.jaci.2012.05.048			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22795372				2022-12-18	WOS:000308463500038
J	Kiani-Alikhan, S; Yong, PFK; Grosse-Kreul, D; Elston, C; Ibrahim, MAA				Kiani-Alikhan, Sorena; Yong, Patrick F. K.; Grosse-Kreul, Dorothea; Elston, Caroline; Ibrahim, Mohammad A. A.			Immunoglobulin replacement therapy: Is there a role for IgA and IgM?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; DEFICIENCY; ANTIBODIES		[Kiani-Alikhan, Sorena; Yong, Patrick F. K.; Grosse-Kreul, Dorothea; Ibrahim, Mohammad A. A.] Kings Coll London, Kings Hlth Partners, Kings Coll Hosp NHS Fdn Trust,Sch Med, Dept Allergy & Clin Immunol,Div Asthma Allergy &, London WC2R 2LS, England; [Elston, Caroline] Kings Coll London, Kings Hlth Partners, Kings Coll Hosp NHS Fdn Trust, Div Asthma Allergy & Lung Biol,Dept Resp Med,Sch, London WC2R 2LS, England	King's College Hospital NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London	Kiani-Alikhan, S (corresponding author), Kings Coll London, Kings Hlth Partners, Kings Coll Hosp NHS Fdn Trust,Sch Med, Dept Allergy & Clin Immunol,Div Asthma Allergy &, London WC2R 2LS, England.	m.ibrahim@kcl.ac.uk	Ibrahim, Mohammad A. A./G-1387-2011	Ibrahim, Mohammad A. A./0000-0002-0116-597X; Yong, Patrick/0000-0003-1736-2756				Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Cunningham-Rundles C, 2009, CLIN EXP IMMUNOL, V157, P12, DOI 10.1111/j.1365-2249.2009.03952.x; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Rachid R, 2012, J ALLERGY CLIN IMMUN, V129, P628, DOI 10.1016/j.jaci.2011.06.047; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013	7	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					553	554		10.1016/j.jaci.2012.04.032	http://dx.doi.org/10.1016/j.jaci.2012.04.032			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22664164				2022-12-18	WOS:000307002200047
J	Matsui, EC				Matsui, Elizabeth C.			Respiratory symptoms in asthma: The view through a wide-angle lens	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University	Matsui, EC (corresponding author), Johns Hopkins Univ, Dept Pediat, 600 N Wolfe St,CMSC 1102, Baltimore, MD 21287 USA.	ematsui@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593				[Anonymous], 3 NAT HEART LUNG BLO; Bisgaard H, 2012, J ALLERGY CLIN IMMUN, V130, P531, DOI 10.1016/j.jaci.2011.10.047; BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Chipps B, 2011, PEDIATRICS, V127, pE737, DOI 10.1542/peds.2010-1465; GINA Science Committee, 2009, GLOB STRAT ASTHM MAN; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Martinez Fernando D, 2002, Paediatr Respir Rev, V3, P193, DOI 10.1016/S1526-0542(02)00188-4; Rivera-Spoljaric K, 2009, J PEDIATR-US, V154, P877, DOI 10.1016/j.jpeds.2008.12.029; Skytt N, 2012, J ALLERGY CLIN IMMUN, V130, P403, DOI 10.1016/j.jaci.2012.04.043	9	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					408	409		10.1016/j.jaci.2012.06.008	http://dx.doi.org/10.1016/j.jaci.2012.06.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22846749				2022-12-18	WOS:000307002200021
J	Szefler, SJ				Szefler, Stanley J.			Early asthma: Stepping closer to primary prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; asthma control; asthma guidelines; biomarkers; chronic obstructive pulmonary disease; early asthma; genetics; inhaled corticosteroids; leukotriene receptor antagonists	WHEEZE; PHENOTYPES; OUTCOMES		[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Rm J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199				Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P287, DOI 10.1016/j.jaci.2012.04.025; Bisgaard H, 2012, J ALLERGY CLIN IMMUN, V130, P531, DOI 10.1016/j.jaci.2011.10.047; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Drazen JM, 2012, J ALLERGY CLIN IMMUN, V129, P1200, DOI 10.1016/j.jaci.2012.03.026; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Herr M, 2012, J ALLERGY CLIN IMMUN, V130, P389, DOI 10.1016/j.jaci.2012.05.054; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V126, P200, DOI 10.1016/j.jaci.2010.06.006; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; James KM, 2012, J ALLERGY CLIN IMMUN, V130, P343, DOI 10.1016/j.jaci.2012.05.056; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Matsui EC, 2012, J ALLERGY CLIN IMMUN, V130, P408, DOI 10.1016/j.jaci.2012.06.008; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Institutes of Health, NIH PUBL; Savenije OEM, 2012, J ALLERGY CLIN IMMUN, V130, P325, DOI 10.1016/j.jaci.2012.05.007; Skytt N, 2012, J ALLERGY CLIN IMMUN, V130, P403, DOI 10.1016/j.jaci.2012.04.043; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, P60, DOI 10.1016/j.jaci.2011.11.011; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P937, DOI 10.1016/j.jaci.2011.09.004; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010	22	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					308	310		10.1016/j.jaci.2012.06.004	http://dx.doi.org/10.1016/j.jaci.2012.06.004			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22846745				2022-12-18	WOS:000307002200008
J	Canani, RB; Nocerino, R; Terrin, G; Di Costanzo, M; Cosenza, L; Troncone, R				Canani, Roberto Berni; Nocerino, Rita; Terrin, Gianluca; Di Costanzo, Margherita; Cosenza, Linda; Troncone, Riccardo			Food allergy diagnostic practice in Italian children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Canani, Roberto Berni; Nocerino, Rita; Terrin, Gianluca; Di Costanzo, Margherita; Cosenza, Linda; Troncone, Riccardo] Univ Naples Federico II, Dept Pediat, Rome, Italy; [Canani, Roberto Berni; Troncone, Riccardo] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Rome, Italy; [Terrin, Gianluca] Univ Roma La Sapienza, Dept Womens Hlth & Territorial Med, Rome, Italy	University of Naples Federico II; University of Naples Federico II; Sapienza University Rome	Canani, RB (corresponding author), Univ Naples Federico II, Dept Pediat, Rome, Italy.	berni@unina.it	NOCERINO, RITA/AAC-1966-2022; Nocerino, Rita/ABD-8087-2020; Canani, Roberto Berni/AAC-4810-2022	NOCERINO, RITA/0000-0003-4681-546X; Canani, Roberto Berni/0000-0002-5169-9574; Di Costanzo, Margherita/0000-0002-8985-770X; Terrin, Gianluca/0000-0003-3541-2876				[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Eller E, 2009, ALLERGY, V64, P1023, DOI 10.1111/j.1398-9995.2009.01952.x; Martelli A, 2005, ALLERGY, V60, P907, DOI 10.1111/j.1398-9995.2005.00777.x; Pongracic JA, 2012, J ALLERGY CLIN IMMUN, V129, P564, DOI 10.1016/j.jaci.2011.09.024	5	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2012	129	5					1423	1424		10.1016/j.jaci.2012.02.044	http://dx.doi.org/10.1016/j.jaci.2012.02.044			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	934CG	22464643	Green Submitted			2022-12-18	WOS:000303418000043
J	Menikou, S; Patel, MP; Rose, KL; Botto, M; Warner, JO; Pickering, MC; Boyle, RJ				Menikou, Stephanie; Patel, Mitali P.; Rose, Kirsten L.; Botto, Marina; Warner, John O.; Pickering, Matthew C.; Boyle, Robert J.			Relationship between complotype and reported severity of systemic allergic reactions to peanut	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POPULATION		[Menikou, Stephanie; Warner, John O.; Boyle, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Paediat Allergy, London, England; [Patel, Mitali P.; Rose, Kirsten L.; Botto, Marina; Pickering, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London, England	Imperial College London; Imperial College London	Menikou, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat Allergy, London, England.	r.boyle@imperial.ac.uk	Warner, John/AAF-9587-2020	Boyle, Robert/0000-0002-4913-7580; Pickering, Matthew/0000-0002-1153-0192	Medical Research Council [G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212, NF-SI-0509-10171] Funding Source: researchfish; Medical Research Council [G1000758] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Ewan PW, 2005, CLIN EXP ALLERGY, V35, P751, DOI 10.1111/j.1365-2222.2005.02266.x; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; Nakanishi H, 2010, INVEST OPHTH VIS SCI, V51, P6183, DOI 10.1167/iovs.09-4948; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P915, DOI 10.1067/mai.2002.129235	9	5	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2012	129	5					1398	1401		10.1016/j.jaci.2011.10.049	http://dx.doi.org/10.1016/j.jaci.2011.10.049			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	934CG	22325069	Bronze			2022-12-18	WOS:000303418000032
J	Pedersen, S; O'Byrne, PM				Pedersen, Soren; O'Byrne, Paul M.			Combination inhaled corticosteroid and long-acting beta(2)-agonist use and severe asthma exacerbations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Inhaled corticosteroid; long-acting beta(2)-agonist; asthma; exacerbation	BETA-AGONISTS; METAANALYSIS; SALMETEROL; CONTROVERSY; SAFETY		[Pedersen, Soren] Kolding Cty Hosp, Paediat Res Unit, DK-6000 Kolding, Denmark; [Pedersen, Soren] Univ So Denmark, Odense, Denmark; [O'Byrne, Paul M.] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [O'Byrne, Paul M.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada	Kolding Hospital; University of Southern Denmark; McMaster University; McMaster University	Pedersen, S (corresponding author), Kolding Cty Hosp, Paediat Res Unit, Skovvangen 2-8, DK-6000 Kolding, Denmark.	sp@spconforsk.dk		O'Byrne, Paul/0000-0003-0979-281X				[Anonymous], 2007, J ALLERGY CLIN IMM S, V120, pS94; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bateman ED, 2007, EUR RESPIR J, V29, P56, DOI 10.1183/09031936.00128505; Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Cates CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006922.pub2; Chowdhury BA, 2011, NEW ENGL J MED, V365, P2247, DOI 10.1056/NEJMp1109621; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; Weiss KB, 2008, ANN INTERN MED, V149, P56, DOI 10.7326/0003-4819-149-1-200807010-00230; Wells KE, 2012, J ALLERGY CLIN IMMUN, V129, P1274, DOI 10.1016/j.jaci.2011.12.974	14	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2012	129	5					1280	1281		10.1016/j.jaci.2012.02.048	http://dx.doi.org/10.1016/j.jaci.2012.02.048			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	934CG	22464645	Bronze			2022-12-18	WOS:000303418000015
J	Gada, S; Haymore, B; McCoy, L; Kosisky, S; Nelson, M				Gada, Satyen; Haymore, Bret; McCoy, Lorne; Kosisky, Susan; Nelson, Michael			Frequency of mold and pollen mixing in allergen immunotherapy prescriptions within a large health care system, 1990-2010	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STABILITY; COCKROACH		[Gada, Satyen] Natl Naval Med Ctr, Dept Allergy Immunol, Bethesda, MD USA; [Haymore, Bret; McCoy, Lorne; Kosisky, Susan; Nelson, Michael] Walter Reed Army Med Ctr, Dept Allergy Immunol, Washington, DC 20307 USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Gada, S (corresponding author), Natl Naval Med Ctr, Dept Allergy Immunol, Bethesda, MD USA.	satyen.gada@med.navy.mil	Nelson, Michael Shawn/GXF-4934-2022	Gada, Satyen/0000-0003-3539-5543				Cox L, 2007, J ALLERGY CLIN IMMUN, V120, pS25, DOI 10.1016/j.jaci.2007.06.019; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Esch RE, 2000, ARB P EHRLICH I, V93, P57; Grier TJ, 2007, ANN ALLERG ASTHMA IM, V99, P151, DOI 10.1016/S1081-1206(10)60639-4; Grier TJ, 2009, ANN ALLERG ASTHMA IM, V103, P411, DOI 10.1016/S1081-1206(10)60361-4; Joint Task Force On Practice Parameter, 2003, ANN ALLERGY ASTHM S1, V90, pS1; KORDASH TR, 1993, ANN ALLERGY, V71, P240; Nelson HS, 1996, J ALLERGY CLIN IMMUN, V98, P382, DOI 10.1016/S0091-6749(96)70162-8; Nicklas RA, 1996, J ALLERGY CLIN IMMUN, V98, P1001, DOI 10.1016/S0091-6749(96)80183-7	9	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					1151	1153		10.1016/j.jaci.2011.10.027	http://dx.doi.org/10.1016/j.jaci.2011.10.027			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	22154380				2022-12-18	WOS:000302144600035
J	Jacobsen, RC; Guess, TM; Burks, AW				Jacobsen, Ryan C.; Guess, Trent M.; Burks, A. Wesley			Comparing activation and recoil forces generated by epinephrine autoinjectors and their training devices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NEEDLE LENGTH; ANAPHYLAXIS		[Jacobsen, Ryan C.] Univ Missouri, Truman Med Ctr, Sch Med,Dept Emergency Med, Div Emergency Med Serv,Childrens Mercy Hosp & Cli, Kansas City, MO 64108 USA; [Guess, Trent M.] Univ Missouri, Dept Mech Engn, Kansas City, MO 64110 USA; [Burks, A. Wesley] Duke Univ, Med Ctr, Div Pediat Allergy & Immunol, Durham, NC USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Duke University	Jacobsen, RC (corresponding author), Univ Missouri, Truman Med Ctr, Sch Med,Dept Emergency Med, Div Emergency Med Serv,Childrens Mercy Hosp & Cli, Kansas City, MO 64108 USA.	ryan.jacobsen@tmcmed.org		Jacobsen MD, Ryan/0000-0001-8181-7917	Div Of Civil, Mechanical, & Manufact Inn [1039524] Funding Source: National Science Foundation	Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Edwards A, WHY USE REAL EPIPENS; Frew AJ, 2011, ALLERGY, V66, P15, DOI 10.1111/j.1398-9995.2010.02450.x; Kemp SF, 2008, ALLERGY, V63, P1061, DOI 10.1111/j.1398-9995.2008.01733.x; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, pe1, DOI 10.1016/j.jaci.2010.06.022; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, P477, DOI 10.1016/j.jaci.2010.06.022; Schwirtz A, 2010, J ASTHMA ALLERGY, V3, P159, DOI 10.2147/JAA.S14419; Simons KJ, 2010, CURR OPIN ALLERGY CL, V10, P354, DOI 10.1097/ACI.0b013e32833bc670; Song TT, 2005, ANN ALLERG ASTHMA IM, V94, P539, DOI 10.1016/S1081-1206(10)61130-1; Stecher D, 2009, PEDIATRICS, V124, P65, DOI 10.1542/peds.2008-3388	9	5	6	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					1143	1145		10.1016/j.jaci.2011.10.007	http://dx.doi.org/10.1016/j.jaci.2011.10.007			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	22078473				2022-12-18	WOS:000302144600031
J	Ward, BR; Arslanian, SA; Andreatta, E; Schwartz, LB				Ward, Brant R.; Arslanian, Silva A.; Andreatta, Elisa; Schwartz, Lawrence B.			Obesity is not linked to increased whole-body mast cell burden in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Ward, Brant R.; Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Div Allergy & Immunol, Richmond, VA 23284 USA; [Arslanian, Silva A.; Andreatta, Elisa] Univ Pittsburgh, Sch Med, Div Weight Management & Wellness, Pittsburgh, PA USA; [Arslanian, Silva A.; Andreatta, Elisa] Univ Pittsburgh, Sch Med, Div Pediat Endocrinol Metab & Diabet Mellitus, Pittsburgh, PA USA; [Andreatta, Elisa] Univ Verona, Dept Pediat, I-37100 Verona, Italy	Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Verona	Ward, BR (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Allergy & Immunol, Richmond, VA 23284 USA.	lbschwar@vcu.edu		Ward, Brant/0000-0001-8056-6466	NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NIAID NIH HHS [R01 AI027517, R01 AI027517-19, R01 AI27517, U19 AI077435] Funding Source: Medline; NICHD NIH HHS [R01 HD027503, R01 HD27503, K24 HD01357, K24 HD001357] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027503, K24HD001357] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027517, U19AI077435] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Fenger RV, 2012, INT ARCH ALLERGY IMM, V157, P151, DOI 10.1159/000327535; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Maffeis C, 2007, J PEDIATR-US, V151, P647, DOI 10.1016/j.jpeds.2007.04.053; Roth CL, 2011, METABOLISM, V60, P445, DOI 10.1016/j.metabol.2010.03.023; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					1164	1166		10.1016/j.jaci.2011.11.050	http://dx.doi.org/10.1016/j.jaci.2011.11.050			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	22244600	Bronze, Green Accepted			2022-12-18	WOS:000302144600041
J	Vercoulen, Y; Guichelaar, T; Meerding, J; Emmelot, M; Pingen, M; Storm, G; Coffer, P; Sawitzki, B; Martens, A; Mutis, T; Prakken, B				Vercoulen, Yvonne; Guichelaar, Teun; Meerding, Jenny; Emmelot, Maarten; Pingen, Marieke; Storm, Gert; Coffer, Paul; Sawitzki, Birgit; Martens, Anton; Mutis, Tuna; Prakken, Berent			Application of cultured human regulatory T cells requires preclinical in vivo evaluation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOXP3 EXPRESSION		[Vercoulen, Yvonne; Meerding, Jenny; Pingen, Marieke; Coffer, Paul; Prakken, Berent] UMC Utrecht, Dept Pediat Immunol, Ctr Mol & Cellular Intervent, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Guichelaar, Teun; Emmelot, Maarten; Mutis, Tuna] UMC Utrecht, Dept Clin Chem & Haematol, Div DBG, Utrecht, Netherlands; [Coffer, Paul; Martens, Anton] UMC Utrecht, Dept Immunol, Div DBG, Utrecht, Netherlands; [Martens, Anton] UMC Utrecht, Dept Cell Biol, Div DBG, Utrecht, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Sawitzki, Birgit] Charite, Inst Med Immunol, D-13353 Berlin, Germany	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Vercoulen, Y (corresponding author), UMC Utrecht, Dept Pediat Immunol, Ctr Mol & Cellular Intervent, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	y.vercoulen@umcutrecht.nl	Guichelaar, Teun/AEQ-7065-2022; Sawitzki, Birgit S/S-2307-2016; Coffer, Paul/AAF-7970-2020; Pingen, Marieke/F-9990-2012; Storm, Gerrit/O-8696-2016	Guichelaar, Teun/0000-0002-5112-8923; Pingen, Marieke/0000-0001-5689-9076; Vercoulen, Yvonne/0000-0002-5060-2603; Emmelot, Maarten/0000-0002-4930-6268; Sawitzki, Birgit/0000-0001-8166-8579	Worldwide Cancer Research [07-0567] Funding Source: Medline	Worldwide Cancer Research		Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015150; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; O'Connor RA, 2010, CLIN EXP IMMUNOL, V159, P137, DOI 10.1111/j.1365-2249.2009.04040.x; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	8	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2012	129	3					852	855		10.1016/j.jaci.2011.10.037	http://dx.doi.org/10.1016/j.jaci.2011.10.037			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	904IW	22168999				2022-12-18	WOS:000301189300037
J	Edwards, ES; Gunn, R; Simons, EF; Carr, K; Chinchilli, VM; Painter, G; Goldwater, R				Edwards, E. S.; Gunn, R.; Simons, E. F.; Carr, K.; Chinchilli, V. M.; Painter, G.; Goldwater, R.			Epinephrine 0.3 mg Bioavailability Following a Single Injection with a Novel Epinephrine Auto-injector, e-cue (TM), in Healthy Adults, with Reference to a Single Injection using EpiPen (R) 0.3 mg	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Edwards, E. S.; Gunn, R.] Intelliject Inc, Richmond, VA USA; [Simons, E. F.] Univ Manitoba, Winnipeg, MB, Canada; [Carr, K.] RRD Int, Rockville, MD USA; [Chinchilli, V. M.] Penn State Hershey Coll Med, Hershey, PA USA; [Painter, G.] Chimerix Inc, Durham, NC USA; [Goldwater, R.] PAREXEL Int, Baltimore, MD USA	University of Manitoba; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Parexel International									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB179	AB179		10.1016/j.jaci.2011.12.234	http://dx.doi.org/10.1016/j.jaci.2011.12.234			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400677
J	Gutta, R; Radojicic, C				Gutta, R.; Radojicic, C.			Safety and Effectiveness of Penicillin Allergy Evaluation in the Pre-Lung Transplant Patient Population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Gutta, R.; Radojicic, C.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB102	AB102		10.1016/j.jaci.2011.12.510	http://dx.doi.org/10.1016/j.jaci.2011.12.510			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL		Bronze			2022-12-18	WOS:000301133400388
J	Henson, M; Edie, A; Steele, P; Kamilaris, J; Kulis, M; Thyagarajan, A; Vickery, BP; Burks, AW				Henson, M.; Edie, A.; Steele, P.; Kamilaris, J.; Kulis, M.; Thyagarajan, A.; Vickery, B. P.; Burks, A. W.			Peanut Oral Immunotherapy and Omalizumab Treatment for Peanut Allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Henson, M.; Edie, A.; Steele, P.; Kamilaris, J.; Kulis, M.; Thyagarajan, A.; Vickery, B. P.; Burks, A. W.] Duke Univ, Sch Med, Durham, NC USA	Duke University									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB28	AB28		10.1016/j.jaci.2011.12.765	http://dx.doi.org/10.1016/j.jaci.2011.12.765			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400106
J	Neagu, F				Neagu, F.			Hypovitaminosis D is Very Frequent but not Associated with AsthmaControl in a Low-Income Pediatric Population Seen in an Allergy and Immunology Clinic	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Neagu, F.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB153	AB153		10.1016/j.jaci.2011.12.332	http://dx.doi.org/10.1016/j.jaci.2011.12.332			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL					2022-12-18	WOS:000301133400575
J	Sheehan, WJ; Hoffman, EB; Friedlander, JL; Gold, DR; Phipatanakul, W				Sheehan, W. J.; Hoffman, E. B.; Friedlander, J. L.; Gold, D. R.; Phipatanakul, W.			Peanut Allergen (Ara h 2) in Settled Dust Samples of Inner-City Schools and Homes of Children with Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Sheehan, W. J.; Friedlander, J. L.; Phipatanakul, W.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Hoffman, E. B.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gold, D. R.] Harvard Univ, Brigham & Womens Hosp, Div Resp Epidemiol, Channing Lab, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB236	AB236		10.1016/j.jaci.2011.12.166	http://dx.doi.org/10.1016/j.jaci.2011.12.166			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL		Bronze			2022-12-18	WOS:000301133401056
J	Apter, AJ				Apter, Andrea J.			Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2011: What goes around comes around	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; adults; genetics; genome-wide association study; inhaled corticosteroids; biomarkers; long-acting beta-agonist; tiotropium	LUNG-FUNCTION; SOCIOECONOMIC-STATUS; DUST-MITE; RISK; IDENTIFICATION; CHILDREN; OBESITY; US; ASSOCIATION; TIOTROPIUM	Last year's review of research advances in adults with asthma emphasized the linear trajectory of translation: the initial studies translating bench findings to the first patients (T1) are connected to larger efficacy studies, including clinical trials studying subjects under tightly controlled conditions (T2), and these in turn are connected to research, including comparative effectiveness research, that tests how the efficacy findings of T2 research fare in the real world, diverse populations, and varied practice settings (T3). This year what was observed was a more interwoven relationship (rather than a linear one), in which each translational level informs the others and new approaches to answering old questions have led to new discoveries. Within this framework, the present review summarizes clinical research on asthma in adults that was reported in the Journal of Allergy and Clinical Immunology in 2011, with emphasis on health outcomes, education, delivery, and quality in terms of discoveries related to mechanisms of disease, environmental exposures, and management. (J Allergy Clin Immunol 2012; 129: 69-75.)	[Apter, Andrea J.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Apter, AJ (corresponding author), Hosp Univ Penn, 829 Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	apter@mail.med.upenn.edu			National Institutes of Health/National Heart, Lung, and Blood Institute; AstraZeneca; Bristol Meyers Squibb	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); Bristol Meyers Squibb(Bristol-Myers Squibb)	A. J. Apter has received research support from the National Institutes of Health/National Heart, Lung, and Blood Institute, AstraZeneca, and Bristol Meyers Squibb.	Andersson CK, 2011, J ALLERGY CLIN IMMUN, V127, P905, DOI 10.1016/j.jaci.2011.01.022; Apter AJ, 2011, J ALLERGY CLIN IMMUN, V128, P516, DOI 10.1016/j.jaci.2011.05.010; Apter AJ, 2011, J ALLERGY CLIN IMMUN, V127, P116, DOI 10.1016/j.jaci.2010.11.017; Apter AJ, 2010, J ALLERGY CLIN IMMUN, V125, P79, DOI 10.1016/j.jaci.2009.11.028; Barnes KC, 2011, LANCET, V378, P967, DOI 10.1016/S0140-6736(11)61422-0; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V126, P1139, DOI 10.1016/j.jaci.2010.10.032; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bateman ED, 2011, J ALLERGY CLIN IMMUN, V128, P315, DOI 10.1016/j.jaci.2011.06.004; BAUMANN LM, 2011, ALLERGY, V127, P875; Bush RK, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Bush RK, 2011, J ALLERGY CLIN IMMUN, V127, P974, DOI 10.1016/j.jaci.2010.11.045; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Chen E, 2011, J ALLERGY CLIN IMMUN, V128, P970, DOI 10.1016/j.jaci.2011.06.040; Chen E, 2011, J ALLERGY CLIN IMMUN, V128, P346, DOI 10.1016/j.jaci.2011.06.020; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Chowdhury BA, 2011, NEW ENGL J MED, V364, P2473, DOI 10.1056/NEJMp1104375; Clerisme-Beaty EM, 2011, J ALLERGY CLIN IMMUN, V127, P406, DOI 10.1016/j.jaci.2010.11.038; Corren J, 2011, J ALLERGY CLIN IMMUN, V127, P398, DOI 10.1016/j.jaci.2010.09.043; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Galanter JM, 2011, J ALLERGY CLIN IMMUN, V128, P37, DOI 10.1016/j.jaci.2011.03.050; Gergen PJ, 2011, J ALLERGY CLIN IMMUN, V127, P370, DOI 10.1016/j.jaci.2010.11.023; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Himes BE, 2011, J ALLERGY CLIN IMMUN, V127, P1067, DOI 10.1016/j.jaci.2010.12.007; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Kanazawa H, 2011, J ALLERGY CLIN IMMUN, V127, P899, DOI 10.1016/j.jaci.2010.11.020; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Koppelman GH, 2011, J ALLERGY CLIN IMMUN, V128, P479, DOI 10.1016/j.jaci.2011.05.036; Krishnan JA, 2011, J ALLERGY CLIN IMMUN, V127, P123, DOI 10.1016/j.jaci.2010.08.032; Lange NE, 2011, J ALLERGY CLIN IMMUN, V127, P734, DOI 10.1016/j.jaci.2010.11.010; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Loisel DA, 2011, J ALLERGY CLIN IMMUN, V128, P524, DOI 10.1016/j.jaci.2011.06.016; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lowe A, 2011, J ALLERGY CLIN IMMUN, V128, P1107, DOI 10.1016/j.jaci.2011.08.025; Mallol J, 2000, PEDIATR PULM, V30, P439, DOI 10.1002/1099-0496(200012)30:6<439::AID-PPUL1>3.0.CO;2-E; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2011, J ALLERGY CLIN IMMUN, V128, P328, DOI 10.1016/j.jaci.2011.02.042; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Motika CA, 2011, J ALLERGY CLIN IMMUN, V128, P774, DOI 10.1016/j.jaci.2011.06.046; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Olmedo O, 2011, J ALLERGY CLIN IMMUN, V128, P284, DOI 10.1016/j.jaci.2011.02.044; Omland O, 2011, J ALLERGY CLIN IMMUN, V128, P761, DOI 10.1016/j.jaci.2011.06.006; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Rabinovitch N, 2011, J ALLERGY CLIN IMMUN, V128, P323, DOI 10.1016/j.jaci.2011.05.035; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sanak M, 2011, J ALLERGY CLIN IMMUN, V127, P1141, DOI 10.1016/j.jaci.2010.12.1108; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Schatz M, 2011, J ALLERGY CLIN IMMUN, V128, pe1; Schatz M, 2011, J ALLERGY CLIN IMMUN, V128, P44, DOI 10.1016/j.jaci.2010.12.1112; Schauberger EM, 2011, J ALLERGY CLIN IMMUN, V128, P753, DOI 10.1016/j.jaci.2011.04.058; Sternthal MJ, 2011, J ALLERGY CLIN IMMUN, V128, P337, DOI 10.1016/j.jaci.2011.05.008; Sullivan PW, 2011, J ALLERGY CLIN IMMUN, V127, P363, DOI 10.1016/j.jaci.2010.10.042; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P937, DOI 10.1016/j.jaci.2011.09.004; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010; Tabar AI, 2011, J ALLERGY CLIN IMMUN, V127, P57, DOI 10.1016/j.jaci.2010.10.025; Taylor DR, 2011, J ALLERGY CLIN IMMUN, V128, P927, DOI 10.1016/j.jaci.2011.03.051; Thamrin C, 2011, J ALLERGY CLIN IMMUN, V127, P1494, DOI 10.1016/j.jaci.2011.01.018; Thomas A, 2011, J ALLERGY CLIN IMMUN, V128, P915, DOI 10.1016/j.jaci.2011.07.014; Todd JL, 2011, AM J RESP CRIT CARE; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Wang L, 2011, J ALLERGY CLIN IMMUN, V127, P161, DOI 10.1016/j.jaci.2010.10.035; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; WILLIAMS L, 2011, J ALLERGY CLIN IMMUN; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589	79	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					69	75		10.1016/j.jaci.2011.11.005	http://dx.doi.org/10.1016/j.jaci.2011.11.005			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	22130423	Bronze			2022-12-18	WOS:000298634000009
J	Hennig, C; Happle, C; Hansen, G				Hennig, Christian; Happle, Christine; Hansen, Gesine			"A bad wound may heal, but a bad name can kill"-lessons learned from "hyper-IgM syndrome"	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IMMUNODEFICIENCIES; UPDATE		[Hennig, Christian; Happle, Christine; Hansen, Gesine] Hannover Med Sch, Dept Paediat Pneumol Allergol & Neonatol, D-3000 Hannover, Germany	Hannover Medical School	Hennig, C (corresponding author), Hannover Med Sch, Dept Paediat Pneumol Allergol & Neonatol, D-3000 Hannover, Germany.	hennig.christian@mh-hannover.de						ADAMS N, 2010, P 2 WORKSH ONT BIOM, P51; Davies EG, 2010, BRIT J HAEMATOL, V149, P167, DOI 10.1111/j.1365-2141.2010.08077.x; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Hennig C, 2010, BRIT J HAEMATOL, V148, P445, DOI 10.1111/j.1365-2141.2009.07987.x; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Pietrucha Barbara Maria, 2010, J Pediatr Hematol Oncol, V32, pe28, DOI 10.1097/MPH.0b013e3181bfd3d9	7	5	7	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1380	1382		10.1016/j.jaci.2011.07.041	http://dx.doi.org/10.1016/j.jaci.2011.07.041			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	21855121	Bronze			2022-12-18	WOS:000298342700041
J	Blaiss, M				Blaiss, Michael			Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents (vol 127, pg 64, 2011)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Correction																		Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI 10.1016/j.jaci.2010.11.034	1	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2011	128	2					436	436						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	799IQ					2022-12-18	WOS:000293280800041
J	Noel, S; Saams, J; Ong, MJC; Breysse, P; Diette, G; Biswal, S; Matsui, EC				Noel, Sanjeev; Saams, Joy; Ong, Mary Jane C.; Breysse, Patrick; Diette, Gregory; Biswal, Shyam; Matsui, Elizabeth C.			Opposing effects of nasal epithelial NAD(P)H dehydrogenase quinine 1 and heme oxygenase 1 expression on upper and lower airway symptoms in adolescents with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							UP-REGULATION; INFLAMMATION; CELLS		[Noel, Sanjeev; Breysse, Patrick; Biswal, Shyam] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Saams, Joy; Ong, Mary Jane C.; Diette, Gregory; Matsui, Elizabeth C.] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Noel, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	sbiswal@jhsph.edu; ematsui@jhmi.edu		Matsui, Elizabeth/0000-0001-8134-5593	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009606, P30ES003819, P50ES015903, P01ES018176] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000052, M01-RR00052] Funding Source: Medline; NIAID NIH HHS [R01 AI070630-05, R01 AI070630, R01AI070630] Funding Source: Medline; NIEHS NIH HHS [P50 ES015903-05, P50 ES015903, P01 ES018176-03, P50 ES015903-04, P01 ES009606, P01 ES018176-02, P50ES015903, P30 ES003819, P01 ES018176-01, P01 ES018176, P01 ES009606-10, 1P50ES015903] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Hinkelmann U, 2010, EUR J PHARM SCI, V41, P118, DOI 10.1016/j.ejps.2010.05.021; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936	9	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2011	128	2					422	424		10.1016/j.jaci.2011.03.029	http://dx.doi.org/10.1016/j.jaci.2011.03.029			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	799IQ	21531452	Green Accepted			2022-12-18	WOS:000293280800029
J	Batra, J; Das, S; Chatterjee, R; Chandra, S; Ghosh, B				Batra, Jyotsna; Das, Sudipta; Chatterjee, Rajshekhar; Chandra, Sunandini; Ghosh, Balaram			Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BLOOD MONONUCLEAR-CELLS; GENE; RESPONSIVENESS; PATTERNS		[Batra, Jyotsna; Das, Sudipta; Chatterjee, Rajshekhar; Chandra, Sunandini; Ghosh, Balaram] Inst Genom & Integrat Biol, Immunogenet Mol Lab, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Batra, J (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.			Das, Sudipta/0000-0001-9380-2907; Chandra, Sunandini/0000-0001-5386-0934				Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chong WP, 2004, GENES IMMUN, V5, P484, DOI 10.1038/sj.gene.6364119; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Heaton T, 2005, LANCET, V365, P142, DOI 10.1016/S0140-6736(05)17704-6; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Pawlik A, 2006, INT IMMUNOPHARMACOL, V6, P351, DOI 10.1016/j.intimp.2005.08.019; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Ramsay CE, 1999, CLIN EXP ALLERGY, V29, P1195; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Sharp MJ, 2003, CLIN EXP ALLERGY, V33, P435, DOI 10.1046/j.1365-2222.2003.01627.x; Steinke JW, 2007, CELL IMMUNOL, V249, P101, DOI 10.1016/j.cellimm.2007.12.001; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	16	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					239	U391		10.1016/j.jaci.2011.01.044	http://dx.doi.org/10.1016/j.jaci.2011.01.044			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21388664				2022-12-18	WOS:000292245600041
J	Hayden, CM; Zhang, GC; Judge, PK; Khoo, SK; Laing, IA; Turner, SW; Goldblatt, J; Holt, PG; Le Souef, PN				Hayden, Catherine M.; Zhang, Guicheng; Judge, Parveenjeet K.; Khoo, Siew-Kim; Laing, Ingrid A.; Turner, Stephen W.; Goldblatt, Jack; Holt, Patrick G.; Le Souef, Peter N.			Regulatory role of IL10 genetic variations in determining allergen-induced T(H)2 cytokine responses in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PROMOTER POLYMORPHISMS; ASSOCIATION; ASTHMA		[Hayden, Catherine M.; Zhang, Guicheng; Judge, Parveenjeet K.; Khoo, Siew-Kim; Laing, Ingrid A.; Turner, Stephen W.; Goldblatt, Jack; Le Souef, Peter N.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Laing, Ingrid A.; Holt, Patrick G.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia	Hayden, CM (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	chayden@meddent.uwa.edu.au	Le Souef, Peter N/H-5256-2014; Laing, Ingrid/I-7092-2013; Khoo, Siew-Kim/D-7655-2016; Khoo, Siew-Kim/B-6493-2012; Zhang, Brad/AAF-8719-2021; Turner, Stephen/GXM-4654-2022; Holt, Patrick/H-1548-2011	Laing, Ingrid/0000-0002-1641-9899; Zhang, Guicheng/0000-0001-9888-5385; Le Souef, Peter/0000-0003-0930-1654; Holt, Patrick/0000-0003-1193-0935				Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chong WP, 2004, GENES IMMUN, V5, P484, DOI 10.1038/sj.gene.6364119; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Pawlik A, 2006, INT IMMUNOPHARMACOL, V6, P351, DOI 10.1016/j.intimp.2005.08.019; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Steinke JW, 2007, CELL IMMUNOL, V249, P101, DOI 10.1016/j.cellimm.2007.12.001; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x	10	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					237	239		10.1016/j.jaci.2011.02.032	http://dx.doi.org/10.1016/j.jaci.2011.02.032			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE	21439624				2022-12-18	WOS:000292245600040
J	Kuijpers, TW; Baars, PA; de Kerk, DJA; Jansen, MH; Dors, N; van Lier, RAW; Pals, ST				Kuijpers, Taco W.; Baars, Paul A.; de Kerk, Daan J. Aan; Jansen, Machiel H.; Dors, Natasja; van Lier, Rene A. W.; Pals, Steven T.			Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; APOPTOSIS		[Kuijpers, Taco W.; de Kerk, Daan J. Aan; Jansen, Machiel H.; Dors, Natasja] Emma Childrens Hosp, Amsterdam, Netherlands; [Baars, Paul A.; de Kerk, Daan J. Aan; Jansen, Machiel H.; van Lier, Rene A. W.] AMC, Dept Expt Immunol, Amsterdam, Netherlands; [Pals, Steven T.] AMC, Dept Pathol, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kuijpers, TW (corresponding author), Emma Childrens Hosp, Amsterdam, Netherlands.	t.w.kuijpers@amc.uva.nl		Pals, Steven/0000-0002-1419-0939; van Lier, Rene/0000-0002-3201-7144				Bayry J, 2005, TRENDS MOL MED, V11, P370, DOI 10.1016/j.molmed.2005.06.005; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FREEMAN HR, 2010, ARCH DIS CHILD; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Lim MS, 1998, AM J PATHOL, V153, P1541, DOI 10.1016/S0002-9440(10)65742-2; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; Rensing-Ehl A, 2010, CLIN IMMUNOL, V137, P357, DOI 10.1016/j.clim.2010.08.008; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121	10	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1411	1414		10.1016/j.jaci.2011.01.046	http://dx.doi.org/10.1016/j.jaci.2011.01.046			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21450335				2022-12-18	WOS:000291048500014
J	Macy, E				Macy, Eric			Penicillin allergy might not be very common in subjects with cephalosporin allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Univ Calif San Diego, San Diego Med Ctr, So Calif Permanente Med Grp, Dept Allergy, San Diego, CA 92103 USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; University of California System; University of California San Diego	Macy, E (corresponding author), Univ Calif San Diego, San Diego Med Ctr, So Calif Permanente Med Grp, Dept Allergy, San Diego, CA 92103 USA.	eric.m.macy@kp.org		Macy, Eric/0000-0002-5857-9444				ASSEM ESK, 1974, IMMUNOLOGY, V27, P255; BUDAVARI S, 1996, MERCK INDEX, P97; Macy E, 2010, ANN ALLERG ASTHMA IM, V105, P136, DOI 10.1016/j.anai.2010.06.014; Park MA, 2007, ANN ALLERG ASTHMA IM, V99, P54, DOI 10.1016/S1081-1206(10)60621-7; Romano A, 2010, J ALLERGY CLIN IMMUN, V126, P994, DOI 10.1016/j.jaci.2010.06.052; VOSS HE, 1966, JAMA-J AM MED ASSOC, V196, P91	6	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1638	1638		10.1016/j.jaci.2010.12.1125	http://dx.doi.org/10.1016/j.jaci.2010.12.1125			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21397308	Bronze			2022-12-18	WOS:000291048500052
J	Chawla, KK; Bencharitiwong, R; Ayuso, R; Grishina, G; Nowak-Wegrzyn, A				Chawla, Kanwaljit K.; Bencharitiwong, Ramon; Ayuso, Rosalia; Grishina, Galina; Nowak-Wegrzyn, Anna			Shea butter contains no IgE-binding soluble proteins	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Chawla, Kanwaljit K.; Bencharitiwong, Ramon; Ayuso, Rosalia; Grishina, Galina; Nowak-Wegrzyn, Anna] Mt Sinai Sch Med, Div Pediat Allergy & Immunol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Chawla, KK (corresponding author), Mt Sinai Sch Med, Div Pediat Allergy & Immunol, New York, NY USA.	kanwaljit.chawla@mssm.edu		Nowak-Wegrzyn, Anna/0000-0002-0960-9854				Ahn K, 2009, CLIN EXP ALLERGY, V39, P926, DOI 10.1111/j.1365-2222.2009.03259.x; Akihisa T, 2010, J OLEO SCI, V59, P351, DOI 10.5650/jos.59.351; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Glew Robert H., 1997, Journal of Food Composition and Analysis, V10, P205, DOI 10.1006/jfca.1997.0539; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; *NAT RES COUNC, 2006, LOST CROPS AFR, V2, P302; Sathe SK, 2009, J AGR FOOD CHEM, V57, P7846, DOI 10.1021/jf9016338; Sharma GM, 2009, J AGR FOOD CHEM, V57, P769, DOI 10.1021/jf803003z	8	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2011	127	3					680	682		10.1016/j.jaci.2010.10.022	http://dx.doi.org/10.1016/j.jaci.2010.10.022			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730FG	21146867				2022-12-18	WOS:000288018400020
J	Basharat, P; Sussman, G; Beezhold, D; Leader, N				Basharat, P.; Sussman, G.; Beezhold, D.; Leader, N.			Hypersensitivity Reactions to Marijuana	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Basharat, P.] Univ Western Ontario, London, ON, Canada; [Sussman, G.; Leader, N.] Univ Toronto, Toronto, ON, Canada; [Beezhold, D.] NIOSH, Morgantown, WV USA	Western University (University of Western Ontario); University of Toronto; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB178	AB178		10.1016/j.jaci.2010.12.707	http://dx.doi.org/10.1016/j.jaci.2010.12.707			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400689
J	Bin, L; Kim, BE; Hall, CF; Zaccaro, DJ; Leung, DY				Bin, L.; Kim, B. E.; Hall, C. F.; Zaccaro, D. J.; Leung, D. Y.			Specificity Protein 1 is Pivotal in the Skin's Anti-viral Response	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Bin, L.; Kim, B. E.; Hall, C. F.; Leung, D. Y.] Natl Jewish Hlth, Denver, CO USA; [Zaccaro, D. J.] Rho Inc, Chapel Hill, NC USA	National Jewish Health; Rho									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB148	AB148		10.1016/j.jaci.2010.12.587	http://dx.doi.org/10.1016/j.jaci.2010.12.587			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400569
J	Boyd, AW; Estell, K; Dransfield, M; Schwiebert, L				Boyd, A. W.; Estell, K.; Dransfield, M.; Schwiebert, L.			The Effect of Aerobic Exercise on Asthma-Related Responses in Adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Boyd, A. W.; Estell, K.; Dransfield, M.; Schwiebert, L.] Univ Alabama, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham									0	5	5	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB223	AB223		10.1016/j.jaci.2010.12.887	http://dx.doi.org/10.1016/j.jaci.2010.12.887			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846401002
J	Church, JA; Howard, V; Sleasman, JW; Borte, M; Berger, M				Church, J. A.; Howard, V.; Sleasman, J. W.; Borte, M.; Berger, M.			Subcutaneous Immunoglobulin Replacement Therapy in Infants and Children with Primary Immunodeficiencies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	National Annual Scientific Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Church, J. A.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Howard, V.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Sleasman, J. W.] Univ S Florida, St Petersburg, FL 33701 USA; [Sleasman, J. W.] Univ Leipzig, Municipal Hosp St Georg Leipzig, Acad Teaching Hosp, Leipzig, Germany; [Berger, M.] CSL Behring LLC, King Of Prussia, PA USA	Children's Hospital Los Angeles; St Jude Children's Research Hospital; State University System of Florida; University of South Florida; Leipzig University; CSL									0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB213	AB213		10.1016/j.jaci.2010.12.849	http://dx.doi.org/10.1016/j.jaci.2010.12.849			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400830
J	Gergen, PJ				Gergen, Peter J.			Surveillance of the cost of asthma in the 21st century	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							UNITED-STATES; COMORBIDITY; THERAPY; BURDEN		NIAID, Div Allergy Immunol & Transplantat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gergen, PJ (corresponding author), NIAID, Div Allergy Immunol & Transplantat, 6610 Rockledge Dr,Rm 3067, Bethesda, MD 20892 USA.	pgergen@niaid.nih.gov						Adair RF, 2005, AM J MED, V118, P881, DOI 10.1016/j.amjmed.2005.02.031; [Anonymous], 2007, J ALLERGY CLIN IMM S, V120, pS94; Cabana MD, 2001, ARCH PEDIAT ADOL MED, V155, P1057, DOI 10.1001/archpedi.155.9.1057; Colice GL, 2008, J ASTHMA, V45, P293, DOI 10.1080/02770900801911178; Gellad ZF, 2007, AM J MED, V120, P475, DOI 10.1016/j.amjmed.2006.09.030; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Haselkorn T, 2010, ANN ALLERG ASTHMA IM, V104, P471, DOI 10.1016/j.anai.2010.04.006; Marino LA, 2010, J ASTHMA, V47, P521, DOI 10.3109/02770900903576320; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Stanford RH, 2010, J ASTHMA, V47, P257, DOI 10.3109/02770900903584019; Sullivan PW, 2011, J ALLERGY CLIN IMMUN, V127, P363, DOI 10.1016/j.jaci.2010.10.042; Weiss KB, 2000, J ALLERGY CLIN IMMUN, V106, P493, DOI 10.1067/mai.2000.109426; WEISS KB, 1992, NEW ENGL J MED, V326, P862, DOI 10.1056/NEJM199203263261304; Ye X, 2009, CURR MED RES OPIN, V25, P2251, DOI 10.1185/03007990903155915; Zhang TT, 2009, J ASTHMA, V46, P1021, DOI 10.3109/02770900903350473	15	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					370	371		10.1016/j.jaci.2010.11.023	http://dx.doi.org/10.1016/j.jaci.2010.11.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21194741				2022-12-18	WOS:000286808000009
J	Shvarts, A; Ballow, M; Senn, K; Lehman, H				Shvarts, A.; Ballow, M.; Senn, K.; Lehman, H.			Impaired Pneumococcal Antibody Titers in Children with Down Syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Shvarts, A.; Ballow, M.; Senn, K.; Lehman, H.] SUNY Buffalo, Womens & Childrens Hosp Buffalo, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo			Lehman, Heather/AAZ-4560-2021						0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB11	AB11		10.1016/j.jaci.2010.12.057	http://dx.doi.org/10.1016/j.jaci.2010.12.057			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400041
J	Bonniaud, P; Georges, M; Blanc-Caille, M; Collet, E; Camus, P				Bonniaud, Philippe; Georges, Marjolaine; Blanc-Caille, Marion; Collet, Evelyne; Camus, Philippe			Salbutamol inhaler misuse resulting in skin burn	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Bonniaud, Philippe] Univ Burgundy, Dijon, France; Ctr Hosp Univ Bocage, Serv Pneumol & Reanimat Resp, Dijon, France; INSERM, UMR 866, Serv Dermatol, Dijon, France	Universite de Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Bonniaud, P (corresponding author), Univ Burgundy, Dijon, France.	philippe.bonniaud@chu-dijon.fr						Akhtar S, 2003, BURNS, V29, P191, DOI 10.1016/S0305-4179(02)00274-7; Arun B, 2009, BRIT J DERMATOL, V160, P197, DOI [10.1111/j.1365-2133.2008.08877.x, 10.1111/j.1365-2133.2008.08873.x]; Connolly M, 2007, PEDIATR DERMATOL, V24, P499, DOI 10.1111/j.1525-1470.2007.00502.x; Patel R, 2004, ARCH DIS CHILD, V89, P1129, DOI 10.1136/adc.2004.050781	4	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					295	295		10.1016/j.jaci.2010.09.042	http://dx.doi.org/10.1016/j.jaci.2010.09.042			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21211663				2022-12-18	WOS:000285917300060
J	Szefler, SJ				Szefler, Stanley J.			Defining asthma phenotypes: Focusing the picture	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; asthma control; asthma impairment; asthma risk; asthma severity; biomarkers; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists	GENE-ENVIRONMENT INTERACTIONS; SEVERITY; EXACERBATIONS; CHILDREN		[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Boulder, CO 80309 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Room J304,Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199				Apter AJ, 2010, J ALLERGY CLIN IMMUN, V125, P79, DOI 10.1016/j.jaci.2009.11.028; Bacharier LB, 2009, J ALLERGY CLIN IMMUN, V123, P1077, DOI 10.1016/j.jaci.2008.12.1120; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; Haselkorn T, 2009, J ALLERGY CLIN IMMUN, V124, P921, DOI 10.1016/j.jaci.2009.09.006; Haselkorn T, 2009, J ALLERGY CLIN IMMUN, V124, P895, DOI 10.1016/j.jaci.2009.07.035; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; *NIH NAT ASTHM ED, 2007, NIH PUBL; Su RC, 2009, J ALLERGY CLIN IMMUN, V124, P1116, DOI 10.1016/j.jaci.2009.08.033; Szefler SJ, 2010, J ALLERGY CLIN IMMUN, V125, P69, DOI 10.1016/j.jaci.2009.11.006; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Vercelli D, 2009, J ALLERGY CLIN IMMUN, V123, P26, DOI 10.1016/j.jaci.2008.11.031; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Zeiger RS, 2009, J ALLERGY CLIN IMMUN, V124, P1106, DOI 10.1016/j.jaci.2009.07.052	15	5	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2010	126	5					939	940		10.1016/j.jaci.2010.09.018	http://dx.doi.org/10.1016/j.jaci.2010.09.018			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	674HB	21050941	Bronze			2022-12-18	WOS:000283727100006
J	White, AA; Stevenson, DD				White, Andrew A.; Stevenson, Donald D.			Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Aspirin-exacerbated respiratory disease; aspirin desensitization; aspirin treatment; IL-4 synthesis	EXACERBATED RESPIRATORY-DISEASE; LONG-TERM TREATMENT; CELLS; SALICYLATE; RESPONSES; EXCRETION; ASTHMA		[Stevenson, Donald D.] Scripps Clin, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stevenson, DD (corresponding author), Scripps Clin, 10666 N Torrey Pines Rd,W-254, La Jolla, CA 92037 USA.	dstevemd@aol.com						Berges-Gimeno MP, 2003, J ALLERGY CLIN IMMUN, V111, P180, DOI 10.1067/mai.2003.7; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; Borish L, 2009, MIDDLETONS ALLERGY P, P165; CHRISTIE PE, 1992, AM REV RESPIR DIS, V145, P1281, DOI 10.1164/ajrccm/145.6.1281; Cianferoni A, 2001, BLOOD, V97, P1742, DOI 10.1182/blood.V97.6.1742; Daffern PJ, 1999, J ALLERGY CLIN IMMUN, V104, P559, DOI 10.1016/S0091-6749(99)70324-6; Furst R, 2006, J PHARMACOL EXP THER, V318, P389, DOI 10.1124/jpet.106.102251; Katial RK, 2010, J ALLERGY CLIN IMMUN, V126, P738, DOI 10.1016/j.jaci.2010.06.036; NIZANKOWSKA E, 1990, CLIN EXP ALLERGY, V20, P647, DOI 10.1111/j.1365-2222.1990.tb02703.x; Perez-G M, 2002, J IMMUNOL, V168, P1428, DOI 10.4049/jimmunol.168.3.1428; Rozsasi A, 2008, ALLERGY, V63, P1228, DOI 10.1111/j.1398-9995.2008.01658.x; SANAK M, 1998, ALLERGY, V53, pS112; Schafer D, 1999, EUR RESPIR J, V13, P638, DOI 10.1183/09031936.99.13363899; Sestini P, 1996, AM J RESP CRIT CARE, V153, P572, DOI 10.1164/ajrccm.153.2.8564100; Steinke JW, 2009, J ALLERGY CLIN IMMUN, V124, P724, DOI 10.1016/j.jaci.2009.07.031	16	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					745	746		10.1016/j.jaci.2010.08.037	http://dx.doi.org/10.1016/j.jaci.2010.08.037			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20920763				2022-12-18	WOS:000282510000009
J	Chaudhry, RQ; Weinstein, ME; Petrova, A				Chaudhry, R. Q.; Weinstein, M. E.; Petrova, A.			Efficacy of Inhaled Compared to Oral Corticosteroids for Acute Asthma Exacerbation in Children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Chaudhry, R. Q.; Petrova, A.] UMDNJ, New Brunswick, NJ USA; [Weinstein, M. E.] UMDNJ, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center									0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB69	AB69		10.1016/j.jaci.2009.12.270	http://dx.doi.org/10.1016/j.jaci.2009.12.270			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100271
J	Commins, SP; James, H; Tran, N; Kelly, E; Mullins, R; Lieberman, P; Platts-Mills, T				Commins, S. P.; James, H.; Tran, N.; Kelly, E.; Mullins, R.; Lieberman, P.; Platts-Mills, T.			Testing for IgE Antibody to the Carbohydrate galactose-alpha-1,3-galactose (alpha-gal) in Patients with Recurrent, Idiopathic Anaphylaxis: How Many Cases Are We Missing?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Commins, S. P.; James, H.; Kelly, E.; Platts-Mills, T.] Univ Virginia, Charlottesville, VA USA; [Tran, N.; Lieberman, P.] Univ Tennessee, Memphis, TN USA; [Mullins, R.] John James Med Ctr, Canberra, ACT, Australia	University of Virginia; University of Tennessee System; University of Tennessee Health Science Center			Mullins, Raymond James/H-8013-2019	Mullins, Raymond James/0000-0002-0267-1591					0	5	5	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB119	AB119		10.1016/j.jaci.2009.12.470	http://dx.doi.org/10.1016/j.jaci.2009.12.470			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100471
J	Gross, G; Meltzer, EO; Gates, D; Shekar, T; Teper, A				Gross, G.; Meltzer, E. O.; Gates, D.; Shekar, T.; Teper, A.			Impact of Concomitant Administration of Mometasone Furoate and Oxymetazoline Nasal Sprays vs Either Drug Alone or Placebo on Quality of Life in Patients with Seasonal Allergic Rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Gross, G.] Dallas Allergy & Asthma Ctr, Dallas, TX USA; [Meltzer, E. O.] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Gates, D.; Shekar, T.; Teper, A.] Schering Plough Res Inst, Kenilworth, NJ USA	Merck & Company; Schering-Plough Research Institute									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB174	AB174		10.1016/j.jaci.2009.12.681	http://dx.doi.org/10.1016/j.jaci.2009.12.681			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100681
J	Jarvinen-Seppo, KM; Sickles, L; Nowak-Wegrzyn, AH				Jarvinen-Seppo, K. M.; Sickles, L.; Nowak-Wegrzyn, A. H.			Clinical Characteristics of Children with Food Protein-Induced Enterocolitis (FPIES)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Jarvinen-Seppo, K. M.; Sickles, L.; Nowak-Wegrzyn, A. H.] Mt Sinai Med Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai									0	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB85	AB85		10.1016/j.jaci.2009.12.335	http://dx.doi.org/10.1016/j.jaci.2009.12.335			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100336
J	Lanier, BQ; Meltzer, EO; Gates, D; Shekar, T; Teper, A				Lanier, B. Q.; Meltzer, E. O.; Gates, D.; Shekar, T.; Teper, A.			Onset and Duration of Action of Concomitant administration of Mometasone Furoate Nasal Spray with Oxymetazoline Nasal Spray Versus Either Drug Alone and placebo in Subjects With Seasonal Allergic Rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Lanier, B. Q.] Univ N Texas, Hlth Sci Ctr, Div Immunol, Ft Worth, TX USA; [Meltzer, E. O.] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Gates, D.; Shekar, T.; Teper, A.] Schering Plough Res Inst, Kenilworth, NJ USA	University of North Texas System; University of North Texas Health Science Center; Merck & Company; Schering-Plough Research Institute									0	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB173	AB173		10.1016/j.jaci.2009.12.678	http://dx.doi.org/10.1016/j.jaci.2009.12.678			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100678
J	Nayak, AS; Prenner, B; Gates, D; Shekar, T; Teper, A				Nayak, A. S.; Prenner, B.; Gates, D.; Shekar, T.; Teper, A.			Tolerability of Concomitant Administration of Mometasone Furoate and Oxymetazoline Nasal Sprays Administered Once Daily vs Oxymetazoline Twice Daily, Mometasone Furoate Once Daily, and Placebo in the Treatment of Subjects With Seasonal Allergic Rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Nayak, A. S.] Sneeze Wheeze & Itch Associates LLC, Normal, IL USA; [Prenner, B.] Allergy Associates Med Grp, San Diego, CA USA; [Gates, D.; Shekar, T.; Teper, A.] Schering Plough Res Inst, Kenilworth, NJ USA	Merck & Company; Schering-Plough Research Institute									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB175	AB175		10.1016/j.jaci.2009.12.685	http://dx.doi.org/10.1016/j.jaci.2009.12.685			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100684
J	Parascandola, J				Parascandola, John			Abel, Takamine, and the isolation of epinephrine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									[Parascandola, John] Univ Maryland, Dept Hist, College Pk, MD 20742 USA; [Parascandola, John] Univ Maryland, Sch Publ Hlth, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Parascandola, J (corresponding author), Univ Maryland, Dept Hist, College Pk, MD 20742 USA.								0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2					514	517		10.1016/j.jaci.2009.11.044	http://dx.doi.org/10.1016/j.jaci.2009.11.044			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	558RU	20196206				2022-12-18	WOS:000274764000044
J	Romero, FA; Allan, RJ; Phillips, PG; Hutchinson, K; Misfeldt, JM; Casale, TB				Romero, F. A., Jr.; Allan, R. J.; Phillips, P. G.; Hutchinson, K.; Misfeldt, J. M.; Casale, T. B.			The Effects Of An H-3 Receptor Antagonist In A Nasal Allergen Challenge Model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Romero, F. A., Jr.; Misfeldt, J. M.; Casale, T. B.] Creighton Univ, Omaha, NE 68178 USA; [Allan, R. J.; Phillips, P. G.; Hutchinson, K.] Pfizer Inc, Sandwich, Kent, England	Creighton University; Pfizer			Beldar, Sagar V/C-8542-2011; Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377					0	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB191	AB191		10.1016/j.jaci.2009.12.750	http://dx.doi.org/10.1016/j.jaci.2009.12.750			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100749
J	Rondon, C; Lopez, S; Lisbona, J; Melendez, L; Torres, J; Blanca, M				Rondon, C.; Lopez, S.; Lisbona, J.; Melendez, L.; Torres M, J.; Blanca, M.			Immunotherapy with Grass Pollen in Patients with "Local Allergic Rhinitis''	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Rondon, C.; Torres M, J.; Blanca, M.] Carlos Haya Hosp, Allergy Serv, Malaga, Spain; [Lopez, S.; Lisbona, J.; Melendez, L.] Carlos Haya Hosp Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Carlos Haya; Hospital Carlos Haya									0	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB37	AB37		10.1016/j.jaci.2009.12.178	http://dx.doi.org/10.1016/j.jaci.2009.12.178			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS					2022-12-18	WOS:000280204100147
J	Sandhu, MS; Dimov, V; Romero, T; Wichman, T; Casale, TB				Sandhu, M. S.; Dimov, V.; Romero, T.; Wichman, T.; Casale, T. B.			Effect of Rosiglitazone on Airway Hyperresponsiveness and Obstruction in Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Sandhu, M. S.; Dimov, V.; Romero, T.; Wichman, T.; Casale, T. B.] Creighton Univ, Omaha, NE 68178 USA	Creighton University			Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377					0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB66	AB66		10.1016/j.jaci.2009.12.258	http://dx.doi.org/10.1016/j.jaci.2009.12.258			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100259
J	Thanik, ES; Cox, AL; Sampson, HA				Thanik, E. S.; Cox, A. L.; Sampson, H. A.			Administration of a Low Egg-Containing Influenza Vaccine [Fluarix (R)] in an Egg-Allergic Pediatric Population	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	FEB 26-MAR 02, 2010	New Orleans, LA	Amer Acad Allergy, Asthma & Immunol					[Thanik, E. S.; Cox, A. L.; Sampson, H. A.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2010	125	2		1			AB25	AB25		10.1016/j.jaci.2009.12.130	http://dx.doi.org/10.1016/j.jaci.2009.12.130			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	629MS		Bronze			2022-12-18	WOS:000280204100099
J	Shah, SS; Bacino, CA; Sheehan, AM; Shearer, WT				Shah, Sweta S.; Bacino, Carlos A.; Sheehan, Andrea M.; Shearer, William T.			Diagnosis of primary immunodeficiency: Let your eyes do the talking	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Primary immune deficiency; physical diagnosis; Shwachman-Bodian-Diamond syndrome; pectus carinatum; B cells	SHWACHMAN-DIAMOND-SYNDROME; DEFICIENCY		[Shah, Sweta S.; Shearer, William T.] Texas Childrens Hosp, Dept Allergy & Immunol, Houston, TX 77030 USA; [Sheehan, Andrea M.] Texas Childrens Hosp, Dept Pediat Pathol, Houston, TX 77030 USA; [Shah, Sweta S.; Shearer, William T.] Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, Houston, TX 77030 USA; [Bacino, Carlos A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sheehan, Andrea M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shah, SS (corresponding author), Texas Childrens Hosp, Dept Allergy & Immunol, 1102 Bates St,Suite 330, Houston, TX 77030 USA.	wtsheare@texaschildrenshospital.org		Shearer, William/0000-0002-2483-2130	NIAID NIH HHS [U54 AI082978] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Burroughs L, 2009, HEMATOL ONCOL CLIN N, V23, P233, DOI 10.1016/j.hoc.2009.01.007; Dror Y, 2005, PEDIATR BLOOD CANCER, V45, P892, DOI 10.1002/pbc.20478; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; KORNFELD SJ, 1995, J ALLERGY CLIN IMMUN, V96, P247, DOI 10.1016/S0091-6749(95)70014-5; Stutes SA, 2009, J ALLERGY CLIN IMMUN, V123, pS14, DOI 10.1016/j.jaci.2008.12.066	6	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2009	124	6					1363	1364		10.1016/j.jaci.2009.10.049	http://dx.doi.org/10.1016/j.jaci.2009.10.049			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	536VH	20004789	Bronze			2022-12-18	WOS:000273071500036
J	Marcon, A; Accordini, S; de Marco, R				Marcon, Alessandro; Accordini, Simone; de Marco, Roberto			Adjustment for baseline value in the analysis of change in FEV1 over time	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Marcon, Alessandro; Accordini, Simone; de Marco, Roberto] Univ Verona, Unit Epidemiol & Med Stat, Dept Med & Publ Hlth, I-37100 Verona, Italy	University of Verona	Marcon, A (corresponding author), Univ Verona, Unit Epidemiol & Med Stat, Dept Med & Publ Hlth, I-37100 Verona, Italy.	alessandro.marcon@univr.it	Marcon, Alessandro/C-3349-2012; de Marco, Roberto/A-5470-2008	Marcon, Alessandro/0000-0002-2778-658X; 				Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Greenland S.L.T, 2008, MODERM EPIDEMIOLOGY, P132; Marcon A, 2009, J ALLERGY CLIN IMMUN, V123, P1069, DOI 10.1016/j.jaci.2009.01.040; PETO R, 1981, LANCET, V2, P467; Tantisira KG, 2009, J ALLERGY CLIN IMMUN, V123, P1075, DOI 10.1016/j.jaci.2009.03.037; VOLLMER WM, 1988, J CLIN EPIDEMIOL, V41, P651, DOI 10.1016/0895-4356(88)90117-5	7	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1120	1120		10.1016/j.jaci.2009.07.038	http://dx.doi.org/10.1016/j.jaci.2009.07.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19748662				2022-12-18	WOS:000272108000043
J	Piippo-Savolainen, E; Ruotsalainen, M; Korppi, M				Piippo-Savolainen, Eija; Ruotsalainen, Marja; Korppi, Matti			Long-term outcome after bronchiolitis: No association with the invasiveness of the infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BRONCHIAL-ASTHMA; CHILDHOOD; PNEUMONIA; INFANCY; AGE		[Piippo-Savolainen, Eija; Ruotsalainen, Marja; Korppi, Matti] Univ Kuopio, Dept Pediat, Kuopio, Finland; Tampere Univ, Pediat Res Ctr, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland	University of Eastern Finland; Tampere University; Tampere University; Tampere University Hospital	Piippo-Savolainen, E (corresponding author), Univ Kuopio, Dept Pediat, Kuopio, Finland.	matti.korppi@uta.fi			NHLBI NIH HHS [F32 HL086048, U01 HL072471-01, U01 HL072471, L40 HL086298] Funding Source: Medline; NIAID NIH HHS [K01 AI070808, K01 AI070808-02, K24 AI077930, K24 AI077930-02, K24 AI077930-01, K01 AI070808-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072471, F32HL086048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930, K01AI070808] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P1055, DOI 10.1016/j.jaci.2009.02.021; Castro-Rodriguez JA, 1999, AM J RESP CRIT CARE, V159, P1891, DOI 10.1164/ajrccm.159.6.9811035; Hyvarinen M, 2005, ACTA PAEDIATR, V94, P1378, DOI 10.1080/08035250510036831; Hyvarinen MK, 2006, PEDIATR PULM, V41, P420, DOI 10.1002/ppul.20360; KORPPI M, 1986, ACTA PAEDIATR SCAND, V75, P457, DOI 10.1111/j.1651-2227.1986.tb10230.x; KORPPI M, 1994, ARCH PEDIAT ADOL MED, V148, P1079, DOI 10.1001/archpedi.1994.02170100077015; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; KUIKKA L, 1994, ACTA PAEDIATR, V83, P744, DOI 10.1111/j.1651-2227.1994.tb13131.x; Piippo-Savolainen E, 2004, ARCH PEDIAT ADOL MED, V158, P1070, DOI 10.1001/archpedi.158.11.1070; RUOTSALAINEN M, ALLERGY IN PRESS, P2991	10	5	5	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1121	1121		10.1016/j.jaci.2009.07.059	http://dx.doi.org/10.1016/j.jaci.2009.07.059			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19896000	Green Accepted			2022-12-18	WOS:000272108000044
J	Keet, CA; Wood, RA				Keet, Corinne A.; Wood, Robert A.			Risk factors for peanut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Keet, Corinne A.; Wood, Robert A.] Johns Hopkins Sch Med, Dept Pediat, Div Pediat Allergy & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Keet, CA (corresponding author), Johns Hopkins Sch Med, Dept Pediat, Div Pediat Allergy & Immunol, Baltimore, MD 21218 USA.	rwood@jhmi.edu		Keet, Corinne/0000-0002-6585-239X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007007] Funding Source: NIH RePORTER; NIAID NIH HHS [ST32AI07007] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755	3	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2					387	387		10.1016/j.jaci.2009.03.048	http://dx.doi.org/10.1016/j.jaci.2009.03.048			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CD	19477498				2022-12-18	WOS:000268860400037
J	Krishnan, JA; Nowak, R; Davis, SQ; Schatz, M				Krishnan, Jerry A.; Nowak, Richard; Davis, Steven Q.; Schatz, Michael			Anti-inflammatory treatment after discharge home from the emergency department in adults with acute asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma exacerbation; acute asthma; emergency department; discharge medications; corticosteroids; leukotriene modifiers	CORTICOSTEROID-THERAPY; FOLLOW-UP; EXACERBATIONS; VISIT; ADHERENCE; RISK		[Krishnan, Jerry A.] Univ Chicago, Pulm & Crit Care Med Sect, Asthma & COPD Ctr, Dept Med, Chicago, IL 60637 USA; [Nowak, Richard] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI USA; [Davis, Steven Q.] Texas Pulm & Crit Care Consultants PA, Ft Worth, TX USA; [Schatz, Michael] Kaiser Permanente Med Ctr, Dept Allergy, San Diego, CA USA	University of Chicago; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente	Krishnan, JA (corresponding author), Univ Chicago, Pulm & Crit Care Med Sect, Asthma & COPD Ctr, Dept Med, 5841 S Maryland Ave,MC 6076,Room M644, Chicago, IL 60637 USA.	jkrishna@medicine.bsd.uchicago.edu						Adams N., 2001, COCHRANE DB SYST REV, V4, pCd003274, DOI [DOI 10.1002/14651858.CD003274, 10.1002/14651858.Cd003274]; Brenner BE, 2000, ANN EMERG MED, V36, P417, DOI 10.1067/mem.2000.110842; Butler K, 2004, PEDIATR EMERG CARE, V20, P730; CAMARGO C, 2000, AM AC ALL SAN DIEG C; Camargo CA, 2007, AM J HEALTH-SYST PH, V64, P1054, DOI 10.2146/ajhp060256; Chan J S, 2001, Can Respir J, V8, P147; Cooper WO, 2001, ARCH PEDIAT ADOL MED, V155, P1111, DOI 10.1001/archpedi.155.10.1111; Cydulka RK, 2005, ANN EMERG MED, V46, P316, DOI 10.1016/j.annemergmed.2004.12.024; Edmonds M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002316; Edmonds ML, 2002, CHEST, V121, P1798, DOI 10.1378/chest.121.6.1798; FitzGerald J M, 2000, Can Respir J, V7, P61; Healy Daniel P, 2007, Curr Infect Dis Rep, V9, P7, DOI 10.1007/s11908-007-0016-1; HOFFMAN IB, 1988, CHEST, V93, P11, DOI 10.1378/chest.93.1.11; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Krishnan JA, 2004, AM J RESP CRIT CARE, V170, P1281, DOI 10.1164/rccm.200403-409OC; Lahn M, 2004, CHEST, V126, P362, DOI 10.1378/chest.126.2.362; Lee C H, 1993, Changgeng Yi Xue Za Zhi, V16, P25; Nana A, 1998, J ASTHMA, V35, P647, DOI 10.3109/02770909809048967; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA; Numata Y, 2002, CHEST, V122, P498, DOI 10.1378/chest.122.2.498; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Rowe BH, 1999, JAMA-J AM MED ASSOC, V281, P2119, DOI 10.1001/jama.281.22.2119; Rowe BH, 2004, RESP MED, V98, P275, DOI 10.1016/j.rmed.2003.11.016; Rowe BH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000195; Salerno Edward L, 2005, Conn Med, V69, P621; Scarfone RJ, 2006, PEDIATRICS, V117, P821, DOI 10.1542/peds.2005-0962; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, pS1, DOI 10.1016/j.jaci.2009.05.001; Schuckman H, 1998, ANN EMERG MED, V31, P333, DOI 10.1016/S0196-0644(98)70343-9; Shrestha M, 1996, AM J EMERG MED, V14, P380, DOI 10.1016/S0735-6757(96)90054-6; Silverman RA, 2004, CHEST, V126, P1480, DOI 10.1378/chest.126.5.1480; Sin DD, 2002, ARCH INTERN MED, V162, P1591, DOI 10.1001/archinte.162.14.1591; Smith MJ, 2004, ANN ALLERG ASTHMA IM, V92, P40, DOI 10.1016/S1081-1206(10)61708-5; TAYLOR GW, 1989, LANCET, V1, P584; U.S. Food and Drug Administration, TEL MARK KET INF; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	36	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2		S			S29	S34		10.1016/j.jaci.2009.05.007	http://dx.doi.org/10.1016/j.jaci.2009.05.007			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CE	19647133				2022-12-18	WOS:000268860500005
J	Szefler, SJ				Szefler, Stanley J.			Managing asthma and allergies in schools: An opportunity to coordinate health care	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Allergy; anaphylaxis; asthma; asthma exacerbations; food allergy; school		Children spend a great deal of time in school and can be exposed to situations that increase their risk for an asthma exacerbation or a reaction to food. As such, the clinician can play a significant role in educating children, their families, and school personnel about principles that can be applied not only to manage reactions when they occur but also to prevent them. This theme issue will provide information on indoor allergens commonly present in school and day care settings, as well as information on how to manage children with asthma and food allergies in these settings. (J Allergy Clin Immunol 2009;124:201-4.)	[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Room J304 Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njc.org			NCRR NIH HHS [1 UL1 RR025780] Funding Source: Medline; NHLBI NIH HHS [HL 51834, HL64288, HR-16048, HL081335, HL075416] Funding Source: Medline; NIAID NIH HHS [AI-25496] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR016048] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081335, U10HL051834, U01HL075416, U10HL064288] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bruzzese JM, 2009, J ALLERGY CLIN IMMUN, V124, P195, DOI 10.1016/j.jaci.2009.05.040; Cicutto L, 2009, J ALLERGY CLIN IMMUN, V124, P390, DOI 10.1016/j.jaci.2009.04.042; Greenhawt MJ, 2009, J ALLERGY CLIN IMMUN, V124, P323, DOI 10.1016/j.jaci.2009.05.028; Kruzick T, 2009, J ALLERGY CLIN IMMUN, V124, P381, DOI 10.1016/j.jaci.2009.05.048; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; *NIH, NIH PUBL; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Young MC, 2009, J ALLERGY CLIN IMMUN, V124, P175, DOI 10.1016/j.jaci.2009.04.004	10	5	5	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2009	124	2					201	204		10.1016/j.jaci.2009.05.045	http://dx.doi.org/10.1016/j.jaci.2009.05.045			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	482CD	19596144				2022-12-18	WOS:000268860400004
J	Bratke, K; Kuepper, M; Julius, P; Lommatzsch, M; Virchow, JC				Bratke, Kai; Kuepper, Michael; Julius, Peter; Lommatzsch, Marek; Virchow, J. Christian			Thrombomodulin: A novel player in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Bratke, Kai; Kuepper, Michael; Julius, Peter; Lommatzsch, Marek; Virchow, J. Christian] Univ Med Clin Rostock, Dept Pneumol, Rostock, Germany	University of Rostock	Bratke, K (corresponding author), Univ Med Clin Rostock, Dept Pneumol, Rostock, Germany.	kabratke@med.uni-rostock.de						Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Nassenstein C, 2003, J EXP MED, V198, P455, DOI 10.1084/jem.20010897; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009	4	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2009	123	5					1192	1192		10.1016/j.jaci.2008.12.1132	http://dx.doi.org/10.1016/j.jaci.2008.12.1132			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	449CW	19251314	Bronze			2022-12-18	WOS:000266309400037
J	Corren, J; Busse, W; Meltzer, E; Mansfield, L; Bensch, G; Chon, Y; Dunn, M; Weng, H; Lin, S				Corren, J.; Busse, W.; Meltzer, E.; Mansfield, L.; Bensch, G.; Chon, Y.; Dunn, M.; Weng, H.; Lin, S.			Efficacy and Safety of AMG 317, an IL-4Ra Antagonist, in Atopic Asthmatic Subjects: A Randomized, Double-blind, Placebo-controlled Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Corren, J.] Allergy Res Fdn, Los Angeles, CA USA; [Busse, W.] Univ Wisconsin, Madison, WI USA; [Meltzer, E.] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; [Mansfield, L.] Western Sky Med Res, El Paso, TX USA; [Bensch, G.] Bensch Res Associates, Stockton, CA USA; [Chon, Y.; Dunn, M.; Weng, H.; Lin, S.] Amgen Inc, Thousand Oaks, CA 91320 USA	University of Wisconsin System; University of Wisconsin Madison; Amgen									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2009	123	3				LB33	732	732		10.1016/j.jaci.2009.01.037	http://dx.doi.org/10.1016/j.jaci.2009.01.037			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	426TQ					2022-12-18	WOS:000264731200077
J	Grossman, J; Gopalan, G				Grossman, J.; Gopalan, G.			Efficacy and Safety of Mometasone Furoate Nasal Spray in Elderly Subjects With Perennial Allergic Rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 13-17, 2009	Washington, DC	Amer Acad Allergy, Asthma & Immunol					[Grossman, J.] Allergy Partners Arizona, Tucson, AZ USA; [Gopalan, G.] Schering Plough Corp, Kenilworth, NJ 07033 USA	Merck & Company; Schering Plough Corporation									0	5	5	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2009	123	2				1048	S271	S271		10.1016/j.jaci.2008.12.1047	http://dx.doi.org/10.1016/j.jaci.2008.12.1047			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	410RR					2022-12-18	WOS:000263596301520
